<SEC-DOCUMENT>0000859737-23-000004.txt : 20230201
<SEC-HEADER>0000859737-23-000004.hdr.sgml : 20230201
<ACCEPTANCE-DATETIME>20230201160457
ACCESSION NUMBER:		0000859737-23-000004
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		94
CONFORMED PERIOD OF REPORT:	20221231
FILED AS OF DATE:		20230201
DATE AS OF CHANGE:		20230201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HOLOGIC INC
		CENTRAL INDEX KEY:			0000859737
		STANDARD INDUSTRIAL CLASSIFICATION:	X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844]
		IRS NUMBER:				042902449
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0928

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36214
		FILM NUMBER:		23576739

	BUSINESS ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
		BUSINESS PHONE:		5082632900

	MAIL ADDRESS:	
		STREET 1:		250 CAMPUS DRIVE
		CITY:			MARLBOROUGH
		STATE:			MA
		ZIP:			01752
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>holx-20221231.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:3332a847-8252-4aec-a26a-afc1f11215d8,g:d9a9812f-c6f0-4dfd-b7fb-8eca4022aaf1,d:18b9fa7ea67d4489b092f7a58ad292ff--><html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:holx="http://www.hologic.com/20221231" xmlns:srt="http://fasb.org/srt/2022" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>holx-20221231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N18yLTEtMS0xLTk3NDc3_de7f4606-5fce-430a-96b8-587b04ab276a">false</ix:nonNumeric><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N18zLTEtMS0xLTk3NDc3_8bf57d8a-a4f7-4448-9ff0-94c61a9fb8a0">2023</ix:nonNumeric><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N180LTEtMS0xLTk3NDc3_efed5702-3ea3-4ec8-8531-cdf2612c72cc">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N181LTEtMS0xLTk3NDc3_7bb23384-d032-4c35-909a-a1bc7b7184e5">0000859737</ix:nonNumeric><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N182LTEtMS0xLTk3NDc3_9f20efd2-9a22-4ec4-ad0f-332d25d78bd4">9-28</ix:nonNumeric><ix:nonNumeric contextRef="iab3be1fea9b347e08c0fbc486d6eba52_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfMi0yLTEtMS05NzQ3Nw_32d79705-e90e-4a4d-85dd-220df1cc069d">P3M</ix:nonNumeric><ix:nonNumeric contextRef="i0170159e5fc647ee9b73c9274f3ad654_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfMy0yLTEtMS05NzQ3Nw_3c33eeb2-3cb1-421f-bb7f-2107aa035e1d">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="ib03f3840b4e04200a761acaf93092033_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfNC0yLTEtMS05NzQ3Nw_eac3498a-5a81-4ff2-9104-9ba123ebf095">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="i343ac5e6f3c84d52b2f78181c3170b97_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfNS0yLTEtMS05NzQ3Nw_c77c42db-3101-4914-bafb-4b48a6ae7fb5">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="if2ae0d1ec03043af95521f9690cafd90_I20221231" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfNi0yLTEtMS05NzQ3Nw_49ba91b7-7c03-4279-b9e1-f8bce3068ae3">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="holx-20221231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5eb0f65df2cc487ab6b5d60164c1f0fc_I20230126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-01-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i748118924a534325be3931e7f281d5da_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b667a34853345ce9fc30f034e33f5b3_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i750b33b8abf7477581f5efbc46a8f09f_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i104836b541db4552a3484725690e4c11_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie4a69d1c0d994885bd6c5a0c8cc6aeb7_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc24a74bca6f45a98e1346313bc6bb4a_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17d494d3ea2f420d85bcf5996162d2ba_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic667279782cb401298855c46a15ab094_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie62b1597841e4a4b91bc223e8929cd2e_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4a684294b69f49c5bb601cb231f23927_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib069c3c83a7d410ca7d70d300726945b_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id614601c4c7b4096a9c5dcbd9f8fe6d6_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7b569b420904a598de952ba3efe933c_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d4f66d97be24ea29c9e72a2c1b943b1_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfec87e83d4e4bf8ae4a9f94883339de_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibb8c751501224cfb8f672b3b5d147581_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-12-26</xbrli:startDate><xbrli:endDate>2022-03-26</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee40c972e79245a48193d5c44a5d488c_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i44bb24d344a2479f88cb3056e9eb7f9d_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icb7a25b0e96544b6bbd05dc3066b58b1_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7df030fd1d484893b2c6f6ca3cbc20b5_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96aafcc8951b43bb843963cb4ef1b0c9_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27baa3824d6f48cba5a8bdecb8c0cc9f_I20220326"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-26</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icdc5975fe0bb4a9f91e698a96eabdbdc_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idffe4e4b122a47f5b0294845f328191d_D20220327-20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-27</xbrli:startDate><xbrli:endDate>2022-06-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46ea4a08bd3042a7ab12381bf4bff328_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c7577051ac8445595d275ea3b4ba6d7_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibb6f35c1e6d84dd5b5f8a049aac44ec4_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia42682bb507a4e48a823cf2bdaafddc5_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5a60e52602c048069d80e58e5129177f_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i68d91b48be7045588cbe38f1d5620c60_I20220625"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-06-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i98e19907377e46229597921f8801edcc_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9301d9a3c6c442bab8060ca751e7563b_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idca511b5b1874691b87e467241ae5b70_D20220626-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-06-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54a740632874ce19cb42642fb2e221a_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie23d7b47d391462891d1fd3901620b20_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i013fa78766bb45bc816b63fed5c22874_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie45f7058af534e8dba563c02009f5cac_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i17c32b5fcbaf409cb7118fbe9bb55a0e_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i671c4997470d4f578166e16141225885_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iffce715dc2d14558a02450be71f516b4_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c096023d23c420bbe6591cb72e10eb9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c1f63693e304533b7ac2c9be6e0e0bf_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie3fc5436b7e04085aaf9f0cc0a424693_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14951cf020f246d1996832691a0edc4c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i576d2b7fc4c843429397ce9929243a48_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3714d8a36f9a4f34b0cbd75cd016e460_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0064a9d141464479bd6959095d0a5614_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if05c15bd87b943b8a89e3a90c5706964_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i67c7d17962b5422eb16f38be2f358d0b_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7494f976d4084d799b3eb03ac448aba0_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i03bc4a9519ab4934844ac430543e9341_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icba05cf621b045f1b0ded77db74e0969_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabf98c37c1ac4489bfce80d1f1a39c3c_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idee014b8532443d785b4a01fa597c5c7_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib42c16151a9a4724a372b6e2e07aec81_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i22f2dbcd7d0a4089b97103d3d3afe54f_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7f36606e666b4146adad29c31c074863_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a65e517835843be8d27d7cb21ff1b36_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51a2e59e54574cd080bad373ef124b26_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7388165a9fbe4c68874d5c98159e6efd_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i08c907a0b9364379897608caed02a091_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id1416b6917304ee989571d01c9094fd5_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe4ef9ffa5b8469f929dfa4f3760db7d_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie73d75b7f9d449cd9fbf4cc4956c951a_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i51bc8c3e08e64a4d966f2689b7b9fca3_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4e1959574bed4110a1c49d33f2343bce_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if28f4b47974c4a738dd6e022d463262a_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04bff6a5d47648fea88ce5c7a9bd0e30_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib015bd8926a441f69d50128b8d601218_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i17810aabf3f24d38be45e8306c3d0ebd_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie4035e7e2acf45e69da33b7c6c319979_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4254426126b9489587816dbe55a313ef_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia7b6e942d3ce4287ae8dd825a5bbc626_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8db75acc45cb41b3936f464bdb0755de_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id80a68949b1d49319e7efed985768c09_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52bce32474874a61a1c93ed216e5bf26_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae21e80b749742799ade28f359a906e9_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1eee1f1f7fda47a79e60a0733d804ab4_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ife508b03a0c24293b8380f77af515a15_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieb2242435a5340c69a48e6d30b767133_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if2f090269cb448819fb3699673bc74d2_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia05653e355504b53be8959ec4476671a_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0eed27597194772ac078e57b5d5f7a4_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf8975b9a0604bacb2f2ab4ca1780919_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib09726cd3d914adbaa7747d82b3d9f72_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ice7600161d394a1f844a8709af83b0be_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84a573e910f34c268f9a51a69f8fa78b_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie1f3865bf0674bd6b94548118ff2d889_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i76b0a758c01b41e190b861904f705b3e_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i972d2eac12d5498a8229fc8889a43517_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8a130a7154a42b4a3e2498da03f0bd9_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8a538d4146054e4d87047cc9f7975933_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic3fd7aa5f38f43d0a2cb58912a4606e3_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1a36d0d1182460d99b0fa319a28cb37_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i121cb63f710c4e60938523f4c50dfe98_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i023b583e3a5743b689087ebe2014e742_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7927fb2683384ee6ba18bcb24820aa75_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9158b0a900c0492c87e53bb0bfe60c76_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7e03307d675a4c4794cdacb42a15022b_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2dd7194daee4e2687e5b9ae50540cdf_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i84475ed4b97b45d2a58bd44b2464b6fd_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5288beb020944838ab3e1ad08f68dad4_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3dbe4b4d36594aadabeeb6b5788626b0_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d55ea19e5c248d3aefe288d6d5f6d43_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b62910ac86e4f18a8f2319faba92b2a_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iae7f2df5e66048c5a4d97e51f384eea7_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i461d5f7bb915496b935d3720acf6161c_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01d38c9b3ccb4db89e86e540ca7bfbba_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a3686a6966f49ad893900200aa534f4_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab3be1fea9b347e08c0fbc486d6eba52_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i0170159e5fc647ee9b73c9274f3ad654_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib03f3840b4e04200a761acaf93092033_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i343ac5e6f3c84d52b2f78181c3170b97_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if2ae0d1ec03043af95521f9690cafd90_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie91293e66d194ed7b35c5cfe9f42b0a4_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1d3fb98231024d8aaeb5bb8323a77efe_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b9400e507d84e678a5c359b9f85f0a5_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f9f58b445784504a1bf2cb52ed1b1dd_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifcc81839fd2d4dabbd199e560f9aff75_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11cfef20f9384ec3a5c511ca3d5c9667_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id87e29cdda514b4fba2087505293883f_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b7d6e54b06f4b8ca98b5e0a69ed1552_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6da937d0b81c484fafd31d8ccb9153a3_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4cc1dbc4bf77455684932730e1b2c790_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idddbd7f5e3d144eb82b55c015f5f4a19_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc27b2eb58e94a3ea4a4352a38a0b0d6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35ebbdfc813948f5b2ac23261acc5170_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9338d4109670455dbe967e46d7506077_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2050fb386a4c429cbc768ceb88089203_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ief97bdd54b7c44619fbcf4a88df99626_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idab2972813444a1590e68c0af622c531_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89cf56ee2c6d48f79ce43d6e357253e1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9895e82979cd46e5b9e29032558cf8f0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7fa3655b5c4b41899337fbf34ce3a418_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib24e943c04e946d3b20fd2005eebdcf2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefd5e2be463d4709a964b3675267c84b_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie8285876f9504f55b719cb94a43fd897_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8106951e543c45718bc14b8faa6ff745_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i73a6b6dfd2a144cdb914d656abdc6688_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8c253e80fb5495fa148fef676c31327_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1c866db25ccd49bf9837ddb6f3695f2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea43d0cf9441456ca855066f24c915b7_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-29</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1481f69a4d9244499f5a549cc0eebe59_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iba6cbbe07ee948f583f8d1f77e05e475_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iab72fa2f468444a685a69c28852ec73b_D20211129-20211129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-11-29</xbrli:startDate><xbrli:endDate>2021-11-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4698c57aad0746b78ce06e44b93c84fc_I20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-08-23</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iae84daa015564a61a94ab772911423dd_D20200823-20200823"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-08-23</xbrli:startDate><xbrli:endDate>2020-08-23</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i343e49832f164c1a89e8c46e7295b5be_D20210926-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iaea12adf8afb44a3a25469e63012eb04_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia8ff31aae0694a0aa8817256292f1722_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iacaca98377e84dea8c3dcc6d430e498c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3506cb7a03e440d886dbc72ce84c14b7_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i30bcf60271074f93a183af070bda3ce1_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ideae2329e17d435e83ee4db40e5b76df_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i333952b4e5b04176801bb8b51ea10d2b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab94eadaf80646c99688a0bc7890d803_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2d07a69cb1c487c91cc762762bc1d0e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iadc35cfa947f44998ff3996d2aa84afd_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i34650814b5cc4021acd04ac86d799f20_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i79d0d70331034758a653310fab36e412_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i345a638c3ba941e1855a959c897f7176_I20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i16715a72d92e441993d6789cac1dbd2f_I20210927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021RevolverMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10401dc3383842b09980d3a937fb7508_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6f5ef2ef76fd4192b1f4f10266a76b4e_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfaac04d4a484d258c3db28ddc02ff2e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ica33b08d41d34461b027e01d397de44f_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e9943e6f8ff4c8aaec563317ae88d47_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0ca833a47aa541e992640c358c110349_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id225da1e135b44f7a25d7b8427d9693e_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9b7e75f146848e4bc229589975b5948_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i34f00671c17749c98d26591f7dc95d11_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c0114bb00874bbcae4df17922168466_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60ac9cd428ef42a7a8b91fa784f5f45e_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6764b5e8e67e48f791728d79a2e34122_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i167654f352a04de29b14663bc8cdcfc0_D20220401-20220430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AssetSecuritizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-04-01</xbrli:startDate><xbrli:endDate>2022-04-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie72a76382d1b4c529a23dfa89ceadc2c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib8c4e34d9d094f1fbf48292741f16b5d_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ied698bc89eaf4b6f80e13382683a1a03_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iec75d669bbf346d6903c94657e8133f1_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadefe818aff343f093532897c969439a_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i55939d7a42bd4556a498a480de79cd50_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifee71b2ee2b34924938fe48b466219ce_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i44fe85004cc04b32b3a10a1559c2e2ef_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibac4befa17b047999f00b91ca7b94ef7_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if13d8d495368452eb77bee9ff19dc345_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9926b76c62324c0b958fed2b0e24ea5a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib2198af10da940cf86ae64d703bc53c5_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56899b92d8d848078cfec5556948bfc9_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id4c139a224444cffae631f02c7acba9f_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib71a2388896942158d0fc786a95eba81_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5fe6a4b393534f29abeeb1a68c843b13_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9e837bb262414d9dbc7e423824de0ec6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i270cd6664faf43379c84adce180639da_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d535ec00f0f411dafec44429b007238_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3ff63602d630435f9e63019c5e7f9b83_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0e402eb79be640de87443d033aa21455_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0dcc9f20204945ec878054956bb77035_I20180727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaaa4b233a9344908933211ba063dc5f_D20160304-20160304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-03-04</xbrli:startDate><xbrli:endDate>2016-03-04</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="petition"><xbrli:measure>holx:petition</xbrli:measure></xbrli:unit><xbrli:context id="i667766d52416443f8777bd5eeca5cef5_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i435ccc0a3ea14ff99da3eb507f45b519_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8933fd8cce38473bb6574d4ef3ed3dda_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i046a8b5e3d6b499bacae51fc5c4a8ab5_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10182a4e9dbd401592fba602d8fc0dfc_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia43275c19d1d4deb9bd1023171cfc883_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i47792d9e50e24ce180eb23c262315201_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibfd8fe55e66344279f13b5494e40abef_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i26800c2f43ab47478ff80253b55d85cc_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if448d6a552274a47bac66865fb2016c6_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5214cfde47fd4e71851f007985469117_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i04a4cd810a09430fa9d6e1eb34765cf6_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idb6f997f16b34e71947022ff6714b032_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85e3227c7fe14f10bc6686036ba0ac71_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i503690e214944a309e402e9960e2e6e6_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idab51929268f46bc932b7830d8baf571_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iddf3093b029a43d79dbb42728abb753e_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9771af51c0794b19a9578e0b8ec0d00a_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib205930814294a04ac8c44fa4d6e33e2_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8512fea0d6de4301aa283764d9659897_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib922bf6da6cc4631a901c3990795d953_D20210627-20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-27</xbrli:startDate><xbrli:endDate>2021-09-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2022-09-24</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>holx:Segment</xbrli:measure></xbrli:unit><xbrli:context id="if1c4506326454758a9ff17a52cc3174d_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4d7693a500ed4ec4af97863e7ccb013a_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5e16a16ccca84227b6bdd8b921503333_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d14d558aa9940c5b745ed86dca4facb_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8044d1c646c14ad7a8ca13af6376e2c0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab62225f35a54fdf891fb942549d470a_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i47bb3619ac514e9396f3997cc99a8206_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88ad24968acd4cb992c6185f64aafc61_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id048a530970b4115ad934dd57bfb2bd1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i922f9de14bf045b4aaeafaf2502b6528_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d3b3986fbd9494f904cb1a010337a73_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7e1bd6b8680642e296a44c25673ce7a7_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ab2eb9bf2244498bacafb726d13a41a_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d747f63ad01496a9ffd93aa08a24d54_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a1210ecf0f441c481be084c5fc7365e_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i56bcae300f9d40398f2e76fd994f2a30_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia9bb3f8b8a35456aa7b21ae62f2ed3ca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie794110f347e4793b515e8bde9c5a5e6_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3aa2073a325f423cbcb061411d2f553b_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbe0934c8334473cad9c3b424110753c_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie1169e0270b74fe6be508c370950a863_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i18960c3349fe4eb0a59368d1094a8ddd_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67fea90f60574367b621cebdab180dd0_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7207b97bd8c2409ea04c174faf5b7855_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i365291db08214202af3bee07bb3e066c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57e724ba87534f28bfba9adaf851c705_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i36ab5815693d4b4c96b98c8708a6fcb8_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2251dfc34b1f4dee9b06523ab53696b9_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i25c1b55962c14bd28656aef42077ee23_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3dd84f06f8354c2c99790984e0e949ec_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba33d49d790247138728e16304550207_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7714e4ad6e2f403ca6e488d1c5b4956c_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6bedb97f35ab4eadbc7dfdf485949c64_I20220924"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6fd0ad2aef5b404eab15f293436efcc7_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2ffc46097a444b81abc0a82e463c5c4e_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3fa140a2e91a4da0849a54c6a2cf483d_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ida477b36723f466a839eca19b439840e_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i053a359de4994764bcc53d5d8bd87247_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if56004b6ce284c0a88a74e229ff23a11_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i05e36b9f6d534537b938515e96a9b738_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i420e29ca33f74637b19b79f051f15a88_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5e589736d905406c8090a6aa9422698b_I20210925"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-09-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa137501c2f640d8a89b78da55d9a00e_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i79417d9e4a134491875ae60fa840bf0d_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i38bcb736614e47149fc6af7f459d9a0e_D20210926-20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-09-26</xbrli:startDate><xbrli:endDate>2021-12-25</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i10878f2ace9949af8c060f1bca337922_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i407e328e7a8e4cb7bd6a3598b8ad7ca3_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6db04a89d01143309b15081f34133a3a_I20211225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-25</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i92f1d854058b4a7badb00114d82a50c1_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib36279872040402a85b53f40877fc6bc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iec5a478ebcd24022ac3b46935f9c1298_D20220925-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000859737</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-25</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_1"></div><div style="min-height:27pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjgx_f743f7d7-dc18-4131-9a5b-4ec1b099bd10">10-Q</ix:nonNumeric> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;__________________________________________________________&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 5.5pt 2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:DocumentQuarterlyReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6YTJmZTU1MDdiMjc5NGFhNjkwNmZjYjg2ZTgwNWU3MWEvdGFibGVyYW5nZTphMmZlNTUwN2IyNzk0YWE2OTA2ZmNiODZlODA1ZTcxYV8wLTAtMS0xLTk3NDc3_acebbb3b-5ea4-4c22-9c68-76bf2e1fd9ca">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yNjA_098ed4b3-9e7e-44e8-9cc0-01e32e0f9a08">December&#160;31, 2022</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:2.267%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.533%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:4.5pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6ZGYwOGVmNWQ3Y2ZmNDFlYWIyODMzYjliODk1OTdmMjAvdGFibGVyYW5nZTpkZjA4ZWY1ZDdjZmY0MWVhYjI4MzNiOWI4OTU5N2YyMF8wLTAtMS0xLTk3NDc3_a577c79b-7267-4a7a-9c69-70bbe8632ed1">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">to</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjgy_e161d83d-63b9-4bb1-b0f6-bb7e7003c766">1-36214</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________&#160;</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg1_3c3f1db0-55da-4eaa-91cd-ec243eefea1c">HOLOGIC, INC</ix:nonNumeric>. </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:48.533%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.581%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.486%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18wLTAtMS0xLTk3NDc3_536d724f-0035-4afa-8e66-88cd0056227d">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18wLTItMS0xLTk3NDc3_e8f6af5a-ec19-4446-88c5-604e00ef7a47">04-2902449</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18yLTAtMS0xLTk3NDc3_f650e35f-5c8f-416d-bafd-201619f7ca3a">250 Campus Drive,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18zLTAtMS0xLTk3NDc3_b1950902-3ddd-4c56-b797-1dc98493a8f9">Marlborough,</ix:nonNumeric> </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM180LTAtMS0xLTk3NDc3_d1d730f0-b5c8-4c64-8163-0ded53dd19b2">Massachusetts</ix:nonNumeric><br/></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM180LTItMS0xLTk3NDc3_d79d707e-e43f-4079-9180-2f3ffe70301e">01752</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg2_3a29e2ba-46b3-4fc7-ad2a-d17def0b1e79">(508)</ix:nonNumeric> <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjgz_8030488b-6636-4e41-bc25-5167120f771d">263-2900</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">__________________________________________________________</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6Mjk0MTdkNmMwYTA4NDFmZmExOTA2MTdhZDRiZGRkYzcvdGFibGVyYW5nZToyOTQxN2Q2YzBhMDg0MWZmYTE5MDYxN2FkNGJkZGRjN18xLTAtMS0xLTk3NDc3_84bcfd05-ace7-4dcb-aba8-ded8ecc5b073">Common Stock, $0.01 par value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6Mjk0MTdkNmMwYTA4NDFmZmExOTA2MTdhZDRiZGRkYzcvdGFibGVyYW5nZToyOTQxN2Q2YzBhMDg0MWZmYTE5MDYxN2FkNGJkZGRjN18xLTEtMS0xLTk3NDc3_4ca0833d-09b1-424b-b72c-6ce622b2c710">HOLX</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6Mjk0MTdkNmMwYTA4NDFmZmExOTA2MTdhZDRiZGRkYzcvdGFibGVyYW5nZToyOTQxN2Q2YzBhMDg0MWZmYTE5MDYxN2FkNGJkZGRjN18xLTItMS0xLTk3NDc3_858512d0-6b69-4563-b0a1-b92a57d56e33">NASDAQ</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:4pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg0_846d940d-aa02-40c4-a127-4694d3457311">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg3_3b683893-c79f-41c2-973d-2b91fd8d45c7">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:21.089%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.281%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.965%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.841%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.573%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.578%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NzdjODM5YzE0YjM5NDhkZGFhMGJkNzdhN2I0OGUwZjQvdGFibGVyYW5nZTo3N2M4MzljMTRiMzk0OGRkYWEwYmQ3N2E3YjQ4ZTBmNF8wLTAtMS0xLTk3NDc3_b31fbd83-806a-400d-86bb-3a072ecd4b0d">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9746;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated&#160;filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#9744;</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NzdjODM5YzE0YjM5NDhkZGFhMGJkNzdhN2I0OGUwZjQvdGFibGVyYW5nZTo3N2M4MzljMTRiMzk0OGRkYWEwYmQ3N2E3YjQ4ZTBmNF8xLTYtMS0xLTk3NDc3_3bc43b17-c9f3-4650-8a03-43f9a86e3293">&#9744;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt;padding-left:2.25pt;padding-right:2.25pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NzdjODM5YzE0YjM5NDhkZGFhMGJkNzdhN2I0OGUwZjQvdGFibGVyYW5nZTo3N2M4MzljMTRiMzk0OGRkYWEwYmQ3N2E3YjQ4ZTBmNF8yLTYtMS0xLTk3NDc3_05803e05-0cbb-4e68-bca6-5056dfa272d6">&#9744;</ix:nonNumeric></span></div></td></tr></table></div><div style="text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span><br/></span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).&#160;&#160;&#160;&#160;Yes&#160;&#160;<ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="dei:EntityShellCompany" format="ixt-sec:boolballotbox" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg4_c563b87b-8c4a-42e2-8c41-8e383af2bf28">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of January&#160;26, 2023, <ix:nonFraction unitRef="shares" contextRef="i5eb0f65df2cc487ab6b5d60164c1f0fc_I20230126" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjAy_608556c2-9f97-4cf4-99f3-13aac820b06f">246,554,026</ix:nonFraction> shares of the registrant&#8217;s Common Stock, $0.01 par value, were outstanding.</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:27pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEX</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:7.099%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.439%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Page</span></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_10">PART I &#8211; FINANCIAL INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_13">Consolidated Financial Statements (unaudited)</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_16">Consolidated Statements of Income for the Three Months Ended December 31, 2022 and December 25, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_16">3</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_19">Consolidated Statements of Comprehensive Income for the Three Months Ended December 31, 2022 and December 25, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_19">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_22">Consolidated Balance Sheets as of December 31, 2022 and September 24, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_22">5</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:8pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_25">Consolidated Statements of Stockholders' Equity for the Three Months Ended December 31, 2022 and Year Ended September 24, 2022</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_25">6</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_28">Consolidated Statements of Cash Flows for the Three Months Ended December 31, 2022 and December 25, 2021</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_28">7</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_31">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_31">8</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_97">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_97">28</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 3.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_118">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_118">41</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item 4.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_121">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_121">43</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_124">PART II &#8211; OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_127">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_127">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;1A.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_130">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_130">44</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;2.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_133">Unregistered Sales of Equity Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_133">45</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Item&#160;6.</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_136">Exhibits</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_136">46</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_139">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_139">47</a></span></div></td></tr><tr style="height:3pt"><td colspan="6" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">EXHIBITS</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:17pt;margin-top:12pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I &#8211; FINANCIAL INFORMATION</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_13"></div><div style="padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Financial Statements (unaudited)</span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_16"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:67.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.240%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:ProductRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMy0xLTEtMS05NzQ3Nw_389927e8-adcf-4d2c-9526-86738d426485">886.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:ProductRevenue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMy0zLTEtMS05NzQ3Nw_5bd47804-0456-4e16-ab55-bdc07c8aa2da">1,303.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNC0xLTEtMS05NzQ3Nw_5c631008-d783-4d62-a60d-a50f884c0a87">187.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:ServiceRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNC0zLTEtMS05NzQ3Nw_c0eb0185-3d97-40d2-a40b-0d07c7804e7a">167.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNS0xLTEtMS05NzQ3Nw_e50d57e7-dcc2-4725-a19c-e564f488afdf">1,074.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNS0zLTEtMS05NzQ3Nw_52979dbb-f70c-4e42-8dfe-667757a605ff">1,471.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Costs of revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNy0xLTEtMS05NzQ3Nw_5f1eeaae-1e13-48a3-b8be-e22040d8e5db">296.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNy0zLTEtMS05NzQ3Nw_7997f2ae-859f-411f-aff1-c267123e85a2">318.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfOC0xLTEtMS05NzQ3Nw_000b027a-c5d1-46f9-9e16-0e52b3373806">55.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:AmortizationCostofGoodsSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfOC0zLTEtMS05NzQ3Nw_44db3814-c7f0-4c61-8feb-34081c835331">74.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTAtMS0xLTEtOTc0Nzc_78765ee6-02a0-48f4-a71b-73bf6b662735">104.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:Costofservice" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTAtMy0xLTEtOTc0Nzc_a1f173c0-27af-473b-a9d9-ce89dc21cd62">91.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTEtMS0xLTEtOTc0Nzc_a68a7474-247e-4390-a398-6d50472b8d25">617.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:GrossProfit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTEtMy0xLTEtOTc0Nzc_550d96fe-dc9b-4ede-a63e-b7d36d31eb20">986.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTMtMS0xLTEtOTc0Nzc_9a5118d0-b912-475b-8538-6915b89c0246">74.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTMtMy0xLTEtOTc0Nzc_49a11e8e-1c1b-463f-b10a-14310d3e11c1">72.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTQtMS0xLTEtOTc0Nzc_16ed7a53-d6af-481d-9917-f358d4f4dc8f">163.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:SellingAndMarketingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTQtMy0xLTEtOTc0Nzc_57935b67-a93c-490b-88d2-aaf39d0db41d">147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTUtMS0xLTEtOTc0Nzc_922586f6-4e9b-4692-a492-c441d41e0bad">108.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:GeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTUtMy0xLTEtOTc0Nzc_5b8e64a9-ffd8-441e-8b45-9a4b228445c8">117.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTYtMS0xLTEtOTc0Nzc_538920e5-92d7-4aca-9d00-52fff10f3fe4">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTYtMy0xLTEtOTc0Nzc_1d8fb2d6-f8dc-46b7-b048-17a63520c1da">10.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTktMS0xLTEtOTc0Nzc_20a53f51-c784-4a59-82e6-8d8b60715919">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTktMy0xLTEtOTc0Nzc_bb14a920-8074-46d2-a94a-14d1cc9418c4">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restructuring charges</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjItMS0xLTEtOTc0Nzc_ff181bc2-b963-4c6a-8871-72c90caa805c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:RestructuringCharges" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjItMy0xLTEtOTc0Nzc_ff22da82-4e04-40c5-8076-ea12faecf4e4">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjMtMS0xLTEtOTc0Nzc_5c6e0e53-e9b7-453b-a0b6-2567da392eae">355.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OperatingExpenses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjMtMy0xLTEtOTc0Nzc_f0f2e588-1ff2-4c48-b6af-8895b224bec6">345.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjQtMS0xLTEtOTc0Nzc_a4609735-9df5-4f5f-8361-83387544e9c4">262.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjQtMy0xLTEtOTc0Nzc_ec346f39-18a7-48b1-ad07-da147f72006c">641.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjUtMS0xLTEtOTc0Nzc_c9f7698c-7535-4c4c-8955-92f97f3e0f8a">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:InvestmentIncomeInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjUtMy0xLTEtOTc0Nzc_ba3a1d94-9ce8-489d-9dca-690acce4eb6f">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjYtMS0xLTEtOTc0Nzc_73f07a31-9bc6-4665-9689-cd82afd55c6f">28.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:InterestExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjYtMy0xLTEtOTc0Nzc_6c90329d-1b35-43d8-867f-cb6179d9fdde">25.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjctMS0xLTEtOTc0Nzc_08d1487c-dd57-4c03-b331-33a6932ad404">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjctMy0xLTEtOTc0Nzc_d78648dc-e238-42ae-ad4b-8b0d27209388">0.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income (expense), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjgtMS0xLTEtOTc0Nzc_8dae8b66-228a-4965-80b8-063a4bfd6efc">15.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjgtMy0xLTEtOTc0Nzc_29e7858a-6869-4b0f-a7e0-9aea2087b05c">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income before income taxes</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjktMS0xLTEtOTc0Nzc_067ab542-49c0-42b2-be71-28981a8b2d27">239.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjktMy0xLTEtOTc0Nzc_1a455f8b-8e7b-424f-a8ec-87cb632ad135">621.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzAtMS0xLTEtOTc0Nzc_e47496c4-42cb-4812-881d-4d659f2f9cdd">51.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzAtMy0xLTEtOTc0Nzc_8b2e55fa-542e-4937-b7bb-ff97557b75b4">122.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzEtMS0xLTEtOTc0Nzc_bed4123a-8e3d-4058-9234-e3c49b4afb1f">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzEtMy0xLTEtOTc0Nzc_ff5f0e72-7804-4142-a231-81101595b8e5">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income per common share:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzUtMS0xLTEtOTc0Nzc_ec210976-d12b-47fc-80ea-c42e1f53c699">0.76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzUtMy0xLTEtOTc0Nzc_d7805194-a7f6-42f0-90a8-115e335b1549">1.97</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzYtMS0xLTEtOTc0Nzc_a697290f-7401-4eec-a6ba-44d8077309f3">0.75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzYtMy0xLTEtOTc0Nzc_3764d394-9fa1-4427-b162-fc56e922e46d">1.95</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average number of shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzgtMS0xLTEtOTc0Nzc_01869c1b-1838-40a1-93a9-973c952da1cf">247,319</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzgtMy0xLTEtOTc0Nzc_2ec5ba01-e3ee-41a2-92f6-cdf4ca45e4cf">253,499</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzktMS0xLTEtOTc0Nzc_2807fb0c-32dc-4735-9ebb-b0a662ef910c">249,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzktMy0xLTEtOTc0Nzc_1271012f-4980-4b5c-9045-90c33215cfbf">256,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_19"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:67.484%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.239%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.240%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net income</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMi0xLTEtMS05NzQ3Nw_450b608c-f13e-4bc0-ae44-22c4d5e959b4">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMi0zLTEtMS05NzQ3Nw_be70d850-1c3d-415c-92c2-ef7a3253f0bd">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in foreign currency translation adjustment</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMy0xLTEtMS05NzQ3Nw_4d474063-1b87-4d28-85c0-84d33ca55f5d">113.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMy0zLTEtMS05NzQ3Nw_834434b8-aab8-4c29-9d53-5d36dae0442c">37.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in value of hedged interest rate swaps and interest rate caps, net of tax of ($<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOC0wLTEtMS05NzQ3Ny90ZXh0cmVnaW9uOjU4YzEyODY0MGQ4ZDQ0MjI4N2M1NGNiMmMwNDg0MWU5XzEwOTk1MTE2Mjc5NzU_8ab5ca9f-e97a-4724-b673-2363f7b1aa4d">0.9</ix:nonFraction>) for the three months ended December 31, 2022 and $<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOC0wLTEtMS05NzQ3Ny90ZXh0cmVnaW9uOjU4YzEyODY0MGQ4ZDQ0MjI4N2M1NGNiMmMwNDg0MWU5XzEwOTk1MTE2Mjc5ODI_4860b554-f394-4670-ada0-44e027345cae">2.6</ix:nonFraction> for the three months ended December 25, 2021.</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gain (loss) recognized in other comprehensive income (loss), net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOS0xLTEtMS05NzQ3Nw_0eeb14c9-b7ce-45cf-a2cd-a164c6712fdb">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOS0zLTEtMS05NzQ3Nw_8cb02eb4-4352-4e36-b963-47c0b0ac8fc5">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss)</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTEtMS0xLTEtOTc0Nzc_39fcd6ac-d150-4d19-a369-78743cfa86ef">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTEtMy0xLTEtOTc0Nzc_2310c322-42c7-487f-bbc9-7ee874a6747c">29.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive income</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTItMS0xLTEtOTc0Nzc_cf7a431a-b7c5-448f-b549-5a0cbf25325d">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTItMy0xLTEtOTc0Nzc_a0845873-8f41-4e11-a71b-70b8d7314677">469.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands, and par value)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:66.202%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.883%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMy0xLTEtMS05NzQ3Nw_67f0ca1d-633b-49e6-a4fe-0a1440de2fd6">2,441.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMy0zLTEtMS05NzQ3Nw_b9841bfc-d703-4be9-aee1-2f456548cb83">2,339.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, less reserves</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNi0xLTEtMS05NzQ3Nw_ba968ed3-5791-4036-8417-d1cb8f0aff0f">673.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNi0zLTEtMS05NzQ3Nw_4cf42595-c39a-42b1-ad1c-6dbd4d817b73">617.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNy0xLTEtMS05NzQ3Nw_a720ae9b-73e8-4a73-be0d-1fa4c5260915">677.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNy0zLTEtMS05NzQ3Nw_c17de386-069f-4af6-8ee0-a59ad610440d">623.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOC0xLTEtMS05NzQ3Nw_b7234944-1ead-481b-918a-2d987acdff50">197.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOC0zLTEtMS05NzQ3Nw_2040dba8-52cc-48e3-8b68-e100de45bc98">232.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOS0xLTEtMS05NzQ3Nw_b9bd6a75-481f-4b66-bd7e-72792835fb9e">31.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="holx:PrepaidIncomeTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOS0zLTEtMS05NzQ3Nw_da59e901-49ba-410a-b9d2-1854589cf58f">49.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTItMS0xLTEtOTc0Nzc_d6cf9fb7-831d-4956-b69c-b4d733733cab">4,021.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTItMy0xLTEtOTc0Nzc_26411e31-b64e-4a34-b498-da0142be28ed">3,862.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTMtMS0xLTEtOTc0Nzc_b5806e24-2d80-4382-ac62-a885df7cffe0">494.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTMtMy0xLTEtOTc0Nzc_ee5458af-7d1f-4fe3-95d7-ea8560e854dd">481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTQtMS0xLTEtOTc0Nzc_9bf621ac-4661-453e-9438-7e8060ea343c">1,255.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTQtMy0xLTEtOTc0Nzc_fdaaebac-4a63-43a9-ab10-ef9e90f9b8ab">1,280.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTUtMS0xLTEtOTc0Nzc_5864c707-2a64-4c5b-8343-031ca744d428">3,289.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:Goodwill" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTUtMy0xLTEtOTc0Nzc_8a3a2a70-803f-4acd-900a-5cd35fbf3c51">3,236.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTYtMS0xLTEtOTc0Nzc_c6385c6d-e3ba-4978-880b-25b498b64754">229.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTYtMy0xLTEtOTc0Nzc_858cdc44-18a7-475c-b647-c9fc34e01334">210.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTctMS0xLTEtOTc0Nzc_4ca11e9f-bf4b-4cc5-84e4-8ef7d5346352">9,290.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTctMy0xLTEtOTc0Nzc_42e4ba77-130b-441d-b12f-19372f8fd693">9,071.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjAtMS0xLTEtOTc0Nzc_0873d8ee-de97-4e76-bee8-23b39f703d19">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjAtMy0xLTEtOTc0Nzc_1f5ab705-d5a7-42df-b2dc-c745876b0cf5">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjEtMS0xLTEtOTc0Nzc_2b864214-bfdf-45ab-a251-b1170ee2473b">201.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AccountsPayableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjEtMy0xLTEtOTc0Nzc_b249624a-695b-4219-9316-f77815a98946">197.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjItMS0xLTEtOTc0Nzc_334010b0-4e4b-492b-a11e-8ebdc5d6f1f2">539.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AccruedLiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjItMy0xLTEtOTc0Nzc_acde446e-50da-42b6-b5d3-e36f0e0dbec3">535.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjMtMS0xLTEtOTc0Nzc_8031df27-09e2-49d7-a573-0ef68620a2f8">191.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:DeferredRevenueCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjMtMy0xLTEtOTc0Nzc_14a631cf-c5bd-4ff6-a9e2-7dce67a31213">186.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjQtMS0xLTEtOTc0Nzc_caa7da15-d0cc-4536-bef8-212f047a0abb">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjQtMy0xLTEtOTc0Nzc_71f9ab8b-eb8e-4293-8d5b-30c8646edd08">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjctMS0xLTEtOTc0Nzc_9a5b9323-c03f-4073-a7bc-0a333c55a80f">956.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LiabilitiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjctMy0xLTEtOTc0Nzc_dc026756-00c3-4491-acce-894488b933c9">937.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt, net of current portion</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjgtMS0xLTEtOTc0Nzc_af52a6a4-5a27-44c7-b10a-7fa32dcdbb1d">2,806.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjgtMy0xLTEtOTc0Nzc_65d9438a-da07-4fab-90ed-aa87ce64884e">2,808.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease obligations, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjktMS0xLTEtOTc0Nzc_a6a3a336-99f3-4968-9cee-9629baf3f661">17.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjktMy0xLTEtOTc0Nzc_15e2c8f0-47f9-428f-9f2c-7e54bc152a09">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income tax liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzAtMS0xLTEtOTc0Nzc_84b8bb73-b99e-4451-874c-34ee1fd094c3">71.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzAtMy0xLTEtOTc0Nzc_24c34e07-3714-4a17-ad46-cd16ddbc13b5">90.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue, net of current portion</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzEtMS0xLTEtOTc0Nzc_375779b2-97e9-4d55-a7f2-43863565811b">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:DeferredRevenueNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzEtMy0xLTEtOTc0Nzc_2b7e251f-7e9c-45ad-acf0-5fbfe8fe49e0">9.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzItMS0xLTEtOTc0Nzc_f9a6be1f-14a7-43d2-a75b-42404b85b2e0">335.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzItMy0xLTEtOTc0Nzc_f79c8aa4-a98e-44b4-9677-87935eb9d41d">330.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18yMQ_245954b2-a281-4b80-ae7f-093d8fcb2e52"><ix:nonFraction unitRef="usdPerShare" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18yMQ_670377d2-45df-4d73-bb6a-b1cdce78fa49">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18zNg_695987a7-f8b4-47d4-9986-14fe97ced981"><ix:nonFraction unitRef="shares" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18zNg_ea047f2f-34a1-4537-ad32-79627c8e74ae">1,623</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y181OA_9501a2d8-37af-48f2-a824-634fd81cca24"><ix:nonFraction unitRef="shares" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-3" name="us-gaap:PreferredStockSharesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y181OA_c8d26ebc-aaa5-4888-83db-88cffd14217d">0</ix:nonFraction></ix:nonFraction> shares issued</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMS0xLTEtOTc0Nzc_a43df575-2b76-439a-b7b3-b5984eec173a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:PreferredStockValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMy0xLTEtOTc0Nzc_e927f7a9-9dd3-4bde-ac94-faa5fbd7bc1c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8xOA_0f380e98-5a01-4e6f-b4c9-a37436e5cdcb"><ix:nonFraction unitRef="usdPerShare" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8xOA_e5391e04-1160-4a89-aa97-16402caa5c23">0.01</ix:nonFraction></ix:nonFraction> par value &#8211; <ix:nonFraction unitRef="shares" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8zMw_368908c1-7c90-47bf-87c5-ab3317c09518"><ix:nonFraction unitRef="shares" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8zMw_8f320e26-c7d2-416e-ae65-54fbb7e274a0">750,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl81NQ_b3f3296a-4b8a-4dda-8e88-d324c8af4a3f">299,485</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-3" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl82Mg_630806d7-1e9d-462a-979f-4245f14a0946">298,533</ix:nonFraction> shares issued, respectively</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMS0xLTEtOTc0Nzc_bf3ec5c5-65bb-4ddf-b741-536541767bb0">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:CommonStockValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMy0xLTEtOTc0Nzc_a9b8b67a-502e-4cc0-a484-51b5ec994690">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzYtMS0xLTEtOTc0Nzc_7701397c-732a-4256-8448-039edc9149b5">6,060.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzYtMy0xLTEtOTc0Nzc_f875773c-b654-4da2-8d98-bd23de860456">6,042.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzctMS0xLTEtOTc0Nzc_1e90b1fa-9abb-4488-b0ab-058e8ef18e67">1,787.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzctMy0xLTEtOTc0Nzc_e8e82cf3-f920-42e1-82c1-8c4d99dd3726">1,600.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Treasury stock, at cost &#8211; <ix:nonFraction unitRef="shares" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo1YjU0NGFhNDU0ZDA0YWRmOThiYzczZDJiMTkxMWY1YV8zMA_8f3ed92b-77a7-4381-98df-cff002869eeb">52,940</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-3" name="us-gaap:TreasuryStockShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo1YjU0NGFhNDU0ZDA0YWRmOThiYzczZDJiMTkxMWY1YV8zNw_fc1b183a-d0f2-4186-925e-791152e5a3d2">51,401</ix:nonFraction> shares, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMS0xLTEtOTc0Nzc_52f48c49-e522-4b54-9608-80509b3fd162">2,631.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:TreasuryStockValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMy0xLTEtOTc0Nzc_1581e364-bbb5-4a8c-b62e-3c639f5c3348">2,531.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzktMS0xLTEtOTc0Nzc_c5cf938a-25a2-4f9e-9662-ba495819e7fe">127.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzktMy0xLTEtOTc0Nzc_5454d0f3-f23c-4b87-9abd-bad7f2384402">238.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDAtMS0xLTEtOTc0Nzc_7277f0b1-81fa-428d-8f01-25abc70be7b7">5,092.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDAtMy0xLTEtOTc0Nzc_a162b5ba-1857-4c75-a8d4-f19c1db4f629">4,876.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDEtMS0xLTEtOTc0Nzc_a7ac8a68-ae36-46e3-a6f0-16fd10a7693e">9,290.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDEtMy0xLTEtOTc0Nzc_9072abcd-2500-435d-9240-1e97397d90cb">9,071.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:7pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Hologic, Inc.</span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders' Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except number of shares, which are reflected in thousands)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.538%"><tr><td style="width:1.0%"></td><td style="width:25.754%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.873%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.466%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.060%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.395%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.582%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.541%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:8.258%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-in-<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Retained<br/>Earnings </span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Other<br/>Comprehensive<br/>Loss</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Stock</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Par&#160;Value</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number&#160;of<br/>Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8b667a34853345ce9fc30f034e33f5b3_I20210925" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTItMS0xLTk3NDc3_c65e2bb5-7b74-4bb0-9c67-c970934a9351">297,306</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b667a34853345ce9fc30f034e33f5b3_I20210925" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTQtMS0xLTk3NDc3_6c334d6b-2aec-4952-95f2-43366ea8747d">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i750b33b8abf7477581f5efbc46a8f09f_I20210925" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTYtMS0xLTk3NDc3_fce43be4-718c-4160-9731-d7e0e5f99a96">5,965.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i104836b541db4552a3484725690e4c11_I20210925" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTgtMS0xLTk3NDc3_c2fd9403-ee17-4afa-9526-04c1bac23df3">298.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4a69d1c0d994885bd6c5a0c8cc6aeb7_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTEwLTEtMS05NzQ3Nw_06ddd3c2-58bf-4aba-88c9-a7d2d05c1c92">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idc24a74bca6f45a98e1346313bc6bb4a_I20210925" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTEyLTEtMS05NzQ3Nw_e6b6bb21-1406-49c7-8d1e-b1e9d40698c6">43,653</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idc24a74bca6f45a98e1346313bc6bb4a_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTE0LTEtMS05NzQ3Nw_58c88698-9919-463e-a41d-e212aefa432b">1,989.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTE4LTEtMS05NzQ3Nw_7b242472-f3ae-460b-a386-c0ea29e6f2dc">4,218.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17d494d3ea2f420d85bcf5996162d2ba_D20210926-20211225" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkzLTItMS0xLTk3NDc3_b09f1b93-0013-47a2-8197-56c3f86d97d9">45</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkzLTYtMS0xLTk3NDc3_47aeefbb-aa2f-4a3a-b218-3630975376d8">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkzLTE4LTEtMS05NzQ3Nw_c8af0163-e2d6-4ae2-be19-e26f317d3af3">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17d494d3ea2f420d85bcf5996162d2ba_D20210926-20211225" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk0LTItMS0xLTk3NDc3_3bccb791-2d58-4866-ad0f-cd2580c90216">534</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk0LTYtMS0xLTk3NDc3_044d1415-7b14-4c50-9231-c21e63c2cbcc">22.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk0LTE4LTEtMS05NzQ3Nw_cecb32ab-2132-4eca-ab7e-9b75837be282">22.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk2LTYtMS0xLTk3NDc3_4d1915d4-a082-4bc4-8cef-7609febc6d20">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk2LTE4LTEtMS05NzQ3Nw_d50cdd0c-995b-414c-b3a5-0a2203faf2b9">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk3LTgtMS0xLTk3NDc3_be67180d-286a-462d-85f7-8d97e47a801e">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk3LTE4LTEtMS05NzQ3Nw_20872481-3b36-4142-be2c-2ffa50137876">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie62b1597841e4a4b91bc223e8929cd2e_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk4LTEwLTEtMS05NzQ3Nw_ed38d3de-7a2c-4992-8f51-07239b27122b">29.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie62b1597841e4a4b91bc223e8929cd2e_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk4LTE4LTEtMS05NzQ3Nw_806a7f54-c48a-4d49-a137-006cdbc28c0c">29.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4a684294b69f49c5bb601cb231f23927_D20210926-20211225" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk5LTEyLTEtMS05NzQ3Nw_e359fbf0-21a2-473c-8ce7-a33e749b1fc3">2,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4a684294b69f49c5bb601cb231f23927_D20210926-20211225" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk5LTE0LTEtMS05NzQ3Nw_7c37cb5a-26c4-4a49-9f17-ee4ace055426">167.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk5LTE4LTEtMS05NzQ3Nw_3b3bc3dd-5a35-4eae-bd30-941a0785e497">167.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 25, 2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib069c3c83a7d410ca7d70d300726945b_I20211225" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTItMS0xLTk3NDc3_56b483f4-c2b4-4343-b770-aab773831276">297,885</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib069c3c83a7d410ca7d70d300726945b_I20211225" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTQtMS0xLTk3NDc3_69187566-70c6-4dd1-b198-e1daed5c926a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id614601c4c7b4096a9c5dcbd9f8fe6d6_I20211225" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTYtMS0xLTk3NDc3_0ab1acd6-f475-4af9-acca-8621efa5ee44">5,964.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7b569b420904a598de952ba3efe933c_I20211225" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTgtMS0xLTk3NDc3_1593c7f7-1d4f-49ed-8af9-344e0ff1558d">797.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d4f66d97be24ea29c9e72a2c1b943b1_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTEwLTEtMS05NzQ3Nw_616872e2-06f0-49a7-9c92-5f25489aa022">89.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icfec87e83d4e4bf8ae4a9f94883339de_I20211225" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTEyLTEtMS05NzQ3Nw_92b896b3-35ab-4911-84ab-3ee3db3d4fb2">45,988</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfec87e83d4e4bf8ae4a9f94883339de_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTE0LTEtMS05NzQ3Nw_6783f726-7d75-462c-9c69-0d0129a3495f">2,156.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTE4LTEtMS05NzQ3Nw_9396034d-4130-422f-a29c-a36b667cc816">4,519.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAxLTItMS0xLTk3NDc3_4e1272e7-d87a-467a-9449-1b2f248f7bf0">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAxLTYtMS0xLTk3NDc3_2d6eef8b-070c-4d20-a56a-a978c5f8b68b">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAxLTE4LTEtMS05NzQ3Nw_45703301-298b-4430-858d-0fe4f6d5911e">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAyLTItMS0xLTk3NDc3_728e0501-b94a-4c20-800d-df485471d2f7">14</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAyLTYtMS0xLTk3NDc3_4a9ec590-ee0f-4133-8553-3f31c0269903">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAyLTE4LTEtMS05NzQ3Nw_e9151463-1b20-4255-80d0-d3c0fdfdd813">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAzLTItMS0xLTk3NDc3_6d306a60-c8f5-4751-b0cc-36be0e58fcee">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAzLTYtMS0xLTk3NDc3_b1e446e9-31ff-4ca4-9fe7-05b39c5cbafd">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAzLTE4LTEtMS05NzQ3Nw_6a7f8428-95a6-4182-8b6c-fa30ac8ebc83">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA0LTYtMS0xLTk3NDc3_8be3a7f6-0933-4fa6-bb9a-d0ed198cbb37">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA0LTE4LTEtMS05NzQ3Nw_52f8cb5c-4036-4543-8978-84045b456ccf">17.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA1LTgtMS0xLTk3NDc3_303b5253-b890-44c6-a09c-cf483750526e">455.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA1LTE4LTEtMS05NzQ3Nw_6e406d59-39bc-4283-a197-de11d1859900">455.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb8c751501224cfb8f672b3b5d147581_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA2LTEwLTEtMS05NzQ3Nw_656736fa-fe02-4776-81cc-d345c842677c">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibb8c751501224cfb8f672b3b5d147581_D20211226-20220326" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA2LTE4LTEtMS05NzQ3Nw_d090b62b-6aea-4f98-8f0d-2b025f20fea8">15.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA3LTEyLTEtMS05NzQ3Nw_7a2f897e-7113-4f46-bf27-cc7d1cd5e212">2,863</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA3LTE0LTEtMS05NzQ3Nw_e50eb186-000e-4c0e-b270-9421ea50552f">200.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA3LTE4LTEtMS05NzQ3Nw_715ba610-4380-44b3-8883-4f01c1da5007">200.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at March 26, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iee40c972e79245a48193d5c44a5d488c_I20220326" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTItMS0xLTk3NDc3_a5c4d4e3-6311-494b-b8cf-91667ac8a2de">298,203</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee40c972e79245a48193d5c44a5d488c_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTQtMS0xLTk3NDc3_2a5cc411-b8dd-4edd-9ebf-6018527bec4a">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44bb24d344a2479f88cb3056e9eb7f9d_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTYtMS0xLTk3NDc3_69443827-e16c-427f-947b-cb041016cbb8">5,997.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icb7a25b0e96544b6bbd05dc3066b58b1_I20220326" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTgtMS0xLTk3NDc3_838ad70f-3a64-46b9-aa07-df0eea230b8a">1,253.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7df030fd1d484893b2c6f6ca3cbc20b5_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTEwLTEtMS05NzQ3Nw_b64bd140-30a7-4f1d-a8b7-28d5822f6c84">104.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i96aafcc8951b43bb843963cb4ef1b0c9_I20220326" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTEyLTEtMS05NzQ3Nw_b5642410-aba8-4a82-9f64-3544c0960b86">48,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i96aafcc8951b43bb843963cb4ef1b0c9_I20220326" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTE0LTEtMS05NzQ3Nw_4adedd7c-8aa9-469d-8d85-21f812f5ec11">2,356.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27baa3824d6f48cba5a8bdecb8c0cc9f_I20220326" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTE4LTEtMS05NzQ3Nw_4204f640-227f-472b-804d-3a152c86451e">4,792.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdc5975fe0bb4a9f91e698a96eabdbdc_D20220327-20220625" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA5LTItMS0xLTk3NDc3_09bd734d-bcd4-428b-8964-b68aec20e294">128</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA5LTYtMS0xLTk3NDc3_ab1d4369-447d-4028-836e-76017a96e98c">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA5LTE4LTEtMS05NzQ3Nw_6e190e13-f2af-42f8-a39a-4a164beaa9af">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icdc5975fe0bb4a9f91e698a96eabdbdc_D20220327-20220625" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEwLTItMS0xLTk3NDc3_2b98f763-b180-4716-8c95-62216328c2f0">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEwLTYtMS0xLTk3NDc3_bd62162e-5577-4a2d-bd6a-95e572a86588">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEwLTE4LTEtMS05NzQ3Nw_fdcd8d3f-a6ef-419b-8469-837887270b85">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEyLTYtMS0xLTk3NDc3_f2b12bef-9af2-46d1-808f-46db042d62fe">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEyLTE4LTEtMS05NzQ3Nw_78f54193-430f-4ccb-8dcc-5e5e92bb7622">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEzLTgtMS0xLTk3NDc3_444ce9cf-5187-46b6-a2a0-dcc0c261cd7f">228.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEzLTE4LTEtMS05NzQ3Nw_43925149-7fbe-456e-828f-acfe6b07fefe">228.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idffe4e4b122a47f5b0294845f328191d_D20220327-20220625" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE0LTEwLTEtMS05NzQ3Nw_c71c26e4-a4d1-465e-a495-4883640beecd">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idffe4e4b122a47f5b0294845f328191d_D20220327-20220625" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE0LTE4LTEtMS05NzQ3Nw_9d94a2b3-d84a-46c9-b385-d6a6f5cdcd04">43.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at June 25, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46ea4a08bd3042a7ab12381bf4bff328_I20220625" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTItMS0xLTk3NDc3_c8d5e731-1e50-4333-b654-55409a98934b">298,335</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46ea4a08bd3042a7ab12381bf4bff328_I20220625" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTQtMS0xLTk3NDc3_bd100e7e-d259-4f88-a643-b0b8f68e0bc2">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c7577051ac8445595d275ea3b4ba6d7_I20220625" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTYtMS0xLTk3NDc3_ea977bf9-d442-4469-a07e-981338775fbe">6,017.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibb6f35c1e6d84dd5b5f8a049aac44ec4_I20220625" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTgtMS0xLTk3NDc3_e37ba672-8366-487d-b735-dde2675609df">1,481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia42682bb507a4e48a823cf2bdaafddc5_I20220625" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTEwLTEtMS05NzQ3Nw_fcf9d065-af42-486e-9c86-a6945a728db8">147.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5a60e52602c048069d80e58e5129177f_I20220625" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTEyLTEtMS05NzQ3Nw_dd34b407-cb10-444d-a663-9e12564fb276">48,851</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5a60e52602c048069d80e58e5129177f_I20220625" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTE0LTEtMS05NzQ3Nw_42fa3a01-257f-4d28-b0b1-3579a0d3444f">2,356.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i68d91b48be7045588cbe38f1d5620c60_I20220625" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTE4LTEtMS05NzQ3Nw_0d55827b-b9e7-4e05-8d40-ee87cd3212b9">4,997.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE3LTItMS0xLTEwNjgxOQ_95837fdd-9ec6-4d5e-ba14-883d8595c37f">23</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE3LTYtMS0xLTEwNjgzNw_5e994a11-04cd-4fcb-bb97-d80cab548fe5">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE3LTE4LTEtMS0xMDY4NTQ_244a6a28-f7b3-437f-9afd-43f155882a25">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE4LTItMS0xLTEwNjgzMw_4a60dc33-39ba-4e52-97d3-09ccf11d7a96">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE4LTYtMS0xLTEwNjgzOQ_30277600-d4f0-4506-8b97-7ea7792b7273">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE4LTE4LTEtMS0xMDY4NTY_fce9888a-a759-4916-8759-ce0d374939ce">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE5LTItMS0xLTEwNjgzNQ_4c1d424f-5c76-495f-bd9f-027592ea1f90">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE5LTYtMS0xLTEwNjg0MQ_882dd0d5-1f60-4888-b8dd-02f5f302a537">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE5LTE4LTEtMS0xMDY4NTg_8729a2f2-291d-4881-bcf3-020862c437f7">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIwLTYtMS0xLTEwNjg0Mw_ce652a9c-4c5a-4c75-8601-57717a0906a9">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIwLTE4LTEtMS0xMDY4NjA_78f01b00-14fe-4810-b24c-03fe240afa72">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIxLTgtMS0xLTEwNjg0NQ_cf73634e-6cf2-42c3-b267-05294333414f">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIxLTE4LTEtMS0xMDY4NjM_739c616e-2543-40be-a785-6623dc059ef0">118.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9301d9a3c6c442bab8060ca751e7563b_D20220626-20220924" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIyLTEwLTEtMS0xMDY4NDc_13c9d67c-32d1-48a4-861d-67b27aef747e">90.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9301d9a3c6c442bab8060ca751e7563b_D20220626-20220924" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIyLTE4LTEtMS0xMDY4NjU_2e5a6e32-b42a-4b5e-bb9b-08389bf99651">90.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idca511b5b1874691b87e467241ae5b70_D20220626-20220924" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIzLTEyLTEtMS0xMDY4NDk_46325a35-09e0-4653-ae43-4013e88a8ced">2,550</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idca511b5b1874691b87e467241ae5b70_D20220626-20220924" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIzLTE0LTEtMS0xMDY4NTI_46e1b7d3-81cf-4cab-8941-6ec26b5cca51">175.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="idca511b5b1874691b87e467241ae5b70_D20220626-20220924" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIzLTE4LTEtMS0xMDY4Njc_5fee790e-3703-4819-8836-444717e3a9f7">175.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at September 24, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="if54a740632874ce19cb42642fb2e221a_I20220924" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTItMS0xLTEwNjc1MQ_00473778-e847-4dab-a591-7143ae8b1381">298,533</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54a740632874ce19cb42642fb2e221a_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTQtMS0xLTEwNjc1Mw_25d0defd-0561-4a51-ac68-1d745c0629f3">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie23d7b47d391462891d1fd3901620b20_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTYtMS0xLTEwNjc1NQ_1c98f950-a8cd-48c9-9092-6a4315d912df">6,042.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i013fa78766bb45bc816b63fed5c22874_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTgtMS0xLTEwNjc1Nw_961f30b6-bcf0-41f0-82fa-c2997a5a4adc">1,600.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie45f7058af534e8dba563c02009f5cac_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTEwLTEtMS0xMDY3NTk_1bb53d60-d1f9-4e80-ad5f-805ed2aa6ebc">238.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i17c32b5fcbaf409cb7118fbe9bb55a0e_I20220924" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTEyLTEtMS0xMDY3NjE_1481a050-00a1-4922-aab0-7f14a223c921">51,401</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i17c32b5fcbaf409cb7118fbe9bb55a0e_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTE0LTEtMS0xMDY3NjM_767e6e78-6af1-4eef-b7f9-aad524ec1053">2,531.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTE4LTEtMS0xMDY3NjU_bd312675-a1f3-4dcf-bca7-e55b682efea5">4,876.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI1LTItMS0xLTEwNjc4Mw_c22631a8-0e3f-4957-9ce2-2af2bb98fc9b">267</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI1LTYtMS0xLTEwNDU3OA_dd6dff20-216c-4b25-8534-b1f20a7d5065">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI1LTE4LTEtMS0xMDY4MDU_05606938-6828-4b9a-9d44-977bc4200bfc">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Vesting of restricted stock units, net</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231" decimals="-3" name="us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI2LTItMS0xLTEwNjc4NQ_c7e7f015-9e11-443a-97bd-cae32747a6e3">514</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI2LTYtMS0xLTEwNDU1Ng_d72aab54-658f-477e-9965-091b98e53505">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI2LTE4LTEtMS0xMDY4MDc_31e7ddab-4ce7-4927-8516-582e1931a19b">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Common stock issued under the employee stock purchase plan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI3LTItMS0xLTEwNjc4Nw_286cbf3b-bc05-464e-81ec-281f6812df71">171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI3LTYtMS0xLTEwNjc5Mw_c6fdef97-83ef-465f-8b20-069adab8e58d">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI3LTE4LTEtMS0xMDY4MDk_af7cc2d0-2b68-4a32-9b5e-e7b370535416">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI4LTYtMS0xLTEwNjc5NQ_923a6cac-7335-4e44-8c0b-80d286047142">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI4LTE4LTEtMS0xMDY4MTE_ad6c4643-2f68-4384-8337-3d61d69b45ff">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:Netincome" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI5LTgtMS0xLTEwNjc5Nw_54b899ad-26a2-44ac-9df7-ee45887cd2c6">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI5LTE4LTEtMS0xMDY4MTM_f72deb9d-3ac3-40f0-945d-bedf394d087e">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other comprehensive income activity</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffce715dc2d14558a02450be71f516b4_D20220925-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMwLTEwLTEtMS0xMDY3OTk_def9691c-47bd-46fd-b223-a6bcdc3b3fb5">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iffce715dc2d14558a02450be71f516b4_D20220925-20221231" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMwLTE4LTEtMS0xMDY4MTU_05126f9e-d0e1-492e-aea5-0dccc5dbe996">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchase of common stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231" decimals="-3" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMxLTEyLTEtMS0xMDY4MDE_124c0743-0ebf-4bac-bd9a-105d881f1899">1,539.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMxLTE0LTEtMS0xMDY4MDM_3315cf14-a96e-42f2-8984-ed251293eef0">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredParValueMethod" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMxLTE4LTEtMS0xMDY4MTc_aa89f3f8-2511-4558-a75e-b1df55c8ccca">100.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8c096023d23c420bbe6591cb72e10eb9_I20221231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTItMS0xLTEwNjc2Nw_10d26203-319b-437e-b410-d26d9f008197">299,485</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8c096023d23c420bbe6591cb72e10eb9_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTQtMS0xLTEwNjc2OQ_d6f17c93-2695-4a28-82ce-e6c00581dc47">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1c1f63693e304533b7ac2c9be6e0e0bf_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTYtMS0xLTEwNjc3MQ_00197fd9-bd34-44c7-85cb-cd6115f18072">6,060.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie3fc5436b7e04085aaf9f0cc0a424693_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTgtMS0xLTEwNjc3Mw_6f0bb64e-6e4f-40f8-9bba-fd0b1d98c568">1,787.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14951cf020f246d1996832691a0edc4c_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTEwLTEtMS0xMDY3NzU_b31d8768-dead-465c-a35e-ff6d7f1ce8f6">127.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i576d2b7fc4c843429397ce9929243a48_I20221231" decimals="-3" name="us-gaap:SharesIssued" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTEyLTEtMS0xMDY3Nzc_4224ce72-c5db-4215-858a-be8d1d525219">52,940</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i576d2b7fc4c843429397ce9929243a48_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTE0LTEtMS0xMDY3Nzk_f8b06ccd-123f-4904-8330-f6f357fb65d6">2,631.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTE4LTEtMS0xMDY3ODE_e31f13d9-a42c-4b7a-b48e-bf0329a19f0d">5,092.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_28"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">(Unaudited) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:72.692%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.637%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.639%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net income </span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMy0xLTEtMS05NzQ3Nw_c46a472a-5987-4b8b-8458-bedf13c5744a">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMy0zLTEtMS05NzQ3Nw_927b198f-53e7-4627-8a13-b85445fc5ca8">499.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Adjustments to reconcile net income to net cash provided by operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNS0xLTEtMS05NzQ3Nw_e5b77a26-2fc7-4486-80a1-4f58a45a2c7c">22.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNS0zLTEtMS05NzQ3Nw_8e7bf09a-4d14-4a58-bbe9-aa723124dbc7">22.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of acquired intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNi0xLTEtMS05NzQ3Nw_d1dd821e-b3f1-461a-b63b-b64eee149ea6">63.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:AdjustmentForAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNi0zLTEtMS05NzQ3Nw_ee2de9e5-cdb2-4f74-9546-1a35b0aa3518">85.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOC0xLTEtMS05NzQ3Nw_5efd3c69-04eb-4738-8b84-3afede987d13">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOC0zLTEtMS05NzQ3Nw_9d15e746-4764-4f21-8517-2a51b24ccf96">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOS0xLTEtMS05NzQ3Nw_5bea23ae-9d97-40db-8e30-37b2ad2b9325">26.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOS0zLTEtMS05NzQ3Nw_e8b75373-5ad3-4a5b-993d-557a70389d6b">21.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Debt extinguishment loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMTMtMS0xLTEtOTc0Nzc_7e3efa55-a628-45af-9124-eb006bac017a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMTMtMy0xLTEtOTc0Nzc_bd06b80d-b63e-46f2-8cd6-2f3aaf556043">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other adjustments and non-cash items</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjEtMS0xLTEtOTc0Nzc_76eef580-3d73-4224-a875-a98cbcf3baed">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjEtMy0xLTEtOTc0Nzc_657e376c-1a17-4223-8696-4045618d2ce4">5.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities, excluding the effect of acquisitions:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjMtMS0xLTEtOTc0Nzc_e91d443d-f425-44a9-8813-d2b10f56498a">45.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjMtMy0xLTEtOTc0Nzc_084d6c3f-1ec1-4b76-a96a-34fd9281dcd6">48.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjQtMS0xLTEtOTc0Nzc_0b6214a5-0149-4e65-b8e9-95854ccea91b">47.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjQtMy0xLTEtOTc0Nzc_d75c88d4-838e-4c20-ac87-7b54829acaa6">17.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid income taxes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjUtMS0xLTEtOTc0Nzc_0a5bc30a-46b2-40a1-a61c-111b9bbe82e4">17.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidTaxes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjUtMy0xLTEtOTc0Nzc_b3a1c248-78f4-4a33-af29-9c34cd5e55d3">4.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Prepaid expenses and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjYtMS0xLTEtOTc0Nzc_d1cd9241-aef0-4c00-8d07-1bf09d2a09a4">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjYtMy0xLTEtOTc0Nzc_5f752abe-0341-4e69-9b71-8a349eb547d7">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjctMS0xLTEtOTc0Nzc_c28ff8d1-9738-4b18-8f8d-a8caac469d6f">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjctMy0xLTEtOTc0Nzc_3858f650-cea3-4e1f-b0a7-ee54090e1796">13.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Accrued expenses and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjgtMS0xLTEtOTc0Nzc_711cc413-1c34-4892-bd32-b31b4777ff44">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjgtMy0xLTEtOTc0Nzc_57e950e5-5a18-4d93-895c-eac720b0c573">42.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjktMS0xLTEtOTc0Nzc_7fcf3526-6607-4dfe-b1c9-2c11ee871cce">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjktMy0xLTEtOTc0Nzc_fcfaff73-9f69-4d7a-b872-6f0049772253">5.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzAtMS0xLTEtOTc0Nzc_9e315d95-e0de-41fd-b7f1-9b7bfd2c8311">253.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzAtMy0xLTEtOTc0Nzc_f5476bbf-0c81-4458-9fc5-189329da72b4">564.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Acquisition of businesses, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzItMS0xLTEtOTc0Nzc_26226ce8-9311-4f12-b35e-effe0020c75e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzItMy0xLTEtOTc0Nzc_b9b81b07-049b-43d6-8dbf-d2e8c548dafb">157.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Capital expenditures</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsForProceedsFromProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzUtMS0xLTEtOTc0Nzc_e9454893-dbe5-44d4-8b7c-3d2f902e5272">15.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsForProceedsFromProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzUtMy0xLTEtOTc0Nzc_2f596f92-c7f4-4307-8e71-4ab0a466ae0c">20.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from the Department of Defense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMS0xLTEtMTAyMDEy_572aec00-b7ef-4018-808e-15c54afe9209">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMy0xLTEtOTk3NDU_e66d072f-b01a-4fc7-b867-02a03400290a">21.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Increase in equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMS0xLTEtOTc0Nzc_a53af8f0-6b66-4d4c-9ca8-d3d0d859ed7c">13.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMy0xLTEtOTc0Nzc_8437ba2c-25c4-4509-934f-d783374c8533">17.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Purchase of equity investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:Purchaseofinsurancecontracts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDMtMS0xLTEtOTc0Nzc_08319f34-898b-417a-941f-cc7a63e01d29">10.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:Purchaseofinsurancecontracts" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDMtMy0xLTEtOTc0Nzc_62ab6c9c-8369-40d8-9bff-668fa8737f3d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Other activity</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDYtMS0xLTEtOTc0Nzc_312c0d56-8ac1-4bcd-8451-d3b6a3810bc1">1.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDYtMy0xLTEtOTc0Nzc_bc5375fb-d895-4b70-8804-a981932b8e16">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDgtMS0xLTEtOTc0Nzc_4d7e0c0e-6905-4b96-a190-1cee41e3d220">41.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDgtMy0xLTEtOTc0Nzc_373c59d6-3def-4022-beb9-04d953ff92ec">173.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from long-term debt, net of issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTAtMS0xLTEtOTc0Nzc_70fa33d6-c88e-4035-8994-e25f02921f4d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTAtMy0xLTEtOTc0Nzc_9bc28196-e13a-4c5f-a455-0fc4ee1a9177">1,491.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTEtMS0xLTEtOTc0Nzc_62d36388-da56-4264-a808-12692ecaf74a">3.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:RepaymentsOfLongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTEtMy0xLTEtOTc0Nzc_42893e2d-01ed-4d7d-9241-fc177430c12d">1,387.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of deferred acquisition consideration</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjEtMS0xLTEtOTc0Nzc_454e5561-9fa0-4c86-b341-67d5c445f604">0.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjEtMy0xLTEtOTc0Nzc_5f37f694-afe8-4e1f-9e21-1e5b4e4219c4">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repayment of acquired long-term debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:Repaymentsofacquiredlongtermdebt" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjItMS0xLTEtOTc0Nzc_67669947-af2e-4046-b750-7646875aeaca">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:Repaymentsofacquiredlongtermdebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjItMy0xLTEtOTc0Nzc_52094651-77c1-4dbb-8cda-40e50dc2189f">63.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Repurchases of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjUtMS0xLTEtOTc0Nzc_0e24717b-bc2d-42ed-9314-c6d57db70f3d">100.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjUtMy0xLTEtOTc0Nzc_c273d092-78db-4084-8cd8-b5bfafe64a08">167.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock pursuant to employee stock plans</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjctMS0xLTEtOTc0Nzc_78c04c91-e507-47fd-b3ff-540ade7647ed">15.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjctMy0xLTEtOTc0Nzc_4b1b251c-092a-4704-891a-e2bd0f33ec75">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payment of minimum tax withholdings on net share settlements of equity awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjgtMS0xLTEtOTc0Nzc_c3cc2220-59a2-4bb2-ad92-1ba89d1e413b">23.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjgtMy0xLTEtOTc0Nzc_41230bbf-9a5f-407a-b1ff-eda34ae9e747">22.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Payments under finance lease obligations</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjktMS0xLTEtOTc0Nzc_2a19aed3-4749-4887-b044-f1a9a6fcdaa9">1.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:PaymentsUnderFinanceLeaseObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjktMy0xLTEtOTc0Nzc_9b375d68-f287-453f-a17e-70425f472f02">0.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzAtMS0xLTEtOTc0Nzc_6b129df4-42c2-48c0-b01f-c8bfd338ec6f">113.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzAtMy0xLTEtOTc0Nzc_3086a80e-4efb-4c94-8759-7aab434b822b">143.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash and cash equivalents</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzEtMS0xLTEtOTc0Nzc_0ed9cbff-63eb-4b3e-8f8a-17343762b470">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzEtMy0xLTEtOTc0Nzc_540fb393-06bf-46a0-92f4-a9b35c7d1b1d">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net increase in cash and cash equivalents</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzItMS0xLTEtOTc0Nzc_6240c863-1ff4-4e07-8a3c-a74810972871">101.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzItMy0xLTEtOTc0Nzc_2b1543a5-e7bb-4a80-b8a2-d1858a7d5a05">250.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzMtMS0xLTEtOTc0Nzc_b9841bfc-d703-4be9-aee1-2f456548cb83">2,339.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzMtMy0xLTEtOTc0Nzc_7bb9602d-a703-43f9-a6ae-b63cba6c20d2">1,170.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cash and cash equivalents, end of period</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzQtMS0xLTEtOTc0Nzc_2f0fa7c6-97d9-4332-8e73-0382ae3f4b97">2,441.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzQtMy0xLTEtOTc0Nzc_5c06eefd-d945-462d-be7d-d10a06f10046">1,420.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">See accompanying notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_31"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HOLOGIC, INC.</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(all tabular amounts in millions, except number of shares, which are reflected in thousands, and per share data)</span></div><div style="text-align:center"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_34"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (1) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNC9mcmFnOmVmMDk1MTExZmNmOTQ3NDJhOWQ1MDUyZTViYTFlNDVjL3RleHRyZWdpb246ZWYwOTUxMTFmY2Y5NDc0MmE5ZDUwNTJlNWJhMWU0NWNfMjM3Mg_7cd90694-a581-4ea8-8f77-00ba881f5dd9" continuedAt="i507e235b0094494c8d841baa89e700a3" escape="true">Basis of Presentation</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i507e235b0094494c8d841baa89e700a3" continuedAt="i177b0869239c4870aa940fec5de92e2a"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These unaudited financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;24, 2022 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;15, 2022. In the opinion of management, the unaudited financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three months ended December&#160;31, 2022 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;30, 2023. Fiscal 2023 is a 53-week fiscal year, and the additional week is included in the first quarter of fiscal 2023 consistent with the Company's historical fiscal calendar.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i177b0869239c4870aa940fec5de92e2a">The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three months ended December&#160;31, 2022.</ix:continuation> </span></div><div style="margin-bottom:18pt;margin-top:6pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_37"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(2) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfODI4NA_5b4eab0a-2da0-4f5f-bff0-2c344b704550" continuedAt="i8b0a34ab63c147e89aea427efc6b5526" escape="true">Revenue</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i8b0a34ab63c147e89aea427efc6b5526" continuedAt="i1310effe8c37440eb2f5aca464f99107"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. In addition, the Company generates service revenue from performing laboratory testing services through its Biotheranostics CLIA laboratory, which is included in its Molecular Diagnostics business. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfODI4Mg_4f4e1ec8-17f3-4352-868d-3180ef976525" continuedAt="if6344b709414450d9dd6fa0f340a3828" escape="true">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="if6344b709414450d9dd6fa0f340a3828" continuedAt="i546080ddabcb494ab5619ee5d7975b9f"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:3.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.680%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3714d8a36f9a4f34b0cbd75cd016e460_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMy0yLTEtMS05NzQ3Nw_595e9f14-8992-4d66-a151-82140bdfd0d3">78.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0064a9d141464479bd6959095d0a5614_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMy0zLTEtMS05NzQ3Nw_afcd1905-83e0-4a7a-aed4-8f468fb2d1bf">48.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if05c15bd87b943b8a89e3a90c5706964_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMy00LTEtMS05NzQ3Nw_6f24be7a-f303-45a4-9325-f26ca34fa822">126.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67c7d17962b5422eb16f38be2f358d0b_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNC0yLTEtMS05NzQ3Nw_6698914e-bf0b-4e42-b302-f4d668bcb15f">328.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7494f976d4084d799b3eb03ac448aba0_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNC0zLTEtMS05NzQ3Nw_5fd90908-c8cd-4afd-b7fa-26317bd895f4">97.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i03bc4a9519ab4934844ac430543e9341_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNC00LTEtMS05NzQ3Nw_b1f5c6ea-fed0-4639-93ef-f8ca55cc9bc6">425.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icba05cf621b045f1b0ded77db74e0969_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNS0yLTEtMS05NzQ3Nw_f98f9a28-8ffe-44a2-93fc-3d0cd55f1c1e">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iabf98c37c1ac4489bfce80d1f1a39c3c_D20220925-20221231" decimals="-6" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNS0zLTEtMS05NzQ3Nw_56552a13-9e8e-47bb-9deb-cee3b7e8b66b">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idee014b8532443d785b4a01fa597c5c7_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNS00LTEtMS05NzQ3Nw_9133f51f-d9f2-4f66-84f1-571479206efc">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib42c16151a9a4724a372b6e2e07aec81_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNi0yLTEtMS05NzQ3Nw_f2c173e4-6cf9-49b0-91a4-889e12f0c925">413.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i22f2dbcd7d0a4089b97103d3d3afe54f_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNi0zLTEtMS05NzQ3Nw_2bbcc649-5113-44fd-9b84-e15531fcd7dc">145.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNi00LTEtMS05NzQ3Nw_c1cd07b1-0e5d-4f90-98a1-7a4aaf796fb4">559.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7f36606e666b4146adad29c31c074863_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfOS0yLTEtMS05NzQ3Nw_8eda560d-1034-46da-acd9-714d0dcd2964">212.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7a65e517835843be8d27d7cb21ff1b36_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfOS0zLTEtMS05NzQ3Nw_89c3001c-fc58-42f5-a985-da70aa1f2f37">52.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51a2e59e54574cd080bad373ef124b26_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfOS00LTEtMS05NzQ3Nw_2915273b-8694-4ae9-8abe-c8539164ab11">264.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7388165a9fbe4c68874d5c98159e6efd_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTAtMi0xLTEtOTc0Nzc_ade7c6b2-36b9-4856-809f-bec16242b2bd">57.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i08c907a0b9364379897608caed02a091_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTAtMy0xLTEtOTc0Nzc_37afbecd-5645-4638-be0f-1cdc181c886c">12.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id1416b6917304ee989571d01c9094fd5_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTAtNC0xLTEtOTc0Nzc_72bea9c6-0005-45cd-af50-aea0294f21bd">69.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe4ef9ffa5b8469f929dfa4f3760db7d_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTItMi0xLTEtOTc0Nzc_cb4f47b7-e414-4d41-a179-05d1227ec1d8">270.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie73d75b7f9d449cd9fbf4cc4956c951a_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTItMy0xLTEtOTc0Nzc_ca261fbf-7f0c-474d-9d81-e719c380c08b">64.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTItNC0xLTEtOTc0Nzc_6524cccf-3e36-4a48-8e71-b8544f511858">334.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51bc8c3e08e64a4d966f2689b7b9fca3_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTQtMi0xLTEtOTc0Nzc_f29f949c-e9a6-49f3-8af8-dc55a41a2bce">123.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e1959574bed4110a1c49d33f2343bce_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTQtMy0xLTEtOTc0Nzc_b8bf0e3e-9509-432a-b362-bbc1b4788bd4">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTQtNC0xLTEtOTc0Nzc_88fb53ae-b628-4b2c-9fa0-2c52229de32d">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if28f4b47974c4a738dd6e022d463262a_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTgtMi0xLTEtOTc0Nzc_0f88bd66-acc0-4367-981d-0fbbf6b15ed6">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i04bff6a5d47648fea88ce5c7a9bd0e30_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTgtMy0xLTEtOTc0Nzc_b9647f5e-36c4-4ba9-a6f4-34f0f748ad49">9.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTgtNC0xLTEtOTc0Nzc_78cdff7a-a690-48ef-a177-eb877492b552">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTktMi0xLTEtOTc0Nzc_e1af5a64-4e25-4771-95aa-5bab9d2d2e7b">823.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i17810aabf3f24d38be45e8306c3d0ebd_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTktMy0xLTEtOTc0Nzc_93064085-f2ea-4a3c-a8d1-52b95769541b">250.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTktNC0xLTEtOTc0Nzc_40a84919-ac30-470f-96e6-6bc82afbc1bf">1,074.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:3.196%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:53.270%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.677%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.680%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie4035e7e2acf45e69da33b7c6c319979_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMy0yLTEtMS05NzQ3Nw_018428a3-e7fe-4afe-bf47-19c813f8c942">80.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4254426126b9489587816dbe55a313ef_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMy0zLTEtMS05NzQ3Nw_740bb86a-623f-457d-b5c9-da58b3277db2">49.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia7b6e942d3ce4287ae8dd825a5bbc626_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMy00LTEtMS05NzQ3Nw_ff137045-7352-4d18-bd07-412857252152">130.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8db75acc45cb41b3936f464bdb0755de_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNC0yLTEtMS05NzQ3Nw_914faf2f-daa8-472b-9bbc-fca53f077853">528.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id80a68949b1d49319e7efed985768c09_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNC0zLTEtMS05NzQ3Nw_756ae398-1eb6-40b7-a1e0-4cb6b900e351">285.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i52bce32474874a61a1c93ed216e5bf26_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNC00LTEtMS05NzQ3Nw_56921375-8744-4d56-9ea3-b5c773749cb7">813.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae21e80b749742799ade28f359a906e9_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNS0yLTEtMS05NzQ3Nw_ed7801a0-88a9-48ec-9339-6ef247aa653f">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1eee1f1f7fda47a79e60a0733d804ab4_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNS0zLTEtMS05NzQ3Nw_22a9fac9-7e00-46e2-a149-c2b4f0081502">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife508b03a0c24293b8380f77af515a15_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNS00LTEtMS05NzQ3Nw_b5b17e0c-ad19-4a4f-80a7-96d1b738b286">6.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb2242435a5340c69a48e6d30b767133_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNi0yLTEtMS05NzQ3Nw_f6d88acd-3752-4348-8655-39ca46518307">615.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if2f090269cb448819fb3699673bc74d2_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNi0zLTEtMS05NzQ3Nw_ed3af565-b6b2-4065-a120-a187c448bc4f">335.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNi00LTEtMS05NzQ3Nw_3f1cc308-e2d8-469d-b867-447bc1e50400">950.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if0eed27597194772ac078e57b5d5f7a4_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfOS0yLTEtMS05NzQ3Nw_56d92f7b-40bc-4df8-b3ad-6cbf4d8ba28c">208.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf8975b9a0604bacb2f2ab4ca1780919_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfOS0zLTEtMS05NzQ3Nw_862e998e-f3c8-40c0-8bbc-5b97088050d8">73.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib09726cd3d914adbaa7747d82b3d9f72_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfOS00LTEtMS05NzQ3Nw_a1395871-a274-4a58-938f-87d73b1bc752">282.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ice7600161d394a1f844a8709af83b0be_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTAtMi0xLTEtOTc0Nzc_250c1423-7ad1-4bcb-af9b-3703eeb05036">62.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84a573e910f34c268f9a51a69f8fa78b_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTAtMy0xLTEtOTc0Nzc_3916a180-a136-432c-8992-4313aa2fad4b">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1f3865bf0674bd6b94548118ff2d889_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTAtNC0xLTEtOTc0Nzc_00371c72-a36a-4500-8ca0-8a978595bd9f">77.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i76b0a758c01b41e190b861904f705b3e_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTItMi0xLTEtOTc0Nzc_f9d94dbb-7986-4ab5-ae05-589f3be6cc47">271.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i972d2eac12d5498a8229fc8889a43517_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTItMy0xLTEtOTc0Nzc_df40cc0d-cdaa-4b37-bbf8-3818c081dbf5">88.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTItNC0xLTEtOTc0Nzc_a0444688-4fbc-48f4-afe6-2b51722bcba2">359.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie8a130a7154a42b4a3e2498da03f0bd9_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTQtMi0xLTEtOTc0Nzc_76b2a5a7-c041-4f0a-9bd5-a03fefc258f7">109.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8a538d4146054e4d87047cc9f7975933_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTQtMy0xLTEtOTc0Nzc_4131925a-1f6e-452e-ae3c-3a4c38fd0c7f">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTQtNC0xLTEtOTc0Nzc_e24eddf1-fd1e-4ff2-98df-f162a0de0fef">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic3fd7aa5f38f43d0a2cb58912a4606e3_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTgtMi0xLTEtOTc0Nzc_8e77ff0a-82ce-499b-a9b5-9f79b111ea1f">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib1a36d0d1182460d99b0fa319a28cb37_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTgtMy0xLTEtOTc0Nzc_6ccc5b94-cdab-4e12-b724-d102ff5f9221">10.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTgtNC0xLTEtOTc0Nzc_a84bb4b7-1aa9-435d-9551-fc497f955412">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTktMi0xLTEtOTc0Nzc_52797bf5-8b74-4bb9-b22d-0e942726b846">1,012.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i121cb63f710c4e60938523f4c50dfe98_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTktMy0xLTEtOTc0Nzc_82123636-0279-41fd-8169-070203f0a510">458.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTktNC0xLTEtOTc0Nzc_3b9075d7-69f3-4a2b-85fd-70b448e3e7b2">1,471.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="i1310effe8c37440eb2f5aca464f99107" continuedAt="i65b30099018747f3b3df1edee5c1d54e"><ix:continuation id="i546080ddabcb494ab5619ee5d7975b9f"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:60.790%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.956%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMi0yLTEtMS05NzQ3Nw_ad7a5b26-2e74-4d5d-b15d-8f40109d6c7c">823.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMi0zLTEtMS05NzQ3Nw_a1b3101b-3ab6-4df9-844e-f0abb73f2b41">1,012.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i023b583e3a5743b689087ebe2014e742_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMy0yLTEtMS05NzQ3Nw_595f2f83-f1ef-4c1d-a52c-5310e122bbc9">147.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7927fb2683384ee6ba18bcb24820aa75_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMy0zLTEtMS05NzQ3Nw_df34ab5a-bad0-4e5a-8a82-94eb1f5c1145">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9158b0a900c0492c87e53bb0bfe60c76_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNC0yLTEtMS05NzQ3Nw_5d247bc1-b8d8-4649-85a2-e8d37a61159b">63.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e03307d675a4c4794cdacb42a15022b_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNC0zLTEtMS05NzQ3Nw_5bb67453-d272-4df1-b3eb-bf95e5f94464">119.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2dd7194daee4e2687e5b9ae50540cdf_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNS0yLTEtMS05NzQ3Nw_9a3fd4ac-33fe-4061-97b1-01ffde16dbd2">39.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i84475ed4b97b45d2a58bd44b2464b6fd_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNS0zLTEtMS05NzQ3Nw_d285cab8-d0c2-411d-9ec6-a8c1eb2715eb">43.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNi0yLTEtMS05NzQ3Nw_4d5d45e7-4d4e-4249-bc59-147f5f58a7f9">1,074.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNi0zLTEtMS05NzQ3Nw_a2168899-9131-4859-aad3-c591cdfeb270">1,471.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"></td><td style="width:60.790%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.954%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.956%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5288beb020944838ab3e1ad08f68dad4_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMi0yLTEtMS05NzQ3Nw_4a2fe078-ca06-43d6-a642-aa3d4ab4f56d">727.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dbe4b4d36594aadabeeb6b5788626b0_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMi0zLTEtMS05NzQ3Nw_3f22f32a-92e2-436d-accb-89a7fbd2f707">1,106.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d55ea19e5c248d3aefe288d6d5f6d43_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMy0yLTEtMS05NzQ3Nw_7c15e32e-65eb-448d-9b45-ba2d36ea56c3">158.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3b62910ac86e4f18a8f2319faba92b2a_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMy0zLTEtMS05NzQ3Nw_e357983e-77e2-4e75-8842-dde83ab5c9ae">197.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iae7f2df5e66048c5a4d97e51f384eea7_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNC0yLTEtMS05NzQ3Nw_d0b5d169-3554-49dc-bd33-863ab5db0210">183.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i461d5f7bb915496b935d3720acf6161c_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNC0zLTEtMS05NzQ3Nw_e4719a62-a239-4ee1-bdf9-5c537cabd1d9">162.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01d38c9b3ccb4db89e86e540ca7bfbba_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNS0yLTEtMS05NzQ3Nw_6aeb2a3d-a066-4008-846b-c781d12eca41">4.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a3686a6966f49ad893900200aa534f4_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNS0zLTEtMS05NzQ3Nw_31c0d6f1-9a59-45f8-85b5-2d62655e49fb">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNi0yLTEtMS05NzQ3Nw_346e6861-f89a-4324-a2fb-645229fb6c6f">1,074.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNi0zLTEtMS05NzQ3Nw_9360b994-90e1-4917-8b45-d69f913f88fe">1,471.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefits of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty, and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from laboratory testing services, which is generated by the Company's Biotheranostics business, is recognized based upon contracted amounts with payors and historical cash collection experience for the same test or same payor group. Revenue is recognized once the laboratory services have been performed, the results have been delivered to the ordering physician, the payor has been identified, and insurance has been verified. The estimated timeframes for cash collection are three months for Medicare payors, six months for Medicare Advantage payors, and nine months for commercial payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="i65b30099018747f3b3df1edee5c1d54e"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company's contracts for the sale of capital equipment and related components, and assays and tests typically do not provide the right to return product, however, its contracts for the sale of its GYN Surgical and Interventional Breast Solutions surgical handpieces provide for a right of return for a limited period of time. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $<ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjMwNQ_6756c54d-1516-44a2-a781-ab559ff34d95">875.7</ix:nonFraction> million. These remaining performance obligations primarily relate to support and maintenance obligations and extended warranty in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately <ix:nonFraction unitRef="number" contextRef="iab3be1fea9b347e08c0fbc486d6eba52_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjU0Ng_907c926f-563c-4caf-a45a-d14784eb8775">35</ix:nonFraction>% of this amount as revenue in fiscal 2023, <ix:nonFraction unitRef="number" contextRef="i0170159e5fc647ee9b73c9274f3ad654_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjU5MQ_6a728109-dab7-4df6-9958-d832b570980d">32</ix:nonFraction>% in fiscal 2024, <ix:nonFraction unitRef="number" contextRef="ib03f3840b4e04200a761acaf93092033_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjYxMA_7d83b456-b737-4c21-8758-d6dc53a6a912">20</ix:nonFraction>% in fiscal 2025, <ix:nonFraction unitRef="number" contextRef="i343ac5e6f3c84d52b2f78181c3170b97_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjYyOQ_71b411ea-9ba3-4346-9a0e-5d18be5df233">9</ix:nonFraction>% in fiscal 2026, and <ix:nonFraction unitRef="number" contextRef="if2ae0d1ec03043af95521f9690cafd90_I20221231" decimals="2" name="us-gaap:RevenueRemainingPerformanceObligationPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjY1Mg_843b17eb-0292-4abe-ade0-b8030df92117">4</ix:nonFraction>% thereafter. As permitted, the Company does not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities in the Consolidated Balance Sheets. The Company recognized revenue of $<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNzk1OA_58d67c11-5a7c-462f-a7d5-b0b9ae591a25">66.8</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNzk2NQ_2a038356-1585-4150-89db-48d452bb7762">56.4</ix:nonFraction>&#160;million in the three months ended December 31, 2022 and December 25, 2021, respectively, that was included in the contract liability balance at September 24, 2022 and September 25, 2021, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_43"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(3) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80My9mcmFnOjI3OWNkNGRiYzMyMzQ3MTFhMTJhY2M3NDk0Y2NiNzcwL3RleHRyZWdpb246Mjc5Y2Q0ZGJjMzIzNDcxMWExMmFjYzc0OTRjY2I3NzBfMTAxMQ_041709af-c3ab-4895-914c-bd47e71ae408" continuedAt="i8cda4b3ddd79492bb255757bf4f542fe" escape="true"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80My9mcmFnOjI3OWNkNGRiYzMyMzQ3MTFhMTJhY2M3NDk0Y2NiNzcwL3RleHRyZWdpb246Mjc5Y2Q0ZGJjMzIzNDcxMWExMmFjYzc0OTRjY2I3NzBfMTAxMQ_060fbf70-38ca-4f23-a69d-03b14eb30da4" continuedAt="ifff338b56d1242a188fd1b5db3394ddc" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="i8cda4b3ddd79492bb255757bf4f542fe" continuedAt="i1b05b0a1ad0049ba8bd3641261f7a6b9"><ix:continuation id="ifff338b56d1242a188fd1b5db3394ddc" continuedAt="i08c32486102e489eaa0b4f3ac6527972">Lessor Activity - Leases where Hologic is the Lessor</ix:continuation></ix:continuation></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i1b05b0a1ad0049ba8bd3641261f7a6b9"><ix:continuation id="i08c32486102e489eaa0b4f3ac6527972">Certain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than <ix:nonFraction unitRef="number" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="2" name="holx:LeaseRevenuePercentageOfTotalRevenue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80My9mcmFnOjI3OWNkNGRiYzMyMzQ3MTFhMTJhY2M3NDk0Y2NiNzcwL3RleHRyZWdpb246Mjc5Y2Q0ZGJjMzIzNDcxMWExMmFjYzc0OTRjY2I3NzBfOTQw_1c9fc5b0-72d8-4d0f-ae71-7cdc0fdfcaff">3</ix:nonFraction>% of the Company's consolidated revenue for all periods presented.</ix:continuation></ix:continuation> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_46"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (4) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzIzMQ_0a8f22db-b307-4290-8e87-06a58dd0ffd3" continuedAt="i155bfba49d4846e2ba51e6e43de95819" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i155bfba49d4846e2ba51e6e43de95819" continuedAt="i2724708d24314603b1e3dd34fb0a4a2c"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative contracts. In addition, the Company has a contingent consideration liability that is recorded at fair value and based on Level 3 inputs. The contingent consideration liability as of December 31, 2022 and December 25, 2021 was related to the Acessa acquisition. </span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="i2724708d24314603b1e3dd34fb0a4a2c" continuedAt="i546c79928848472a97be757ee6adccef"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzIzMg_45b9e6fb-ad6f-4689-b5ad-36d7fce320d9" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;31, 2022:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:40.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.525%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie91293e66d194ed7b35c5cfe9f42b0a4_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC0xLTEtMS05NzQ3Nw_44c90b20-6723-4c5f-b40b-03d7d9f49afb">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d3fb98231024d8aaeb5bb8323a77efe_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC0zLTEtMS05NzQ3Nw_c07f2cbe-cdc1-45d1-ba3c-bc7c75097642">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9b9400e507d84e678a5c359b9f85f0a5_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC01LTEtMS05NzQ3Nw_a2c41ad6-4f30-4575-b36c-7cf4203e23cd">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6f9f58b445784504a1bf2cb52ed1b1dd_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC03LTEtMS05NzQ3Nw_e82863b1-217e-4f23-a8da-fb91b9914324">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifcc81839fd2d4dabbd199e560f9aff75_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi0xLTEtMS0xMDY2OTg_18de4f8d-fadc-4297-bcc2-b126741c3520">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11cfef20f9384ec3a5c511ca3d5c9667_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi01LTEtMS0xMDY3MDA_69e25a10-a869-4c8f-8060-c575958f744f">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id87e29cdda514b4fba2087505293883f_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi0xLTEtMS05NzQ3Nw_19ea0c4e-5bf4-4731-beb1-307530ba042b">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8b7d6e54b06f4b8ca98b5e0a69ed1552_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi0zLTEtMS05NzQ3Nw_08c21c87-210a-42be-bd46-ad7ef30013dc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6da937d0b81c484fafd31d8ccb9153a3_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi01LTEtMS05NzQ3Nw_4369d2cc-ef0a-449b-b255-bcf12209f5b4">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4cc1dbc4bf77455684932730e1b2c790_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi03LTEtMS05NzQ3Nw_cf3b5cc2-6e43-47bf-b07a-5568db8bcb14">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy0xLTEtMS05NzQ3Nw_afbd5e03-61d3-43c9-9cf5-337bf97dad9e">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idddbd7f5e3d144eb82b55c015f5f4a19_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy0zLTEtMS05NzQ3Nw_28802a0a-1f15-4b37-8abc-ab9e1807ec26">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc27b2eb58e94a3ea4a4352a38a0b0d6_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy01LTEtMS05NzQ3Nw_df408ffd-4f49-40d8-96cf-fcf39b6b0428">39.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ebbdfc813948f5b2ac23261acc5170_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy03LTEtMS05NzQ3Nw_925d1cda-1fd1-4eb4-b5d7-d6c9e57e4b24">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9338d4109670455dbe967e46d7506077_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS0xLTEtMS05NzQ3Nw_2056295f-8f83-40a2-98d7-4c7f37145f08">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2050fb386a4c429cbc768ceb88089203_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS0zLTEtMS05NzQ3Nw_60d956e5-688d-4870-86e8-74ecfb0230b2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ief97bdd54b7c44619fbcf4a88df99626_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS01LTEtMS05NzQ3Nw_97ccf89d-f0b5-4270-a3bb-aed7cd7afc8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idab2972813444a1590e68c0af622c531_I20221231" decimals="-5" name="us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS03LTEtMS05NzQ3Nw_9c78f0a6-762e-4a39-bc29-2cf62a4678f8">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89cf56ee2c6d48f79ce43d6e357253e1_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtMS0xLTEtOTc0Nzc_db805ca1-7be1-438b-9a59-a958ce38f027">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9895e82979cd46e5b9e29032558cf8f0_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtMy0xLTEtOTc0Nzc_b07baf98-8ebe-4537-a815-d5ce5c101170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7fa3655b5c4b41899337fbf34ce3a418_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtNS0xLTEtOTc0Nzc_fed6cf6f-fb81-4363-bcfa-260505a636bc">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib24e943c04e946d3b20fd2005eebdcf2_I20221231" decimals="-5" name="us-gaap:InvestmentsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtNy0xLTEtOTc0Nzc_be877132-2092-4ece-a451-0e49cd78b869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItMS0xLTEtOTc0Nzc_03c2fce5-20ea-44f4-a5d0-f415d45d598f">24.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idddbd7f5e3d144eb82b55c015f5f4a19_I20221231" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItMy0xLTEtOTc0Nzc_432b24d2-13dd-4034-ad6f-4247d6879150">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibc27b2eb58e94a3ea4a4352a38a0b0d6_I20221231" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItNS0xLTEtOTc0Nzc_309ae921-2f7d-4b94-9f2d-cae936f511c4">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ebbdfc813948f5b2ac23261acc5170_I20221231" decimals="-5" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItNy0xLTEtOTc0Nzc_a746a339-2749-4f7e-9221-0447dc9ede39">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 31, 2022 and December 25, 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.976%"><tr><td style="width:1.0%"></td><td style="width:8.583%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:54.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.698%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.590%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.701%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMi0yLTEtMS05NzQ3Nw_ad0610d8-99c1-4901-9b5a-d2ff1faacf78">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMi00LTEtMS05NzQ3Nw_2584fe26-6752-432a-877c-8a76230eb3b8">75.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMy0yLTEtMS05NzQ3Nw_6700ad90-928f-489b-9633-c9e877396437">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMy00LTEtMS05NzQ3Nw_d6e3adb8-bc97-4d27-ab6a-fd570f8e93fd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNC0yLTEtMS05NzQ3Nw_86e69df9-efff-4a06-a4f2-2362c2a3d3e1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNC00LTEtMS05NzQ3Nw_b31330b9-3d4e-4459-97f7-7ee3a0a09de3">4.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNS0yLTEtMS05NzQ3Nw_f69b8ca1-919a-483f-bb57-81efa82280fb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNS00LTEtMS05NzQ3Nw_b0b5da9c-954b-494e-9d35-43141b1546fa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNi0yLTEtMS05NzQ3Nw_bbef819e-5628-461f-8686-46b9bac2cc4b">23.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225" decimals="-5" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNi00LTEtMS05NzQ3Nw_3994bf0b-c7e8-4cc3-8e3b-a879a59f1322">71.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets, and goodwill. During the first quarter of fiscal 2022, the Company recorded a $<ix:nonFraction unitRef="usd" contextRef="iefd5e2be463d4709a964b3675267c84b_D20210926-20211225" decimals="-5" name="us-gaap:LossOnSaleOfInvestments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMTY2Ng_c45f3cc9-25e8-4ed1-a73f-d95ccca3cc89">4.3</ix:nonFraction>&#160;million charge to write-off an equity method investment acquired in the Mobidiag acquisition. There were no other remeasurements in the three months ended December&#160;31, 2022 and December&#160;25, 2021. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its equity investments approximate fair value.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i546c79928848472a97be757ee6adccef">Amounts outstanding under the Company&#8217;s 2021 Credit Agreement of $<ix:nonFraction unitRef="usd" contextRef="ie8285876f9504f55b719cb94a43fd897_I20221231" decimals="-8" name="holx:PrincipalAmountOfBorrowings" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMjY2Ng_0be8e1ee-05b3-4675-b1ce-143d92885aa3">1.5</ix:nonFraction> billion aggregate principal as of December&#160;31, 2022 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s <ix:nonFraction unitRef="number" contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMjkxNw_a170d7a7-706b-4ec4-801b-47157937809c">4.625</ix:nonFraction>% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) and <ix:nonFraction unitRef="number" contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMjk3Mg_30b630f3-1000-4278-b36b-11ee949a8b62">3.250</ix:nonFraction>% Senior Notes due 2029 (the &#8220;2029 Senior Notes&#8221;) had fair values of $<ix:nonFraction unitRef="usd" contextRef="ib8c253e80fb5495fa148fef676c31327_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzA0Mg_45e49d86-fb92-4de9-b9c1-6e86b2ab660b">373.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i1c866db25ccd49bf9837ddb6f3695f2e_I20221231" decimals="-5" name="us-gaap:DebtInstrumentFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzA0OQ_a7c58b62-ce67-41c1-98a8-4fc6b1984aa7">819.2</ix:nonFraction> million, respectively, as of December&#160;31, 2022 based on their trading prices, representing a Level 1 measurement. Refer to Note 7 for the carrying amounts of the various components of the Company&#8217;s debt.</ix:continuation></span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_49"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> (5) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:BusinessCombinationDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ4MDM_7f73a07e-500a-4441-af33-c806b784ec8e" continuedAt="i74f9ccad8707423f8555da6db5a2ab38" escape="true">Business Combinations</ix:nonNumeric></span></div><div style="text-indent:27pt"><span><br/></span></div><ix:continuation id="i74f9ccad8707423f8555da6db5a2ab38" continuedAt="i4e7d826eb2c446d195b9a29b4960ede1"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2022 Acquisition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bolder Surgical</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, the Company completed the acquisition of Bolder Surgical Holdings, Inc. ("Bolder"), for a purchase price of $<ix:nonFraction unitRef="usd" contextRef="iea43d0cf9441456ca855066f24c915b7_D20211129-20211129" decimals="-5" name="us-gaap:BusinessCombinationConsiderationTransferred1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjA2_177a918b-811a-4501-9eb9-e6991c5bfce7">160.1</ix:nonFraction>&#160;million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Bolder's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ4MDQ_4d45a8f1-2168-430b-b97f-3f6fb7026ac3" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Bolder's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"></td><td style="width:7.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:62.853%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.878%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMC0yLTEtMS05NzQ3Nw_4ecd7d87-fa73-46e2-b1c6-e64659457705">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMS0yLTEtMS05NzQ3Nw_80430051-e027-474f-b648-b68c5740a200">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMi0yLTEtMS05NzQ3Nw_cbae4e68-3eae-47d3-a86a-cf9b47b237ff">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfNC0yLTEtMS05NzQ3Nw_e33ce48c-03f6-4df7-9b7b-fb8ef5ed4635">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfNS0yLTEtMS05NzQ3Nw_0792a70e-69ed-4bc4-8052-1194db01c2ae">3.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfOC0yLTEtMS05NzQ3Nw_afa10c9b-1bca-4b0a-87fb-ec4fa2c67c70">73.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationship</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfOS0yLTEtMS05NzQ3Nw_86eae5ce-5870-43b5-ac8c-d5d370375bbb">21.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTAtMi0xLTEtOTc0Nzc_35dcccb0-83b3-4649-87d9-c5260b66574b">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTMtMi0xLTEtOTc0Nzc_89da620c-c4fb-46af-a930-80f7558ac806">11.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTQtMi0xLTEtOTc0Nzc_9786a75b-e7f3-48bd-8ea6-b6c583b4bcc8">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129" decimals="-5" name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTUtMi0xLTEtOTc0Nzc_61017e3a-722f-47e1-bfeb-8f4fa734ef3b">160.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Bolder's business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the purchase price allocation, the Company determined the identifiable intangible assets are developed technology, customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a <ix:nonFraction unitRef="number" contextRef="iea43d0cf9441456ca855066f24c915b7_D20211129-20211129" decimals="2" name="holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTU0NQ_c3b8f993-abb3-40cd-bef2-4edc78b64884">16.0</ix:nonFraction>% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Bolder's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the JustRight and CoolSeal technology platforms.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of the weighted average life for the developed technology, customer relationship, and trade name assets is <ix:nonNumeric contextRef="i1481f69a4d9244499f5a549cc0eebe59_D20211129-20211129" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjIwMQ_48af52b9-57ab-4f48-b9fe-163887f4912a"><ix:nonNumeric contextRef="iba6cbbe07ee948f583f8d1f77e05e475_D20211129-20211129" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjIwMQ_a5579a2e-de85-4f6a-90a9-108357ed8da5"><ix:nonNumeric contextRef="iab72fa2f468444a685a69c28852ec73b_D20211129-20211129" name="us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjIwMQ_a6ca8004-d527-4a35-97da-76f944bc0346">10</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Bolder acquisition. These benefits include expanding the Company's surgical portfolio and utilizing GYN Surgical's sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i4e7d826eb2c446d195b9a29b4960ede1"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contingent consideration liability related to its acquisition of Acessa Health, Inc. ("Acessa"), which occurred in August 2020. Acessa developed the ProVu laparoscopic radiofrequency ablation system. The Company estimated the fair value of this liability to be $<ix:nonFraction unitRef="usd" contextRef="i4698c57aad0746b78ce06e44b93c84fc_I20200823" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTIzNjA_1a08f645-964f-4b23-b14d-56d331044f70">81.8</ix:nonFraction>&#160;million as of the acquisition date. The contingent payments are based on a multiple of annual incremental revenue growth over a <ix:nonNumeric contextRef="iae84daa015564a61a94ab772911423dd_D20200823-20200823" name="holx:AnnualIncrementalRevenueGrowthPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ4MDg_1a7d2de8-8227-4c3b-957d-ba131d807196">three-year</ix:nonNumeric> period ending annually in December of each of 2021, 2022, and 2023. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 805), the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, revenue growth rates of comparable companies, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change and such adjustments are recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or gains. During the year ended September 24, 2022, the Company remeasured the contingent consideration and recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="i343e49832f164c1a89e8c46e7295b5be_D20210926-20220924" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTA5OTUxMTY2ODMzNQ_f6e0b41a-d1a7-4787-a7cf-a26ed52dd92b">39.5</ix:nonFraction>&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period and to a much lesser extent an increase in the discount rate driven by market rates. During the three months ended December 25, 2021, the first measurement period was completed, and the Company recorded a gain of $<ix:nonFraction unitRef="usd" contextRef="iaea12adf8afb44a3a25469e63012eb04_D20210926-20211225" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ0ODc_dd3cd79e-ee95-460b-9f07-3d5d5f8abfb2">4.1</ix:nonFraction>&#160;million to decrease the contingent consideration liability to fair value based on actual revenue results in the first earn-out period. During the second quarter of fiscal 2022, the Company made a payment of $<ix:nonFraction unitRef="usd" contextRef="ia8ff31aae0694a0aa8817256292f1722_D20220925-20221231" decimals="-5" name="holx:BusinessCombinationContingentConsiderationPayments" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ2ODk_b57bbcea-3098-46b8-9474-e74dda024abc">12.2</ix:nonFraction>&#160;million for the first earn-out period. During the three months ended December 31, 2022, the second measurement period was completed, resulting in an estimated amount of $<ix:nonFraction unitRef="usd" contextRef="ia8ff31aae0694a0aa8817256292f1722_D20220925-20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTA5OTUxMTY2ODY1OA_45d8bab9-9197-4344-b235-ea0caef9f0e6">7.2</ix:nonFraction>&#160;million. No additional adjustment was recorded based on actual and forecasted results. As of December 31, 2022, the contingent consideration liability was $<ix:nonFraction unitRef="usd" contextRef="iacaca98377e84dea8c3dcc6d430e498c_I20221231" decimals="-5" name="us-gaap:BusinessCombinationContingentConsiderationLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ3ODc_86f7aa05-b328-4034-b840-4447a7f191ca">23.4</ix:nonFraction>&#160;million.</span></div></ix:continuation><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_52"></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfMTQ2Mw_d90897cf-0d57-43d5-815a-5c65cf738f09" escape="true"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company finalized its decision to close its Danbury, Connecticut facility where it manufactures its Breast Health capital equipment products. The manufacturing of the Breast Health capital equipment products and all other support services will be moved to the Company's Newark, Delaware facility. In addition, research and development, sales and services support and administrative functions will be moved to the Newark, Delaware and Marlborough, Massachusetts facilities. The transition is expected to be completed by the third quarter of fiscal 2025. The majority of employees located in Danbury were given the option to relocate to the new locations. As a result of this plan, the Company expects a number of employees to not relocate resulting in their termination. The employees were notified of the closure during the first quarter of fiscal 2022, but were not communicated about their termination and related severance benefits until the third quarter of fiscal 2022. The Company is recording severance benefits pursuant to pursuant to ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 420), and the severance benefits are being expensed ratably over the required service period. As a result, the Company recorded severance charges of $<ix:nonFraction unitRef="usd" contextRef="i3506cb7a03e440d886dbc72ce84c14b7_D20220925-20221231" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfNTQ5NzU1ODE5ODYz_33ea71c2-59fc-40b7-bbaa-95b1096a8f1e">0.7</ix:nonFraction>&#160;million in the first quarter of fiscal 2023 and $<ix:nonFraction unitRef="usd" contextRef="i30bcf60271074f93a183af070bda3ce1_D20210926-20211225" decimals="-5" name="us-gaap:RestructuringCharges" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfNTQ5NzU1ODE5ODkw_47e8b682-8486-4838-9925-ae5ff08dd4d1">1.6</ix:nonFraction>&#160;million in fiscal 2022, respectively. The Company estimates that total severance charges, including retention, will be approximately $<ix:nonFraction unitRef="usd" contextRef="ideae2329e17d435e83ee4db40e5b76df_I20221231" decimals="-5" name="us-gaap:RestructuringAndRelatedCostExpectedCost1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfMTQ2MA_9493d04a-aa5c-476f-93ef-065d405bfcb6">7.0</ix:nonFraction>&#160;million.</span></div></ix:nonNumeric><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_55"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(7) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0NjU_b6a50394-269b-4dab-b93a-6772b4249aff" continuedAt="ifd357b35dcb3460c9884814ad2640c5c" escape="true">Borrowings and Credit Arrangements</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="ifd357b35dcb3460c9884814ad2640c5c" continuedAt="i94aeb774abbe4c028ec67fffc5679489"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0ODM_dda80a07-e79f-4d5c-9f60-c6cf63c3df95" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.461%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.329%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i333952b4e5b04176801bb8b51ea10d2b_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMi0xLTEtMS05NzQ3Nw_d1f5efc7-2b64-4ddd-b4ec-67c69931dfc5">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab94eadaf80646c99688a0bc7890d803_I20220924" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMi0zLTEtMS05NzQ3Nw_0d00930a-a070-43b0-90cd-52ba1615d237">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfNi0xLTEtMS05NzQ3Nw_e9743203-b173-4c55-b0a0-fdad180d99c6">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LongTermDebtCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfNi0zLTEtMS05NzQ3Nw_1f5ab705-d5a7-42df-b2dc-c745876b0cf5">15.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i333952b4e5b04176801bb8b51ea10d2b_I20221231" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfOC0xLTEtMS05NzQ3Nw_4b611c00-a8be-48c1-863c-6f201edca1e1">1,472.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab94eadaf80646c99688a0bc7890d803_I20220924" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfOC0zLTEtMS05NzQ3Nw_be340dab-09e2-49ad-98ff-a08fe2b1144b">1,475.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia2d07a69cb1c487c91cc762762bc1d0e_I20221231" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTAtMS0xLTEtOTc0Nzc_c7f82ed0-2aa0-409a-b4de-49c2f7e28b41">396.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc35cfa947f44998ff3996d2aa84afd_I20220924" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTAtMy0xLTEtOTc0Nzc_ee78a108-b07b-44c3-8d6e-403fe03fe91d">396.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34650814b5cc4021acd04ac86d799f20_I20221231" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTEtMS0xLTEtOTc0Nzc_a57791fc-213f-48e1-bb9f-1196c7454be4">937.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79d0d70331034758a653310fab36e412_I20220924" decimals="-5" name="holx:LongTermDebtObligationsWithoutConvertibleNotes" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTEtMy0xLTEtOTc0Nzc_e24cb36f-849a-4dca-8c77-89182695838d">936.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTMtMS0xLTEtOTc0Nzc_befff357-3af3-49cf-9314-375e86b00427">2,806.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LongTermDebtNoncurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTMtMy0xLTEtOTc0Nzc_65d9438a-da07-4fab-90ed-aa87ce64884e">2,808.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTQtMS0xLTEtOTc0Nzc_9113939d-bf7b-4197-9199-ce58c733cba0">2,826.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LongTermDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTQtMy0xLTEtOTc0Nzc_ad079fc7-018d-4a8c-9cd7-cf17a6893aa0">2,823.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 27, 2021, the Company refinanced its then existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders (the "2018 Credit Agreement") by entering into a Refinancing Amendment (the "2021 Credit Agreement"). On August 22, 2022, the Company further amended the 2021 Credit Agreement by entering into an amendment to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rates applicable to the loans under the 2021 Credit Agreement denominated in U.S. Dollars were converted to a variant of the secured overnight financing rate (&#8220;SOFR&#8221;), as established from time to time by the Federal Reserve Bank of New York, plus a corresponding spread.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provides for a $<ix:nonFraction unitRef="usd" contextRef="i345a638c3ba941e1855a959c897f7176_I20210927" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3MjkzNw_46f64623-e009-4c59-9f90-efdb09931a4e">1.5</ix:nonFraction>&#160;billion secured term loan facility (the "2021 Term Loan") and a $<ix:nonFraction unitRef="usd" contextRef="i16715a72d92e441993d6789cac1dbd2f_I20210927" decimals="-8" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTQ1NQ_e38bcc57-0ad6-4a8f-b7e2-34954843a9f6">2.0</ix:nonFraction>&#160;billion revolving credit facility (the "2021 Revolver"). As of December 31, 2022, the principal amount outstanding under the 2021 Term Loan was $<ix:nonFraction unitRef="usd" contextRef="i10401dc3383842b09980d3a937fb7508_I20221231" decimals="-8" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfNDUxNDU_f9f366f3-4555-4428-904a-26d0a0e850cb">1.5</ix:nonFraction>&#160;billion, and the interest rate was <ix:nonFraction unitRef="number" contextRef="i10401dc3383842b09980d3a937fb7508_I20221231" decimals="4" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3MjkwOQ_8632dcd8-f21f-4b86-b820-3d86fd53b08a">5.43</ix:nonFraction>% per annum. No amounts were outstanding under the 2021 Revolver and the full amount was available to be borrowed by the Company. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 470), the accounting for the refinancing was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2018 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $<ix:nonFraction unitRef="usd" contextRef="i6f5ef2ef76fd4192b1f4f10266a76b4e_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:GainsLossesOnExtinguishmentOfDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfNjU2MQ_4de1b635-860f-440a-8e5d-aa7c3e972bbb">0.7</ix:nonFraction>&#160;million in the first quarter of fiscal 2022 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification. Pursuant to ASC 470, third-party costs of $<ix:nonFraction unitRef="usd" contextRef="idfaac04d4a484d258c3db28ddc02ff2e_I20221231" decimals="-5" name="us-gaap:DeferredFinanceCostsNet" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfNjg1MA_02882f86-8a25-4a3d-be97-4dd8bc95b4b4">7.0</ix:nonFraction>&#160;million were recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0NjA_5f277121-b412-4f87-ada2-3fbae6c5f977" escape="true"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.274%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.128%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.129%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMi0xLTEtMS05NzQ3Nw_38e70d84-c2f9-4b2b-b831-72b014ae93fa">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ica33b08d41d34461b027e01d397de44f_D20210926-20211225" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMi0zLTEtMS05NzQ3Nw_73bb2d00-f49d-4c32-8311-0c036770212d">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMy0xLTEtMS05NzQ3Nw_2a7ddc6a-6b2e-48ec-bb5c-699b7780469d">4.63</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ica33b08d41d34461b027e01d397de44f_D20210926-20211225" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateDuringPeriod" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMy0zLTEtMS05NzQ3Nw_d8f0987b-c2d3-45cf-83bb-346210431bd4">1.09</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie8285876f9504f55b719cb94a43fd897_I20221231" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfNC0xLTEtMS05NzQ3Nw_c7c2c984-95f5-49bf-90bc-ed73d01388bc">5.43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i0e9943e6f8ff4c8aaec563317ae88d47_I20211225" decimals="INF" name="us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfNC0zLTEtMS05NzQ3Nw_5ca90e2b-ee10-4c7a-9ed1-814f4dbad994">1.10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest rate swap, which fixes the rate on $<ix:nonFraction unitRef="usd" contextRef="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231" decimals="-5" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk1MQ_bc1884d1-e4a0-4844-b0fa-e2e708f3bd53">1</ix:nonFraction>&#160;billion of aggregate principal under the 2021 Term Loan at <ix:nonFraction unitRef="number" contextRef="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk2Mw_2e0a4d9d-954a-495c-bb89-756cd7c80777">1.23</ix:nonFraction>%, resulted in the Company receiving $<ix:nonFraction unitRef="usd" contextRef="i0ca833a47aa541e992640c358c110349_D20220925-20221231" decimals="-5" name="us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk3MA_35ce33b0-c5a4-4224-80a5-02a3ef19aa32">6.6</ix:nonFraction>&#160;million in the first quarter of fiscal 2023, which was recorded as a reduction to interest expense.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="i94aeb774abbe4c028ec67fffc5679489"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2021 Credit Agreement. As of December 31, 2022, the Company was in compliance with these covenants.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had <ix:nonFraction unitRef="number" contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk4NA_9cf80363-2030-4f83-9935-2ed31c56d29c">4.625</ix:nonFraction>% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231" decimals="-6" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfOTQ3MA_e03a6dc0-1464-431a-abbb-2c6d841ae139">400</ix:nonFraction> million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had <ix:nonFraction unitRef="number" contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231" decimals="5" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk5Mg_549010d1-9c08-4124-9be9-891d2cf7b679">3.250</ix:nonFraction>% Senior Notes due 2029 (the "2029 Senior Notes") outstanding in the aggregate principal balance of $<ix:nonFraction unitRef="usd" contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231" decimals="-6" name="us-gaap:SeniorNotes" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfOTgxNg_01e2ced5-052d-4432-a8c1-fc6e5002a157">950</ix:nonFraction>&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries and mature on February 15, 2029.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0NzQ_7457e9f7-00dc-4fe5-b939-80ce952371df" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:58.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.792%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfMy0xLTEtMS05NzQ3Nw_a170d7a7-706b-4ec4-801b-47157937809c">4.625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id225da1e135b44f7a25d7b8427d9693e_D20220925-20221231" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfMy0zLTEtMS05NzQ3Nw_fe4ba797-1251-4d55-811f-c8292680e398">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id9b7e75f146848e4bc229589975b5948_D20210926-20211225" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfMy01LTEtMS05NzQ3Nw_aba58075-2856-4939-bcc2-cbe6dc6172db">4.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNC0xLTEtMS05NzQ3Nw_30b630f3-1000-4278-b36b-11ee949a8b62">3.250</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i34f00671c17749c98d26591f7dc95d11_D20220925-20221231" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNC0zLTEtMS05NzQ3Nw_77980c3c-5048-4cc4-9fd4-4a6420be49d6">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c0114bb00874bbcae4df17922168466_D20210926-20211225" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNC01LTEtMS05NzQ3Nw_6433a86b-43df-4971-9148-621552346255">8.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60ac9cd428ef42a7a8b91fa784f5f45e_D20220925-20221231" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNS0zLTEtMS05NzQ3Nw_fed6ecd2-8d75-4cb5-a3c4-9a68b965951e">14.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6764b5e8e67e48f791728d79a2e34122_D20210926-20211225" decimals="-5" name="us-gaap:InterestExpenseBorrowings" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNS01LTEtMS05NzQ3Nw_c60c6a84-5d8d-4506-a42d-2cfd9d22e40b">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During April 2022, the Company repaid the outstanding balance of $<ix:nonFraction unitRef="usd" contextRef="i167654f352a04de29b14663bc8cdcfc0_D20220401-20220430" decimals="-5" name="us-gaap:RepaymentsOfOtherDebt" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTAyNDI_851bd551-cf66-4eb3-b145-3f1e729d6eba">248.5</ix:nonFraction>&#160;million under its accounts receivable securitization program (the "Securitization Program"). On June 10, 2022, the Company amended the Credit and Security agreement with lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of December 31, 2022, the Company did not have any borrowings under this program.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_58"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(8) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RleHRyZWdpb246YmQzNTRkYzIwMDNmNGFkZWJkMmUyMzQzMDYzYWUxYzZfMTkwMg_00dbfbd7-83a8-4422-b3a7-8e6da13fe15f" continuedAt="i675df595dc004d848b25652dc5e571b7" escape="true">Trade Receivables and Allowance for Credit Losses</ix:nonNumeric></span></div><div><span><br/></span></div><ix:continuation id="i675df595dc004d848b25652dc5e571b7" continuedAt="i674ea3fcbb84447797b0917cd78b3c46"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to its trade receivables and allowances for credit losses, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RleHRyZWdpb246YmQzNTRkYzIwMDNmNGFkZWJkMmUyMzQzMDYzYWUxYzZfMTkwMw_0012a15f-30b9-46e1-856f-38b44895056d" escape="true">The following is a rollforward of the allowance for credit losses as of December 31, 2022 compared to December 25, 2021:</ix:nonNumeric></span></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="i674ea3fcbb84447797b0917cd78b3c46"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:22.455%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.270%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-offs,<br/>Payments and Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi0yLTEtMS05NzQ3Nw_b3062c16-1905-4c46-92ee-23b1619732f6">37.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi00LTEtMS05NzQ3Nw_f368c13c-8045-4f4a-bef9-bbc2d402e5f3">1.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi04LTEtMS05NzQ3Nw_76fd22be-16f2-446f-945e-114c1ca93d95">0.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi0xMC0xLTEtOTc0Nzc_4a42dc93-34cc-434a-9cd2-3a67cdeaf5a7">39.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy0yLTEtMS05NzQ3Nw_9031c6b7-3873-403e-b323-06d89a4b9494">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ProvisionForDoubtfulAccounts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy00LTEtMS05NzQ3Nw_48c5796b-89a2-4a5d-8b0c-cc11bb16ec80">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy04LTEtMS05NzQ3Nw_15b93fdf-1b4b-41e3-9a08-c13819d5e4ce">1.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy0xMC0xLTEtOTc0Nzc_39793575-6bcd-4e4f-8b5b-d63e8d3166dc">42.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_61"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(9) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:DerivativesAndFairValueTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg2OQ_788828fa-d6c1-4550-b580-411d0f61ddca" continuedAt="i895879aba3414f40bc39ccaa29ba4363" escape="true">Derivatives</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i895879aba3414f40bc39ccaa29ba4363" continuedAt="id561ed4582d1489c8314b4ce11b6b4b4"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate swaps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023.  On August 25, 2022, the interest rate swap agreement was restructured (consistent with the 2021 Credit Agreement)  to convert the benchmark interest rate from LIBOR to the SOFR rate effective September 23, 2022 with a termination date of December 17, 2023. The Company applied the practical and optional expedients in ASC 848, Reference Rate Reform, in evaluating the impact of modifying the contract, which resulted in no change to the accounting for this derivative contract. The notional amount of this swap is $<ix:nonFraction unitRef="usd" contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTE2MQ_87813d74-76e3-4ea3-a5c9-6690c0841689">1.0</ix:nonFraction> billion. The restructured interest rate swap effectively fixes the SOFR component of the variable interest rate on $<ix:nonFraction unitRef="usd" contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTI1OQ_6bfde1a5-4e6a-44c5-b31c-8a2f49bf7b4d">1.0</ix:nonFraction> billion of the notional amount under the 2021 Credit Agreement at <ix:nonFraction unitRef="number" contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924" decimals="4" name="us-gaap:DerivativeVariableInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTMyMA_e3953590-7ef8-45d3-b595-c730a0957146">1.23</ix:nonFraction>%. The critical terms of the restructured interest rate swap are designed to mirror the terms of the Company&#8217;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $<ix:nonFraction unitRef="usd" contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924" decimals="-8" name="us-gaap:DerivativeNotionalAmount" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTY2Ng_e4ffad0d-1183-46a8-b15e-58f7c08bad47">1.0</ix:nonFraction> billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in an asset position of $<ix:nonFraction unitRef="usd" contextRef="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTgxNg_21b1c7ee-3a99-45ed-a627-7a498b1842e1">35.1</ix:nonFraction> million as of December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Exchange Contracts and Foreign Currency Option Contracts</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts and as of December 31, 2022 the notional amount was $<ix:nonFraction unitRef="usd" contextRef="ie72a76382d1b4c529a23dfa89ceadc2c_I20221231" decimals="-5" name="holx:NotationalAmount" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfNTQ5NzU1ODIxNTY2_2a495cc9-77a6-4e20-b272-a28a55111a2c">369.2</ix:nonFraction>&#160;million. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense) income, net.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three months ended December 31, 2022 and December 25, 2021, respectively, were as follows:</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="id561ed4582d1489c8314b4ce11b6b4b4"><div style="text-align:justify"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg3Mg_378e806b-d8dd-4827-9f89-06642402f140" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:64.341%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.535%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.813%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c4e34d9d094f1fbf48292741f16b5d_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMy0xLTEtMS05NzQ3Nw_4107415d-55de-4d49-9ba4-45cf88090161">2.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied698bc89eaf4b6f80e13382683a1a03_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMy0zLTEtMS05NzQ3Nw_51be3c6a-0896-4bda-af4b-7608de83d573">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec75d669bbf346d6903c94657e8133f1_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNC0xLTEtMS05NzQ3Nw_e29010df-194a-475c-b0f3-29a358c9fce5">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadefe818aff343f093532897c969439a_D20210926-20211225" decimals="-5" name="us-gaap:DerivativeGainLossOnDerivativeNet" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNC0zLTEtMS05NzQ3Nw_972742dd-eb3b-4737-b022-c3405a98e883">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55939d7a42bd4556a498a480de79cd50_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNS0xLTEtMS05NzQ3Nw_b7a5ab38-a47c-4451-a76d-1447a88d33a7">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee71b2ee2b34924938fe48b466219ce_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:DerivativeGainLossOnDerivativeNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNS0zLTEtMS05NzQ3Nw_a4616a89-de68-4823-be9e-bb68d336c471">12.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib8c4e34d9d094f1fbf48292741f16b5d_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNy0xLTEtMS05NzQ3Nw_65ab0370-d53f-4fda-b2ad-b5e12b29452d">13.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ied698bc89eaf4b6f80e13382683a1a03_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNy0zLTEtMS05NzQ3Nw_7e521f17-caa7-4c54-af55-529412460fb4">6.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iec75d669bbf346d6903c94657e8133f1_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOC0xLTEtMS05NzQ3Nw_79c8ec60-10a8-49e1-ac39-eeecab83a4cb">8.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadefe818aff343f093532897c969439a_D20210926-20211225" decimals="-5" name="us-gaap:UnrealizedGainLossOnDerivatives" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOC0zLTEtMS05NzQ3Nw_3cfe22e7-98a6-40bb-b5f5-f9bb01012333">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55939d7a42bd4556a498a480de79cd50_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOS0xLTEtMS05NzQ3Nw_00d5b2a2-db0b-4443-9411-a800dd22e570">22.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifee71b2ee2b34924938fe48b466219ce_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOS0zLTEtMS05NzQ3Nw_b8df3b0e-12fd-483e-a52f-981c7c52e6ab">6.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMTEtMS0xLTEtOTc0Nzc_159d4fba-67d5-40cb-90cc-c3de421ae99a">24.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMTEtMy0xLTEtOTc0Nzc_50d1fc01-8429-486d-9f02-e60b247cea02">19.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:nonNumeric></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg2NQ_0eb9052d-6d7b-42d6-8a3e-95658db8e0af" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;31, 2022: </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.215%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.882%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.524%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i44fe85004cc04b32b3a10a1559c2e2ef_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNS0zLTEtMS05NzQ3Nw_4fbae32a-1537-4531-ae36-488f8c4fcfcf">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibac4befa17b047999f00b91ca7b94ef7_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNS01LTEtMS05NzQ3Nw_becf4555-4b15-4f69-b1bf-d5904f4a8a1b">31.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if13d8d495368452eb77bee9ff19dc345_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNi01LTEtMS05NzQ3Nw_cf8709ce-4756-4964-9ca4-a4e86a055b33">7.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9926b76c62324c0b958fed2b0e24ea5a_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNy0zLTEtMS05NzQ3Nw_547c484f-d6f1-4aef-ae3b-0b466bc49d77">35.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib2198af10da940cf86ae64d703bc53c5_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNy01LTEtMS05NzQ3Nw_e2dccc5d-196b-404b-9078-3136aa888760">38.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i56899b92d8d848078cfec5556948bfc9_I20221231" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTAtMy0xLTEtOTc0Nzc_424f31a2-e40a-4515-b60b-531cffb45062">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id4c139a224444cffae631f02c7acba9f_I20220924" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTAtNS0xLTEtOTc0Nzc_f0f00ddd-4993-4979-8a7b-c6c83626a5c6">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib71a2388896942158d0fc786a95eba81_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTEtMy0xLTEtOTc0Nzc_217e98b7-1a93-4f71-b88e-172ba3a81a21">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5fe6a4b393534f29abeeb1a68c843b13_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTEtNS0xLTEtOTc0Nzc_7e4c1e08-c035-4f36-968f-4534da880b56">10.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9e837bb262414d9dbc7e423824de0ec6_I20221231" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTItMy0xLTEtOTc0Nzc_b12e996d-7c30-4621-a73b-10391b2f540c">4.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i270cd6664faf43379c84adce180639da_I20220924" decimals="-5" name="us-gaap:DerivativeFairValueOfDerivativeAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTItNS0xLTEtOTc0Nzc_d873d9b8-657b-4373-9392-757a40daa76d">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6d535ec00f0f411dafec44429b007238_I20221231" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMjAtMy0xLTEtOTc0Nzc_379965fd-4a9a-4b67-b2ad-152102308278">0.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ff63602d630435f9e63019c5e7f9b83_I20220924" decimals="-5" name="us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMjAtNS0xLTEtOTc0Nzc_0cf5f290-9c6d-4072-a75c-48e090e7d650">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg1NQ_d6813788-8c41-4bb7-8af1-2897be66fe23" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.636%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.666%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.668%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0ca833a47aa541e992640c358c110349_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfMy0xLTEtMS05NzQ3Nw_070c808e-1b88-4f1a-94e3-cdc86c76d618">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e402eb79be640de87443d033aa21455_D20210926-20211225" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfMy0zLTEtMS05NzQ3Nw_bc009732-ab0f-42c4-9908-42fadcabe41e">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfNS0xLTEtMS05NzQ3Nw_2b7eee11-cc1b-45f8-9943-438665fa2b6f">2.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfNS0zLTEtMS05NzQ3Nw_5e8d2db1-f6bc-4042-9716-14bf3cbe4dae">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(10) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfNzkxMQ_d999ca3d-1e86-4eec-9ca7-6bd0e5f8a68c" continuedAt="i96a05456f3a649c7bc32fc8734b63ade" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i96a05456f3a649c7bc32fc8734b63ade" continuedAt="i675cf07753d04586ab849eb53a6ca451"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $<ix:nonFraction unitRef="usd" contextRef="i0dcc9f20204945ec878054956bb77035_I20180727" decimals="-5" name="holx:AmountAssessedInDamages" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfMTg4Ng_652180f5-8d84-4dad-a534-b42156c2d533">4.8</ix:nonFraction> million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed <ix:nonFraction unitRef="petition" contextRef="idaaa4b233a9344908933211ba063dc5f_D20160304-20160304" decimals="INF" name="us-gaap:LossContingencyNewClaimsFiledNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfMjQzNA_fa8c4086-f4a7-482b-b94f-32d37d4e71b0">two</ix:nonFraction> petitions at the United States Patent and Trademark Office ("USPTO") for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the Patent Trial and Appeal Board of the USPTO (&#8220;PTAB") declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018, the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied the Company's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor&#8217;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. On August 11, 2022, the Court of Appeals affirmed the district court ruling on the issue of assignor estoppel, which barred Minerva from challenging the validity of the patent rights it assigned to the Company and reinstated its earlier judgment against Minerva on infringement. On September 11, 2022, Minerva petitioned for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">en banc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the Court of Appeals decision. The Company filed its response on October 25, 2022, and on November 10, 2022, the Court of Appeals denied Minerva's petition ending the appeals process. During the first quarter of 2023, the Company received a payment for infringement damages in the amount of $<ix:nonFraction unitRef="usd" contextRef="i667766d52416443f8777bd5eeca5cef5_D20220925-20221231" decimals="-5" name="us-gaap:ProceedsFromLegalSettlements" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfNTQ5NzU1ODI1MDI5_0286e2d5-7054-4baf-8be1-7f096026b79b">7.4</ix:nonFraction>&#160;million, which included the original award of  $<ix:nonFraction unitRef="usd" contextRef="i0dcc9f20204945ec878054956bb77035_I20180727" decimals="-5" name="holx:AmountAssessedInDamages" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfNTQ5NzU1ODI1MDU2_c473f646-689e-4eae-9247-04b8ab578b0c">4.8</ix:nonFraction>&#160;million plus post-trial damages and interest. This amount was recorded as a credit to general and administrative expenses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On July 27, 2021, the Delaware district court granted the Company&#8217;s motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On </span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="i675cf07753d04586ab849eb53a6ca451"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it, the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 450). Legal costs are expensed as incurred.</span></div></ix:continuation><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_67"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(11) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RleHRyZWdpb246YzdmZmFmYmZlMDNjNDI3YmI2YjI1NWNjOTJmZTdiMDdfMTEy_ac92a23b-2ffb-4f08-9df6-0fb87115343b" continuedAt="i3f617e10990b4e0ab7a531d6a5541a1c" escape="true">Net Income Per Share</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i3f617e10990b4e0ab7a531d6a5541a1c"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RleHRyZWdpb246YzdmZmFmYmZlMDNjNDI3YmI2YjI1NWNjOTJmZTdiMDdfMTE0_72aa47bf-892c-4ab0-9b30-364673068323" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:68.797%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.584%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.534%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.585%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMi0xLTEtMS05NzQ3Nw_01869c1b-1838-40a1-93a9-973c952da1cf">247,319</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-3" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMi0zLTEtMS05NzQ3Nw_2ec5ba01-e3ee-41a2-92f6-cdf4ca45e4cf">253,499</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMy0xLTEtMS05NzQ3Nw_68600656-f112-46ea-a7a4-297a07655683">1,962</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-3" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMy0zLTEtMS05NzQ3Nw_e31223d8-804f-4086-81a8-82729c679b00">2,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNS0xLTEtMS05NzQ3Nw_dc3e3392-748e-411e-b507-1339e15118e2">249,281</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-3" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNS0zLTEtMS05NzQ3Nw_a9d382bb-4b4d-4f73-8ee3-09728d4f1135">256,070</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i435ccc0a3ea14ff99da3eb507f45b519_D20220925-20221231" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNy0xLTEtMS05NzQ3Nw_30a470fa-8d13-4d4f-9b96-341bfb372da9">1,631</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8933fd8cce38473bb6574d4ef3ed3dda_D20210926-20211225" decimals="-3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNy0zLTEtMS05NzQ3Nw_0a4d10b1-946d-4e0b-9357-643b9c235494">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:4pt;text-indent:24.75pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(12) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE5OQ_530e854b-9d90-4b29-8005-0496cf5f0571" continuedAt="i79d3b858358744c19a764a121b3468de" escape="true">Stock-Based Compensation</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i79d3b858358744c19a764a121b3468de" continuedAt="i966393e52a6245a0806c9aabce45e6db"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE4NQ_17cf6fb0-fe15-44bf-9d15-21b7ce99e127" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"></td><td style="width:63.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i046a8b5e3d6b499bacae51fc5c4a8ab5_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMi0xLTEtMS05NzQ3Nw_77a9041d-f3d4-4dab-969a-2da4e4d20c81">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i10182a4e9dbd401592fba602d8fc0dfc_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMi0zLTEtMS05NzQ3Nw_0b33eb57-6272-4bd7-aa36-a67effe45ca5">2.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia43275c19d1d4deb9bd1023171cfc883_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMy0xLTEtMS05NzQ3Nw_9ae27b61-717b-4424-8327-17e9dd84b694">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47792d9e50e24ce180eb23c262315201_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMy0zLTEtMS05NzQ3Nw_b015be61-1b7b-482c-b897-e2849edf2b23">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfd8fe55e66344279f13b5494e40abef_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNC0xLTEtMS05NzQ3Nw_cad31447-b4ac-4ee7-8933-6d42a24b747d">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i26800c2f43ab47478ff80253b55d85cc_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNC0zLTEtMS05NzQ3Nw_7be74396-3317-4310-a427-e68a35484aae">2.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if448d6a552274a47bac66865fb2016c6_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNS0xLTEtMS05NzQ3Nw_2fcf8544-6643-4036-937a-16d72eea0524">10.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5214cfde47fd4e71851f007985469117_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNS0zLTEtMS05NzQ3Nw_9fe159a7-9606-49c4-ab7f-9274ddf38f6a">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNy0xLTEtMS05NzQ3Nw_ae694529-9198-4eb5-8745-4f69e95d7349">20.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNy0zLTEtMS05NzQ3Nw_ca8815ab-f15e-4849-943a-d3013df3ad07">18.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase <ix:nonFraction unitRef="shares" contextRef="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTg4_deaa6563-9e25-4cd2-84b4-5a9a4faa1244">0.5</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i04a4cd810a09430fa9d6e1eb34765cf6_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTk1_bcf4245b-4f14-4a60-8ef4-e3b680dbc9b5">0.6</ix:nonFraction> million shares of the Company's common stock during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, with weighted-average exercise prices of $<ix:nonFraction unitRef="usdPerShare" contextRef="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE1_a6ad263b-b0cc-4ff6-a3e8-1d3489b21189">74.26</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i04a4cd810a09430fa9d6e1eb34765cf6_D20210926-20211225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzIy_b81c8fa2-417e-4c7f-aac5-40fbe559b482">71.15</ix:nonFraction>, respectively. There were <ix:nonFraction unitRef="shares" contextRef="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzUx_5386d14e-0fe8-4d7c-b73d-faab0bc0c017">4.5</ix:nonFraction> million options outstanding at December&#160;31, 2022 with a weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNDIy_d80b2214-659e-4a86-8369-db98a7f1a341">51.67</ix:nonFraction>.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="i966393e52a6245a0806c9aabce45e6db"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE5Nw_036dd188-f9ee-4a55-b0d6-665336d6043c" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"></td><td style="width:63.100%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.300%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMi0xLTEtMS05NzQ3Nw_e48d50a0-7f2b-4ae7-8389-e9a6baef278a">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMi0zLTEtMS05NzQ3Nw_46d023e9-aa99-4199-8a6a-25b8c663318d">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMy0xLTEtMS05NzQ3Nw_7149cd2f-bf0c-4bd4-9c93-d593769349c7">33.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMy0zLTEtMS05NzQ3Nw_bbdfcb8d-9157-487d-be31-18566d2e3efa">34.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNC0xLTEtMS05NzQ3Nw_9db3b5af-12a7-4ec9-bc8b-022f6f61b711">4.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNC0zLTEtMS05NzQ3Nw_67ef15fb-1c3e-4d79-b1dd-a6867fd51d97">4.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNS0xLTEtMS05NzQ3Nw_e50afd70-8839-43ef-8980-dd98da7543f2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNS0zLTEtMS05NzQ3Nw_8864dc82-ee14-4472-8357-6b548dd2f991">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNi0xLTEtMS05NzQ3Nw_f6d36ae4-834a-4608-90fc-db82a4f76fe3">25.81</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNi0zLTEtMS05NzQ3Nw_1dcdc1b6-a2d1-4d24-a8e7-77b246512cee">21.03</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted <ix:nonFraction unitRef="shares" contextRef="idb6f997f16b34e71947022ff6714b032_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNjQ0_e8c1ee37-c598-4e9d-aabf-4200c8ef6bcf">0.6</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i85e3227c7fe14f10bc6686036ba0ac71_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNjUx_4f3147c0-1437-45b6-82c8-8bbae277f3c0">0.6</ix:nonFraction> million restricted stock units ("RSUs") during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, with weighted-average grant date fair values of $<ix:nonFraction unitRef="usdPerShare" contextRef="idb6f997f16b34e71947022ff6714b032_D20220925-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNzg2_99301e57-f47c-44da-aa03-98c565b17f72">74.30</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i85e3227c7fe14f10bc6686036ba0ac71_D20210926-20211225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNzkz_bb62995e-8193-4ebd-aa49-6c79ccc73896">71.15</ix:nonFraction> per unit, respectively. In addition, the Company granted <ix:nonFraction unitRef="shares" contextRef="i503690e214944a309e402e9960e2e6e6_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfODUz_142f714b-3284-4bd4-9e3c-e2bb511291a0">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="idab51929268f46bc932b7830d8baf571_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfODYw_1e13b1d1-7271-4c08-b750-196d78527c8e">0.1</ix:nonFraction> million performance stock units ("PSUs") during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i503690e214944a309e402e9960e2e6e6_D20220925-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTA0NQ_2422dde1-40dd-460f-80b1-6eae4445922e">74.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="idab51929268f46bc932b7830d8baf571_D20210926-20211225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTA1Mg_bb8c6690-4af9-404e-86c2-e2913e5dff16">71.16</ix:nonFraction> per unit, respectively. Each recipient of PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" decimals="INF" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTEzMw_2aa91e3a-9945-4604-b745-c4f139464659">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTE0MA_7459e811-bdeb-4487-92f0-4c9cb668152b">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period, provided that the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTMyNg_c211e2bf-a723-4a64-ad4c-edf2a039c262">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="iddf3093b029a43d79dbb42728abb753e_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTMzMw_bf2f7b67-69b1-4a0d-87f5-7379e142276c">0.1</ix:nonFraction>&#160;million of FCF PSUs based on a three-year cumulative free cash flow measure ("FCF PSUs") to its senior management team, which had a grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTQ4MQ_3401a8ab-306a-40d5-be0d-855771dfe716">74.35</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="iddf3093b029a43d79dbb42728abb753e_D20210926-20211225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTQ4OA_5d7f6e73-9d0e-43fa-a131-a2b5acc740f8">71.16</ix:nonFraction> per unit during the three months ended December 31, 2022 and December 25, 2021, respectively. Each recipient of FCF PSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231" decimals="INF" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" format="ixt:fixed-zero" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTYzNA_9f333566-dc45-442d-a987-39b621a45fc9">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTY0MQ_eec84346-a20a-49ca-9673-f2d1c6bd024c">200</ix:nonFraction>% of the target number of shares of the Company's common stock at the end of the three-year measurement period. The PSUs and FCF PSUs cliff-vest <ix:nonNumeric contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTc4Nw_d7a01cfe-66a8-4d40-9784-52e6d2942de3">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted <ix:nonFraction unitRef="shares" contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjIzMA_19d5a48f-59da-480f-bd21-321ed01114b1">0.1</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="i9771af51c0794b19a9578e0b8ec0d00a_D20210926-20211225" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjIzNw_97ba693d-fede-4e45-b47d-d28e7e6a0236">0.1</ix:nonFraction> million market-based awards ("MSUs") to its senior management team during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively. Each recipient of MSUs is eligible to receive between <ix:nonFraction unitRef="number" contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" decimals="INF" name="holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" format="ixt-sec:numwordsen" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjQwNw_2aa91e3a-9945-4604-b745-c4f139464659">zero</ix:nonFraction> and <ix:nonFraction unitRef="number" contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" decimals="INF" name="holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjQxNA_7459e811-bdeb-4487-92f0-4c9cb668152b">200</ix:nonFraction>% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $<ix:nonFraction unitRef="usdPerShare" contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjYwOQ_76f778c6-70b2-414c-afc0-8b7d781fc589">97.91</ix:nonFraction> and $<ix:nonFraction unitRef="usdPerShare" contextRef="i9771af51c0794b19a9578e0b8ec0d00a_D20210926-20211225" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjYxNg_f397a42e-71b0-4a09-9f97-d82ccb459d2f">75.43</ix:nonFraction> per share using the Monte Carlo simulation model in fiscal 2023 and 2022, respectively. The MSUs cliff-vest <ix:nonNumeric contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231" name="holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjcyNw_6beac003-4721-4e48-aee6-1e03fa46f267">three years</ix:nonNumeric> from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At December&#160;31, 2022, there was <ix:nonFraction unitRef="shares" contextRef="ib205930814294a04ac8c44fa4d6e33e2_I20221231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjg2NQ_de3de514-a843-4771-b5d9-0724bb8c3399">1.7</ix:nonFraction> million in aggregate unvested RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, there was $<ix:nonFraction unitRef="usd" contextRef="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjk1Mg_9d332ddb-ebc0-4668-a1ca-c4dde35ad4fe">23.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8512fea0d6de4301aa283764d9659897_I20221231" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjk1OQ_5481d419-829a-4982-9c82-bac1e3f06244">95.3</ix:nonFraction> million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of <ix:nonNumeric contextRef="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE1MQ_4edbe580-61de-4ec3-a364-60e1586552e6">2.4</ix:nonNumeric> and <ix:nonNumeric contextRef="idb6f997f16b34e71947022ff6714b032_D20220925-20221231" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE1OA_5f0d008c-0774-46cc-a689-88cfdf693499">2.2</ix:nonNumeric> years, respectively.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_73"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(13) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="holx:DetailsOfCertainBalanceSheetAccountsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTc5NQ_a681bf25-911c-4cb3-b24e-3ae57c2cf245" continuedAt="i2518e096a0c6499c98319f44b5da7d17" escape="true">Other Balance Sheet Information</ix:nonNumeric></span></div><ix:continuation id="i2518e096a0c6499c98319f44b5da7d17"><div style="text-align:center"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTc5Nw_453c7e87-eaff-44c4-88ca-6f254f52b045" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:71.318%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.321%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.324%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMi0xLTEtMS05NzQ3Nw_7dca046a-ff2f-4e58-9687-8ea267d157e5">308.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMi0zLTEtMS05NzQ3Nw_e8716034-5ab3-4eee-8b25-e781e52e67a8">252.9</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMy0xLTEtMS05NzQ3Nw_e2a1d6b2-5044-4ad4-a193-41c5f3ace7de">70.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMy0zLTEtMS05NzQ3Nw_131092bc-d357-4204-9ba6-21da338441a2">60.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNC0xLTEtMS05NzQ3Nw_52d149aa-e4c9-4db3-b570-a6b4922869fd">298.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNC0zLTEtMS05NzQ3Nw_4759cfee-8122-4889-b8a5-2eeae60fbd17">310.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNS0xLTEtMS05NzQ3Nw_0f590a7c-1f36-44ad-a49b-5c4ab2d8fa5e">677.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNS0zLTEtMS05NzQ3Nw_c17de386-069f-4af6-8ee0-a59ad610440d">623.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTgwNA_6d836b0c-9656-4ea9-80d6-d5899ecee7b7" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:71.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.243%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.244%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMS0xLTEtMS05NzQ3Nw_b75a26df-3fa0-4278-af7f-8f7765097da2">396.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="holx:ManufacturingEquipmentAndSoftware" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMS0zLTEtMS05NzQ3Nw_2d167c5d-546c-4255-bd47-61fe5a12580d">394.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMi0xLTEtMS05NzQ3Nw_301d099a-5bee-4f76-9089-ea32e15fcc25">506.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="holx:EquipmentUnderCustomerUsageAgreements" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMi0zLTEtMS05NzQ3Nw_907871fd-8270-47ae-ab87-ec2d61c74001">486.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMy0xLTEtMS05NzQ3Nw_ab34ce87-f318-45c7-abd6-594791fe1191">206.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:BuildingsAndImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMy0zLTEtMS05NzQ3Nw_9f95f438-53f4-4115-9746-fc1bb75e613f">196.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNC0xLTEtMS05NzQ3Nw_a7e7b580-5822-4932-bbf4-30f38acc1e2e">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:LeaseholdImprovementsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNC0zLTEtMS05NzQ3Nw_41bc2b9c-5af3-4f26-9d88-c6008ee203da">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNS0xLTEtMS05NzQ3Nw_d960ae81-a068-4c0f-baeb-6367ee665f93">41.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:Land" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNS0zLTEtMS05NzQ3Nw_085e47a8-02a0-4d5e-8a36-5fc2f380e020">40.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNi0xLTEtMS05NzQ3Nw_c14f68f2-6995-46d8-8daa-8992c180de87">18.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FurnitureAndFixturesGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNi0zLTEtMS05NzQ3Nw_3ceb59fb-a73d-4132-93ce-85b5ef658c99">16.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNy0xLTEtMS05NzQ3Nw_cdf3cba8-b6b0-4fcb-b60c-3fc4b76794cc">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNy0zLTEtMS05NzQ3Nw_36302914-ca03-4746-bf79-0f6160806eec">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOC0xLTEtMS05NzQ3Nw_8fa376d3-fcfe-4550-a471-cd385e4b079b">1,222.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOC0zLTEtMS05NzQ3Nw_85262fdf-4f1f-42a6-ad94-1e66f39905d8">1,187.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOS0xLTEtMS05NzQ3Nw_7b7d3278-e64d-49c7-a2a5-af43d543d7b2">728.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOS0zLTEtMS05NzQ3Nw_a025afea-800f-424a-ae61-40ffa7f9e2d3">705.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMTAtMS0xLTEtOTc0Nzc_25a2b47a-f0a8-42df-965a-96204a7268c8">494.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMTAtMy0xLTEtOTc0Nzc_ee5458af-7d1f-4fe3-95d7-ea8560e854dd">481.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:nonNumeric></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company was awarded grants of $<ix:nonFraction unitRef="usd" contextRef="ib922bf6da6cc4631a901c3990795d953_D20210627-20210925" decimals="-5" name="holx:GrantsReceivedFromDepartmentOfDefense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTE1_baddbc1d-e15b-40f6-9f00-b15ee7245a19">7.6</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:GrantsReceivedFromDepartmentOfDefense" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTIy_ad0e0a4d-5838-4501-b4b1-c3d5cb2ee782">119.3</ix:nonFraction>&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants were specifically to fund capital equipment and labor investments to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to the Company paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements. However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts and obtaining approval from the DOD that the respective milestone has been met. As of December 31, 2022, the Company had $<ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:GrantsReceivableCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTI0MA_1020ada9-cc53-4b2d-b86e-935609854c32">20.5</ix:nonFraction>&#160;million of capital equipment that was awaiting approval from the DOD pending approval of completion of the defined milestones. In fiscal 2022, the Company received $<ix:nonFraction unitRef="usd" contextRef="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924" decimals="-5" name="holx:DepartmentOfDefenseFundsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfNTQ5NzU1ODE3MzM5_27adbd6a-abc0-4cc1-a2df-d98e046e09c5">75.0</ix:nonFraction>&#160;million from the DOD for reimbursement of capital equipment, which was recorded as a reduction of the cost basis of the purchased equipment. In addition, a portion of the DOD grant funds expenditures in connection with the project that do not qualify for capitalization and are recorded as a reduction to expenses, which was $<ix:nonFraction unitRef="usd" contextRef="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924" decimals="-5" name="holx:DepartmentOfDefenseFundsReceivedNotCapitalized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfNTQ5NzU1ODE3Mzk3_f6dc219f-fe94-4bb3-8b43-4a4f43353d1f">7.6</ix:nonFraction>&#160;million in fiscal 2022. During the three months ended December 31, 2022 and December 25, 2021, the Company received $<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="holx:DepartmentOfDefenseFundsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTQyMA_9aaf003d-54de-4698-bcd1-c0d7fb0626da">0.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="holx:DepartmentOfDefenseFundsReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTQyNw_77921e6d-7768-4928-a69e-00150daa49c4">21.3</ix:nonFraction>&#160;million, respectively, from the DOD, which was recorded as a reduction of the cost basis of the purchased equipment. Payments under these grants are subject to satisfaction of the conditions of the grants, including applicable governmental appropriations.</span></div></ix:continuation><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(14) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfMTgxMw_863988b3-6181-487a-bfd6-843cf52bb41c" continuedAt="ib37d10f6234d497ea519dadbc274aa91" escape="true">Business Segments and Geographic Information</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ib37d10f6234d497ea519dadbc274aa91" continuedAt="id80da73585894a00a9e4e5c3b9724ae2">The Company has <ix:nonFraction unitRef="segment" contextRef="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfNzI_d8bedf2d-ad52-480a-8613-247d6f11a32e">four</ix:nonFraction> reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. </ix:continuation></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="id80da73585894a00a9e4e5c3b9724ae2" continuedAt="iff167171bda4445fb65ef4572b1de6c0"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were <ix:nonFraction unitRef="usd" contextRef="if1c4506326454758a9ff17a52cc3174d_D20220925-20221231" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_23075d20-e6e9-44b5-a812-b1a7c7ea40fb"><ix:nonFraction unitRef="usd" contextRef="if1c4506326454758a9ff17a52cc3174d_D20220925-20221231" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_a51de1d4-6eda-4c46-8cd6-dc2d85c46858"><ix:nonFraction unitRef="usd" contextRef="i4d7693a500ed4ec4af97863e7ccb013a_D20210926-20211225" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_ac75e167-0d23-4404-aa30-7fabafc4695d"><ix:nonFraction unitRef="usd" contextRef="i4d7693a500ed4ec4af97863e7ccb013a_D20210926-20211225" decimals="INF" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_edd44283-8347-48a7-9cb1-0528562e1c85">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> inter-segment revenues during the three months ended December&#160;31, 2022 and December&#160;25, 2021. S<ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfMTgwNw_cb928c4e-b196-448b-adfb-f297312240fc" continuedAt="i4359e61673f24485bf8db9109873a94b" escape="true">egment information is as follows:</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:continuation id="i4359e61673f24485bf8db9109873a94b"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:69.134%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.416%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.533%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.417%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMy0xLTEtMS05NzQ3Nw_66c08712-5154-403a-b0f0-83005734de5a">559.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMy0zLTEtMS05NzQ3Nw_a73e3d25-19a2-4b42-87aa-82a7920e74de">950.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNC0xLTEtMS05NzQ3Nw_1d3f6048-fe29-456e-a887-ba5c14790d5a">334.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNC0zLTEtMS05NzQ3Nw_660d32ad-6528-4b3a-b7ed-e2888a994c0d">359.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNS0xLTEtMS05NzQ3Nw_4473a990-69a0-4c35-a0fa-b1f939cc23b0">154.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNS0zLTEtMS05NzQ3Nw_f8227678-792c-4e0e-b719-6daee4f2400b">134.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNi0xLTEtMS05NzQ3Nw_3305c7ce-6842-404e-9d25-16f6a0c5a837">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNi0zLTEtMS05NzQ3Nw_a8a29310-65e5-4df2-a682-db2f09c3cec9">27.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfOC0xLTEtMS05NzQ3Nw_bb84b9e4-9d98-4961-94e8-284cd42ae2db">1,074.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfOC0zLTEtMS05NzQ3Nw_6cb3e026-3050-43e9-9836-202d9998c2f7">1,471.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTAtMS0xLTEtOTc0Nzc_3b3ca1ff-c6b9-498c-a85e-14ea7ac4edf9">151.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTAtMy0xLTEtOTc0Nzc_8fafac86-9bee-4ecd-9b3c-2ac5de92fef7">531.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTEtMS0xLTEtOTc0Nzc_97a99f81-7bb0-428d-a346-07cf2948077e">60.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTEtMy0xLTEtOTc0Nzc_50ee6b13-3eab-4234-8fee-7a663d8855f2">81.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTItMS0xLTEtOTc0Nzc_3cdd67c8-d9b5-4ee0-bdad-a9a9b1a62f1a">48.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTItMy0xLTEtOTc0Nzc_598c285c-fe64-4a78-b9c0-c1c265ffb49f">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTMtMS0xLTEtOTc0Nzc_562fad43-0289-4048-a56f-79b24b70c787">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTMtMy0xLTEtOTc0Nzc_a2ae872d-de66-4ead-b41a-c64dfbbce544">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTUtMS0xLTEtOTc0Nzc_0a467110-fbd2-4ec0-ab9e-2b51bc7685c2">262.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTUtMy0xLTEtOTc0Nzc_23e54e5e-aeee-4817-950b-5b7f9d268083">641.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTctMS0xLTEtOTc0Nzc_cb138800-2345-43ff-b025-2ddbd044a79f">59.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTctMy0xLTEtOTc0Nzc_32c17cbb-8fbd-4247-95f6-9dd738d561f1">69.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTgtMS0xLTEtOTc0Nzc_c6979f10-95a8-4095-9450-4e29da70a0b0">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTgtMy0xLTEtOTc0Nzc_1102afc6-c520-4056-b045-3727e3130f24">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTktMS0xLTEtOTc0Nzc_310f3bf8-a35f-46e0-b4b5-8437112b78c4">12.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTktMy0xLTEtOTc0Nzc_e8992984-88a7-4bd4-a521-ceae6eb7e27f">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjAtMS0xLTEtOTc0Nzc_840cd126-76f6-4e00-8338-9528e37e827b">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjAtMy0xLTEtOTc0Nzc_7ec0c305-3c9b-48bc-b614-43014b86f37a">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjItMS0xLTEtOTc0Nzc_d4a9aac1-ff13-4f62-ac6f-c70c56361f07">85.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:DepreciationAmortizationAndAccretionNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjItMy0xLTEtOTc0Nzc_fe26ec07-8bf9-4c43-b313-54636c488917">108.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjQtMS0xLTEtOTc0Nzc_5443c99f-546f-40d9-ab58-8ba3e0df2dbf">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjQtMy0xLTEtOTc0Nzc_b5ad67b5-5697-4dfa-bf21-7725c4837c81">31.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjUtMS0xLTEtOTc0Nzc_77b9aef1-b8b1-403f-94ce-1cc7cf4954ad">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjUtMy0xLTEtOTc0Nzc_6018db35-18ef-42bd-aa1b-af6eba4d47ab">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjYtMS0xLTEtOTc0Nzc_07d0026e-41e7-40fe-9c43-b74d8b349e99">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjYtMy0xLTEtOTc0Nzc_eddb94ad-6b2a-4d21-b278-29ac9b8d4f96">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjctMS0xLTEtOTc0Nzc_e856a896-8507-41d7-82c5-111453dde87a">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjctMy0xLTEtOTc0Nzc_8c570446-e0cc-4a13-9d3f-599153764e17">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5e16a16ccca84227b6bdd8b921503333_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjktMS0xLTEtOTc0Nzc_915df54d-682c-439b-a266-5bf112fa8a81">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2d14d558aa9940c5b745ed86dca4facb_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjktMy0xLTEtOTc0Nzc_e02b2653-db99-4086-a103-d3ce4f20f882">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMzAtMS0xLTEtOTc0Nzc_560f34ab-ef99-4394-920b-81804c2b1b53">29.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:PaymentsToAcquireProductiveAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMzAtMy0xLTEtOTc0Nzc_bfae66ae-bf6d-42cb-bdd2-4819e4a8fe65">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.929%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.522%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8044d1c646c14ad7a8ca13af6376e2c0_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMi0xLTEtMS05NzQ3Nw_96abef08-9fcc-4de6-9528-8f8a7cabbbec">2,950.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab62225f35a54fdf891fb942549d470a_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMi0zLTEtMS05NzQ3Nw_a7d7a735-c0a2-4c03-acc2-8debe781ad69">2,881.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i47bb3619ac514e9396f3997cc99a8206_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMy0xLTEtMS05NzQ3Nw_b037f7bf-df99-4a54-b717-7bf188f228ac">1,262.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i88ad24968acd4cb992c6185f64aafc61_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMy0zLTEtMS05NzQ3Nw_1a7dc551-7ac1-4916-803e-ff7384f020ef">1,245.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id048a530970b4115ad934dd57bfb2bd1_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNC0xLTEtMS05NzQ3Nw_b300fe7d-3375-44d8-80ba-e6ffbadaf88f">1,466.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i922f9de14bf045b4aaeafaf2502b6528_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNC0zLTEtMS05NzQ3Nw_d7ee9711-b72d-438b-93ea-2dc7d29f9361">1,461.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d3b3986fbd9494f904cb1a010337a73_I20221231" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNi0xLTEtMS05NzQ3Nw_66875151-d3f1-46a7-be2d-84f704292869">31.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7e1bd6b8680642e296a44c25673ce7a7_I20220924" decimals="-5" name="us-gaap:Assets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNi0zLTEtMS05NzQ3Nw_10b726b6-9fae-4a42-9424-8323df4d9745">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ab2eb9bf2244498bacafb726d13a41a_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNy0xLTEtMS05NzQ3Nw_363446da-68cb-4b82-b395-e4c238df043a">3,579.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d747f63ad01496a9ffd93aa08a24d54_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNy0zLTEtMS05NzQ3Nw_e2db7b03-29db-465e-8964-f5e4447a95a4">3,454.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfOC0xLTEtMS05NzQ3Nw_57fda0bd-82c8-4d0c-99e5-b89843c890ac">9,290.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfOC0zLTEtMS05NzQ3Nw_fac04f3d-b1c0-4b00-81eb-785fdc21a309">9,071.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:continuation><div style="margin-top:5pt;text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December&#160;31, 2022 and December&#160;25, 2021.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><ix:continuation id="iff167171bda4445fb65ef4572b1de6c0"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands . The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of World&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfMTgyMA_b3a18df1-6a2d-4aac-9569-7b1729e5d02c" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"></td><td style="width:69.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.206%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.537%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.209%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMi0xLTEtMS05NzQ3Nw_dff2dcb1-df23-4686-b936-196c4481da29">76.7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMi0zLTEtMS05NzQ3Nw_3042d91b-4eb3-4d99-bb3f-d7dd1a73ae20">68.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i023b583e3a5743b689087ebe2014e742_D20220925-20221231" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMy0xLTEtMS05NzQ3Nw_a3aad290-67cb-4bb4-85ac-bed31e3adf1d">13.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7927fb2683384ee6ba18bcb24820aa75_D20210926-20211225" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMy0zLTEtMS05NzQ3Nw_ab828c66-2ac0-4fdc-bd9f-724db47cdb34">20.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9158b0a900c0492c87e53bb0bfe60c76_D20220925-20221231" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNC0xLTEtMS05NzQ3Nw_4cf76b9a-a00c-4be7-b957-fed28e67860d">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7e03307d675a4c4794cdacb42a15022b_D20210926-20211225" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNC0zLTEtMS05NzQ3Nw_a5b84a65-41f3-41ed-a840-44f97f02606a">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i9a1210ecf0f441c481be084c5fc7365e_D20220925-20221231" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNS0xLTEtMS05NzQ3Nw_6955b3a5-94c3-427b-a81e-daa1f4181cc4">3.7</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i56bcae300f9d40398f2e76fd994f2a30_D20210926-20211225" decimals="3" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNS0zLTEtMS05NzQ3Nw_0a406a5e-fa69-4baa-9729-9f5800f21da4">3.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNi0xLTEtMS05NzQ3Nw_97f9c489-fd31-486b-82ec-abdf0785c2e4">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="INF" name="holx:PercentageOfRevenues" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNi0zLTEtMS05NzQ3Nw_9adb140e-3498-45ab-9438-e34c7feb34cc">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_79"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(15) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83OS9mcmFnOmQzZmUxNjIzNDc1NjRlYmE5ZDRhNjIxMzA2ZmZjMmZmL3RleHRyZWdpb246ZDNmZTE2MjM0NzU2NGViYTlkNGE2MjEzMDZmZmMyZmZfMzIyNQ_6aca18ca-5086-4b37-b272-7faaf4bf35ab" continuedAt="ide4e7efdc79944df8c3208682b6158e8" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><ix:continuation id="ide4e7efdc79944df8c3208682b6158e8"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three months ended December 31, 2022 and December 25, 2021 was <ix:nonFraction unitRef="number" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83OS9mcmFnOmQzZmUxNjIzNDc1NjRlYmE5ZDRhNjIxMzA2ZmZjMmZmL3RleHRyZWdpb246ZDNmZTE2MjM0NzU2NGViYTlkNGE2MjEzMDZmZmMyZmZfNTg3_57f69fb8-7747-4276-b0c4-94b90cd5d9a5">21.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83OS9mcmFnOmQzZmUxNjIzNDc1NjRlYmE5ZDRhNjIxMzA2ZmZjMmZmL3RleHRyZWdpb246ZDNmZTE2MjM0NzU2NGViYTlkNGE2MjEzMDZmZmMyZmZfNjI0_ced0d3cc-3677-4269-96ee-ec9a85bcbef1">19.7</ix:nonFraction>%, respectively. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended December 31, 2022 was higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate for the three months ended December 25, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by the Company's international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes, and unbenefited foreign losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. Such amounts were not material for the three months ended December 31, 2022 and December 25, 2021. While the Company believes its estimated losses recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div></ix:continuation><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(16) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RleHRyZWdpb246ZjFjNzk3YzNkM2QzNDYxNzlmN2MxYWMyMDRmM2IwOWJfMjQ0_eb6bafe8-58d4-4b0d-b41d-1f665183f7aa" continuedAt="i4f5ce9f807284b468099d757c8735ff0" escape="true">Intangible Assets</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i4f5ce9f807284b468099d757c8735ff0"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RleHRyZWdpb246ZjFjNzk3YzNkM2QzNDYxNzlmN2MxYWMyMDRmM2IwOWJfMjQ2_81181745-86ab-43c6-b804-0f1f7cf77403" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 24, 2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bb3f8b8a35456aa7b21ae62f2ed3ca_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy0xLTEtMS05NzQ3Nw_e1a675e1-5d08-4362-b2a8-3605f5413da3">4,602.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia9bb3f8b8a35456aa7b21ae62f2ed3ca_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy0zLTEtMS05NzQ3Nw_ad28c0e9-045d-4d71-9b8e-1d41c2ebb4b6">3,520.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie794110f347e4793b515e8bde9c5a5e6_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy01LTEtMS05NzQ3Nw_9accd188-19f1-410e-b65f-7a2783964719">4,565.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie794110f347e4793b515e8bde9c5a5e6_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy03LTEtMS05NzQ3Nw_d928b1ee-6ca8-4cb3-8577-eb19e3c989f2">3,458.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa2073a325f423cbcb061411d2f553b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC0xLTEtMS05NzQ3Nw_3806da71-cdeb-40f8-9c70-7d6b4785ef8d">36.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3aa2073a325f423cbcb061411d2f553b_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC0zLTEtMS05NzQ3Nw_dac59110-0b29-4997-babf-1e80ca811314">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe0934c8334473cad9c3b424110753c_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC01LTEtMS05NzQ3Nw_6f9dcd53-9f61-4cb1-8254-767243e6101c">33.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbe0934c8334473cad9c3b424110753c_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC03LTEtMS05NzQ3Nw_01f43e35-e7af-4b95-978b-8b776d301d1e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1169e0270b74fe6be508c370950a863_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS0xLTEtMS05NzQ3Nw_1e6fb5ec-a6e1-4a9c-89a9-d96cb3e17497">607.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie1169e0270b74fe6be508c370950a863_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS0zLTEtMS05NzQ3Nw_fa613c72-3df6-4a22-b481-9b40f863e560">542.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18960c3349fe4eb0a59368d1094a8ddd_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS01LTEtMS05NzQ3Nw_bd96e95b-3615-4cea-bd0f-5b3b128184f7">601.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i18960c3349fe4eb0a59368d1094a8ddd_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS03LTEtMS05NzQ3Nw_9b53d753-212a-448c-9ed9-6799eb5a642d">535.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67fea90f60574367b621cebdab180dd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi0xLTEtMS05NzQ3Nw_2ee3cae0-beab-4299-a194-8c0a201c996c">267.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i67fea90f60574367b621cebdab180dd0_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi0zLTEtMS05NzQ3Nw_92213234-ab05-47dc-be03-78bfe476f3ac">206.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7207b97bd8c2409ea04c174faf5b7855_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi01LTEtMS05NzQ3Nw_46e4f63d-1b51-4760-b687-7e81d9784615">265.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7207b97bd8c2409ea04c174faf5b7855_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi03LTEtMS05NzQ3Nw_b14a9003-97a5-4a87-910c-50779a5a4b85">203.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i365291db08214202af3bee07bb3e066c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtMS0xLTEtOTc0Nzc_e75ff995-0e8e-46d0-a854-51a715eb502f">5,513.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i365291db08214202af3bee07bb3e066c_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtMy0xLTEtOTc0Nzc_93567ee3-6a39-45ff-9f7c-a2ec87518d8a">4,269.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e724ba87534f28bfba9adaf851c705_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtNS0xLTEtOTc0Nzc_f05c69d0-3fc1-4ab9-8d71-918be1ab3936">5,465.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i57e724ba87534f28bfba9adaf851c705_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtNy0xLTEtOTc0Nzc_744dc4d9-2548-40f4-b0af-b37de0eb2b36">4,197.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ab5815693d4b4c96b98c8708a6fcb8_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItMS0xLTEtOTc0Nzc_d4068141-ac7b-4846-a0b7-c4f68279d9ab">26.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i36ab5815693d4b4c96b98c8708a6fcb8_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItMy0xLTEtOTc0Nzc_3aab5284-c597-4063-90d8-20718d30aa8f">20.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2251dfc34b1f4dee9b06523ab53696b9_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItNS0xLTEtOTc0Nzc_98717d7a-ec40-45c0-89ba-22191002344c">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2251dfc34b1f4dee9b06523ab53696b9_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItNy0xLTEtOTc0Nzc_1639fc67-fc84-4e89-90be-f2fffb07615d">19.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c1b55962c14bd28656aef42077ee23_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtMS0xLTEtOTc0Nzc_304b09c3-5e8d-4dae-98cf-a3d713f989be">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i25c1b55962c14bd28656aef42077ee23_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtMy0xLTEtOTc0Nzc_6681ff67-abd8-4bdb-92d5-7e2556157a93">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd84f06f8354c2c99790984e0e949ec_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtNS0xLTEtOTc0Nzc_cb37fe11-7c5e-4f0f-a77b-571ca975af51">26.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3dd84f06f8354c2c99790984e0e949ec_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtNy0xLTEtOTc0Nzc_1b87849b-e0dc-4b39-b9af-b2f3ed606806">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtMS0xLTEtOTc0Nzc_ccc52e83-4591-4bbd-b139-a4264dcbe77e">5,567.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtMy0xLTEtOTc0Nzc_4a090919-f3b4-4821-a1b4-f2dc467b508f">4,311.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtNS0xLTEtOTc0Nzc_3a2f27bb-d68e-420c-aea6-29bab4c3faac">5,518.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtNy0xLTEtOTc0Nzc_74b4d3ad-7868-4bb9-964f-9a10d91ed4ea">4,237.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div><span><br/></span></div><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RleHRyZWdpb246ZjFjNzk3YzNkM2QzNDYxNzlmN2MxYWMyMDRmM2IwOWJfMjYw_4dbce382-d856-41dc-b624-bea174d1ea3d" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;31, 2022 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:82.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.836%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMC0xLTEtMS05NzQ3Nw_3402a77f-2e31-48ef-bbbb-d50ebb4fec69">175.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMS0xLTEtMS05NzQ3Nw_74e1094c-5fd7-4ec0-9bdf-223d863f9ae1">224.2</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMi0xLTEtMS05NzQ3Nw_ee18d2d0-997a-4122-b78c-002f53b096e8">209.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMy0xLTEtMS05NzQ3Nw_8d735142-a52e-4138-8231-afe5eb05e80b">177.1</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfNC0xLTEtMS05NzQ3Nw_41b2b964-2792-4b17-bc0d-e44bbb944b2a">89.9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_85"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(17) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ProductWarrantyDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RleHRyZWdpb246NjQ1MGM4YmY2MjhjNDY4NGIyNzdkYjJhM2ZlY2UwNTJfODk_05e0bc95-9c81-40d5-b4bf-6fc844ddf2db" continuedAt="icaf946fda1e64ac7a99f3be92334261a" escape="true">Product Warranties</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="icaf946fda1e64ac7a99f3be92334261a"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RleHRyZWdpb246NjQ1MGM4YmY2MjhjNDY4NGIyNzdkYjJhM2ZlY2UwNTJfODE_0fa20056-6c17-4048-8754-114e3ef5d2cc" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.624%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i748118924a534325be3931e7f281d5da_I20220924" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi0xLTEtMS05NzQ3Nw_cc1e4e21-e046-4fbf-a69b-8f9aa2b30f88">8.0</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi0zLTEtMS05NzQ3Nw_80ef45b7-6959-4aac-8c7a-79d11ebef5a6">2.6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi05LTEtMS05NzQ3Nw_6dcdc3a8-4371-4b4e-9088-819aeb3083d3">2.2</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi0xMS0xLTEtOTc0Nzc_d87d8399-45bd-4705-8d7e-618d625991a2">8.4</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 25, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy0xLTEtMS05NzQ3Nw_41809795-b9ed-45d3-ac49-2b5666af7a09">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ProductWarrantyAccrualWarrantiesIssued" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy0zLTEtMS05NzQ3Nw_6d475058-a0b2-473b-b84f-2e05098139d0">2.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy05LTEtMS05NzQ3Nw_00ea6c0e-33c5-46dc-bebb-4f8dd8232034">2.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225" decimals="-5" name="us-gaap:ProductWarrantyAccrual" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy0xMS0xLTEtOTc0Nzc_cf5ea3b4-b7c3-452f-bbe3-2a97e0199d25">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:18pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_88"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(18) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ComprehensiveIncomeNoteTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RleHRyZWdpb246OGRhM2ZhN2U2NTU5NDU3YThmZmY4MTg5NzZiOTk4NzZfMTc0_f0cd1226-2132-4aa6-8873-e3fdabd8fe66" continuedAt="i763e7a6d44c845789fecadd792178195" escape="true">Accumulated Other Comprehensive Loss</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><ix:continuation id="i763e7a6d44c845789fecadd792178195" continuedAt="ibee0e1a46a2b4008aa59cce8e9fc618d"><ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RleHRyZWdpb246OGRhM2ZhN2U2NTU5NDU3YThmZmY4MTg5NzZiOTk4NzZfMTc4_c692af2b-95da-40d2-9675-a23a8c9c2ada" continuedAt="ie1d3cf090ae74194860d9e4f68327ddd" escape="true"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"></td><td style="width:50.239%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.507%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.508%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iba33d49d790247138728e16304550207_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi0xLTEtMS05NzQ3Nw_88f8ac23-9203-488c-96f8-7e12da079760">267.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7714e4ad6e2f403ca6e488d1c5b4956c_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi0zLTEtMS05NzQ3Nw_74641618-2263-4976-9cf8-87b91eb874b6">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6bedb97f35ab4eadbc7dfdf485949c64_I20220924" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi03LTEtMS05NzQ3Nw_9de35f26-adac-4ee4-ad31-e898870e7654">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie45f7058af534e8dba563c02009f5cac_I20220924" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi05LTEtMS05NzQ3Nw_56e28d8e-e6e9-4147-bc6e-1da4698ce9a5">238.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6fd0ad2aef5b404eab15f293436efcc7_D20220925-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy0xLTEtMS05NzQ3Nw_7002edb4-50fb-4d41-9bea-5e6a74904ac6">113.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2ffc46097a444b81abc0a82e463c5c4e_D20220925-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy0zLTEtMS05NzQ3Nw_6037986b-78f0-47de-8d3c-02bf8b1dabd7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i3fa140a2e91a4da0849a54c6a2cf483d_D20220925-20221231" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy03LTEtMS05NzQ3Nw_e257c79c-0b65-40ce-9676-1d65d09be37b">2.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy05LTEtMS05NzQ3Nw_d9ee4628-1cbc-48d9-a424-af7a41f82f60">110.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ida477b36723f466a839eca19b439840e_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi0xLTEtMS05NzQ3Nw_5e94057e-1ba0-4d85-9fa1-1460fc8281c3">153.4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i053a359de4994764bcc53d5d8bd87247_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi0zLTEtMS05NzQ3Nw_3a7eb600-2f98-4eb0-b1d3-39c408aa38cd">0.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if56004b6ce284c0a88a74e229ff23a11_I20221231" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi03LTEtMS05NzQ3Nw_70655b51-9e84-48d5-a7fd-78f3f4bd1304">26.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i14951cf020f246d1996832691a0edc4c_I20221231" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi05LTEtMS05NzQ3Nw_7488b929-bb7a-4aa7-b1b9-91b80d55e57c">127.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><ix:continuation id="ibee0e1a46a2b4008aa59cce8e9fc618d"><ix:continuation id="ie1d3cf090ae74194860d9e4f68327ddd"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"></td><td style="width:49.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.586%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.539%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.590%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i05e36b9f6d534537b938515e96a9b738_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi0xLTEtMS05NzQ3Nw_ad00b81e-a1ec-4395-9608-0fcc5eb8e6a3">43.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i420e29ca33f74637b19b79f051f15a88_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi01LTEtMS05NzQ3Nw_a5a7fbbe-a027-4a25-86fc-502c9b5beb4e">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5e589736d905406c8090a6aa9422698b_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi05LTEtMS05NzQ3Nw_19cb9c9e-07da-48a8-b9ab-1a2b3802e097">14.7</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ie4a69d1c0d994885bd6c5a0c8cc6aeb7_I20210925" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi0xMS0xLTEtOTc0Nzc_a37bec89-2cec-4cfc-9d9e-1bf03224853c">59.1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ifa137501c2f640d8a89b78da55d9a00e_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy0xLTEtMS05NzQ3Nw_7c26361f-c9e5-41b1-b9e9-3c50aad640ba">37.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i79417d9e4a134491875ae60fa840bf0d_D20210926-20211225" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" format="ixt:fixed-zero" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy01LTEtMS05NzQ3Nw_a24eefd9-67d9-4eca-922c-5c5bc29a12a0">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38bcb736614e47149fc6af7f459d9a0e_D20210926-20211225" decimals="-5" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy05LTEtMS05NzQ3Nw_3cf94793-77a2-4cfd-a133-f35faebc5615">7.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225" decimals="-5" sign="-" name="us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy0xMS0xLTEtOTc0Nzc_361bec1f-c40e-4bce-afa6-2d962e17bd30">29.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i10878f2ace9949af8c060f1bca337922_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS0xLTEtMS05NzQ3Nw_4f30d422-ec30-4d09-94d3-bc801462a8ed">80.9</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i407e328e7a8e4cb7bd6a3598b8ad7ca3_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS01LTEtMS05NzQ3Nw_a1412a23-df12-413a-8dcd-ab509612eab6">1.3</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6db04a89d01143309b15081f34133a3a_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS05LTEtMS05NzQ3Nw_22f4e4fb-cf9d-4217-896c-f521f6c8e9ea">6.8</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i5d4f66d97be24ea29c9e72a2c1b943b1_I20211225" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS0xMS0xLTEtOTc0Nzc_0b14d019-4626-46c6-8232-efe2a8d5b5e1">89.0</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></ix:continuation></div><div style="text-align:center"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_91"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(19) <ix:nonNumeric contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTM0_24628e8f-34cb-41b0-a8d0-91f7e9a2d66a" continuedAt="i00118c7e1ec24885a07e370590121fef" escape="true">Share Repurchase</ix:nonNumeric></span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i00118c7e1ec24885a07e370590121fef">On September 22, 2022, the Board of Directors authorized a new stock repurchase program, with a five-year term, to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="i92f1d854058b4a7badb00114d82a50c1_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTQ5NzU1ODE3MzI0_bdd28ea9-8972-46ad-8364-c10471acd525">1.0</ix:nonFraction>&#160;billion of the Company's outstanding common stock, effective as of the close of trading September 23, 2022. This new repurchase program replaced the previous $<ix:nonFraction unitRef="usd" contextRef="ib36279872040402a85b53f40877fc6bc_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="9" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTQ5NzU1ODE3NTU5_53d1f8e7-4781-4172-bb9a-2d76cdb05d01">1.0</ix:nonFraction>&#160;billion authorization. During the three months ended December 31, 2022, the Company repurchased <ix:nonFraction unitRef="shares" contextRef="iec5a478ebcd24022ac3b46935f9c1298_D20220925-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodShares" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfMzM1_d2fce962-f830-49dd-9b35-8cefbfa0adc9">1.5</ix:nonFraction>&#160;million shares of its common stock for total consideration of $<ix:nonFraction unitRef="usd" contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231" decimals="-5" name="us-gaap:StockRepurchasedDuringPeriodValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfMzky_4a8a4522-410b-423e-ae2c-c111c9f5651d">100.0</ix:nonFraction>&#160;million. As of December 31, 2022, $<ix:nonFraction unitRef="usd" contextRef="i92f1d854058b4a7badb00114d82a50c1_I20221231" decimals="-5" name="us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTQ5NzU1ODE2MDAx_7284c6f0-f8db-4f58-b3f3-12aa674b8894">900.0</ix:nonFraction>&#160;million remained available under this authorization.</ix:continuation></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_97"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY STATEMENT</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the statements contained in this report and documents incorporated by reference herein are forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933 and Section&#160;21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). These statements involve known and unknown risks, uncertainties and other factors which may cause our or our industry&#8217;s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Forward-looking statements may include, but are not limited to, statements regarding:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ongoing and possible future effects of global challenges, including macroeconomic uncertainties, the war in Ukraine, other economic disruptions and U.S. and global recession concerns, on our customers and suppliers and on our business, financial condition, results of operations and cash flows and our ability to draw down our revolver;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of the worldwide political and social uncertainty and divisions, including the impact on trade regulation and tariffs, that may adversely impact the cost and sale of our products in certain countries, or increase the costs we may incur to purchase materials, parts and equipment from our suppliers;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ongoing and possible future effects of supply chain constraints, including the availability of critical raw materials and components, including semiconductor chips, as well as cost inflation in materials, packaging and transportation;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility of interruptions or delays at our manufacturing facilities, or the failure to secure alternative suppliers if any of our sole source third-party manufacturers fail to supply us;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the development of new competitive technologies and products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to predict accurately the demand for our products, and products under development and to develop strategies to address markets successfully;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">continued demand for our COVID-19 assays; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic and any future public health crises; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">potential cybersecurity threats and targeted computer crime;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to execute acquisitions and the impact and anticipated benefits of completed acquisitions and acquisitions we may complete in the future;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to consolidate certain of our manufacturing and other operations on a timely basis and within budget, without disrupting our business and to achieve anticipated cost synergies related to such actions; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the ability to successfully manage ongoing organizational and strategic changes, including our ability to attract, motivate and retain key employees and maintain engagement and efficiency in remote work environments; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to obtain regulatory approvals and clearances for our products, including the implementation of the European Union Medical Device Regulations, and maintain compliance with complex and evolving regulations; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the coverage and reimbursement decisions of third-party payors; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the uncertainty of the impact of cost containment efforts and federal healthcare reform legislation on our business and results of operations;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the guidelines, recommendations, and studies published by various organizations relating to the use of our products;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the effect of consolidation in the healthcare industry;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to meet production and delivery schedules for our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our ability to protect our intellectual property rights; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the possibility that products may contain undetected errors or defects or otherwise not perform as anticipated;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated development of markets we sell our products into and the success of our products in these markets; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the anticipated performance and benefits of our products; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">business strategies; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">anticipated trends relating to our financial condition or results of operations, including the impact of interest rate and foreign currency exchange fluctuations;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">estimated asset and liability values; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact of future tax legislation;</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">conducting business internationally;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">the impact and costs and expenses of any litigation we may be subject to now or in the future; </span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our compliance with covenants contained in our debt agreements; and</span></div><div style="margin-top:3pt;padding-left:18pt;text-align:justify;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:7.75pt">our liquidity, capital resources and the adequacy thereof.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In some cases, you can identify forward-looking statements by terms such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;expects,&#8221; &#8220;plans,&#8221; "intends," &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;projects,&#8221; &#8220;predicts,&#8221; "likely," "future," "strategy." &#8220;potential,&#8221; "seeks," "goal" and similar expressions intended to identify forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Also, these forward-looking statements represent our estimates and assumptions only as of the date of this report. Except as otherwise required by law, we expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement contained in this report to reflect any change in our expectations or any change in events, conditions or circumstances on which any of our forward-looking statements are based. Factors that could cause or contribute to differences in our future financial results include the cautionary statements set forth herein and in our other filings with the Securities and Exchange Commission, including the "Risk Factors" set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those described in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022 or any other of our subsequently filed reports. We qualify all of our forward-looking statements by these cautionary statements.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_100"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a developer, manufacturer and supplier of premium diagnostics products, medical imaging systems, and surgical products focused on women's health and well-being through early detection and treatment. We sell and service our products through a combination of direct sales and service personnel and a network of independent distributors and sales representatives. We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Through our Diagnostics segment, we offer a wide range of diagnostic products, which are used primarily to aid in the screening and diagnosis of human diseases. Our primary Diagnostics products include our molecular diagnostic assays, which run on our advanced instrumentation systems (Panther, Panther Fusion and Tigris), our ThinPrep cytology system, and the Rapid Fetal Fibronectin Test. Our Aptima family of molecular diagnostic assays is used to detect, among other things, the infectious microorganisms that cause common sexually transmitted diseases, or STDs, such as chlamydia and gonorrhea, or GTGC; certain high-risk strains of human papillomavirus, or HPV; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Trichomonas vaginalis,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> the parasite that causes trichomoniasis; Mycoplasma genitalium; and Herpes Simplex viruses 1 and 2. We also offer viral load tests for the quantitation of Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, or HIV, and human cytomegalo virus, or CMV, for use on our Panther instrument system. In addition, we offer bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis, a common and complex ailment affecting millions of women a year. Our assay portfolio also includes diagnostic tests for a range of acute respiratory infections, including SARS-CoV-2, various strains of influenza and parainfluenza, and respiratory syncytial virus that are run on the Panther Fusion system, a field upgradeable instrument addition to the base Panther system. In response to the COVID-19 pandemic, we developed and launched the Aptima SARS-CoV-2 assay and the Aptima SARS-CoV-2/Flu assay (each of which runs on our standard Panther system) and the Panther Fusion SARS-CoV-2 assay (which runs on our Panther Fusion system). In May 2022, we CE-marked two new molecular assays, Panther Fusion EBV Quant assay for quantitation of Epstein-Barr virus, and the Panther Fusion BKV Quant assay for quantitation of the BK virus. These two new assays are the first quantitative real-time PCR assays on the Panther Fusion system. These assays, along with the Aptima CMV Quant assay already available in Europe, expand our Panther Fusion menu of transplant monitoring assays. The ThinPrep System is primarily used in cytology applications, such as cervical cancer screening, and the Rapid Fetal Fibronectin Test assists physicians in assessing the risk of pre-term birth. We also generate service revenues from our CLIA-certified laboratory for testing related to breast cancer and all metastatic cancers.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Breast Health segment offers a broad portfolio of solutions for breast cancer care primarily in the areas of radiology, breast surgery, pathology and treatment. These solutions include 3D digital mammography systems, image analytics software utilizing artificial intelligence, reading workstations, ultrasound imaging, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, connectivity solutions and breast conserving surgery products. Our most advanced breast imaging platforms, Selenia Dimensions and 3Dimensions, utilize tomosynthesis to produce 3D images that show multiple contiguous slice images of the breast, which we refer to as the Genius 3D Mammography exam. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our GYN Surgical products include our NovaSure Endometrial Ablation System, or NovaSure, our MyoSure Hysteroscopic Tissue Removal System, or MyoSure, our Fluent Fluid Management system, or Fluent, our Acessa ProVu laparoscopic radiofrequency ablation system, or Acessa ProVu system, as well as our CoolSeal vessel sealing portfolio and our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JustRight surgical stapler. The NovaSure portfolio is comprised of the NovaSure CLASSIC and NovaSure ADVANCED devices and most recently, the NovaSure V5 device for the treatment of abnormal uterine bleeding. The MyoSure suite of devices offers four options to provide incision-less removal of fibroids, polyps, and other pathology within the uterus. The Fluent system is a fluid management system that provides liquid distention during diagnostic and operative hysteroscopic procedures. The Acessa ProVu system is a fully integrated system that uses laparoscopic ultrasound, guidance mapping and radio frequency ablation to treat nearly all types of fibroids. The CoolSeal portfolio includes the Trinity, Reveal, and Mini advanced bipolar vessel sealing devices. The JustRight 5 mm stapler features a smaller instrument profile and is used for laparoscopic general and pediatric surgery.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Skeletal Health segment's products includes the Horizon DXA, a dual energy x-ray system, which evaluates bone density and performs body composition assessments, and the Fluoroscan InSight FD mini C-arm, which assists in performing minimally invasive orthopedic surgical procedures on a patient's extremities, such as the hand, wrist, knee, foot, and ankle.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise requires, references to we, us, Hologic or our company refer to Hologic, Inc. and its consolidated subsidiaries.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Supply Chain Considerations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current worldwide supply chain shortages and constraints are impacting our ability to obtain certain critical raw materials and components used primarily in our Breast Health capital equipment products. The supply chain shortages and disruptions primarily affecting our Breast Health manufacturing lines are related to electronic components, primarily semiconductor chips. We are dependent on a small number of semiconductor manufacturers and their allocation of chips to us. Based on our current understanding of their allocation of chips to us we expect we will be able to increase production on a sequential quarterly basis throughout fiscal 2023. If such allocation does not meet our expectations or we are not able to obtain alternative sources of chips, we believe we will not be able to manufacture sufficient quantities of our capital equipment products, primarily 3D Dimension systems, Trident specimen radiography systems and Affirm Prone biopsy systems to meet customer demand. As a result, if we are unable to obtain sufficient quantities of chips, sales of these products may decline or will not increase in fiscal 2023 compared to fiscal 2022 levels. In addition, the prices of raw materials and components, as well as freight, have been rising and continued supply chain shortages could increase the costs further. These factors may result in a lower gross margin for Breast Health in fiscal 2023 for our affected products. Our procurement team has and will continue to expend significant time and resources to try to secure sufficient quantities to meet demand.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Trademark Notice</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hologic is a trademark of Hologic, Inc. Other trademarks, logos, and slogans registered or used by Hologic and its divisions and subsidiaries in the United States and other countries include, but are not limited to, the following: 3Dimensions, 3D Mammography, Acessa, Acessa ProVu, Affirm, Amplidiag, Aptima, ATEC, Biotheranostics, Brevera, CoolSeal, Diagenode, Eviva, Faxitron, Fluent, Fluoroscan, Focal, Genius 3D, Genius 3D Mammography, Horizon , InSight, JustRight, Mobidiag, MyoSure, Novodiag, NovaSure, Panther, Panther Fusion, Rapid fFN, Selenia, Selenia Dimensions, Somatex, SuperSonic Imagine, ThinPrep, Tigris, Trident, and Tumark. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All other brand names or trademarks appearing in this Quarterly Report on Form 10-Q are the property of their respective owners. Hologic's use or display of other parties' trademarks, trade dress or products in this Quarterly Report does not imply that Hologic has a relationship with, or endorsement or sponsorship of, the trademark or trade dress owners.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_103"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ACQUISITIONS</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bolder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Surgical</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, we completed the acquisition of Bolder Surgical Holdings, Inc., or Bolder, for a purchase price of $160.1 million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Based on our valuation, we allocated $96.7 million of the purchase price to the value of intangible assets and $68.8 million to goodwill. Bolder's results of operations are reported in our GYN Surgical segment. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_106"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESULTS OF OPERATIONS</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All dollar amounts in tables are presented in millions.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:29.809%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.415%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.416%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="18" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="6" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of<br/>Total<br/>Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Product Revenues</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Diagnostics</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">532.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">49.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">929.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">63.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(397.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(42.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">182.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">220.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(37.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(17.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">153.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">134.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Skeletal&#160;Health</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(1.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(7.7)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">886.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">82.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,303.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">88.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(417.0)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(32.0)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a decrease in product revenues in the current quarter compared to the corresponding period in the prior year primarily due to the decrease in revenues in the Diagnostics business as COVID-19 assay sales declined significantly and a decrease in Breast Health revenue primarily due to supply chain constraints. These decreases were partially offset by an increase in GYN Surgical revenues as well as an extra week of activity in the current quarter compared to the corresponding period in the prior year due to our fiscal calendar.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics product revenues decreased $397.2 million or 42.7% in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in Molecular Diagnostics of $394.4 million and a decrease in Cytology &amp; Perinatal revenue of $3.8 million, partially offset by an increase in Blood Screening of $1.0 million. Molecular Diagnostics product revenue was $400.4 million in the current quarter compared to $794.8 million in the corresponding period in the prior year. The decrease was primarily attributable to a decrease of $395.9 million in sales from our SARS-CoV-2 assays (primarily the Aptima SARS-CoV-2 assay and to a lesser extent the Panther Fusion SARS-CoV-2 assay) due to lower volumes which we primarily attribute to lower demand from an improvement in the COVID-19 pandemic, the impact of at-home testing alternatives, and lower average selling prices in the international markets. We expect sales of our SARS-CoV-2 assays to be significantly lower in fiscal 2023 compared to fiscal 2022. We also had a decrease in sales of collection devices as a result of lower assay sales, and lower Panther instruments sales as demand for those instruments has decreased, which we primarily attribute to our significantly expanded install base and the decline in the COVID-19 pandemic in the current year period compared to the corresponding period in the prior year. In addition, revenue from our Mobidiag and Diagenode businesses declined in the current quarter compared to the corresponding period in the prior year primarily driven by a decrease in demand for respiratory assays in Europe. These decreases were partially offset by an increase in sales of $20.8 million for our Aptima assays (exclusive of our Aptima SARS-CoV-2 assays), which primarily consisted of our Bacterial Vaginosis and CV Candida assays. This increase was primarily due to expanded adoption by our laboratory customers. In addition, we had an increase in sales from our Quant Viral assays, primarily HIV assays sold in Africa, and Fusion flu assays. The decrease in Cytology &amp; Perinatal was primarily due to a decrease in sales in China from COVID-19 related shutdowns. We also experienced a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health product revenues decreased $37.6 million or 17.1% in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in volumes of our digital mammography systems, primarily 3D Dimensions systems and related workflow and workstation products and Affirm biopsy systems. The decrease in volume was primarily driven by supply chain constraints related to electronic components, primarily semiconductor chips, which impacted our ability to manufacture sufficient quantities to meet customer demand, which was partially offset by an increase in average selling prices for our 3Dimensions systems and related workflow products. In addition, we had a decrease in sales of our interventional breast solutions products, primarily driven by ATEC and Eviva devices as customers had previously built up inventory levels and staffing constraints impacted procedure volumes, partially offset by an increase in sales of Brevera devices. We also experienced a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical product revenues increased $19.3 million or 14.4% in the current quarter compared to the corresponding period in the prior year primarily due to increases in the sales volume of our Fluent Fluid Management products, MyoSure system sales, CoolSeal vessel sealers, NovaSure systems sales, and Acessa ProVu systems. These increases were partially offset by a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health product revenues decreased $1.5 million or 7.7% in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in sales volume of our Horizon DXA systems and InSight FD Fluoroscan systems. The sales volume decrease was largely associated with supply chain constraints. We also experienced a decrease in revenue from international sales denominated in foreign currencies from the unfavorable foreign currency exchange impact of the strengthened U.S. dollar against a number of currencies.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product revenues by geography as a percentage of total product revenues were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.134%"><tr><td style="width:1.0%"></td><td style="width:64.168%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.848%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">67.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the current quarter compared to the corresponding period in the prior year, the percentage of product revenue derived from the U.S. increased while Europe and Asia-Pacific decreased, which we primarily attributed to a greater increase in the U.S. for Aptima and Fusion assay sales (exclusive of our Aptima SARS-CoV-2 assays), as well as a lesser decline in SARS-CoV-2 assay volume compared to Europe and Asia-Pacific. Product revenue decreased in China, which we primarily attribute to continued city-wide shutdowns as a result of COVID-19. These shutdowns primarily impacted the sale of our Diagnostics products and to a lesser extent our digital mammography systems. The U.S. also experienced a lesser decline in sales of our digital mammography systems compared to Europe and Asia-Pacific. In addition, the strengthening of the U.S. Dollar against a number of currencies contributed to the increase in the percentage of revenue derived from the U.S. compared to revenue derived from the other geographic regions. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service and Other Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.941%"><tr><td style="width:1.0%"></td><td style="width:36.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.710%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.488%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.717%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Service and Other Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">187.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">17.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">167.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues consist primarily of revenue generated from our field service organization to provide ongoing service, installation, and repair of our products. The majority of these revenues are generated within our Breast Health segment. The increase in service and other revenue in the current quarter compared to the corresponding period in the prior year was primarily due to an increase in Breast Health service contract revenue primarily due to the extra week in the quarter, resulting in incremental revenue of $7.9 million from service contracts, and to a lesser extent continued conversion of a high percentage of our installed base of digital mammography systems to service contracts upon expiration of the warranty period. In our Diagnostics business, lab testing revenue from Biotheranostics increased $6.4 million in the current quarter compared to the corresponding period in the prior year. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.964%"><tr><td style="width:1.0%"></td><td style="width:36.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.480%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.593%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.650%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.600%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Product<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Product Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">296.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">318.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(21.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(6.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Amortization of Intangible Assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(19.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(25.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">351.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">39.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">393.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">30.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(41.2)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(10.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Product Revenues.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The cost of product revenues as a percentage of product revenues was 33.4% in the current quarter compared to 24.4% in the corresponding period in the prior year. Cost of product revenues as a percentage of revenue increased in the current quarter primarily due to a decrease in sales of our SARS-CoV-2 assays, which have higher gross margins compared to our other diagnostic products, and comprised 14.3% of total product revenue in the current quarter compared to 40.1% in the corresponding period in the prior year. Lower digital mammography system sales and higher product costs from supply chain constraints and inflation also contributed to the increase in cost of product revenues.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics' product costs as a percentage of revenue increased in the current quarter compared to the corresponding period in the prior year primarily due to lower sales of our SARS-CoV-2 assays, an increase in unfavorable manufacturing variances, higher field service costs and freight, partially offset by an increase in core Aptima, Fusion, and Quant Viral assay volume.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health&#8217;s product costs as a percentage of revenue increased in the current quarter compared to the corresponding period in the prior year primarily due to supply chain constraints resulting in lower sales volumes of our higher margin products, higher prices of raw materials and components from supply chain constraints and inflation, an increase in inventory reserves and higher freight internationally, partially offset by a slight increase in average selling prices of our 3Dimensions systems and related workflow products.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical&#8217;s product costs as a percentage of revenue increased in the current quarter compared to the corresponding periods in the prior year primarily due to product mix of higher volumes of lower margin products, mostly attributable to sales of our Fluent Fluid Management systems and CoolSeal vessel sealers, partially offset by higher average selling prices of our NovaSure V5 device.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health&#8217;s product costs as a percentage of revenue increased in the current quarter compared to the corresponding period in the prior year due to higher component costs from supply chain constraints and inflation and to a lesser extent lower sales volume of our Horizon DXA systems and InSight FD Fluoroscan systems.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets relates to acquired developed technology, which is generally amortized over its estimated useful life of between 5 and 15 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic benefits of the assets are expected to be consumed. Amortization expense decreased in the current quarter compared to the corresponding period in the prior year primarily due to lower amortization of intangible assets acquired in the Cytyc acquisition which became fully amortized in the beginning of the first quarter of fiscal 2023 and lower amortization of intangible assets acquired in the Focal and Faxitron acquisitions due to impairments in the prior year, partially offset by an increase from developed technology intangible assets acquired in the Bolder acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Service and Other Revenues</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"><tr><td style="width:1.0%"></td><td style="width:35.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.817%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Service<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Cost of Service and Other Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">55.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">91.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">54.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">12.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Service and other revenues gross margin decreased to 44.4% in the current quarter compared to 45.3% in the corresponding period in the prior year. The decrease in the current quarter was primarily due to higher field service costs from increased labor and spare parts costs for our expanded Breast Health install base. This decrease was partially offset by the inclusion of lab testing revenue from Biotheranostics, which has higher margins than our legacy service business, and by an increase in Breast Health service contract revenue.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.064%"><tr><td style="width:1.0%"></td><td style="width:35.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.813%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.495%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.817%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%&#160;of<br/>Total<br/>Revenue</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:100%">Operating Expenses</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">74.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">72.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">163.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">147.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">108.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">117.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(9.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(8.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Amortization of intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(29.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Contingent consideration - fair value adjustment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(100.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Restructuring and Divestiture charges</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">450.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">355.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">33.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">345.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Research and development expenses increased 2.7% in the current quarter compared to the corresponding period in the prior year primarily due to higher compensation and benefits from the extra week in the quarter, and the inclusion of incremental expenses from the Bolder acquisition. Partially offsetting these increases was a higher credit in the current quarter of $1.6 million recorded to research and development expenses for funds received from the Biomedical Advanced Research and Development Authority (BARDA) grant to obtain FDA approval of our SARS-CoV-2 assays, a reduction in spend to implement the European Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) requirements, and lower headcount primarily in Diagnostics.  At any point in time, we have a number of different research projects and clinical trials being conducted and the timing of these projects and related costs can vary from period to period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling and Marketing Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Selling and marketing expenses increased 10.9% in the current quarter compared to the corresponding period in the prior year. The increase was due to higher compensation and benefits primarily from the extra week in the quarter, and to a lesser extent an increase in headcount, an increase in meetings and travel that were lower in the prior year primarily due to curtailed events as a result of the COVID-19 pandemic, higher severance expense, net increased spend on marketing initiatives primarily from our sponsorship of the Women's Tennis Association and the inclusion of incremental expenses from the Bolder acquisition of $1.6 million.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">General and Administrative Expenses.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General and administrative expenses decreased 8.0% in the current quarter compared to the corresponding period in the prior year. The decrease was primarily due to a decrease in charitable donations of $10.0 million, a $7.4 million credit from the Minerva litigation settlement received in the quarter, lower tax project and legal expenses, and a decrease in bad debt expense, partially offset by an $8.9 million charge to settle a business dispute in connection with terminating the Mobidiag joint venture agreement in China, an increase in reserves for sales and use tax matters and higher compensation and benefits from the extra week in the quarter.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Amortization of Intangible Assets.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Amortization of intangible assets primarily results from customer relationships and trade names related to our acquisitions. These intangible assets are generally amortized over their estimated useful lives of between 5 and 30 years using a straight-line method or, if reliably determinable, based on the pattern in which the economic </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">benefits of the assets are expected to be consumed utilizing expected undiscounted future cash flows. Amortization expense decreased in the current year period due to assets from our Cytyc acquisition becoming fully amortized at the beginning of the first quarter of fiscal 2023. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration Fair Value Adjustments.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the acquisition of Acessa Health, Inc. ("Acessa"), we are obligated to make contingent earn-out payments. The payments are based on achieving incremental revenue growth over a three-year period ending annually in December of each of 2021, 2022, and 2023. As of the acquisition date, we recorded a contingent consideration liability for the estimated fair value of the amount we expected to pay to the former shareholders of the acquired business. This liability is not contingent on future employment, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, comparable company revenue growth rates, implied volatility and applying a risk adjusted discount rate. Increases or decreases in the fair value of contingent consideration liability can result from the passage of time, changes in discount rates, and changes in the timing, probabilities and amount of revenue estimates. There was no change in the fair value of the liability in the current quarter. In the first quarter of fiscal 2022, we recorded a gain of $4.1 million based on actual amounts owed for the first earn-out period being lower than the amount accrued as of September 25, 2021. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.116%"><tr><td style="width:1.0%"></td><td style="width:35.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Interest Expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(25.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of the cash interest costs and the related amortization of the debt discount and deferred issuance costs on our outstanding debt. Interest expense increased in the current quarter compared to the corresponding period in the prior year primarily due to an increase in the variable interest rate, SOFR, under our 2021 Credit Agreement partially offset by amounts received under our interest rate swap, which hedges the benchmark interest rate, versus payments made under the interest rate swap in the prior year period. In addition, the prior year interest expense included debt refinancing costs for our 2021 Credit Agreement, and interest expense related to debt from the Mobidiag acquisition that was paid off in the prior year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Extinguishment Loss</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.555%"><tr><td style="width:1.0%"></td><td style="width:35.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.707%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.147%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Debt Extinguishment Loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of fiscal 2022, we entered into a Refinancing Amendment No. 2 to our 2021 Credit Agreement with Bank of America, N.A. The proceeds were used to pay off the term loan outstanding under our 2018 Credit Agreement. In connection with this transaction we recorded a debt extinguishment charge of $0.7 million. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), net</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:80.116%"><tr><td style="width:1.0%"></td><td style="width:35.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.228%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.529%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.233%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Other Income (Expense), net</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">**</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**Percentage not meaningful</span></div><div style="margin-top:5pt;padding-left:27pt;text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the current quarter, this account primarily consisted of net foreign currency exchange losses of $18.1 million, primarily from the mark-to-market of foreign currency contracts used to hedge operating results, partially offset by a gain of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.5 million from the change in cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the first quarter of fiscal 2022, this account primarily consisted of net foreign currency exchange gains of $9.3 million, primarily from settling transactions, and a gain of $1.3 million from the change in cash surrender value of life insurance contracts related to our deferred compensation plan driven by stock market gains, partially offset by a charge of $4.3 million to write off an equity method investment acquired in the Mobidiag acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.140%"><tr><td style="width:1.0%"></td><td style="width:36.197%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.035%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.035%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.035%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Provision for Income Taxes</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">51.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">122.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(71.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(57.9)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended December 31, 2022 was 21.6% compared to 19.7% for the corresponding period in the prior year.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our effective tax rate for the three months ended December 31, 2022 was higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:24.3pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Our effective tax rate for the three months ended December 25, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes, and unbenefited foreign losses. </span></div><div style="text-indent:24pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_109"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Results of Operations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The accounting policies of the segments are the same as those described in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022. We measure segment performance based on total revenues and operating income. Revenues from product sales of each of these segments are described in further detail above. The discussion that follows is a summary analysis of total revenues and the primary changes in operating income or loss by segment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diagnostics</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:36.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">950.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(391.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(41.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">531.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(380.7)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(71.6)</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">55.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diagnostics revenues decreased in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in sales of our SARS-CoV-2 assays, a decrease in our Mobidiag and Diagenode businesses and a decrease in sales of our Cytology &amp; Perinatal products, partially offset by an increase in sales of our Aptima, Fusion and Quant Viral assays (exclusive of our Aptima SARS-CoV-2 assays) and lab testing revenue from our Biotheranostics acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current quarter compared to the corresponding period in the prior year due to a decrease in gross profit from lower COVID-19 assay sales and an increase in operating expenses. Gross margin was 57.9% in the current quarter, compared to 72.9% in the corresponding period in the prior year. The decrease in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">gross profit in the current quarter was primarily due to lower sales volume of our SARS-CoV-2 assays which have a higher margin, higher field service costs for our expanded instrument install base, an increase in freight charges and unfavorable manufacturing variances, partially offset by increases in core Aptima and Quant Viral assay volumes and higher lab testing revenue and a decrease in intangible asset amortization expense.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current quarter compared to the corresponding period in the prior year primarily due to a settlement charge of $8.9 million related to the termination of the Mobidiag joint venture in China, an increase in non-income tax charges, an increase in compensation and benefits due to the extra week in the quarter, and higher severance expense and an increase in meeting expense partially offset by a decrease in marketing initiatives and allocated advertising and charitable contributions, and an increase in the BARDA credit.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Breast Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:36.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">334.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(7.0)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(21.2)</span></td><td style="border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(25.9)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Breast Health revenues decreased in the current quarter compared to the corresponding period in the prior year due to a decrease of $37.6 million in product revenue primarily due to the decrease in volume driven by supply chain constraints discussed above. This decrease was partially offset by an increase of $12.4 million in service revenue primarily driven by an increase in service contract revenue from the extra week in the quarter and the continued conversion of our digital mammography systems to service contracts.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment decreased in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in product sales and an increase in operating expenses, partially offset by an increase in service gross profit. Gross margin was 54.0% in the current quarter compared to 55.6% in the corresponding period in the prior year. The decrease in gross margin is primarily due to lower volumes of capital equipment sales and interventional breast solutions devices, higher costs for raw materials and components from supply chain constraints, and an increase in inventory reserves, partially offset by an increase in service margin from the extra week in the quarter and continued conversion of digital mammography systems to service contracts.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses increased in the current quarter compared to the corresponding period in the prior year primarily due to an increase in compensation and benefits from the extra week in the quarter and an increase in meeting and travel expense, partially offset by a decrease in allocated advertising and charitable contributions and lower headcount.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">GYN Surgical</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:36.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">83.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GYN Surgical revenues increased in the current quarter compared to the corresponding period in the prior year primarily due to the increase in product revenues discussed above. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current quarter compared to the corresponding period in the prior year primarily due to an increase in gross profit. Gross margin was 68.6% in the current quarter compared to 62.3% in the corresponding period in the prior year. The increase in gross margin was primarily due to a decrease in intangible asset amortization expense partially offset by higher volume sales of lower margin products discussed above.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses were flat in the current quarter compared to the corresponding period in the prior year primarily due to a $7.4 million credit from the Minerva litigation settlement, offset by an increase in compensation and benefits from the extra week in the quarter, a gain of $4.1 million recorded in the prior period to decrease the contingent consideration liability to fair value related to the Acessa acquisition, the inclusion of expenses from Bolder and higher research and development project spend and an increase in meeting and travel expenses. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Skeletal Health</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.871%"><tr><td style="width:1.0%"></td><td style="width:36.757%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.900%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.514%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.901%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total Revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(1.8)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">0.8&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">66.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating Income as a % of Segment Revenue</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Skeletal Health revenues decreased in the current quarter compared to the corresponding period in the prior year primarily due to the decrease in product revenues discussed above partially offset by an increase in service contract revenue from the extra week in the quarter.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income for this business segment increased in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in operating expenses partially offset by a decrease in gross profit. Gross margin was 29.8% in the current quarter compared to 35.8% in the corresponding period in the prior year. The decrease in gross margin was primarily due to increased costs from supply chain constraints and inflation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses decreased in the current quarter compared to the corresponding period in the prior year primarily due to a decrease in commissions.</span></div><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_112"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">LIQUIDITY AND CAPITAL RESOURCES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, we had $3,065.0 million of working capital and our cash and cash equivalents totaled $2,441.3 million. Our cash and cash equivalents increased by $101.8 million during the first three months of fiscal 2023 primarily due to cash generated from operating activities, partially offset by cash used in investing and financing activities primarily related to repurchases of our common stock and capital expenditures.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of fiscal 2023, our operating activities provided cash of $253.4 million, primarily due to net income of $187.4 million, non-cash charges for depreciation and amortization aggregating $85.9 million, and stock-based compensation expense of $20.5 million. These adjustments to net income were partially offset by a decrease in deferred taxes of $26.2 million primarily due to the capitalization of research expenditures and to a lesser extent the amortization of intangible assets. Cash provided by operations included a net cash outflow of $43.3 million from changes in our operating assets and liabilities. The net cash outflow was primarily driven by an increase in inventory of $47.0 million principally due to the continued strategic buildup of emergency sourced components for our Breast Health business to hedge against the continuing worldwide supply constraints, and a $45.0 million increase in accounts receivable due to higher sales in the first quarter of fiscal 2023 in our Breast Health and Surgical divisions compared to the fourth quarter of fiscal 2022. These cash outflows were partially offset by a decrease in prepaid expenses and other assets of $26.2 million primarily due to normal amortization related to the Women's Tennis Association sponsorship and service and software subscriptions and a decrease in prepaid income taxes of $17.9 million primarily due to timing of tax payments relative to the provision for income taxes.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of fiscal 2023, our investing activities used cash of $41.0 million primarily due to capital expenditures of $29.1 million, which primarily consisted of the placement of equipment under customer usage agreements and purchase of manufacturing equipment and to a lesser extent building improvements to certain facilities, and $10.0 million for the purchase of an equity investment.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first three months of fiscal 2023, our financing activities used cash of $113.5 million primarily due to $100.0 million for repurchases of our common stock and $23.0 million for the payment of employee taxes withheld for the net share </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">settlement of vested restricted stock units. Partially offsetting these uses of cash were $15.1 million from our equity plans, primarily from the exercise of stock options. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Debt</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had total recorded debt outstanding of $2.83 billion at December&#160;31, 2022, which was comprised of amounts outstanding under our 2021 Credit Agreement of $1.49 billion (principal of $1.50 billion), 2029 Senior Notes of $937.2 million (principal of $950.0 million), and 2028 Senior Notes of $396.3 million (principal of $400.0 million).</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 27, 2021, we refinanced our existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders from time to time party thereto (the "2018 Credit Agreement") by entering into a Refinancing Amendment (the "2021 Credit Agreement"). Borrowings under the 2021 Credit Agreement are secured by first-priority liens on, and a first priority security interest in, substantially all of our and our Subsidiary Guarantors' U.S. assets. The credit facilities (the "2021 Credit Facilities") under the 2021 Credit Agreement consist of:</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A $1.5 billion secured term loan ("2021 Term Loan") with a stated maturity date of September 25, 2026; and</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A secured revolving credit facility (the "2021 Revolver") under which the Borrowers may borrow up to $2.0 billion, subject to certain sublimits, with a stated maturity date of September 25, 2026.</span></div><div style="margin-top:3pt;text-align:justify"><span><br/></span></div><div style="margin-top:3pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the principal amount outstanding under the 2021 Term Loan was $1.5 billion, no amounts were outstanding under the 2021 Revolver, and the full amount of the 2021 Revolver was available to be borrowed by the Company.</span></div><div style="margin-top:9pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 22, 2022, the Company and its subsidiaries further amended the 2021 Credit Agreement by entering into an amendment to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rate applicable to the loans under the 2021 Credit Agreement denominated in U.S. Dollars were converted to a variant of the secured overnight financing rate (&#8220;SOFR&#8221;), as established from time to time by the Federal Reserve Bank of New York, plus an applicable spread. As of December 31, 2022, the interest rate under the 2021 Term Loan was 5.43% per annum.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also required to pay a quarterly commitment fee calculated on a daily basis equal to the Applicable Rate as of such day multiplied by the undrawn committed amount available under the 2021 Revolver. As of December 31, 2022, this commitment fee was 0.15% per annum. </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are required to make scheduled principal payments under the 2021 Term Loan in increasing amounts ranging from $3.75 million per three-month period commencing with the three-month period ended on December 29, 2022 to $18.75 million per three-month period commencing with the three-month period ending on December 26, 2025. The remaining scheduled balance of $1.335 billion (or such lesser aggregate principal amount then outstanding) on the 2021 Term Loan and any amounts outstanding under the 2021 Revolver are due at their respective maturities. In addition, subject to the terms and conditions set forth in the 2021 Credit Agreement, we may be required to make certain mandatory prepayments from the net proceeds of specified types of asset sales (subject to certain reinvestment rights), debt issuances (excluding permitted debt) and insurance recoveries (subject to certain reinvestment rights). Certain of the mandatory prepayments are subject to reduction or elimination if certain financial covenants are met. Subject to certain limitations, we may voluntarily prepay any of the 2021 Credit Facilities without premium or penalty.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains affirmative and negative covenants customarily applicable to senior secured credit facilities, including the requirement that we maintain certain financial ratios. As of December 31, 2022, we were in compliance with these covenants. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2028 Senior Notes is $400.0 million. The 2028 Senior Notes are general senior unsecured obligations and are guaranteed on a senior unsecured basis by certain of our domestic subsidiaries. The 2028 Senior Notes mature on February&#160;1, 2028 and bear interest at the rate of&#160;4.625%&#160;per year, payable semi-annually on February&#160;1 and August&#160;1 of each year. We may redeem the 2028 Senior Notes at any time prior to February 1, 2023 at a price equal to&#160;100%&#160;of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make-whole premium set forth in the indenture. We also have the option to redeem the 2028 Senior Notes on or after: February 1, 2023 through February 1, 2024 at&#160;102.312%&#160;of par; February 1, 2024 through February 1, 2025 at&#160;101.541%&#160;of par; February 1, 2025 through February 1, 2026 at&#160;100.770%&#160;of par; and February 1, 2026 and thereafter at&#160;100%&#160;of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2028 Senior Notes at a price equal to&#160;101%&#160;of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total aggregate principal balance of the 2029 Senior Notes is $950.0 million. The 2029 Senior Notes are general senior unsecured obligations and are guaranteed on a senior unsecured basis by certain domestic subsidiaries. The 2029 Senior Notes mature on February 15, 2029 and bear interest at the rate of 3.250%&#160;per year, payable semi-annually on February&#160;15 and August&#160;15 of each year. We may redeem the 2029 Senior Notes at any time prior to September 28, 2023 at a price equal to 100% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date and a make-whole premium set forth in the indenture. We may also redeem up to 40% of the aggregate principal amount of the 2029 Senior Notes with the net cash proceeds of certain equity offerings at any time and from time to time before September 28, 2023, at a redemption price equal to 103.250% of the aggregate principal amount so redeemed, plus accrued and unpaid interest, if any, to the redemption date. We have the option to redeem the 2029 Senior Notes on or after: September 28, 2023 through September 27, 2024 at 101.625% of par; September 28, 2024 through September 27, 2025 at 100.813% of par; and September 28, 2025 and thereafter at 100% of par. In addition, if there is a change of control coupled with a decline in ratings, as provided in the indenture, we will be required to make an offer to purchase each holder&#8217;s 2029 Senior Notes at a price equal to 101% of their principal amount, plus accrued and unpaid interest, if any, to the repurchase date.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On June 10, 2022, we amended the Credit and Security agreement and temporarily suspended the ability to borrow and the need to comply with covenants for up to a year. As of December 31, 2022, we did not have any borrowings under this program.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contingent Consideration Earn-Out Payments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, our only contingent consideration liability is related to our Acessa acquisition. We have an obligation to the former Acessa shareholders to make contingent payments based on a multiple of annual incremental revenue growth over a three-year period ending annually in December. There is no maximum earnout. Pursuant to ASC 805, the contingent consideration was deemed to be part of the purchase price, and we recorded our estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of the business, comparable companies revenue growth rates, implied volatility and applying a risk adjusted discount rate. The first earn-out period was completed in December 2021, and we paid $12.2 million to the former shareholders in the second quarter of fiscal 2022. The second earn-out period was completed in December 2022, resulting in an estimated amount of $7.2 million, and payment is expected to be made in the second quarter of fiscal 2023. As of December 31, 2022, the contingent consideration liability was recorded at its fair value of $23.4 million. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Repurchase Program</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September 22 2022, the Board of Directors authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.0 billion of the Company's outstanding common stock, effective as of the close of trading September 23, 2022. This new repurchase program replaced the previous $1.0 billion authorization. During the three months ended December 31, 2022, the Company repurchased 1.5&#160;million shares of its common stock for total consideration of $100.0&#160;million. As of December 31, 2022, $900.0&#160;million remained available under this authorization. The timing of the share repurchases will be based upon our continuing analysis of market, financial, and other factors. Repurchases under the authorized share repurchase plan may be made using a variety of methods, which may include, but are not limited to, open market purchases, privately negotiated transactions, accelerated share repurchase agreements, or purchases pursuant to a Rule 10b5-1 plan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under the Exchange Act. The authorized share repurchase plan may be suspended, delayed or discontinued at any time.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Legal Contingencies</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently involved in several legal proceedings and claims. In connection with these legal proceedings and claims, management periodically reviews estimates of potential costs to be incurred by us in connection with the adjudication or settlement, if any, of these proceedings. These estimates are developed, as applicable in consultation with outside counsel, and are based on an analysis of potential litigation outcomes and settlement strategies. In accordance with ASC 450, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingencies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, loss contingencies are accrued if, in the opinion of management, an adverse outcome is probable and such financial outcome can be reasonably estimated. It is possible that future results for any particular quarter or annual period may be materially affected by changes in our assumptions or the effectiveness of our strategies relating to these proceedings. Information with respect to this disclosure may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Future Liquidity Considerations</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to review and evaluate potential strategic transactions that we believe will complement our current or future business. Subject to the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022 or any other of our subsequently filed reports, and the general disclaimers set forth in our "Cautionary Statement" regarding forward-looking statements at the outset of this Item 2, we believe that our cash and cash equivalents, cash flows from operations, and the cash available under our 2021 Revolver will provide us with sufficient funds in order to fund our expected normal operations and debt payments over the next twelve months. Our longer-term liquidity is contingent upon future operating performance. We may also require additional capital in the future to fund capital expenditures, repayment of debt, acquisitions, strategic transactions or other investments. As described above, we have significant indebtedness outstanding under our 2021 Credit Agreement, 2028 Senior Notes, and 2029 Senior Notes. These capital requirements could be substantial. For a description of risks to our operating performance and our indebtedness, see the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q, as well as those described in Part I, Item&#160;1A of our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022.</span></div><div><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_115"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CRITICAL ACCOUNTING POLICIES AND ESTIMATES</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based upon our interim consolidated financial statements, which have been prepared in accordance with U.S. generally accepted accounting principles. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition for multiple element arrangements, allowance for doubtful accounts, reserves for excess and obsolete inventories, valuations, purchase price allocations and contingent consideration related to business combinations, expected future cash flows including growth rates, discount rates, terminal values and other assumptions used to evaluate the recoverability of long-lived assets and goodwill, estimated fair values of intangible assets and goodwill, amortization methods and periods, warranty reserves, certain accrued expenses, restructuring and other related charges, stock-based compensation, contingent liabilities, tax reserves and recoverability of our net deferred tax assets and related valuation allowances. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances. Actual results could differ from these estimates if past experience or other assumptions do not turn out to be substantially accurate. Any differences may have a material impact on our financial condition and results of operations. For a discussion of how these and other factors may affect our business, see the &#8220;Cautionary Statement&#8221; regarding forward-looking statements set forth at the outset of this Item 2 and the &#8220;Risk Factors&#8221; set forth or incorporated by reference in Part II, Item 1A of this Quarterly Report on Form 10-Q as well as those described in Part I, Item 1A of our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022 or any other of our subsequently filed reports.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical accounting estimates that we believe affect our more significant judgments and estimates used in the preparation of our consolidated financial statements presented in this report are described in Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations and in the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022. There have been no material changes to our critical accounting policies or estimates from those set forth in our Annual Report on Form 10-K for the fiscal year ended September&#160;24, 2022.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_118"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3.&#160;&#160;&#160;&#160;Quantitative and Qualitative Disclosures About Market Risk.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments, Other Financial Instruments, and Derivative Commodity Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Financial instruments consist of cash and cash equivalents, accounts receivable, equity investments, foreign currency derivative contracts, an interest rate swap agreement, insurance contracts, accounts payable and debt obligations. Except for our outstanding 2028 and 2029 </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Notes, the fair value of these financial instruments approximate their carrying amount. The fair value of our 2028 and 2029 Senior Notes was approximately $373.9 million and $819.2 million, respectively as of December&#160;31, 2022. Amounts outstanding under our 2021 Credit Agreement of $1.5 billion aggregate principal as of December&#160;31, 2022 are subject to variable rates of interest based on current market rates, and as such, we believe the carrying amount of these obligations approximates fair value. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Primary Market Risk Exposures</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our primary market risk exposure is in the areas of interest rate risk and foreign currency exchange rate risk. We incur interest expense on borrowings outstanding under our 2028 and 2029 Senior Notes, and 2021 Credit Agreement. The 2028 and 2029 Senior Notes have fixed interest rates. Effective September 25, 2022 (the first day of fiscal 2023), borrowings under our 2021 Credit Agreement bear interest at the SOFR Rate plus SOFR Adjustment of 0.10% plus the applicable margin of 1.00% per annum.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2022, there was $1.5 billion of aggregate principal outstanding under our 2021 Credit Agreement. Since this debt obligation is a variable rate instrument, our interest expense associated with the instrument is subject to change. A hypothetical 10% adverse movement (increase in the SOFR rate) would increase annual interest expense by approximately $2.2 million, which is net of the impact of our interest rate swap hedge. We previously entered into an interest rate swap agreement to help mitigate the interest rate volatility associated with the variable rate interest on the amounts outstanding under our credit facilities. The critical terms of the interest rate swap were designed to mirror the terms of our SOFR-based borrowings under our 2021 Credit Agreement, and therefore the interest rate swap is highly effective at offsetting the cash flows being hedged. We designated this derivative instrument as a cash flow hedge of the variability of the Term SOFR-based interest payments on $1.0 billion of principal. The interest rate swap contract expires on December 17, 2023.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The return from cash and cash equivalents will vary as short-term interest rates change. A hypothetical 10% increase or decrease in interest rates, however, would not have a material adverse effect on our financial condition or results of operations.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our international business is subject to risks, including, but not limited to: unique economic conditions, changes in political climate, differing tax structures, other regulations and restrictions, and foreign exchange rate volatility. Accordingly, our future results could be materially adversely impacted by changes in these or other factors.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct business worldwide and maintain sales and service offices outside the U.S. as well as manufacturing facilities primarily in Costa Rica and the United Kingdom. Our international sales are denominated in a number of currencies, primarily the Euro, U.S. dollar, UK Pound and Chinese Yuan. The majority of our foreign subsidiaries' functional currency is the local currency, although certain foreign subsidiaries functional currency is the U.S. dollar based on the nature of their operations or functions. Our revenues denominated in foreign currencies are positively affected when the U.S. dollar weakens against them and adversely affected when the U.S. dollar strengthens. Fluctuations in foreign currency rates could affect our sales, cost of goods and operating margins and could result in exchange losses. In addition, currency devaluations can result in a loss if we hold deposits of that currency. We have executed forward foreign currency contracts and foreign currency option contracts to hedge a portion of results denominated in the Euro, UK Pound, Australian dollar, Japanese Yen,  Canadian dollar and Chinese Yuan. These contracts do not qualify for hedge accounting. As a result, we may experience volatility in our Consolidated Statements of Income due to (i) the impact of unrealized gains and losses reported in other income, net on the mark-to-market of outstanding contracts and (ii) realized gains and losses recognized in other income, net, whereas the offsetting economic gains and losses are reported in the line item of the underlying cash flow, for example, revenue. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the operating expenses of our international subsidiaries that are incurred in local currencies will not have a material adverse effect on our business, results of operations or financial condition. Our operating results and certain assets and liabilities that are denominated in foreign currencies are affected by changes in the relative strength of the U.S. dollar against those currencies. Our expenses, denominated in foreign currencies, are positively affected when the U.S. dollar strengthens against those currencies and adversely affected when the U.S. dollar weakens. However, we believe that the foreign currency exchange risk is not significant. We believe a hypothetical 10% increase or decrease in foreign currencies that we transact in would not have a material adverse impact on our financial condition or results of operations. </span></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_121"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4.&#160;&#160;&#160;&#160;Controls and Procedures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. In designing and evaluating the disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, as ours are designed to do, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as defined in Rules&#160;13a-15(e) and 15d-15(e) under the Exchange Act. Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures are effective as of December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">An evaluation was also performed under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of any change in our internal control over financial reporting that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. That evaluation did not identify any change in our internal control over financial reporting that occurred during our latest fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_124"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II &#8211; OTHER INFORMATION</span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_127"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1.&#160;&#160;&#160;&#160;Legal Proceedings.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information with respect to this Item may be found in Note 10 to the Consolidated Financial Statements in this Quarterly Report on Form 10-Q, which information is incorporated herein by reference.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information on our commitments and contingencies can be found in our Annual Report on Form 10-K for our fiscal year ended September&#160;24, 2022.</span></div><div style="text-indent:24.75pt"><span><br/></span></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_130"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;1A. Risk Factors.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no material changes from the risk factors as previously disclosed in our Annual Report on Form 10-K for our fiscal year ended September&#160;24, 2022 or any of our subsequently filed reports.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_133"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;2. Unregistered Sales of Equity Securities and Use of Proceeds.</span></div><div><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Issuer's Purchases of Equity Securities</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.549%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.911%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.765%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.918%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Period of Repurchase</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares&#160;Purchased<br/>(#)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average&#160;Price<br/>Paid&#160;Per&#160;Share<br/>($)&#160;(1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total&#160;Number&#160;of<br/>Shares Purchased As Part of Publicly<br/>Announced Plans or Programs&#160;<br/>(#)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Price Paid Per Share As Part of Publicly Announced Plans or Programs($)&#160;(2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Maximum<br/>Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under Our<br/>Programs  <br/>(in millions)      ($) (2)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 25, 2022 &#8211; October 22, 2022</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">576&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.52&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539,671&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.97&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 23, 2022 &#8211; November 26, 2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">302,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.99&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 27, 2022 &#8211; December 31, 2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,556&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.09&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">306,371&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">74.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,539,671&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">900.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;___________________________________</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">For the majority of restricted stock units granted, the number of shares issued on the date that the restricted stock units vest is net of the minimum statutory tax withholding requirements that we pay in cash to the appropriate taxing authorities on behalf of our employees. These repurchases of our common stock were to cover employee income tax withholding obligations in connection with the vesting of restricted stock units under our equity incentive plans.</span></div><div style="margin-bottom:6pt;padding-left:18pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">On September 22, 2022, the Board of Directors authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.0 billion of the Company's outstanding common stock, effective as of the close of trading on September 23, 2022. This new stock repurchase authorization replaced the previous $1.0 billion authorization.</span></div><div style="padding-left:18pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_136"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div><span><br/></span></div><div style="-sec-extract:summary"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6.&#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">(a) Exhibits </span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:11.021%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.384%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.557%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.570%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Incorporated by<br/>Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit<br/>Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Exhibit Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing&#160;Date/<br/>Period End<br/>Date</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2023ex311.htm">Certification of Hologic&#8217;s CEO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2023ex312.htm">Certification of Hologic&#8217;s CFO pursuant to Item&#160;601(b)(31) of Regulation S-K, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2023ex321.htm">Certification of Hologic&#8217;s CEO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="holx_q1-2023ex322.htm">Certification of Hologic&#8217;s CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.INS*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.SCH*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.CAL*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.LAB*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.PRE*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101.DEF*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101).</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_______________</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*             Filed herewith.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**&#160;&#160;&#160;&#160;Furnished herewith.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="margin-bottom:17pt;margin-top:17pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i18b9fa7ea67d4489b092f7a58ad292ff_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i18b9fa7ea67d4489b092f7a58ad292ff_7">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:12pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:4.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.926%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:2.292%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:39.517%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Hologic, Inc.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Registrant)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan<br/>Chairman, President and Chief Executive Officer<br/>(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 1, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/&#160;&#160;&#160;&#160;Karleen M. Oberton&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer<br/>(Principal Financial Officer)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>holx_q1-2023ex311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i3f22a3c2d11941e0a843c6cf0deb2fb9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;1, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>holx_q1-2023ex312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id1cc8068a76a4fa199f7dcca5a9ea4c8_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, certify that&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">I have reviewed this quarterly report on Form 10-Q of Hologic, Inc.&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.91pt">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:12pt;padding-left:18pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="margin-top:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date&#58; February&#160;1, 2023 </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>holx_q1-2023ex321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i0befe101ec13491a9332643941ae818b_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Stephen P. MacMillan, Chief Executive Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2022 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February&#160;1, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Stephen P. MacMillan&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stephen P. MacMillan</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chairman, President and Chief Executive Officer</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>holx_q1-2023ex322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i245f2fd4bbcf4f089635b5b1900b027e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Certification</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code)</font></div><div style="margin-top:12pt;text-indent:24.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Karleen M. Oberton, Chief Financial Officer of Hologic, Inc., a Delaware corporation (the &#8220;Company&#8221;), do hereby certify, pursuant to Section&#160;906 of the Sarbanes-Oxley Act of 2002 (subsections (a)&#160;and (b)&#160;of Section&#160;1350, Chapter 63 of Title 18, United States Code), that&#58;</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The Quarterly Report on Form 10-Q for the quarter ended December&#160;31, 2022 (the &#8220;Form 10-Q&#8221;) of the Company fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:12pt;padding-left:40.5pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; February&#160;1, 2023</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47;&#160;&#160;&#160;&#160;Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Karleen M. Oberton</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Chief Financial Officer</font></td></tr></table></div><div style="margin-top:7pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A SIGNED ORIGINAL OF THIS WRITTEN STATEMENT REQUIRED BY SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 HAS BEEN PROVIDED TO HOLOGIC, INC. AND WILL BE RETAINED BY HOLOGIC, INC. AND FURNISHED TO THE SECURITIES AND EXCHANGE COMMISSION OR ITS STAFF UPON REQUEST.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>holx-20221231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:3332a847-8252-4aec-a26a-afc1f11215d8,g:d9a9812f-c6f0-4dfd-b7fb-8eca4022aaf1-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:holx="http://www.hologic.com/20221231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.hologic.com/20221231">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2022" schemaLocation="https://xbrl.sec.gov/country/2022/country-2022.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20221231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20221231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20221231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="holx-20221231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.hologic.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofIncome" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome">
        <link:definition>0000002 - Statement - Consolidated Statements of Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLoss" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss">
        <link:definition>0000003 - Statement - Consolidated Statements of Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveLossParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical">
        <link:definition>0000004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets">
        <link:definition>0000005 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>0000007 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>0000008 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BasisofPresentation" roleURI="http://www.hologic.com/role/BasisofPresentation">
        <link:definition>0000009 - Disclosure - Basis of Presentation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.hologic.com/role/Revenue">
        <link:definition>0000010 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.hologic.com/role/Leases">
        <link:definition>0000011 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.hologic.com/role/FairValueMeasurements">
        <link:definition>0000012 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinations" roleURI="http://www.hologic.com/role/BusinessCombinations">
        <link:definition>0000013 - Disclosure - Business Combinations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLosses" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses">
        <link:definition>0000014 - Disclosure - Trade Receivables and Allowance for Credit Losses</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Restructuring" roleURI="http://www.hologic.com/role/Restructuring">
        <link:definition>0000015 - Disclosure - Restructuring</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangements" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements">
        <link:definition>0000016 - Disclosure - Borrowings and Credit Arrangements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Derivatives" roleURI="http://www.hologic.com/role/Derivatives">
        <link:definition>0000017 - Disclosure - Derivatives</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://www.hologic.com/role/CommitmentsandContingencies">
        <link:definition>0000018 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShare" roleURI="http://www.hologic.com/role/NetIncomeLossPerShare">
        <link:definition>0000019 - Disclosure - Net Income (Loss) Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensation" roleURI="http://www.hologic.com/role/StockBasedCompensation">
        <link:definition>0000020 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformation" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation">
        <link:definition>0000021 - Disclosure - Other Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformation" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation">
        <link:definition>0000022 - Disclosure - Business Segments and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.hologic.com/role/IncomeTaxes">
        <link:definition>0000023 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwill" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill">
        <link:definition>0000024 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarranties" roleURI="http://www.hologic.com/role/ProductWarranties">
        <link:definition>0000025 - Disclosure - Product Warranties</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLoss" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss">
        <link:definition>0000026 - Disclosure - Accumulated Other Comprehensive Loss</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchase" roleURI="http://www.hologic.com/role/ShareRepurchase">
        <link:definition>0000027 - Disclosure - Share Repurchase</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.hologic.com/role/RevenueTables">
        <link:definition>0000028 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.hologic.com/role/FairValueMeasurementsTables">
        <link:definition>0000029 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsTables" roleURI="http://www.hologic.com/role/BusinessCombinationsTables">
        <link:definition>0000030 - Disclosure - Business Combinations (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesTables" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables">
        <link:definition>0000031 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsTables" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables">
        <link:definition>0000032 - Disclosure - Borrowings and Credit Arrangements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesTables" roleURI="http://www.hologic.com/role/DerivativesTables">
        <link:definition>0000033 - Disclosure - Derivatives (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareTables" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables">
        <link:definition>0000034 - Disclosure - Net Income (Loss) Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationTables" roleURI="http://www.hologic.com/role/StockBasedCompensationTables">
        <link:definition>0000035 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationTables" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables">
        <link:definition>0000036 - Disclosure - Other Balance Sheet Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationTables" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables">
        <link:definition>0000037 - Disclosure - Business Segments and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillTables" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables">
        <link:definition>0000038 - Disclosure - Intangible Assets and Goodwill (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesTables" roleURI="http://www.hologic.com/role/ProductWarrantiesTables">
        <link:definition>0000039 - Disclosure - Product Warranties (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveLossTables" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables">
        <link:definition>0000040 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueBusinessRevenueDetails" roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails">
        <link:definition>0000041 - Disclosure - Revenue - Business Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueGeographicalRevenueDetails" roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails">
        <link:definition>0000042 - Disclosure - Revenue - Geographical Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRevenuebyTypeDetails" roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails">
        <link:definition>0000043 - Disclosure - Revenue - Revenue by Type (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.hologic.com/role/RevenueNarrativeDetails">
        <link:definition>0000044 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails">
        <link:definition>0000045 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueRemainingPerformanceObligationDetails_1" roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1">
        <link:definition>0000045 - Disclosure - Revenue - Remaining Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesAdditionalLeaseInformationDetails" roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails">
        <link:definition>0000046 - Disclosure - Leases - Additional Lease Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
        <link:definition>0000047 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail">
        <link:definition>0000048 - Disclosure - Fair Value Measurements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsRollForwardDetails" roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails">
        <link:definition>0000049 - Disclosure - Fair Value Measurements - Roll Forward (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationNarrativeDetails" roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails">
        <link:definition>0000050 - Disclosure - Business Combination - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
        <link:definition>0000051 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="TradeReceivablesandAllowanceforCreditLossesDetails" roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails">
        <link:definition>0000052 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RestructuringDetails" roleURI="http://www.hologic.com/role/RestructuringDetails">
        <link:definition>0000053 - Disclosure - Restructuring (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsCompanysBorrowingsDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
        <link:definition>0000054 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail">
        <link:definition>0000055 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
        <link:definition>0000056 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
        <link:definition>0000057 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesAdditionalInformationDetails" roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails">
        <link:definition>0000058 - Disclosure - Derivatives - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
        <link:definition>0000059 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesFairValueofDerivativeFinancialInstrumentsDetails" roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
        <link:definition>0000060 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
        <link:definition>0000061 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingenciesDetail" roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail">
        <link:definition>0000062 - Disclosure - Commitments and Contingencies (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
        <link:definition>0000063 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
        <link:definition>0000064 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail">
        <link:definition>0000065 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail">
        <link:definition>0000066 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationInventoriesDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail">
        <link:definition>0000067 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail">
        <link:definition>0000068 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationAdditionalInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
        <link:definition>0000069 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationSegmentInformationDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail">
        <link:definition>0000070 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
        <link:definition>0000071 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.hologic.com/role/IncomeTaxesDetails">
        <link:definition>0000072 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
        <link:definition>0000073 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail">
        <link:definition>0000074 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ProductWarrantiesProductWarrantyActivityDetail" roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail">
        <link:definition>0000075 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccumulatedOtherComprehensiveIncomeDetail" roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail">
        <link:definition>0000076 - Disclosure - Accumulated Other Comprehensive Income (Detail)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareRepurchaseSharerepurchaseDetails" roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails">
        <link:definition>0000077 - Disclosure - Share Repurchase Share repurchase (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="holx_InternationalMember" abstract="true" name="InternationalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" abstract="false" name="MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_AccumulatedOtherComprehensiveIncomeAbstract" abstract="true" name="AccumulatedOtherComprehensiveIncomeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" abstract="false" name="PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_A2021RevolverMember" abstract="true" name="A2021RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_NotationalAmount" abstract="false" name="NotationalAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_LeaseRevenuePercentageOfTotalRevenue" abstract="false" name="LeaseRevenuePercentageOfTotalRevenue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_TermLoanMember" abstract="true" name="TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" abstract="false" name="MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_AmountAssessedInDamages" abstract="false" name="AmountAssessedInDamages" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_GrantsReceivedFromDepartmentOfDefense" abstract="false" name="GrantsReceivedFromDepartmentOfDefense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" abstract="false" name="PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_InternalusesoftwareMember" abstract="true" name="InternalusesoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_Costofservice" abstract="false" name="Costofservice" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PaymentsUnderFinanceLeaseObligations" abstract="false" name="PaymentsUnderFinanceLeaseObligations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MinervaMember" abstract="true" name="MinervaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_SharerepurchaseplanLineItems" abstract="true" name="SharerepurchaseplanLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_CytologyPerinatalMember" abstract="true" name="CytologyPerinatalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_CapitalEquipmentComponentsandSoftwareMember" abstract="true" name="CapitalEquipmentComponentsandSoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_CapitalizedsoftwareMember" abstract="true" name="CapitalizedsoftwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BreastImagingMember" abstract="true" name="BreastImagingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AnnualIncrementalRevenueGrowthPeriod" abstract="false" name="AnnualIncrementalRevenueGrowthPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_December112020Member" abstract="true" name="December112020Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_DevelopedTechnologyMember" abstract="true" name="DevelopedTechnologyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ContingentConsiderationMember" abstract="true" name="ContingentConsiderationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BolderSurgicalMember" abstract="true" name="BolderSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_Netincome" abstract="false" name="Netincome" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BasisofPresentationAbstract" abstract="true" name="BasisofPresentationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_DepartmentOfDefenseFundsReceivedNotCapitalized" abstract="false" name="DepartmentOfDefenseFundsReceivedNotCapitalized" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SkeletalHealthMember" abstract="true" name="SkeletalHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ManufacturingEquipmentAndSoftware" abstract="false" name="ManufacturingEquipmentAndSoftware" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" abstract="false" name="SharedBasedCompensationArrangementRestrictedStockVestingPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="holx_EarningsPerShareLineItems" abstract="true" name="EarningsPerShareLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_GynSurgicalMember" abstract="true" name="GynSurgicalMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" abstract="false" name="ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_PrincipalAmountOfBorrowings" abstract="false" name="PrincipalAmountOfBorrowings" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_SegmentReportingDisclosureLineItems" abstract="true" name="SegmentReportingDisclosureLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_SharerepurchaseplanTable" abstract="true" name="SharerepurchaseplanTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_A2028SeniorNotesMember" abstract="true" name="A2028SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_DetailsOfCertainBalanceSheetAccountsTextBlock" abstract="false" name="DetailsOfCertainBalanceSheetAccountsTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="holx_BloodScreeningMember" abstract="true" name="BloodScreeningMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_SecuredTermLoanMember" abstract="true" name="SecuredTermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_EarningsPerShareTable" abstract="true" name="EarningsPerShareTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_ServiceRevenue" abstract="false" name="ServiceRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AcquiredintangibleassetsMember" abstract="true" name="AcquiredintangibleassetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ConsumablesMember" abstract="true" name="ConsumablesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_EquipmentUnderCustomerUsageAgreements" abstract="false" name="EquipmentUnderCustomerUsageAgreements" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RSUPSUMSUMember" abstract="true" name="RSUPSUMSUMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_InterventionalBreastSolutionsMember" abstract="true" name="InterventionalBreastSolutionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="holx_RestofWorldMember" abstract="true" name="RestofWorldMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AssetSecuritizationMember" abstract="true" name="AssetSecuritizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BreastHealthMember" abstract="true" name="BreastHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_MolecularDiagnosticsMember" abstract="true" name="MolecularDiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_CreditAgreementMember" abstract="true" name="CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AcessaHealthMember" abstract="true" name="AcessaHealthMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ProductRevenue" abstract="false" name="ProductRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherTypeofRevenueMember" abstract="true" name="OtherTypeofRevenueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_DanburyClosureMember" abstract="true" name="DanburyClosureMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_LongTermDebtObligationsWithoutConvertibleNotes" abstract="false" name="LongTermDebtObligationsWithoutConvertibleNotes" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" abstract="false" name="OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_BusinessCombinationContingentConsiderationPayments" abstract="false" name="BusinessCombinationContingentConsiderationPayments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_MarketBasedAwardsMember" abstract="true" name="MarketBasedAwardsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_AmortizationCostofGoodsSold" abstract="false" name="AmortizationCostofGoodsSold" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_AllOtherCountriesMember" abstract="true" name="AllOtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_Repaymentsofacquiredlongtermdebt" abstract="false" name="Repaymentsofacquiredlongtermdebt" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_DepartmentOfDefenseFundsReceived" abstract="false" name="DepartmentOfDefenseFundsReceived" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_CustomerRelationshipsContractsMember" abstract="true" name="CustomerRelationshipsContractsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PercentageOfRevenues" abstract="false" name="PercentageOfRevenues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsTable" abstract="true" name="ScheduleOfGeographicalSegmentsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="holx_ScheduleOfGeographicalSegmentsLineItems" abstract="true" name="ScheduleOfGeographicalSegmentsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="holx_September222022Member" abstract="true" name="September222022Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_A2028And2029SeniorNotesMember" abstract="true" name="A2028And2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_PSUFreeCashFlowMember" abstract="true" name="PSUFreeCashFlowMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" abstract="false" name="BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_Purchaseofinsurancecontracts" abstract="false" name="Purchaseofinsurancecontracts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_RevolverMember" abstract="true" name="RevolverMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" abstract="false" name="ScheduleOfShareBasedCompensationExpenseTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="holx_PrepaidIncomeTaxesCurrent" abstract="false" name="PrepaidIncomeTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="holx_A2029SeniorNotesMember" abstract="true" name="A2029SeniorNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_A2021TermLoanMember" abstract="true" name="A2021TermLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_A2021CreditAgreementMember" abstract="true" name="A2021CreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="holx_DiagnosticsMember" abstract="true" name="DiagnosticsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>holx-20221231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:3332a847-8252-4aec-a26a-afc1f11215d8,g:d9a9812f-c6f0-4dfd-b7fb-8eca4022aaf1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofIncome"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d9e8aade-2b85-4231-9054-eec1d2dc39c8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_691bfd68-df8c-4c6e-a8a0-41bd1bb75cad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d9e8aade-2b85-4231-9054-eec1d2dc39c8" xlink:to="loc_us-gaap_Revenues_691bfd68-df8c-4c6e-a8a0-41bd1bb75cad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_29951723-02f4-49f6-8c47-90a30b393a03" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d9e8aade-2b85-4231-9054-eec1d2dc39c8" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_29951723-02f4-49f6-8c47-90a30b393a03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_72c92de3-c907-4e77-b497-3509c4f93d55" xlink:href="holx-20221231.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d9e8aade-2b85-4231-9054-eec1d2dc39c8" xlink:to="loc_holx_AmortizationCostofGoodsSold_72c92de3-c907-4e77-b497-3509c4f93d55" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_9d59dc1f-60a6-4981-96dc-e42e1f9de2ec" xlink:href="holx-20221231.xsd#holx_Costofservice"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_d9e8aade-2b85-4231-9054-eec1d2dc39c8" xlink:to="loc_holx_Costofservice_9d59dc1f-60a6-4981-96dc-e42e1f9de2ec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_3539eb43-ede3-4474-b7ee-7fc4aaaa7784" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_3539eb43-ede3-4474-b7ee-7fc4aaaa7784" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_dc534c86-7e1f-4675-8cad-5b7862c96063" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:to="loc_us-gaap_SellingAndMarketingExpense_dc534c86-7e1f-4675-8cad-5b7862c96063" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_6d607e0d-50a6-4e9b-a9a2-66416c614870" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_6d607e0d-50a6-4e9b-a9a2-66416c614870" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_1bb71b0a-3e14-45c1-a245-02d2c7ec810e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:to="loc_us-gaap_RestructuringCharges_1bb71b0a-3e14-45c1-a245-02d2c7ec810e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_b8fac692-c82c-496f-aac5-8d367ab700f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_b8fac692-c82c-496f-aac5-8d367ab700f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_846e259b-a22e-487e-ab34-c98a2b18fac9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_c3833c05-9937-4c19-bacb-ead2398d6f6a" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_846e259b-a22e-487e-ab34-c98a2b18fac9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0812b5c7-b1be-4479-9d93-57be7baf38b2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_0a6d59ab-0257-40e2-a100-6802f52f9511" xlink:href="holx-20221231.xsd#holx_ProductRevenue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0812b5c7-b1be-4479-9d93-57be7baf38b2" xlink:to="loc_holx_ProductRevenue_0a6d59ab-0257-40e2-a100-6802f52f9511" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_3f41bd3c-5652-4bd4-8943-73d1f63d2cdc" xlink:href="holx-20221231.xsd#holx_ServiceRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Revenues_0812b5c7-b1be-4479-9d93-57be7baf38b2" xlink:to="loc_holx_ServiceRevenue_3f41bd3c-5652-4bd4-8943-73d1f63d2cdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e32102f-a0f4-42e3-acd4-8c403798a850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6bc2aa12-5261-4588-b90c-31eb85cf627f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e32102f-a0f4-42e3-acd4-8c403798a850" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_6bc2aa12-5261-4588-b90c-31eb85cf627f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_17c7767c-69d7-4fe7-85d5-89626aa9a8f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e32102f-a0f4-42e3-acd4-8c403798a850" xlink:to="loc_us-gaap_OperatingIncomeLoss_17c7767c-69d7-4fe7-85d5-89626aa9a8f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_99a29cb2-2165-498b-89ad-af4f04bdb732" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e32102f-a0f4-42e3-acd4-8c403798a850" xlink:to="loc_us-gaap_InterestExpense_99a29cb2-2165-498b-89ad-af4f04bdb732" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_69846e21-327a-42e1-beb6-b47ae51f68c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e32102f-a0f4-42e3-acd4-8c403798a850" xlink:to="loc_us-gaap_InvestmentIncomeInterest_69846e21-327a-42e1-beb6-b47ae51f68c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_53e2317b-7474-4e6d-8767-1136c955b77d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1e32102f-a0f4-42e3-acd4-8c403798a850" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_53e2317b-7474-4e6d-8767-1136c955b77d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_76931885-a673-45bb-a644-128829520392" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_aba689a7-d81e-4136-a1e8-34df8a63ecd3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_76931885-a673-45bb-a644-128829520392" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_aba689a7-d81e-4136-a1e8-34df8a63ecd3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_287545da-b1ea-402e-9c03-3a792617eb88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_76931885-a673-45bb-a644-128829520392" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_287545da-b1ea-402e-9c03-3a792617eb88" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_22c2d681-5b7b-4e20-8812-84467b61d22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_a106d8bb-bed2-4354-84f1-5b24509ec001" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_22c2d681-5b7b-4e20-8812-84467b61d22a" xlink:to="loc_us-gaap_GrossProfit_a106d8bb-bed2-4354-84f1-5b24509ec001" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_ee98f311-64cf-4beb-a50f-8a0bd050b78f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_22c2d681-5b7b-4e20-8812-84467b61d22a" xlink:to="loc_us-gaap_OperatingExpenses_ee98f311-64cf-4beb-a50f-8a0bd050b78f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_217c59d3-e021-4505-b837-6dfae7ac3779" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c21fcf8b-4504-48be-884c-73f29af4a000" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_217c59d3-e021-4505-b837-6dfae7ac3779" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_c21fcf8b-4504-48be-884c-73f29af4a000" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bba01071-707e-46ee-bdfe-ee658aff1bc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_217c59d3-e021-4505-b837-6dfae7ac3779" xlink:to="loc_us-gaap_NetIncomeLoss_bba01071-707e-46ee-bdfe-ee658aff1bc3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_951fb74b-3e4d-4a97-9f76-34715c88ba3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a54a6d7b-dab3-4c61-a730-1f019a9f5c80" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_951fb74b-3e4d-4a97-9f76-34715c88ba3e" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_a54a6d7b-dab3-4c61-a730-1f019a9f5c80" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_ec3b3716-ea41-4da1-b27b-9751faccc6fa" xlink:href="holx-20221231.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_951fb74b-3e4d-4a97-9f76-34715c88ba3e" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_ec3b3716-ea41-4da1-b27b-9751faccc6fa" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_4997a049-7679-478f-a8c1-ba88acc17e46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:to="loc_us-gaap_PreferredStockValue_4997a049-7679-478f-a8c1-ba88acc17e46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_ea99c7c2-931d-4195-8556-c78071fc91c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:to="loc_us-gaap_CommonStockValue_ea99c7c2-931d-4195-8556-c78071fc91c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_01e7e921-85e0-427b-8275-0fbeeaa79a74" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:to="loc_us-gaap_AdditionalPaidInCapital_01e7e921-85e0-427b-8275-0fbeeaa79a74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c80a3d5-4535-46c0-997c-ce0301e5fe60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_1c80a3d5-4535-46c0-997c-ce0301e5fe60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_4c28019e-0f0a-4eb0-a66d-0a98f48f7048" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:to="loc_us-gaap_TreasuryStockValue_4c28019e-0f0a-4eb0-a66d-0a98f48f7048" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_22c3fcff-837d-4502-aae1-f2fe5a3503dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_9518b689-3148-4af9-a9db-e68db840e8ba" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_22c3fcff-837d-4502-aae1-f2fe5a3503dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_76761ae6-5853-454b-b498-8f7a26bdda3f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_1700bc8c-f13c-44d8-9245-477d0777a529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_76761ae6-5853-454b-b498-8f7a26bdda3f" xlink:to="loc_us-gaap_LongTermDebtCurrent_1700bc8c-f13c-44d8-9245-477d0777a529" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_936eae7a-df5f-4df1-a362-d96775d5635b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_76761ae6-5853-454b-b498-8f7a26bdda3f" xlink:to="loc_us-gaap_AccountsPayableCurrent_936eae7a-df5f-4df1-a362-d96775d5635b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_7d61cdd7-e841-4a17-9ecb-74642faa78ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_76761ae6-5853-454b-b498-8f7a26bdda3f" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_7d61cdd7-e841-4a17-9ecb-74642faa78ac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_02daf4ca-d841-41d5-b930-612e9a065003" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_76761ae6-5853-454b-b498-8f7a26bdda3f" xlink:to="loc_us-gaap_DeferredRevenueCurrent_02daf4ca-d841-41d5-b930-612e9a065003" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_2a38e57e-d472-4119-8747-b0dc76d8d86a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_76761ae6-5853-454b-b498-8f7a26bdda3f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_2a38e57e-d472-4119-8747-b0dc76d8d86a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1e70b443-bc5d-419e-ba47-617f6f6d2a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_LiabilitiesCurrent_1e70b443-bc5d-419e-ba47-617f6f6d2a8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_3469e858-7291-4d60-a210-643be2b58f2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_3469e858-7291-4d60-a210-643be2b58f2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6960fcb2-c1d2-4e3c-8028-e3ade74ead3a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_6960fcb2-c1d2-4e3c-8028-e3ade74ead3a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0179669d-5b72-4ae4-a11c-bdcf03a3b104" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_0179669d-5b72-4ae4-a11c-bdcf03a3b104" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_2e3dd65d-4d2d-4aa7-8f6f-6f9ca91739a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_2e3dd65d-4d2d-4aa7-8f6f-6f9ca91739a8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_62a96cd2-be1d-4c6f-95ad-6060e2b33901" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_62a96cd2-be1d-4c6f-95ad-6060e2b33901" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_fe118b54-66cd-4370-b6ec-f8547eb1dc60" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_8c8af726-a84d-406b-9758-f83dac1030fe" xlink:to="loc_us-gaap_StockholdersEquity_fe118b54-66cd-4370-b6ec-f8547eb1dc60" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_00e0464d-86d2-4f2a-a13b-c213ccc8992c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_3fd05a39-6f7f-4395-9f87-57e7eb7fc386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_00e0464d-86d2-4f2a-a13b-c213ccc8992c" xlink:to="loc_us-gaap_AssetsCurrent_3fd05a39-6f7f-4395-9f87-57e7eb7fc386" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_a4a21717-23f5-40d4-b1eb-0c21f311712e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_00e0464d-86d2-4f2a-a13b-c213ccc8992c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_a4a21717-23f5-40d4-b1eb-0c21f311712e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_35da2cb2-97b7-4e5c-b1d3-74f70d257355" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_00e0464d-86d2-4f2a-a13b-c213ccc8992c" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_35da2cb2-97b7-4e5c-b1d3-74f70d257355" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d6371b2f-c4f0-4e66-b3c4-7a334862a65f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_00e0464d-86d2-4f2a-a13b-c213ccc8992c" xlink:to="loc_us-gaap_Goodwill_d6371b2f-c4f0-4e66-b3c4-7a334862a65f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_75cb2640-a8b2-4e79-9083-5e0041b21726" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_00e0464d-86d2-4f2a-a13b-c213ccc8992c" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_75cb2640-a8b2-4e79-9083-5e0041b21726" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_fb58f6f4-cb78-4179-a67e-47147ecea235" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_ef552873-aced-48bf-b241-dc2d86bf6bbb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fb58f6f4-cb78-4179-a67e-47147ecea235" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_ef552873-aced-48bf-b241-dc2d86bf6bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_dab60965-a1e7-4910-86ea-81d215a76bb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fb58f6f4-cb78-4179-a67e-47147ecea235" xlink:to="loc_us-gaap_InventoryNet_dab60965-a1e7-4910-86ea-81d215a76bb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_c776c8fe-75b8-4485-bb00-a6b4834f7cbb" xlink:href="holx-20221231.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fb58f6f4-cb78-4179-a67e-47147ecea235" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_c776c8fe-75b8-4485-bb00-a6b4834f7cbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_6c372879-6896-46bd-9b2a-36006c54a769" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fb58f6f4-cb78-4179-a67e-47147ecea235" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_6c372879-6896-46bd-9b2a-36006c54a769" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ee02f93-9673-4025-9e4b-eb2bb5fd301a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_fb58f6f4-cb78-4179-a67e-47147ecea235" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5ee02f93-9673-4025-9e4b-eb2bb5fd301a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_a7d72b32-a55d-4d08-8ac4-8589f0f546f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_a7d72b32-a55d-4d08-8ac4-8589f0f546f1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_af1c9ccf-77cd-4702-9b84-170a814a7ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_af1c9ccf-77cd-4702-9b84-170a814a7ce1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentsofacquiredlongtermdebt_1bb7c7b6-d410-4e37-afed-3605a8e54e65" xlink:href="holx-20221231.xsd#holx_Repaymentsofacquiredlongtermdebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_holx_Repaymentsofacquiredlongtermdebt_1bb7c7b6-d410-4e37-afed-3605a8e54e65" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e3bde10f-6f34-4cba-ae70-28e1b18e595f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_e3bde10f-6f34-4cba-ae70-28e1b18e595f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations_a2aa5517-2cd3-4b48-8c8a-eed403cff934" xlink:href="holx-20221231.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_holx_PaymentsUnderFinanceLeaseObligations_a2aa5517-2cd3-4b48-8c8a-eed403cff934" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_43dfca3c-416c-4032-9f56-8210ef5e661c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_43dfca3c-416c-4032-9f56-8210ef5e661c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_d8ca5a52-ad0c-4227-b564-bcb554bf562d" xlink:href="holx-20221231.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_d8ca5a52-ad0c-4227-b564-bcb554bf562d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9bffbf27-d44a-4ce3-8bd6-d400a11bd533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9ded064f-6b29-4a32-8bd4-9bae32b58211" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_9bffbf27-d44a-4ce3-8bd6-d400a11bd533" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_04f86730-921a-480f-8d07-b55c898a1126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_04f86730-921a-480f-8d07-b55c898a1126" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_064886df-8313-46e9-a5b4-c40d8b971095" xlink:href="holx-20221231.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:to="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_064886df-8313-46e9-a5b4-c40d8b971095" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_b7562261-10db-4d15-95e9-9a36af76e177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:to="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_b7562261-10db-4d15-95e9-9a36af76e177" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_9c67d2da-b40c-41c8-92d0-4243af281b40" xlink:href="holx-20221231.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_9c67d2da-b40c-41c8-92d0-4243af281b40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_4ac8aee2-9d90-4b3f-bbfd-f3079a7c62cc" xlink:href="holx-20221231.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:to="loc_holx_Purchaseofinsurancecontracts_4ac8aee2-9d90-4b3f-bbfd-f3079a7c62cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_680aea5e-7b19-415c-b660-14e016effd0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9bc03e09-cd95-46bb-bb86-fd61130385c5" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_680aea5e-7b19-415c-b660-14e016effd0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3968c7b0-271d-4afd-9ff0-6353fff32b27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_62737f3e-9a7b-441d-b9fe-b65cd45f8088" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3968c7b0-271d-4afd-9ff0-6353fff32b27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_62737f3e-9a7b-441d-b9fe-b65cd45f8088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ced364a-ce55-42ba-b6e8-12ad9d58653b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3968c7b0-271d-4afd-9ff0-6353fff32b27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_2ced364a-ce55-42ba-b6e8-12ad9d58653b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6120cff4-da47-445d-85d0-b3e7004744ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3968c7b0-271d-4afd-9ff0-6353fff32b27" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_6120cff4-da47-445d-85d0-b3e7004744ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e1eed28e-6222-45d2-9d37-084b90edd317" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3968c7b0-271d-4afd-9ff0-6353fff32b27" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e1eed28e-6222-45d2-9d37-084b90edd317" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f9422a8c-2bde-4e95-b8a1-e73e91c07e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_ShareBasedCompensation_f9422a8c-2bde-4e95-b8a1-e73e91c07e2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_137bcac1-9b29-451f-b754-9bf498921824" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_137bcac1-9b29-451f-b754-9bf498921824" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_13da2197-7078-414c-8fd8-2ab7864d4385" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_13da2197-7078-414c-8fd8-2ab7864d4385" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f7327e1e-7407-40c1-b85e-ce22d66e9446" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_NetIncomeLoss_f7327e1e-7407-40c1-b85e-ce22d66e9446" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_129e4792-ac26-49c9-91d5-8a4ede04eaaa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_AdjustmentForAmortization_129e4792-ac26-49c9-91d5-8a4ede04eaaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_7f43bcdc-f801-416b-9f44-0a58b65126ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_7f43bcdc-f801-416b-9f44-0a58b65126ba" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_a64c49d8-6c7a-4dee-914c-0170af33df90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_Depreciation_a64c49d8-6c7a-4dee-914c-0170af33df90" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bbdf9659-ab64-48fc-b760-f99819ee0df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_bbdf9659-ab64-48fc-b760-f99819ee0df6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_004e0338-273c-4071-86e7-d31e88b3401b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_004e0338-273c-4071-86e7-d31e88b3401b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6c729274-5dc7-4287-92e9-1cf665432c14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6c729274-5dc7-4287-92e9-1cf665432c14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18226eb8-10c0-423e-b216-2a5bcef9f350" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_18226eb8-10c0-423e-b216-2a5bcef9f350" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_244a1536-ccf5-4739-ba1d-78fc85608ba5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_244a1536-ccf5-4739-ba1d-78fc85608ba5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1f3a694b-aa7c-4838-825d-dab2c6af23ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_1f3a694b-aa7c-4838-825d-dab2c6af23ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_8d04387c-0d23-44d6-9686-3ab81b11acc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_e280bf2e-3a04-4222-9a74-7ca53e6c6df4" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_8d04387c-0d23-44d6-9686-3ab81b11acc4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_47d61613-064a-4213-add2-b6aa8e580d6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_47d61613-064a-4213-add2-b6aa8e580d6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e2353637-637a-410d-bb84-062162357afd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_e2353637-637a-410d-bb84-062162357afd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_88fe3c13-34c4-4392-a2d0-c1358bd0375a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_88fe3c13-34c4-4392-a2d0-c1358bd0375a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d176b23c-c19e-4bb7-937b-e33a161e8024" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_d176b23c-c19e-4bb7-937b-e33a161e8024" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f8636a36-9a29-4fbd-b05b-277ab85f53fa" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_f8636a36-9a29-4fbd-b05b-277ab85f53fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a04bccea-8769-491f-bf4e-fa2d4c4efa71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a04bccea-8769-491f-bf4e-fa2d4c4efa71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_d901460e-5a7e-444a-9242-6474637df82a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_Goodwill_d901460e-5a7e-444a-9242-6474637df82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_ba460e80-bc14-40fb-a4c3-8384a6803515" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_ba460e80-bc14-40fb-a4c3-8384a6803515" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_f2880e64-f470-4d54-9f66-8be16ce2d9a1" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_f2880e64-f470-4d54-9f66-8be16ce2d9a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_87cba86b-bfc9-4b27-864c-a27f4ffbfeeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_d8afa3d1-aced-4c7a-845c-0b152a63bb85" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_87cba86b-bfc9-4b27-864c-a27f4ffbfeeb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_a5660575-c06c-4b14-afc5-e79d8ffe1b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_02093ede-24fe-45cb-9b3a-e4c158ae858c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a5660575-c06c-4b14-afc5-e79d8ffe1b16" xlink:to="loc_us-gaap_LongTermDebtCurrent_02093ede-24fe-45cb-9b3a-e4c158ae858c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_672c7e71-369c-4d49-9a35-f2c4061da214" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a5660575-c06c-4b14-afc5-e79d8ffe1b16" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_672c7e71-369c-4d49-9a35-f2c4061da214" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_b0297c7e-ebff-4c8b-8038-c0d192c74437" xlink:href="holx-20221231.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_a5660575-c06c-4b14-afc5-e79d8ffe1b16" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_b0297c7e-ebff-4c8b-8038-c0d192c74437" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c20f404-625d-46ce-8ff7-45c6ac6b4e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2e6d156d-7063-4368-bc3a-542f3171d1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c20f404-625d-46ce-8ff7-45c6ac6b4e38" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_2e6d156d-7063-4368-bc3a-542f3171d1e1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0b8679b9-c33a-4ad4-981e-0342b0c8e49c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_4c20f404-625d-46ce-8ff7-45c6ac6b4e38" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_0b8679b9-c33a-4ad4-981e-0342b0c8e49c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_0d01f8c7-cec5-4580-b6f1-a17c52110f28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7dc0d687-1ed3-40fd-88b1-ed481cbb047e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0d01f8c7-cec5-4580-b6f1-a17c52110f28" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7dc0d687-1ed3-40fd-88b1-ed481cbb047e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_cdf8d507-4661-4211-9459-a2dc5bd56687" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0d01f8c7-cec5-4580-b6f1-a17c52110f28" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_cdf8d507-4661-4211-9459-a2dc5bd56687" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_e2f35e87-e4db-4bf4-8283-d809218b05b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_0d01f8c7-cec5-4580-b6f1-a17c52110f28" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_e2f35e87-e4db-4bf4-8283-d809218b05b4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:calculationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_85732ca2-23a6-4146-91b1-66e97064c65e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_9a489200-f29e-4b69-85d7-dc02971c9aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_85732ca2-23a6-4146-91b1-66e97064c65e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_9a489200-f29e-4b69-85d7-dc02971c9aa1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5b7bafa5-00fd-466c-8713-efee8512d8ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_85732ca2-23a6-4146-91b1-66e97064c65e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_5b7bafa5-00fd-466c-8713-efee8512d8ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_80895cfc-1317-4701-ba8f-183a259cf116" xlink:href="holx-20221231.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_80895cfc-1317-4701-ba8f-183a259cf116" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_7c831d01-9e3d-478c-a57e-316da5b895bc" xlink:href="holx-20221231.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_7c831d01-9e3d-478c-a57e-316da5b895bc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_fde5dfba-c4a8-468c-9072-3ec927c92747" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_fde5dfba-c4a8-468c-9072-3ec927c92747" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_73ed7995-3f92-48e1-8f53-9a99d16c4298" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_73ed7995-3f92-48e1-8f53-9a99d16c4298" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_ebf07feb-f85e-41b7-81d9-cd3168dc9f1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_us-gaap_Land_ebf07feb-f85e-41b7-81d9-cd3168dc9f1e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_974ffda3-a550-475b-b4b2-f4f096561352" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_974ffda3-a550-475b-b4b2-f4f096561352" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_56b963f3-c0dd-4692-be7f-5e0feb1cb72c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross_53e426d2-d172-4d3f-b45a-92b7b31ee3a2" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_56b963f3-c0dd-4692-be7f-5e0feb1cb72c" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>holx-20221231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:3332a847-8252-4aec-a26a-afc1f11215d8,g:d9a9812f-c6f0-4dfd-b7fb-8eca4022aaf1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended" id="i8d3bda8585d94a5c97a8410004b56a74_ConsolidatedStatementsofStockholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_75c35ff5-9301-4760-b8ac-c5ec96601fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_75c35ff5-9301-4760-b8ac-c5ec96601fff" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6f7b4c49-c64e-4121-86d5-dcec15e9a3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_SharesIssued_6f7b4c49-c64e-4121-86d5-dcec15e9a3e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a42fa83-6cda-4f06-91a4-0a5a48b21a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockholdersEquity_0a42fa83-6cda-4f06-91a4-0a5a48b21a7a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a19bd6de-b007-4851-a1c3-00ffb600045b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a19bd6de-b007-4851-a1c3-00ffb600045b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c884dd8-703c-4b5a-bba7-39bf6f65d00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c884dd8-703c-4b5a-bba7-39bf6f65d00d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_b05ad811-c120-43b7-bb72-aaf005f1ff72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_b05ad811-c120-43b7-bb72-aaf005f1ff72" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a4e0cb46-b013-4e17-ab12-fc22762c396d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a4e0cb46-b013-4e17-ab12-fc22762c396d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3c941e01-6df3-4fd6-a4ac-1395e25cd7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3c941e01-6df3-4fd6-a4ac-1395e25cd7d5" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_94cd2b29-d327-4c4b-90e6-1aba0490fa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_94cd2b29-d327-4c4b-90e6-1aba0490fa9e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ce968c-3d55-4ad0-b6bb-c98d864d9eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ce968c-3d55-4ad0-b6bb-c98d864d9eb0" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d3a32df-27c2-4154-ab1d-f5b1083e6d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_NetIncomeLoss_9d3a32df-27c2-4154-ab1d-f5b1083e6d5c" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_642a37e4-0f32-42f3-8500-5d699bd67baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_642a37e4-0f32-42f3-8500-5d699bd67baf" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4b450bbc-0a80-49ea-b6f9-121bf2cacfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_4b450bbc-0a80-49ea-b6f9-121bf2cacfc6" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_701f07cd-8464-4405-985e-d8ab1ee97342" xlink:href="holx-20221231.xsd#holx_Netincome"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_holx_Netincome_701f07cd-8464-4405-985e-d8ab1ee97342" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e0c1305a-ad01-434d-877e-3503074b342c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e0c1305a-ad01-434d-877e-3503074b342c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_46d0adbb-2d0e-4d49-a4f2-7ff591cf2181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_113b590f-a163-470d-9e07-911c95bf8f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05a49906-f1d6-43c3-afb7-dab75276a626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05a49906-f1d6-43c3-afb7-dab75276a626" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_75c35ff5-9301-4760-b8ac-c5ec96601fff" xlink:to="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_c2bfa072-ca10-43c2-b85d-868aaf72623a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:to="loc_us-gaap_EquityComponentDomain_c2bfa072-ca10-43c2-b85d-868aaf72623a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:to="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6dbb084d-a056-40e8-872a-0b77be9dfb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_CommonStockMember_6dbb084d-a056-40e8-872a-0b77be9dfb1f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_311acf16-d0af-480c-a615-3f0eaf46eddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_311acf16-d0af-480c-a615-3f0eaf46eddc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cc3bf724-88bb-4eb8-a1f3-7d339452fe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_RetainedEarningsMember_cc3bf724-88bb-4eb8-a1f3-7d339452fe7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b48a5704-5ae2-491c-bf5e-f1438f0a72fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b48a5704-5ae2-491c-bf5e-f1438f0a72fa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_f6e47d8f-2fed-4ed4-a21f-c51b546ed246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_TreasuryStockMember_f6e47d8f-2fed-4ed4-a21f-c51b546ed246" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_c596def1-a00e-4556-8427-6aa1e1127f30_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:to="loc_us-gaap_TypeOfAdoptionMember_c596def1-a00e-4556-8427-6aa1e1127f30_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_37abc044-cca2-4ae4-9dfb-ce77862a5127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:to="loc_us-gaap_TypeOfAdoptionMember_37abc044-cca2-4ae4-9dfb-ce77862a5127" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7a445dae-0752-47b0-a525-a3ee3ada646c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7a445dae-0752-47b0-a525-a3ee3ada646c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_16e1783c-42af-456e-bcb0-223a9fa2f041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_16e1783c-42af-456e-bcb0-223a9fa2f041" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_a35b6961-67d0-4244-a66a-31e4905a971c" xlink:href="holx-20221231.xsd#holx_September222022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_16e1783c-42af-456e-bcb0-223a9fa2f041" xlink:to="loc_holx_September222022Member_a35b6961-67d0-4244-a66a-31e4905a971c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueBusinessRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended" id="idfa4d5dfd3a0486ebbad9ed746137344_RevenueBusinessRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_146dff4d-53db-466f-b883-f652fee93b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b80a1769-4341-411c-8765-7a3eb0408178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_146dff4d-53db-466f-b883-f652fee93b9b" xlink:to="loc_us-gaap_Revenues_b80a1769-4341-411c-8765-7a3eb0408178" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_146dff4d-53db-466f-b883-f652fee93b9b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2dada6f4-3849-480c-92d1-cff2ac41a177_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:to="loc_us-gaap_SegmentDomain_2dada6f4-3849-480c-92d1-cff2ac41a177_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:to="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_e6a79c30-405e-4fe5-beeb-6d95924483ee" xlink:href="holx-20221231.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_DiagnosticsMember_e6a79c30-405e-4fe5-beeb-6d95924483ee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_5bf3205c-d887-4ce1-8ee8-d09cc803bef9" xlink:href="holx-20221231.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_BreastHealthMember_5bf3205c-d887-4ce1-8ee8-d09cc803bef9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_76532e56-b526-4a44-a572-b2963622e16e" xlink:href="holx-20221231.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_GynSurgicalMember_76532e56-b526-4a44-a572-b2963622e16e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_0e92dad2-50cd-4099-aa02-aac9e1484814" xlink:href="holx-20221231.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_SkeletalHealthMember_0e92dad2-50cd-4099-aa02-aac9e1484814" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_14f289ec-73b2-4ea0-84e7-3913fa3df6e4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:to="loc_srt_ProductsAndServicesDomain_14f289ec-73b2-4ea0-84e7-3913fa3df6e4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:to="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_81cf043f-fe0d-4b34-b96a-ea70b55b942c" xlink:href="holx-20221231.xsd#holx_CytologyPerinatalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_CytologyPerinatalMember_81cf043f-fe0d-4b34-b96a-ea70b55b942c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_59e8b8f0-7d86-477a-888a-952e103b1389" xlink:href="holx-20221231.xsd#holx_MolecularDiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_MolecularDiagnosticsMember_59e8b8f0-7d86-477a-888a-952e103b1389" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_649cd1c8-1115-49dd-a36c-8bb9bb084fe0" xlink:href="holx-20221231.xsd#holx_BloodScreeningMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_BloodScreeningMember_649cd1c8-1115-49dd-a36c-8bb9bb084fe0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_ae774984-19f2-440b-8168-766819122265" xlink:href="holx-20221231.xsd#holx_BreastImagingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_BreastImagingMember_ae774984-19f2-440b-8168-766819122265" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_b29cd6e1-4f63-41bf-a9be-ea7bcd86c839" xlink:href="holx-20221231.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_InterventionalBreastSolutionsMember_b29cd6e1-4f63-41bf-a9be-ea7bcd86c839" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_0fedcf3c-b7b9-4047-a782-acad120ab583_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:to="loc_srt_SegmentGeographicalDomain_0fedcf3c-b7b9-4047-a782-acad120ab583_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:to="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_66698a1a-69b4-4716-845c-c1d4f8812908" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:to="loc_country_US_66698a1a-69b4-4716-845c-c1d4f8812908" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_406d9f5f-140d-45ca-b25c-863bb158d120" xlink:href="holx-20221231.xsd#holx_InternationalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:to="loc_holx_InternationalMember_406d9f5f-140d-45ca-b25c-863bb158d120" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueGeographicalRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended" id="ic6e756a7008d4f699ae7f2fef29fde3b_RevenueGeographicalRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ffcdfbf9-956a-46ab-a666-2c80fbc983a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_13bba0bc-4acd-4dd5-9cb4-5084cd80117c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ffcdfbf9-956a-46ab-a666-2c80fbc983a4" xlink:to="loc_us-gaap_Revenues_13bba0bc-4acd-4dd5-9cb4-5084cd80117c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ffcdfbf9-956a-46ab-a666-2c80fbc983a4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:to="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_b474e3fa-230c-4fcc-9870-f8850efedf8d_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:to="loc_srt_SegmentGeographicalDomain_b474e3fa-230c-4fcc-9870-f8850efedf8d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:to="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d7e2bb02-2c11-4421-8c04-6a0fd718a89c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_country_US_d7e2bb02-2c11-4421-8c04-6a0fd718a89c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f9beb2b1-b0e1-4f55-8628-e13c5edd5484" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_srt_EuropeMember_f9beb2b1-b0e1-4f55-8628-e13c5edd5484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c4432418-b6f1-4e44-a739-e593ff7298ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_srt_AsiaPacificMember_c4432418-b6f1-4e44-a739-e593ff7298ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_6360275d-9ab5-4c6b-bb6a-a19305e39eb5" xlink:href="holx-20221231.xsd#holx_RestofWorldMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_holx_RestofWorldMember_6360275d-9ab5-4c6b-bb6a-a19305e39eb5" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueRevenuebyTypeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended" id="i32bf120955664d8e90507401f8a370bd_RevenueRevenuebyTypeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5e6800be-172f-4a37-b0eb-506e4d7fc24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_303b6dbf-69df-4a39-a428-4cab20c240ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5e6800be-172f-4a37-b0eb-506e4d7fc24f" xlink:to="loc_us-gaap_Revenues_303b6dbf-69df-4a39-a428-4cab20c240ce" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5e6800be-172f-4a37-b0eb-506e4d7fc24f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:to="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_a4d0c1bb-8f82-4296-9d43-886ebba0cda4_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:to="loc_srt_ProductsAndServicesDomain_a4d0c1bb-8f82-4296-9d43-886ebba0cda4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:to="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_0c36c77d-1985-4baf-9fd4-4f32ebb65380" xlink:href="holx-20221231.xsd#holx_ConsumablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_holx_ConsumablesMember_0c36c77d-1985-4baf-9fd4-4f32ebb65380" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_ab7f684a-995e-4d62-a05e-e6db1e419cc4" xlink:href="holx-20221231.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_ab7f684a-995e-4d62-a05e-e6db1e419cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_c542bb32-d5bf-400c-851e-abbedcd7310e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_us-gaap_ServiceMember_c542bb32-d5bf-400c-851e-abbedcd7310e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_6a0237cf-30a2-4d02-9383-74e6d89dea9a" xlink:href="holx-20221231.xsd#holx_OtherTypeofRevenueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_holx_OtherTypeofRevenueMember_6a0237cf-30a2-4d02-9383-74e6d89dea9a" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended" id="ice5c89955f664e4cb4a422a700f3e55a_RevenueRemainingPerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_507f2c19-e423-4a9a-a817-95b900eac077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_507f2c19-e423-4a9a-a817-95b900eac077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_eb368acf-864a-4822-b494-851041cf9d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_eb368acf-864a-4822-b494-851041cf9d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_594f1087-02e4-4ca2-a959-978b89b8bc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_594f1087-02e4-4ca2-a959-978b89b8bc54" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended" id="i83d04e5aee4a47e78871691c52573c12_RevenueRemainingPerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_507f2c19-e423-4a9a-a817-95b900eac077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_507f2c19-e423-4a9a-a817-95b900eac077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_eb368acf-864a-4822-b494-851041cf9d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_eb368acf-864a-4822-b494-851041cf9d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended" id="i502cc01f78804de8a17a742d7dfab282_FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9707c20f-d8c8-47ac-bd98-013a14b289b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9707c20f-d8c8-47ac-bd98-013a14b289b5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_28a11ece-71bd-44ef-8a66-d3171529ed02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9707c20f-d8c8-47ac-bd98-013a14b289b5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_28a11ece-71bd-44ef-8a66-d3171529ed02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_7849a4d5-5b53-4114-9f2a-02df914137da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_7849a4d5-5b53-4114-9f2a-02df914137da" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_554ff2dc-8969-4b72-a9c3-eca8c1a389bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_554ff2dc-8969-4b72-a9c3-eca8c1a389bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d3d7fe41-ec79-4b3d-bd20-9083900f258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d3d7fe41-ec79-4b3d-bd20-9083900f258e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a0f53465-e901-478c-be7a-6001988c9a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a0f53465-e901-478c-be7a-6001988c9a12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fe20c470-e412-4a42-ab10-c8ecbd521b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fe20c470-e412-4a42-ab10-c8ecbd521b30" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_db08a0ff-271a-42df-9fa6-7b508e0179a3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_db08a0ff-271a-42df-9fa6-7b508e0179a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_ae306c37-a49a-458c-9192-55a62242d4b7" xlink:href="holx-20221231.xsd#holx_ContingentConsiderationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_holx_ContingentConsiderationMember_ae306c37-a49a-458c-9192-55a62242d4b7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e9a77e57-717a-4ba7-93ce-4598611b2f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_us-gaap_InterestRateSwapMember_e9a77e57-717a-4ba7-93ce-4598611b2f02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_cb4a9b6c-8ada-4741-ad99-f02095ab48bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_cb4a9b6c-8ada-4741-ad99-f02095ab48bb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_87639721-cbc7-413f-843b-4c1a86782f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_87639721-cbc7-413f-843b-4c1a86782f01" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f2186063-8f1e-4193-9b23-b0bda6d7f10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f2186063-8f1e-4193-9b23-b0bda6d7f10a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_c6f2811d-18d3-4847-958d-9fac56c75533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f2186063-8f1e-4193-9b23-b0bda6d7f10a" xlink:to="loc_us-gaap_LiabilityMember_c6f2811d-18d3-4847-958d-9fac56c75533" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended" id="if9e20c87d2e94c14bca8463c016bd7f2_FairValueMeasurementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_5603029d-20bf-4344-a1e2-81d3d62fc77c" xlink:href="holx-20221231.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_holx_PrincipalAmountOfBorrowings_5603029d-20bf-4344-a1e2-81d3d62fc77c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_685bcbd2-aa6e-408b-ae11-14f0d03fb565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_685bcbd2-aa6e-408b-ae11-14f0d03fb565" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e172b836-8fd4-47ed-87dc-4a845b4aac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e172b836-8fd4-47ed-87dc-4a845b4aac3b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_ae2e6102-111c-41dc-92ed-ef0e228465fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnSaleOfInvestments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_ae2e6102-111c-41dc-92ed-ef0e228465fd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8019b5c-8e19-458c-acda-3efcdf2a2e62_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8019b5c-8e19-458c-acda-3efcdf2a2e62_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_f28c85da-dcc1-488c-895a-8498c42a66ef" xlink:href="holx-20221231.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:to="loc_holx_CreditAgreementMember_f28c85da-dcc1-488c-895a-8498c42a66ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_5e7731e3-9d9a-4323-95a6-9023f27cafd9" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:to="loc_holx_A2028SeniorNotesMember_5e7731e3-9d9a-4323-95a6-9023f27cafd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_f852f823-801f-4f98-a33f-ffa8ab6e080b" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:to="loc_holx_A2029SeniorNotesMember_f852f823-801f-4f98-a33f-ffa8ab6e080b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_33bce137-bd16-432a-a9bb-02f7c6c3be87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_33bce137-bd16-432a-a9bb-02f7c6c3be87" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_4f190efc-96e9-49df-8245-11d9549de658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_33bce137-bd16-432a-a9bb-02f7c6c3be87" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_4f190efc-96e9-49df-8245-11d9549de658" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_40662d20-c797-4740-879e-309fefae9173_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_40662d20-c797-4740-879e-309fefae9173_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70de705b-ed55-42c1-a81b-24f74b3a56e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70de705b-ed55-42c1-a81b-24f74b3a56e8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_bfbc958c-6408-43d0-a9df-72fb1442e84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70de705b-ed55-42c1-a81b-24f74b3a56e8" xlink:to="loc_us-gaap_SeniorNotesMember_bfbc958c-6408-43d0-a9df-72fb1442e84b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended" id="i43e858d38c204d60b83e116f3a4faff5_BusinessCombinationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_345f3cc5-5bb2-426a-a816-f25f9dbaa02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_345f3cc5-5bb2-426a-a816-f25f9dbaa02c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_87d72f42-dfa2-4405-a81d-8954be6f8dfe" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_87d72f42-dfa2-4405-a81d-8954be6f8dfe" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0e9cea7-d23a-4336-ab56-928038d2d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0e9cea7-d23a-4336-ab56-928038d2d7dc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907a518a-60c6-4c41-9efe-edfd8bf2d939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907a518a-60c6-4c41-9efe-edfd8bf2d939" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_ff8ca6b4-15d8-499c-9cee-310ded063260" xlink:href="holx-20221231.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_ff8ca6b4-15d8-499c-9cee-310ded063260" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b7858fd9-5570-46c7-8889-cf1f60471d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b7858fd9-5570-46c7-8889-cf1f60471d53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationPayments_c855ddef-a1b3-4e2f-acc2-a09bb29c13ee" xlink:href="holx-20221231.xsd#holx_BusinessCombinationContingentConsiderationPayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_holx_BusinessCombinationContingentConsiderationPayments_c855ddef-a1b3-4e2f-acc2-a09bb29c13ee" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_b945c419-da93-48b9-86ed-036e01fdeda2" xlink:href="holx-20221231.xsd#holx_BolderSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:to="loc_holx_BolderSurgicalMember_b945c419-da93-48b9-86ed-036e01fdeda2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_33b7ec46-e864-4ea6-9623-5bfe271001b8" xlink:href="holx-20221231.xsd#holx_AcessaHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:to="loc_holx_AcessaHealthMember_33b7ec46-e864-4ea6-9623-5bfe271001b8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_7f6413cb-f7ad-4567-b0d6-c21f4e33fe7d" xlink:href="holx-20221231.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:to="loc_holx_DevelopedTechnologyMember_7f6413cb-f7ad-4567-b0d6-c21f4e33fe7d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5c91f0cc-80f6-4760-be47-3489e506654e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5c91f0cc-80f6-4760-be47-3489e506654e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_77823a46-5ce4-4a4e-8122-922964c6bd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:to="loc_us-gaap_TradeNamesMember_77823a46-5ce4-4a4e-8122-922964c6bd09" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended" id="i17b708fe5bff4e189827c7c581e46b39_BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fd51c781-d759-4989-98e1-3c08af68f96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fd51c781-d759-4989-98e1-3c08af68f96e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a070781c-9541-4287-acff-388f9966c6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a070781c-9541-4287-acff-388f9966c6e4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1c5effd4-51f4-473c-862d-31dbfbddfc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1c5effd4-51f4-473c-862d-31dbfbddfc62" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_95635c7f-76f5-428c-9aaa-112edc53ed9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_95635c7f-76f5-428c-9aaa-112edc53ed9c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b224feed-1f4f-462d-a937-5091d8b51cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b224feed-1f4f-462d-a937-5091d8b51cd5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_199c5f2a-2e70-4cd9-9694-b8b04d7f023e" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_199c5f2a-2e70-4cd9-9694-b8b04d7f023e" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_79d0f689-39eb-4489-9433-cf280a70f2e9" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_79d0f689-39eb-4489-9433-cf280a70f2e9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_9ac27f96-2b50-48df-97e3-fe5d2c4a3cd2" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_9ac27f96-2b50-48df-97e3-fe5d2c4a3cd2" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_aab3aba3-3577-4f61-8553-708f02769755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_aab3aba3-3577-4f61-8553-708f02769755" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_81ee34c7-9c1b-4ccf-9562-fb32a991625d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_Goodwill_81ee34c7-9c1b-4ccf-9562-fb32a991625d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9ee38524-755b-4fbf-bdfb-f4639fea0ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9ee38524-755b-4fbf-bdfb-f4639fea0ccf" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6375bd34-24df-494f-b335-133081a63e57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_6375bd34-24df-494f-b335-133081a63e57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_470fb4b1-deb5-43a7-93ba-363678005046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_470fb4b1-deb5-43a7-93ba-363678005046" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_522d305f-cbab-4e56-8a82-cfaf2ebcdbaf" xlink:href="holx-20221231.xsd#holx_BolderSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_470fb4b1-deb5-43a7-93ba-363678005046" xlink:to="loc_holx_BolderSurgicalMember_522d305f-cbab-4e56-8a82-cfaf2ebcdbaf" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RestructuringDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/RestructuringDetails" xlink:type="extended" id="i720cbd74a6194768b7d87a37ccef6ea5_RestructuringDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b44ff903-f859-4717-a123-579703282dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b44ff903-f859-4717-a123-579703282dbc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_04836557-4bff-45c8-8b92-6772df4d48ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:to="loc_us-gaap_RestructuringCharges_04836557-4bff-45c8-8b92-6772df4d48ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:to="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_8df58dd4-25a0-44e3-a700-b6cfc256d4b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:to="loc_us-gaap_RestructuringPlanDomain_8df58dd4-25a0-44e3-a700-b6cfc256d4b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ed55ad53-5403-4991-a019-e02ad93ca233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:to="loc_us-gaap_RestructuringPlanDomain_ed55ad53-5403-4991-a019-e02ad93ca233" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DanburyClosureMember_79e3ab7b-d2f4-403f-9f2e-897a4bded4b5" xlink:href="holx-20221231.xsd#holx_DanburyClosureMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestructuringPlanDomain_ed55ad53-5403-4991-a019-e02ad93ca233" xlink:to="loc_holx_DanburyClosureMember_79e3ab7b-d2f4-403f-9f2e-897a4bded4b5" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended" id="id2492b602d044c078cccd92f170aba2f_BorrowingsandCreditArrangementsCompanysBorrowingsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_abdcdbd4-2c33-432d-a095-b17f6e94fd90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_LongTermDebtCurrent_abdcdbd4-2c33-432d-a095-b17f6e94fd90" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_c5faed43-1dfd-4729-95f2-d9e973171aec" xlink:href="holx-20221231.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_c5faed43-1dfd-4729-95f2-d9e973171aec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_08ea09a0-d8ab-436c-9f9a-11644910b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_08ea09a0-d8ab-436c-9f9a-11644910b0e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8cc79acc-1968-4c72-8efb-19d34d26d3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_LongTermDebt_8cc79acc-1968-4c72-8efb-19d34d26d3b8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_092ca0ad-e70f-47bd-bd49-31966f9e320a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_092ca0ad-e70f-47bd-bd49-31966f9e320a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_580ba7c1-e4e0-4ebd-a519-9e7caca4072d" xlink:href="holx-20221231.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:to="loc_holx_TermLoanMember_580ba7c1-e4e0-4ebd-a519-9e7caca4072d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_394a9c32-519a-4be6-ba84-31f5b447c3dc" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:to="loc_holx_A2028SeniorNotesMember_394a9c32-519a-4be6-ba84-31f5b447c3dc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_5caa7425-a68f-4c0d-9d77-db2472e5417e" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:to="loc_holx_A2029SeniorNotesMember_5caa7425-a68f-4c0d-9d77-db2472e5417e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended" id="i3208179242bc49f2b85505a778920480_BorrowingsandCreditArrangementsAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_72e7db7d-9e6a-49c9-b75e-00d653dafdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_72e7db7d-9e6a-49c9-b75e-00d653dafdc3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_38140cdc-4784-4840-8678-ffbb1a99dcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_38140cdc-4784-4840-8678-ffbb1a99dcfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3a55c0e3-c127-442e-b762-807e8c47fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3a55c0e3-c127-442e-b762-807e8c47fedf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ceb0a009-7b61-4bc7-a9fc-10b1ac587884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ceb0a009-7b61-4bc7-a9fc-10b1ac587884" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_340d2403-5731-45da-a76f-f0ec992a5677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_340d2403-5731-45da-a76f-f0ec992a5677" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_dc385f17-cb33-49dd-926d-6fb12db26372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_dc385f17-cb33-49dd-926d-6fb12db26372" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_2a6c36e3-5a57-4c19-8f85-d8e9972011f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_2a6c36e3-5a57-4c19-8f85-d8e9972011f0" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_90fe6d2f-5bfb-4034-86f0-ac265845dee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_SeniorNotes_90fe6d2f-5bfb-4034-86f0-ac265845dee8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_3fced5bd-36d7-4652-acfc-8a8ecef780a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_3fced5bd-36d7-4652-acfc-8a8ecef780a3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_28780632-5748-4011-8969-10fe1dfac860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_28780632-5748-4011-8969-10fe1dfac860" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8a90b565-8af7-406e-b3e8-a79213068ca1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8a90b565-8af7-406e-b3e8-a79213068ca1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_0b925f91-12d1-4bdc-b000-786cb1a0abb3" xlink:href="holx-20221231.xsd#holx_SecuredTermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_SecuredTermLoanMember_0b925f91-12d1-4bdc-b000-786cb1a0abb3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_5ff59776-a8b9-49ef-9fb2-b8e2218848bd" xlink:href="holx-20221231.xsd#holx_RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_RevolverMember_5ff59776-a8b9-49ef-9fb2-b8e2218848bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_7824adc7-feea-4f6f-97d6-384717298379" xlink:href="holx-20221231.xsd#holx_TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_TermLoanMember_7824adc7-feea-4f6f-97d6-384717298379" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3abbdc85-885c-48c7-9d32-03e68944820f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_us-gaap_SeniorNotesMember_3abbdc85-885c-48c7-9d32-03e68944820f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetSecuritizationMember_79f9df24-e228-48c7-aa5a-0e36670d9907" xlink:href="holx-20221231.xsd#holx_AssetSecuritizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_AssetSecuritizationMember_79f9df24-e228-48c7-aa5a-0e36670d9907" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_0c63ade0-1484-46f7-8bb7-0feffe908271_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_0c63ade0-1484-46f7-8bb7-0feffe908271_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember_553896d0-83a1-4bf6-b276-43988beecc91" xlink:href="holx-20221231.xsd#holx_A2021TermLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2021TermLoanMember_553896d0-83a1-4bf6-b276-43988beecc91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember_43c00bce-f35e-4320-a8fc-ae41ca6c5db9" xlink:href="holx-20221231.xsd#holx_A2021RevolverMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2021RevolverMember_43c00bce-f35e-4320-a8fc-ae41ca6c5db9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember_85e4e8b8-c934-4d7f-93ed-1dc6a4a7e406" xlink:href="holx-20221231.xsd#holx_A2021CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2021CreditAgreementMember_85e4e8b8-c934-4d7f-93ed-1dc6a4a7e406" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_5a21091b-16a9-4b07-96b6-932d9634f79d" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2028SeniorNotesMember_5a21091b-16a9-4b07-96b6-932d9634f79d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_dd3559ba-b8d1-4502-812e-681bf74bfe61" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2029SeniorNotesMember_dd3559ba-b8d1-4502-812e-681bf74bfe61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_65c410b9-e6e6-476f-af13-e92ed34b5f59_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_65c410b9-e6e6-476f-af13-e92ed34b5f59_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ced10aa7-8cfe-46ee-80fb-777e84435aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ced10aa7-8cfe-46ee-80fb-777e84435aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_af8a4223-d698-4ced-bfb6-02ac121e0fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ced10aa7-8cfe-46ee-80fb-777e84435aa9" xlink:to="loc_us-gaap_InterestRateSwapMember_af8a4223-d698-4ced-bfb6-02ac121e0fec" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended" id="if595d1f795fe48038be6e1ed847b122c_BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_b951e34e-b5b8-4803-a0d3-96b88efc6fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_InterestExpenseBorrowings_b951e34e-b5b8-4803-a0d3-96b88efc6fb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_d2cdef71-16cc-42bb-8b1f-dec5694bf54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_d2cdef71-16cc-42bb-8b1f-dec5694bf54c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1b98c598-0bc1-43e4-9771-2ae6276b732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1b98c598-0bc1-43e4-9771-2ae6276b732e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:to="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7ce18234-8f74-4ce9-bc4b-cfc903d6221e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7ce18234-8f74-4ce9-bc4b-cfc903d6221e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d907498e-af95-40ab-bc7d-20e8ecc882c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d907498e-af95-40ab-bc7d-20e8ecc882c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_6cc0aceb-ff61-4989-9489-daa9d06c5e7e" xlink:href="holx-20221231.xsd#holx_CreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d907498e-af95-40ab-bc7d-20e8ecc882c0" xlink:to="loc_holx_CreditAgreementMember_6cc0aceb-ff61-4989-9489-daa9d06c5e7e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended" id="i7e1a774bc3e84afd956ad74ef848ae0c_BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae6e824c-33df-48cd-9c48-f072cff65ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae6e824c-33df-48cd-9c48-f072cff65ba3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_843445ff-4771-4056-8c74-de9929a41cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:to="loc_us-gaap_InterestExpenseBorrowings_843445ff-4771-4056-8c74-de9929a41cc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_04df1d40-c6b7-46c9-9315-731452afc3fa_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_04df1d40-c6b7-46c9-9315-731452afc3fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f276054e-8f7d-4ba5-a90c-faf075840ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f276054e-8f7d-4ba5-a90c-faf075840ce3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ab8ff61d-7c75-4835-82f9-2c0b0015170c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f276054e-8f7d-4ba5-a90c-faf075840ce3" xlink:to="loc_us-gaap_SeniorNotesMember_ab8ff61d-7c75-4835-82f9-2c0b0015170c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:to="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_9eb3122c-0f81-4c84-a605-39a1b0b294d5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_9eb3122c-0f81-4c84-a605-39a1b0b294d5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_dcd2e79b-c228-4eaa-9565-c7be4f0d98cf" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:to="loc_holx_A2028SeniorNotesMember_dcd2e79b-c228-4eaa-9565-c7be4f0d98cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_a191dcc2-7a72-4336-b2f0-29ebf4ad7ffb" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:to="loc_holx_A2029SeniorNotesMember_a191dcc2-7a72-4336-b2f0-29ebf4ad7ffb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028And2029SeniorNotesMember_41e7e336-1d42-4b40-9ecb-f11be911b52b" xlink:href="holx-20221231.xsd#holx_A2028And2029SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:to="loc_holx_A2028And2029SeniorNotesMember_41e7e336-1d42-4b40-9ecb-f11be911b52b" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesAdditionalInformationDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended" id="i3ff3fcf40cc546de9eee08c1768d67ea_DerivativesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_071ceb9b-540d-4bf9-99b7-9bd1da43d728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_071ceb9b-540d-4bf9-99b7-9bd1da43d728" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_719bdefe-d628-4f6e-81c7-7d5601630569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_719bdefe-d628-4f6e-81c7-7d5601630569" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ca7e6d51-50f1-41af-9ae5-19ff70b0aa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ca7e6d51-50f1-41af-9ae5-19ff70b0aa45" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_32d29604-8c1c-4e8e-a182-38a385ae102e" xlink:href="holx-20221231.xsd#holx_NotationalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_holx_NotationalAmount_32d29604-8c1c-4e8e-a182-38a385ae102e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_cb9ef674-f5e0-4355-a16f-ad09f602eb72_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_cb9ef674-f5e0-4355-a16f-ad09f602eb72_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3604719f-5382-4d94-98a9-411488e1cec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:to="loc_us-gaap_InterestRateSwapMember_3604719f-5382-4d94-98a9-411488e1cec8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a979e984-b0a6-4922-900d-b778c228db1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a979e984-b0a6-4922-900d-b778c228db1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_5fcf84a1-9ed7-4d97-8152-90d0750e6aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:to="loc_us-gaap_ForwardContractsMember_5fcf84a1-9ed7-4d97-8152-90d0750e6aa5" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended" id="i14ad8fe8c59047f5bae8b4c182e202a3_DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6f053cea-a9ca-42cc-b82e-0df0e92cdf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6f053cea-a9ca-42cc-b82e-0df0e92cdf1a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_6b2e14e9-1dc0-4f2f-8bf6-33e0d57e5d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_6b2e14e9-1dc0-4f2f-8bf6-33e0d57e5d19" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_20eeed33-ce48-44bf-aae4-5305fd9c06de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_20eeed33-ce48-44bf-aae4-5305fd9c06de" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9860bb7b-9d7d-48f3-a685-06ff521dcb1a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9860bb7b-9d7d-48f3-a685-06ff521dcb1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_2d0f9802-cbd9-44c4-8f0d-3aa302a41693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_2d0f9802-cbd9-44c4-8f0d-3aa302a41693" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_ea20fedc-c06b-44e2-a052-2f8cac323b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_ea20fedc-c06b-44e2-a052-2f8cac323b45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:to="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d0d9329a-995a-489f-96b2-ce096b6cfb3e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d0d9329a-995a-489f-96b2-ce096b6cfb3e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cdc98015-17e9-41b8-a456-960d07ab6918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:to="loc_us-gaap_HedgingDesignationDomain_cdc98015-17e9-41b8-a456-960d07ab6918" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_719c89ad-431f-419b-b554-4b8d67cb65dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_cdc98015-17e9-41b8-a456-960d07ab6918" xlink:to="loc_us-gaap_NondesignatedMember_719c89ad-431f-419b-b554-4b8d67cb65dc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended" id="i8069e333f89a4d7f95bf7aea412abcd0_DerivativesFairValueofDerivativeFinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_be83199b-3f22-4ce1-a3d8-e2d5e771e50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_be83199b-3f22-4ce1-a3d8-e2d5e771e50c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a82ad0a8-b1e0-4ae3-be1f-8bd07b21018b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a82ad0a8-b1e0-4ae3-be1f-8bd07b21018b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_b104522d-ad00-4d01-9dff-a92808ceb0f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_b104522d-ad00-4d01-9dff-a92808ceb0f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c486ba79-f03c-4113-9c10-b59063c17f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:to="loc_us-gaap_NondesignatedMember_c486ba79-f03c-4113-9c10-b59063c17f51" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e3170c32-9447-4e5c-9731-ba2620df6813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e3170c32-9447-4e5c-9731-ba2620df6813" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_8ccae942-a28f-4e58-aec2-bc7064764cac_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_8ccae942-a28f-4e58-aec2-bc7064764cac_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_4fa52625-b27b-4846-8abd-827ac27414d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_4fa52625-b27b-4846-8abd-827ac27414d4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a422b363-477d-4556-9e29-5be3562bce1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a422b363-477d-4556-9e29-5be3562bce1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f0a11707-f26c-4c54-a1a6-e49b7f5aef5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:to="loc_us-gaap_InterestRateSwapMember_f0a11707-f26c-4c54-a1a6-e49b7f5aef5e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d643444f-5d97-49aa-901d-fe33bca2e0e9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d643444f-5d97-49aa-901d-fe33bca2e0e9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_9e702069-e699-49ef-a26d-06a104ea3fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_9e702069-e699-49ef-a26d-06a104ea3fba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_46faf5f5-bfe9-4527-a1d8-390b7dfc0969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_OtherAssetsMember_46faf5f5-bfe9-4527-a1d8-390b7dfc0969" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_11520a9a-d3c2-4ee3-a44d-315748644224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_11520a9a-d3c2-4ee3-a44d-315748644224" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_73550c40-ac79-4d78-90d4-1fc0a19c543b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_73550c40-ac79-4d78-90d4-1fc0a19c543b" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended" id="iaefb7ecb0b7546cfb6f00600a3c46523_DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4ff52c57-0e34-440c-a225-a555a1a19d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3d822611-d001-466b-8738-0274015d427c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4ff52c57-0e34-440c-a225-a555a1a19d32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3d822611-d001-466b-8738-0274015d427c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4ff52c57-0e34-440c-a225-a555a1a19d32" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_72b7536b-408d-4546-9c89-4dd189fbc5b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_72b7536b-408d-4546-9c89-4dd189fbc5b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_60388414-de3f-416d-82a5-9518934cec3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_60388414-de3f-416d-82a5-9518934cec3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_976e526f-c07c-4f20-8b43-dc850053ff96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60388414-de3f-416d-82a5-9518934cec3e" xlink:to="loc_us-gaap_InterestRateSwapMember_976e526f-c07c-4f20-8b43-dc850053ff96" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#CommitmentsandContingenciesDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended" id="i820e8a3d1f6d43d39da9520a0fcbe0aa_CommitmentsandContingenciesDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_66c92b8a-72a9-4bb3-9a9e-8b024af743c4" xlink:href="holx-20221231.xsd#holx_AmountAssessedInDamages"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_holx_AmountAssessedInDamages_66c92b8a-72a9-4bb3-9a9e-8b024af743c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3ce1d836-21f7-4ef8-b17b-5f5aab689b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3ce1d836-21f7-4ef8-b17b-5f5aab689b06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_6ab7a064-ab29-477b-b05b-1c2f85366aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_6ab7a064-ab29-477b-b05b-1c2f85366aa0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:to="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:to="loc_dei_EntityDomain_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e29b70e6-7ea8-4ee4-832c-0da349c5fbb2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:to="loc_dei_EntityDomain_e29b70e6-7ea8-4ee4-832c-0da349c5fbb2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_3c80c4c8-ff6e-4d33-ab6c-d422989609f4" xlink:href="holx-20221231.xsd#holx_MinervaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_e29b70e6-7ea8-4ee4-832c-0da349c5fbb2" xlink:to="loc_holx_MinervaMember_3c80c4c8-ff6e-4d33-ab6c-d422989609f4" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended" id="ic77689c2ee8a4af7b9e4efdf633ab661_NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:href="holx-20221231.xsd#holx_EarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_55043227-936a-4dce-96cc-b4fb76c2eba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_55043227-936a-4dce-96cc-b4fb76c2eba7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_274f71ec-2ce7-40ca-b21c-76fa3b472706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_274f71ec-2ce7-40ca-b21c-76fa3b472706" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47b94726-c826-416c-8ca8-8858d31486f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47b94726-c826-416c-8ca8-8858d31486f1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ff2cb3e-036e-4e56-b2d1-574a6bba57da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ff2cb3e-036e-4e56-b2d1-574a6bba57da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f2d71076-67ad-4100-b03e-4157ec1f2d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ff2cb3e-036e-4e56-b2d1-574a6bba57da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f2d71076-67ad-4100-b03e-4157ec1f2d9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:href="holx-20221231.xsd#holx_EarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3045b471-d52a-4d19-8659-7d0ae5fc0ed5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_3045b471-d52a-4d19-8659-7d0ae5fc0ed5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfbca6ac-7c87-48d4-80f0-322df7f15f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfbca6ac-7c87-48d4-80f0-322df7f15f1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_a3804f3e-481b-42bd-b631-f2f6c54dc1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfbca6ac-7c87-48d4-80f0-322df7f15f1f" xlink:to="loc_us-gaap_StockCompensationPlanMember_a3804f3e-481b-42bd-b631-f2f6c54dc1c6" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended" id="i892ccb66b2a442769e69be2aa7e208ff_StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c0ff489-aad0-4a9b-8e09-f4e77b989fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e252ae3a-e3d0-4f9f-99d4-2c40757a1647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c0ff489-aad0-4a9b-8e09-f4e77b989fba" xlink:to="loc_us-gaap_ShareBasedCompensation_e252ae3a-e3d0-4f9f-99d4-2c40757a1647" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c0ff489-aad0-4a9b-8e09-f4e77b989fba" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_8c00470c-3448-4e93-bc7a-c9e629053c6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_8c00470c-3448-4e93-bc7a-c9e629053c6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c36cf9b7-9efc-4f6b-bbc7-91082f87ac5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_CostOfSalesMember_c36cf9b7-9efc-4f6b-bbc7-91082f87ac5f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_935541b3-310d-464a-8bdc-84a82dcf7512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_935541b3-310d-464a-8bdc-84a82dcf7512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_ebc62561-8f81-4056-b678-d6105fa7cadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_ebc62561-8f81-4056-b678-d6105fa7cadb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_27133bc9-44dd-4b5d-9f45-ec91861c0102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_27133bc9-44dd-4b5d-9f45-ec91861c0102" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended" id="iac7dd4a5574b46de985088620b576939_StockBasedCompensationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3669a976-6fa6-4865-9547-f6326abe75f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3669a976-6fa6-4865-9547-f6326abe75f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d3bb2ac1-a054-4030-902e-caa64c494222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d3bb2ac1-a054-4030-902e-caa64c494222" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9e22db15-d491-434c-8e21-a6b4159d4e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9e22db15-d491-434c-8e21-a6b4159d4e24" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0244ea93-534e-4381-9154-1c88a9adcb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0244ea93-534e-4381-9154-1c88a9adcb15" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bdb4ea-bc33-4ecf-9232-4574aba19f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bdb4ea-bc33-4ecf-9232-4574aba19f04" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dcfdf17a-9bfa-4a0a-bdba-15e0a5964625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dcfdf17a-9bfa-4a0a-bdba-15e0a5964625" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4f1439c2-3188-43ca-836f-8a7a9f1c8908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4f1439c2-3188-43ca-836f-8a7a9f1c8908" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d117c04c-a991-4870-b5af-a93d432a04b8" xlink:href="holx-20221231.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d117c04c-a991-4870-b5af-a93d432a04b8" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_c6174555-71ae-49d5-a3ae-5f700abc11b8" xlink:href="holx-20221231.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_c6174555-71ae-49d5-a3ae-5f700abc11b8" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_6200edcf-2aed-4458-bcfc-ee78971bba19" xlink:href="holx-20221231.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_6200edcf-2aed-4458-bcfc-ee78971bba19" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3e97daad-ff16-4a9a-83cc-60dba68de289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3e97daad-ff16-4a9a-83cc-60dba68de289" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7c269d30-3d91-4c05-9f63-8f1e6e944506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7c269d30-3d91-4c05-9f63-8f1e6e944506" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:to="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_565c6640-8d65-4539-b522-c35853c878ec_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_565c6640-8d65-4539-b522-c35853c878ec_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_032a8ca3-5684-4357-96d3-472c0549f8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_032a8ca3-5684-4357-96d3-472c0549f8bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_261fbe17-dd76-44a3-a652-f86d1b0a3ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_261fbe17-dd76-44a3-a652-f86d1b0a3ee1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b13704e0-02be-48ab-b7fc-e0069a9da408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_us-gaap_PerformanceSharesMember_b13704e0-02be-48ab-b7fc-e0069a9da408" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_90fb0e25-5a5e-4dfb-a48c-0ce07120ebcd" xlink:href="holx-20221231.xsd#holx_MarketBasedAwardsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_holx_MarketBasedAwardsMember_90fb0e25-5a5e-4dfb-a48c-0ce07120ebcd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_8ce7a76f-c221-425e-8b0f-639d9fdc09dd" xlink:href="holx-20221231.xsd#holx_PSUFreeCashFlowMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_holx_PSUFreeCashFlowMember_8ce7a76f-c221-425e-8b0f-639d9fdc09dd" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_45c76d40-8f0f-4a7c-b652-5b43e2d5dd54" xlink:href="holx-20221231.xsd#holx_RSUPSUMSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_holx_RSUPSUMSUMember_45c76d40-8f0f-4a7c-b652-5b43e2d5dd54" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended" id="i8d51ec9913444963837c52afc95dca3b_BusinessSegmentsandGeographicInformationAdditionalInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:href="holx-20221231.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ba12464a-b22e-437a-bf52-bf4124abc6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:to="loc_us-gaap_NumberOfReportableSegments_ba12464a-b22e-437a-bf52-bf4124abc6e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7f8a1de8-6356-4a7d-bd84-836e8d5d2d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:to="loc_us-gaap_Revenues_7f8a1de8-6356-4a7d-bd84-836e8d5d2d7a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:to="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_5a40cac8-58c1-47b6-8002-e7b6035b65a2_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:to="loc_srt_ConsolidationItemsDomain_5a40cac8-58c1-47b6-8002-e7b6035b65a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77d656ea-7288-4bef-b19f-297654ac7534" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:to="loc_srt_ConsolidationItemsDomain_77d656ea-7288-4bef-b19f-297654ac7534" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5e3a1824-2511-4375-a67c-15941eb13d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ConsolidationItemsDomain_77d656ea-7288-4bef-b19f-297654ac7534" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5e3a1824-2511-4375-a67c-15941eb13d6a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended" id="i14ad16206a074d6aaa333edb6ee59688_BusinessSegmentsandGeographicInformationSegmentInformationDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_32817f71-a0db-4142-9bc3-841f6f6f833e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_Revenues_32817f71-a0db-4142-9bc3-841f6f6f833e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4814323f-fffd-4fc5-995f-1952712c4525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_OperatingIncomeLoss_4814323f-fffd-4fc5-995f-1952712c4525" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1d542a4c-905c-4f9c-9986-4b9cfda50727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1d542a4c-905c-4f9c-9986-4b9cfda50727" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_5f1c0f2f-86e4-4918-a050-55c7803175cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_5f1c0f2f-86e4-4918-a050-55c7803175cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e88568c6-79b3-44c7-9565-9f7a1d3b15d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_Assets_e88568c6-79b3-44c7-9565-9f7a1d3b15d3" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_55fe073b-7f4a-4778-84c1-646b4452e578_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:to="loc_us-gaap_SegmentDomain_55fe073b-7f4a-4778-84c1-646b4452e578_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:to="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5f5f0100-f1fe-4aeb-8ab6-91f4539645f5" xlink:href="holx-20221231.xsd#holx_DiagnosticsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_DiagnosticsMember_5f5f0100-f1fe-4aeb-8ab6-91f4539645f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_d97e62d4-4bc0-45b5-9436-3e75abd54470" xlink:href="holx-20221231.xsd#holx_BreastHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_BreastHealthMember_d97e62d4-4bc0-45b5-9436-3e75abd54470" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_d6ccffb5-5eb7-4720-9e95-342d19dbf475" xlink:href="holx-20221231.xsd#holx_GynSurgicalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_GynSurgicalMember_d6ccffb5-5eb7-4720-9e95-342d19dbf475" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_e7641b5a-7955-4680-bd25-007c567681db" xlink:href="holx-20221231.xsd#holx_SkeletalHealthMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_SkeletalHealthMember_e7641b5a-7955-4680-bd25-007c567681db" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_83ab887d-d057-4f3c-a9f5-92ea7e0c5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_us-gaap_CorporateMember_83ab887d-d057-4f3c-a9f5-92ea7e0c5e2a" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended" id="i587ced792ceb426eae918e502014f01d_BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail">
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_6884ff6b-2b5e-44fd-931e-0a2df596de0b" xlink:href="holx-20221231.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_d238da86-9790-43e1-9b09-e519d4c5d84b" xlink:href="holx-20221231.xsd#holx_PercentageOfRevenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_6884ff6b-2b5e-44fd-931e-0a2df596de0b" xlink:to="loc_holx_PercentageOfRevenues_d238da86-9790-43e1-9b09-e519d4c5d84b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:href="holx-20221231.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_6884ff6b-2b5e-44fd-931e-0a2df596de0b" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:to="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_9415682c-d400-49d1-b4f3-f60f590710fa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:to="loc_srt_SegmentGeographicalDomain_9415682c-d400-49d1-b4f3-f60f590710fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:to="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_99a0e88f-7cff-4741-bee9-64fad8b27837" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_country_US_99a0e88f-7cff-4741-bee9-64fad8b27837" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f940cc2c-7907-43a2-8344-28e5e142a767" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_srt_EuropeMember_f940cc2c-7907-43a2-8344-28e5e142a767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_5902ea06-2945-46a9-b2e6-633c16948488" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_srt_AsiaPacificMember_5902ea06-2945-46a9-b2e6-633c16948488" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_bebe7a32-ca09-4cdb-9ed5-d2125fb6f0cb" xlink:href="holx-20221231.xsd#holx_AllOtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_holx_AllOtherCountriesMember_bebe7a32-ca09-4cdb-9ed5-d2125fb6f0cb" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended" id="i4d937e4e9f7d42f3894d4c0243276881_IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_470dd5ba-53ca-42e1-9e6d-f4002eea82c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_470dd5ba-53ca-42e1-9e6d-f4002eea82c2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bf78a43c-c9be-44fb-a78d-cef97ff1cd64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bf78a43c-c9be-44fb-a78d-cef97ff1cd64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_39b42586-e559-4d64-aca0-654dfe5ae2bd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_39b42586-e559-4d64-aca0-654dfe5ae2bd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_a4490af8-4f67-4fca-97cf-f39532df7988" xlink:href="holx-20221231.xsd#holx_DevelopedTechnologyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_DevelopedTechnologyMember_a4490af8-4f67-4fca-97cf-f39532df7988" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_57dfdd86-5e95-4849-8c05-e8724005626b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_57dfdd86-5e95-4849-8c05-e8724005626b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_e5fa4ac3-1363-4ad4-887b-78dfd639cd0d" xlink:href="holx-20221231.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_CustomerRelationshipsContractsMember_e5fa4ac3-1363-4ad4-887b-78dfd639cd0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a7e895f9-1099-4111-bf7b-d9b2e3fb7f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_us-gaap_TradeNamesMember_a7e895f9-1099-4111-bf7b-d9b2e3fb7f5c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_c80d1781-c300-4123-8709-9ca0a15f3923" xlink:href="holx-20221231.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_AcquiredintangibleassetsMember_c80d1781-c300-4123-8709-9ca0a15f3923" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_4cb2aaf6-24f0-47f5-9570-8decee4ee228" xlink:href="holx-20221231.xsd#holx_InternalusesoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_InternalusesoftwareMember_4cb2aaf6-24f0-47f5-9570-8decee4ee228" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_95f9c94f-2941-4753-b095-fecf92250c4a" xlink:href="holx-20221231.xsd#holx_CapitalizedsoftwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_CapitalizedsoftwareMember_95f9c94f-2941-4753-b095-fecf92250c4a" xlink:type="arc" order="6"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended" id="ia516f1fc094e4baeb795d46cf72da9e9_AccumulatedOtherComprehensiveIncomeDetail">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b9e7217-d0a8-44de-a663-fe673cd8c7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:to="loc_us-gaap_StockholdersEquity_8b9e7217-d0a8-44de-a663-fe673cd8c7f8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f8269ef8-ef28-4eb4-ac19-c5366ad2b682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f8269ef8-ef28-4eb4-ac19-c5366ad2b682" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a003c5ba-25a7-4f37-aa58-b1b7fdf23f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ae88159-11fe-4333-b564-cfe0b441333e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_0ae88159-11fe-4333-b564-cfe0b441333e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7b1d611-a650-4077-b89a-0237cd9856dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7b1d611-a650-4077-b89a-0237cd9856dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0acd46ba-73bd-4c85-aff8-da7a2b45b172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7b1d611-a650-4077-b89a-0237cd9856dd" xlink:to="loc_us-gaap_InterestRateSwapMember_0acd46ba-73bd-4c85-aff8-da7a2b45b172" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ed147303-db89-4db4-b86b-291a586d73b4_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:to="loc_us-gaap_EquityComponentDomain_ed147303-db89-4db4-b86b-291a586d73b4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b34ad09-75ab-4b4e-a031-97db99c2a787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:to="loc_us-gaap_EquityComponentDomain_8b34ad09-75ab-4b4e-a031-97db99c2a787" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_8b34ad09-75ab-4b4e-a031-97db99c2a787" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dbe59c91-aafd-4da8-abce-532b52df4f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dbe59c91-aafd-4da8-abce-532b52df4f8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_82a7e43b-552d-4228-ac3c-0c1612af53c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_82a7e43b-552d-4228-ac3c-0c1612af53c0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8127b76f-196c-4adb-8bd2-143a814fced1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8127b76f-196c-4adb-8bd2-143a814fced1" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:definitionLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended" id="i31fad3f3cd6d48d2826cd6042dfa2e52_ShareRepurchaseSharerepurchaseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:href="holx-20221231.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ced1762e-bc40-4703-a26c-b958f924b27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ced1762e-bc40-4703-a26c-b958f924b27b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_34663870-ca49-4133-be37-b6b7ecee1f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_34663870-ca49-4133-be37-b6b7ecee1f0f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c54b813f-7cd0-4335-a1e0-cad2df3c95db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c54b813f-7cd0-4335-a1e0-cad2df3c95db" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e6e3bce0-ef25-4a4f-8c0e-b14d4b4feeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e6e3bce0-ef25-4a4f-8c0e-b14d4b4feeff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:href="holx-20221231.xsd#holx_SharerepurchaseplanTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_a80f7fd2-28da-43bd-89af-aa3a95fdb90c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_a80f7fd2-28da-43bd-89af-aa3a95fdb90c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_0cdaa851-3e56-4682-992b-aa0e4784a702" xlink:href="holx-20221231.xsd#holx_September222022Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:to="loc_holx_September222022Member_0cdaa851-3e56-4682-992b-aa0e4784a702" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_4cb23587-9272-4373-9c6c-de624aa96967" xlink:href="holx-20221231.xsd#holx_December112020Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:to="loc_holx_December112020Member_4cb23587-9272-4373-9c6c-de624aa96967" xlink:type="arc" order="1"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>holx-20221231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:3332a847-8252-4aec-a26a-afc1f11215d8,g:d9a9812f-c6f0-4dfd-b7fb-8eca4022aaf1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_47e014a6-8e8d-4255-a7fb-f67cd8d2f97b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAxis_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAxis" xlink:to="lab_us-gaap_BusinessAcquisitionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_880a3c7d-f028-4d15-aa14-c423364ca205_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_24bac5d3-5bbb-4fe8-ac66-692844032a22_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Loss</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_0830f605-e7b8-42e1-96a0-efdf3f359686_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_f1d4841b-549a-4228-9e80-dfd2129c4292_terseLabel_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_EquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:href="holx-20221231.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_EquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_646dc2cb-cf02-4858-8fda-282b021da14a_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_e70d35db-1adb-4011-8136-ef4e2e3a10ee_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_InvestmentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentsFairValueDisclosure" xlink:to="lab_us-gaap_InvestmentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_c1708009-6d37-4999-beec-e1c610846edf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_a359f12a-eff5-426b-8bfa-077d2d62398b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_7191b5b5-4263-4c29-a18f-77ea6c3840bc_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolving credit facility borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_e7e88bf6-b7d7-42d3-80fd-2de64526e6be_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_541272e7-a7dd-4202-83be-de6c140796ba_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of debt instrument</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFairValue_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFairValue" xlink:to="lab_us-gaap_DebtInstrumentFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastHealthMember_9767535d-4e90-4ccb-8444-1347fac006f0_terseLabel_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health</link:label>
    <link:label id="lab_holx_BreastHealthMember_label_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Health [Member]</link:label>
    <link:label id="lab_holx_BreastHealthMember_documentation_en-US" xlink:label="lab_holx_BreastHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember" xlink:href="holx-20221231.xsd#holx_BreastHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastHealthMember" xlink:to="lab_holx_BreastHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_f3732f46-fd8b-44fa-a432-1d28c406f062_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Financing Activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Derivative Instrument, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_0bdef150-6894-4217-a2ce-e89a21e5286f_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeContractMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeContractMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Contract [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeContractMember" xlink:to="lab_us-gaap_ForeignExchangeContractMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BolderSurgicalMember_612a4dcc-0799-452e-a04b-c493a731283f_terseLabel_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical</link:label>
    <link:label id="lab_holx_BolderSurgicalMember_label_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical [Member]</link:label>
    <link:label id="lab_holx_BolderSurgicalMember_documentation_en-US" xlink:label="lab_holx_BolderSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bolder Surgical</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember" xlink:href="holx-20221231.xsd#holx_BolderSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BolderSurgicalMember" xlink:to="lab_holx_BolderSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_6e931109-db36-4a23-b474-a43429e04a91_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ec891132-298e-468c-aa1a-e16e318cca67_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_4f04dfec-b0d9-4e87-bf2b-6d6140c98a8b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_bd14ac75-1b44-42b8-bd1d-ccd67ce47173_terseLabel_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration Classified as Equity, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:to="lab_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_79df1309-064f-44cc-9b68-fca54ecb7f7a_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_55783737-d2ce-4156-a476-461646a83d82_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_f8b4a315-fad0-4943-9e81-7aa5fc75c42d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stated interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_8976358d-7f77-4684-b7c2-783a956d5190_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c5b003d5-c734-40e5-a170-a7639a51287f_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_2204807a-1b7c-4d3a-82e4-7bccaa3dd04f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from long-term debt, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from (Repayments of) Other Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_ac0b6075-574f-40fd-9d42-19fe6fbc4232_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets</link:label>
    <link:label id="lab_us-gaap_OtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentAssetsMember" xlink:to="lab_us-gaap_OtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PercentageOfRevenues_0802d200-27d3-4930-8937-c4a1199351a7_terseLabel_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_label_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage Of Revenues</link:label>
    <link:label id="lab_holx_PercentageOfRevenues_documentation_en-US" xlink:label="lab_holx_PercentageOfRevenues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percentage of revenues.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues" xlink:href="holx-20221231.xsd#holx_PercentageOfRevenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PercentageOfRevenues" xlink:to="lab_holx_PercentageOfRevenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_320ff68f-de4c-4f98-850a-a2cad0c3644e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other adjustments and non-cash items</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ef9e2713-75ae-45b5-a585-3a48c2d86c07_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_def1bfa7-1127-49f0-93ea-f1f2da24a632_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_2b2abd0f-271f-4fa3-86fd-4927529276a0_terseLabel_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual incremental revenue growth period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_label_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:label id="lab_holx_AnnualIncrementalRevenueGrowthPeriod_documentation_en-US" xlink:label="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual Incremental Revenue Growth Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:href="holx-20221231.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:to="lab_holx_AnnualIncrementalRevenueGrowthPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_62d05b45-7261-4910-a03e-3b1f183932b2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_674ef1fd-5c3f-4f31-ba6b-0023a596b155_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_f0a74e36-6b9f-4cff-b5bb-69a37c39b5f4_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_ce2e551b-b0a5-46f6-bb80-02212edbb420_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain" xlink:to="lab_us-gaap_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_defb8b47-cdb4-46c1-a04e-3270256e0506_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028SeniorNotesMember_122b74d4-1f53-41e3-8acf-61b50968a1bf_terseLabel_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028SeniorNotesMember" xlink:to="lab_holx_A2028SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_aa71a759-f986-4478-a169-9dbbba9e9139_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanAxis_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanAxis" xlink:to="lab_us-gaap_RestructuringPlanAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_1fe33e92-3a59-46be-bf0d-f7a5db4139ed_terseLabel_en-US" xlink:label="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from the Department of Defense</link:label>
    <link:label id="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_label_en-US" xlink:label="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from government grants for capacity expansion</link:label>
    <link:label id="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_documentation_en-US" xlink:label="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds received from government grants for capacity expansion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:href="holx-20221231.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:to="lab_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_9945614b-5f72-424e-baa7-538cca0e6976_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_a8fe1400-e945-4c67-a6e3-ae9c1c857b45_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BreastImagingMember_a155e0b2-2f41-4102-840c-9b203040d555_terseLabel_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging</link:label>
    <link:label id="lab_holx_BreastImagingMember_label_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:label id="lab_holx_BreastImagingMember_documentation_en-US" xlink:label="lab_holx_BreastImagingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Breast Imaging [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember" xlink:href="holx-20221231.xsd#holx_BreastImagingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BreastImagingMember" xlink:to="lab_holx_BreastImagingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_eecd4a7b-a27e-4478-841b-4e8886b1d319_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_2163e855-24a0-44ee-b4aa-f3fa58a72aa3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_58857007-4053-42ed-af67-363707beeda5_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_c01d5392-afcc-425b-9ffb-af02c82be50c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DanburyClosureMember_26d67ac4-e8e8-4f80-ae85-573a4183c37a_terseLabel_en-US" xlink:label="lab_holx_DanburyClosureMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danbury closure</link:label>
    <link:label id="lab_holx_DanburyClosureMember_label_en-US" xlink:label="lab_holx_DanburyClosureMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danbury closure [Member]</link:label>
    <link:label id="lab_holx_DanburyClosureMember_documentation_en-US" xlink:label="lab_holx_DanburyClosureMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Danbury closure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DanburyClosureMember" xlink:href="holx-20221231.xsd#holx_DanburyClosureMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DanburyClosureMember" xlink:to="lab_holx_DanburyClosureMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_66b98799-1452-4c4a-b468-e58ac17cfa88_terseLabel_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_label_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:label id="lab_holx_GrantsReceivedFromDepartmentOfDefense_documentation_en-US" xlink:label="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants received from Department of defense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:href="holx-20221231.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GrantsReceivedFromDepartmentOfDefense" xlink:to="lab_holx_GrantsReceivedFromDepartmentOfDefense" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SecuredTermLoanMember_0d2fdac4-628d-43c2-8cc7-6c4aa36a40f2_terseLabel_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_label_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan [Member]</link:label>
    <link:label id="lab_holx_SecuredTermLoanMember_documentation_en-US" xlink:label="lab_holx_SecuredTermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Secured Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember" xlink:href="holx-20221231.xsd#holx_SecuredTermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SecuredTermLoanMember" xlink:to="lab_holx_SecuredTermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_91bed8aa-1e81-4eb7-b1c7-01a4b72466f4_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_a4b1673e-9cc4-4839-8335-452d6eee5d76_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average anti-dilutive shares related to:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_b923b138-f7cd-4ad3-9725-dba05db69c75_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_d0125022-f272-439c-a0a6-059445718bca_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLegalSettlements_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLegalSettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Legal Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLegalSettlements" xlink:to="lab_us-gaap_ProceedsFromLegalSettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_cc657c35-ef81-4b19-851c-cc315c7235c9_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_1fefed20-6884-4109-a715-597961dc3af5_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DevelopedTechnologyMember_ec1fb654-e9d1-4078-baee-b701cefaf119_terseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_9e233e74-ff9c-4a82-aadd-3fe68fa96e7b_verboseLabel_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed&#160;technology</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_label_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology [Member]</link:label>
    <link:label id="lab_holx_DevelopedTechnologyMember_documentation_en-US" xlink:label="lab_holx_DevelopedTechnologyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember" xlink:href="holx-20221231.xsd#holx_DevelopedTechnologyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DevelopedTechnologyMember" xlink:to="lab_holx_DevelopedTechnologyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_6281dbcc-ef91-4b03-911e-8e3a4083cac1_terseLabel_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum Target Number Of Shares Issued Based On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum target number percentage of shares issued based on stock performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:href="holx-20221231.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:to="lab_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_0cd7848b-3af3-4264-a6af-50255fbb92b4_terseLabel_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_label_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships Contracts [Member]</link:label>
    <link:label id="lab_holx_CustomerRelationshipsContractsMember_documentation_en-US" xlink:label="lab_holx_CustomerRelationshipsContractsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships contracts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember" xlink:href="holx-20221231.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CustomerRelationshipsContractsMember" xlink:to="lab_holx_CustomerRelationshipsContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_7c6369d8-be1e-40d6-ac21-990eeb7886c8_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Cost, Expected Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:to="lab_us-gaap_RestructuringAndRelatedCostExpectedCost1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_b1b7db39-9067-4ccd-b1fe-ec593ec4c5dd_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, fair value (percentage)</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesAbstract_label_en-US" xlink:label="lab_us-gaap_ReceivablesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesAbstract" xlink:to="lab_us-gaap_ReceivablesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_56ea6a17-339e-4fd3-b38b-118d6e7ccdb6_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_ab044f1f-90ef-4099-aca0-72ed2ffb36d1_terseLabel_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_label_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:label id="lab_holx_InterventionalBreastSolutionsMember_documentation_en-US" xlink:label="lab_holx_InterventionalBreastSolutionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interventional Breast Solutions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember" xlink:href="holx-20221231.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InterventionalBreastSolutionsMember" xlink:to="lab_holx_InterventionalBreastSolutionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_58b999c8-1f72-4c0e-83a2-677663e25654_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_1eff4660-06c9-4c9e-b0bc-6768e52d3e2c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_2efed8c2-de49-47b9-8282-8c4812a7dc94_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, net of current portion</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_7af66dfe-48f6-4a26-8640-56eb612a6f90_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total long-term debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_3f536e74-8b2d-48db-8c30-47190a7f904f_terseLabel_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Receivables and Allowance for Credit Losses</link:label>
    <link:label id="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loans, Notes, Trade and Other Receivables Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:to="lab_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021CreditAgreementMember_3e6e7702-2b1d-46f1-9ce7-3bf7accfd88d_terseLabel_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement</link:label>
    <link:label id="lab_holx_A2021CreditAgreementMember_label_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_A2021CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_A2021CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember" xlink:href="holx-20221231.xsd#holx_A2021CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021CreditAgreementMember" xlink:to="lab_holx_A2021CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Costofservice_19ad4144-97a0-4210-96ee-35db6be83430_terseLabel_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_Costofservice_label_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:label id="lab_holx_Costofservice_documentation_en-US" xlink:label="lab_holx_Costofservice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of service</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice" xlink:href="holx-20221231.xsd#holx_Costofservice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Costofservice" xlink:to="lab_holx_Costofservice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9c730c09-751e-47ec-948f-ae94d56f1a40_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_642505e7-d5dd-4214-9883-ed83335160c7_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_f58cd580-b744-4200-922b-d511818c4c90_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_7510323c-1673-4b5d-9e8e-a8776eb0f651_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_331e9351-ab85-4219-b132-39d2c64ebed4_negatedLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Settlements/ Adjustments</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_311c3f06-010b-4d7f-a16e-d18647d8fea1_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_8d223c11-33a4-4769-b409-6edcff139f47_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_89401a85-e8b3-453e-8a1f-e616c8b856f0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_74049e0b-eaf1-4ece-82fe-42b4f0f6cd8a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_95765357-74a2-4f7d-bea9-0af5872b057f_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_d10f185e-7b9d-4c9a-b869-6663fae39921_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation Expense in Consolidated Statements of Operations</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Share Based Compensation Expense [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of share-based compensation expense.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:href="holx-20221231.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:to="lab_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_8d732ec3-5bb3-445a-b7b4-26813454f8e7_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets:</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract" xlink:to="lab_us-gaap_AssetsFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c5a787b9-ebb1-4e80-ac52-d83ffb278f18_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_806ff7d7-3b21-4f4f-b08e-7b71cc59ebb9_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_cf224f03-e131-4059-b7c9-7bca5ca78459_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings and Credit Arrangements</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_89c68a3d-cb40-4ea3-b6e3-2f33b5f3972e_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Costs of revenues:</link:label>
    <link:label id="lab_us-gaap_CostOfRevenueAbstract_label_en-US" xlink:label="lab_us-gaap_CostOfRevenueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenueAbstract" xlink:to="lab_us-gaap_CostOfRevenueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MarketBasedAwardsMember_85fc1840-4413-491c-aabd-a3cd0ff24b08_terseLabel_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_label_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:label id="lab_holx_MarketBasedAwardsMember_documentation_en-US" xlink:label="lab_holx_MarketBasedAwardsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market Based Awards [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember" xlink:href="holx-20221231.xsd#holx_MarketBasedAwardsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MarketBasedAwardsMember" xlink:to="lab_holx_MarketBasedAwardsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_88452a68-5e3b-4499-b525-8a4a82aad310_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_1afc4e3a-7031-4bac-ae86-a5cc546e7905_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_8316cdca-0690-4d30-848c-cb5742b4faf9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_25f336b5-a4d4-448b-ba50-ca6529561665_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_437a78d1-5e40-4130-a938-3f76858f92fc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_3b2bcd49-bdbb-403f-8dfb-3d17d2203f8a_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of minimum tax withholdings on net share settlements of equity awards</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_label_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment For Tax Withholding Related To Vested And Released Restricted Stock Units</link:label>
    <link:label id="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_documentation_en-US" xlink:label="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:href="holx-20221231.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:to="lab_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CreditAgreementMember_dd93748b-bbc5-47c6-9387-2924467f67dd_terseLabel_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement</link:label>
    <link:label id="lab_holx_CreditAgreementMember_label_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit Agreement [Member]</link:label>
    <link:label id="lab_holx_CreditAgreementMember_documentation_en-US" xlink:label="lab_holx_CreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember" xlink:href="holx-20221231.xsd#holx_CreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CreditAgreementMember" xlink:to="lab_holx_CreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_b9e34aba-5e62-4219-8191-affd9d784137_terseLabel_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equipment</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_label_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Manufacturing Equipment And Software</link:label>
    <link:label id="lab_holx_ManufacturingEquipmentAndSoftware_documentation_en-US" xlink:label="lab_holx_ManufacturingEquipmentAndSoftware" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware" xlink:href="holx-20221231.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ManufacturingEquipmentAndSoftware" xlink:to="lab_holx_ManufacturingEquipmentAndSoftware" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_bed4bdae-9b40-40f0-aa97-78f449858a26_verboseLabel_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowed principal</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_label_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal Amount Of Borrowings</link:label>
    <link:label id="lab_holx_PrincipalAmountOfBorrowings_documentation_en-US" xlink:label="lab_holx_PrincipalAmountOfBorrowings" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings" xlink:href="holx-20221231.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrincipalAmountOfBorrowings" xlink:to="lab_holx_PrincipalAmountOfBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_cf05cb98-3dfb-4aa4-9547-438dd8cfb165_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_ccbffd25-3536-4c9f-a55c-5a8a1b85f189_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsDomain_6dcdefeb-9bf7-44a6-ae14-f5d642570c62_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:label id="lab_srt_ConsolidationItemsDomain_label_en-US" xlink:label="lab_srt_ConsolidationItemsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsDomain" xlink:to="lab_srt_ConsolidationItemsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_ea4c13d6-c66a-4dd4-9706-8bd38d3cea34_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_95e97ee1-e1d5-41b1-8432-cb9465a57aa2_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesGross_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesGross" xlink:to="lab_us-gaap_FurnitureAndFixturesGross" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_dd460980-be05-4e90-9d1b-4f9e1f078532_terseLabel_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_label_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:label id="lab_holx_AmortizationCostofGoodsSold_documentation_en-US" xlink:label="lab_holx_AmortizationCostofGoodsSold" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization, Cost of Goods Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold" xlink:href="holx-20221231.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmortizationCostofGoodsSold" xlink:to="lab_holx_AmortizationCostofGoodsSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_e74b16fc-1a31-47c8-a282-e0597146dfc3_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_877f73ad-c113-4f13-b5a5-00edf38db3a7_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5975a52b-f903-455d-b7fa-c98b404fb90f_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_001ae341-8b30-4bce-91ee-a203810f312e_terseLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Identifiable assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_609bf375-f467-40e5-96bf-20807721537f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Write-offs, Payments and Foreign Exchange</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Writeoff</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CytologyPerinatalMember_b5096ff8-eb39-403b-85ee-983c09c2570d_terseLabel_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_label_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:label id="lab_holx_CytologyPerinatalMember_documentation_en-US" xlink:label="lab_holx_CytologyPerinatalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cytology &amp; Perinatal [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember" xlink:href="holx-20221231.xsd#holx_CytologyPerinatalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CytologyPerinatalMember" xlink:to="lab_holx_CytologyPerinatalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_1944d46f-d072-420d-a0dd-7fbb68a71364_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_bf955d6a-484b-4638-8513-9859896c925c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income per common share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_a0b7fd20-dd8c-461d-a8c6-b92c02097fb1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_a2afbf2e-d598-43b4-9677-b294dc54df52_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency option contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_f61cb6d8-05e7-4426-b25a-518e7c53c901_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeOptionMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeOptionMember" xlink:to="lab_us-gaap_ForeignExchangeOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_641add58-50e9-45c3-ba82-df399c77a98e_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_0bbd2f35-5781-4ae5-85e6-7af80f1e886f_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_6da08c31-228e-4db3-92ca-fe7ad42e783f_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_label_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Line Items]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanLineItems_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems" xlink:href="holx-20221231.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanLineItems" xlink:to="lab_holx_SharerepurchaseplanLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_1bfd78bc-8430-43aa-964e-948a7f9cf902_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsLineItems_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:href="holx-20221231.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestRateSwapMember_a712d12a-0697-49e1-b404-129a22d9b69b_verboseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_506802da-a8fe-49e0-bb4a-a35e39595070_terseLabel_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap</link:label>
    <link:label id="lab_us-gaap_InterestRateSwapMember_label_en-US" xlink:label="lab_us-gaap_InterestRateSwapMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Rate Swap [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestRateSwapMember" xlink:to="lab_us-gaap_InterestRateSwapMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_74a8f54c-34aa-4f07-ba46-7efc275172fc_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_7ca92e78-8396-4f1a-b97b-fc70871e8d26_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_c40402c4-eca4-44ba-a580-16b9192ff683_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_0c6e7b5f-9603-42cf-a8e7-13c01944ca33_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restructuring and Related Costs [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:to="lab_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_7424a844-3dde-4544-81eb-b39354eb5beb_verboseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_8e9e0e6e-0b37-49a6-a6e4-c6e73d3c76a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_5c257878-1baf-4ffd-aa0b-e325af6048c1_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_58ce0350-54fd-4bee-914d-553a84651a79_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareTable_a0621370-90d1-484e-b8b8-4dd276916342_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_label_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:label id="lab_holx_EarningsPerShareTable_documentation_en-US" xlink:label="lab_holx_EarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable" xlink:href="holx-20221231.xsd#holx_EarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareTable" xlink:to="lab_holx_EarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AssetSecuritizationMember_eb805cdc-d30e-470f-82c2-89290922177c_terseLabel_en-US" xlink:label="lab_holx_AssetSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Securitization</link:label>
    <link:label id="lab_holx_AssetSecuritizationMember_label_en-US" xlink:label="lab_holx_AssetSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Securitization [Member]</link:label>
    <link:label id="lab_holx_AssetSecuritizationMember_documentation_en-US" xlink:label="lab_holx_AssetSecuritizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Securitization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetSecuritizationMember" xlink:href="holx-20221231.xsd#holx_AssetSecuritizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AssetSecuritizationMember" xlink:to="lab_holx_AssetSecuritizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_eaf87590-23a8-494a-b54e-f6ccc0db9f5c_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9be94bd4-faf9-408f-8c98-255ce05a3bb9_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized_dd51dc87-96e7-418f-9445-5867a7b94677_terseLabel_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of Defense funds received, not capitalized</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized_label_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of Defense funds received, not capitalized</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized_documentation_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of Defense funds received, not capitalized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceivedNotCapitalized" xlink:href="holx-20221231.xsd#holx_DepartmentOfDefenseFundsReceivedNotCapitalized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DepartmentOfDefenseFundsReceivedNotCapitalized" xlink:to="lab_holx_DepartmentOfDefenseFundsReceivedNotCapitalized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_5783a658-ec88-4581-9430-c9441a5fda5a_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_dc4ea559-778f-4db5-ba38-cf4e5a399832_negatedTerseLabel_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_label_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:label id="lab_holx_Purchaseofinsurancecontracts_documentation_en-US" xlink:label="lab_holx_Purchaseofinsurancecontracts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance contracts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts" xlink:href="holx-20221231.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Purchaseofinsurancecontracts" xlink:to="lab_holx_Purchaseofinsurancecontracts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_0f5420f8-56e6-4994-8ba6-2b36a2fb6d04_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_9f161e04-3a4e-411b-863c-a7301a814cfc_verboseLabel_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock units vesting period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_label_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shared Based Compensation Arrangement Restricted Stock Vesting Period</link:label>
    <link:label id="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_documentation_en-US" xlink:label="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Period of time that must lapse in order for the restricted stock units to vest.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:href="holx-20221231.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:to="lab_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForwardContractsMember_0f4701ad-89f9-455c-956e-453d097f1ae1_terseLabel_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts</link:label>
    <link:label id="lab_us-gaap_ForwardContractsMember_label_en-US" xlink:label="lab_us-gaap_ForwardContractsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward Contracts [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForwardContractsMember" xlink:to="lab_us-gaap_ForwardContractsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_e11af219-6684-4321-b1fe-eb4a2c188c00_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Assumptions Utilized to Value Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_3b3b9249-a4b0-4104-90c9-ab0c6eb01b29_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value, Acquired, Par Value Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredParValueMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_a8291a3e-e2c7-4005-9d9d-16fe9e7104fb_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations, net of current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_67d9436e-b785-4b05-a7c2-c585b0beb487_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_fcc1e0a4-da25-4d19-836b-b41d47a64a95_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building and improvements</link:label>
    <link:label id="lab_us-gaap_BuildingsAndImprovementsGross_label_en-US" xlink:label="lab_us-gaap_BuildingsAndImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Buildings and Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingsAndImprovementsGross" xlink:to="lab_us-gaap_BuildingsAndImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_46a0ef12-cf8b-4d8f-8158-a6173830d647_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average period for recognition of unrecognized stock-based compensation, years</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_fc218f36-b3c7-4530-93dc-a0820127867e_terseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_886fd150-1057-4d58-97e2-7872c57e55d2_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment loss</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_2c78806c-de15-414b-8821-96040e281c3b_negatedLabel_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt extinguishment losses</link:label>
    <link:label id="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt_label_en-US" xlink:label="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Extinguishment of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:to="lab_us-gaap_GainsLossesOnExtinguishmentOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_5045e5cc-78c9-4aa8-bf6f-4667437314ea_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposal Groups, Including Discontinued Operations [Table]</link:label>
    <link:label id="lab_us-gaap_RestructuringPlanDomain_label_en-US" xlink:label="lab_us-gaap_RestructuringPlanDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Plan [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringPlanDomain" xlink:to="lab_us-gaap_RestructuringPlanDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_afb28328-ac68-4f7d-88a8-8c4d415cec1b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_September222022Member_02c433b8-17c9-4b3c-a0e6-610f667cb0be_terseLabel_en-US" xlink:label="lab_holx_September222022Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 22, 2022</link:label>
    <link:label id="lab_holx_September222022Member_label_en-US" xlink:label="lab_holx_September222022Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 22, 2022 [Member]</link:label>
    <link:label id="lab_holx_September222022Member_documentation_en-US" xlink:label="lab_holx_September222022Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">September 22, 2022</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member" xlink:href="holx-20221231.xsd#holx_September222022Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_September222022Member" xlink:to="lab_holx_September222022Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_bb670019-5d32-45e9-96ec-b798dcfd6193_terseLabel_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total acquired intangible assets</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_label_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:label id="lab_holx_AcquiredintangibleassetsMember_documentation_en-US" xlink:label="lab_holx_AcquiredintangibleassetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired intangible assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember" xlink:href="holx-20221231.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcquiredintangibleassetsMember" xlink:to="lab_holx_AcquiredintangibleassetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_d60ae02b-9db5-4279-ac47-24386e1ca250_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_3e8ad01d-2f0b-4d0b-a64a-cfa75a2420c8_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_8baf518c-c05e-48d0-b09d-778667ed922d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SkeletalHealthMember_2e5d7be3-abf7-4a18-8d62-f9029ca57f4f_terseLabel_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_label_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal Health [Member]</link:label>
    <link:label id="lab_holx_SkeletalHealthMember_documentation_en-US" xlink:label="lab_holx_SkeletalHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Skeletal health.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember" xlink:href="holx-20221231.xsd#holx_SkeletalHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SkeletalHealthMember" xlink:to="lab_holx_SkeletalHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternalusesoftwareMember_7dc93b71-19fe-4e58-bfeb-55ed6e8f4d14_terseLabel_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_label_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:label id="lab_holx_InternalusesoftwareMember_documentation_en-US" xlink:label="lab_holx_InternalusesoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Internal-use software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember" xlink:href="holx-20221231.xsd#holx_InternalusesoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternalusesoftwareMember" xlink:to="lab_holx_InternalusesoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_0038dc7f-f1fc-48eb-8e8d-4329b45941aa_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_9388d9a9-437b-4ea0-9fe4-733a44d9e7de_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Translation</link:label>
    <link:label id="lab_us-gaap_AccumulatedTranslationAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Foreign Currency Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedTranslationAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_95ef9d83-cb5f-424c-931a-075e165f7fa3_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_b700ef9f-328c-4093-8fa1-8cf47ef97c54_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_0e7ee0c9-a5c0-45ab-9ae5-0e6872d64aac_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</link:label>
    <link:label id="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:to="lab_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_38b25af2-dbf4-44bf-b787-c25390e8b165_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ba4fae82-f4f7-472b-b03e-bcb4be93d2e7_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_457357aa-504f-49a6-bc64-37ff1e44e156_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_7d89286e-ec5a-4368-b124-450db390bbf7_terseLabel_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment</link:label>
    <link:label id="lab_us-gaap_IntersegmentEliminationMember_label_en-US" xlink:label="lab_us-gaap_IntersegmentEliminationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intersegment Eliminations [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntersegmentEliminationMember" xlink:to="lab_us-gaap_IntersegmentEliminationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_0c5846f3-4df3-495c-9037-0bb4424c904a_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Obligations, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BloodScreeningMember_87e32c0a-d06f-4a4f-bc0b-f35b2c5650fb_terseLabel_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening</link:label>
    <link:label id="lab_holx_BloodScreeningMember_label_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:label id="lab_holx_BloodScreeningMember_documentation_en-US" xlink:label="lab_holx_BloodScreeningMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Blood Screening [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember" xlink:href="holx-20221231.xsd#holx_BloodScreeningMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BloodScreeningMember" xlink:to="lab_holx_BloodScreeningMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_ef1fa47e-4a83-4205-926b-cec627d6ddb0_terseLabel_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum eligible percentage to receive target number of shares of company's common stock</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_label_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum Target Number Of Shares Issued On Stock Performance In Percent</link:label>
    <link:label id="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_documentation_en-US" xlink:label="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum target number percentage of shares that would be issued based on stock price performance.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:href="holx-20221231.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:to="lab_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_f5fefed1-1e9a-4e75-8ca1-198c172b2993_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_57e0f1c4-e4a7-4d59-ab9d-70c06652f18e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_d1afdbb8-10a8-4d14-9d11-f80e98f800f5_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_332e9a55-0d50-4e2e-aa08-b849286e3c01_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_81d02234-ed9a-46be-ac78-32f97d8caf53_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (loss) recognized in other comprehensive income (loss), net</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_35210959-a78b-42c0-a2c0-a13f1fe590a0_terseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of unrealized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_21ad400b-d5b2-411b-b5ce-2c8ef7177136_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_9dd22aae-1ce2-47e4-90df-327d8b627fff_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_fdaf2693-7c3f-45a0-b7dc-458448478096_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_964d791d-3bce-4dca-a541-42925af5379d_terseLabel_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_label_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details Of Certain Balance Sheet Accounts [Text Block]</link:label>
    <link:label id="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_documentation_en-US" xlink:label="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Details of certain balance sheet accounts.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:href="holx-20221231.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:to="lab_holx_DetailsOfCertainBalanceSheetAccountsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_84ce0bde-8966-4a6a-b684-0679cf0a67c2_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments for New Accounting Pronouncements [Axis]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_label_en-US" xlink:label="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:to="lab_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_bdc9912e-ce38-4820-96e2-045c07245e19_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_2e9f16b7-7b9a-4d97-b2eb-ad7929d33439_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_1e866cfa-40be-4811-83a6-597e650e8402_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets and Goodwill</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_642f0d16-2adf-4a7b-bc5b-86615f191e17_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_1dae0d13-326c-4e10-bed8-0eed52b9f035_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_a92c157f-9c69-472e-9a68-e660c6bd054e_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_6cab3882-3e75-4ee2-b85e-532e9b50f76c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsGross_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsGross" xlink:to="lab_us-gaap_LeaseholdImprovementsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_725b2b96-0d0c-4009-b92f-6d78c2e0cf9f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueCurrent" xlink:to="lab_us-gaap_DeferredRevenueCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e40068e4-0e4a-427d-9dcc-91ccbccdd036_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_a54e1b1b-d94a-416b-bc3c-e2cbe85a63ed_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_85eed8f8-9e10-4453-ac74-1d3b46f4eff9_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's effective tax rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_282a8bb5-82e9-4bad-b9c9-66c23c0e27f0_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_8df9eb11-0d1e-4513-82e8-38409b2fda2a_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:to="lab_us-gaap_BusinessCombinationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationPayments_ea5bbce4-437c-4960-bd39-a24c17d258dc_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration payment</link:label>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationPayments_label_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Payments</link:label>
    <link:label id="lab_holx_BusinessCombinationContingentConsiderationPayments_documentation_en-US" xlink:label="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationPayments" xlink:href="holx-20221231.xsd#holx_BusinessCombinationContingentConsiderationPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationContingentConsiderationPayments" xlink:to="lab_holx_BusinessCombinationContingentConsiderationPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_0412f8a9-16b2-455b-b03b-5b3c88180e38_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_1c3553c5-2246-49d9-8566-99583183e52a_terseLabel_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations. excluding convertible notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_label_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long Term Debt Obligations Without Convertible Notes</link:label>
    <link:label id="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes_documentation_en-US" xlink:label="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long term debt obligations without convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:href="holx-20221231.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:to="lab_holx_LongTermDebtObligationsWithoutConvertibleNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_5a7a8634-4655-419c-a470-fcc4aa5155db_totalLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Price</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0d0935c8-1910-41ae-89eb-e1d8b19d40e2_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_e4a63880-7175-4540-970f-44adc39c1159_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_53e53004-58e3-4fa8-aeaa-70ea6431c81c_totalLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_990ddb60-f594-42ee-a857-9f777b9b70ca_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_183c94c4-18c3-4207-8371-3ca7ff0168e1_verboseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenues</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PSUFreeCashFlowMember_28bf411d-3cca-462b-ac22-fd881050cf15_terseLabel_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_label_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:label id="lab_holx_PSUFreeCashFlowMember_documentation_en-US" xlink:label="lab_holx_PSUFreeCashFlowMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PSU Free Cash Flow [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember" xlink:href="holx-20221231.xsd#holx_PSUFreeCashFlowMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PSUFreeCashFlowMember" xlink:to="lab_holx_PSUFreeCashFlowMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_c93e3734-815d-4959-a37c-db4032694aca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning&#160;of Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_371f042f-17a9-4912-bfa7-8c7590b6fbe3_periodEndLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End&#160;of&#160;Period</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrual" xlink:to="lab_us-gaap_ProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_b9f5de6b-213c-4a02-a961-796b3d5b0a9a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AmountAssessedInDamages_75fd7529-5b57-4b6a-8c58-a67b0bad78b5_terseLabel_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assessed damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_label_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount Assessed In Damages</link:label>
    <link:label id="lab_holx_AmountAssessedInDamages_documentation_en-US" xlink:label="lab_holx_AmountAssessedInDamages" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount assessed in damages.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages" xlink:href="holx-20221231.xsd#holx_AmountAssessedInDamages"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AmountAssessedInDamages" xlink:to="lab_holx_AmountAssessedInDamages" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_1d422454-7f3d-4cb9-8f88-e7828b1698db_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration - fair value adjustment</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GuaranteesAbstract_d14f042c-fe46-4ee1-ac77-a4d56f1ff667_terseLabel_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:label id="lab_us-gaap_GuaranteesAbstract_label_en-US" xlink:label="lab_us-gaap_GuaranteesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Guarantees [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GuaranteesAbstract" xlink:to="lab_us-gaap_GuaranteesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_33358048-6c40-46b7-857c-8acf9ca29823_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MolecularDiagnosticsMember_9897cbc2-abe8-4c6d-9888-ef8f6bcd7230_terseLabel_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_label_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:label id="lab_holx_MolecularDiagnosticsMember_documentation_en-US" xlink:label="lab_holx_MolecularDiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Molecular Diagnostics [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember" xlink:href="holx-20221231.xsd#holx_MolecularDiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MolecularDiagnosticsMember" xlink:to="lab_holx_MolecularDiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_fed169f1-5d43-4863-abd1-e1d4a73352c4_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_e408e909-8deb-4b18-a454-3d89dad4f6fd_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Interest Expense Under Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of interest expense under convertible notes.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:href="holx-20221231.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:to="lab_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_420088cf-92fc-4870-80d3-bdb771ef636d_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_December112020Member_dac6575f-c19a-4fb2-93db-ef44d4525cc6_terseLabel_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:label id="lab_holx_December112020Member_label_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020 [Member]</link:label>
    <link:label id="lab_holx_December112020Member_documentation_en-US" xlink:label="lab_holx_December112020Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">December 11, 2020</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member" xlink:href="holx-20221231.xsd#holx_December112020Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_December112020Member" xlink:to="lab_holx_December112020Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_4bc86791-9082-4811-91a4-26de0ce7b322_terseLabel_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease revenue as a percentage of total (percentage)</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_label_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:label id="lab_holx_LeaseRevenuePercentageOfTotalRevenue_documentation_en-US" xlink:label="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Revenue, Percentage Of Total Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:href="holx-20221231.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:to="lab_holx_LeaseRevenuePercentageOfTotalRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsMember_0c37e7ed-23e0-4e56-8ff7-aa7019f882bf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsMember" xlink:to="lab_us-gaap_OtherAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AcessaHealthMember_9df8cd47-301f-421e-a8c9-9a4bb75cc507_terseLabel_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:label id="lab_holx_AcessaHealthMember_label_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health [Member]</link:label>
    <link:label id="lab_holx_AcessaHealthMember_documentation_en-US" xlink:label="lab_holx_AcessaHealthMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acessa Health</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember" xlink:href="holx-20221231.xsd#holx_AcessaHealthMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AcessaHealthMember" xlink:to="lab_holx_AcessaHealthMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_d77697d2-7e93-44b0-95a2-a1b74e1290df_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pension Plans</link:label>
    <link:label id="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:to="lab_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_d83859bd-2274-49de-ae56-a9f9221d94d4_negatedLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021RevolverMember_8ada53ac-2df4-4ca6-a41b-2a245c791a3e_terseLabel_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver</link:label>
    <link:label id="lab_holx_A2021RevolverMember_label_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver [Member]</link:label>
    <link:label id="lab_holx_A2021RevolverMember_documentation_en-US" xlink:label="lab_holx_A2021RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Revolver</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember" xlink:href="holx-20221231.xsd#holx_A2021RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021RevolverMember" xlink:to="lab_holx_A2021RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostsAbstract_label_en-US" xlink:label="lab_us-gaap_RestructuringCostsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Costs [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostsAbstract" xlink:to="lab_us-gaap_RestructuringCostsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_7e76637b-3fe2-411e-8abc-2f9a61b15492_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_82a1e155-1f79-4af2-b825-ba55b4658bd4_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpense_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpense" xlink:to="lab_us-gaap_SellingAndMarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_95dbfd98-d5ad-4e96-9e3c-8359f896cab0_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_ff71cff0-5750-49b8-ab1f-06622fc157ad_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_1855dae5-c096-46b9-b611-c0420f030a72_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_a36986ec-45fc-474f-b9bc-261bbec4db56_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_cbe13c92-7031-454b-b000-f16967f7efd0_terseLabel_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_label_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:label id="lab_holx_SegmentReportingDisclosureLineItems_documentation_en-US" xlink:label="lab_holx_SegmentReportingDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems" xlink:href="holx-20221231.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SegmentReportingDisclosureLineItems" xlink:to="lab_holx_SegmentReportingDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_a37fe99d-4703-4689-985b-0643e4f33685_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_5cd507e9-01a6-4dd8-94e9-950e1880dcd8_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsGainLossLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments, Gain (Loss) [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsGainLossLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_062e0d01-48f2-40fa-ad20-02b5e381dc2a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_0cefe8be-3ce3-4b07-a778-7bd392e900e2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_5aa2776f-9c63-4fd5-bec4-74b3e446a40c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueByBalanceSheetGroupingTable_label_en-US" xlink:label="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, by Balance Sheet Grouping [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:to="lab_us-gaap_FairValueByBalanceSheetGroupingTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_e135e9d5-369a-4ee7-a388-1fb8c10dae48_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes</link:label>
    <link:label id="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Value, Shares Issued Net of Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_674cb02c-0c95-42e0-9041-3e9b663236cf_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BasisofPresentationAbstract_eb093e12-deb5-4bc4-af78-f702f8238b93_terseLabel_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_label_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:label id="lab_holx_BasisofPresentationAbstract_documentation_en-US" xlink:label="lab_holx_BasisofPresentationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract" xlink:href="holx-20221231.xsd#holx_BasisofPresentationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BasisofPresentationAbstract" xlink:to="lab_holx_BasisofPresentationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_f40e8033-05e6-452b-a31b-4e471880a8fe_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities, excluding the effect of acquisitions:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8827bb7e-c039-4600-8763-4b01811b58ad_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_df309bf8-658a-4e32-8311-c62dac33de8d_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_e1df57ab-d4cb-495f-9600-19420d8c642e_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2021TermLoanMember_0b85467c-f024-480d-b698-69a3219a3ddc_terseLabel_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan</link:label>
    <link:label id="lab_holx_A2021TermLoanMember_label_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan [Member]</link:label>
    <link:label id="lab_holx_A2021TermLoanMember_documentation_en-US" xlink:label="lab_holx_A2021TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 Term Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember" xlink:href="holx-20221231.xsd#holx_A2021TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2021TermLoanMember" xlink:to="lab_holx_A2021TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_a8519b60-1168-4254-ab9e-8ea451f6022b_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_13532091-1f4d-4dae-a69f-db93599da299_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss)</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_6141f8f9-3454-4acc-ab45-36db32c56fd5_terseLabel_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_label_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:label id="lab_holx_ScheduleOfGeographicalSegmentsTable_documentation_en-US" xlink:label="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Geographical Segments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:href="holx-20221231.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable" xlink:to="lab_holx_ScheduleOfGeographicalSegmentsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_59e14ac1-c809-4e55-aa8b-130f4adc7023_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_712879c4-b73e-4fd5-a3ce-4f1cabd0e838_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_79f930c5-c09f-4329-84ab-c1cd1e284de6_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationLiability_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dc8a9855-f203-412d-8077-846e96999e68_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_bc9ab31e-d2b1-42db-ba9c-daeb2d383493_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_ee938326-47c3-487d-9527-d1bf51d57b0a_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_eeabc739-5c0b-4451-85f3-5aa9cd4c536a_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repurchase of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_1cba363a-e237-4c83-b63f-69989e822dff_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of deferred acquisition consideration</link:label>
    <link:label id="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment for Contingent Consideration Liability, Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:to="lab_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4caa9274-ade2-42a5-a7d1-64b3eab88e80_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_a4972591-b4fa-406e-b8f1-d8b61912cd93_terseLabel_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital equipment, components and software</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_label_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:label id="lab_holx_CapitalEquipmentComponentsandSoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Equipment, Components and Software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:href="holx-20221231.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:to="lab_holx_CapitalEquipmentComponentsandSoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Repaymentsofacquiredlongtermdebt_8bb0411a-aa9e-47ff-a9ff-07c42ffe7c95_negatedTerseLabel_en-US" xlink:label="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of acquired long term debt</link:label>
    <link:label id="lab_holx_Repaymentsofacquiredlongtermdebt_label_en-US" xlink:label="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of acquired long term debt</link:label>
    <link:label id="lab_holx_Repaymentsofacquiredlongtermdebt_documentation_en-US" xlink:label="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of acquired long term debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentsofacquiredlongtermdebt" xlink:href="holx-20221231.xsd#holx_Repaymentsofacquiredlongtermdebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Repaymentsofacquiredlongtermdebt" xlink:to="lab_holx_Repaymentsofacquiredlongtermdebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_70cef2d5-e86e-4d90-ac62-a28465dfbc63_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, less reserves</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_e9e4ad31-2d28-4b20-9f1e-1d80e76d891d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilityMember_1c1bc092-eb49-4c65-879c-615aae6c0799_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability</link:label>
    <link:label id="lab_us-gaap_LiabilityMember_label_en-US" xlink:label="lab_us-gaap_LiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilityMember" xlink:to="lab_us-gaap_LiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_EarningsPerShareLineItems_f126990e-4dab-4a59-8212-8cd5307d987f_terseLabel_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_label_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_holx_EarningsPerShareLineItems_documentation_en-US" xlink:label="lab_holx_EarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems" xlink:href="holx-20221231.xsd#holx_EarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_EarningsPerShareLineItems" xlink:to="lab_holx_EarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_5e287424-87b8-46d2-824e-f9e585f34545_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2029SeniorNotesMember_9702246c-9652-40e3-a278-0e6806d89a20_terseLabel_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2029SeniorNotesMember" xlink:to="lab_holx_A2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_fa336dc3-cf62-45b0-886a-617235584cc9_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_85aa243a-87df-4f5b-9812-a97b1b13d3dc_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_c17d7351-b6bc-409a-a600-3a9ae466438f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_a4c09428-bd21-47c6-a786-5851c7aee6a4_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate swap at fair value</link:label>
    <link:label id="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_label_en-US" xlink:label="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow Hedge Derivative Instrument Assets at Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:to="lab_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_e67feee8-3487-4e93-8abc-abe14cc2d91c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_44e8a5d9-313a-48b1-96dc-c9ed59cbca82_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_bd075cc0-71fc-4425-b548-6a131722f170_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Value</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_36b750bd-698e-498b-b852-2bcb96870674_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DiagnosticsMember_0bf30e70-de72-4d58-99df-6e8c4f029685_terseLabel_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics</link:label>
    <link:label id="lab_holx_DiagnosticsMember_label_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics [Member]</link:label>
    <link:label id="lab_holx_DiagnosticsMember_documentation_en-US" xlink:label="lab_holx_DiagnosticsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diagnostics.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember" xlink:href="holx-20221231.xsd#holx_DiagnosticsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DiagnosticsMember" xlink:to="lab_holx_DiagnosticsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_16073d59-0ccf-4343-98e1-599103450496_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3cb4cba9-086e-49df-8547-35337004bebf_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_175a833b-55bb-4b3a-9b3b-c8725630b906_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodValue_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodValue" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_1272bc2c-6398-4e7b-94d2-07fd6064455b_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_423fce5f-fa28-4148-8d37-665a2eb72ee1_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNoteTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss) Note [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomeNoteTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_99a14f7b-78c7-45f3-a6bb-84be7524ac53_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireProductiveAssets" xlink:to="lab_us-gaap_PaymentsToAcquireProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_26e6116c-805c-47a3-ab59-993b4ab052db_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2e27f822-fc1d-44ed-8c7a-4b31f32e9ded_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_2c300495-4cde-4e7d-8ac4-a8688add8b2d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_bcee50c2-51a7-4345-ba3a-d1e4aa69bf2a_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (loss) from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_1fbe729b-2ed7-4107-ab33-2e95502aefbb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_fd5c0f97-29b5-4d81-8fbe-a9acf3be0624_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ServiceMember_9e47c23b-c82f-4292-88fc-bf682d307423_terseLabel_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service</link:label>
    <link:label id="lab_us-gaap_ServiceMember_label_en-US" xlink:label="lab_us-gaap_ServiceMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ServiceMember" xlink:to="lab_us-gaap_ServiceMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_5834b7eb-8cc2-4928-88a2-28b1c3513c09_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a156f258-e9e0-43aa-baf6-58d39aae7c0f_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Related Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:to="lab_us-gaap_BalanceSheetRelatedDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_3d7f6539-cd51-436b-b99e-99866e575c0b_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_86c11f76-3df3-4b20-a4e4-b7cf2a70f83b_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:label id="lab_us-gaap_StockRepurchasedDuringPeriodShares_label_en-US" xlink:label="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchased During Period, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchasedDuringPeriodShares" xlink:to="lab_us-gaap_StockRepurchasedDuringPeriodShares" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_A2028And2029SeniorNotesMember_d7c5f0f8-4765-4737-978b-7fbfd2dec72e_terseLabel_en-US" xlink:label="lab_holx_A2028And2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_holx_A2028And2029SeniorNotesMember_label_en-US" xlink:label="lab_holx_A2028And2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and 2029 Senior Notes [Member]</link:label>
    <link:label id="lab_holx_A2028And2029SeniorNotesMember_documentation_en-US" xlink:label="lab_holx_A2028And2029SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028 and 2029 Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028And2029SeniorNotesMember" xlink:href="holx-20221231.xsd#holx_A2028And2029SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_A2028And2029SeniorNotesMember" xlink:to="lab_holx_A2028And2029SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_3b66adf9-0980-44ea-b10c-67c248a8e8a6_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net income to net cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_152eed29-ddad-478c-b738-64c8ef68c82f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_58807eeb-6489-476b-95c0-871f8cb78219_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_4455c6ea-ccea-45f1-a115-d237cd60acbb_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_34da2a36-faab-44a3-9332-f5ba4882be6c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_3acdc909-5694-468e-8a79-d6420e2b5517_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ContingentConsiderationMember_d47a955e-610e-4277-9d4c-f34cf4fe89e6_terseLabel_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_label_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration [Member]</link:label>
    <link:label id="lab_holx_ContingentConsiderationMember_documentation_en-US" xlink:label="lab_holx_ContingentConsiderationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent Consideration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember" xlink:href="holx-20221231.xsd#holx_ContingentConsiderationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ContingentConsiderationMember" xlink:to="lab_holx_ContingentConsiderationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_9480e116-d8b4-473a-9c54-27d3af5869c4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_1c12b2f8-2b87-408a-8915-94c629ce4afc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_8f4e898d-f273-4651-8238-936b47fb281d_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0175a0ed-17f4-4ba7-b244-872f419f20dc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_fab861d4-ab8a-41ee-9239-050e04b53755_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLineItems_cb86911a-04e7-452e-82f5-fcc185ec3ef6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLineItems" xlink:to="lab_us-gaap_DerivativeLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_f14bbbfc-fe95-49fb-a9ff-6905e23e0182_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_52ff96fa-a299-4e73-bafc-6c8510b45840_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d075f3fa-7f8d-4e55-b6df-1610bcbea2cc_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less &#8211; accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d19aa6fa-8877-4880-824e-ce178b310ba2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Balance Sheet Information of Inventories</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_acb57b5c-90e4-4a4c-b8c7-b0a9338658c2_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_39a1a2a5-e2d4-4085-85ad-c7cf0676a91c_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_28f00489-97c7-4ac3-b25f-4d9d02b7e6a8_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseBorrowings_label_en-US" xlink:label="lab_us-gaap_InterestExpenseBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Borrowings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseBorrowings" xlink:to="lab_us-gaap_InterestExpenseBorrowings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_24121fce-9e9d-4830-b26c-31f594f52027_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_f6194acc-295a-48e1-b78c-bc16acda45d3_negatedTerseLabel_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_label_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:label id="lab_holx_PaymentsUnderFinanceLeaseObligations_documentation_en-US" xlink:label="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments under finance lease obligations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations" xlink:href="holx-20221231.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsUnderFinanceLeaseObligations" xlink:to="lab_holx_PaymentsUnderFinanceLeaseObligations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_4bad6d4d-09e4-4b5e-8691-6e550c63b6d7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 299,485 and 298,533 shares issued, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ServiceRevenue_da966cf0-e89b-4a5a-9366-dc63af86f84e_terseLabel_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service and other</link:label>
    <link:label id="lab_holx_ServiceRevenue_label_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:label id="lab_holx_ServiceRevenue_documentation_en-US" xlink:label="lab_holx_ServiceRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Service Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue" xlink:href="holx-20221231.xsd#holx_ServiceRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ServiceRevenue" xlink:to="lab_holx_ServiceRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_1e94f6c7-6db3-4f96-9fc1-8525fb1c310d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_265670ab-4296-4895-a13b-0ae30b9f3ec7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionAcquireeDomain_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Acquiree [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:to="lab_us-gaap_BusinessAcquisitionAcquireeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_3948580d-82f3-4ca3-829d-29b3311ff948_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provisions</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Increase for Warranties Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:to="lab_us-gaap_ProductWarrantyAccrualWarrantiesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_62b99c40-3ee6-44b6-b4d6-35634acb5eed_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_b34e55ad-ec84-4089-abae-faa31980baaa_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_label_en-US" xlink:label="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock, Shares Issued Net of Shares for Tax Withholdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:to="lab_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_b616e3e6-8788-4c5b-b236-e45ee5f5d372_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_AsiaPacificMember_edafa74e-840b-4c3e-9d06-8331b41b1635_terseLabel_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific</link:label>
    <link:label id="lab_srt_AsiaPacificMember_label_en-US" xlink:label="lab_srt_AsiaPacificMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_AsiaPacificMember" xlink:to="lab_srt_AsiaPacificMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ae611ddd-570c-46d9-bb4f-336021ab0f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrealized Loss Recognized in AOCI</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_6096ab61-ec3a-46fd-ad96-4e0f3c4daa47_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Assets and Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_d17888ef-56c4-4d2c-bd3b-c397b78334da_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranties</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:to="lab_us-gaap_ProductWarrantyDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_a7fa6d6a-12ff-4f58-a039-3e3d57fd349d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_44953c26-f1b4-40b9-ad43-6aeedca45d9b_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_459648f5-b490-44cf-9982-3cc1aae4dc78_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5933e3fa-3bea-4ff6-b7bc-c1e036427128_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherTypeofRevenueMember_f58f6b66-1ae1-4d86-a7a1-084488f55893_terseLabel_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_label_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:label id="lab_holx_OtherTypeofRevenueMember_documentation_en-US" xlink:label="lab_holx_OtherTypeofRevenueMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Type of Revenue [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember" xlink:href="holx-20221231.xsd#holx_OtherTypeofRevenueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherTypeofRevenueMember" xlink:to="lab_holx_OtherTypeofRevenueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_bc159840-d9ea-43ba-bdd3-d88745099051_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_e708142e-3d87-4973-b367-00acb4b05c7f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_44070767-feba-4dbc-8c91-ba60734d4082_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forward foreign currency contracts</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_8dd4508d-a5eb-46f6-88c1-cb2c98857109_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_13c55733-afde-4514-b0cf-61614b620dde_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contingent consideration recorded at acquisition</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ec4ba8e8-c121-4de7-a11a-826014270561_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_NotationalAmount_84bb6cb4-807d-4d26-8ade-21a8fcf4cb4d_terseLabel_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_label_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:label id="lab_holx_NotationalAmount_documentation_en-US" xlink:label="lab_holx_NotationalAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notational Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount" xlink:href="holx-20221231.xsd#holx_NotationalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_NotationalAmount" xlink:to="lab_holx_NotationalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_d803f019-196b-40a0-a59a-7062dff41188_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_696a8522-9c00-4ae8-87a3-8fa52abeeab2_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_5541974b-86e3-4522-9420-a52bc4be7b0e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_e319d687-473f-4c02-9c84-21023efc8200_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_7d3f03bf-468f-4302-ae20-6c1a440609d0_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes, face amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_ca5312a8-3621-475d-9eb3-24b838d9f669_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeAxis_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeAxis" xlink:to="lab_us-gaap_InvestmentTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_5494e66a-2b27-4183-a380-76c80c299030_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Petitions filed</link:label>
    <link:label id="lab_us-gaap_LossContingencyNewClaimsFiledNumber_label_en-US" xlink:label="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingency, New Claims Filed, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:to="lab_us-gaap_LossContingencyNewClaimsFiledNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_e2c856ac-b790-425c-9b59-4954e72da8a2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income activity</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_12d26a34-3c7b-4135-8a31-85eb9781fd8f_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_daa4afd9-f91d-4262-9cb6-cb2fab31b0dd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ConsumablesMember_bd233fcf-2dc4-4088-9405-6582bd517dc3_terseLabel_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disposables</link:label>
    <link:label id="lab_holx_ConsumablesMember_label_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:label id="lab_holx_ConsumablesMember_documentation_en-US" xlink:label="lab_holx_ConsumablesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember" xlink:href="holx-20221231.xsd#holx_ConsumablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ConsumablesMember" xlink:to="lab_holx_ConsumablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_84edf66a-79e8-498e-a42b-e9543e1cc039_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock pursuant to employee stock plans</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_45346953-0536-471d-b5c4-33b8d92425a7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_2c0511e1-cb7b-4483-af82-67ac793b2624_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8bb93a99-7c71-4bb4-8fb3-d02fc4941b40_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_4f78d3d1-851f-457b-8334-95f7c3d84ddc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred income taxes, net</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_8c12fcc0-9d05-493a-b4c9-c46b5a2247ba_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_a24cbcff-c537-4a22-a8bc-bdcde2267642_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid income taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_938a6f36-2434-4374-91d5-e9a85cc311ea_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_GynSurgicalMember_51086840-6321-47f5-8198-8323f06a10a1_terseLabel_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN Surgical</link:label>
    <link:label id="lab_holx_GynSurgicalMember_label_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gyn Surgical [Member]</link:label>
    <link:label id="lab_holx_GynSurgicalMember_documentation_en-US" xlink:label="lab_holx_GynSurgicalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">GYN surgical.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember" xlink:href="holx-20221231.xsd#holx_GynSurgicalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_GynSurgicalMember" xlink:to="lab_holx_GynSurgicalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromProductiveAssets_06d6d1f4-c439-40c4-a169-22b2e50be630_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital expenditures</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromProductiveAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments for (Proceeds from) Productive Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:to="lab_us-gaap_PaymentsForProceedsFromProductiveAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_4b4500d1-0849-4cd9-af8f-d2c42f687829_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued under the employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_339e88db-0a66-490d-9641-8f94b3dbae5d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTable_f75e5b67-ccc6-42f3-ac97-27998c1c804e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:label id="lab_us-gaap_DerivativeTable_label_en-US" xlink:label="lab_us-gaap_DerivativeTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTable" xlink:to="lab_us-gaap_DerivativeTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_4c7783cb-08ba-4929-87bb-24e1e2315d4e_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss) [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ea8910ef-de32-467e-b7b7-f622bbd86afb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation, stock options outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_75c5e454-eb7d-4df0-a371-1b2e74b04c88_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2d89fa86-f4ae-4dfb-b605-a743e5c78bdd_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_34b1b5d5-08ba-4db6-95b3-d85b91a27f34_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b6cb602d-f7ca-4982-bfa1-efd9fc3abd72_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_7afdb221-cedb-4a3a-9feb-3cafe03d8d06_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAmortizationAndAccretionNet_label_en-US" xlink:label="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Amortization and Accretion, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:to="lab_us-gaap_DepreciationAmortizationAndAccretionNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_a79ff4fe-3db3-4a62-b972-79f4c30151af_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of long-term debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfLongTermDebt" xlink:to="lab_us-gaap_RepaymentsOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_da42a72e-3836-427f-8760-a8107f89f4da_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Estimated Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_408f45b5-4af1-4f00-b511-8ee0ab229bd3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value adjustments</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_075240d1-1a4b-480d-be71-a8368b843f6e_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option plans</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_d07bf3f6-8075-4b47-8e01-eb519ddd0274_terseLabel_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and marketing</link:label>
    <link:label id="lab_us-gaap_SellingAndMarketingExpenseMember_label_en-US" xlink:label="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling and Marketing Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingAndMarketingExpenseMember" xlink:to="lab_us-gaap_SellingAndMarketingExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_8755298b-8154-4814-8c3a-1709d6f1b77a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, at cost &#8211; 52,940 and 51,401 shares, respectively</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_ebe4b64c-a7e8-460f-b0db-35da5e1295d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at Beginning of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_2f0444b2-213e-4282-842c-0c2d1b1c2e14_periodEndLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance&#160;at End of Period</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_151f1b9c-6013-474e-b051-b7ecab45cd73_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_1fd78da0-0e69-4a11-941c-9a98b0853144_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total debt obligations</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_a390efbf-6fb6-489c-a6e5-ea3050b1a759_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_9ab32692-aaa6-437c-b122-c0ff1813ed56_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_70321a64-6d27-401a-8faf-09ab91bef6ad_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure</link:label>
    <link:label id="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring and Related Activities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:to="lab_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_a6737658-8911-4341-9948-5a418d526ec9_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_4768f30b-15ee-4255-ba6a-a89d7590dcb6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:to="lab_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_52e7adfa-d5bf-4fee-8cbb-80cd4ce16cf6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_a4093c73-b47b-49c4-a3c4-af0f31b4cf4a_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_11c70e41-38aa-4c8c-b9df-14a6007e7e20_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_b2861070-b7b3-4bfb-898a-4ad1b7eed540_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_07938603-fe23-4d40-91e5-21abeefac12d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues by Geography</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:to="lab_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_f4c34527-1108-495e-b75f-610dc3a25fc2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions, by Acquisition [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_e95e90c6-e37d-4fcb-bd21-807211685cad_terseLabel_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding Stock Options and stock units</link:label>
    <link:label id="lab_us-gaap_StockCompensationPlanMember_label_en-US" xlink:label="lab_us-gaap_StockCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockCompensationPlanMember" xlink:to="lab_us-gaap_StockCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_ef0cb046-1a1b-4ff5-9c45-38200931b575_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_7a0d8a67-e5e3-450f-863a-93ddee40b31f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative instruments designated as a cash flow hedge</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_3abe20c1-42fb-4182-8b02-f6c92149b8e3_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_65696db3-d677-430d-b224-2b8f08004e38_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_7e83733d-bb17-47e6-b955-18fb4ceee565_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_f5971912-b95a-463a-8e4a-9c3482524661_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotes_eaffbb5e-24f8-4ed4-b422-3fc2cd683cac_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotes_label_en-US" xlink:label="lab_us-gaap_SeniorNotes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Senior Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotes" xlink:to="lab_us-gaap_SeniorNotes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenuesAbstract_e58c83e4-1edd-473b-8843-f67c361aa087_terseLabel_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues:</link:label>
    <link:label id="lab_us-gaap_RevenuesAbstract_label_en-US" xlink:label="lab_us-gaap_RevenuesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenuesAbstract" xlink:to="lab_us-gaap_RevenuesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_fa5843d3-57a7-46fb-b4fa-dee331a954c6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_731bd18a-1eea-4a46-a496-9ba440d96884_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_MinervaMember_50110463-9854-4f07-ba83-24ddcac51d20_terseLabel_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva</link:label>
    <link:label id="lab_holx_MinervaMember_label_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:label id="lab_holx_MinervaMember_documentation_en-US" xlink:label="lab_holx_MinervaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minerva [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember" xlink:href="holx-20221231.xsd#holx_MinervaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_MinervaMember" xlink:to="lab_holx_MinervaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_c3f8d0ea-846c-4121-a8bd-058530a90088_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_ca680fd7-9269-4497-9fdc-74d22e4ec05a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_f991d54a-6fc9-45ab-b173-be411534e3f8_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_898ca2f1-f2f9-403b-901c-10cd6dffcc02_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_1a7320ad-7938-4c9b-ab75-c0c856572e21_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_a4e67bc7-9d4c-470c-a814-170d3f13d17c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_28411f16-706b-4c56-96b3-3d48d3a8ab20_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, off-Balance-Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_a6b8e482-5c70-4b2a-851f-69966d1c75ce_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Segments and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Land_92026d16-4031-4db0-b68d-4d4ec6c2c454_terseLabel_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_Land_label_en-US" xlink:label="lab_us-gaap_Land" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Land" xlink:to="lab_us-gaap_Land" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_2c325650-6719-4158-b7c7-e6b30b71c7d6_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_6157912f-d10c-4568-bf57-881b3846d0a5_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_a0f47c0c-8e2d-494f-8673-ba1cc03f8937_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount of realized gain (loss) recognized in income</link:label>
    <link:label id="lab_us-gaap_DerivativeGainLossOnDerivativeNet_label_en-US" xlink:label="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Gain (Loss) on Derivative, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:to="lab_us-gaap_DerivativeGainLossOnDerivativeNet" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RestofWorldMember_85b250ef-8e3c-42c2-a422-33ce4c4e3f97_terseLabel_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_RestofWorldMember_label_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:label id="lab_holx_RestofWorldMember_documentation_en-US" xlink:label="lab_holx_RestofWorldMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember" xlink:href="holx-20221231.xsd#holx_RestofWorldMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RestofWorldMember" xlink:to="lab_holx_RestofWorldMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_d04f62ee-aac5-4bb4-942f-dcd1e1e33fa3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c05d6128-c682-4ddb-811d-429387e31edb_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise prices (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_InternationalMember_1dd32f58-dd60-4b28-9bbd-fba0d88c9632_terseLabel_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International</link:label>
    <link:label id="lab_holx_InternationalMember_label_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:label id="lab_holx_InternationalMember_documentation_en-US" xlink:label="lab_holx_InternationalMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">International [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember" xlink:href="holx-20221231.xsd#holx_InternationalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_InternationalMember" xlink:to="lab_holx_InternationalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_bb28aaf5-9683-4a4b-b5ea-18734cdd6645_terseLabel_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income (loss) before reclassifications</link:label>
    <link:label id="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OCI, before Reclassifications, before Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:to="lab_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_8d39bbfb-d9a6-49e4-bea9-770818975fb0_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average number of shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_4585ff2f-7670-41a1-a9e9-f2e91bee9fd8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_308c6b3e-9bd3-4990-8276-b2fe185fd683_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_ce35f8ae-9a44-4e0d-a565-81b1571b2e6c_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCharges_a5c85a01-9f0a-49ae-8e6c-68e3b1c11455_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring charges</link:label>
    <link:label id="lab_us-gaap_RestructuringCharges_label_en-US" xlink:label="lab_us-gaap_RestructuringCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCharges" xlink:to="lab_us-gaap_RestructuringCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_af30954d-2df3-479f-bdc8-de95a70614ff_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AllOtherCountriesMember_effd0aed-a292-4409-8800-72a4eb3fd466_terseLabel_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rest of World</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_label_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All Other Countries [Member]</link:label>
    <link:label id="lab_holx_AllOtherCountriesMember_documentation_en-US" xlink:label="lab_holx_AllOtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">All other countries.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember" xlink:href="holx-20221231.xsd#holx_AllOtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AllOtherCountriesMember" xlink:to="lab_holx_AllOtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c3af3b6b-a6c7-4c1c-b49c-837d237c7582_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_5c6518ce-8c26-4046-a35d-3f30afb48d03_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_dbc90c08-93bc-48dd-b6b7-9a689fce7960_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic weighted average common shares outstanding</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_9a28f251-6111-4139-b77c-eb80b783af6b_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_96f4bb0d-9d72-42d2-927f-2497a7332183_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Fair Value Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:to="lab_us-gaap_LiabilitiesFairValueDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_26249124-82c2-4fb2-bcc1-13799d716108_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_7e6d9f03-dfc9-450e-8903-19bcc576909c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average exercise price of options outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_eb0a15ab-c59a-46a4-bdc1-658c19ca9a0e_terseLabel_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets useful life</link:label>
    <link:label id="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_label_en-US" xlink:label="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:to="lab_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_9150c7e9-0279-4e7f-8ddf-2ec8832a1659_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative notional amount</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_290f69fd-011d-410f-b66b-eeac0913a5fb_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:to="lab_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_a8dc6bd4-9282-4702-8ad4-c75998de51f0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_ProductRevenue_8ebf0fb1-1d49-44c9-b4cd-9f287acb695d_terseLabel_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product</link:label>
    <link:label id="lab_holx_ProductRevenue_label_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:label id="lab_holx_ProductRevenue_documentation_en-US" xlink:label="lab_holx_ProductRevenue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue" xlink:href="holx-20221231.xsd#holx_ProductRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_ProductRevenue" xlink:to="lab_holx_ProductRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_5470f043-391b-4d94-b59d-05805ad74f71_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Company's Borrowings</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_9b99ca94-d1a5-48fa-b138-6f6d391e4aca_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpenseMember_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RSUPSUMSUMember_5038d8c3-e431-4f4f-b939-52205f5f4b01_terseLabel_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_label_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:label id="lab_holx_RSUPSUMSUMember_documentation_en-US" xlink:label="lab_holx_RSUPSUMSUMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSU, PSU, MSU [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember" xlink:href="holx-20221231.xsd#holx_RSUPSUMSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RSUPSUMSUMember" xlink:to="lab_holx_RSUPSUMSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_6be1b3aa-f928-40d9-a94a-cd4c41e79ab0_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationship</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_bab47725-92df-45c9-9093-0fc89753637f_terseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfOtherDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfOtherDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Other Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfOtherDebt" xlink:to="lab_us-gaap_RepaymentsOfOtherDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_c2f2fe60-7ed7-4fa9-8389-95c04be7039c_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_ecdab72e-e8eb-4914-9014-3de1fea1780f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_TermLoanMember_772d4b3c-d5c7-4414-af77-e478f60d88ae_terseLabel_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan</link:label>
    <link:label id="lab_holx_TermLoanMember_label_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:label id="lab_holx_TermLoanMember_documentation_en-US" xlink:label="lab_holx_TermLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term Loan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember" xlink:href="holx-20221231.xsd#holx_TermLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_TermLoanMember" xlink:to="lab_holx_TermLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_ad098f9b-9bfc-43cb-9900-f63cfc438a8e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Unobservable Inputs&#160;(Level&#160;3)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_d4d63112-f1dc-4542-a4ac-1ac641d431ce_terseLabel_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract_documentation_en-US" xlink:label="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:href="holx-20221231.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:to="lab_holx_AccumulatedOtherComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_67221bf9-0999-48cf-873c-6746803c1570_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-Based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_8fb1ebca-643b-4d21-89db-6911f504a415_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_d3937104-ce59-4aa2-86df-657c6c6d0f9b_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationsAbstract_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combinations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationsAbstract" xlink:to="lab_us-gaap_BusinessCombinationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_c0f7fba9-80fe-4637-b04f-653ad6c87c67_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_0bb64e0f-1826-4a55-a1a7-0f05ae548db3_terseLabel_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_label_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:label id="lab_holx_DepartmentOfDefenseFundsReceived_documentation_en-US" xlink:label="lab_holx_DepartmentOfDefenseFundsReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Department of defense funds received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived" xlink:href="holx-20221231.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_DepartmentOfDefenseFundsReceived" xlink:to="lab_holx_DepartmentOfDefenseFundsReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_43dc89eb-3198-42c7-a5ea-a13b32f60a35_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateMember_7d6ed961-59a0-4355-afb8-4ae734e5d3d0_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate</link:label>
    <link:label id="lab_us-gaap_CorporateMember_label_en-US" xlink:label="lab_us-gaap_CorporateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Corporate Segment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateMember" xlink:to="lab_us-gaap_CorporateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_9d0141a8-c43d-48f8-9acb-c04fa29954e5_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:label id="lab_us-gaap_InvestmentTypeCategorizationMember_label_en-US" xlink:label="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember" xlink:to="lab_us-gaap_InvestmentTypeCategorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_bb4ae7df-40e2-4900-a676-c7461c9b99d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_a5a33722-7ae1-41b6-8e84-eb83a475aa82_terseLabel_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:label id="lab_us-gaap_LossOnSaleOfInvestments_label_en-US" xlink:label="lab_us-gaap_LossOnSaleOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on Sale of Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnSaleOfInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnSaleOfInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossOnSaleOfInvestments" xlink:to="lab_us-gaap_LossOnSaleOfInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_e25afe0b-e570-460b-8566-72247354aaef_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_c1734ab2-c4f1-4297-b85e-e4d665dde993_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_78ce56e7-b7b2-4de4-a3ef-9d5ce8b51dea_terseLabel_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:label id="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_label_en-US" xlink:label="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Repurchase Program, Remaining Authorized Repurchase Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:to="lab_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_62e67a18-9047-4296-962b-50c98a852ae3_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NondesignatedMember_02e273e3-6653-4b39-80ab-a553f0467190_terseLabel_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives not designated as hedging instruments</link:label>
    <link:label id="lab_us-gaap_NondesignatedMember_label_en-US" xlink:label="lab_us-gaap_NondesignatedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Not Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NondesignatedMember" xlink:to="lab_us-gaap_NondesignatedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_d949e022-0501-4a93-9734-21e50eda4f98_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Acquisition of businesses, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8e0ad0c9-5f44-48a4-8916-645a457726e2_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Other Observable Inputs&#160;(Level&#160;2)</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_e2dd4a99-1450-4208-9e55-a7c627e12e06_terseLabel_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments</link:label>
    <link:label id="lab_us-gaap_EquityMethodInvestmentsMember_label_en-US" xlink:label="lab_us-gaap_EquityMethodInvestmentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Method Investments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityMethodInvestmentsMember" xlink:to="lab_us-gaap_EquityMethodInvestmentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_dde9c237-7fad-45f2-a0a6-d72a54126b65_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_RevolverMember_e13b66ad-8210-4050-a692-09be5353a908_terseLabel_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver</link:label>
    <link:label id="lab_holx_RevolverMember_label_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:label id="lab_holx_RevolverMember_documentation_en-US" xlink:label="lab_holx_RevolverMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revolver [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember" xlink:href="holx-20221231.xsd#holx_RevolverMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_RevolverMember" xlink:to="lab_holx_RevolverMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_b7eee538-f645-4a43-920c-0f8ffa9f1deb_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b7b18fa4-7369-4252-884a-9a7eb464ff63_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_97ed725a-5e45-47aa-86ea-f39de62b1450_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Diluted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_Netincome_cc346c5e-9f11-4b17-9bf2-effe6e21935b_terseLabel_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_label_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_holx_Netincome_documentation_en-US" xlink:label="lab_holx_Netincome" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net income attributable to Hologic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome" xlink:href="holx-20221231.xsd#holx_Netincome"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_Netincome" xlink:to="lab_holx_Netincome" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_4afa4cfd-911e-4f3d-938b-1e2f5929a5eb_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ConsolidationItemsAxis_49d8d496-42b3-40e9-bb28-48146187c8c8_terseLabel_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:label id="lab_srt_ConsolidationItemsAxis_label_en-US" xlink:label="lab_srt_ConsolidationItemsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation Items [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ConsolidationItemsAxis" xlink:to="lab_srt_ConsolidationItemsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_d75776d2-514d-4c14-8615-341d62b2236a_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_5ee695a6-2a32-4163-ad3a-9b54b002128d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_SharerepurchaseplanTable_02204f5b-c7e8-4b38-84c1-29ec4625c386_terseLabel_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_label_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:label id="lab_holx_SharerepurchaseplanTable_documentation_en-US" xlink:label="lab_holx_SharerepurchaseplanTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">share repurchase plan [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable" xlink:href="holx-20221231.xsd#holx_SharerepurchaseplanTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_SharerepurchaseplanTable" xlink:to="lab_holx_SharerepurchaseplanTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_fca3535c-5627-4c08-87df-1c33b5ae8f02_terseLabel_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</link:label>
    <link:label id="lab_us-gaap_RestructuringCostAndReserveLineItems_label_en-US" xlink:label="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restructuring Cost and Reserve [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems" xlink:to="lab_us-gaap_RestructuringCostAndReserveLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_06ac9dbc-da3c-4eab-a579-1b9ed9fa39c7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis" xlink:to="lab_us-gaap_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_790f53bb-b1f5-4763-b952-9f6748747d99_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_1d9b8a38-759d-4f20-81b8-dffcb8adf22d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesAndFairValueTextBlock_label_en-US" xlink:label="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives and Fair Value [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesAndFairValueTextBlock" xlink:to="lab_us-gaap_DerivativesAndFairValueTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_d4380390-eb13-4207-856e-7fa99b021d0b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:label id="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_label_en-US" xlink:label="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:to="lab_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_31d480c0-5e2b-49f1-a76c-503ac14da519_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Derivative Assets at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_4949d552-5645-4d38-a8f9-d2911513de2d_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of acquired intangible assets</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_334b622c-de31-4b1b-86ee-a355d1f158fa_terseLabel_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in foreign currency translation adjustment</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_label_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:label id="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_documentation_en-US" xlink:label="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:href="holx-20221231.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:to="lab_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_7add9322-3d7f-4eff-84b0-150081a1b516_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative asset</link:label>
    <link:label id="lab_us-gaap_DerivativeFairValueOfDerivativeAsset_label_en-US" xlink:label="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Asset, Subject to Master Netting Arrangement, before Offset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:to="lab_us-gaap_DerivativeFairValueOfDerivativeAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_4fe79c8d-bd49-456e-a130-0343ede8fdfc_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_7a5b9422-dce2-4993-bc29-5851a136edb6_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_28bdb76f-6bcf-4a82-8ed0-cccbfef6c59b_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_5b767525-88bb-4cad-9db5-f7f6de7f312c_verboseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:to="lab_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_e2310e61-e4bd-44f8-8f96-ccfff33bab51_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_d2c97693-7bb6-451b-833a-1958861592e5_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue, net of current portion</link:label>
    <link:label id="lab_us-gaap_DeferredRevenueNoncurrent_label_en-US" xlink:label="lab_us-gaap_DeferredRevenueNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Revenue, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredRevenueNoncurrent" xlink:to="lab_us-gaap_DeferredRevenueNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_7e5cf536-cf6e-46a5-bb5d-e804bdd6f144_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_f591610e-5297-44f7-961d-599234a0cb91_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Instruments and Hedging Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_519dfcc9-80bb-4b6d-bc2c-adb8516de489_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_d11a7bba-ac5d-4e11-b06f-3b01d055685e_verboseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_ee231a46-1504-477b-8109-7069a901142f_terseLabel_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_label_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:label id="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_documentation_en-US" xlink:label="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:to="lab_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_5a55ea3e-1362-48d6-b441-1369f88929b6_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable interest rate</link:label>
    <link:label id="lab_us-gaap_DerivativeVariableInterestRate_label_en-US" xlink:label="lab_us-gaap_DerivativeVariableInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative, Variable Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeVariableInterestRate" xlink:to="lab_us-gaap_DerivativeVariableInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_9e2259bd-f16e-491d-a7c9-011cf9002bea_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrantsReceivableCurrent_cba45cb3-7c73-421d-b72e-8ab4156f7500_terseLabel_en-US" xlink:label="lab_us-gaap_GrantsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants Receivable, Current</link:label>
    <link:label id="lab_us-gaap_GrantsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_GrantsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrantsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrantsReceivableCurrent" xlink:to="lab_us-gaap_GrantsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_e1fc2d17-9b4f-4168-a1a6-4b6da0e6c09b_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_54adb024-7279-4aa5-b23b-8128ef1a29b6_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_d387f2fc-c6ec-446e-9fb3-d242fdb32cf1_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_77dc1ed7-1dce-4950-b7dc-79d7fddc7137_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of Fiscal 2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_2d89feb1-5d42-41e3-871f-ff007cf54721_terseLabel_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_label_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:label id="lab_holx_PrepaidIncomeTaxesCurrent_documentation_en-US" xlink:label="lab_holx_PrepaidIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Income Taxes-Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent" xlink:href="holx-20221231.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PrepaidIncomeTaxesCurrent" xlink:to="lab_holx_PrepaidIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_448a465b-ed9e-4349-bc56-0da6fc7ab610_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:to="lab_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_0ce61ebb-9a59-4d60-996a-d082c2f67434_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_636a477f-fca7-4f85-94aa-a3ed5d6fd7a7_negatedLabel_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in equipment under customer usage agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_label_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments To Manufacture Equipment Under Customer Usage Agreements</link:label>
    <link:label id="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_documentation_en-US" xlink:label="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:href="holx-20221231.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:to="lab_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c01973b6-f844-4b0a-8129-d755987f3a8e_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_cad4302e-49a3-49dc-b961-904a71e022c4_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_holx_CapitalizedsoftwareMember_b7686c2f-2b5c-40cf-8961-76dd74de7457_terseLabel_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software embedded in products</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_label_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:label id="lab_holx_CapitalizedsoftwareMember_documentation_en-US" xlink:label="lab_holx_CapitalizedsoftwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember" xlink:href="holx-20221231.xsd#holx_CapitalizedsoftwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_holx_CapitalizedsoftwareMember" xlink:to="lab_holx_CapitalizedsoftwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_61196f57-d38f-4c12-9bfc-3219d35efb49_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_da002640-1290-4243-8423-0bacd403ee65_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_0a7bc925-e346-4b8c-b17d-1e2e7ec4ed35_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_20de7e9a-e86e-40a3-8048-c6654c7b5b1f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_efc0be4a-e961-4cac-b736-ce5ca2d85c93_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_7223d496-7083-4981-99cf-d506e61466d7_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration transferred</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationConsiderationTransferred1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Consideration Transferred</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:to="lab_us-gaap_BusinessCombinationConsiderationTransferred1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_7a72fafe-1a76-41d6-b910-6cf3e145c40e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_ef3651ce-0231-4724-a004-e5e48edbabe5_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_ed1347ec-cabe-46ec-b067-b4431f35c5ab_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Type of Adoption [Domain]</link:label>
    <link:label id="lab_us-gaap_TypeOfAdoptionMember_label_en-US" xlink:label="lab_us-gaap_TypeOfAdoptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfAdoptionMember" xlink:to="lab_us-gaap_TypeOfAdoptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6654a979-f909-4207-b251-f795a5ce241c_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_9b0981cf-517a-490e-92d8-4765b7931f87_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ASSETS</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e32772c6-a82a-4764-88b0-54fa56d6a148_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_088d2701-4f60-4c21-989f-5669d859c1de_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_8e3f63f2-ab7f-4694-a5b3-db9e73599f5b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_61947d0d-31af-4048-a011-0ac1bf8db113_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1edc42e9-c4c6-4bd5-9b6b-26d5c59aa05d_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_20c18f24-437b-42b4-8ca4-4a3ecf2a4bdf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_4837c4b7-ba25-47e6-80bd-7f6552344574_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value of options granted</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_beb5874d-8b63-45e7-802d-0cbc0a33a38f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9cc7c3df-55fc-4744-b33f-d22ce452addd_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_20346df9-6b4e-4e05-a51d-80573a98a01d_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_8cfa5b53-a3c0-43a6-953c-9ac895f277af_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fiscal 2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_44fca972-2ff9-4312-8739-5df62599dcc6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Basic and Diluted Share Amounts</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_ee70a7f9-8d73-4e96-b861-76b32797d2e6_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate at end of period</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Interest Rate at Period End</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:to="lab_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_a370ade2-195b-4e8f-883a-d5e54491719a_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenues</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>holx-20221231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:3332a847-8252-4aec-a26a-afc1f11215d8,g:d9a9812f-c6f0-4dfd-b7fb-8eca4022aaf1-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.hologic.com/role/CoverPage" xlink:type="simple" xlink:href="holx-20221231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_b076e0a0-1f28-4e3f-a15b-ebaf70dbd8fb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_Security12bTitle_b076e0a0-1f28-4e3f-a15b-ebaf70dbd8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_75ebc7a4-f49e-4fac-90d6-a697a5b756db" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_DocumentTransitionReport_75ebc7a4-f49e-4fac-90d6-a697a5b756db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_d00c39bc-b2d6-413b-8581-873277dd60a1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_DocumentQuarterlyReport_d00c39bc-b2d6-413b-8581-873277dd60a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a9d2e85d-9ec3-4b5d-bc71-6252d0ab7449" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a9d2e85d-9ec3-4b5d-bc71-6252d0ab7449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_f7b35445-c84b-4139-b6db-1c6b876d770b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityAddressPostalZipCode_f7b35445-c84b-4139-b6db-1c6b876d770b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_ada6d261-aadb-4d6b-919e-56bacdd02b97" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityFileNumber_ada6d261-aadb-4d6b-919e-56bacdd02b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_52a1711c-81e2-4496-846a-9e2bbf4929de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_DocumentType_52a1711c-81e2-4496-846a-9e2bbf4929de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_e76eaeee-3402-4f3d-9c18-4911e42d499e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_AmendmentFlag_e76eaeee-3402-4f3d-9c18-4911e42d499e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_3fa0271a-5d76-44c7-9900-7f7db876b3ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_DocumentPeriodEndDate_3fa0271a-5d76-44c7-9900-7f7db876b3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_d5cdac7d-5e96-4ed2-97f4-6c6bb956746f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_DocumentFiscalYearFocus_d5cdac7d-5e96-4ed2-97f4-6c6bb956746f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_49380db1-41d2-42e1-a60a-6df125342922" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_DocumentFiscalPeriodFocus_49380db1-41d2-42e1-a60a-6df125342922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_d8f18abd-04fc-430c-b6dc-b08ef8ebe931" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityRegistrantName_d8f18abd-04fc-430c-b6dc-b08ef8ebe931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9df348e1-d94c-43d0-b8e5-f9326e8cd8dc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityCentralIndexKey_9df348e1-d94c-43d0-b8e5-f9326e8cd8dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_43adb212-ec19-493f-9ab3-800ae4dc91fd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_CurrentFiscalYearEndDate_43adb212-ec19-493f-9ab3-800ae4dc91fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_fcd1e7b2-2049-41a0-bd62-12ece3e4cb1c" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityFilerCategory_fcd1e7b2-2049-41a0-bd62-12ece3e4cb1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_3ff54e64-5823-45b9-a773-2d014b51ca40" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityEmergingGrowthCompany_3ff54e64-5823-45b9-a773-2d014b51ca40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_31bc8191-0895-4ce0-9e54-73c8ed12fd51" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntitySmallBusiness_31bc8191-0895-4ce0-9e54-73c8ed12fd51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_e78b5f72-6044-4016-90cf-34ce29ce5d8b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_e78b5f72-6044-4016-90cf-34ce29ce5d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_a1aab2cb-f5a1-405a-a48d-2a5bdb142b45" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityShellCompany_a1aab2cb-f5a1-405a-a48d-2a5bdb142b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_4908396e-a6c5-4fdc-9a9d-733e3fb9c95f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityCurrentReportingStatus_4908396e-a6c5-4fdc-9a9d-733e3fb9c95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_9b75b2dc-dbfd-4a1d-990c-5e81e1d91c78" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityInteractiveDataCurrent_9b75b2dc-dbfd-4a1d-990c-5e81e1d91c78" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_7bb4927c-0289-453b-ab7f-2dce23f5bec5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_CityAreaCode_7bb4927c-0289-453b-ab7f-2dce23f5bec5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_784eeb21-c0bd-455c-88d1-181ecc890d46" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_LocalPhoneNumber_784eeb21-c0bd-455c-88d1-181ecc890d46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_3436b962-2978-454d-9a8b-d86150a074de" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityTaxIdentificationNumber_3436b962-2978-454d-9a8b-d86150a074de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_be5c407a-0b1b-474e-aded-de83dafa92ed" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityAddressAddressLine1_be5c407a-0b1b-474e-aded-de83dafa92ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_13c5975f-b3cd-486d-baa4-ab1bf6ee5ed9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityAddressCityOrTown_13c5975f-b3cd-486d-baa4-ab1bf6ee5ed9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_267f041e-1f16-493f-a8b5-fcbdd76fb5cf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_EntityAddressStateOrProvince_267f041e-1f16-493f-a8b5-fcbdd76fb5cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_a7717b6d-aad4-47f0-96a6-5d09232deb2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_TradingSymbol_a7717b6d-aad4-47f0-96a6-5d09232deb2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_2bd9659b-9ab5-4a50-85d2-dae5aadc9cc8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_d8dd21c0-5df7-46cc-96fb-fa27cd3ca23d" xlink:to="loc_dei_SecurityExchangeName_2bd9659b-9ab5-4a50-85d2-dae5aadc9cc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofIncome"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_4845082e-8a27-4e39-b67f-ef14cbe82f96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenuesAbstract_be9086f9-67b1-4670-be5c-b551c5415a16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenuesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4845082e-8a27-4e39-b67f-ef14cbe82f96" xlink:to="loc_us-gaap_RevenuesAbstract_be9086f9-67b1-4670-be5c-b551c5415a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProductRevenue_857ca47b-356e-462c-8976-3728129439f1" xlink:href="holx-20221231.xsd#holx_ProductRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_be9086f9-67b1-4670-be5c-b551c5415a16" xlink:to="loc_holx_ProductRevenue_857ca47b-356e-462c-8976-3728129439f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ServiceRevenue_ce9c19a4-72a6-4096-90ba-906976529c18" xlink:href="holx-20221231.xsd#holx_ServiceRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_be9086f9-67b1-4670-be5c-b551c5415a16" xlink:to="loc_holx_ServiceRevenue_ce9c19a4-72a6-4096-90ba-906976529c18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_20e22fd7-1db6-4be8-8a42-72c92258ca73" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenuesAbstract_be9086f9-67b1-4670-be5c-b551c5415a16" xlink:to="loc_us-gaap_Revenues_20e22fd7-1db6-4be8-8a42-72c92258ca73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenueAbstract_83e9d4f3-b924-4e12-b9e3-73a3374b1296" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4845082e-8a27-4e39-b67f-ef14cbe82f96" xlink:to="loc_us-gaap_CostOfRevenueAbstract_83e9d4f3-b924-4e12-b9e3-73a3374b1296" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_2e158393-ae2c-4074-9661-3810879758ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_83e9d4f3-b924-4e12-b9e3-73a3374b1296" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_2e158393-ae2c-4074-9661-3810879758ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmortizationCostofGoodsSold_914a48e9-dcd5-4f47-930b-47fc88ecf6b4" xlink:href="holx-20221231.xsd#holx_AmortizationCostofGoodsSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_83e9d4f3-b924-4e12-b9e3-73a3374b1296" xlink:to="loc_holx_AmortizationCostofGoodsSold_914a48e9-dcd5-4f47-930b-47fc88ecf6b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Costofservice_9a4bec87-18d9-4307-84d9-2b2a1b8b5177" xlink:href="holx-20221231.xsd#holx_Costofservice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_83e9d4f3-b924-4e12-b9e3-73a3374b1296" xlink:to="loc_holx_Costofservice_9a4bec87-18d9-4307-84d9-2b2a1b8b5177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_67770b89-89ae-450c-9d57-9d5aaa2d81fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CostOfRevenueAbstract_83e9d4f3-b924-4e12-b9e3-73a3374b1296" xlink:to="loc_us-gaap_GrossProfit_67770b89-89ae-450c-9d57-9d5aaa2d81fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4845082e-8a27-4e39-b67f-ef14cbe82f96" xlink:to="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0896f225-f167-40c1-b46c-6760171e721f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0896f225-f167-40c1-b46c-6760171e721f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpense_7da0219a-d49a-41f1-afef-ae15f5929a46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_SellingAndMarketingExpense_7da0219a-d49a-41f1-afef-ae15f5929a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_ac1010c1-caa6-495a-b52e-17638ab61050" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_ac1010c1-caa6-495a-b52e-17638ab61050" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_cca9a2cf-41d3-4ab3-9a37-25fecb101456" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_cca9a2cf-41d3-4ab3-9a37-25fecb101456" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_40554077-329f-4fb1-8ab9-aeffbf6bcdc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1_40554077-329f-4fb1-8ab9-aeffbf6bcdc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_942f17fb-96c9-4f10-9b21-dd0173bf49ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_RestructuringCharges_942f17fb-96c9-4f10-9b21-dd0173bf49ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6ac6502a-9361-42f5-872a-e52046d16af9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_OperatingExpenses_6ac6502a-9361-42f5-872a-e52046d16af9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4d3f1ec5-ef48-4c18-ab26-3ba913c900c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_OperatingIncomeLoss_4d3f1ec5-ef48-4c18-ab26-3ba913c900c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_e8d8764c-9ef7-47be-ab1a-ac85f4488139" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_InvestmentIncomeInterest_e8d8764c-9ef7-47be-ab1a-ac85f4488139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_f5cc530e-08d5-4ced-85c5-759b513d2991" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_InterestExpense_f5cc530e-08d5-4ced-85c5-759b513d2991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2fddb102-299a-4ef3-82a7-1704971e2608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_2fddb102-299a-4ef3-82a7-1704971e2608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_aa643bac-9470-4429-abfd-611b35dd20d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_aa643bac-9470-4429-abfd-611b35dd20d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d020dde1-7eda-4a02-af3a-3ea579111b8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_d020dde1-7eda-4a02-af3a-3ea579111b8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5aa0f0c2-36b6-4ff2-aec6-4b5756a4934e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5aa0f0c2-36b6-4ff2-aec6-4b5756a4934e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_04cf2bc2-c819-42ba-9eec-44bce1828f89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_eeea1595-0782-455a-b7b7-f4a9c7ac9ef2" xlink:to="loc_us-gaap_NetIncomeLoss_04cf2bc2-c819-42ba-9eec-44bce1828f89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_ad2c8abd-758b-47bc-a483-75e48d9fc4db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4845082e-8a27-4e39-b67f-ef14cbe82f96" xlink:to="loc_us-gaap_EarningsPerShareAbstract_ad2c8abd-758b-47bc-a483-75e48d9fc4db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a7713ede-83f3-4508-bc01-7b079947e2c4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad2c8abd-758b-47bc-a483-75e48d9fc4db" xlink:to="loc_us-gaap_EarningsPerShareBasic_a7713ede-83f3-4508-bc01-7b079947e2c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_044c821b-56a4-4169-abc5-64319ace7f06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_ad2c8abd-758b-47bc-a483-75e48d9fc4db" xlink:to="loc_us-gaap_EarningsPerShareDiluted_044c821b-56a4-4169-abc5-64319ace7f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_84f984d2-cedd-44f4-ad81-4f5e392db107" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_4845082e-8a27-4e39-b67f-ef14cbe82f96" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_84f984d2-cedd-44f4-ad81-4f5e392db107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6c937ca7-e8bb-488b-9a46-f3ba7836e31c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_84f984d2-cedd-44f4-ad81-4f5e392db107" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_6c937ca7-e8bb-488b-9a46-f3ba7836e31c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72767865-692c-45bd-b785-7ba6dd8fc727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_84f984d2-cedd-44f4-ad81-4f5e392db107" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_72767865-692c-45bd-b785-7ba6dd8fc727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5828b4e8-e1c6-42cb-9d14-2eca62c3ac7b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_42a26799-c20b-492c-9975-8802dd83c002" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5828b4e8-e1c6-42cb-9d14-2eca62c3ac7b" xlink:to="loc_us-gaap_NetIncomeLoss_42a26799-c20b-492c-9975-8802dd83c002" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_5a406cd4-a3b9-4fbd-b56a-f7ef031db49c" xlink:href="holx-20221231.xsd#holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5828b4e8-e1c6-42cb-9d14-2eca62c3ac7b" xlink:to="loc_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI_5a406cd4-a3b9-4fbd-b56a-f7ef031db49c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_36ee18ac-2412-4409-ad31-6c92b89247ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5828b4e8-e1c6-42cb-9d14-2eca62c3ac7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax_36ee18ac-2412-4409-ad31-6c92b89247ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_82520ec5-876f-40d8-8545-a273f7d09630" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5828b4e8-e1c6-42cb-9d14-2eca62c3ac7b" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_82520ec5-876f-40d8-8545-a273f7d09630" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b58c96d-73c9-4d42-8be4-91c8e6f39c40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_5828b4e8-e1c6-42cb-9d14-2eca62c3ac7b" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_3b58c96d-73c9-4d42-8be4-91c8e6f39c40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofComprehensiveLossParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7ed21386-18c3-4bfc-a822-9ebe738080eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ec97bf9b-2aaf-49c3-a390-d1cd924e6079" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_7ed21386-18c3-4bfc-a822-9ebe738080eb" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax_ec97bf9b-2aaf-49c3-a390-d1cd924e6079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_bf3e660f-6fca-432b-a31d-d74adec94fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf3e660f-6fca-432b-a31d-d74adec94fb1" xlink:to="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:to="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac99ac2b-a7e6-435a-b260-001a7bd72c45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ac99ac2b-a7e6-435a-b260-001a7bd72c45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_2c7b6b99-8000-422f-b802-67dbfbadf749" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_2c7b6b99-8000-422f-b802-67dbfbadf749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_745aa4c8-5db9-4e6d-9755-81e8d7de7895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:to="loc_us-gaap_InventoryNet_745aa4c8-5db9-4e6d-9755-81e8d7de7895" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_facfd6e5-0c7d-4d3d-b126-b2389eef597c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_facfd6e5-0c7d-4d3d-b126-b2389eef597c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrepaidIncomeTaxesCurrent_3d342cbc-1515-4b81-a7b0-6cf03ffc26f3" xlink:href="holx-20221231.xsd#holx_PrepaidIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:to="loc_holx_PrepaidIncomeTaxesCurrent_3d342cbc-1515-4b81-a7b0-6cf03ffc26f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_cf406a9e-99c1-4591-891b-3aa2bbd9a5ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_d6c642ff-6b3e-41ab-b7c3-5eaad0de8270" xlink:to="loc_us-gaap_AssetsCurrent_cf406a9e-99c1-4591-891b-3aa2bbd9a5ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_def7213b-3c52-46a8-a58d-0e497f0144fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_def7213b-3c52-46a8-a58d-0e497f0144fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4eb422e4-f112-4c56-ba3e-b84a47b14341" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_4eb422e4-f112-4c56-ba3e-b84a47b14341" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_968e7e61-d13f-46e2-975c-9b5eb6207586" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:to="loc_us-gaap_Goodwill_968e7e61-d13f-46e2-975c-9b5eb6207586" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_43d3cb54-e023-4c48-91ef-49902149dc5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_43d3cb54-e023-4c48-91ef-49902149dc5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_6d573aff-313e-4348-988b-1bc7d4d834dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_1a2481fe-d897-45c9-81f1-29c3f4ba655e" xlink:to="loc_us-gaap_Assets_6d573aff-313e-4348-988b-1bc7d4d834dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_bf3e660f-6fca-432b-a31d-d74adec94fb1" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_6014660c-8b57-4999-bbe4-2aec73fb343e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:to="loc_us-gaap_LongTermDebtCurrent_6014660c-8b57-4999-bbe4-2aec73fb343e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_59147485-93f6-4f09-b6fb-b731cf0ef02d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:to="loc_us-gaap_AccountsPayableCurrent_59147485-93f6-4f09-b6fb-b731cf0ef02d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_469c761f-1f05-405b-a3e7-83961b0863cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_469c761f-1f05-405b-a3e7-83961b0863cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueCurrent_66cc49af-beb7-457a-a3d5-c5892f13dee5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:to="loc_us-gaap_DeferredRevenueCurrent_66cc49af-beb7-457a-a3d5-c5892f13dee5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_02efb062-b9b0-4c33-a903-922d35f954e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_02efb062-b9b0-4c33-a903-922d35f954e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d120e2ff-df84-4cd7-80c7-3a773e9d2dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_940d358b-e7b9-4631-82f9-6526bcfc3b89" xlink:to="loc_us-gaap_LiabilitiesCurrent_d120e2ff-df84-4cd7-80c7-3a773e9d2dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_57179e9f-8c3f-4e2d-ae09-213017fe4d5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_57179e9f-8c3f-4e2d-ae09-213017fe4d5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3bd76b43-bf6a-430c-a2d4-a2f920586dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_3bd76b43-bf6a-430c-a2d4-a2f920586dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_08e29185-d37a-439d-8ba0-8b4aad865d08" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_08e29185-d37a-439d-8ba0-8b4aad865d08" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredRevenueNoncurrent_a64afe5c-cf22-4c0a-a76c-3b9a25f7dcb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredRevenueNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_DeferredRevenueNoncurrent_a64afe5c-cf22-4c0a-a76c-3b9a25f7dcb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_72535c31-3f16-467d-b6b6-108cd563dce5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_72535c31-3f16-467d-b6b6-108cd563dce5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_cb69d9cc-bd5d-475a-b22e-e0742a7a8a72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_PreferredStockValue_cb69d9cc-bd5d-475a-b22e-e0742a7a8a72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_baf54df4-fcd6-4852-93e7-4ebcad401f79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_CommonStockValue_baf54df4-fcd6-4852-93e7-4ebcad401f79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_62103ffa-6056-4d89-afb9-2d4e8befebe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_AdditionalPaidInCapital_62103ffa-6056-4d89-afb9-2d4e8befebe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fb01f09e-ba10-4095-97b0-bb693889e97d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_fb01f09e-ba10-4095-97b0-bb693889e97d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_ed32307d-39c8-4600-bef9-6e7b0bac31d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_TreasuryStockValue_ed32307d-39c8-4600-bef9-6e7b0bac31d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7efd10b7-ee48-4a7f-9f08-08b9b5bd070a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_7efd10b7-ee48-4a7f-9f08-08b9b5bd070a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_f37bd9fc-84fc-4086-ba52-873e0a45a969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_170e1d94-1def-40cf-a90b-e413b883e9ab" xlink:to="loc_us-gaap_StockholdersEquity_f37bd9fc-84fc-4086-ba52-873e0a45a969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_a81d513c-9343-46c4-b429-071524690f97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_55c69831-5c7f-4913-87d2-143c77ce1e1c" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_a81d513c-9343-46c4-b429-071524690f97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8e4ad282-caca-4e7c-bd65-2f95bd02d25b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_8e4ad282-caca-4e7c-bd65-2f95bd02d25b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_36925411-8e8f-422c-9afb-6b62ed54ec50" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_36925411-8e8f-422c-9afb-6b62ed54ec50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ad4840a2-5580-4929-93ed-92e3d1fa4a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ad4840a2-5580-4929-93ed-92e3d1fa4a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_f10e9916-926c-4b8f-9806-6d2405ff4e94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_f10e9916-926c-4b8f-9806-6d2405ff4e94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_e40cddce-6c31-4949-a639-d1bcdbb9134f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_e40cddce-6c31-4949-a639-d1bcdbb9134f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_6ba2ed01-1c06-41dc-9777-67bcbf6a45d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_CommonStockSharesIssued_6ba2ed01-1c06-41dc-9777-67bcbf6a45d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_c8814b03-08f6-4bed-949e-314c4b283ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_0edaa463-255a-419d-af1f-9a74f171e608" xlink:to="loc_us-gaap_TreasuryStockShares_c8814b03-08f6-4bed-949e-314c4b283ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_bf99e2fe-f41d-4769-b55f-09f9de73c3cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_bf99e2fe-f41d-4769-b55f-09f9de73c3cb" xlink:to="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_c2bfa072-ca10-43c2-b85d-868aaf72623a" xlink:to="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_6dbb084d-a056-40e8-872a-0b77be9dfb1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_CommonStockMember_6dbb084d-a056-40e8-872a-0b77be9dfb1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_311acf16-d0af-480c-a615-3f0eaf46eddc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_311acf16-d0af-480c-a615-3f0eaf46eddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cc3bf724-88bb-4eb8-a1f3-7d339452fe7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_RetainedEarningsMember_cc3bf724-88bb-4eb8-a1f3-7d339452fe7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b48a5704-5ae2-491c-bf5e-f1438f0a72fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_b48a5704-5ae2-491c-bf5e-f1438f0a72fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_f6e47d8f-2fed-4ed4-a21f-c51b546ed246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2260bdbe-a9c2-4a1a-a4be-8501a202faca" xlink:to="loc_us-gaap_TreasuryStockMember_f6e47d8f-2fed-4ed4-a21f-c51b546ed246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsForNewAccountingPronouncementsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfAdoptionMember_37abc044-cca2-4ae4-9dfb-ce77862a5127" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TypeOfAdoptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsForNewAccountingPronouncementsAxis_c596def1-a00e-4556-8427-6aa1e1127f30" xlink:to="loc_us-gaap_TypeOfAdoptionMember_37abc044-cca2-4ae4-9dfb-ce77862a5127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_16e1783c-42af-456e-bcb0-223a9fa2f041" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_7a445dae-0752-47b0-a525-a3ee3ada646c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_16e1783c-42af-456e-bcb0-223a9fa2f041" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_a35b6961-67d0-4244-a66a-31e4905a971c" xlink:href="holx-20221231.xsd#holx_September222022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_16e1783c-42af-456e-bcb0-223a9fa2f041" xlink:to="loc_holx_September222022Member_a35b6961-67d0-4244-a66a-31e4905a971c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_75c35ff5-9301-4760-b8ac-c5ec96601fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_e52092e7-f24b-4be2-9006-969926eb9f95" xlink:to="loc_us-gaap_StatementLineItems_75c35ff5-9301-4760-b8ac-c5ec96601fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_75c35ff5-9301-4760-b8ac-c5ec96601fff" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_6f7b4c49-c64e-4121-86d5-dcec15e9a3e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_SharesIssued_6f7b4c49-c64e-4121-86d5-dcec15e9a3e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0a42fa83-6cda-4f06-91a4-0a5a48b21a7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockholdersEquity_0a42fa83-6cda-4f06-91a4-0a5a48b21a7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a19bd6de-b007-4851-a1c3-00ffb600045b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_a19bd6de-b007-4851-a1c3-00ffb600045b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c884dd8-703c-4b5a-bba7-39bf6f65d00d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3c884dd8-703c-4b5a-bba7-39bf6f65d00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_b05ad811-c120-43b7-bb72-aaf005f1ff72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings_b05ad811-c120-43b7-bb72-aaf005f1ff72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a4e0cb46-b013-4e17-ab12-fc22762c396d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings_a4e0cb46-b013-4e17-ab12-fc22762c396d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3c941e01-6df3-4fd6-a4ac-1395e25cd7d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_3c941e01-6df3-4fd6-a4ac-1395e25cd7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_94cd2b29-d327-4c4b-90e6-1aba0490fa9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_94cd2b29-d327-4c4b-90e6-1aba0490fa9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ce968c-3d55-4ad0-b6bb-c98d864d9eb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_c2ce968c-3d55-4ad0-b6bb-c98d864d9eb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9d3a32df-27c2-4154-ab1d-f5b1083e6d5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_NetIncomeLoss_9d3a32df-27c2-4154-ab1d-f5b1083e6d5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_642a37e4-0f32-42f3-8500-5d699bd67baf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTax_642a37e4-0f32-42f3-8500-5d699bd67baf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_4b450bbc-0a80-49ea-b6f9-121bf2cacfc6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_4b450bbc-0a80-49ea-b6f9-121bf2cacfc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Netincome_701f07cd-8464-4405-985e-d8ab1ee97342" xlink:href="holx-20221231.xsd#holx_Netincome"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_holx_Netincome_701f07cd-8464-4405-985e-d8ab1ee97342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e0c1305a-ad01-434d-877e-3503074b342c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TreasuryStockValueAcquiredParValueMethod"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredParValueMethod_e0c1305a-ad01-434d-877e-3503074b342c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_46d0adbb-2d0e-4d49-a4f2-7ff591cf2181" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_SharesIssued_46d0adbb-2d0e-4d49-a4f2-7ff591cf2181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_113b590f-a163-470d-9e07-911c95bf8f93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockholdersEquity_113b590f-a163-470d-9e07-911c95bf8f93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05a49906-f1d6-43c3-afb7-dab75276a626" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_d220cd6f-48e4-40a2-b0bd-633974ec9bc9" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_05a49906-f1d6-43c3-afb7-dab75276a626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="holx-20221231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfae2cd3-a265-4800-a8e2-4f5182da0b41" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfae2cd3-a265-4800-a8e2-4f5182da0b41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_046df428-3fe2-4ef3-a352-e2a465dd34f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfae2cd3-a265-4800-a8e2-4f5182da0b41" xlink:to="loc_us-gaap_NetIncomeLoss_046df428-3fe2-4ef3-a352-e2a465dd34f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfae2cd3-a265-4800-a8e2-4f5182da0b41" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_015b9810-97bc-49e4-b332-e02148cc6199" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:to="loc_us-gaap_Depreciation_015b9810-97bc-49e4-b332-e02148cc6199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_b9bfa7a7-849f-4453-829e-23d56cb36b97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:to="loc_us-gaap_AdjustmentForAmortization_b9bfa7a7-849f-4453-829e-23d56cb36b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f96babd8-f143-4bbf-888c-1c44bf659417" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:to="loc_us-gaap_ShareBasedCompensation_f96babd8-f143-4bbf-888c-1c44bf659417" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_841a7a3e-f3d6-430a-b249-79da1d53e5a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_841a7a3e-f3d6-430a-b249-79da1d53e5a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1c923b99-cb92-4204-b019-7722ce6d26be" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_1c923b99-cb92-4204-b019-7722ce6d26be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_44fb4ec2-5182-4881-a980-73ba314f7792" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_063a4990-e47a-429f-b53c-e9be15dd5fb9" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_44fb4ec2-5182-4881-a980-73ba314f7792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfae2cd3-a265-4800-a8e2-4f5182da0b41" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f1a3081a-0ca3-4026-9a0b-8ee77fca7ddd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_f1a3081a-0ca3-4026-9a0b-8ee77fca7ddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7cb248f2-bbf5-42a6-9465-74cf127f5c06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7cb248f2-bbf5-42a6-9465-74cf127f5c06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_1abf17d5-9b31-42db-8b0f-423cb0ae41f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidTaxes"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidTaxes_1abf17d5-9b31-42db-8b0f-423cb0ae41f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3688aa89-7c53-43ef-bcd1-28f43b5b8406" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3688aa89-7c53-43ef-bcd1-28f43b5b8406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_473c2110-fb44-4e68-87d9-43d609aba464" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_473c2110-fb44-4e68-87d9-43d609aba464" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_820ee3d0-e8a4-4dd2-ab14-4cb070f379a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_820ee3d0-e8a4-4dd2-ab14-4cb070f379a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_9885824f-64da-4ad5-a944-a61cd80d90fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_9725fed3-a8bb-41ea-9325-117ba9027eb3" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_9885824f-64da-4ad5-a944-a61cd80d90fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_784e7590-7964-4e09-af8a-060af8538e02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_cfae2cd3-a265-4800-a8e2-4f5182da0b41" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_784e7590-7964-4e09-af8a-060af8538e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e6f90204-6f40-40ac-9ce3-10b7810b48fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_e6f90204-6f40-40ac-9ce3-10b7810b48fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_be039281-e0b4-47ee-a5c5-7193cc39653c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromProductiveAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_us-gaap_PaymentsForProceedsFromProductiveAssets_be039281-e0b4-47ee-a5c5-7193cc39653c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_367c339e-6f13-4842-97e9-8163a5df6659" xlink:href="holx-20221231.xsd#holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion_367c339e-6f13-4842-97e9-8163a5df6659" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_c70d68d4-279f-449d-896a-1297e7b7e00d" xlink:href="holx-20221231.xsd#holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements_c70d68d4-279f-449d-896a-1297e7b7e00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9f864cb0-c1ba-4de1-a1f8-d239474e1661" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_9f864cb0-c1ba-4de1-a1f8-d239474e1661" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Purchaseofinsurancecontracts_b76cfcba-86ff-4445-b06b-1ecd080ae7ff" xlink:href="holx-20221231.xsd#holx_Purchaseofinsurancecontracts"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_holx_Purchaseofinsurancecontracts_b76cfcba-86ff-4445-b06b-1ecd080ae7ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a350c3cc-5284-42b2-9c34-db965fc69aeb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_2376b4e0-0c2a-45e7-bbe4-37bd242de58f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_a350c3cc-5284-42b2-9c34-db965fc69aeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_181eb73d-5987-4fca-b0d3-67103fc83093" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt_181eb73d-5987-4fca-b0d3-67103fc83093" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_4421bc1f-d587-481e-91be-b481ec938d65" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_4421bc1f-d587-481e-91be-b481ec938d65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_bcdd17c7-211c-4d73-b12e-9aebaa875647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities_bcdd17c7-211c-4d73-b12e-9aebaa875647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_Repaymentsofacquiredlongtermdebt_29bc4bc6-eea3-459a-af09-d95e2b8050d8" xlink:href="holx-20221231.xsd#holx_Repaymentsofacquiredlongtermdebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_holx_Repaymentsofacquiredlongtermdebt_29bc4bc6-eea3-459a-af09-d95e2b8050d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f340f26f-5848-44f5-a9e1-faab48dad79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_f340f26f-5848-44f5-a9e1-faab48dad79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_65c4b4ed-9987-480e-be65-e85dcb878727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_65c4b4ed-9987-480e-be65-e85dcb878727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_5af72562-9e72-4128-80ae-86aa1922338a" xlink:href="holx-20221231.xsd#holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits_5af72562-9e72-4128-80ae-86aa1922338a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PaymentsUnderFinanceLeaseObligations_c571fbcb-6890-4334-a101-6d212f18a187" xlink:href="holx-20221231.xsd#holx_PaymentsUnderFinanceLeaseObligations"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_holx_PaymentsUnderFinanceLeaseObligations_c571fbcb-6890-4334-a101-6d212f18a187" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39573052-86d7-4a9c-af30-ae43686aff79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_a2b61f36-b641-4199-8919-79e3d253ae9f" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_39573052-86d7-4a9c-af30-ae43686aff79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e2f65bbe-c1a8-4451-9807-48b9c87a3975" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_e2f65bbe-c1a8-4451-9807-48b9c87a3975" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c3d84d0a-17e3-4422-bdd2-a9c4605e614d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c3d84d0a-17e3-4422-bdd2-a9c4605e614d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48b273b1-b396-42bc-b65f-f490229553a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_48b273b1-b396-42bc-b65f-f490229553a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f33f9986-0044-4119-8dc8-dd7af0235e1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_f664898f-46fa-4c57-b335-90525d3653af" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f33f9986-0044-4119-8dc8-dd7af0235e1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BasisofPresentation" xlink:type="simple" xlink:href="holx-20221231.xsd#BasisofPresentation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BasisofPresentation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_BasisofPresentationAbstract_21bf488e-7436-4714-aabe-529e13d1b990" xlink:href="holx-20221231.xsd#holx_BasisofPresentationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6f95b15f-db16-485c-9455-b50c2137e9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_BasisofPresentationAbstract_21bf488e-7436-4714-aabe-529e13d1b990" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_6f95b15f-db16-485c-9455-b50c2137e9ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Revenue" xlink:type="simple" xlink:href="holx-20221231.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db840a59-76e3-4c29-adc2-ca34422a3e38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a51ca85f-43f1-421c-804a-720c9ad299b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_db840a59-76e3-4c29-adc2-ca34422a3e38" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_a51ca85f-43f1-421c-804a-720c9ad299b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Leases" xlink:type="simple" xlink:href="holx-20221231.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_f4201bff-df35-45a6-9387-e5eca6c538f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_2bde6cea-ab6d-4a70-9b3f-f66189a47dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f4201bff-df35-45a6-9387-e5eca6c538f7" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_2bde6cea-ab6d-4a70-9b3f-f66189a47dd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_ff5e585b-c82e-435d-ad92-44bf8bffdf75" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_f4201bff-df35-45a6-9387-e5eca6c538f7" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_ff5e585b-c82e-435d-ad92-44bf8bffdf75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_194b2b53-6ad1-4e8c-a117-2032ae4aeec2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_96417fb0-4726-469d-a280-a8f85081b394" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_194b2b53-6ad1-4e8c-a117-2032ae4aeec2" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_96417fb0-4726-469d-a280-a8f85081b394" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinations" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinations"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_af46fdfd-d901-4d61-8568-0c96746b6c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationDisclosureTextBlock_43726f08-eca0-447d-8a84-b9ff3562ded1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_af46fdfd-d901-4d61-8568-0c96746b6c43" xlink:to="loc_us-gaap_BusinessCombinationDisclosureTextBlock_43726f08-eca0-447d-8a84-b9ff3562ded1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="simple" xlink:href="holx-20221231.xsd#TradeReceivablesandAllowanceforCreditLosses"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_3f5671df-29c1-48e1-81d3-f1e89113be6c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_93ac50fe-bd23-4f36-9134-9f74c06c78e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_3f5671df-29c1-48e1-81d3-f1e89113be6c" xlink:to="loc_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock_93ac50fe-bd23-4f36-9134-9f74c06c78e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Restructuring" xlink:type="simple" xlink:href="holx-20221231.xsd#Restructuring"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Restructuring" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAbstract_de124a08-d1b4-4993-b4e9-dec97dfbaced" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6dfabb4d-3490-4b50-908c-7cd8da0dcbd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostsAbstract_de124a08-d1b4-4993-b4e9-dec97dfbaced" xlink:to="loc_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock_6dfabb4d-3490-4b50-908c-7cd8da0dcbd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangements"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d43dd9b1-c260-4bb9-ad1c-8d2d42c0e3b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_faa819c7-38d1-41b0-abe3-5d60a4ee00a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d43dd9b1-c260-4bb9-ad1c-8d2d42c0e3b3" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_faa819c7-38d1-41b0-abe3-5d60a4ee00a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/Derivatives" xlink:type="simple" xlink:href="holx-20221231.xsd#Derivatives"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/Derivatives" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_06ac3d4d-2501-486f-840f-74f1c864771d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesAndFairValueTextBlock_bba7f5a3-d284-4e65-ab50-f0f149eb8c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativesAndFairValueTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_06ac3d4d-2501-486f-840f-74f1c864771d" xlink:to="loc_us-gaap_DerivativesAndFairValueTextBlock_bba7f5a3-d284-4e65-ab50-f0f149eb8c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="holx-20221231.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_62d36f83-8f7c-415e-bd94-9e794ca9c914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_27d4134a-43c7-47fb-a418-ceedc465bc4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_62d36f83-8f7c-415e-bd94-9e794ca9c914" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_27d4134a-43c7-47fb-a418-ceedc465bc4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="simple" xlink:href="holx-20221231.xsd#NetIncomeLossPerShare"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_095e866f-643f-4514-a52b-e104ec3a9629" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_66d0209d-b47b-4bf9-9bda-28897d22d5dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_095e866f-643f-4514-a52b-e104ec3a9629" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_66d0209d-b47b-4bf9-9bda-28897d22d5dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensation" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e20111f1-3101-4488-a748-f5c8e5489acf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5fd242ae-cc0e-4b76-9158-87df0aef1cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e20111f1-3101-4488-a748-f5c8e5489acf" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_5fd242ae-cc0e-4b76-9158-87df0aef1cf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="simple" xlink:href="holx-20221231.xsd#OtherBalanceSheetInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a5b300cb-9cc4-4574-af4a-e3f5d0cbfb38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_7b7c375c-79e6-4b1b-87aa-416167f68065" xlink:href="holx-20221231.xsd#holx_DetailsOfCertainBalanceSheetAccountsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_a5b300cb-9cc4-4574-af4a-e3f5d0cbfb38" xlink:to="loc_holx_DetailsOfCertainBalanceSheetAccountsTextBlock_7b7c375c-79e6-4b1b-87aa-416167f68065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_13f2029b-6f86-4019-b565-71eecc7d8052" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_8102cbe1-41f2-4136-bc5d-a6607129fe2d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_13f2029b-6f86-4019-b565-71eecc7d8052" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_8102cbe1-41f2-4136-bc5d-a6607129fe2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxes" xlink:type="simple" xlink:href="holx-20221231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_67c5e941-6158-4c7d-9d12-eb19e847d2d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_a7087385-8fd6-4c8a-bef9-03c0c5c617b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_67c5e941-6158-4c7d-9d12-eb19e847d2d3" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_a7087385-8fd6-4c8a-bef9-03c0c5c617b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="simple" xlink:href="holx-20221231.xsd#IntangibleAssetsandGoodwill"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwill" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b17964a-691e-4ca7-89d7-8b8ffe0596bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a5f94994-056e-41d4-b762-19215633252f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_6b17964a-691e-4ca7-89d7-8b8ffe0596bb" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_a5f94994-056e-41d4-b762-19215633252f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarranties" xlink:type="simple" xlink:href="holx-20221231.xsd#ProductWarranties"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarranties" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_37f0d16e-a9ab-4825-b75c-cf502fe36c28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyDisclosureTextBlock_291cb033-67f5-49b8-afc6-8985b9e228b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_37f0d16e-a9ab-4825-b75c-cf502fe36c28" xlink:to="loc_us-gaap_ProductWarrantyDisclosureTextBlock_291cb033-67f5-49b8-afc6-8985b9e228b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="simple" xlink:href="holx-20221231.xsd#AccumulatedOtherComprehensiveLoss"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_07528a4f-0081-446d-beb3-03c96cb220ef" xlink:href="holx-20221231.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_5f7bfbb5-4cf8-4277-b0b2-1f954bf5e04c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ComprehensiveIncomeNoteTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_07528a4f-0081-446d-beb3-03c96cb220ef" xlink:to="loc_us-gaap_ComprehensiveIncomeNoteTextBlock_5f7bfbb5-4cf8-4277-b0b2-1f954bf5e04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchase" xlink:type="simple" xlink:href="holx-20221231.xsd#ShareRepurchase"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchase" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_de4f1fe1-60de-4ceb-a234-c0b19899d087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_38065486-08cc-49c7-9585-ac80708f1f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_de4f1fe1-60de-4ceb-a234-c0b19899d087" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_38065486-08cc-49c7-9585-ac80708f1f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueTables" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_67de3c8b-b396-46eb-adef-34b1416c33f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_4d07cca4-5bd2-44ea-9634-3f824a87e933" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_67de3c8b-b396-46eb-adef-34b1416c33f4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_4d07cca4-5bd2-44ea-9634-3f824a87e933" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5ee70e8f-6974-4044-94d2-76ad81d78864" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fa7f3c97-cd01-4f80-82ce-d0b8d6d49ef8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5ee70e8f-6974-4044-94d2-76ad81d78864" xlink:to="loc_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_fa7f3c97-cd01-4f80-82ce-d0b8d6d49ef8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinationsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_695cad1c-8eef-4895-8924-fc8679082da0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b47ce470-6959-45e3-9bd3-7b4e705d7f66" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_695cad1c-8eef-4895-8924-fc8679082da0" xlink:to="loc_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_b47ce470-6959-45e3-9bd3-7b4e705d7f66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="simple" xlink:href="holx-20221231.xsd#TradeReceivablesandAllowanceforCreditLossesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_2c0a99f1-a439-4e5f-b206-0aabc7551071" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_418b3997-2e8b-48d1-82ed-ac25b4b9cb69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_2c0a99f1-a439-4e5f-b206-0aabc7551071" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_418b3997-2e8b-48d1-82ed-ac25b4b9cb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_94ad8934-d2ed-4b4d-9cd6-76da740147db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_812c5fd0-ae0a-40f3-8c97-7ee2940fecd6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_94ad8934-d2ed-4b4d-9cd6-76da740147db" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_812c5fd0-ae0a-40f3-8c97-7ee2940fecd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_cd8f7ca6-e6ad-4f02-8bba-dd098935decc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_94ad8934-d2ed-4b4d-9cd6-76da740147db" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_cd8f7ca6-e6ad-4f02-8bba-dd098935decc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_2acdcc3a-faaa-45fb-b4a1-197f58cd066c" xlink:href="holx-20221231.xsd#holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_94ad8934-d2ed-4b4d-9cd6-76da740147db" xlink:to="loc_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock_2acdcc3a-faaa-45fb-b4a1-197f58cd066c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesTables" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dd4580e7-1ed9-45fc-a79e-2ea7616a68b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_92c1f0f2-8223-4569-9106-9d9904b9066b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dd4580e7-1ed9-45fc-a79e-2ea7616a68b6" xlink:to="loc_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock_92c1f0f2-8223-4569-9106-9d9904b9066b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_91898f36-5a86-4451-ac4e-44686fa10386" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dd4580e7-1ed9-45fc-a79e-2ea7616a68b6" xlink:to="loc_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock_91898f36-5a86-4451-ac4e-44686fa10386" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c61a1486-691f-44e5-88ab-468d3312ad6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_dd4580e7-1ed9-45fc-a79e-2ea7616a68b6" xlink:to="loc_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock_c61a1486-691f-44e5-88ab-468d3312ad6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="simple" xlink:href="holx-20221231.xsd#NetIncomeLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_a1675b47-7151-49f5-a063-51a5cfe5e167" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c607fe92-df3a-4373-999f-36486563b9bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_a1675b47-7151-49f5-a063-51a5cfe5e167" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_c607fe92-df3a-4373-999f-36486563b9bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00826502-a720-409e-a6ce-cadb2248cbd8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_fc7971c1-d34d-4209-8ad1-12f7e4b28c77" xlink:href="holx-20221231.xsd#holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00826502-a720-409e-a6ce-cadb2248cbd8" xlink:to="loc_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock_fc7971c1-d34d-4209-8ad1-12f7e4b28c77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3c6fc89d-445a-40aa-b508-3ff1fe18dd25" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_00826502-a720-409e-a6ce-cadb2248cbd8" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_3c6fc89d-445a-40aa-b508-3ff1fe18dd25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="simple" xlink:href="holx-20221231.xsd#OtherBalanceSheetInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4b0780ca-01aa-49bd-a780-610861d0a40e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d1196ade-81ad-4cb3-96e8-c87e8c86c4eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4b0780ca-01aa-49bd-a780-610861d0a40e" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_d1196ade-81ad-4cb3-96e8-c87e8c86c4eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6cab9ee0-f935-46e9-8138-db8b1cd1ec98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_4b0780ca-01aa-49bd-a780-610861d0a40e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_6cab9ee0-f935-46e9-8138-db8b1cd1ec98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_2c755cda-d716-43ef-930c-9d9680d34fc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cd3bcb0a-87da-4661-a551-26036b6955a6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2c755cda-d716-43ef-930c-9d9680d34fc8" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_cd3bcb0a-87da-4661-a551-26036b6955a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_b0ac2193-d131-4266-9633-8da7120557b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_2c755cda-d716-43ef-930c-9d9680d34fc8" xlink:to="loc_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock_b0ac2193-d131-4266-9633-8da7120557b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="simple" xlink:href="holx-20221231.xsd#IntangibleAssetsandGoodwillTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a4ed19f8-b62d-488c-b5e7-4dcf7713da7e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_61915ec4-baf8-4ec0-aaf6-129dc47cb9ab" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a4ed19f8-b62d-488c-b5e7-4dcf7713da7e" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_61915ec4-baf8-4ec0-aaf6-129dc47cb9ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_85ac18d2-8234-4f9a-b89a-9becb829e90b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_a4ed19f8-b62d-488c-b5e7-4dcf7713da7e" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_85ac18d2-8234-4f9a-b89a-9becb829e90b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="simple" xlink:href="holx-20221231.xsd#ProductWarrantiesTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_374cbd2c-e715-4bd3-8a14-7fc6eecf87fb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_d5933cdf-d38e-41f0-a327-7c68812a4ba0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_374cbd2c-e715-4bd3-8a14-7fc6eecf87fb" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_d5933cdf-d38e-41f0-a327-7c68812a4ba0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="simple" xlink:href="holx-20221231.xsd#AccumulatedOtherComprehensiveLossTables"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_34441636-19a5-4b63-b474-2b42ab00091e" xlink:href="holx-20221231.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ddaf8e58-ee0b-440c-88f6-f0877231c1e0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_34441636-19a5-4b63-b474-2b42ab00091e" xlink:to="loc_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock_ddaf8e58-ee0b-440c-88f6-f0877231c1e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueBusinessRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueBusinessRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_40959bd1-672d-4608-a6fc-40e3ffb9ead1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_40959bd1-672d-4608-a6fc-40e3ffb9ead1" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_2dada6f4-3849-480c-92d1-cff2ac41a177" xlink:to="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_e6a79c30-405e-4fe5-beeb-6d95924483ee" xlink:href="holx-20221231.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_DiagnosticsMember_e6a79c30-405e-4fe5-beeb-6d95924483ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_5bf3205c-d887-4ce1-8ee8-d09cc803bef9" xlink:href="holx-20221231.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_BreastHealthMember_5bf3205c-d887-4ce1-8ee8-d09cc803bef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_76532e56-b526-4a44-a572-b2963622e16e" xlink:href="holx-20221231.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_GynSurgicalMember_76532e56-b526-4a44-a572-b2963622e16e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_0e92dad2-50cd-4099-aa02-aac9e1484814" xlink:href="holx-20221231.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_d787e4c9-1108-44d2-a93b-eedf0c337029" xlink:to="loc_holx_SkeletalHealthMember_0e92dad2-50cd-4099-aa02-aac9e1484814" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_14f289ec-73b2-4ea0-84e7-3913fa3df6e4" xlink:to="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CytologyPerinatalMember_81cf043f-fe0d-4b34-b96a-ea70b55b942c" xlink:href="holx-20221231.xsd#holx_CytologyPerinatalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_CytologyPerinatalMember_81cf043f-fe0d-4b34-b96a-ea70b55b942c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MolecularDiagnosticsMember_59e8b8f0-7d86-477a-888a-952e103b1389" xlink:href="holx-20221231.xsd#holx_MolecularDiagnosticsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_MolecularDiagnosticsMember_59e8b8f0-7d86-477a-888a-952e103b1389" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BloodScreeningMember_649cd1c8-1115-49dd-a36c-8bb9bb084fe0" xlink:href="holx-20221231.xsd#holx_BloodScreeningMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_BloodScreeningMember_649cd1c8-1115-49dd-a36c-8bb9bb084fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastImagingMember_ae774984-19f2-440b-8168-766819122265" xlink:href="holx-20221231.xsd#holx_BreastImagingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_BreastImagingMember_ae774984-19f2-440b-8168-766819122265" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InterventionalBreastSolutionsMember_b29cd6e1-4f63-41bf-a9be-ea7bcd86c839" xlink:href="holx-20221231.xsd#holx_InterventionalBreastSolutionsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_994149ac-a942-4422-8596-3baa28c855e1" xlink:to="loc_holx_InterventionalBreastSolutionsMember_b29cd6e1-4f63-41bf-a9be-ea7bcd86c839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_0fedcf3c-b7b9-4047-a782-acad120ab583" xlink:to="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_66698a1a-69b4-4716-845c-c1d4f8812908" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:to="loc_country_US_66698a1a-69b4-4716-845c-c1d4f8812908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternationalMember_406d9f5f-140d-45ca-b25c-863bb158d120" xlink:href="holx-20221231.xsd#holx_InternationalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_3890a2a1-978b-42ca-9089-d76e7bfa02ea" xlink:to="loc_holx_InternationalMember_406d9f5f-140d-45ca-b25c-863bb158d120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_146dff4d-53db-466f-b883-f652fee93b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_8d78f7e6-cf7f-406a-9a06-971afbba71fc" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_146dff4d-53db-466f-b883-f652fee93b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_b80a1769-4341-411c-8765-7a3eb0408178" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_146dff4d-53db-466f-b883-f652fee93b9b" xlink:to="loc_us-gaap_Revenues_b80a1769-4341-411c-8765-7a3eb0408178" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_92a0377f-a952-4ad8-8353-3292e398e8d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_40959bd1-672d-4608-a6fc-40e3ffb9ead1" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_92a0377f-a952-4ad8-8353-3292e398e8d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueGeographicalRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueGeographicalRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_580e8189-ca77-4280-8217-c9f1a21ab559" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_580e8189-ca77-4280-8217-c9f1a21ab559" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:to="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_b474e3fa-230c-4fcc-9870-f8850efedf8d" xlink:to="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_d7e2bb02-2c11-4421-8c04-6a0fd718a89c" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_country_US_d7e2bb02-2c11-4421-8c04-6a0fd718a89c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f9beb2b1-b0e1-4f55-8628-e13c5edd5484" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_srt_EuropeMember_f9beb2b1-b0e1-4f55-8628-e13c5edd5484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_c4432418-b6f1-4e44-a739-e593ff7298ce" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_srt_AsiaPacificMember_c4432418-b6f1-4e44-a739-e593ff7298ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RestofWorldMember_6360275d-9ab5-4c6b-bb6a-a19305e39eb5" xlink:href="holx-20221231.xsd#holx_RestofWorldMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_aea5caf1-51fd-496a-a7fe-e48bfdadcfe7" xlink:to="loc_holx_RestofWorldMember_6360275d-9ab5-4c6b-bb6a-a19305e39eb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_ffcdfbf9-956a-46ab-a666-2c80fbc983a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_bb926b88-064a-4d55-9857-fad05610e3ae" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_ffcdfbf9-956a-46ab-a666-2c80fbc983a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_13bba0bc-4acd-4dd5-9cb4-5084cd80117c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_ffcdfbf9-956a-46ab-a666-2c80fbc983a4" xlink:to="loc_us-gaap_Revenues_13bba0bc-4acd-4dd5-9cb4-5084cd80117c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueRevenuebyTypeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRevenuebyTypeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8b8b14f5-2cf0-4ef1-b941-ae5e358f41e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8b8b14f5-2cf0-4ef1-b941-ae5e358f41e8" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:to="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_a4d0c1bb-8f82-4296-9d43-886ebba0cda4" xlink:to="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ConsumablesMember_0c36c77d-1985-4baf-9fd4-4f32ebb65380" xlink:href="holx-20221231.xsd#holx_ConsumablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_holx_ConsumablesMember_0c36c77d-1985-4baf-9fd4-4f32ebb65380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalEquipmentComponentsandSoftwareMember_ab7f684a-995e-4d62-a05e-e6db1e419cc4" xlink:href="holx-20221231.xsd#holx_CapitalEquipmentComponentsandSoftwareMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_holx_CapitalEquipmentComponentsandSoftwareMember_ab7f684a-995e-4d62-a05e-e6db1e419cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ServiceMember_c542bb32-d5bf-400c-851e-abbedcd7310e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ServiceMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_us-gaap_ServiceMember_c542bb32-d5bf-400c-851e-abbedcd7310e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_OtherTypeofRevenueMember_6a0237cf-30a2-4d02-9383-74e6d89dea9a" xlink:href="holx-20221231.xsd#holx_OtherTypeofRevenueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_46245e6b-f1da-4e74-ba12-d6cfa34c0810" xlink:to="loc_holx_OtherTypeofRevenueMember_6a0237cf-30a2-4d02-9383-74e6d89dea9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_5e6800be-172f-4a37-b0eb-506e4d7fc24f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_ac9bdd8c-4483-4f8c-ae43-5ef113eb53ed" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_5e6800be-172f-4a37-b0eb-506e4d7fc24f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_303b6dbf-69df-4a39-a428-4cab20c240ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_5e6800be-172f-4a37-b0eb-506e4d7fc24f" xlink:to="loc_us-gaap_Revenues_303b6dbf-69df-4a39-a428-4cab20c240ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4526f8cd-94f3-4f88-817e-d58f3380dd6b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_8b8b14f5-2cf0-4ef1-b941-ae5e358f41e8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_4526f8cd-94f3-4f88-817e-d58f3380dd6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c3659228-64d9-4666-9d10-8ed30db68f98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_a677b0ca-3f33-42fc-981b-fa6ba327cdf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c3659228-64d9-4666-9d10-8ed30db68f98" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_a677b0ca-3f33-42fc-981b-fa6ba327cdf0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_78e7218a-f814-4390-9e1e-16fe291b9d71" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_c3659228-64d9-4666-9d10-8ed30db68f98" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_78e7218a-f814-4390-9e1e-16fe291b9d71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueRemainingPerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eefec169-07fc-441b-bbac-9f40a1b30e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_eefec169-07fc-441b-bbac-9f40a1b30e79" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_594f1087-02e4-4ca2-a959-978b89b8bc54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_594f1087-02e4-4ca2-a959-978b89b8bc54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_1e186a6a-8999-4d98-9818-6b90d64709e9" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_507f2c19-e423-4a9a-a817-95b900eac077" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationPercentage_507f2c19-e423-4a9a-a817-95b900eac077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_eb368acf-864a-4822-b494-851041cf9d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_f0d75ee3-585f-48ee-b84f-f41ec5b3e9b3" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_eb368acf-864a-4822-b494-851041cf9d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="simple" xlink:href="holx-20221231.xsd#RevenueRemainingPerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#LeasesAdditionalLeaseInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6188e75d-f499-44f1-87e3-8c590c237284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LeaseRevenuePercentageOfTotalRevenue_b3a832a4-a28c-449d-b681-91a20eb7df54" xlink:href="holx-20221231.xsd#holx_LeaseRevenuePercentageOfTotalRevenue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6188e75d-f499-44f1-87e3-8c590c237284" xlink:to="loc_holx_LeaseRevenuePercentageOfTotalRevenue_b3a832a4-a28c-449d-b681-91a20eb7df54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5aca2230-08c3-4a25-9afd-356a0a1733cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByBalanceSheetGroupingTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5aca2230-08c3-4a25-9afd-356a0a1733cf" xlink:to="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_bf88eb48-5ce6-4635-a6b0-b25ba8ec43f7" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d3d7fe41-ec79-4b3d-bd20-9083900f258e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d3d7fe41-ec79-4b3d-bd20-9083900f258e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_a0f53465-e901-478c-be7a-6001988c9a12" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_a0f53465-e901-478c-be7a-6001988c9a12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_fe20c470-e412-4a42-ab10-c8ecbd521b30" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_45beb6f2-3b8c-4448-98bb-378fcbaa94ae" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_fe20c470-e412-4a42-ab10-c8ecbd521b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_db08a0ff-271a-42df-9fa6-7b508e0179a3" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ContingentConsiderationMember_ae306c37-a49a-458c-9192-55a62242d4b7" xlink:href="holx-20221231.xsd#holx_ContingentConsiderationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_holx_ContingentConsiderationMember_ae306c37-a49a-458c-9192-55a62242d4b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_e9a77e57-717a-4ba7-93ce-4598611b2f02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_us-gaap_InterestRateSwapMember_e9a77e57-717a-4ba7-93ce-4598611b2f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeContractMember_cb4a9b6c-8ada-4741-ad99-f02095ab48bb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeContractMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_us-gaap_ForeignExchangeContractMember_cb4a9b6c-8ada-4741-ad99-f02095ab48bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_87639721-cbc7-413f-843b-4c1a86782f01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_88cdf9d7-185f-4a3b-97a7-a6078fac00d4" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_87639721-cbc7-413f-843b-4c1a86782f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_f2186063-8f1e-4193-9b23-b0bda6d7f10a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_b9103a4c-9a84-46d7-aa4a-0ac4afe7b05a" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_f2186063-8f1e-4193-9b23-b0bda6d7f10a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilityMember_c6f2811d-18d3-4847-958d-9fac56c75533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_f2186063-8f1e-4193-9b23-b0bda6d7f10a" xlink:to="loc_us-gaap_LiabilityMember_c6f2811d-18d3-4847-958d-9fac56c75533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByBalanceSheetGroupingTable_503815d7-66a6-4a52-82ea-aaaff815a0a1" xlink:to="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosureAbstract_9707c20f-d8c8-47ac-bd98-013a14b289b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsFairValueDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:to="loc_us-gaap_AssetsFairValueDisclosureAbstract_9707c20f-d8c8-47ac-bd98-013a14b289b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentsFairValueDisclosure_28a11ece-71bd-44ef-8a66-d3171529ed02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentsFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsFairValueDisclosureAbstract_9707c20f-d8c8-47ac-bd98-013a14b289b5" xlink:to="loc_us-gaap_InvestmentsFairValueDisclosure_28a11ece-71bd-44ef-8a66-d3171529ed02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesFairValueDisclosureAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems_98d3f275-17a0-456b-974e-c8c6ae032836" xlink:to="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_7849a4d5-5b53-4114-9f2a-02df914137da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:to="loc_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure_7849a4d5-5b53-4114-9f2a-02df914137da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_554ff2dc-8969-4b72-a9c3-eca8c1a389bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosureAbstract_a17accc4-7bd3-44dc-a415-b91b1688b2b8" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations_554ff2dc-8969-4b72-a9c3-eca8c1a389bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_9a8fc4e4-4a3a-4084-a91b-cbe967a384e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_9a8fc4e4-4a3a-4084-a91b-cbe967a384e8" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8019b5c-8e19-458c-acda-3efcdf2a2e62" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_f28c85da-dcc1-488c-895a-8498c42a66ef" xlink:href="holx-20221231.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:to="loc_holx_CreditAgreementMember_f28c85da-dcc1-488c-895a-8498c42a66ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_5e7731e3-9d9a-4323-95a6-9023f27cafd9" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:to="loc_holx_A2028SeniorNotesMember_5e7731e3-9d9a-4323-95a6-9023f27cafd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_f852f823-801f-4f98-a33f-ffa8ab6e080b" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_175fd65a-4aec-4419-a59b-154dc1c2c115" xlink:to="loc_holx_A2029SeniorNotesMember_f852f823-801f-4f98-a33f-ffa8ab6e080b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentTypeCategorizationMember_33bce137-bd16-432a-a9bb-02f7c6c3be87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InvestmentTypeCategorizationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeAxis_2495c9eb-41f3-4bd7-b0ac-3e2e056a2617" xlink:to="loc_us-gaap_InvestmentTypeCategorizationMember_33bce137-bd16-432a-a9bb-02f7c6c3be87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityMethodInvestmentsMember_4f190efc-96e9-49df-8245-11d9549de658" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityMethodInvestmentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InvestmentTypeCategorizationMember_33bce137-bd16-432a-a9bb-02f7c6c3be87" xlink:to="loc_us-gaap_EquityMethodInvestmentsMember_4f190efc-96e9-49df-8245-11d9549de658" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_70de705b-ed55-42c1-a81b-24f74b3a56e8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_40662d20-c797-4740-879e-309fefae9173" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_70de705b-ed55-42c1-a81b-24f74b3a56e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_bfbc958c-6408-43d0-a9df-72fb1442e84b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_70de705b-ed55-42c1-a81b-24f74b3a56e8" xlink:to="loc_us-gaap_SeniorNotesMember_bfbc958c-6408-43d0-a9df-72fb1442e84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_752e453e-cca0-4a5c-875f-4867cecfab5a" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PrincipalAmountOfBorrowings_5603029d-20bf-4344-a1e2-81d3d62fc77c" xlink:href="holx-20221231.xsd#holx_PrincipalAmountOfBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_holx_PrincipalAmountOfBorrowings_5603029d-20bf-4344-a1e2-81d3d62fc77c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_685bcbd2-aa6e-408b-ae11-14f0d03fb565" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_685bcbd2-aa6e-408b-ae11-14f0d03fb565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFairValue_e172b836-8fd4-47ed-87dc-4a845b4aac3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_DebtInstrumentFairValue_e172b836-8fd4-47ed-87dc-4a845b4aac3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossOnSaleOfInvestments_ae2e6102-111c-41dc-92ed-ef0e228465fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossOnSaleOfInvestments"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_9e522643-7c14-4f73-80ba-67d1d1fd17e5" xlink:to="loc_us-gaap_LossOnSaleOfInvestments_ae2e6102-111c-41dc-92ed-ef0e228465fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#FairValueMeasurementsRollForwardDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_4d9f4f02-280e-4237-ada2-2a856c15d9e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_88c8c5ba-cb42-43b3-9285-e2e5accd99eb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d9f4f02-280e-4237-ada2-2a856c15d9e9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_88c8c5ba-cb42-43b3-9285-e2e5accd99eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_e70f2f88-b9d6-49f6-9bd0-3eddcbd21fed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d9f4f02-280e-4237-ada2-2a856c15d9e9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases_e70f2f88-b9d6-49f6-9bd0-3eddcbd21fed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f7ac6e56-0774-4535-a125-9b5cbaba5c4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d9f4f02-280e-4237-ada2-2a856c15d9e9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f7ac6e56-0774-4535-a125-9b5cbaba5c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_16f05f95-d502-407b-a89c-c28031e33cd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d9f4f02-280e-4237-ada2-2a856c15d9e9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements_16f05f95-d502-407b-a89c-c28031e33cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5aa514e3-4ba0-4c0c-925c-f2853c2402c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_4d9f4f02-280e-4237-ada2-2a856c15d9e9" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_5aa514e3-4ba0-4c0c-925c-f2853c2402c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_b84c103e-8d52-4903-b91c-ca246294f898" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_b84c103e-8d52-4903-b91c-ca246294f898" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_1a9d28a8-9c1e-4b7f-9a83-372fa0906d8b" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_b945c419-da93-48b9-86ed-036e01fdeda2" xlink:href="holx-20221231.xsd#holx_BolderSurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:to="loc_holx_BolderSurgicalMember_b945c419-da93-48b9-86ed-036e01fdeda2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcessaHealthMember_33b7ec46-e864-4ea6-9623-5bfe271001b8" xlink:href="holx-20221231.xsd#holx_AcessaHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_5da6c4f0-13ba-429e-816f-6d0d144796ae" xlink:to="loc_holx_AcessaHealthMember_33b7ec46-e864-4ea6-9623-5bfe271001b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_b9fcc9bd-f31e-4f1a-9e21-4e8afa1f8334" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_7f6413cb-f7ad-4567-b0d6-c21f4e33fe7d" xlink:href="holx-20221231.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:to="loc_holx_DevelopedTechnologyMember_7f6413cb-f7ad-4567-b0d6-c21f4e33fe7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_5c91f0cc-80f6-4760-be47-3489e506654e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:to="loc_us-gaap_CustomerRelationshipsMember_5c91f0cc-80f6-4760-be47-3489e506654e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_77823a46-5ce4-4a4e-8122-922964c6bd09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_505a23f8-2f1c-45da-867b-36dff8577192" xlink:to="loc_us-gaap_TradeNamesMember_77823a46-5ce4-4a4e-8122-922964c6bd09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_90193382-be9c-433f-b508-5acf8d69a3f9" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationConsiderationTransferred1_345f3cc5-5bb2-426a-a816-f25f9dbaa02c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationConsiderationTransferred1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_BusinessCombinationConsiderationTransferred1_345f3cc5-5bb2-426a-a816-f25f9dbaa02c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_87d72f42-dfa2-4405-a81d-8954be6f8dfe" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue_87d72f42-dfa2-4405-a81d-8954be6f8dfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0e9cea7-d23a-4336-ab56-928038d2d7dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife_d0e9cea7-d23a-4336-ab56-928038d2d7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907a518a-60c6-4c41-9efe-edfd8bf2d939" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationLiability_907a518a-60c6-4c41-9efe-edfd8bf2d939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AnnualIncrementalRevenueGrowthPeriod_ff8ca6b4-15d8-499c-9cee-310ded063260" xlink:href="holx-20221231.xsd#holx_AnnualIncrementalRevenueGrowthPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_holx_AnnualIncrementalRevenueGrowthPeriod_ff8ca6b4-15d8-499c-9cee-310ded063260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b7858fd9-5570-46c7-8889-cf1f60471d53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_b7858fd9-5570-46c7-8889-cf1f60471d53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationContingentConsiderationPayments_c855ddef-a1b3-4e2f-acc2-a09bb29c13ee" xlink:href="holx-20221231.xsd#holx_BusinessCombinationContingentConsiderationPayments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_53bca00d-0ba0-4d24-98ba-7b772537e9fe" xlink:to="loc_holx_BusinessCombinationContingentConsiderationPayments_c855ddef-a1b3-4e2f-acc2-a09bb29c13ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationsAbstract_0fdb04cb-7ba5-421a-964b-d9e63bd6e290" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessCombinationsAbstract_0fdb04cb-7ba5-421a-964b-d9e63bd6e290" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:to="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionAcquireeDomain_470fb4b1-deb5-43a7-93ba-363678005046" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionAcquireeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAxis_6375bd34-24df-494f-b335-133081a63e57" xlink:to="loc_us-gaap_BusinessAcquisitionAcquireeDomain_470fb4b1-deb5-43a7-93ba-363678005046" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BolderSurgicalMember_522d305f-cbab-4e56-8a82-cfaf2ebcdbaf" xlink:href="holx-20221231.xsd#holx_BolderSurgicalMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionAcquireeDomain_470fb4b1-deb5-43a7-93ba-363678005046" xlink:to="loc_holx_BolderSurgicalMember_522d305f-cbab-4e56-8a82-cfaf2ebcdbaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable_a533cdaf-4b2a-45fd-81f8-6104012f0e1e" xlink:to="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fd51c781-d759-4989-98e1-3c08af68f96e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents_fd51c781-d759-4989-98e1-3c08af68f96e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a070781c-9541-4287-acff-388f9966c6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_a070781c-9541-4287-acff-388f9966c6e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1c5effd4-51f4-473c-862d-31dbfbddfc62" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory_1c5effd4-51f4-473c-862d-31dbfbddfc62" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_95635c7f-76f5-428c-9aaa-112edc53ed9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets_95635c7f-76f5-428c-9aaa-112edc53ed9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b224feed-1f4f-462d-a937-5091d8b51cd5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_b224feed-1f4f-462d-a937-5091d8b51cd5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_199c5f2a-2e70-4cd9-9694-b8b04d7f023e" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology_199c5f2a-2e70-4cd9-9694-b8b04d7f023e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_79d0f689-39eb-4489-9433-cf280a70f2e9" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships_79d0f689-39eb-4489-9433-cf280a70f2e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_9ac27f96-2b50-48df-97e3-fe5d2c4a3cd2" xlink:href="holx-20221231.xsd#holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames_9ac27f96-2b50-48df-97e3-fe5d2c4a3cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_aab3aba3-3577-4f61-8553-708f02769755" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_aab3aba3-3577-4f61-8553-708f02769755" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_81ee34c7-9c1b-4ccf-9562-fb32a991625d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_Goodwill_81ee34c7-9c1b-4ccf-9562-fb32a991625d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9ee38524-755b-4fbf-bdfb-f4639fea0ccf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionLineItems_467b2500-6e56-45cf-9894-761a7d29c20a" xlink:to="loc_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_9ee38524-755b-4fbf-bdfb-f4639fea0ccf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#TradeReceivablesandAllowanceforCreditLossesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesAbstract_bf71897f-751f-4cc3-8f54-8212775fa807" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ReceivablesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5a514c41-88d1-40e0-9b83-d251dd713a9e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReceivablesAbstract_bf71897f-751f-4cc3-8f54-8212775fa807" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5a514c41-88d1-40e0-9b83-d251dd713a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e9c24690-8848-4be5-9e58-9f1ba9b32555" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5a514c41-88d1-40e0-9b83-d251dd713a9e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_e9c24690-8848-4be5-9e58-9f1ba9b32555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_29f71841-edaf-4498-8771-d5b43ffd9c04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5a514c41-88d1-40e0-9b83-d251dd713a9e" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_29f71841-edaf-4498-8771-d5b43ffd9c04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_87b2b0ee-b698-4f67-9c96-207f2c285efd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5a514c41-88d1-40e0-9b83-d251dd713a9e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs_87b2b0ee-b698-4f67-9c96-207f2c285efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c983dc7f-0d60-4dc9-ab99-3844fe92d727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_5a514c41-88d1-40e0-9b83-d251dd713a9e" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_c983dc7f-0d60-4dc9-ab99-3844fe92d727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/RestructuringDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#RestructuringDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/RestructuringDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostsAbstract_fae352b1-a7cc-4ee6-9724-ebc05cb68476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_35c1e447-f447-4cc2-96ea-834bf4aeca00" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostsAbstract_fae352b1-a7cc-4ee6-9724-ebc05cb68476" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_35c1e447-f447-4cc2-96ea-834bf4aeca00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfRestructuringAndRelatedCostsTable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostsAbstract_fae352b1-a7cc-4ee6-9724-ebc05cb68476" xlink:to="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:to="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringPlanDomain_ed55ad53-5403-4991-a019-e02ad93ca233" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringPlanDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanAxis_8df58dd4-25a0-44e3-a700-b6cfc256d4b6" xlink:to="loc_us-gaap_RestructuringPlanDomain_ed55ad53-5403-4991-a019-e02ad93ca233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DanburyClosureMember_79e3ab7b-d2f4-403f-9f2e-897a4bded4b5" xlink:href="holx-20221231.xsd#holx_DanburyClosureMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringPlanDomain_ed55ad53-5403-4991-a019-e02ad93ca233" xlink:to="loc_holx_DanburyClosureMember_79e3ab7b-d2f4-403f-9f2e-897a4bded4b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCostAndReserveLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRestructuringAndRelatedCostsTable_38b641d7-ffd2-4e85-9d5a-ca502a12506c" xlink:to="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b44ff903-f859-4717-a123-579703282dbc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringAndRelatedCostExpectedCost1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:to="loc_us-gaap_RestructuringAndRelatedCostExpectedCost1_b44ff903-f859-4717-a123-579703282dbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestructuringCharges_04836557-4bff-45c8-8b92-6772df4d48ad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestructuringCharges"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestructuringCostAndReserveLineItems_d54069fb-4cdf-4b6a-a401-e8cb20e96206" xlink:to="loc_us-gaap_RestructuringCharges_04836557-4bff-45c8-8b92-6772df4d48ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsCompanysBorrowingsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_79b3f362-6de9-4558-9635-41f681f710e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_79b3f362-6de9-4558-9635-41f681f710e2" xlink:to="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_092ca0ad-e70f-47bd-bd49-31966f9e320a" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_580ba7c1-e4e0-4ebd-a519-9e7caca4072d" xlink:href="holx-20221231.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:to="loc_holx_TermLoanMember_580ba7c1-e4e0-4ebd-a519-9e7caca4072d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_394a9c32-519a-4be6-ba84-31f5b447c3dc" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:to="loc_holx_A2028SeniorNotesMember_394a9c32-519a-4be6-ba84-31f5b447c3dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_5caa7425-a68f-4c0d-9d77-db2472e5417e" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f119ddf9-6a4a-4273-ac4c-a14555883395" xlink:to="loc_holx_A2029SeniorNotesMember_5caa7425-a68f-4c0d-9d77-db2472e5417e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_cdc5ad91-a594-4a82-a4b6-c117a9883123" xlink:to="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_abdcdbd4-2c33-432d-a095-b17f6e94fd90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_LongTermDebtCurrent_abdcdbd4-2c33-432d-a095-b17f6e94fd90" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_c5faed43-1dfd-4729-95f2-d9e973171aec" xlink:href="holx-20221231.xsd#holx_LongTermDebtObligationsWithoutConvertibleNotes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_holx_LongTermDebtObligationsWithoutConvertibleNotes_c5faed43-1dfd-4729-95f2-d9e973171aec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_08ea09a0-d8ab-436c-9f9a-11644910b0e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_08ea09a0-d8ab-436c-9f9a-11644910b0e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_8cc79acc-1968-4c72-8efb-19d34d26d3b8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_ace2bf87-ac57-427d-b315-1fc560b4d8ac" xlink:to="loc_us-gaap_LongTermDebt_8cc79acc-1968-4c72-8efb-19d34d26d3b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d0c2d3bb-60fb-4cbd-9734-f3dd604f57ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d0c2d3bb-60fb-4cbd-9734-f3dd604f57ee" xlink:to="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8a90b565-8af7-406e-b3e8-a79213068ca1" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SecuredTermLoanMember_0b925f91-12d1-4bdc-b000-786cb1a0abb3" xlink:href="holx-20221231.xsd#holx_SecuredTermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_SecuredTermLoanMember_0b925f91-12d1-4bdc-b000-786cb1a0abb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RevolverMember_5ff59776-a8b9-49ef-9fb2-b8e2218848bd" xlink:href="holx-20221231.xsd#holx_RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_RevolverMember_5ff59776-a8b9-49ef-9fb2-b8e2218848bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_TermLoanMember_7824adc7-feea-4f6f-97d6-384717298379" xlink:href="holx-20221231.xsd#holx_TermLoanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_TermLoanMember_7824adc7-feea-4f6f-97d6-384717298379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_3abbdc85-885c-48c7-9d32-03e68944820f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_us-gaap_SeniorNotesMember_3abbdc85-885c-48c7-9d32-03e68944820f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AssetSecuritizationMember_79f9df24-e228-48c7-aa5a-0e36670d9907" xlink:href="holx-20221231.xsd#holx_AssetSecuritizationMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_535ced76-db1d-499e-961d-b780b0ea73ba" xlink:to="loc_holx_AssetSecuritizationMember_79f9df24-e228-48c7-aa5a-0e36670d9907" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_0c63ade0-1484-46f7-8bb7-0feffe908271" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021TermLoanMember_553896d0-83a1-4bf6-b276-43988beecc91" xlink:href="holx-20221231.xsd#holx_A2021TermLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2021TermLoanMember_553896d0-83a1-4bf6-b276-43988beecc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021RevolverMember_43c00bce-f35e-4320-a8fc-ae41ca6c5db9" xlink:href="holx-20221231.xsd#holx_A2021RevolverMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2021RevolverMember_43c00bce-f35e-4320-a8fc-ae41ca6c5db9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2021CreditAgreementMember_85e4e8b8-c934-4d7f-93ed-1dc6a4a7e406" xlink:href="holx-20221231.xsd#holx_A2021CreditAgreementMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2021CreditAgreementMember_85e4e8b8-c934-4d7f-93ed-1dc6a4a7e406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_5a21091b-16a9-4b07-96b6-932d9634f79d" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2028SeniorNotesMember_5a21091b-16a9-4b07-96b6-932d9634f79d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_dd3559ba-b8d1-4502-812e-681bf74bfe61" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1870c989-b81a-4aee-bc21-4f83c7f9d5c5" xlink:to="loc_holx_A2029SeniorNotesMember_dd3559ba-b8d1-4502-812e-681bf74bfe61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_ced10aa7-8cfe-46ee-80fb-777e84435aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_65c410b9-e6e6-476f-af13-e92ed34b5f59" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_ced10aa7-8cfe-46ee-80fb-777e84435aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_af8a4223-d698-4ced-bfb6-02ac121e0fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_ced10aa7-8cfe-46ee-80fb-777e84435aa9" xlink:to="loc_us-gaap_InterestRateSwapMember_af8a4223-d698-4ced-bfb6-02ac121e0fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_faa32c4e-613b-435e-a805-808b2c973a8f" xlink:to="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_72e7db7d-9e6a-49c9-b75e-00d653dafdc3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_72e7db7d-9e6a-49c9-b75e-00d653dafdc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_38140cdc-4784-4840-8678-ffbb1a99dcfb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_38140cdc-4784-4840-8678-ffbb1a99dcfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3a55c0e3-c127-442e-b762-807e8c47fedf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_3a55c0e3-c127-442e-b762-807e8c47fedf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ceb0a009-7b61-4bc7-a9fc-10b1ac587884" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_ceb0a009-7b61-4bc7-a9fc-10b1ac587884" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_340d2403-5731-45da-a76f-f0ec992a5677" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_340d2403-5731-45da-a76f-f0ec992a5677" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_dc385f17-cb33-49dd-926d-6fb12db26372" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_dc385f17-cb33-49dd-926d-6fb12db26372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_2a6c36e3-5a57-4c19-8f85-d8e9972011f0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_2a6c36e3-5a57-4c19-8f85-d8e9972011f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotes_90fe6d2f-5bfb-4034-86f0-ac265845dee8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotes"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_SeniorNotes_90fe6d2f-5bfb-4034-86f0-ac265845dee8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfOtherDebt_3fced5bd-36d7-4652-acfc-8a8ecef780a3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RepaymentsOfOtherDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_RepaymentsOfOtherDebt_3fced5bd-36d7-4652-acfc-8a8ecef780a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_28780632-5748-4011-8969-10fe1dfac860" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_664c33e5-4a5e-4cb5-8487-58b8aa470aa7" xlink:to="loc_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities_28780632-5748-4011-8969-10fe1dfac860" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c781c031-6d92-4a9b-bbce-35edc2eba22e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c781c031-6d92-4a9b-bbce-35edc2eba22e" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:to="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d907498e-af95-40ab-bc7d-20e8ecc882c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_7ce18234-8f74-4ce9-bc4b-cfc903d6221e" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d907498e-af95-40ab-bc7d-20e8ecc882c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CreditAgreementMember_6cc0aceb-ff61-4989-9489-daa9d06c5e7e" xlink:href="holx-20221231.xsd#holx_CreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_d907498e-af95-40ab-bc7d-20e8ecc882c0" xlink:to="loc_holx_CreditAgreementMember_6cc0aceb-ff61-4989-9489-daa9d06c5e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_c4ec99a8-dff3-494f-b9c5-2e2c79608017" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_b951e34e-b5b8-4803-a0d3-96b88efc6fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_InterestExpenseBorrowings_b951e34e-b5b8-4803-a0d3-96b88efc6fb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_d2cdef71-16cc-42bb-8b1f-dec5694bf54c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod_d2cdef71-16cc-42bb-8b1f-dec5694bf54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1b98c598-0bc1-43e4-9771-2ae6276b732e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_a884d0fd-8d06-435b-bab6-4ba7d9c103c3" xlink:to="loc_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd_1b98c598-0bc1-43e4-9771-2ae6276b732e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7fa1791d-b056-4b86-9e2e-f3a497baa95c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7fa1791d-b056-4b86-9e2e-f3a497baa95c" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f276054e-8f7d-4ba5-a90c-faf075840ce3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_04df1d40-c6b7-46c9-9315-731452afc3fa" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f276054e-8f7d-4ba5-a90c-faf075840ce3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_ab8ff61d-7c75-4835-82f9-2c0b0015170c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f276054e-8f7d-4ba5-a90c-faf075840ce3" xlink:to="loc_us-gaap_SeniorNotesMember_ab8ff61d-7c75-4835-82f9-2c0b0015170c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:to="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_9eb3122c-0f81-4c84-a605-39a1b0b294d5" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028SeniorNotesMember_dcd2e79b-c228-4eaa-9565-c7be4f0d98cf" xlink:href="holx-20221231.xsd#holx_A2028SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:to="loc_holx_A2028SeniorNotesMember_dcd2e79b-c228-4eaa-9565-c7be4f0d98cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2029SeniorNotesMember_a191dcc2-7a72-4336-b2f0-29ebf4ad7ffb" xlink:href="holx-20221231.xsd#holx_A2029SeniorNotesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:to="loc_holx_A2029SeniorNotesMember_a191dcc2-7a72-4336-b2f0-29ebf4ad7ffb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_A2028And2029SeniorNotesMember_41e7e336-1d42-4b40-9ecb-f11be911b52b" xlink:href="holx-20221231.xsd#holx_A2028And2029SeniorNotesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fa0d1189-8d63-4f91-9898-b4859bb6c0f1" xlink:to="loc_holx_A2028And2029SeniorNotesMember_41e7e336-1d42-4b40-9ecb-f11be911b52b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_e9190369-2970-401f-b620-6066b808c7d4" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae6e824c-33df-48cd-9c48-f072cff65ba3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ae6e824c-33df-48cd-9c48-f072cff65ba3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseBorrowings_843445ff-4771-4056-8c74-de9929a41cc9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestExpenseBorrowings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_7772e5b0-7a2a-4b01-b12d-3290aa5ff5ba" xlink:to="loc_us-gaap_InterestExpenseBorrowings_843445ff-4771-4056-8c74-de9929a41cc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesAdditionalInformationDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesAdditionalInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2f00115b-ea63-40ec-ae2c-70e3e8e1b660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_2f00115b-ea63-40ec-ae2c-70e3e8e1b660" xlink:to="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_cb9ef674-f5e0-4355-a16f-ad09f602eb72" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_3604719f-5382-4d94-98a9-411488e1cec8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:to="loc_us-gaap_InterestRateSwapMember_3604719f-5382-4d94-98a9-411488e1cec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a979e984-b0a6-4922-900d-b778c228db1b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a979e984-b0a6-4922-900d-b778c228db1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForwardContractsMember_5fcf84a1-9ed7-4d97-8152-90d0750e6aa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForwardContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99cadf8d-8119-40bc-ae71-1c23b9d73f69" xlink:to="loc_us-gaap_ForwardContractsMember_5fcf84a1-9ed7-4d97-8152-90d0750e6aa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeTable_60b0cd99-0b76-4790-96a9-b53f787418e6" xlink:to="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_071ceb9b-540d-4bf9-99b7-9bd1da43d728" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_DerivativeNotionalAmount_071ceb9b-540d-4bf9-99b7-9bd1da43d728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeVariableInterestRate_719bdefe-d628-4f6e-81c7-7d5601630569" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeVariableInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_DerivativeVariableInterestRate_719bdefe-d628-4f6e-81c7-7d5601630569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ca7e6d51-50f1-41af-9ae5-19ff70b0aa45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_ca7e6d51-50f1-41af-9ae5-19ff70b0aa45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_NotationalAmount_32d29604-8c1c-4e8e-a182-38a385ae102e" xlink:href="holx-20221231.xsd#holx_NotationalAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeLineItems_c13ea29a-bb3d-4458-bf1a-c5f50bd97fa7" xlink:to="loc_holx_NotationalAmount_32d29604-8c1c-4e8e-a182-38a385ae102e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a0fc3fe3-99cd-404b-8280-fb65872c889a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_a0fc3fe3-99cd-404b-8280-fb65872c889a" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_9860bb7b-9d7d-48f3-a685-06ff521dcb1a" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_2d0f9802-cbd9-44c4-8f0d-3aa302a41693" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_2d0f9802-cbd9-44c4-8f0d-3aa302a41693" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_ea20fedc-c06b-44e2-a052-2f8cac323b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_9769db53-b8ac-4780-a72a-890fe7002cbf" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_ea20fedc-c06b-44e2-a052-2f8cac323b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:to="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_cdc98015-17e9-41b8-a456-960d07ab6918" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_d0d9329a-995a-489f-96b2-ce096b6cfb3e" xlink:to="loc_us-gaap_HedgingDesignationDomain_cdc98015-17e9-41b8-a456-960d07ab6918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_719c89ad-431f-419b-b554-4b8d67cb65dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_cdc98015-17e9-41b8-a456-960d07ab6918" xlink:to="loc_us-gaap_NondesignatedMember_719c89ad-431f-419b-b554-4b8d67cb65dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_bda5eb78-0534-4971-b37c-d5acb6091152" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6f053cea-a9ca-42cc-b82e-0df0e92cdf1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_6f053cea-a9ca-42cc-b82e-0df0e92cdf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_6b2e14e9-1dc0-4f2f-8bf6-33e0d57e5d19" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_6b2e14e9-1dc0-4f2f-8bf6-33e0d57e5d19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_20eeed33-ce48-44bf-aae4-5305fd9c06de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_6080024b-badb-40be-a6e4-023b2287f529" xlink:to="loc_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet_20eeed33-ce48-44bf-aae4-5305fd9c06de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesFairValueofDerivativeFinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b47040fd-36b2-4b4a-b40f-907d9eb03948" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_b47040fd-36b2-4b4a-b40f-907d9eb03948" xlink:to="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_b104522d-ad00-4d01-9dff-a92808ceb0f6" xlink:to="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NondesignatedMember_c486ba79-f03c-4113-9c10-b59063c17f51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NondesignatedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:to="loc_us-gaap_NondesignatedMember_c486ba79-f03c-4113-9c10-b59063c17f51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e3170c32-9447-4e5c-9731-ba2620df6813" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_381546aa-18cf-41d3-9284-6f2a02500aa9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_e3170c32-9447-4e5c-9731-ba2620df6813" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_8ccae942-a28f-4e58-aec2-bc7064764cac" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_4fa52625-b27b-4846-8abd-827ac27414d4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_4fa52625-b27b-4846-8abd-827ac27414d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeOptionMember_a422b363-477d-4556-9e29-5be3562bce1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ForeignExchangeOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:to="loc_us-gaap_ForeignExchangeOptionMember_a422b363-477d-4556-9e29-5be3562bce1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_f0a11707-f26c-4c54-a1a6-e49b7f5aef5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_99664c0d-a7f3-4922-a315-7a18fc2d1f4c" xlink:to="loc_us-gaap_InterestRateSwapMember_f0a11707-f26c-4c54-a1a6-e49b7f5aef5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_d643444f-5d97-49aa-901d-fe33bca2e0e9" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentAssetsMember_9e702069-e699-49ef-a26d-06a104ea3fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherCurrentAssetsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_OtherCurrentAssetsMember_9e702069-e699-49ef-a26d-06a104ea3fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsMember_46faf5f5-bfe9-4527-a1d8-390b7dfc0969" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_OtherAssetsMember_46faf5f5-bfe9-4527-a1d8-390b7dfc0969" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_11520a9a-d3c2-4ee3-a44d-315748644224" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_11520a9a-d3c2-4ee3-a44d-315748644224" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_73550c40-ac79-4d78-90d4-1fc0a19c543b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_c7db762f-3fee-4d1b-addf-6bc08952ef63" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_73550c40-ac79-4d78-90d4-1fc0a19c543b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable_549dcb1f-b103-464b-8d12-b2387410c53d" xlink:to="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_be83199b-3f22-4ce1-a3d8-e2d5e771e50c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:to="loc_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue_be83199b-3f22-4ce1-a3d8-e2d5e771e50c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a82ad0a8-b1e0-4ae3-be1f-8bd07b21018b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeFairValueOfDerivativeAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems_c98638b9-5a67-442f-add5-3d4e4afdb8ea" xlink:to="loc_us-gaap_DerivativeFairValueOfDerivativeAsset_a82ad0a8-b1e0-4ae3-be1f-8bd07b21018b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c8393ad5-d594-4350-a7ff-b4effca9e545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract_c8393ad5-d594-4350-a7ff-b4effca9e545" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_60388414-de3f-416d-82a5-9518934cec3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_72b7536b-408d-4546-9c89-4dd189fbc5b4" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_60388414-de3f-416d-82a5-9518934cec3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_976e526f-c07c-4f20-8b43-dc850053ff96" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_60388414-de3f-416d-82a5-9518934cec3e" xlink:to="loc_us-gaap_InterestRateSwapMember_976e526f-c07c-4f20-8b43-dc850053ff96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4ff52c57-0e34-440c-a225-a555a1a19d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DerivativeInstrumentsGainLossLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable_be91f0e2-e70e-48dd-8be7-95274aea6958" xlink:to="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4ff52c57-0e34-440c-a225-a555a1a19d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3d822611-d001-466b-8738-0274015d427c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentsGainLossLineItems_4ff52c57-0e34-440c-a225-a555a1a19d32" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax_3d822611-d001-466b-8738-0274015d427c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#CommitmentsandContingenciesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/CommitmentsandContingenciesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3cb2097-788d-45a5-a46c-a95aeb48a78a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_e3cb2097-788d-45a5-a46c-a95aeb48a78a" xlink:to="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:to="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_e29b70e6-7ea8-4ee4-832c-0da349c5fbb2" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_c4d4ea7b-8dc1-4882-a316-f31ee7fa34fc" xlink:to="loc_dei_EntityDomain_e29b70e6-7ea8-4ee4-832c-0da349c5fbb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinervaMember_3c80c4c8-ff6e-4d33-ab6c-d422989609f4" xlink:href="holx-20221231.xsd#holx_MinervaMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_e29b70e6-7ea8-4ee4-832c-0da349c5fbb2" xlink:to="loc_holx_MinervaMember_3c80c4c8-ff6e-4d33-ab6c-d422989609f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_9419569d-5488-4f17-a019-416fecf18f0b" xlink:to="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AmountAssessedInDamages_66c92b8a-72a9-4bb3-9a9e-8b024af743c4" xlink:href="holx-20221231.xsd#holx_AmountAssessedInDamages"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_holx_AmountAssessedInDamages_66c92b8a-72a9-4bb3-9a9e-8b024af743c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3ce1d836-21f7-4ef8-b17b-5f5aab689b06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LossContingencyNewClaimsFiledNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_us-gaap_LossContingencyNewClaimsFiledNumber_3ce1d836-21f7-4ef8-b17b-5f5aab689b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLegalSettlements_6ab7a064-ab29-477b-b05b-1c2f85366aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromLegalSettlements"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_675ac0f7-5120-4062-9765-071f5d965e21" xlink:to="loc_us-gaap_ProceedsFromLegalSettlements_6ab7a064-ab29-477b-b05b-1c2f85366aa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_db87b396-9d8b-48d0-b43a-c2224c255d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:href="holx-20221231.xsd#holx_EarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_db87b396-9d8b-48d0-b43a-c2224c255d22" xlink:to="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfbca6ac-7c87-48d4-80f0-322df7f15f1f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_3045b471-d52a-4d19-8659-7d0ae5fc0ed5" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfbca6ac-7c87-48d4-80f0-322df7f15f1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockCompensationPlanMember_a3804f3e-481b-42bd-b631-f2f6c54dc1c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockCompensationPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_bfbca6ac-7c87-48d4-80f0-322df7f15f1f" xlink:to="loc_us-gaap_StockCompensationPlanMember_a3804f3e-481b-42bd-b631-f2f6c54dc1c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:href="holx-20221231.xsd#holx_EarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareTable_e4ded58d-aa7c-4182-b885-416e2e439e9c" xlink:to="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_55043227-936a-4dce-96cc-b4fb76c2eba7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_55043227-936a-4dce-96cc-b4fb76c2eba7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_274f71ec-2ce7-40ca-b21c-76fa3b472706" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_274f71ec-2ce7-40ca-b21c-76fa3b472706" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47b94726-c826-416c-8ca8-8858d31486f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_47b94726-c826-416c-8ca8-8858d31486f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ff2cb3e-036e-4e56-b2d1-574a6bba57da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_EarningsPerShareLineItems_9e8d0114-4f72-4fd0-ad54-ee5ca40254cc" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ff2cb3e-036e-4e56-b2d1-574a6bba57da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f2d71076-67ad-4100-b03e-4157ec1f2d9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract_5ff2cb3e-036e-4e56-b2d1-574a6bba57da" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_f2d71076-67ad-4100-b03e-4157ec1f2d9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a599f75-f29b-49e4-a7cf-f3d0c4692aac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_0a599f75-f29b-49e4-a7cf-f3d0c4692aac" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_8c00470c-3448-4e93-bc7a-c9e629053c6e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c36cf9b7-9efc-4f6b-bbc7-91082f87ac5f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_CostOfSalesMember_c36cf9b7-9efc-4f6b-bbc7-91082f87ac5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_935541b3-310d-464a-8bdc-84a82dcf7512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_935541b3-310d-464a-8bdc-84a82dcf7512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingAndMarketingExpenseMember_ebc62561-8f81-4056-b678-d6105fa7cadb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingAndMarketingExpenseMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_SellingAndMarketingExpenseMember_ebc62561-8f81-4056-b678-d6105fa7cadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpenseMember_27133bc9-44dd-4b5d-9f45-ec91861c0102" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ff98b9c1-02d5-4225-b8b9-8a1a5c2f5a4b" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpenseMember_27133bc9-44dd-4b5d-9f45-ec91861c0102" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c0ff489-aad0-4a9b-8e09-f4e77b989fba" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_6f013d5b-3780-42b8-ad5e-972b4db4e79e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c0ff489-aad0-4a9b-8e09-f4e77b989fba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e252ae3a-e3d0-4f9f-99d4-2c40757a1647" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_1c0ff489-aad0-4a9b-8e09-f4e77b989fba" xlink:to="loc_us-gaap_ShareBasedCompensation_e252ae3a-e3d0-4f9f-99d4-2c40757a1647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_461f2d1c-8c3b-413e-aeec-ce18dfb711d6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_461f2d1c-8c3b-413e-aeec-ce18dfb711d6" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:to="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_565c6640-8d65-4539-b522-c35853c878ec" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_032a8ca3-5684-4357-96d3-472c0549f8bf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_us-gaap_EmployeeStockOptionMember_032a8ca3-5684-4357-96d3-472c0549f8bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_261fbe17-dd76-44a3-a652-f86d1b0a3ee1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_261fbe17-dd76-44a3-a652-f86d1b0a3ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_b13704e0-02be-48ab-b7fc-e0069a9da408" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_us-gaap_PerformanceSharesMember_b13704e0-02be-48ab-b7fc-e0069a9da408" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MarketBasedAwardsMember_90fb0e25-5a5e-4dfb-a48c-0ce07120ebcd" xlink:href="holx-20221231.xsd#holx_MarketBasedAwardsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_holx_MarketBasedAwardsMember_90fb0e25-5a5e-4dfb-a48c-0ce07120ebcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PSUFreeCashFlowMember_8ce7a76f-c221-425e-8b0f-639d9fdc09dd" xlink:href="holx-20221231.xsd#holx_PSUFreeCashFlowMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_holx_PSUFreeCashFlowMember_8ce7a76f-c221-425e-8b0f-639d9fdc09dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_RSUPSUMSUMember_45c76d40-8f0f-4a7c-b652-5b43e2d5dd54" xlink:href="holx-20221231.xsd#holx_RSUPSUMSUMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8547ae91-f062-4502-960f-f42b4f8492d5" xlink:to="loc_holx_RSUPSUMSUMember_45c76d40-8f0f-4a7c-b652-5b43e2d5dd54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_65831fbb-613c-4cff-927e-ad91e5f3f87c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3669a976-6fa6-4865-9547-f6326abe75f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_3669a976-6fa6-4865-9547-f6326abe75f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d3bb2ac1-a054-4030-902e-caa64c494222" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_d3bb2ac1-a054-4030-902e-caa64c494222" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9e22db15-d491-434c-8e21-a6b4159d4e24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_9e22db15-d491-434c-8e21-a6b4159d4e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0244ea93-534e-4381-9154-1c88a9adcb15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0244ea93-534e-4381-9154-1c88a9adcb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bdb4ea-bc33-4ecf-9232-4574aba19f04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_01bdb4ea-bc33-4ecf-9232-4574aba19f04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dcfdf17a-9bfa-4a0a-bdba-15e0a5964625" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_dcfdf17a-9bfa-4a0a-bdba-15e0a5964625" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4f1439c2-3188-43ca-836f-8a7a9f1c8908" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_4f1439c2-3188-43ca-836f-8a7a9f1c8908" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d117c04c-a991-4870-b5af-a93d432a04b8" xlink:href="holx-20221231.xsd#holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent_d117c04c-a991-4870-b5af-a93d432a04b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_c6174555-71ae-49d5-a3ae-5f700abc11b8" xlink:href="holx-20221231.xsd#holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent_c6174555-71ae-49d5-a3ae-5f700abc11b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_6200edcf-2aed-4458-bcfc-ee78971bba19" xlink:href="holx-20221231.xsd#holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod_6200edcf-2aed-4458-bcfc-ee78971bba19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3e97daad-ff16-4a9a-83cc-60dba68de289" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_3e97daad-ff16-4a9a-83cc-60dba68de289" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7c269d30-3d91-4c05-9f63-8f1e6e944506" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_f3dd1891-59b8-449a-bfee-779f691a7571" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_7c269d30-3d91-4c05-9f63-8f1e6e944506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f657599-908a-4a9f-b868-4ee36d812f47" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ca8ba64-8673-4a66-b172-d464968a37cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f657599-908a-4a9f-b868-4ee36d812f47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_5ca8ba64-8673-4a66-b172-d464968a37cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_7468bf70-a793-49bc-957b-000f770853ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f657599-908a-4a9f-b868-4ee36d812f47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_7468bf70-a793-49bc-957b-000f770853ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_397b197e-dbed-484d-8dfa-34192725ae7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f657599-908a-4a9f-b868-4ee36d812f47" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_397b197e-dbed-484d-8dfa-34192725ae7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_5e0f69e4-d022-435c-a34d-8afbfda56c88" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f657599-908a-4a9f-b868-4ee36d812f47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend_5e0f69e4-d022-435c-a34d-8afbfda56c88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab71d559-629a-4313-a763-148e2cc3301b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_7f657599-908a-4a9f-b868-4ee36d812f47" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_ab71d559-629a-4313-a763-148e2cc3301b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#OtherBalanceSheetInformationInventoriesDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_199da11f-5f8c-439c-b0cb-7276d45179d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_40701fa6-2492-49cd-afeb-b933b8f8add4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_199da11f-5f8c-439c-b0cb-7276d45179d7" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_40701fa6-2492-49cd-afeb-b933b8f8add4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4597edf7-e6c7-4883-be25-5ccbfd17bab2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_199da11f-5f8c-439c-b0cb-7276d45179d7" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_4597edf7-e6c7-4883-be25-5ccbfd17bab2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c6c5d094-6e5b-4bbf-a89d-29bb864c4c69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_199da11f-5f8c-439c-b0cb-7276d45179d7" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_c6c5d094-6e5b-4bbf-a89d-29bb864c4c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_7b4380a6-b918-48f6-b5c9-69c832996c72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_199da11f-5f8c-439c-b0cb-7276d45179d7" xlink:to="loc_us-gaap_InventoryNet_7b4380a6-b918-48f6-b5c9-69c832996c72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BalanceSheetRelatedDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ManufacturingEquipmentAndSoftware_4661b184-871e-45b2-9ad0-331c6c9f637f" xlink:href="holx-20221231.xsd#holx_ManufacturingEquipmentAndSoftware"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_holx_ManufacturingEquipmentAndSoftware_4661b184-871e-45b2-9ad0-331c6c9f637f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_EquipmentUnderCustomerUsageAgreements_24a0e42a-cbd5-43bb-992c-760e4c197ae9" xlink:href="holx-20221231.xsd#holx_EquipmentUnderCustomerUsageAgreements"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_holx_EquipmentUnderCustomerUsageAgreements_24a0e42a-cbd5-43bb-992c-760e4c197ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingsAndImprovementsGross_9ff16664-bd22-4df8-b3ef-f79473e6b718" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BuildingsAndImprovementsGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_BuildingsAndImprovementsGross_9ff16664-bd22-4df8-b3ef-f79473e6b718" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsGross_62af2a3b-7e05-4748-b72a-5db2838440f3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_LeaseholdImprovementsGross_62af2a3b-7e05-4748-b72a-5db2838440f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Land_aadd2fac-d394-4c37-a4f0-576070bad924" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Land"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_Land_aadd2fac-d394-4c37-a4f0-576070bad924" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesGross_28f2ee7b-ddba-4bcc-a9ad-13542c361e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_FurnitureAndFixturesGross_28f2ee7b-ddba-4bcc-a9ad-13542c361e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_142db92e-35b9-4625-b9b9-3963d1003eb3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_142db92e-35b9-4625-b9b9-3963d1003eb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_e5d07b27-7e6e-4363-8a43-111d9595e22a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_e5d07b27-7e6e-4363-8a43-111d9595e22a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_722a1278-3ea7-4257-ad70-35d675e063b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_722a1278-3ea7-4257-ad70-35d675e063b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_f29525cb-b7f8-4ef3-ab21-d3ddd4e83379" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_f29525cb-b7f8-4ef3-ab21-d3ddd4e83379" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GrantsReceivedFromDepartmentOfDefense_35cfd8c9-24ff-48a5-9665-62b00ff24cd4" xlink:href="holx-20221231.xsd#holx_GrantsReceivedFromDepartmentOfDefense"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_holx_GrantsReceivedFromDepartmentOfDefense_35cfd8c9-24ff-48a5-9665-62b00ff24cd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrantsReceivableCurrent_6646fadd-8804-4e39-9804-897a880d990a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrantsReceivableCurrent"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_us-gaap_GrantsReceivableCurrent_6646fadd-8804-4e39-9804-897a880d990a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceived_5c2dde8e-5d03-4d82-b5d5-672c0e9d0eea" xlink:href="holx-20221231.xsd#holx_DepartmentOfDefenseFundsReceived"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_holx_DepartmentOfDefenseFundsReceived_5c2dde8e-5d03-4d82-b5d5-672c0e9d0eea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DepartmentOfDefenseFundsReceivedNotCapitalized_2c7d495e-39dd-4d94-add7-88af17ebce0e" xlink:href="holx-20221231.xsd#holx_DepartmentOfDefenseFundsReceivedNotCapitalized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetRelatedDisclosuresAbstract_029a0a94-633d-45e4-beb1-74f68a04d162" xlink:to="loc_holx_DepartmentOfDefenseFundsReceivedNotCapitalized_2c7d495e-39dd-4d94-add7-88af17ebce0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationAdditionalInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_41e03a24-6507-4ace-ad48-729fa9de2f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_41e03a24-6507-4ace-ad48-729fa9de2f85" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:to="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ConsolidationItemsDomain_77d656ea-7288-4bef-b19f-297654ac7534" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ConsolidationItemsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsAxis_5a40cac8-58c1-47b6-8002-e7b6035b65a2" xlink:to="loc_srt_ConsolidationItemsDomain_77d656ea-7288-4bef-b19f-297654ac7534" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntersegmentEliminationMember_5e3a1824-2511-4375-a67c-15941eb13d6a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IntersegmentEliminationMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ConsolidationItemsDomain_77d656ea-7288-4bef-b19f-297654ac7534" xlink:to="loc_us-gaap_IntersegmentEliminationMember_5e3a1824-2511-4375-a67c-15941eb13d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:href="holx-20221231.xsd#holx_SegmentReportingDisclosureLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_8fa72bc8-2f3f-4544-b26c-58b1d4c368b1" xlink:to="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_ba12464a-b22e-437a-bf52-bf4124abc6e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:to="loc_us-gaap_NumberOfReportableSegments_ba12464a-b22e-437a-bf52-bf4124abc6e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_7f8a1de8-6356-4a7d-bd84-836e8d5d2d7a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SegmentReportingDisclosureLineItems_24820cc1-1f87-407e-b4ec-bc4ae1dc6b8b" xlink:to="loc_us-gaap_Revenues_7f8a1de8-6356-4a7d-bd84-836e8d5d2d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationSegmentInformationDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_17b7ee76-2a7d-487b-84c5-60f5e329179b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_17b7ee76-2a7d-487b-84c5-60f5e329179b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_55fe073b-7f4a-4778-84c1-646b4452e578" xlink:to="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DiagnosticsMember_5f5f0100-f1fe-4aeb-8ab6-91f4539645f5" xlink:href="holx-20221231.xsd#holx_DiagnosticsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_DiagnosticsMember_5f5f0100-f1fe-4aeb-8ab6-91f4539645f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_BreastHealthMember_d97e62d4-4bc0-45b5-9436-3e75abd54470" xlink:href="holx-20221231.xsd#holx_BreastHealthMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_BreastHealthMember_d97e62d4-4bc0-45b5-9436-3e75abd54470" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_GynSurgicalMember_d6ccffb5-5eb7-4720-9e95-342d19dbf475" xlink:href="holx-20221231.xsd#holx_GynSurgicalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_GynSurgicalMember_d6ccffb5-5eb7-4720-9e95-342d19dbf475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SkeletalHealthMember_e7641b5a-7955-4680-bd25-007c567681db" xlink:href="holx-20221231.xsd#holx_SkeletalHealthMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_holx_SkeletalHealthMember_e7641b5a-7955-4680-bd25-007c567681db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateMember_83ab887d-d057-4f3c-a9f5-92ea7e0c5e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CorporateMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_9ec18c2b-c6da-4d56-8ac3-322bed02c0c2" xlink:to="loc_us-gaap_CorporateMember_83ab887d-d057-4f3c-a9f5-92ea7e0c5e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_a1909039-0759-47c7-999c-0e062ede15b5" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_32817f71-a0db-4142-9bc3-841f6f6f833e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_Revenues_32817f71-a0db-4142-9bc3-841f6f6f833e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_4814323f-fffd-4fc5-995f-1952712c4525" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_OperatingIncomeLoss_4814323f-fffd-4fc5-995f-1952712c4525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1d542a4c-905c-4f9c-9986-4b9cfda50727" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationAmortizationAndAccretionNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_DepreciationAmortizationAndAccretionNet_1d542a4c-905c-4f9c-9986-4b9cfda50727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireProductiveAssets_5f1c0f2f-86e4-4918-a050-55c7803175cc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquireProductiveAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_PaymentsToAcquireProductiveAssets_5f1c0f2f-86e4-4918-a050-55c7803175cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_e88568c6-79b3-44c7-9565-9f7a1d3b15d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_ad2e6668-456a-499f-ad84-c46445618bdd" xlink:to="loc_us-gaap_Assets_e88568c6-79b3-44c7-9565-9f7a1d3b15d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_c5017153-6b00-4596-b0ad-0752c440895b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:href="holx-20221231.xsd#holx_ScheduleOfGeographicalSegmentsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_c5017153-6b00-4596-b0ad-0752c440895b" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:to="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_9415682c-d400-49d1-b4f3-f60f590710fa" xlink:to="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_99a0e88f-7cff-4741-bee9-64fad8b27837" xlink:href="https://xbrl.sec.gov/country/2022/country-2022.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_country_US_99a0e88f-7cff-4741-bee9-64fad8b27837" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_f940cc2c-7907-43a2-8344-28e5e142a767" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_EuropeMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_srt_EuropeMember_f940cc2c-7907-43a2-8344-28e5e142a767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_AsiaPacificMember_5902ea06-2945-46a9-b2e6-633c16948488" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_AsiaPacificMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_srt_AsiaPacificMember_5902ea06-2945-46a9-b2e6-633c16948488" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AllOtherCountriesMember_bebe7a32-ca09-4cdb-9ed5-d2125fb6f0cb" xlink:href="holx-20221231.xsd#holx_AllOtherCountriesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_bf8e5cee-e481-42ff-868f-64db318e36ed" xlink:to="loc_holx_AllOtherCountriesMember_bebe7a32-ca09-4cdb-9ed5-d2125fb6f0cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_ScheduleOfGeographicalSegmentsLineItems_6884ff6b-2b5e-44fd-931e-0a2df596de0b" xlink:href="holx-20221231.xsd#holx_ScheduleOfGeographicalSegmentsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsTable_5a46e14d-d99c-45ab-9bea-f1874db24009" xlink:to="loc_holx_ScheduleOfGeographicalSegmentsLineItems_6884ff6b-2b5e-44fd-931e-0a2df596de0b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_PercentageOfRevenues_d238da86-9790-43e1-9b09-e519d4c5d84b" xlink:href="holx-20221231.xsd#holx_PercentageOfRevenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_ScheduleOfGeographicalSegmentsLineItems_6884ff6b-2b5e-44fd-931e-0a2df596de0b" xlink:to="loc_holx_PercentageOfRevenues_d238da86-9790-43e1-9b09-e519d4c5d84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_710810e4-14af-4fe7-8f30-830d69d6eb94" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fd0a41e4-4021-4f12-baf5-597b6f982835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_710810e4-14af-4fe7-8f30-830d69d6eb94" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_fd0a41e4-4021-4f12-baf5-597b6f982835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5bd5eb3a-39ab-4f7c-96c4-542bb4e215ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_5bd5eb3a-39ab-4f7c-96c4-542bb4e215ee" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_39b42586-e559-4d64-aca0-654dfe5ae2bd" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_DevelopedTechnologyMember_a4490af8-4f67-4fca-97cf-f39532df7988" xlink:href="holx-20221231.xsd#holx_DevelopedTechnologyMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_DevelopedTechnologyMember_a4490af8-4f67-4fca-97cf-f39532df7988" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_57dfdd86-5e95-4849-8c05-e8724005626b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_57dfdd86-5e95-4849-8c05-e8724005626b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CustomerRelationshipsContractsMember_e5fa4ac3-1363-4ad4-887b-78dfd639cd0d" xlink:href="holx-20221231.xsd#holx_CustomerRelationshipsContractsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_CustomerRelationshipsContractsMember_e5fa4ac3-1363-4ad4-887b-78dfd639cd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_a7e895f9-1099-4111-bf7b-d9b2e3fb7f5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_us-gaap_TradeNamesMember_a7e895f9-1099-4111-bf7b-d9b2e3fb7f5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_AcquiredintangibleassetsMember_c80d1781-c300-4123-8709-9ca0a15f3923" xlink:href="holx-20221231.xsd#holx_AcquiredintangibleassetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_AcquiredintangibleassetsMember_c80d1781-c300-4123-8709-9ca0a15f3923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_InternalusesoftwareMember_4cb2aaf6-24f0-47f5-9570-8decee4ee228" xlink:href="holx-20221231.xsd#holx_InternalusesoftwareMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_InternalusesoftwareMember_4cb2aaf6-24f0-47f5-9570-8decee4ee228" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_CapitalizedsoftwareMember_95f9c94f-2941-4753-b095-fecf92250c4a" xlink:href="holx-20221231.xsd#holx_CapitalizedsoftwareMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_21217e87-4d8a-4c66-baea-e2faece70980" xlink:to="loc_holx_CapitalizedsoftwareMember_95f9c94f-2941-4753-b095-fecf92250c4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_b91e9b11-988d-4ad8-a550-d3be473c3189" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_470dd5ba-53ca-42e1-9e6d-f4002eea82c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_470dd5ba-53ca-42e1-9e6d-f4002eea82c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bf78a43c-c9be-44fb-a78d-cef97ff1cd64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3b0e048e-0a0b-4d1a-8475-3109e2b210de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bf78a43c-c9be-44fb-a78d-cef97ff1cd64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9309a47-688e-450d-b1db-ca22d165a7f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ffd52b33-272c-4057-a338-9447ca8522e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9309a47-688e-450d-b1db-ca22d165a7f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_ffd52b33-272c-4057-a338-9447ca8522e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fa2b8795-9ec9-489d-b812-d687217ef7e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9309a47-688e-450d-b1db-ca22d165a7f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fa2b8795-9ec9-489d-b812-d687217ef7e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c76d4b12-bd81-40d7-8d75-38cedd889a22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9309a47-688e-450d-b1db-ca22d165a7f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_c76d4b12-bd81-40d7-8d75-38cedd889a22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_af073cd1-da79-482c-a849-14aac9b45d3e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9309a47-688e-450d-b1db-ca22d165a7f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_af073cd1-da79-482c-a849-14aac9b45d3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_132137e0-51ff-4bc6-9238-70f833489bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_c9309a47-688e-450d-b1db-ca22d165a7f2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_132137e0-51ff-4bc6-9238-70f833489bbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#ProductWarrantiesProductWarrantyActivityDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GuaranteesAbstract_e9ae0565-b52a-45a7-b5ce-6350b5c639e3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GuaranteesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_b6050c34-3fb6-4d3c-abfe-270a4820c255" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GuaranteesAbstract_e9ae0565-b52a-45a7-b5ce-6350b5c639e3" xlink:to="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_b6050c34-3fb6-4d3c-abfe-270a4820c255" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_cbacf0ca-6c01-4a7a-8f86-16c11ecf1fec" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_b6050c34-3fb6-4d3c-abfe-270a4820c255" xlink:to="loc_us-gaap_ProductWarrantyAccrual_cbacf0ca-6c01-4a7a-8f86-16c11ecf1fec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_6583e7a0-187e-4df6-b746-fbd669245712" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualWarrantiesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_b6050c34-3fb6-4d3c-abfe-270a4820c255" xlink:to="loc_us-gaap_ProductWarrantyAccrualWarrantiesIssued_6583e7a0-187e-4df6-b746-fbd669245712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_6c4a7885-934b-49c5-9947-cfb08cf9752c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_b6050c34-3fb6-4d3c-abfe-270a4820c255" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_6c4a7885-934b-49c5-9947-cfb08cf9752c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrual_b3855c52-3db6-4c56-b1cc-07a9d8497243" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward_b6050c34-3fb6-4d3c-abfe-270a4820c255" xlink:to="loc_us-gaap_ProductWarrantyAccrual_b3855c52-3db6-4c56-b1cc-07a9d8497243" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="simple" xlink:href="holx-20221231.xsd#AccumulatedOtherComprehensiveIncomeDetail"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_83bee124-cbd6-4868-9b57-34c8c1526d91" xlink:href="holx-20221231.xsd#holx_AccumulatedOtherComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_AccumulatedOtherComprehensiveIncomeAbstract_83bee124-cbd6-4868-9b57-34c8c1526d91" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:to="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7b1d611-a650-4077-b89a-0237cd9856dd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_0ae88159-11fe-4333-b564-cfe0b441333e" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7b1d611-a650-4077-b89a-0237cd9856dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestRateSwapMember_0acd46ba-73bd-4c85-aff8-da7a2b45b172" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InterestRateSwapMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_d7b1d611-a650-4077-b89a-0237cd9856dd" xlink:to="loc_us-gaap_InterestRateSwapMember_0acd46ba-73bd-4c85-aff8-da7a2b45b172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_8b34ad09-75ab-4b4e-a031-97db99c2a787" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ed147303-db89-4db4-b86b-291a586d73b4" xlink:to="loc_us-gaap_EquityComponentDomain_8b34ad09-75ab-4b4e-a031-97db99c2a787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_8b34ad09-75ab-4b4e-a031-97db99c2a787" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dbe59c91-aafd-4da8-abce-532b52df4f8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedTranslationAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:to="loc_us-gaap_AccumulatedTranslationAdjustmentMember_dbe59c91-aafd-4da8-abce-532b52df4f8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_82a7e43b-552d-4228-ac3c-0c1612af53c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:to="loc_us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember_82a7e43b-552d-4228-ac3c-0c1612af53c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8127b76f-196c-4adb-8bd2-143a814fced1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_eba95ccd-f3d6-4dac-86dc-61eebac12430" xlink:to="loc_us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember_8127b76f-196c-4adb-8bd2-143a814fced1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossTable_72e85db1-e6c1-47de-afbb-c4499c3df340" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8b9e7217-d0a8-44de-a663-fe673cd8c7f8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:to="loc_us-gaap_StockholdersEquity_8b9e7217-d0a8-44de-a663-fe673cd8c7f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f8269ef8-ef28-4eb4-ac19-c5366ad2b682" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:to="loc_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent_f8269ef8-ef28-4eb4-ac19-c5366ad2b682" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a003c5ba-25a7-4f37-aa58-b1b7fdf23f6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems_1e99b3ed-ca8f-40e9-b621-28b60687ff54" xlink:to="loc_us-gaap_StockholdersEquity_a003c5ba-25a7-4f37-aa58-b1b7fdf23f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="simple" xlink:href="holx-20221231.xsd#ShareRepurchaseSharerepurchaseDetails"/>
  <link:presentationLink xlink:role="http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_e33ec653-acb2-49dd-8764-c553e8a18b4c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:href="holx-20221231.xsd#holx_SharerepurchaseplanTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_e33ec653-acb2-49dd-8764-c553e8a18b4c" xlink:to="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:to="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramAxis_a80f7fd2-28da-43bd-89af-aa3a95fdb90c" xlink:to="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_September222022Member_0cdaa851-3e56-4682-992b-aa0e4784a702" xlink:href="holx-20221231.xsd#holx_September222022Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:to="loc_holx_September222022Member_0cdaa851-3e56-4682-992b-aa0e4784a702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_December112020Member_4cb23587-9272-4373-9c6c-de624aa96967" xlink:href="holx-20221231.xsd#holx_December112020Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareRepurchaseProgramDomain_7b9b6e7d-8d4f-4cbd-a251-e69b38d7c4f1" xlink:to="loc_holx_December112020Member_4cb23587-9272-4373-9c6c-de624aa96967" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:href="holx-20221231.xsd#holx_SharerepurchaseplanLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanTable_3b7e44b8-bd53-4590-8962-050a59185efa" xlink:to="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ced1762e-bc40-4703-a26c-b958f924b27b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchaseProgramAuthorizedAmount1_ced1762e-bc40-4703-a26c-b958f924b27b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodShares_34663870-ca49-4133-be37-b6b7ecee1f0f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodShares_34663870-ca49-4133-be37-b6b7ecee1f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c54b813f-7cd0-4335-a1e0-cad2df3c95db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1_c54b813f-7cd0-4335-a1e0-cad2df3c95db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockRepurchasedDuringPeriodValue_e6e3bce0-ef25-4a4f-8c0e-b14d4b4feeff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockRepurchasedDuringPeriodValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_holx_SharerepurchaseplanLineItems_6d4d855c-f736-41ce-9523-e5941dde7c38" xlink:to="loc_us-gaap_StockRepurchasedDuringPeriodValue_e6e3bce0-ef25-4a4f-8c0e-b14d4b4feeff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732150336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">01752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-36214<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">HOLOGIC, INC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000859737<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--09-28<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">246,554,026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(508)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">263-2900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">04-2902449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">250 Campus Drive,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Marlborough,<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HOLX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732935568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Income - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenuesAbstract', window );"><strong>Revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ProductRevenue', window );">Product</a></td>
<td class="nump">$ 886.3<span></span>
</td>
<td class="nump">$ 1,303.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ServiceRevenue', window );">Service and other</a></td>
<td class="nump">187.9<span></span>
</td>
<td class="nump">167.8<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">1,074.2<span></span>
</td>
<td class="nump">1,471.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenueAbstract', window );"><strong>Costs of revenues:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Product</a></td>
<td class="nump">296.2<span></span>
</td>
<td class="nump">318.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AmortizationCostofGoodsSold', window );">Amortization, Cost of Goods Sold</a></td>
<td class="nump">55.6<span></span>
</td>
<td class="nump">74.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Costofservice', window );">Service and other</a></td>
<td class="nump">104.5<span></span>
</td>
<td class="nump">91.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">617.9<span></span>
</td>
<td class="nump">986.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">74.8<span></span>
</td>
<td class="nump">72.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingAndMarketingExpense', window );">Selling and marketing</a></td>
<td class="nump">163.5<span></span>
</td>
<td class="nump">147.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">108.5<span></span>
</td>
<td class="nump">117.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="nump">10.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1', window );">Contingent consideration - fair value adjustment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Operating expenses</a></td>
<td class="nump">355.5<span></span>
</td>
<td class="nump">345.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income from operations</a></td>
<td class="nump">262.4<span></span>
</td>
<td class="nump">641.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(28.1)<span></span>
</td>
<td class="num">(25.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="num">(15.8)<span></span>
</td>
<td class="nump">6.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">239.1<span></span>
</td>
<td class="nump">621.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="nump">51.7<span></span>
</td>
<td class="nump">122.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 187.4<span></span>
</td>
<td class="nump">$ 499.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net income per common share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic (in usd per share)</a></td>
<td class="nump">$ 0.76<span></span>
</td>
<td class="nump">$ 1.97<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted (in usd per share)</a></td>
<td class="nump">$ 0.75<span></span>
</td>
<td class="nump">$ 1.95<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted average number of shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic (in shares)</a></td>
<td class="nump">247,319<span></span>
</td>
<td class="nump">253,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted (in shares)</a></td>
<td class="nump">249,281<span></span>
</td>
<td class="nump">256,070<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmortizationCostofGoodsSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization, Cost of Goods Sold</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmortizationCostofGoodsSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Costofservice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cost of service</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Costofservice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProductRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Product Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProductRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ServiceRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Service Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ServiceRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of right to a contingent consideration asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI https://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941158&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenuesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenuesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total amount of expenses directly related to the marketing or selling of products or services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732918976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 187.4<span></span>
</td>
<td class="nump">$ 499.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI', window );">Changes in foreign currency translation adjustment</a></td>
<td class="nump">113.8<span></span>
</td>
<td class="num">(37.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax', window );">Gain (loss) recognized in other comprehensive income (loss), net</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income (loss)</a></td>
<td class="nump">110.9<span></span>
</td>
<td class="num">(29.9)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 298.3<span></span>
</td>
<td class="nump">$ 469.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727966016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Loss (Parenthetical) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax', window );">Tax</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="nump">$ 2.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e640-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445731994208">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 2,441.3<span></span>
</td>
<td class="nump">$ 2,339.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, less reserves</a></td>
<td class="nump">673.8<span></span>
</td>
<td class="nump">617.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">677.7<span></span>
</td>
<td class="nump">623.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid Expense, Current</a></td>
<td class="nump">197.3<span></span>
</td>
<td class="nump">232.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PrepaidIncomeTaxesCurrent', window );">Prepaid Income Taxes-Current</a></td>
<td class="nump">31.1<span></span>
</td>
<td class="nump">49.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,021.2<span></span>
</td>
<td class="nump">3,862.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">494.3<span></span>
</td>
<td class="nump">481.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net</a></td>
<td class="nump">1,255.4<span></span>
</td>
<td class="nump">1,280.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">3,289.6<span></span>
</td>
<td class="nump">3,236.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">229.8<span></span>
</td>
<td class="nump">210.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">9,290.3<span></span>
</td>
<td class="nump">9,071.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">201.8<span></span>
</td>
<td class="nump">197.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">539.0<span></span>
</td>
<td class="nump">535.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueCurrent', window );">Deferred revenue</a></td>
<td class="nump">191.6<span></span>
</td>
<td class="nump">186.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease obligations</a></td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">956.2<span></span>
</td>
<td class="nump">937.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term debt, net of current portion</a></td>
<td class="nump">2,806.2<span></span>
</td>
<td class="nump">2,808.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations, net of current portion</a></td>
<td class="nump">17.7<span></span>
</td>
<td class="nump">18.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred Income Tax Liabilities, Net</a></td>
<td class="nump">71.7<span></span>
</td>
<td class="nump">90.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredRevenueNoncurrent', window );">Deferred revenue, net of current portion</a></td>
<td class="nump">10.9<span></span>
</td>
<td class="nump">9.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">335.1<span></span>
</td>
<td class="nump">330.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.01 par value &#8211; 1,623 shares authorized; 0 shares issued</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.01 par value &#8211; 750,000 shares authorized; 299,485 and 298,533 shares issued, respectively</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">6,060.6<span></span>
</td>
<td class="nump">6,042.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,787.7<span></span>
</td>
<td class="nump">1,600.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury stock, at cost &#8211; 52,940 and 51,401 shares, respectively</a></td>
<td class="num">(2,631.5)<span></span>
</td>
<td class="num">(2,531.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(127.3)<span></span>
</td>
<td class="num">(238.2)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">5,092.5<span></span>
</td>
<td class="nump">4,876.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 9,290.3<span></span>
</td>
<td class="nump">$ 9,071.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrepaidIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Income Taxes-Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrepaidIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredRevenueNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredRevenueNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126905020&amp;loc=d3e5879-108316<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732048368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, authorized (in shares)</a></td>
<td class="nump">1,623,000,000<span></span>
</td>
<td class="nump">1,623,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 10,000.00<span></span>
</td>
<td class="nump">$ 10,000.00<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">750,000,000,000<span></span>
</td>
<td class="nump">750,000,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">299,485,000,000<span></span>
</td>
<td class="nump">298,533,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock (in shares)</a></td>
<td class="nump">52,940,000,000<span></span>
</td>
<td class="nump">51,401,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720622080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Thousands, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 4,218.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,653<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Sep. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 5,965.8<span></span>
</td>
<td class="nump">$ 298.3<span></span>
</td>
<td class="num">$ (59.1)<span></span>
</td>
<td class="num">$ (1,989.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">534<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(22.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">499.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(29.9)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,335<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">499.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="num">(167.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (167.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">297,885<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,988<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 25, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,964.0<span></span>
</td>
<td class="nump">797.5<span></span>
</td>
<td class="num">(89.0)<span></span>
</td>
<td class="num">$ (2,156.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,519.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">164<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">455.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(15.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">455.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (200.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Mar. 26, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,203<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,851<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 26, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">5,997.0<span></span>
</td>
<td class="nump">1,253.2<span></span>
</td>
<td class="num">(104.1)<span></span>
</td>
<td class="num">$ (2,356.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,792.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">228.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">228.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Jun. 25, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,851<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Jun. 25, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,017.4<span></span>
</td>
<td class="nump">1,481.6<span></span>
</td>
<td class="num">(147.7)<span></span>
</td>
<td class="num">$ (2,356.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,997.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">166<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">118.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(90.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,550<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">118.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (175.1)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Sep. 24, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">298,533<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,401<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Sep. 24, 2022</a></td>
<td class="nump">4,876.2<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">6,042.6<span></span>
</td>
<td class="nump">1,600.3<span></span>
</td>
<td class="num">(238.2)<span></span>
</td>
<td class="nump">$ 2,531.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">4,876.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">267<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings', window );">Vesting of restricted stock units, net of shares withheld for employee taxes</a></td>
<td class="num">(23.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(23.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Common stock issued under the employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">171<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Common stock issued under the employee stock purchase plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">187.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax', window );">Other comprehensive income activity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Repurchase of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,539<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Netincome', window );">Net income</a></td>
<td class="nump">187.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredParValueMethod', window );">Repurchase of common stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (100.0)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Balance (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">299,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,940<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2022</a></td>
<td class="nump">5,092.5<span></span>
</td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="nump">$ 6,060.6<span></span>
</td>
<td class="nump">$ 1,787.7<span></span>
</td>
<td class="num">$ (127.3)<span></span>
</td>
<td class="num">$ (2,631.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest</a></td>
<td class="nump">$ 5,092.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Netincome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net income attributable to Hologic</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Netincome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442407-227067<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=124507222&amp;loc=d3e1436-108581<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124442411-227067<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568740-111683<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21711-107793<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 17<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32136-110900<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -URI https://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4590271-111686<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br><br>Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126929396&amp;loc=SL4568447-111683<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredParValueMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredParValueMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445719315104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 187.4<span></span>
</td>
<td class="nump">$ 499.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to net cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">22.7<span></span>
</td>
<td class="nump">22.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization of acquired intangible assets</a></td>
<td class="nump">63.2<span></span>
</td>
<td class="nump">85.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">20.5<span></span>
</td>
<td class="nump">18.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(26.2)<span></span>
</td>
<td class="num">(21.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other adjustments and non-cash items</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">5.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities, excluding the effect of acquisitions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(45.0)<span></span>
</td>
<td class="num">(48.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(47.0)<span></span>
</td>
<td class="num">(17.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidTaxes', window );">Prepaid income taxes</a></td>
<td class="nump">17.9<span></span>
</td>
<td class="num">(4.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other assets</a></td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(13.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued expenses and other liabilities</a></td>
<td class="nump">0.8<span></span>
</td>
<td class="nump">42.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">2.3<span></span>
</td>
<td class="num">(5.0)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">253.4<span></span>
</td>
<td class="nump">564.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisition of businesses, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(157.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromProductiveAssets', window );">Capital expenditures</a></td>
<td class="num">(15.8)<span></span>
</td>
<td class="num">(20.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion', window );">Proceeds from the Department of Defense</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">21.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements', window );">Increase in equipment under customer usage agreements</a></td>
<td class="num">(13.3)<span></span>
</td>
<td class="num">(17.0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Payments for (Proceeds from) Other Investing Activities</a></td>
<td class="num">(1.9)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Purchaseofinsurancecontracts', window );">Purchase of insurance contracts</a></td>
<td class="num">(10.0)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(41.0)<span></span>
</td>
<td class="num">(173.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt', window );">Proceeds from long-term debt, net of issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,491.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfLongTermDebt', window );">Repayment of long-term debt</a></td>
<td class="num">(3.8)<span></span>
</td>
<td class="num">(1,387.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities', window );">Payment of deferred acquisition consideration</a></td>
<td class="num">(0.8)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_Repaymentsofacquiredlongtermdebt', window );">Repayments of acquired long term debt</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(63.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Repurchase of common stock</a></td>
<td class="num">(100.0)<span></span>
</td>
<td class="num">(167.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions', window );">Proceeds from issuance of common stock pursuant to employee stock plans</a></td>
<td class="nump">15.1<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits', window );">Payment of minimum tax withholdings on net share settlements of equity awards</a></td>
<td class="num">(23.0)<span></span>
</td>
<td class="num">(22.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PaymentsUnderFinanceLeaseObligations', window );">Payments under finance lease obligations</a></td>
<td class="num">(1.0)<span></span>
</td>
<td class="num">(0.6)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(113.5)<span></span>
</td>
<td class="num">(143.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash and cash equivalents</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash and cash equivalents</a></td>
<td class="nump">101.8<span></span>
</td>
<td class="nump">250.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, beginning of period</a></td>
<td class="nump">2,339.5<span></span>
</td>
<td class="nump">1,170.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash and cash equivalents, end of period</a></td>
<td class="nump">$ 2,441.3<span></span>
</td>
<td class="nump">$ 1,420.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PaymentsUnderFinanceLeaseObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments under finance lease obligations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PaymentsUnderFinanceLeaseObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Proceeds received from government grants for capacity expansion</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Purchaseofinsurancecontracts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Purchase of insurance contracts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Purchaseofinsurancecontracts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_Repaymentsofacquiredlongtermdebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Repayments of acquired long term debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_Repaymentsofacquiredlongtermdebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3179-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from other long-term debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445730290528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Basis of Presentation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BasisofPresentationAbstract', window );"><strong>Basis of Presentation [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements of Hologic, Inc. (&#8220;Hologic&#8221; or the &#8220;Company&#8221;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#8220;SEC&#8221;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#8220;GAAP&#8221;) for annual financial statements. These unaudited financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;24, 2022 included in the Company&#8217;s Form&#160;10-K filed with the SEC on November&#160;15, 2022. In the opinion of management, the unaudited financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#8217;s financial position, results of operations and cash flows for the periods presented.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#8217;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three months ended December&#160;31, 2022 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;30, 2023. Fiscal 2023 is a 53-week fiscal year, and the additional week is included in the first quarter of fiscal 2023 consistent with the Company's historical fiscal calendar.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Subsequent Events Consideration</span></div>The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three months ended December&#160;31, 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BasisofPresentationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Basis of Presentation [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BasisofPresentationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445730251024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company accounts for revenue pursuant to ASC 606, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue from Contracts with Customer</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. In addition, the Company generates service revenue from performing laboratory testing services through its Biotheranostics CLIA laboratory, which is included in its Molecular Diagnostics business. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:3.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:3.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:60.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:60.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefits of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty, and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Revenue from laboratory testing services, which is generated by the Company's Biotheranostics business, is recognized based upon contracted amounts with payors and historical cash collection experience for the same test or same payor group. Revenue is recognized once the laboratory services have been performed, the results have been delivered to the ordering physician, the payor has been identified, and insurance has been verified. The estimated timeframes for cash collection are three months for Medicare payors, six months for Medicare Advantage payors, and nine months for commercial payors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Variable Consideration</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company's contracts for the sale of capital equipment and related components, and assays and tests typically do not provide the right to return product, however, its contracts for the sale of its GYN Surgical and Interventional Breast Solutions surgical handpieces provide for a right of return for a limited period of time. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Remaining Performance Obligations</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $875.7 million. These remaining performance obligations primarily relate to support and maintenance obligations and extended warranty in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 35% of this amount as revenue in fiscal 2023, 32% in fiscal 2024, 20% in fiscal 2025, 9% in fiscal 2026, and 4% thereafter. As permitted, the Company does not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contract Assets and Liabilities</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities in the Consolidated Balance Sheets. The Company recognized revenue of $66.8&#160;million and $56.4&#160;million in the three months ended December 31, 2022 and December 25, 2021, respectively, that was included in the contract liability balance at September 24, 2022 and September 25, 2021, respectively. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Practical Expedients</span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727167520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company's consolidated revenue for all periods presented.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company's consolidated revenue for all periods presented.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726261968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</a></td>
<td class="text">Fair Value Measurements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative contracts. In addition, the Company has a contingent consideration liability that is recorded at fair value and based on Level 3 inputs. The contingent consideration liability as of December 31, 2022 and December 25, 2021 was related to the Acessa acquisition. </span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;31, 2022:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 31, 2022 and December 25, 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.976%"><tr><td style="width:1.0%"/><td style="width:8.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:54.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Assets Measured and Recorded at Fair Value on a Nonrecurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets, and goodwill. During the first quarter of fiscal 2022, the Company recorded a $4.3&#160;million charge to write-off an equity method investment acquired in the Mobidiag acquisition. There were no other remeasurements in the three months ended December&#160;31, 2022 and December&#160;25, 2021. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disclosure of Fair Value of Financial Instruments</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#8217;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#8217;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its equity investments approximate fair value.</span></div>Amounts outstanding under the Company&#8217;s 2021 Credit Agreement of $1.5 billion aggregate principal as of December&#160;31, 2022 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#8217;s 4.625% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) and 3.250% Senior Notes due 2029 (the &#8220;2029 Senior Notes&#8221;) had fair values of $373.9 million and $819.2 million, respectively, as of December&#160;31, 2022 based on their trading prices, representing a Level 1 measurement. Refer to Note 7 for the carrying amounts of the various components of the Company&#8217;s debt.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726279520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationDisclosureTextBlock', window );">Business Combinations</a></td>
<td class="text">Business Combinations<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fiscal 2022 Acquisition</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bolder Surgical</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 29, 2021, the Company completed the acquisition of Bolder Surgical Holdings, Inc. ("Bolder"), for a purchase price of $160.1&#160;million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Bolder's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Bolder's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationship</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Bolder's business. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the purchase price allocation, the Company determined the identifiable intangible assets are developed technology, customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 16.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The developed technology assets are comprised of know-how, patents and technologies embedded in Bolder's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the JustRight and CoolSeal technology platforms.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimate of the weighted average life for the developed technology, customer relationship, and trade name assets is 10 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Bolder acquisition. These benefits include expanding the Company's surgical portfolio and utilizing GYN Surgical's sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingent Consideration</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a contingent consideration liability related to its acquisition of Acessa Health, Inc. ("Acessa"), which occurred in August 2020. Acessa developed the ProVu laparoscopic radiofrequency ablation system. The Company estimated the fair value of this liability to be $81.8&#160;million as of the acquisition date. The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December of each of 2021, 2022, and 2023. There is no maximum earnout. Pursuant to ASC 805, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Business Combinations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 805), the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, revenue growth rates of comparable companies, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change and such adjustments are recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or gains. During the year ended September 24, 2022, the Company remeasured the contingent consideration and recorded a gain of $39.5&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period and to a much lesser extent an increase in the discount rate driven by market rates. During the three months ended December 25, 2021, the first measurement period was completed, and the Company recorded a gain of $4.1&#160;million to decrease the contingent consideration liability to fair value based on actual revenue results in the first earn-out period. During the second quarter of fiscal 2022, the Company made a payment of $12.2&#160;million for the first earn-out period. During the three months ended December 31, 2022, the second measurement period was completed, resulting in an estimated amount of $7.2&#160;million. No additional adjustment was recorded based on actual and forecasted results. As of December 31, 2022, the contingent consideration liability was $23.4&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -URI https://asc.fasb.org/topic&amp;trid=2303972<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4946-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726257376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock', window );">Trade Receivables and Allowance for Credit Losses</a></td>
<td class="text">Trade Receivables and Allowance for Credit Losses<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies ASU No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to its trade receivables and allowances for credit losses, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is a rollforward of the allowance for credit losses as of December 31, 2022 compared to December 25, 2021:</span></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:22.455%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.270%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning<br/>of Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Credit Loss</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Write-offs,<br/>Payments and Foreign Exchange</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End of<br/>Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 25, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -URI https://asc.fasb.org/subtopic&amp;trid=2196772<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726252560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAbstract', window );"><strong>Restructuring Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock', window );">Restructuring and Related Activities Disclosure</a></td>
<td class="text"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(6) Restructuring</span></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of fiscal 2022, the Company finalized its decision to close its Danbury, Connecticut facility where it manufactures its Breast Health capital equipment products. The manufacturing of the Breast Health capital equipment products and all other support services will be moved to the Company's Newark, Delaware facility. In addition, research and development, sales and services support and administrative functions will be moved to the Newark, Delaware and Marlborough, Massachusetts facilities. The transition is expected to be completed by the third quarter of fiscal 2025. The majority of employees located in Danbury were given the option to relocate to the new locations. As a result of this plan, the Company expects a number of employees to not relocate resulting in their termination. The employees were notified of the closure during the first quarter of fiscal 2022, but were not communicated about their termination and related severance benefits until the third quarter of fiscal 2022. The Company is recording severance benefits pursuant to pursuant to ASC 420, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Exit or Disposal Cost Obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 420), and the severance benefits are being expensed ratably over the required service period. As a result, the Company recorded severance charges of $0.7&#160;million in the first quarter of fiscal 2023 and $1.6&#160;million in fiscal 2022, respectively. The Company estimates that total severance charges, including retention, will be approximately $7.0&#160;million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(e))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -URI https://asc.fasb.org/topic&amp;trid=2175745<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726255792">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Borrowings and Credit Arrangements</a></td>
<td class="text">Borrowings and Credit Arrangements<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:4pt;text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2021 Credit Agreement</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On September 27, 2021, the Company refinanced its then existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders (the "2018 Credit Agreement") by entering into a Refinancing Amendment (the "2021 Credit Agreement"). On August 22, 2022, the Company further amended the 2021 Credit Agreement by entering into an amendment to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rates applicable to the loans under the 2021 Credit Agreement denominated in U.S. Dollars were converted to a variant of the secured overnight financing rate (&#8220;SOFR&#8221;), as established from time to time by the Federal Reserve Bank of New York, plus a corresponding spread.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement provides for a $1.5&#160;billion secured term loan facility (the "2021 Term Loan") and a $2.0&#160;billion revolving credit facility (the "2021 Revolver"). As of December 31, 2022, the principal amount outstanding under the 2021 Term Loan was $1.5&#160;billion, and the interest rate was 5.43% per annum. No amounts were outstanding under the 2021 Revolver and the full amount was available to be borrowed by the Company. </span></div><div style="text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to ASC 470, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ASC 470), the accounting for the refinancing was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2018 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.7&#160;million in the first quarter of fiscal 2022 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification. Pursuant to ASC 470, third-party costs of $7.0&#160;million were recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.</span></div><div style="text-indent:36pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's interest rate swap, which fixes the rate on $1&#160;billion of aggregate principal under the 2021 Term Loan at 1.23%, resulted in the Company receiving $6.6&#160;million in the first quarter of fiscal 2023, which was recorded as a reduction to interest expense.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2021 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2021 Credit Agreement. As of December 31, 2022, the Company was in compliance with these covenants.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Senior Notes</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries and mature on February&#160;1, 2028. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2029 Senior Notes</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2022, the Company had 3.250% Senior Notes due 2029 (the "2029 Senior Notes") outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries and mature on February 15, 2029.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounts Receivable Securitization Program</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During April 2022, the Company repaid the outstanding balance of $248.5&#160;million under its accounts receivable securitization program (the "Securitization Program"). On June 10, 2022, the Company amended the Credit and Security agreement with lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of December 31, 2022, the Company did not have any borrowings under this program.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI https://asc.fasb.org/topic&amp;trid=2208564<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495334-112611<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495371-112611<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726325360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativesAndFairValueTextBlock', window );">Derivatives</a></td>
<td class="text">Derivatives<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Swap - Cash Flow Hedge</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate swaps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In fiscal 2019, in order to hedge a portion of its variable rate debt, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023.  On August 25, 2022, the interest rate swap agreement was restructured (consistent with the 2021 Credit Agreement)  to convert the benchmark interest rate from LIBOR to the SOFR rate effective September 23, 2022 with a termination date of December 17, 2023. The Company applied the practical and optional expedients in ASC 848, Reference Rate Reform, in evaluating the impact of modifying the contract, which resulted in no change to the accounting for this derivative contract. The notional amount of this swap is $1.0 billion. The restructured interest rate swap effectively fixes the SOFR component of the variable interest rate on $1.0 billion of the notional amount under the 2021 Credit Agreement at 1.23%. The critical terms of the restructured interest rate swap are designed to mirror the terms of the Company&#8217;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in an asset position of $35.1 million as of December&#160;31, 2022.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Forward Foreign Currency Exchange Contracts and Foreign Currency Option Contracts</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts and as of December 31, 2022 the notional amount was $369.2&#160;million. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense) income, net.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three months ended December 31, 2022 and December 25, 2021, respectively, were as follows:</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.813%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financial Instrument Presentation</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;31, 2022: </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.668%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesAndFairValueTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for derivatives and fair value of assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -URI https://asc.fasb.org/topic&amp;trid=2155941<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -URI https://asc.fasb.org/topic&amp;trid=2229140<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesAndFairValueTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445725505552">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Litigation and Related Matters</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#8220;Minerva&#8221;) in the United States District Court for the District of Delaware, alleging that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#8217;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#8217;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#8217;s motion for a preliminary injunction on its patent claims and denied Minerva&#8217;s request for preliminary injunction related to the Company&#8217;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#8216;183 and &#8216;348 patents. The Court also granted the Company&#8217;s motion for summary judgment on assignor estoppel, which bars Minerva&#8217;s invalidity defenses. The Court also denied all of Minerva&#8217;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#8217;s infringement; (2) found that Minerva&#8217;s infringement was not willful; and (3) found for the Company regarding Minerva&#8217;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the United States Patent and Trademark Office ("USPTO") for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '348 patent. On September 12, 2016, the Patent Trial and Appeal Board of the USPTO (&#8220;PTAB") declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">inter partes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#8216;183 patent. On February 9, 2018, the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#8217;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#8217;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#8216;348 patent. The Court of Appeals also denied the Company&#8217;s motion for a permanent injunction and ongoing royalties for infringement of the &#8216;183 patent. The Court of Appeals denied Minerva&#8217;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#8217;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#8217;s petition to address the issue of assignor estoppel and denied the Company's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor&#8217;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. On August 11, 2022, the Court of Appeals affirmed the district court ruling on the issue of assignor estoppel, which barred Minerva from challenging the validity of the patent rights it assigned to the Company and reinstated its earlier judgment against Minerva on infringement. On September 11, 2022, Minerva petitioned for </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">en banc</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> review of the Court of Appeals decision. The Company filed its response on October 25, 2022, and on November 10, 2022, the Court of Appeals denied Minerva's petition ending the appeals process. During the first quarter of 2023, the Company received a payment for infringement damages in the amount of $7.4&#160;million, which included the original award of  $4.8&#160;million plus post-trial damages and interest. This amount was recorded as a credit to general and administrative expenses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#8220;Cytyc&#8221;) in the United States District Court for the Northern District of California alleging that the Company&#8217;s and Cytyc&#8217;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#8217;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#8217; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On July 27, 2021, the Delaware district court granted the Company&#8217;s motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it, the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Contingencies </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ASC 450). Legal costs are expensed as incurred.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726311952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text">Net Income Per Share<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:68.797%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.585%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721755760">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text">Stock-Based Compensation<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"/><td style="width:63.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted options to purchase 0.5 million and 0.6 million shares of the Company's common stock during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, with weighted-average exercise prices of $74.26 and $71.15, respectively. There were 4.5 million options outstanding at December&#160;31, 2022 with a weighted-average exercise price of $51.67.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"/><td style="width:63.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company granted 0.6 million and 0.6 million restricted stock units ("RSUs") during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, with weighted-average grant date fair values of $74.30 and $71.15 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units ("PSUs") during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $74.35 and $71.16 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period, provided that the Company&#8217;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of FCF PSUs based on a three-year cumulative free cash flow measure ("FCF PSUs") to its senior management team, which had a grant date fair value of $74.35 and $71.16 per unit during the three months ended December 31, 2022 and December 25, 2021, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the three-year measurement period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards ("MSUs") to its senior management team during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#8217;s common stock at the end of a three-year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $97.91 and $75.43 per share using the Monte Carlo simulation model in fiscal 2023 and 2022, respectively. The MSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At December&#160;31, 2022, there was 1.7 million in aggregate unvested RSUs, PSUs, FCF PSUs and MSUs outstanding. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At December&#160;31, 2022, there was $23.1 million and $95.3 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.4 and 2.2 years, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI https://asc.fasb.org/topic&amp;trid=2228938<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (l)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726447312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock', window );">Other Balance Sheet Information</a></td>
<td class="text">Other Balance Sheet Information<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants were specifically to fund capital equipment and labor investments to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to the Company paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements. However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts and obtaining approval from the DOD that the respective milestone has been met. As of December 31, 2022, the Company had $20.5&#160;million of capital equipment that was awaiting approval from the DOD pending approval of completion of the defined milestones. In fiscal 2022, the Company received $75.0&#160;million from the DOD for reimbursement of capital equipment, which was recorded as a reduction of the cost basis of the purchased equipment. In addition, a portion of the DOD grant funds expenditures in connection with the project that do not qualify for capitalization and are recorded as a reduction to expenses, which was $7.6&#160;million in fiscal 2022. During the three months ended December 31, 2022 and December 25, 2021, the Company received $0.0&#160;million and $21.3&#160;million, respectively, from the DOD, which was recorded as a reduction of the cost basis of the purchased equipment. Payments under these grants are subject to satisfaction of the conditions of the grants, including applicable governmental appropriations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DetailsOfCertainBalanceSheetAccountsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Details of certain balance sheet accounts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DetailsOfCertainBalanceSheetAccountsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727590352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segments and Geographic Information</a></td>
<td class="text">Business Segments and Geographic InformationThe Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. <div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three months ended December&#160;31, 2022 and December&#160;25, 2021. Segment information is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:69.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.417%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,579.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,290.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:5pt;text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December&#160;31, 2022 and December&#160;25, 2021.</span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#8217;s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands . The Company&#8217;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#8220;Rest of World&#8221; designation includes Canada, Latin America and the Middle East.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:69.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.209%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI https://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727590352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income Taxes<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with ASC 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s effective tax rate for the three months ended December 31, 2022 and December 25, 2021 was 21.6% and 19.7%, respectively. </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The effective tax rate for the three months ended December 31, 2022 was higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The effective tax rate for the three months ended December 25, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by the Company's international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes, and unbenefited foreign losses.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Income Tax Matters</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. Such amounts were not material for the three months ended December 31, 2022 and December 25, 2021. While the Company believes its estimated losses recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726332560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">Intangible Assets and Goodwill</a></td>
<td class="text">Intangible Assets<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 24, 2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,602.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,513.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,465.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,237.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;31, 2022 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -URI https://asc.fasb.org/subtopic&amp;trid=2144471<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726252560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyDisclosureTextBlock', window );">Product Warranties</a></td>
<td class="text">Product Warranties<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 25, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -URI https://asc.fasb.org/topic&amp;trid=2155896<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726511984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNoteTextBlock', window );">Accumulated Other Comprehensive Loss</a></td>
<td class="text">Accumulated Other Comprehensive Loss<div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:50.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.508%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:49.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.590%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNoteTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -URI https://asc.fasb.org/topic&amp;trid=2134417<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(21))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(19))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNoteTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726475712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Share Repurchase</a></td>
<td class="text">Share RepurchaseOn September 22, 2022, the Board of Directors authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.0&#160;billion of the Company's outstanding common stock, effective as of the close of trading September 23, 2022. This new repurchase program replaced the previous $1.0&#160;billion authorization. During the three months ended December 31, 2022, the Company repurchased 1.5&#160;million shares of its common stock for total consideration of $100.0&#160;million. As of December 31, 2022, $900.0&#160;million remained available under this authorization.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726257376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:3.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">78.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">328.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">97.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">413.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">145.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">212.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">52.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">264.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">57.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">64.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:3.196%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:53.270%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.677%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.680%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Business </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">United States</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">International</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cytology &amp; Perinatal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">130.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Molecular Diagnostics</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">528.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">285.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">813.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Blood Screening</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">615.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">335.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Imaging</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">282.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interventional Breast Solutions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">271.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">88.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">458.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:60.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Geographic Regions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">in millions</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">823.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,012.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides revenue recognized by source:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"><tr><td style="width:1.0%"/><td style="width:60.790%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:17.954%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.956%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Revenue by type </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%">(in millions)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Disposables</span></td><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">727.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,106.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital equipment, components and software</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">158.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">197.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Service</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">183.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726272160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Fair Value Assets and Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;31, 2022:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:40.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.765%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.525%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value at Reporting Date Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Quoted&#160;Prices&#160;in<br/>Active&#160;Market&#160;for<br/>Identical&#160;Assets<br/>(Level&#160;1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Other<br/>Observable<br/>Inputs&#160;(Level&#160;2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Significant<br/>Unobservable<br/>Inputs&#160;(Level&#160;3)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">39.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Liabilities Measured and Recorded at Fair Value on a Recurring Basis</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 31, 2022 and December 25, 2021 were as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.976%"><tr><td style="width:1.0%"/><td style="width:8.583%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:54.828%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.698%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.590%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.701%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Month Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at beginning of period</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contingent consideration recorded at acquisition</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4.1)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payments</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at end of period</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">71.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726257376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationsAbstract', window );"><strong>Business Combinations [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock', window );">Schedule of Recognized Identified Assets Acquired and Liabilities Assumed</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total purchase price was allocated to Bolder's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><span><br/></span></div><div style="text-align:center;text-indent:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"><tr><td style="width:1.0%"/><td style="width:7.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:62.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.878%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable intangible assets: </span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">73.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationship</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred income taxes, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase Price</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726261968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesAbstract', window );"><strong>Receivables [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts, Notes, Loans and Financing Receivable</a></td>
<td class="text">The following is a rollforward of the allowance for credit losses as of December 31, 2022 compared to December 25, 2021:<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.3,4)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445731931888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Company's Borrowings</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s borrowings consisted of the following:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.461%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.329%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current debt obligations, net of debt discount and deferred issuance costs:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current debt obligations</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term debt obligations, net of debt discount and issuance costs:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term Loan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,472.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,475.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">937.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">936.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total long-term debt obligations</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,806.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,808.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total debt obligations</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,826.8&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,823.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Line of Credit Facilities</a></td>
<td class="text"><div style="text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.274%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.128%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.129%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.4&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average interest rate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.63&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.09&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate at end of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.10&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock', window );">Schedule Of Interest Expense Under Convertible Notes</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:58.549%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.792%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest Rate</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028 Senior Notes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.625&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2029 Senior Notes</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.250&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of interest expense under convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727167520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract', window );"><strong>Derivative Instruments and Hedging Activities Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock', window );">Derivative Instruments, Gain (Loss)</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:64.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.535%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.813%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of realized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of unrealized gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22.1)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount of gain (loss) recognized in income</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24.7)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19.2)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock', window );">Schedule of Derivative Assets at Fair Value</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;31, 2022: </span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.215%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.882%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.524%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance Sheet Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24, 2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivative instruments designated as a cash flow hedge:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap contract</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency option contracts</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derivatives not designated as hedging instruments:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forward foreign currency contracts</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Schedule of Unrealized Loss Recognized in AOCI</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.636%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.666%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.668%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate swap</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of derivative assets at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4E<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624181-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726318064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Reconciliation of Basic and Diluted Share Amounts</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of basic and diluted share amounts is as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:68.797%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.584%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.585%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">247,319&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">253,499&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,571&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diluted weighted average common shares outstanding</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">249,281&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">256,070&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average anti-dilutive shares related to:</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding stock options and restricted stock units</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,631&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445731877680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock', window );">Stock-Based Compensation Expense in Consolidated Statements of Operations</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following presents stock-based compensation expense in the Company&#8217;s Consolidated Statements of Income:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"/><td style="width:63.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenues</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling and marketing</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Weighted-Average Assumptions Utilized to Value Stock Options</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"><tr><td style="width:1.0%"/><td style="width:63.100%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.300%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected life (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.8</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average fair value of options granted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.81&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.03&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of share-based compensation expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726419136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Other Balance Sheet Information of Inventories</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:71.318%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.321%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.324%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Inventories</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">252.9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work-in-process</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">298.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">310.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">677.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">623.7&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Other Balance Sheet Information of Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:71.480%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.243%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.244%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Property, plant and equipment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">396.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">394.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Equipment under customer usage agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">506.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">486.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building and improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">196.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right of use asset</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,222.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,187.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less &#8211; accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(728.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(705.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726477120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Segment Information</a></td>
<td class="text">egment information is as follows:<div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:69.134%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.417%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenues:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">559.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">950.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">334.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">359.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">154.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">134.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,074.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,471.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income from operations:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">151.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">531.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">81.7&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">262.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">641.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">69.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85.9&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital expenditures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.1&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37.5&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.929%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.522%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">September 24,<br/>2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Identifiable assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diagnostics</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,950.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,881.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Breast Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,262.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,245.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">GYN Surgical</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,466.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,461.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Skeletal Health</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Corporate</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,579.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,454.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,290.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,071.2&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock', window );">Revenues by Geography</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenues by geography as a percentage of total revenues were as follows:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:69.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.206%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.537%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.209%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2022</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 25,<br/>2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United States</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76.7&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rest of World</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726477120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible Assets and Goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consisted of the following:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Description</span></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of December 31, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">As of September 24, 2022</span></td></tr><tr style="height:29pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross<br/>Carrying<br/>Value</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Amortization</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Acquired intangible assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed&#160;technology</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,602.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,520.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,565.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,458.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">33.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">607.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">542.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">601.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">535.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">267.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">265.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total acquired intangible assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,513.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,269.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,465.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,197.1&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Internal-use software</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software embedded in products</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.0&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total intangible assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,567.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,311.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,518.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,237.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Estimated Amortization Expense</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;31, 2022 for each of the five succeeding fiscal years was as follows:</span></div><div style="text-align:justify;text-indent:27pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:82.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.836%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of Fiscal 2023</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">175.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2024</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">224.2&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2025</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209.3&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2026</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177.1&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fiscal 2027</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89.9&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726450048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GuaranteesAbstract', window );"><strong>Guarantees [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Product Warranty Activity</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product warranty activity was as follows:</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.624%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>Beginning&#160;of<br/>Period</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Provisions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Settlements/<br/>Adjustments</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance&#160;at<br/>End&#160;of&#160;Period</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Three Months Ended:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 31, 2022</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.0&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.2)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.4&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">December 25, 2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.3)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GuaranteesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GuaranteesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727833392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Loss (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AccumulatedOtherComprehensiveIncomeAbstract', window );"><strong>Accumulated Other Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock', window );">Changes in Accumulated Other Comprehensive Income</a></td>
<td class="text"><div style="text-align:justify;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:50.239%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.507%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.508%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 31, 2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(267.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29.3&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(238.2)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(153.4)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26.4&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(127.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:49.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.586%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.590%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended December 25, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Foreign Currency Translation</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Pension Plans</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Hedged Interest Rate Swaps</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beginning Balance</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(43.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14.7)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(59.1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income (loss) before reclassifications</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(37.8)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ending Balance</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(80.9)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1.3)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6.8)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(89.0)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AccumulatedOtherComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated Other Comprehensive Income [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AccumulatedOtherComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accumulated other comprehensive income (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6450520&amp;loc=d3e32583-110901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 30<br> -Section 45<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=118261656&amp;loc=d3e32211-110900<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720951936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Business Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,074.2<span></span>
</td>
<td class="nump">$ 1,471.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">66.8<span></span>
</td>
<td class="nump">56.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">823.6<span></span>
</td>
<td class="nump">1,012.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_InternationalMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">250.6<span></span>
</td>
<td class="nump">458.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">559.3<span></span>
</td>
<td class="nump">950.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">413.7<span></span>
</td>
<td class="nump">615.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">145.6<span></span>
</td>
<td class="nump">335.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">126.8<span></span>
</td>
<td class="nump">130.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">78.2<span></span>
</td>
<td class="nump">80.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Cytology &amp; Perinatal | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">48.6<span></span>
</td>
<td class="nump">49.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">425.2<span></span>
</td>
<td class="nump">813.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">328.2<span></span>
</td>
<td class="nump">528.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Molecular Diagnostics | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">97.0<span></span>
</td>
<td class="nump">285.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics | Blood Screening | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">334.2<span></span>
</td>
<td class="nump">359.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">270.0<span></span>
</td>
<td class="nump">271.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">64.2<span></span>
</td>
<td class="nump">88.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">264.4<span></span>
</td>
<td class="nump">282.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">212.2<span></span>
</td>
<td class="nump">208.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Breast Imaging | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">52.2<span></span>
</td>
<td class="nump">73.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">69.8<span></span>
</td>
<td class="nump">77.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">57.8<span></span>
</td>
<td class="nump">62.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health | Interventional Breast Solutions | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">12.0<span></span>
</td>
<td class="nump">14.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">123.1<span></span>
</td>
<td class="nump">109.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">31.0<span></span>
</td>
<td class="nump">25.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">16.8<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health | International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 9.8<span></span>
</td>
<td class="nump">$ 10.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_InternationalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_InternationalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CytologyPerinatalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CytologyPerinatalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_MolecularDiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BloodScreeningMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BloodScreeningMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_BreastImagingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_BreastImagingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_InterventionalBreastSolutionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732002432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Geographical Revenue (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,074.2<span></span>
</td>
<td class="nump">$ 1,471.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">823.6<span></span>
</td>
<td class="nump">1,012.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">147.4<span></span>
</td>
<td class="nump">295.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">63.8<span></span>
</td>
<td class="nump">119.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_RestofWorldMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 39.4<span></span>
</td>
<td class="nump">$ 43.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_RestofWorldMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_RestofWorldMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721598096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Revenue by Type (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,074.2<span></span>
</td>
<td class="nump">$ 1,471.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">66.8<span></span>
</td>
<td class="nump">56.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_ConsumablesMember', window );">Disposables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">727.8<span></span>
</td>
<td class="nump">1,106.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember', window );">Capital equipment, components and software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">158.5<span></span>
</td>
<td class="nump">197.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember', window );">Service</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">183.3<span></span>
</td>
<td class="nump">162.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_ConsumablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_ConsumablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_CapitalEquipmentComponentsandSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ServiceMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ServiceMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=holx_OtherTypeofRevenueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445727301296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, Remaining Performance Obligation, Amount</a></td>
<td class="nump">$ 875.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Contract with Customer, Liability, Revenue Recognized</a></td>
<td class="nump">$ 66.8<span></span>
</td>
<td class="nump">$ 56.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732864832">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Remaining Performance Obligation (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">35.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">3 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">20.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">9.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-03-29', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-03-29</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationPercentage', window );">Revenue, Remaining Performance Obligation, Percentage</a></td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2022-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2025-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-03-29">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2026-03-29</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445726458608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Lease Information (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2022</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LeaseRevenuePercentageOfTotalRevenue', window );">Lease revenue as a percentage of total (percentage)</a></td>
<td class="nump">0.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LeaseRevenuePercentageOfTotalRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lease Revenue, Percentage Of Total Revenue</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LeaseRevenuePercentageOfTotalRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720758576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 39.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">24.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">35.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember', window );">Foreign currency option contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Foreign currency option contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Quoted&#160;Prices&#160;in Active&#160;Market&#160;for Identical&#160;Assets (Level&#160;1) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">39.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">35.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Significant Other Observable Inputs&#160;(Level&#160;2) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations', window );">Total</a></td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesFairValueDisclosureAbstract', window );"><strong>Liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure', window );">Contingent consideration</a></td>
<td class="nump">23.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Foreign currency option contracts | Liability</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Significant Unobservable Inputs&#160;(Level&#160;3) | Foreign currency option contracts</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosureAbstract', window );"><strong>Assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentsFairValueDisclosure', window );">Assets measured at fair value on a recurring basis</a></td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of contingent consideration in a business combination that is classified in shareholders' equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of obligations measured on a recurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesFairValueDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesFairValueDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=holx_ContingentConsiderationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeContractMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_LiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445731906064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 25, 2021</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentTypeAxis=us-gaap_EquityMethodInvestmentsMember', window );">Equity Method Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossOnSaleOfInvestments', window );">Loss on Sale of Investments</a></td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember', window );">Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PrincipalAmountOfBorrowings', window );">Borrowed principal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 373.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFairValue', window );">Fair value of debt instrument</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 819.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems', window );"><strong>Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PrincipalAmountOfBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PrincipalAmountOfBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13433-108611<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossOnSaleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(9)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(b)(7)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossOnSaleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_EquityMethodInvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_EquityMethodInvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445719178784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Roll Forward (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning balance</a></td>
<td class="nump">$ 23.4<span></span>
</td>
<td class="nump">$ 75.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases', window );">Contingent consideration recorded at acquisition</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Fair value adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(4.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements', window );">Payments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending balance</a></td>
<td class="nump">$ 23.4<span></span>
</td>
<td class="nump">$ 71.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126976982&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721728896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Combination - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 29, 2021</div></th>
<th class="th"><div>Aug. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationConsiderationTransferred1', window );">Consideration transferred</a></td>
<td class="nump">$ 160.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue', window );">Intangible assets, fair value (percentage)</a></td>
<td class="nump">16.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Developed Technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Customer Relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical | Trade Names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife', window );">Intangible assets useful life</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember', window );">Acessa Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationLiability', window );">Contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 81.8<span></span>
</td>
<td class="nump">$ 23.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AnnualIncrementalRevenueGrowthPeriod', window );">Annual incremental revenue growth period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in contingent consideration</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">$ 4.1<span></span>
</td>
<td class="nump">$ 39.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationContingentConsiderationPayments', window );">Contingent consideration payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AnnualIncrementalRevenueGrowthPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Annual Incremental Revenue Growth Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AnnualIncrementalRevenueGrowthPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationContingentConsiderationPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Contingent Consideration, Payments</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationContingentConsiderationPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationConsiderationTransferred1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6613-128477<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 30<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126966197&amp;loc=d3e6578-128477<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationConsiderationTransferred1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized arising from contingent consideration in a business combination.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126975305&amp;loc=d3e6927-128479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 35<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126966325&amp;loc=d3e6819-128478<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 25<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=6911189&amp;loc=d3e6408-128476<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_AcessaHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721006176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Combinations Business Combinations - Purchase Price Allocation (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
<th class="th"><div>Nov. 29, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">$ 3,289.6<span></span>
</td>
<td class="nump">$ 3,236.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember', window );">Bolder Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionLineItems', window );"><strong>Business Acquisition [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables', window );">Accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory', window );">Inventory</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable', window );">Accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3.2)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">73.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships', window );">Customer relationship</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities', window );">Deferred income taxes, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.8<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet', window );">Purchase Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 160.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of inventory recognized as of the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 10<br> -Section 55<br> -Paragraph 37<br> -URI https://asc.fasb.org/extlink&amp;oid=123455525&amp;loc=d3e2207-128464<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092470&amp;loc=d3e4845-128472<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 55<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=122137925&amp;loc=d3e14258-109268<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionAxis=holx_BolderSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445728004384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade Receivables and Allowance for Credit Losses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at Beginning of Period</a></td>
<td class="nump">$ 37.7<span></span>
</td>
<td class="nump">$ 40.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Credit Loss</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs', window );">Write-offs, Payments and Foreign Exchange</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Balance&#160;at End of Period</a></td>
<td class="nump">$ 39.1<span></span>
</td>
<td class="nump">$ 42.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=123577603&amp;loc=d3e5074-111524<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124255206&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of direct write-downs of accounts receivable charged against the allowance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124255953&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732826928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Restructuring (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringPlanAxis=holx_DanburyClosureMember', window );">Danbury closure</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostsAbstract', window );"><strong>Restructuring Costs [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCostAndReserveLineItems', window );"><strong>Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringAndRelatedCostExpectedCost1', window );">Restructuring and Related Cost, Expected Cost</a></td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestructuringCharges', window );">Restructuring charges</a></td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="nump">$ 1.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringAndRelatedCostExpectedCost1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount expected to be recognized in earnings for the specified restructuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=6394359&amp;loc=d3e17939-110869<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(d))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringAndRelatedCostExpectedCost1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109237686&amp;loc=d3e17752-110868<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.P.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140864-122747<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 420<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.P.4(b)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=115931487&amp;loc=d3e140904-122747<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostAndReserveLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostAndReserveLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringCostsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringCostsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestructuringPlanAxis=holx_DanburyClosureMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestructuringPlanAxis=holx_DanburyClosureMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721591712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Company's Borrowings (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">$ 20.6<span></span>
</td>
<td class="nump">$ 15.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Total long-term debt obligations</a></td>
<td class="nump">2,806.2<span></span>
</td>
<td class="nump">2,808.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Total debt obligations</a></td>
<td class="nump">2,826.8<span></span>
</td>
<td class="nump">2,823.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">15.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">1,472.7<span></span>
</td>
<td class="nump">1,475.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">396.3<span></span>
</td>
<td class="nump">396.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_LongTermDebtObligationsWithoutConvertibleNotes', window );">Long term debt obligations. excluding convertible notes</a></td>
<td class="nump">$ 937.2<span></span>
</td>
<td class="nump">$ 936.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_LongTermDebtObligationsWithoutConvertibleNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long term debt obligations without convertible notes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_LongTermDebtObligationsWithoutConvertibleNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466204&amp;loc=SL6031897-161870<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721115088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Additional Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 30, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
<th class="th"><div>Sep. 27, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities', window );">Proceeds from Derivative Instrument, Financing Activities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember', window );">Secured Term Loan | 2021 Term Loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,500.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.43%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember', window );">Revolver | 2021 Revolver</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Revolving credit facility borrowings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember', window );">Term Loan | 2021 Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainsLossesOnExtinguishmentOfDebt', window );">Debt extinguishment losses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Debt Issuance Costs, Net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Senior notes, face amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 400.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes | 2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorNotes', window );">Senior notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 950.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=holx_AssetSecuritizationMember', window );">Asset Securitization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfOtherDebt', window );">Repayments of Other Debt</a></td>
<td class="nump">$ 248.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429444&amp;loc=SL124452920-239629<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69C<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495737-112612<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 55<br> -Paragraph 69B<br> -URI https://asc.fasb.org/extlink&amp;oid=123466577&amp;loc=SL123495735-112612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495340-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124435984&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainsLossesOnExtinguishmentOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12355-112629<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 50<br> -Section 40<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126972273&amp;loc=d3e12317-112629<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainsLossesOnExtinguishmentOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3505-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfOtherDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for the payment of debt classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfOtherDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorNotes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.16(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.16)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorNotes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_SecuredTermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021RevolverMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021RevolverMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_TermLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2021CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=holx_AssetSecuritizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=holx_AssetSecuritizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445731991024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details) - Credit Agreement - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 20.4<span></span>
</td>
<td class="nump">$ 5.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod', window );">Weighted average interest rate</a></td>
<td class="nump">4.63%<span></span>
</td>
<td class="nump">1.09%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd', window );">Interest rate at end of period</a></td>
<td class="nump">5.43%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityInterestRateDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The effective interest rate during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityInterestRateDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_CreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721687536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2028 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">4.625%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 5.2<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">2029 Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Stated interest rate</a></td>
<td class="nump">3.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 8.9<span></span>
</td>
<td class="nump">8.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseBorrowings', window );">Interest expense</a></td>
<td class="nump">$ 14.1<span></span>
</td>
<td class="nump">$ 13.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495323-112611<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate amount of interest expense on all borrowings.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.7,8)<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=holx_A2028And2029SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=holx_A2028And2029SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732857152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Additional Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Derivative notional amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeVariableInterestRate', window );">Variable interest rate</a></td>
<td class="nump">1.23%<span></span>
</td>
<td class="nump">1.23%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 35.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember', window );">Forward Contracts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeLineItems', window );"><strong>Derivative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_NotationalAmount', window );">Notational Amount</a></td>
<td class="nump">$ 369.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_NotationalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Notational Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_NotationalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1B<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5580258-113959<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5579245-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeVariableInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeVariableInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForwardContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720887200">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet', window );">Total</a></td>
<td class="num">$ (24.7)<span></span>
</td>
<td class="num">$ (19.2)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(2.6)<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="num">(22.1)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember', window );">Forward foreign currency contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(2.4)<span></span>
</td>
<td class="num">(12.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="num">(13.8)<span></span>
</td>
<td class="num">(6.8)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember', window );">Foreign currency option contracts | Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeGainLossOnDerivativeNet', window );">Amount of realized gain (loss) recognized in income</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Amount of unrealized gain (loss) recognized in income</a></td>
<td class="num">$ (8.3)<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeGainLossOnDerivativeNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeGainLossOnDerivativeNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4CC<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL109998890-113959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721708112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Derivatives - Fair Value of Derivative Financial Instruments (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">$ 35.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">4.0<span></span>
</td>
<td class="nump">$ 26.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Forward foreign currency contracts | Accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue', window );">Interest rate swap at fair value</a></td>
<td class="nump">0.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember', window );">Derivatives not designated as hedging instruments | Foreign currency option contracts | Prepaid expenses and other current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">1.0<span></span>
</td>
<td class="nump">10.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as a cash flow hedge | Interest rate swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">35.1<span></span>
</td>
<td class="nump">38.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as a cash flow hedge | Interest rate swap | Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="nump">$ 35.1<span></span>
</td>
<td class="nump">31.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Derivative instruments designated as a cash flow hedge | Interest rate swap | Other assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems', window );"><strong>Derivative Instruments and Hedging Activities Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeFairValueOfDerivativeAsset', window );">Derivative asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of all asset derivatives designated as cash flow hedging instruments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeFairValueOfDerivativeAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226052-175313<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226000-175313<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 860<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4D<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=121570589&amp;loc=SL51823488-111719<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (a),(c)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeFairValueOfDerivativeAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_NondesignatedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445719316384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeInstrumentsGainLossLineItems', window );"><strong>Derivative Instruments, Gain (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax', window );">Amount of (loss) gain recognized in other comprehensive income, net of taxes:</a></td>
<td class="num">$ (2.9)<span></span>
</td>
<td class="nump">$ 7.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentsGainLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentsGainLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=121577181&amp;loc=SL110061190-113977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5618551-113959<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4C<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=125515794&amp;loc=SL5624171-113959<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=d3e637-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669646-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445728004128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies (Detail) - Minerva<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 04, 2016 </div>
<div>petition</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 27, 2018 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_AmountAssessedInDamages', window );">Assessed damages</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LossContingencyNewClaimsFiledNumber', window );">Petitions filed | petition</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromLegalSettlements', window );">Proceeds from Legal Settlements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_AmountAssessedInDamages">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount assessed in damages.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_AmountAssessedInDamages</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingencyNewClaimsFiledNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total number of new claims filed pertaining to a loss contingency during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14435-108349<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14557-108349<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingencyNewClaimsFiledNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLegalSettlements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received for the settlement of litigation during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLegalSettlements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=holx_MinervaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=holx_MinervaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721697728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail) - shares<br> shares in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_EarningsPerShareLineItems', window );"><strong>Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average common shares outstanding</a></td>
<td class="nump">247,319<span></span>
</td>
<td class="nump">253,499<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units</a></td>
<td class="nump">1,962<span></span>
</td>
<td class="nump">2,571<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average common shares outstanding</a></td>
<td class="nump">249,281<span></span>
</td>
<td class="nump">256,070<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember', window );">Outstanding Stock Options and stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract', window );"><strong>Weighted-average anti-dilutive shares related to:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Weighted-average anti-dilutive shares (in shares)</a></td>
<td class="nump">1,631<span></span>
</td>
<td class="nump">868<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Earnings Per Share [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126962052&amp;loc=d3e4991-113900<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1707-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28A<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1500-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1757-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_StockCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445731906432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 20.5<span></span>
</td>
<td class="nump">$ 18.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenues</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember', window );">Selling and marketing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">3.3<span></span>
</td>
<td class="nump">2.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation expense</a></td>
<td class="nump">$ 10.9<span></span>
</td>
<td class="nump">$ 11.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingAndMarketingExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720698432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Detail) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock option plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Options granted (in shares)</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-average exercise prices (in dollars per share)</a></td>
<td class="nump">$ 74.26<span></span>
</td>
<td class="nump">$ 71.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Share-based compensation, stock options outstanding (in shares)</a></td>
<td class="nump">4.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-average exercise price of options outstanding (in dollars per share)</a></td>
<td class="nump">$ 51.67<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 23.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.6<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 74.30<span></span>
</td>
<td class="nump">$ 71.15<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense</a></td>
<td class="nump">$ 95.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted-average period for recognition of unrecognized stock-based compensation, years</a></td>
<td class="text">2 years 2 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">Performance Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 74.35<span></span>
</td>
<td class="nump">$ 71.16<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember', window );">Market Based Awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 97.91<span></span>
</td>
<td class="nump">$ 75.43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember', window );">PSU Free Cash Flow [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Shares granted (in shares)</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)</a></td>
<td class="nump">$ 74.35<span></span>
</td>
<td class="nump">$ 71.16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent', window );">Minimum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent', window );">Maximum eligible percentage to receive target number of shares of company's common stock</a></td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod', window );">Performance stock units vesting period</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember', window );">RSU, PSU, MSU</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum target number percentage of shares issued based on stock performance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum target number percentage of shares that would be issued based on stock price performance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time that must lapse in order for the restricted stock units to vest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_MarketBasedAwardsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_PSUFreeCashFlowMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=holx_RSUPSUMSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721589728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">4.30%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">33.90%<span></span>
</td>
<td class="nump">34.20%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
<td class="text">4 years 9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend', window );">Dividend yield</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value of options granted</a></td>
<td class="nump">$ 25.81<span></span>
</td>
<td class="nump">$ 21.03<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Rate of weighted-average expected volatility for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732058672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other Balance Sheet Information - Inventories (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 308.4<span></span>
</td>
<td class="nump">$ 252.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">70.7<span></span>
</td>
<td class="nump">60.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">298.6<span></span>
</td>
<td class="nump">310.7<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">$ 677.7<span></span>
</td>
<td class="nump">$ 623.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720733888">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other Balance Sheet Information - Property, Plant and Equipment (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
<th class="th"><div>Sep. 25, 2021</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract', window );"><strong>Balance Sheet Related Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ManufacturingEquipmentAndSoftware', window );">Equipment</a></td>
<td class="nump">$ 396.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 394.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_EquipmentUnderCustomerUsageAgreements', window );">Equipment under customer usage agreements</a></td>
<td class="nump">506.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">486.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BuildingsAndImprovementsGross', window );">Building and improvements</a></td>
<td class="nump">206.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">196.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseholdImprovementsGross', window );">Leasehold improvements</a></td>
<td class="nump">46.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Land', window );">Land</a></td>
<td class="nump">41.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FurnitureAndFixturesGross', window );">Furniture and fixtures</a></td>
<td class="nump">18.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</a></td>
<td class="nump">8.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">1,222.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,187.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less &#8211; accumulated depreciation and amortization</a></td>
<td class="num">(728.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(705.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">494.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">481.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_GrantsReceivedFromDepartmentOfDefense', window );">Grants received from Department of defense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrantsReceivableCurrent', window );">Grants Receivable, Current</a></td>
<td class="nump">20.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_DepartmentOfDefenseFundsReceived', window );">Department of defense funds received</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 21.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_DepartmentOfDefenseFundsReceivedNotCapitalized', window );">Department of Defense funds received, not capitalized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DepartmentOfDefenseFundsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Department of defense funds received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DepartmentOfDefenseFundsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_DepartmentOfDefenseFundsReceivedNotCapitalized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Department of Defense funds received, not capitalized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_DepartmentOfDefenseFundsReceivedNotCapitalized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_EquipmentUnderCustomerUsageAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_EquipmentUnderCustomerUsageAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_GrantsReceivedFromDepartmentOfDefense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Grants received from Department of defense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_GrantsReceivedFromDepartmentOfDefense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ManufacturingEquipmentAndSoftware">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ManufacturingEquipmentAndSoftware</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetRelatedDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetRelatedDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BuildingsAndImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BuildingsAndImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FurnitureAndFixturesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FurnitureAndFixturesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrantsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrantsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Land">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Land</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseholdImprovementsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseholdImprovementsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732830032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Additional Information (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 25, 2021 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 24, 2022 </div>
<div>Segment</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 1,074,200,000<span></span>
</td>
<td class="nump">$ 1,471,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember', window );">Intersegment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SegmentReportingDisclosureLineItems', window );"><strong>Segment Reporting Disclosure [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenues</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SegmentReportingDisclosureLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Segment Reporting Disclosure [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SegmentReportingDisclosureLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ConsolidationItemsAxis=us-gaap_IntersegmentEliminationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720760576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Segment Information (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">$ 1,074.2<span></span>
</td>
<td class="nump">$ 1,471.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">262.4<span></span>
</td>
<td class="nump">641.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">85.9<span></span>
</td>
<td class="nump">108.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">29.1<span></span>
</td>
<td class="nump">37.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">9,290.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9,071.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember', window );">Diagnostics</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">559.3<span></span>
</td>
<td class="nump">950.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">151.1<span></span>
</td>
<td class="nump">531.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">59.9<span></span>
</td>
<td class="nump">69.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">15.9<span></span>
</td>
<td class="nump">31.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">2,950.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,881.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember', window );">Breast Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">334.2<span></span>
</td>
<td class="nump">359.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">60.5<span></span>
</td>
<td class="nump">81.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">13.6<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,262.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,245.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember', window );">GYN Surgical</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">154.1<span></span>
</td>
<td class="nump">134.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">48.8<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">12.3<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">1,466.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,461.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember', window );">Skeletal Health</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Total revenues</a></td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">27.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Income (loss) from operations</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAmortizationAndAccretionNet', window );">Depreciation and amortization</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">31.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">27.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember', window );">Corporate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireProductiveAssets', window );">Capital expenditures</a></td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Identifiable assets</a></td>
<td class="nump">$ 3,579.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,454.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAmortizationAndAccretionNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAmortizationAndAccretionNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireProductiveAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9212-128498<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 30<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126928898&amp;loc=d3e9215-128498<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 50<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=127000608&amp;loc=d3e9135-128495<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireProductiveAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_DiagnosticsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_BreastHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_GynSurgicalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=holx_SkeletalHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=us-gaap_CorporateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445722793008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segments and Geographic Information - Revenues by Geography (Detail)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">76.70%<span></span>
</td>
<td class="nump">68.80%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">13.70%<span></span>
</td>
<td class="nump">20.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember', window );">Asia-Pacific</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">5.90%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember', window );">Rest of World</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_ScheduleOfGeographicalSegmentsLineItems', window );"><strong>Schedule Of Geographical Segments [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_PercentageOfRevenues', window );">Revenues</a></td>
<td class="nump">3.70%<span></span>
</td>
<td class="nump">3.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_PercentageOfRevenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_PercentageOfRevenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_ScheduleOfGeographicalSegmentsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Geographical Segments [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_ScheduleOfGeographicalSegmentsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_AsiaPacificMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_AsiaPacificMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=holx_AllOtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=holx_AllOtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721757648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Company's effective tax rate</a></td>
<td class="nump">21.60%<span></span>
</td>
<td class="nump">19.70%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445720669104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Sep. 24, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">$ 5,567.0<span></span>
</td>
<td class="nump">$ 5,518.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,311.6<span></span>
</td>
<td class="nump">4,237.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember', window );">Developed&#160;technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">4,602.5<span></span>
</td>
<td class="nump">4,565.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">3,520.6<span></span>
</td>
<td class="nump">3,458.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">36.2<span></span>
</td>
<td class="nump">33.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">607.2<span></span>
</td>
<td class="nump">601.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">542.6<span></span>
</td>
<td class="nump">535.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">267.4<span></span>
</td>
<td class="nump">265.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">206.6<span></span>
</td>
<td class="nump">203.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember', window );">Total acquired intangible assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">5,513.3<span></span>
</td>
<td class="nump">5,465.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">4,269.8<span></span>
</td>
<td class="nump">4,197.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember', window );">Internal-use software</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">26.7<span></span>
</td>
<td class="nump">26.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">20.7<span></span>
</td>
<td class="nump">19.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember', window );">Capitalized software embedded in products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Value</a></td>
<td class="nump">27.0<span></span>
</td>
<td class="nump">26.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">$ 21.1<span></span>
</td>
<td class="nump">$ 20.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_DevelopedTechnologyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CustomerRelationshipsContractsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_AcquiredintangibleassetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_InternalusesoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=holx_CapitalizedsoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445732043248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">Remainder of Fiscal 2023</a></td>
<td class="nump">$ 175.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">Fiscal 2024</a></td>
<td class="nump">224.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Fiscal 2025</a></td>
<td class="nump">209.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">Fiscal 2026</a></td>
<td class="nump">177.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">Fiscal 2027</a></td>
<td class="nump">$ 89.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445719250848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Product Warranties - Product Warranty Activity (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward', window );"><strong>Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at Beginning&#160;of Period</a></td>
<td class="nump">$ 8.0<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued', window );">Provisions</a></td>
<td class="nump">2.6<span></span>
</td>
<td class="nump">2.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Settlements/ Adjustments</a></td>
<td class="num">(2.2)<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrual', window );">Balance&#160;at End&#160;of&#160;Period</a></td>
<td class="nump">$ 8.4<span></span>
</td>
<td class="nump">$ 8.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualWarrantiesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in the standard and extended product warranty accrual from warranties issued.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph ((c)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=126907703&amp;loc=d3e12565-110249<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualWarrantiesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445719242752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accumulated Other Comprehensive Income (Detail) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 25, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">$ 4,876.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">110.9<span></span>
</td>
<td class="num">$ (29.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">5,092.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(238.2)<span></span>
</td>
<td class="num">(59.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(127.3)<span></span>
</td>
<td class="num">(89.0)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember', window );">Foreign Currency Translation</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(267.2)<span></span>
</td>
<td class="num">(43.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">113.8<span></span>
</td>
<td class="num">(37.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(153.4)<span></span>
</td>
<td class="num">(80.9)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember', window );">Pension Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(1.3)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember', window );">Interest Rate Swap | Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems', window );"><strong>Accumulated Other Comprehensive Income (Loss) [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance</a></td>
<td class="nump">29.3<span></span>
</td>
<td class="num">(14.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent', window );">Other comprehensive income (loss) before reclassifications</a></td>
<td class="num">(2.9)<span></span>
</td>
<td class="nump">7.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance</a></td>
<td class="nump">$ 26.4<span></span>
</td>
<td class="num">$ (6.8)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669686-108580<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedOtherComprehensiveIncomeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedTranslationAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_InterestRateSwapMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.4</span><table class="report" border="0" cellspacing="2" id="idm140445721603744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share Repurchase Share repurchase (Details)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($) </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodValue', window );">Stock Repurchased During Period, Value</a></td>
<td class="nump">$ 100.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_September222022Member', window );">September 22, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchasedDuringPeriodShares', window );">Stock Repurchased During Period, Shares | shares</a></td>
<td class="nump">1.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1', window );">Stock Repurchase Program, Remaining Authorized Repurchase Amount</a></td>
<td class="nump">$ 900.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member', window );">December 11, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_holx_SharerepurchaseplanLineItems', window );"><strong>share repurchase plan [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1', window );">Stock Repurchase Program, Authorized Amount</a></td>
<td class="nump">$ 1,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_holx_SharerepurchaseplanLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for share repurchase plan [Table]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">holx_SharerepurchaseplanLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>holx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount remaining of a stock repurchase plan authorized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockRepurchasedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockRepurchasedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_September222022Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_September222022Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareRepurchaseProgramAxis=holx_December112020Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>holx-20221231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2022"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:holx="http://www.hologic.com/20221231"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="holx-20221231.xsd" xlink:type="simple"/>
    <context id="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5eb0f65df2cc487ab6b5d60164c1f0fc_I20230126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2023-01-26</instant>
        </period>
    </context>
    <context id="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i381b04db1e184cdfbcb810bfeedfddfd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i748118924a534325be3931e7f281d5da_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i8b667a34853345ce9fc30f034e33f5b3_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i750b33b8abf7477581f5efbc46a8f09f_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i104836b541db4552a3484725690e4c11_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ie4a69d1c0d994885bd6c5a0c8cc6aeb7_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="idc24a74bca6f45a98e1346313bc6bb4a_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i17d494d3ea2f420d85bcf5996162d2ba_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ic667279782cb401298855c46a15ab094_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ie62b1597841e4a4b91bc223e8929cd2e_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i4a684294b69f49c5bb601cb231f23927_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ib069c3c83a7d410ca7d70d300726945b_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="id614601c4c7b4096a9c5dcbd9f8fe6d6_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="ie7b569b420904a598de952ba3efe933c_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i5d4f66d97be24ea29c9e72a2c1b943b1_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="icfec87e83d4e4bf8ae4a9f94883339de_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="ibb8c751501224cfb8f672b3b5d147581_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-12-26</startDate>
            <endDate>2022-03-26</endDate>
        </period>
    </context>
    <context id="iee40c972e79245a48193d5c44a5d488c_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i44bb24d344a2479f88cb3056e9eb7f9d_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="icb7a25b0e96544b6bbd05dc3066b58b1_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i7df030fd1d484893b2c6f6ca3cbc20b5_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i96aafcc8951b43bb843963cb4ef1b0c9_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="i27baa3824d6f48cba5a8bdecb8c0cc9f_I20220326">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-03-26</instant>
        </period>
    </context>
    <context id="icdc5975fe0bb4a9f91e698a96eabdbdc_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="idffe4e4b122a47f5b0294845f328191d_D20220327-20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-27</startDate>
            <endDate>2022-06-25</endDate>
        </period>
    </context>
    <context id="i46ea4a08bd3042a7ab12381bf4bff328_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i3c7577051ac8445595d275ea3b4ba6d7_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="ibb6f35c1e6d84dd5b5f8a049aac44ec4_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="ia42682bb507a4e48a823cf2bdaafddc5_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i5a60e52602c048069d80e58e5129177f_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="i68d91b48be7045588cbe38f1d5620c60_I20220625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <instant>2022-06-25</instant>
        </period>
    </context>
    <context id="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="i98e19907377e46229597921f8801edcc_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="i9301d9a3c6c442bab8060ca751e7563b_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="idca511b5b1874691b87e467241ae5b70_D20220626-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-06-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="if54a740632874ce19cb42642fb2e221a_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ie23d7b47d391462891d1fd3901620b20_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i013fa78766bb45bc816b63fed5c22874_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ie45f7058af534e8dba563c02009f5cac_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i17c32b5fcbaf409cb7118fbe9bb55a0e_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i671c4997470d4f578166e16141225885_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iffce715dc2d14558a02450be71f516b4_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8c096023d23c420bbe6591cb72e10eb9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c1f63693e304533b7ac2c9be6e0e0bf_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie3fc5436b7e04085aaf9f0cc0a424693_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i14951cf020f246d1996832691a0edc4c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i576d2b7fc4c843429397ce9929243a48_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3714d8a36f9a4f34b0cbd75cd016e460_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0064a9d141464479bd6959095d0a5614_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if05c15bd87b943b8a89e3a90c5706964_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i67c7d17962b5422eb16f38be2f358d0b_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7494f976d4084d799b3eb03ac448aba0_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i03bc4a9519ab4934844ac430543e9341_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="icba05cf621b045f1b0ded77db74e0969_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iabf98c37c1ac4489bfce80d1f1a39c3c_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idee014b8532443d785b4a01fa597c5c7_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib42c16151a9a4724a372b6e2e07aec81_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i22f2dbcd7d0a4089b97103d3d3afe54f_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7f36606e666b4146adad29c31c074863_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7a65e517835843be8d27d7cb21ff1b36_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i51a2e59e54574cd080bad373ef124b26_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7388165a9fbe4c68874d5c98159e6efd_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i08c907a0b9364379897608caed02a091_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id1416b6917304ee989571d01c9094fd5_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ibe4ef9ffa5b8469f929dfa4f3760db7d_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie73d75b7f9d449cd9fbf4cc4956c951a_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i51bc8c3e08e64a4d966f2689b7b9fca3_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4e1959574bed4110a1c49d33f2343bce_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="if28f4b47974c4a738dd6e022d463262a_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04bff6a5d47648fea88ce5c7a9bd0e30_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ib015bd8926a441f69d50128b8d601218_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i17810aabf3f24d38be45e8306c3d0ebd_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ie4035e7e2acf45e69da33b7c6c319979_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i4254426126b9489587816dbe55a313ef_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ia7b6e942d3ce4287ae8dd825a5bbc626_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CytologyPerinatalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i8db75acc45cb41b3936f464bdb0755de_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="id80a68949b1d49319e7efed985768c09_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i52bce32474874a61a1c93ed216e5bf26_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:MolecularDiagnosticsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="iae21e80b749742799ade28f359a906e9_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i1eee1f1f7fda47a79e60a0733d804ab4_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ife508b03a0c24293b8380f77af515a15_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BloodScreeningMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ieb2242435a5340c69a48e6d30b767133_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="if2f090269cb448819fb3699673bc74d2_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ia05653e355504b53be8959ec4476671a_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="if0eed27597194772ac078e57b5d5f7a4_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="icf8975b9a0604bacb2f2ab4ca1780919_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ib09726cd3d914adbaa7747d82b3d9f72_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:BreastImagingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ice7600161d394a1f844a8709af83b0be_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i84a573e910f34c268f9a51a69f8fa78b_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ie1f3865bf0674bd6b94548118ff2d889_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:InterventionalBreastSolutionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i76b0a758c01b41e190b861904f705b3e_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i972d2eac12d5498a8229fc8889a43517_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ie8a130a7154a42b4a3e2498da03f0bd9_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i8a538d4146054e4d87047cc9f7975933_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ic3fd7aa5f38f43d0a2cb58912a4606e3_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ib1a36d0d1182460d99b0fa319a28cb37_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i121cb63f710c4e60938523f4c50dfe98_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:InternationalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i023b583e3a5743b689087ebe2014e742_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7927fb2683384ee6ba18bcb24820aa75_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i9158b0a900c0492c87e53bb0bfe60c76_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i7e03307d675a4c4794cdacb42a15022b_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:AsiaPacificMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ia2dd7194daee4e2687e5b9ae50540cdf_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i84475ed4b97b45d2a58bd44b2464b6fd_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:RestofWorldMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i5288beb020944838ab3e1ad08f68dad4_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3dbe4b4d36594aadabeeb6b5788626b0_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:ConsumablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i1d55ea19e5c248d3aefe288d6d5f6d43_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3b62910ac86e4f18a8f2319faba92b2a_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:CapitalEquipmentComponentsandSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="iae7f2df5e66048c5a4d97e51f384eea7_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i461d5f7bb915496b935d3720acf6161c_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ServiceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i01d38c9b3ccb4db89e86e540ca7bfbba_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3a3686a6966f49ad893900200aa534f4_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">holx:OtherTypeofRevenueMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="iab3be1fea9b347e08c0fbc486d6eba52_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2022-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0170159e5fc647ee9b73c9274f3ad654_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib03f3840b4e04200a761acaf93092033_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i343ac5e6f3c84d52b2f78181c3170b97_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2025-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if2ae0d1ec03043af95521f9690cafd90_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2026-03-29</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie91293e66d194ed7b35c5cfe9f42b0a4_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1d3fb98231024d8aaeb5bb8323a77efe_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9b9400e507d84e678a5c359b9f85f0a5_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f9f58b445784504a1bf2cb52ed1b1dd_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ifcc81839fd2d4dabbd199e560f9aff75_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i11cfef20f9384ec3a5c511ca3d5c9667_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id87e29cdda514b4fba2087505293883f_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8b7d6e54b06f4b8ca98b5e0a69ed1552_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6da937d0b81c484fafd31d8ccb9153a3_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i4cc1dbc4bf77455684932730e1b2c790_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idddbd7f5e3d144eb82b55c015f5f4a19_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibc27b2eb58e94a3ea4a4352a38a0b0d6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i35ebbdfc813948f5b2ac23261acc5170_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9338d4109670455dbe967e46d7506077_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2050fb386a4c429cbc768ceb88089203_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ief97bdd54b7c44619fbcf4a88df99626_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idab2972813444a1590e68c0af622c531_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">holx:ContingentConsiderationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i89cf56ee2c6d48f79ce43d6e357253e1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i9895e82979cd46e5b9e29032558cf8f0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7fa3655b5c4b41899337fbf34ce3a418_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib24e943c04e946d3b20fd2005eebdcf2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:LiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:ForeignExchangeContractMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iefd5e2be463d4709a964b3675267c84b_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:EquityMethodInvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ie8285876f9504f55b719cb94a43fd897_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8106951e543c45718bc14b8faa6ff745_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i73a6b6dfd2a144cdb914d656abdc6688_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8c253e80fb5495fa148fef676c31327_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i1c866db25ccd49bf9837ddb6f3695f2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iea43d0cf9441456ca855066f24c915b7_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-29</instant>
        </period>
    </context>
    <context id="i1481f69a4d9244499f5a549cc0eebe59_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="iba6cbbe07ee948f583f8d1f77e05e475_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="iab72fa2f468444a685a69c28852ec73b_D20211129-20211129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:BolderSurgicalMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-29</startDate>
            <endDate>2021-11-29</endDate>
        </period>
    </context>
    <context id="i4698c57aad0746b78ce06e44b93c84fc_I20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-08-23</instant>
        </period>
    </context>
    <context id="iae84daa015564a61a94ab772911423dd_D20200823-20200823">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-23</startDate>
            <endDate>2020-08-23</endDate>
        </period>
    </context>
    <context id="i343e49832f164c1a89e8c46e7295b5be_D20210926-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="iaea12adf8afb44a3a25469e63012eb04_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ia8ff31aae0694a0aa8817256292f1722_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iacaca98377e84dea8c3dcc6d430e498c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">holx:AcessaHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3506cb7a03e440d886dbc72ce84c14b7_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i30bcf60271074f93a183af070bda3ce1_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ideae2329e17d435e83ee4db40e5b76df_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RestructuringPlanAxis">holx:DanburyClosureMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i333952b4e5b04176801bb8b51ea10d2b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab94eadaf80646c99688a0bc7890d803_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ia2d07a69cb1c487c91cc762762bc1d0e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iadc35cfa947f44998ff3996d2aa84afd_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i34650814b5cc4021acd04ac86d799f20_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i79d0d70331034758a653310fab36e412_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i345a638c3ba941e1855a959c897f7176_I20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="i16715a72d92e441993d6789cac1dbd2f_I20210927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021RevolverMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:RevolverMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-27</instant>
        </period>
    </context>
    <context id="i10401dc3383842b09980d3a937fb7508_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021TermLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:SecuredTermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6f5ef2ef76fd4192b1f4f10266a76b4e_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idfaac04d4a484d258c3db28ddc02ff2e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2021CreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:TermLoanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ica33b08d41d34461b027e01d397de44f_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i0e9943e6f8ff4c8aaec563317ae88d47_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:CreditAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i0ca833a47aa541e992640c358c110349_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id225da1e135b44f7a25d7b8427d9693e_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="id9b7e75f146848e4bc229589975b5948_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i34f00671c17749c98d26591f7dc95d11_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3c0114bb00874bbcae4df17922168466_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i60ac9cd428ef42a7a8b91fa784f5f45e_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i6764b5e8e67e48f791728d79a2e34122_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">holx:A2028And2029SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i167654f352a04de29b14663bc8cdcfc0_D20220401-20220430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">holx:AssetSecuritizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-04-01</startDate>
            <endDate>2022-04-30</endDate>
        </period>
    </context>
    <context id="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ie72a76382d1b4c529a23dfa89ceadc2c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForwardContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib8c4e34d9d094f1fbf48292741f16b5d_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ied698bc89eaf4b6f80e13382683a1a03_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="iec75d669bbf346d6903c94657e8133f1_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iadefe818aff343f093532897c969439a_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i55939d7a42bd4556a498a480de79cd50_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ifee71b2ee2b34924938fe48b466219ce_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i44fe85004cc04b32b3a10a1559c2e2ef_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ibac4befa17b047999f00b91ca7b94ef7_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="if13d8d495368452eb77bee9ff19dc345_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i9926b76c62324c0b958fed2b0e24ea5a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib2198af10da940cf86ae64d703bc53c5_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i56899b92d8d848078cfec5556948bfc9_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id4c139a224444cffae631f02c7acba9f_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ib71a2388896942158d0fc786a95eba81_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5fe6a4b393534f29abeeb1a68c843b13_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i9e837bb262414d9dbc7e423824de0ec6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i270cd6664faf43379c84adce180639da_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i6d535ec00f0f411dafec44429b007238_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3ff63602d630435f9e63019c5e7f9b83_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:NondesignatedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i0e402eb79be640de87443d033aa21455_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i0dcc9f20204945ec878054956bb77035_I20180727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-07-27</instant>
        </period>
    </context>
    <context id="idaaa4b233a9344908933211ba063dc5f_D20160304-20160304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-03-04</startDate>
            <endDate>2016-03-04</endDate>
        </period>
    </context>
    <context id="i667766d52416443f8777bd5eeca5cef5_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">holx:MinervaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i435ccc0a3ea14ff99da3eb507f45b519_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i8933fd8cce38473bb6574d4ef3ed3dda_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:StockCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i046a8b5e3d6b499bacae51fc5c4a8ab5_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i10182a4e9dbd401592fba602d8fc0dfc_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ia43275c19d1d4deb9bd1023171cfc883_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i47792d9e50e24ce180eb23c262315201_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ibfd8fe55e66344279f13b5494e40abef_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i26800c2f43ab47478ff80253b55d85cc_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingAndMarketingExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="if448d6a552274a47bac66865fb2016c6_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i5214cfde47fd4e71851f007985469117_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i04a4cd810a09430fa9d6e1eb34765cf6_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="idb6f997f16b34e71947022ff6714b032_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i85e3227c7fe14f10bc6686036ba0ac71_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i503690e214944a309e402e9960e2e6e6_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="idab51929268f46bc932b7830d8baf571_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="iddf3093b029a43d79dbb42728abb753e_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:PSUFreeCashFlowMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i9771af51c0794b19a9578e0b8ec0d00a_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:MarketBasedAwardsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ib205930814294a04ac8c44fa4d6e33e2_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">holx:RSUPSUMSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i8512fea0d6de4301aa283764d9659897_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib922bf6da6cc4631a901c3990795d953_D20210627-20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-06-27</startDate>
            <endDate>2021-09-25</endDate>
        </period>
    </context>
    <context id="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2022-09-24</endDate>
        </period>
    </context>
    <context id="if1c4506326454758a9ff17a52cc3174d_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i4d7693a500ed4ec4af97863e7ccb013a_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ConsolidationItemsAxis">us-gaap:IntersegmentEliminationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i5e16a16ccca84227b6bdd8b921503333_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2d14d558aa9940c5b745ed86dca4facb_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i8044d1c646c14ad7a8ca13af6376e2c0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iab62225f35a54fdf891fb942549d470a_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:DiagnosticsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i47bb3619ac514e9396f3997cc99a8206_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i88ad24968acd4cb992c6185f64aafc61_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:BreastHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="id048a530970b4115ad934dd57bfb2bd1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i922f9de14bf045b4aaeafaf2502b6528_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:GynSurgicalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i9d3b3986fbd9494f904cb1a010337a73_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7e1bd6b8680642e296a44c25673ce7a7_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">holx:SkeletalHealthMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i1ab2eb9bf2244498bacafb726d13a41a_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7d747f63ad01496a9ffd93aa08a24d54_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">us-gaap:CorporateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i9a1210ecf0f441c481be084c5fc7365e_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i56bcae300f9d40398f2e76fd994f2a30_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">holx:AllOtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="ia9bb3f8b8a35456aa7b21ae62f2ed3ca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ie794110f347e4793b515e8bde9c5a5e6_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:DevelopedTechnologyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i3aa2073a325f423cbcb061411d2f553b_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="icbe0934c8334473cad9c3b424110753c_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="ie1169e0270b74fe6be508c370950a863_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i18960c3349fe4eb0a59368d1094a8ddd_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CustomerRelationshipsContractsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i67fea90f60574367b621cebdab180dd0_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i7207b97bd8c2409ea04c174faf5b7855_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i365291db08214202af3bee07bb3e066c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i57e724ba87534f28bfba9adaf851c705_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:AcquiredintangibleassetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i36ab5815693d4b4c96b98c8708a6fcb8_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2251dfc34b1f4dee9b06523ab53696b9_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:InternalusesoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i25c1b55962c14bd28656aef42077ee23_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i3dd84f06f8354c2c99790984e0e949ec_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">holx:CapitalizedsoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="iba33d49d790247138728e16304550207_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i7714e4ad6e2f403ca6e488d1c5b4956c_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i6bedb97f35ab4eadbc7dfdf485949c64_I20220924">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-24</instant>
        </period>
    </context>
    <context id="i6fd0ad2aef5b404eab15f293436efcc7_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i2ffc46097a444b81abc0a82e463c5c4e_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i3fa140a2e91a4da0849a54c6a2cf483d_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="ida477b36723f466a839eca19b439840e_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i053a359de4994764bcc53d5d8bd87247_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="if56004b6ce284c0a88a74e229ff23a11_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i05e36b9f6d534537b938515e96a9b738_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i420e29ca33f74637b19b79f051f15a88_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="i5e589736d905406c8090a6aa9422698b_I20210925">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-09-25</instant>
        </period>
    </context>
    <context id="ifa137501c2f640d8a89b78da55d9a00e_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i79417d9e4a134491875ae60fa840bf0d_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i38bcb736614e47149fc6af7f459d9a0e_D20210926-20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-09-26</startDate>
            <endDate>2021-12-25</endDate>
        </period>
    </context>
    <context id="i10878f2ace9949af8c060f1bca337922_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedTranslationAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i407e328e7a8e4cb7bd6a3598b8ad7ca3_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i6db04a89d01143309b15081f34133a3a_I20211225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:InterestRateSwapMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-25</instant>
        </period>
    </context>
    <context id="i92f1d854058b4a7badb00114d82a50c1_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib36279872040402a85b53f40877fc6bc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:December112020Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iec5a478ebcd24022ac3b46935f9c1298_D20220925-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000859737</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareRepurchaseProgramAxis">holx:September222022Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-25</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="petition">
        <measure>holx:petition</measure>
    </unit>
    <unit id="segment">
        <measure>holx:Segment</measure>
    </unit>
    <dei:AmendmentFlag
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N18yLTEtMS0xLTk3NDc3_de7f4606-5fce-430a-96b8-587b04ab276a">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N18zLTEtMS0xLTk3NDc3_8bf57d8a-a4f7-4448-9ff0-94c61a9fb8a0">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N180LTEtMS0xLTk3NDc3_efed5702-3ea3-4ec8-8531-cdf2612c72cc">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N181LTEtMS0xLTk3NDc3_7bb23384-d032-4c35-909a-a1bc7b7184e5">0000859737</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80L2ZyYWc6MTgzNzhjYTg0MjkxNDE3NzkyOWNmYjdhYTVjMmJkMTcvdGFibGU6YWI1ZGY1YjcwYTFlNDZlZWI1ZWExMjI0YjQzOTM1OTcvdGFibGVyYW5nZTphYjVkZjViNzBhMWU0NmVlYjVlYTEyMjRiNDM5MzU5N182LTEtMS0xLTk3NDc3_9f20efd2-9a22-4ec4-ad0f-332d25d78bd4">--09-28</dei:CurrentFiscalYearEndDate>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="iab3be1fea9b347e08c0fbc486d6eba52_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfMi0yLTEtMS05NzQ3Nw_32d79705-e90e-4a4d-85dd-220df1cc069d">P3M</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i0170159e5fc647ee9b73c9274f3ad654_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfMy0yLTEtMS05NzQ3Nw_3c33eeb2-3cb1-421f-bb7f-2107aa035e1d">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="ib03f3840b4e04200a761acaf93092033_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfNC0yLTEtMS05NzQ3Nw_eac3498a-5a81-4ff2-9104-9ba123ebf095">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i343ac5e6f3c84d52b2f78181c3170b97_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfNS0yLTEtMS05NzQ3Nw_c77c42db-3101-4914-bafb-4b48a6ae7fb5">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="if2ae0d1ec03043af95521f9690cafd90_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80MC9mcmFnOmE0NjIzNjVlZWM2ODRkMjk5OThmZmFkYWY2YjZhOGY1L3RhYmxlOjEyNmJkY2JmZjJjZjRjZWViZjM0ZTRhOGJlZDM0YmVkL3RhYmxlcmFuZ2U6MTI2YmRjYmZmMmNmNGNlZWJmMzRlNGE4YmVkMzRiZWRfNi0yLTEtMS05NzQ3Nw_49ba91b7-7c03-4279-b9e1-f8bce3068ae3">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjgx_f743f7d7-dc18-4131-9a5b-4ec1b099bd10">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6YTJmZTU1MDdiMjc5NGFhNjkwNmZjYjg2ZTgwNWU3MWEvdGFibGVyYW5nZTphMmZlNTUwN2IyNzk0YWE2OTA2ZmNiODZlODA1ZTcxYV8wLTAtMS0xLTk3NDc3_acebbb3b-5ea4-4c22-9c68-76bf2e1fd9ca">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yNjA_098ed4b3-9e7e-44e8-9cc0-01e32e0f9a08">2022-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6ZGYwOGVmNWQ3Y2ZmNDFlYWIyODMzYjliODk1OTdmMjAvdGFibGVyYW5nZTpkZjA4ZWY1ZDdjZmY0MWVhYjI4MzNiOWI4OTU5N2YyMF8wLTAtMS0xLTk3NDc3_a577c79b-7267-4a7a-9c69-70bbe8632ed1">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjgy_e161d83d-63b9-4bb1-b0f6-bb7e7003c766">1-36214</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg1_3c3f1db0-55da-4eaa-91cd-ec243eefea1c">HOLOGIC, INC</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18wLTAtMS0xLTk3NDc3_536d724f-0035-4afa-8e66-88cd0056227d">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18wLTItMS0xLTk3NDc3_e8f6af5a-ec19-4446-88c5-604e00ef7a47">04-2902449</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18yLTAtMS0xLTk3NDc3_f650e35f-5c8f-416d-bafd-201619f7ca3a">250 Campus Drive,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM18zLTAtMS0xLTk3NDc3_b1950902-3ddd-4c56-b797-1dc98493a8f9">Marlborough,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM180LTAtMS0xLTk3NDc3_d1d730f0-b5c8-4c64-8163-0ded53dd19b2">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NGQ5NzdlNzk5MDYxNDQ3ODg2YWY2NWMwMjdjODBjYjMvdGFibGVyYW5nZTo0ZDk3N2U3OTkwNjE0NDc4ODZhZjY1YzAyN2M4MGNiM180LTItMS0xLTk3NDc3_d79d707e-e43f-4079-9180-2f3ffe70301e">01752</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg2_3a29e2ba-46b3-4fc7-ad2a-d17def0b1e79">(508)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjgz_8030488b-6636-4e41-bc25-5167120f771d">263-2900</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6Mjk0MTdkNmMwYTA4NDFmZmExOTA2MTdhZDRiZGRkYzcvdGFibGVyYW5nZToyOTQxN2Q2YzBhMDg0MWZmYTE5MDYxN2FkNGJkZGRjN18xLTAtMS0xLTk3NDc3_84bcfd05-ace7-4dcb-aba8-ded8ecc5b073">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6Mjk0MTdkNmMwYTA4NDFmZmExOTA2MTdhZDRiZGRkYzcvdGFibGVyYW5nZToyOTQxN2Q2YzBhMDg0MWZmYTE5MDYxN2FkNGJkZGRjN18xLTEtMS0xLTk3NDc3_4ca0833d-09b1-424b-b72c-6ce622b2c710">HOLX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6Mjk0MTdkNmMwYTA4NDFmZmExOTA2MTdhZDRiZGRkYzcvdGFibGVyYW5nZToyOTQxN2Q2YzBhMDg0MWZmYTE5MDYxN2FkNGJkZGRjN18xLTItMS0xLTk3NDc3_858512d0-6b69-4563-b0a1-b92a57d56e33">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg0_846d940d-aa02-40c4-a127-4694d3457311">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg3_3b683893-c79f-41c2-973d-2b91fd8d45c7">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NzdjODM5YzE0YjM5NDhkZGFhMGJkNzdhN2I0OGUwZjQvdGFibGVyYW5nZTo3N2M4MzljMTRiMzk0OGRkYWEwYmQ3N2E3YjQ4ZTBmNF8wLTAtMS0xLTk3NDc3_b31fbd83-806a-400d-86bb-3a072ecd4b0d">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NzdjODM5YzE0YjM5NDhkZGFhMGJkNzdhN2I0OGUwZjQvdGFibGVyYW5nZTo3N2M4MzljMTRiMzk0OGRkYWEwYmQ3N2E3YjQ4ZTBmNF8xLTYtMS0xLTk3NDc3_3bc43b17-c9f3-4650-8a03-43f9a86e3293">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGFibGU6NzdjODM5YzE0YjM5NDhkZGFhMGJkNzdhN2I0OGUwZjQvdGFibGVyYW5nZTo3N2M4MzljMTRiMzk0OGRkYWEwYmQ3N2E3YjQ4ZTBmNF8yLTYtMS0xLTk3NDc3_05803e05-0cbb-4e68-bca6-5056dfa272d6">false</dei:EntityEmergingGrowthCompany>
    <dei:EntityShellCompany
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjg4_c563b87b-8c4a-42e2-8c41-8e383af2bf28">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i5eb0f65df2cc487ab6b5d60164c1f0fc_I20230126"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xL2ZyYWc6ODU2NmVmMGQ3YjgxNGI1NGE1MzYxYzEzNWZkYzY5NDgvdGV4dHJlZ2lvbjo4NTY2ZWYwZDdiODE0YjU0YTUzNjFjMTM1ZmRjNjk0OF8yMjAy_608556c2-9f97-4cf4-99f3-13aac820b06f"
      unitRef="shares">246554026</dei:EntityCommonStockSharesOutstanding>
    <holx:ProductRevenue
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMy0xLTEtMS05NzQ3Nw_389927e8-adcf-4d2c-9526-86738d426485"
      unitRef="usd">886300000</holx:ProductRevenue>
    <holx:ProductRevenue
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMy0zLTEtMS05NzQ3Nw_5bd47804-0456-4e16-ab55-bdc07c8aa2da"
      unitRef="usd">1303300000</holx:ProductRevenue>
    <holx:ServiceRevenue
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNC0xLTEtMS05NzQ3Nw_5c631008-d783-4d62-a60d-a50f884c0a87"
      unitRef="usd">187900000</holx:ServiceRevenue>
    <holx:ServiceRevenue
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNC0zLTEtMS05NzQ3Nw_c0eb0185-3d97-40d2-a40b-0d07c7804e7a"
      unitRef="usd">167800000</holx:ServiceRevenue>
    <us-gaap:Revenues
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNS0xLTEtMS05NzQ3Nw_e50d57e7-dcc2-4725-a19c-e564f488afdf"
      unitRef="usd">1074200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNS0zLTEtMS05NzQ3Nw_52979dbb-f70c-4e42-8dfe-667757a605ff"
      unitRef="usd">1471100000</us-gaap:Revenues>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNy0xLTEtMS05NzQ3Nw_5f1eeaae-1e13-48a3-b8be-e22040d8e5db"
      unitRef="usd">296200000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfNy0zLTEtMS05NzQ3Nw_7997f2ae-859f-411f-aff1-c267123e85a2"
      unitRef="usd">318100000</us-gaap:CostOfGoodsAndServicesSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfOC0xLTEtMS05NzQ3Nw_000b027a-c5d1-46f9-9e16-0e52b3373806"
      unitRef="usd">55600000</holx:AmortizationCostofGoodsSold>
    <holx:AmortizationCostofGoodsSold
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfOC0zLTEtMS05NzQ3Nw_44db3814-c7f0-4c61-8feb-34081c835331"
      unitRef="usd">74900000</holx:AmortizationCostofGoodsSold>
    <holx:Costofservice
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTAtMS0xLTEtOTc0Nzc_78765ee6-02a0-48f4-a71b-73bf6b662735"
      unitRef="usd">104500000</holx:Costofservice>
    <holx:Costofservice
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTAtMy0xLTEtOTc0Nzc_a1f173c0-27af-473b-a9d9-ce89dc21cd62"
      unitRef="usd">91800000</holx:Costofservice>
    <us-gaap:GrossProfit
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTEtMS0xLTEtOTc0Nzc_a68a7474-247e-4390-a398-6d50472b8d25"
      unitRef="usd">617900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTEtMy0xLTEtOTc0Nzc_550d96fe-dc9b-4ede-a63e-b7d36d31eb20"
      unitRef="usd">986300000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTMtMS0xLTEtOTc0Nzc_9a5118d0-b912-475b-8538-6915b89c0246"
      unitRef="usd">74800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTMtMy0xLTEtOTc0Nzc_49a11e8e-1c1b-463f-b10a-14310d3e11c1"
      unitRef="usd">72800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTQtMS0xLTEtOTc0Nzc_16ed7a53-d6af-481d-9917-f358d4f4dc8f"
      unitRef="usd">163500000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:SellingAndMarketingExpense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTQtMy0xLTEtOTc0Nzc_57935b67-a93c-490b-88d2-aaf39d0db41d"
      unitRef="usd">147400000</us-gaap:SellingAndMarketingExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTUtMS0xLTEtOTc0Nzc_922586f6-4e9b-4692-a492-c441d41e0bad"
      unitRef="usd">108500000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTUtMy0xLTEtOTc0Nzc_5b8e64a9-ffd8-441e-8b45-9a4b228445c8"
      unitRef="usd">117900000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTYtMS0xLTEtOTc0Nzc_538920e5-92d7-4aca-9d00-52fff10f3fe4"
      unitRef="usd">7600000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTYtMy0xLTEtOTc0Nzc_1d8fb2d6-f8dc-46b7-b048-17a63520c1da"
      unitRef="usd">10800000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTktMS0xLTEtOTc0Nzc_20a53f51-c784-4a59-82e6-8d8b60715919"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMTktMy0xLTEtOTc0Nzc_bb14a920-8074-46d2-a94a-14d1cc9418c4"
      unitRef="usd">4100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:RestructuringCharges
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjItMS0xLTEtOTc0Nzc_ff181bc2-b963-4c6a-8871-72c90caa805c"
      unitRef="usd">1100000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjItMy0xLTEtOTc0Nzc_ff22da82-4e04-40c5-8076-ea12faecf4e4"
      unitRef="usd">200000</us-gaap:RestructuringCharges>
    <us-gaap:OperatingExpenses
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjMtMS0xLTEtOTc0Nzc_5c6e0e53-e9b7-453b-a0b6-2567da392eae"
      unitRef="usd">355500000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjMtMy0xLTEtOTc0Nzc_f0f2e588-1ff2-4c48-b6af-8895b224bec6"
      unitRef="usd">345000000.0</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjQtMS0xLTEtOTc0Nzc_a4609735-9df5-4f5f-8361-83387544e9c4"
      unitRef="usd">262400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjQtMy0xLTEtOTc0Nzc_ec346f39-18a7-48b1-ad07-da147f72006c"
      unitRef="usd">641300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjUtMS0xLTEtOTc0Nzc_c9f7698c-7535-4c4c-8955-92f97f3e0f8a"
      unitRef="usd">20600000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjUtMy0xLTEtOTc0Nzc_ba3a1d94-9ce8-489d-9dca-690acce4eb6f"
      unitRef="usd">500000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjYtMS0xLTEtOTc0Nzc_73f07a31-9bc6-4665-9689-cd82afd55c6f"
      unitRef="usd">28100000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjYtMy0xLTEtOTc0Nzc_6c90329d-1b35-43d8-867f-cb6179d9fdde"
      unitRef="usd">25700000</us-gaap:InterestExpense>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjctMS0xLTEtOTc0Nzc_08d1487c-dd57-4c03-b331-33a6932ad404"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjctMy0xLTEtOTc0Nzc_d78648dc-e238-42ae-ad4b-8b0d27209388"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjgtMS0xLTEtOTc0Nzc_8dae8b66-228a-4965-80b8-063a4bfd6efc"
      unitRef="usd">-15800000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjgtMy0xLTEtOTc0Nzc_29e7858a-6869-4b0f-a7e0-9aea2087b05c"
      unitRef="usd">6500000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjktMS0xLTEtOTc0Nzc_067ab542-49c0-42b2-be71-28981a8b2d27"
      unitRef="usd">239100000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMjktMy0xLTEtOTc0Nzc_1a455f8b-8e7b-424f-a8ec-87cb632ad135"
      unitRef="usd">621900000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzAtMS0xLTEtOTc0Nzc_e47496c4-42cb-4812-881d-4d659f2f9cdd"
      unitRef="usd">51700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzAtMy0xLTEtOTc0Nzc_8b2e55fa-542e-4937-b7bb-ff97557b75b4"
      unitRef="usd">122700000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzEtMS0xLTEtOTc0Nzc_bed4123a-8e3d-4058-9234-e3c49b4afb1f"
      unitRef="usd">187400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzEtMy0xLTEtOTc0Nzc_ff5f0e72-7804-4142-a231-81101595b8e5"
      unitRef="usd">499200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzUtMS0xLTEtOTc0Nzc_ec210976-d12b-47fc-80ea-c42e1f53c699"
      unitRef="usdPerShare">0.76</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzUtMy0xLTEtOTc0Nzc_d7805194-a7f6-42f0-90a8-115e335b1549"
      unitRef="usdPerShare">1.97</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzYtMS0xLTEtOTc0Nzc_a697290f-7401-4eec-a6ba-44d8077309f3"
      unitRef="usdPerShare">0.75</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzYtMy0xLTEtOTc0Nzc_3764d394-9fa1-4427-b162-fc56e922e46d"
      unitRef="usdPerShare">1.95</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzgtMS0xLTEtOTc0Nzc_01869c1b-1838-40a1-93a9-973c952da1cf"
      unitRef="shares">247319000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzgtMy0xLTEtOTc0Nzc_2ec5ba01-e3ee-41a2-92f6-cdf4ca45e4cf"
      unitRef="shares">253499000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzktMS0xLTEtOTc0Nzc_2807fb0c-32dc-4735-9ebb-b0a662ef910c"
      unitRef="shares">249281000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xNi9mcmFnOjk1OGRjYTBlMmE3ZDQ0NGY5NDg5MzliYTk2ZGUyNGJmL3RhYmxlOmUxYjRiMWM1MDBiMjRiODdiYTA0NzRkZTNjNDIxZjg1L3RhYmxlcmFuZ2U6ZTFiNGIxYzUwMGIyNGI4N2JhMDQ3NGRlM2M0MjFmODVfMzktMy0xLTEtOTc0Nzc_1271012f-4980-4b5c-9045-90c33215cfbf"
      unitRef="shares">256070000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMi0xLTEtMS05NzQ3Nw_450b608c-f13e-4bc0-ae44-22c4d5e959b4"
      unitRef="usd">187400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMi0zLTEtMS05NzQ3Nw_be70d850-1c3d-415c-92c2-ef7a3253f0bd"
      unitRef="usd">499200000</us-gaap:NetIncomeLoss>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMy0xLTEtMS05NzQ3Nw_4d474063-1b87-4d28-85c0-84d33ca55f5d"
      unitRef="usd">113800000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI>
    <holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMy0zLTEtMS05NzQ3Nw_834434b8-aab8-4c29-9d53-5d36dae0442c"
      unitRef="usd">-37800000</holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOC0wLTEtMS05NzQ3Ny90ZXh0cmVnaW9uOjU4YzEyODY0MGQ4ZDQ0MjI4N2M1NGNiMmMwNDg0MWU5XzEwOTk1MTE2Mjc5NzU_8ab5ca9f-e97a-4724-b673-2363f7b1aa4d"
      unitRef="usd">900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOC0wLTEtMS05NzQ3Ny90ZXh0cmVnaW9uOjU4YzEyODY0MGQ4ZDQ0MjI4N2M1NGNiMmMwNDg0MWU5XzEwOTk1MTE2Mjc5ODI_4860b554-f394-4670-ada0-44e027345cae"
      unitRef="usd">2600000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOS0xLTEtMS05NzQ3Nw_0eeb14c9-b7ce-45cf-a2cd-a164c6712fdb"
      unitRef="usd">-2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfOS0zLTEtMS05NzQ3Nw_8cb02eb4-4352-4e36-b963-47c0b0ac8fc5"
      unitRef="usd">7900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTEtMS0xLTEtOTc0Nzc_39fcd6ac-d150-4d19-a369-78743cfa86ef"
      unitRef="usd">110900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTEtMy0xLTEtOTc0Nzc_2310c322-42c7-487f-bbc9-7ee874a6747c"
      unitRef="usd">-29900000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTItMS0xLTEtOTc0Nzc_cf7a431a-b7c5-448f-b549-5a0cbf25325d"
      unitRef="usd">298300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8xOS9mcmFnOjY0M2FmZjhiN2I0NjQ1YTZhNTY0MGY5MDdmOTA5YjgwL3RhYmxlOjE5Mjg2YjgyNDE4NjQ2NzU5OWMwMjM2NzcyOTRiM2Y1L3RhYmxlcmFuZ2U6MTkyODZiODI0MTg2NDY3NTk5YzAyMzY3NzI5NGIzZjVfMTItMy0xLTEtOTc0Nzc_a0845873-8f41-4e11-a71b-70b8d7314677"
      unitRef="usd">469300000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMy0xLTEtMS05NzQ3Nw_67f0ca1d-633b-49e6-a4fe-0a1440de2fd6"
      unitRef="usd">2441300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMy0zLTEtMS05NzQ3Nw_b9841bfc-d703-4be9-aee1-2f456548cb83"
      unitRef="usd">2339500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNi0xLTEtMS05NzQ3Nw_ba968ed3-5791-4036-8417-d1cb8f0aff0f"
      unitRef="usd">673800000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNi0zLTEtMS05NzQ3Nw_4cf42595-c39a-42b1-ad1c-6dbd4d817b73"
      unitRef="usd">617600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNy0xLTEtMS05NzQ3Nw_a720ae9b-73e8-4a73-be0d-1fa4c5260915"
      unitRef="usd">677700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNy0zLTEtMS05NzQ3Nw_c17de386-069f-4af6-8ee0-a59ad610440d"
      unitRef="usd">623700000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOC0xLTEtMS05NzQ3Nw_b7234944-1ead-481b-918a-2d987acdff50"
      unitRef="usd">197300000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOC0zLTEtMS05NzQ3Nw_2040dba8-52cc-48e3-8b68-e100de45bc98"
      unitRef="usd">232200000</us-gaap:PrepaidExpenseCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOS0xLTEtMS05NzQ3Nw_b9bd6a75-481f-4b66-bd7e-72792835fb9e"
      unitRef="usd">31100000</holx:PrepaidIncomeTaxesCurrent>
    <holx:PrepaidIncomeTaxesCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfOS0zLTEtMS05NzQ3Nw_da59e901-49ba-410a-b9d2-1854589cf58f"
      unitRef="usd">49000000.0</holx:PrepaidIncomeTaxesCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTItMS0xLTEtOTc0Nzc_d6cf9fb7-831d-4956-b69c-b4d733733cab"
      unitRef="usd">4021200000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTItMy0xLTEtOTc0Nzc_26411e31-b64e-4a34-b498-da0142be28ed"
      unitRef="usd">3862000000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTMtMS0xLTEtOTc0Nzc_b5806e24-2d80-4382-ac62-a885df7cffe0"
      unitRef="usd">494300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTMtMy0xLTEtOTc0Nzc_ee5458af-7d1f-4fe3-95d7-ea8560e854dd"
      unitRef="usd">481600000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTQtMS0xLTEtOTc0Nzc_9bf621ac-4661-453e-9438-7e8060ea343c"
      unitRef="usd">1255400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTQtMy0xLTEtOTc0Nzc_fdaaebac-4a63-43a9-ab10-ef9e90f9b8ab"
      unitRef="usd">1280600000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:Goodwill
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTUtMS0xLTEtOTc0Nzc_5864c707-2a64-4c5b-8343-031ca744d428"
      unitRef="usd">3289600000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTUtMy0xLTEtOTc0Nzc_8a3a2a70-803f-4acd-900a-5cd35fbf3c51"
      unitRef="usd">3236500000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTYtMS0xLTEtOTc0Nzc_c6385c6d-e3ba-4978-880b-25b498b64754"
      unitRef="usd">229800000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTYtMy0xLTEtOTc0Nzc_858cdc44-18a7-475c-b647-c9fc34e01334"
      unitRef="usd">210500000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTctMS0xLTEtOTc0Nzc_4ca11e9f-bf4b-4cc5-84e4-8ef7d5346352"
      unitRef="usd">9290300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMTctMy0xLTEtOTc0Nzc_42e4ba77-130b-441d-b12f-19372f8fd693"
      unitRef="usd">9071200000</us-gaap:Assets>
    <us-gaap:LongTermDebtCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjAtMS0xLTEtOTc0Nzc_0873d8ee-de97-4e76-bee8-23b39f703d19"
      unitRef="usd">20600000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjAtMy0xLTEtOTc0Nzc_1f5ab705-d5a7-42df-b2dc-c745876b0cf5"
      unitRef="usd">15000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjEtMS0xLTEtOTc0Nzc_2b864214-bfdf-45ab-a251-b1170ee2473b"
      unitRef="usd">201800000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjEtMy0xLTEtOTc0Nzc_b249624a-695b-4219-9316-f77815a98946"
      unitRef="usd">197700000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjItMS0xLTEtOTc0Nzc_334010b0-4e4b-492b-a11e-8ebdc5d6f1f2"
      unitRef="usd">539000000.0</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjItMy0xLTEtOTc0Nzc_acde446e-50da-42b6-b5d3-e36f0e0dbec3"
      unitRef="usd">535300000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjMtMS0xLTEtOTc0Nzc_8031df27-09e2-49d7-a573-0ef68620a2f8"
      unitRef="usd">191600000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:DeferredRevenueCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjMtMy0xLTEtOTc0Nzc_14a631cf-c5bd-4ff6-a9e2-7dce67a31213"
      unitRef="usd">186500000</us-gaap:DeferredRevenueCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjQtMS0xLTEtOTc0Nzc_caa7da15-d0cc-4536-bef8-212f047a0abb"
      unitRef="usd">3200000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjQtMy0xLTEtOTc0Nzc_71f9ab8b-eb8e-4293-8d5b-30c8646edd08"
      unitRef="usd">3200000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjctMS0xLTEtOTc0Nzc_9a5b9323-c03f-4073-a7bc-0a333c55a80f"
      unitRef="usd">956200000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjctMy0xLTEtOTc0Nzc_dc026756-00c3-4491-acce-894488b933c9"
      unitRef="usd">937700000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjgtMS0xLTEtOTc0Nzc_af52a6a4-5a27-44c7-b10a-7fa32dcdbb1d"
      unitRef="usd">2806200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjgtMy0xLTEtOTc0Nzc_65d9438a-da07-4fab-90ed-aa87ce64884e"
      unitRef="usd">2808400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjktMS0xLTEtOTc0Nzc_a6a3a336-99f3-4968-9cee-9629baf3f661"
      unitRef="usd">17700000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMjktMy0xLTEtOTc0Nzc_15e2c8f0-47f9-428f-9f2c-7e54bc152a09"
      unitRef="usd">18000000.0</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzAtMS0xLTEtOTc0Nzc_84b8bb73-b99e-4451-874c-34ee1fd094c3"
      unitRef="usd">71700000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzAtMy0xLTEtOTc0Nzc_24c34e07-3714-4a17-ad46-cd16ddbc13b5"
      unitRef="usd">90800000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzEtMS0xLTEtOTc0Nzc_375779b2-97e9-4d55-a7f2-43863565811b"
      unitRef="usd">10900000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:DeferredRevenueNoncurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzEtMy0xLTEtOTc0Nzc_2b7e251f-7e9c-45ad-acf0-5fbfe8fe49e0"
      unitRef="usd">9400000</us-gaap:DeferredRevenueNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzItMS0xLTEtOTc0Nzc_f9a6be1f-14a7-43d2-a75b-42404b85b2e0"
      unitRef="usd">335100000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzItMy0xLTEtOTc0Nzc_f79c8aa4-a98e-44b4-9677-87935eb9d41d"
      unitRef="usd">330700000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18yMQ_245954b2-a281-4b80-ae7f-093d8fcb2e52"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18yMQ_670377d2-45df-4d73-bb6a-b1cdce78fa49"
      unitRef="usdPerShare">10000.00</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18zNg_695987a7-f8b4-47d4-9986-14fe97ced981"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y18zNg_ea047f2f-34a1-4537-ad32-79627c8e74ae"
      unitRef="shares">1623000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y181OA_9501a2d8-37af-48f2-a824-634fd81cca24"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo3NDQ0ZDRhMDZmZGE0MDAxODBmM2FhNzU2ZjFjMzM1Y181OA_c8d26ebc-aaa5-4888-83db-88cffd14217d"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMS0xLTEtOTc0Nzc_a43df575-2b76-439a-b7b3-b5984eec173a"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzQtMy0xLTEtOTc0Nzc_e927f7a9-9dd3-4bde-ac94-faa5fbd7bc1c"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8xOA_0f380e98-5a01-4e6f-b4c9-a37436e5cdcb"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8xOA_e5391e04-1160-4a89-aa97-16402caa5c23"
      unitRef="usdPerShare">10000.00</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8zMw_368908c1-7c90-47bf-87c5-ab3317c09518"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl8zMw_8f320e26-c7d2-416e-ae65-54fbb7e274a0"
      unitRef="shares">750000000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl81NQ_b3f3296a-4b8a-4dda-8e88-d324c8af4a3f"
      unitRef="shares">299485000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjozYmNkMzAzZTc4YTg0NjY0OTU0Y2ZjZjlkNjhhNzhkZl82Mg_630806d7-1e9d-462a-979f-4245f14a0946"
      unitRef="shares">298533000000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMS0xLTEtOTc0Nzc_bf3ec5c5-65bb-4ddf-b741-536541767bb0"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzUtMy0xLTEtOTc0Nzc_a9b8b67a-502e-4cc0-a484-51b5ec994690"
      unitRef="usd">3000000.0</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzYtMS0xLTEtOTc0Nzc_7701397c-732a-4256-8448-039edc9149b5"
      unitRef="usd">6060600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzYtMy0xLTEtOTc0Nzc_f875773c-b654-4da2-8d98-bd23de860456"
      unitRef="usd">6042600000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzctMS0xLTEtOTc0Nzc_1e90b1fa-9abb-4488-b0ab-058e8ef18e67"
      unitRef="usd">1787700000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzctMy0xLTEtOTc0Nzc_e8e82cf3-f920-42e1-82c1-8c4d99dd3726"
      unitRef="usd">1600300000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockShares
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo1YjU0NGFhNDU0ZDA0YWRmOThiYzczZDJiMTkxMWY1YV8zMA_8f3ed92b-77a7-4381-98df-cff002869eeb"
      unitRef="shares">52940000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMC0xLTEtOTc0NzcvdGV4dHJlZ2lvbjo1YjU0NGFhNDU0ZDA0YWRmOThiYzczZDJiMTkxMWY1YV8zNw_fc1b183a-d0f2-4186-925e-791152e5a3d2"
      unitRef="shares">51401000000</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMS0xLTEtOTc0Nzc_52f48c49-e522-4b54-9608-80509b3fd162"
      unitRef="usd">2631500000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzgtMy0xLTEtOTc0Nzc_1581e364-bbb5-4a8c-b62e-3c639f5c3348"
      unitRef="usd">2531500000</us-gaap:TreasuryStockValue>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzktMS0xLTEtOTc0Nzc_c5cf938a-25a2-4f9e-9662-ba495819e7fe"
      unitRef="usd">-127300000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfMzktMy0xLTEtOTc0Nzc_5454d0f3-f23c-4b87-9abd-bad7f2384402"
      unitRef="usd">-238200000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDAtMS0xLTEtOTc0Nzc_7277f0b1-81fa-428d-8f01-25abc70be7b7"
      unitRef="usd">5092500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDAtMy0xLTEtOTc0Nzc_a162b5ba-1857-4c75-a8d4-f19c1db4f629"
      unitRef="usd">4876200000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDEtMS0xLTEtOTc0Nzc_a7ac8a68-ae36-46e3-a6f0-16fd10a7693e"
      unitRef="usd">9290300000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yMi9mcmFnOjE2ZTQzYmFlMzgyMjQ1YzliMGFiNzc4NWFjMzhmNGNjL3RhYmxlOjcyMzIxYWFjYjc3ZDQ4ODVhMDVkOTc2Mjc5YmVhZTZjL3RhYmxlcmFuZ2U6NzIzMjFhYWNiNzdkNDg4NWEwNWQ5NzYyNzliZWFlNmNfNDEtMy0xLTEtOTc0Nzc_9072abcd-2500-435d-9240-1e97397d90cb"
      unitRef="usd">9071200000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i8b667a34853345ce9fc30f034e33f5b3_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTItMS0xLTk3NDc3_c65e2bb5-7b74-4bb0-9c67-c970934a9351"
      unitRef="shares">297306000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i8b667a34853345ce9fc30f034e33f5b3_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTQtMS0xLTk3NDc3_6c334d6b-2aec-4952-95f2-43366ea8747d"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i750b33b8abf7477581f5efbc46a8f09f_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTYtMS0xLTk3NDc3_fce43be4-718c-4160-9731-d7e0e5f99a96"
      unitRef="usd">5965800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i104836b541db4552a3484725690e4c11_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTgtMS0xLTk3NDc3_c2fd9403-ee17-4afa-9526-04c1bac23df3"
      unitRef="usd">298300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4a69d1c0d994885bd6c5a0c8cc6aeb7_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTEwLTEtMS05NzQ3Nw_06ddd3c2-58bf-4aba-88c9-a7d2d05c1c92"
      unitRef="usd">-59100000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="idc24a74bca6f45a98e1346313bc6bb4a_I20210925"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTEyLTEtMS05NzQ3Nw_e6b6bb21-1406-49c7-8d1e-b1e9d40698c6"
      unitRef="shares">43653000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="idc24a74bca6f45a98e1346313bc6bb4a_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTE0LTEtMS05NzQ3Nw_58c88698-9919-463e-a41d-e212aefa432b"
      unitRef="usd">-1989400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkyLTE4LTEtMS05NzQ3Nw_7b242472-f3ae-460b-a386-c0ea29e6f2dc"
      unitRef="usd">4218600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i17d494d3ea2f420d85bcf5996162d2ba_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkzLTItMS0xLTk3NDc3_b09f1b93-0013-47a2-8197-56c3f86d97d9"
      unitRef="shares">45000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkzLTYtMS0xLTk3NDc3_47aeefbb-aa2f-4a3a-b218-3630975376d8"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTkzLTE4LTEtMS05NzQ3Nw_c8af0163-e2d6-4ae2-be19-e26f317d3af3"
      unitRef="usd">1900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i17d494d3ea2f420d85bcf5996162d2ba_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk0LTItMS0xLTk3NDc3_3bccb791-2d58-4866-ad0f-cd2580c90216"
      unitRef="shares">534000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk0LTYtMS0xLTk3NDc3_044d1415-7b14-4c50-9231-c21e63c2cbcc"
      unitRef="usd">22400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk0LTE4LTEtMS05NzQ3Nw_cecb32ab-2132-4eca-ab7e-9b75837be282"
      unitRef="usd">22400000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk2LTYtMS0xLTk3NDc3_4d1915d4-a082-4bc4-8cef-7609febc6d20"
      unitRef="usd">18700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic667279782cb401298855c46a15ab094_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk2LTE4LTEtMS05NzQ3Nw_d50cdd0c-995b-414c-b3a5-0a2203faf2b9"
      unitRef="usd">18700000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk3LTgtMS0xLTk3NDc3_be67180d-286a-462d-85f7-8d97e47a801e"
      unitRef="usd">499200000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk3LTE4LTEtMS05NzQ3Nw_20872481-3b36-4142-be2c-2ffa50137876"
      unitRef="usd">499200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie62b1597841e4a4b91bc223e8929cd2e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk4LTEwLTEtMS05NzQ3Nw_ed38d3de-7a2c-4992-8f51-07239b27122b"
      unitRef="usd">-29900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ie62b1597841e4a4b91bc223e8929cd2e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk4LTE4LTEtMS05NzQ3Nw_806a7f54-c48a-4d49-a137-006cdbc28c0c"
      unitRef="usd">-29900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i4a684294b69f49c5bb601cb231f23927_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk5LTEyLTEtMS05NzQ3Nw_e359fbf0-21a2-473c-8ce7-a33e749b1fc3"
      unitRef="shares">2335000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i4a684294b69f49c5bb601cb231f23927_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk5LTE0LTEtMS05NzQ3Nw_7c37cb5a-26c4-4a49-9f17-ee4ace055426"
      unitRef="usd">167000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMTk5LTE4LTEtMS05NzQ3Nw_3b3bc3dd-5a35-4eae-bd30-941a0785e497"
      unitRef="usd">167000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="ib069c3c83a7d410ca7d70d300726945b_I20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTItMS0xLTk3NDc3_56b483f4-c2b4-4343-b770-aab773831276"
      unitRef="shares">297885000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ib069c3c83a7d410ca7d70d300726945b_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTQtMS0xLTk3NDc3_69187566-70c6-4dd1-b198-e1daed5c926a"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id614601c4c7b4096a9c5dcbd9f8fe6d6_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTYtMS0xLTk3NDc3_0ab1acd6-f475-4af9-acca-8621efa5ee44"
      unitRef="usd">5964000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie7b569b420904a598de952ba3efe933c_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTgtMS0xLTk3NDc3_1593c7f7-1d4f-49ed-8af9-344e0ff1558d"
      unitRef="usd">797500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d4f66d97be24ea29c9e72a2c1b943b1_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTEwLTEtMS05NzQ3Nw_616872e2-06f0-49a7-9c92-5f25489aa022"
      unitRef="usd">-89000000.0</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="icfec87e83d4e4bf8ae4a9f94883339de_I20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTEyLTEtMS05NzQ3Nw_92b896b3-35ab-4911-84ab-3ee3db3d4fb2"
      unitRef="shares">45988000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icfec87e83d4e4bf8ae4a9f94883339de_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTE0LTEtMS05NzQ3Nw_6783f726-7d75-462c-9c69-0d0129a3495f"
      unitRef="usd">-2156400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAwLTE4LTEtMS05NzQ3Nw_9396034d-4130-422f-a29c-a36b667cc816"
      unitRef="usd">4519100000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAxLTItMS0xLTk3NDc3_4e1272e7-d87a-467a-9449-1b2f248f7bf0"
      unitRef="shares">140000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAxLTYtMS0xLTk3NDc3_2d6eef8b-070c-4d20-a56a-a978c5f8b68b"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAxLTE4LTEtMS05NzQ3Nw_45703301-298b-4430-858d-0fe4f6d5911e"
      unitRef="usd">5800000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAyLTItMS0xLTk3NDc3_728e0501-b94a-4c20-800d-df485471d2f7"
      unitRef="shares">14000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAyLTYtMS0xLTk3NDc3_4a9ec590-ee0f-4133-8553-3f31c0269903"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAyLTE4LTEtMS05NzQ3Nw_e9151463-1b20-4255-80d0-d3c0fdfdd813"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="ia855acff9ffd46f2bb96ada68f023b06_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAzLTItMS0xLTk3NDc3_6d306a60-c8f5-4751-b0cc-36be0e58fcee"
      unitRef="shares">164000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAzLTYtMS0xLTk3NDc3_b1e446e9-31ff-4ca4-9fe7-05b39c5cbafd"
      unitRef="usd">9500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjAzLTE4LTEtMS05NzQ3Nw_6a7f8428-95a6-4182-8b6c-fa30ac8ebc83"
      unitRef="usd">9500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA0LTYtMS0xLTk3NDc3_8be3a7f6-0933-4fa6-bb9a-d0ed198cbb37"
      unitRef="usd">17800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i69c857686ec641fdafc4c2b00fa077e6_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA0LTE4LTEtMS05NzQ3Nw_52f8cb5c-4036-4543-8978-84045b456ccf"
      unitRef="usd">17800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA1LTgtMS0xLTk3NDc3_303b5253-b890-44c6-a09c-cf483750526e"
      unitRef="usd">455700000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i16201ab87ee449c0b1d27fbc0810f522_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA1LTE4LTEtMS05NzQ3Nw_6e406d59-39bc-4283-a197-de11d1859900"
      unitRef="usd">455700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibb8c751501224cfb8f672b3b5d147581_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA2LTEwLTEtMS05NzQ3Nw_656736fa-fe02-4776-81cc-d345c842677c"
      unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="ibb8c751501224cfb8f672b3b5d147581_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA2LTE4LTEtMS05NzQ3Nw_d090b62b-6aea-4f98-8f0d-2b025f20fea8"
      unitRef="usd">-15100000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA3LTEyLTEtMS05NzQ3Nw_7a2f897e-7113-4f46-bf27-cc7d1cd5e212"
      unitRef="shares">2863000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA3LTE0LTEtMS05NzQ3Nw_e50eb186-000e-4c0e-b270-9421ea50552f"
      unitRef="usd">200000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="i580b6afb85b547a191c81a65f4c39e74_D20211226-20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA3LTE4LTEtMS05NzQ3Nw_715ba610-4380-44b3-8883-4f01c1da5007"
      unitRef="usd">200000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="iee40c972e79245a48193d5c44a5d488c_I20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTItMS0xLTk3NDc3_a5c4d4e3-6311-494b-b8cf-91667ac8a2de"
      unitRef="shares">298203000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="iee40c972e79245a48193d5c44a5d488c_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTQtMS0xLTk3NDc3_2a5cc411-b8dd-4edd-9ebf-6018527bec4a"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i44bb24d344a2479f88cb3056e9eb7f9d_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTYtMS0xLTk3NDc3_69443827-e16c-427f-947b-cb041016cbb8"
      unitRef="usd">5997000000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icb7a25b0e96544b6bbd05dc3066b58b1_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTgtMS0xLTk3NDc3_838ad70f-3a64-46b9-aa07-df0eea230b8a"
      unitRef="usd">1253200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7df030fd1d484893b2c6f6ca3cbc20b5_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTEwLTEtMS05NzQ3Nw_b64bd140-30a7-4f1d-a8b7-28d5822f6c84"
      unitRef="usd">-104100000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i96aafcc8951b43bb843963cb4ef1b0c9_I20220326"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTEyLTEtMS05NzQ3Nw_b5642410-aba8-4a82-9f64-3544c0960b86"
      unitRef="shares">48851000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i96aafcc8951b43bb843963cb4ef1b0c9_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTE0LTEtMS05NzQ3Nw_4adedd7c-8aa9-469d-8d85-21f812f5ec11"
      unitRef="usd">-2356400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i27baa3824d6f48cba5a8bdecb8c0cc9f_I20220326"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA4LTE4LTEtMS05NzQ3Nw_4204f640-227f-472b-804d-3a152c86451e"
      unitRef="usd">4792700000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="icdc5975fe0bb4a9f91e698a96eabdbdc_D20220327-20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA5LTItMS0xLTk3NDc3_09bd734d-bcd4-428b-8964-b68aec20e294"
      unitRef="shares">128000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA5LTYtMS0xLTk3NDc3_ab1d4369-447d-4028-836e-76017a96e98c"
      unitRef="usd">5200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjA5LTE4LTEtMS05NzQ3Nw_6e190e13-f2af-42f8-a39a-4a164beaa9af"
      unitRef="usd">5200000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="icdc5975fe0bb4a9f91e698a96eabdbdc_D20220327-20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEwLTItMS0xLTk3NDc3_2b98f763-b180-4716-8c95-62216328c2f0"
      unitRef="shares">4000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEwLTYtMS0xLTk3NDc3_bd62162e-5577-4a2d-bd6a-95e572a86588"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEwLTE4LTEtMS05NzQ3Nw_fdcd8d3f-a6ef-419b-8469-837887270b85"
      unitRef="usd">100000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEyLTYtMS0xLTk3NDc3_f2b12bef-9af2-46d1-808f-46db042d62fe"
      unitRef="usd">15300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7e36cc29f725470b951d3fefed4f08af_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEyLTE4LTEtMS05NzQ3Nw_78f54193-430f-4ccb-8dcc-5e5e92bb7622"
      unitRef="usd">15300000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEzLTgtMS0xLTk3NDc3_444ce9cf-5187-46b6-a2a0-dcc0c261cd7f"
      unitRef="usd">228400000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i6a89a6e42d674e54938adddec42357dd_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjEzLTE4LTEtMS05NzQ3Nw_43925149-7fbe-456e-828f-acfe6b07fefe"
      unitRef="usd">228400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idffe4e4b122a47f5b0294845f328191d_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE0LTEwLTEtMS05NzQ3Nw_c71c26e4-a4d1-465e-a495-4883640beecd"
      unitRef="usd">-43600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="idffe4e4b122a47f5b0294845f328191d_D20220327-20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE0LTE4LTEtMS05NzQ3Nw_9d94a2b3-d84a-46c9-b385-d6a6f5cdcd04"
      unitRef="usd">-43600000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i46ea4a08bd3042a7ab12381bf4bff328_I20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTItMS0xLTk3NDc3_c8d5e731-1e50-4333-b654-55409a98934b"
      unitRef="shares">298335000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i46ea4a08bd3042a7ab12381bf4bff328_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTQtMS0xLTk3NDc3_bd100e7e-d259-4f88-a643-b0b8f68e0bc2"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3c7577051ac8445595d275ea3b4ba6d7_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTYtMS0xLTk3NDc3_ea977bf9-d442-4469-a07e-981338775fbe"
      unitRef="usd">6017400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ibb6f35c1e6d84dd5b5f8a049aac44ec4_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTgtMS0xLTk3NDc3_e37ba672-8366-487d-b735-dde2675609df"
      unitRef="usd">1481600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia42682bb507a4e48a823cf2bdaafddc5_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTEwLTEtMS05NzQ3Nw_fcf9d065-af42-486e-9c86-a6945a728db8"
      unitRef="usd">-147700000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i5a60e52602c048069d80e58e5129177f_I20220625"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTEyLTEtMS05NzQ3Nw_dd34b407-cb10-444d-a663-9e12564fb276"
      unitRef="shares">48851000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5a60e52602c048069d80e58e5129177f_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTE0LTEtMS05NzQ3Nw_42fa3a01-257f-4d28-b0b1-3579a0d3444f"
      unitRef="usd">-2356400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i68d91b48be7045588cbe38f1d5620c60_I20220625"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE2LTE4LTEtMS05NzQ3Nw_0d55827b-b9e7-4e05-8d40-ee87cd3212b9"
      unitRef="usd">4997900000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE3LTItMS0xLTEwNjgxOQ_95837fdd-9ec6-4d5e-ba14-883d8595c37f"
      unitRef="shares">23000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE3LTYtMS0xLTEwNjgzNw_5e994a11-04cd-4fcb-bb97-d80cab548fe5"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE3LTE4LTEtMS0xMDY4NTQ_244a6a28-f7b3-437f-9afd-43f155882a25"
      unitRef="usd">900000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE4LTItMS0xLTEwNjgzMw_4a60dc33-39ba-4e52-97d3-09ccf11d7a96"
      unitRef="shares">9000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE4LTYtMS0xLTEwNjgzOQ_30277600-d4f0-4506-8b97-7ea7792b7273"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE4LTE4LTEtMS0xMDY4NTY_fce9888a-a759-4916-8759-ce0d374939ce"
      unitRef="usd">300000</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="id531d470be734681a6b0e23aa2012cc1_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE5LTItMS0xLTEwNjgzNQ_4c1d424f-5c76-495f-bd9f-027592ea1f90"
      unitRef="shares">166000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE5LTYtMS0xLTEwNjg0MQ_882dd0d5-1f60-4888-b8dd-02f5f302a537"
      unitRef="usd">9700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjE5LTE4LTEtMS0xMDY4NTg_8729a2f2-291d-4881-bcf3-020862c437f7"
      unitRef="usd">9700000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIwLTYtMS0xLTEwNjg0Mw_ce652a9c-4c5a-4c75-8601-57717a0906a9"
      unitRef="usd">14900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i98e19907377e46229597921f8801edcc_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIwLTE4LTEtMS0xMDY4NjA_78f01b00-14fe-4810-b24c-03fe240afa72"
      unitRef="usd">14900000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIxLTgtMS0xLTEwNjg0NQ_cf73634e-6cf2-42c3-b267-05294333414f"
      unitRef="usd">118700000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="i4e045d0fb69344a6abdbe02795d8bf85_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIxLTE4LTEtMS0xMDY4NjM_739c616e-2543-40be-a785-6623dc059ef0"
      unitRef="usd">118700000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9301d9a3c6c442bab8060ca751e7563b_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIyLTEwLTEtMS0xMDY4NDc_13c9d67c-32d1-48a4-861d-67b27aef747e"
      unitRef="usd">-90500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="i9301d9a3c6c442bab8060ca751e7563b_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIyLTE4LTEtMS0xMDY4NjU_2e5a6e32-b42a-4b5e-bb9b-08389bf99651"
      unitRef="usd">-90500000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="idca511b5b1874691b87e467241ae5b70_D20220626-20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIzLTEyLTEtMS0xMDY4NDk_46325a35-09e0-4653-ae43-4013e88a8ced"
      unitRef="shares">2550000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="idca511b5b1874691b87e467241ae5b70_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIzLTE0LTEtMS0xMDY4NTI_46e1b7d3-81cf-4cab-8941-6ec26b5cca51"
      unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="idca511b5b1874691b87e467241ae5b70_D20220626-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjIzLTE4LTEtMS0xMDY4Njc_5fee790e-3703-4819-8836-444717e3a9f7"
      unitRef="usd">175100000</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="if54a740632874ce19cb42642fb2e221a_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTItMS0xLTEwNjc1MQ_00473778-e847-4dab-a591-7143ae8b1381"
      unitRef="shares">298533000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="if54a740632874ce19cb42642fb2e221a_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTQtMS0xLTEwNjc1Mw_25d0defd-0561-4a51-ac68-1d745c0629f3"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie23d7b47d391462891d1fd3901620b20_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTYtMS0xLTEwNjc1NQ_1c98f950-a8cd-48c9-9092-6a4315d912df"
      unitRef="usd">6042600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i013fa78766bb45bc816b63fed5c22874_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTgtMS0xLTEwNjc1Nw_961f30b6-bcf0-41f0-82fa-c2997a5a4adc"
      unitRef="usd">1600300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie45f7058af534e8dba563c02009f5cac_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTEwLTEtMS0xMDY3NTk_1bb53d60-d1f9-4e80-ad5f-805ed2aa6ebc"
      unitRef="usd">-238200000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i17c32b5fcbaf409cb7118fbe9bb55a0e_I20220924"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTEyLTEtMS0xMDY3NjE_1481a050-00a1-4922-aab0-7f14a223c921"
      unitRef="shares">51401000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i17c32b5fcbaf409cb7118fbe9bb55a0e_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTE0LTEtMS0xMDY3NjM_767e6e78-6af1-4eef-b7f9-aad524ec1053"
      unitRef="usd">2531500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI0LTE4LTEtMS0xMDY3NjU_bd312675-a1f3-4dcf-bca7-e55b682efea5"
      unitRef="usd">4876200000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI1LTItMS0xLTEwNjc4Mw_c22631a8-0e3f-4957-9ce2-2af2bb98fc9b"
      unitRef="shares">267000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI1LTYtMS0xLTEwNDU3OA_dd6dff20-216c-4b25-8534-b1f20a7d5065"
      unitRef="usd">10300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI1LTE4LTEtMS0xMDY4MDU_05606938-6828-4b9a-9d44-977bc4200bfc"
      unitRef="usd">10300000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings
      contextRef="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI2LTItMS0xLTEwNjc4NQ_c7e7f015-9e11-443a-97bd-cae32747a6e3"
      unitRef="shares">514000</us-gaap:RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI2LTYtMS0xLTEwNDU1Ng_d72aab54-658f-477e-9965-091b98e53505"
      unitRef="usd">23000000.0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI2LTE4LTEtMS0xMDY4MDc_31e7ddab-4ce7-4927-8516-582e1931a19b"
      unitRef="usd">23000000.0</us-gaap:RestrictedStockValueSharesIssuedNetOfTaxWithholdings>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="i9c4247598cb440c2a2f269891e9aefcf_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI3LTItMS0xLTEwNjc4Nw_286cbf3b-bc05-464e-81ec-281f6812df71"
      unitRef="shares">171000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI3LTYtMS0xLTEwNjc5Mw_c6fdef97-83ef-465f-8b20-069adab8e58d"
      unitRef="usd">10200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI3LTE4LTEtMS0xMDY4MDk_af7cc2d0-2b68-4a32-9b5e-e7b370535416"
      unitRef="usd">10200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI4LTYtMS0xLTEwNjc5NQ_923a6cac-7335-4e44-8c0b-80d286047142"
      unitRef="usd">20500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i671c4997470d4f578166e16141225885_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI4LTE4LTEtMS0xMDY4MTE_ad6c4643-2f68-4384-8337-3d61d69b45ff"
      unitRef="usd">20500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <holx:Netincome
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI5LTgtMS0xLTEwNjc5Nw_54b899ad-26a2-44ac-9df7-ee45887cd2c6"
      unitRef="usd">187400000</holx:Netincome>
    <us-gaap:NetIncomeLoss
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjI5LTE4LTEtMS0xMDY4MTM_f72deb9d-3ac3-40f0-945d-bedf394d087e"
      unitRef="usd">187400000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iffce715dc2d14558a02450be71f516b4_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMwLTEwLTEtMS0xMDY3OTk_def9691c-47bd-46fd-b223-a6bcdc3b3fb5"
      unitRef="usd">110900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTax
      contextRef="iffce715dc2d14558a02450be71f516b4_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMwLTE4LTEtMS0xMDY4MTU_05126f9e-d0e1-492e-aea5-0dccc5dbe996"
      unitRef="usd">110900000</us-gaap:OtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMxLTEyLTEtMS0xMDY4MDE_124c0743-0ebf-4bac-bd9a-105d881f1899"
      unitRef="shares">1539000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMxLTE0LTEtMS0xMDY4MDM_3315cf14-a96e-42f2-8984-ed251293eef0"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:TreasuryStockValueAcquiredParValueMethod
      contextRef="ifa39dabbdb614a9e838472064a9ac35f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMxLTE4LTEtMS0xMDY4MTc_aa89f3f8-2511-4558-a75e-b1df55c8ccca"
      unitRef="usd">100000000.0</us-gaap:TreasuryStockValueAcquiredParValueMethod>
    <us-gaap:SharesIssued
      contextRef="i8c096023d23c420bbe6591cb72e10eb9_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTItMS0xLTEwNjc2Nw_10d26203-319b-437e-b410-d26d9f008197"
      unitRef="shares">299485000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i8c096023d23c420bbe6591cb72e10eb9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTQtMS0xLTEwNjc2OQ_d6f17c93-2695-4a28-82ce-e6c00581dc47"
      unitRef="usd">3000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1c1f63693e304533b7ac2c9be6e0e0bf_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTYtMS0xLTEwNjc3MQ_00197fd9-bd34-44c7-85cb-cd6115f18072"
      unitRef="usd">6060600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie3fc5436b7e04085aaf9f0cc0a424693_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTgtMS0xLTEwNjc3Mw_6f0bb64e-6e4f-40f8-9bba-fd0b1d98c568"
      unitRef="usd">1787700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14951cf020f246d1996832691a0edc4c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTEwLTEtMS0xMDY3NzU_b31d8768-dead-465c-a35e-ff6d7f1ce8f6"
      unitRef="usd">-127300000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i576d2b7fc4c843429397ce9929243a48_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTEyLTEtMS0xMDY3Nzc_4224ce72-c5db-4215-858a-be8d1d525219"
      unitRef="shares">52940000</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i576d2b7fc4c843429397ce9929243a48_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTE0LTEtMS0xMDY3Nzk_f8b06ccd-123f-4904-8330-f6f357fb65d6"
      unitRef="usd">-2631500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yNS9mcmFnOjM2NjA5N2VjMDcyZjQ2YzY5MjllNzM5MzE4YWE1OTNhL3RhYmxlOmJiOTRhMjczMGU0OTQxNjNhNTkyYmY3YzJmMGIyNjQxL3RhYmxlcmFuZ2U6YmI5NGEyNzMwZTQ5NDE2M2E1OTJiZjdjMmYwYjI2NDFfMjMyLTE4LTEtMS0xMDY3ODE_e31f13d9-a42c-4b7a-b48e-bf0329a19f0d"
      unitRef="usd">5092500000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:NetIncomeLoss
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMy0xLTEtMS05NzQ3Nw_c46a472a-5987-4b8b-8458-bedf13c5744a"
      unitRef="usd">187400000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMy0zLTEtMS05NzQ3Nw_927b198f-53e7-4627-8a13-b85445fc5ca8"
      unitRef="usd">499200000</us-gaap:NetIncomeLoss>
    <us-gaap:Depreciation
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNS0xLTEtMS05NzQ3Nw_e5b77a26-2fc7-4486-80a1-4f58a45a2c7c"
      unitRef="usd">22700000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNS0zLTEtMS05NzQ3Nw_8e7bf09a-4d14-4a58-bbe9-aa723124dbc7"
      unitRef="usd">22300000</us-gaap:Depreciation>
    <us-gaap:AdjustmentForAmortization
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNi0xLTEtMS05NzQ3Nw_d1dd821e-b3f1-461a-b63b-b64eee149ea6"
      unitRef="usd">63200000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNi0zLTEtMS05NzQ3Nw_ee2de9e5-cdb2-4f74-9546-1a35b0aa3518"
      unitRef="usd">85700000</us-gaap:AdjustmentForAmortization>
    <us-gaap:ShareBasedCompensation
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOC0xLTEtMS05NzQ3Nw_5efd3c69-04eb-4738-8b84-3afede987d13"
      unitRef="usd">20500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOC0zLTEtMS05NzQ3Nw_9d15e746-4764-4f21-8517-2a51b24ccf96"
      unitRef="usd">18700000</us-gaap:ShareBasedCompensation>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOS0xLTEtMS05NzQ3Nw_5bea23ae-9d97-40db-8e30-37b2ad2b9325"
      unitRef="usd">-26200000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfOS0zLTEtMS05NzQ3Nw_e8b75373-5ad3-4a5b-993d-557a70389d6b"
      unitRef="usd">-21900000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMTMtMS0xLTEtOTc0Nzc_7e3efa55-a628-45af-9124-eb006bac017a"
      unitRef="usd">0</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMTMtMy0xLTEtOTc0Nzc_bd06b80d-b63e-46f2-8cd6-2f3aaf556043"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjEtMS0xLTEtOTc0Nzc_76eef580-3d73-4224-a875-a98cbcf3baed"
      unitRef="usd">-29100000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjEtMy0xLTEtOTc0Nzc_657e376c-1a17-4223-8696-4045618d2ce4"
      unitRef="usd">-5700000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjMtMS0xLTEtOTc0Nzc_e91d443d-f425-44a9-8813-d2b10f56498a"
      unitRef="usd">45000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjMtMy0xLTEtOTc0Nzc_084d6c3f-1ec1-4b76-a96a-34fd9281dcd6"
      unitRef="usd">48100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjQtMS0xLTEtOTc0Nzc_0b6214a5-0149-4e65-b8e9-95854ccea91b"
      unitRef="usd">47000000.0</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjQtMy0xLTEtOTc0Nzc_d75c88d4-838e-4c20-ac87-7b54829acaa6"
      unitRef="usd">17400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjUtMS0xLTEtOTc0Nzc_0a5bc30a-46b2-40a1-a61c-111b9bbe82e4"
      unitRef="usd">-17900000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidTaxes
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjUtMy0xLTEtOTc0Nzc_b3a1c248-78f4-4a33-af29-9c34cd5e55d3"
      unitRef="usd">4600000</us-gaap:IncreaseDecreaseInPrepaidTaxes>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjYtMS0xLTEtOTc0Nzc_d1cd9241-aef0-4c00-8d07-1bf09d2a09a4"
      unitRef="usd">-26200000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjYtMy0xLTEtOTc0Nzc_5f752abe-0341-4e69-9b71-8a349eb547d7"
      unitRef="usd">-300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjctMS0xLTEtOTc0Nzc_c28ff8d1-9738-4b18-8f8d-a8caac469d6f"
      unitRef="usd">1500000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjctMy0xLTEtOTc0Nzc_3858f650-cea3-4e1f-b0a7-ee54090e1796"
      unitRef="usd">-13800000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjgtMS0xLTEtOTc0Nzc_711cc413-1c34-4892-bd32-b31b4777ff44"
      unitRef="usd">800000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjgtMy0xLTEtOTc0Nzc_57e950e5-5a18-4d93-895c-eac720b0c573"
      unitRef="usd">42400000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjktMS0xLTEtOTc0Nzc_7fcf3526-6607-4dfe-b1c9-2c11ee871cce"
      unitRef="usd">2300000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMjktMy0xLTEtOTc0Nzc_fcfaff73-9f69-4d7a-b872-6f0049772253"
      unitRef="usd">-5000000.0</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzAtMS0xLTEtOTc0Nzc_9e315d95-e0de-41fd-b7f1-9b7bfd2c8311"
      unitRef="usd">253400000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzAtMy0xLTEtOTc0Nzc_f5476bbf-0c81-4458-9fc5-189329da72b4"
      unitRef="usd">564200000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzItMS0xLTEtOTc0Nzc_26226ce8-9311-4f12-b35e-effe0020c75e"
      unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzItMy0xLTEtOTc0Nzc_b9b81b07-049b-43d6-8dbf-d2e8c548dafb"
      unitRef="usd">157300000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzUtMS0xLTEtOTc0Nzc_e9454893-dbe5-44d4-8b7c-3d2f902e5272"
      unitRef="usd">15800000</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <us-gaap:PaymentsForProceedsFromProductiveAssets
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzUtMy0xLTEtOTc0Nzc_2f596f92-c7f4-4307-8e71-4ab0a466ae0c"
      unitRef="usd">20500000</us-gaap:PaymentsForProceedsFromProductiveAssets>
    <holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMS0xLTEtMTAyMDEy_572aec00-b7ef-4018-808e-15c54afe9209"
      unitRef="usd">0</holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion>
    <holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMy0xLTEtOTk3NDU_e66d072f-b01a-4fc7-b867-02a03400290a"
      unitRef="usd">21300000</holx:ProceedsReceivedFromGovernmentGrantsForCapacityExpansion>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMS0xLTEtOTc0Nzc_a53af8f0-6b66-4d4c-9ca8-d3d0d859ed7c"
      unitRef="usd">13300000</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfMzctMy0xLTEtOTc0Nzc_8437ba2c-25c4-4509-934f-d783374c8533"
      unitRef="usd">17000000.0</holx:PaymentsToManufactureEquipmentUnderCustomerUsageAgreements>
    <holx:Purchaseofinsurancecontracts
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDMtMS0xLTEtOTc0Nzc_08319f34-898b-417a-941f-cc7a63e01d29"
      unitRef="usd">10000000.0</holx:Purchaseofinsurancecontracts>
    <holx:Purchaseofinsurancecontracts
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDMtMy0xLTEtOTc0Nzc_62ab6c9c-8369-40d8-9bff-668fa8737f3d"
      unitRef="usd">0</holx:Purchaseofinsurancecontracts>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDYtMS0xLTEtOTc0Nzc_312c0d56-8ac1-4bcd-8451-d3b6a3810bc1"
      unitRef="usd">1900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDYtMy0xLTEtOTc0Nzc_bc5375fb-d895-4b70-8804-a981932b8e16"
      unitRef="usd">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDgtMS0xLTEtOTc0Nzc_4d7e0c0e-6905-4b96-a190-1cee41e3d220"
      unitRef="usd">-41000000.0</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNDgtMy0xLTEtOTc0Nzc_373c59d6-3def-4022-beb9-04d953ff92ec"
      unitRef="usd">-173500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTAtMS0xLTEtOTc0Nzc_70fa33d6-c88e-4035-8994-e25f02921f4d"
      unitRef="usd">0</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTAtMy0xLTEtOTc0Nzc_9bc28196-e13a-4c5f-a455-0fc4ee1a9177"
      unitRef="usd">1491200000</us-gaap:ProceedsFromRepaymentsOfOtherLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTEtMS0xLTEtOTc0Nzc_62d36388-da56-4264-a808-12692ecaf74a"
      unitRef="usd">3800000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:RepaymentsOfLongTermDebt
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNTEtMy0xLTEtOTc0Nzc_42893e2d-01ed-4d7d-9241-fc177430c12d"
      unitRef="usd">1387500000</us-gaap:RepaymentsOfLongTermDebt>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjEtMS0xLTEtOTc0Nzc_454e5561-9fa0-4c86-b341-67d5c445f604"
      unitRef="usd">800000</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjEtMy0xLTEtOTc0Nzc_5f37f694-afe8-4e1f-9e21-1e5b4e4219c4"
      unitRef="usd">0</us-gaap:PaymentForContingentConsiderationLiabilityFinancingActivities>
    <holx:Repaymentsofacquiredlongtermdebt
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjItMS0xLTEtOTc0Nzc_67669947-af2e-4046-b750-7646875aeaca"
      unitRef="usd">0</holx:Repaymentsofacquiredlongtermdebt>
    <holx:Repaymentsofacquiredlongtermdebt
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjItMy0xLTEtOTc0Nzc_52094651-77c1-4dbb-8cda-40e50dc2189f"
      unitRef="usd">63600000</holx:Repaymentsofacquiredlongtermdebt>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjUtMS0xLTEtOTc0Nzc_0e24717b-bc2d-42ed-9314-c6d57db70f3d"
      unitRef="usd">100000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjUtMy0xLTEtOTc0Nzc_c273d092-78db-4084-8cd8-b5bfafe64a08"
      unitRef="usd">167000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjctMS0xLTEtOTc0Nzc_78c04c91-e507-47fd-b3ff-540ade7647ed"
      unitRef="usd">15100000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjctMy0xLTEtOTc0Nzc_4b1b251c-092a-4704-891a-e2bd0f33ec75"
      unitRef="usd">6400000</us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjgtMS0xLTEtOTc0Nzc_c3cc2220-59a2-4bb2-ad92-1ba89d1e413b"
      unitRef="usd">23000000.0</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjgtMy0xLTEtOTc0Nzc_41230bbf-9a5f-407a-b1ff-eda34ae9e747"
      unitRef="usd">22400000</holx:PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjktMS0xLTEtOTc0Nzc_2a19aed3-4749-4887-b044-f1a9a6fcdaa9"
      unitRef="usd">1000000.0</holx:PaymentsUnderFinanceLeaseObligations>
    <holx:PaymentsUnderFinanceLeaseObligations
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNjktMy0xLTEtOTc0Nzc_9b375d68-f287-453f-a17e-70425f472f02"
      unitRef="usd">600000</holx:PaymentsUnderFinanceLeaseObligations>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzAtMS0xLTEtOTc0Nzc_6b129df4-42c2-48c0-b01f-c8bfd338ec6f"
      unitRef="usd">-113500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzAtMy0xLTEtOTc0Nzc_3086a80e-4efb-4c94-8759-7aab434b822b"
      unitRef="usd">-143500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzEtMS0xLTEtOTc0Nzc_0ed9cbff-63eb-4b3e-8f8a-17343762b470"
      unitRef="usd">2900000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzEtMy0xLTEtOTc0Nzc_540fb393-06bf-46a0-92f4-a9b35c7d1b1d"
      unitRef="usd">3300000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzItMS0xLTEtOTc0Nzc_6240c863-1ff4-4e07-8a3c-a74810972871"
      unitRef="usd">101800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzItMy0xLTEtOTc0Nzc_2b1543a5-e7bb-4a80-b8a2-d1858a7d5a05"
      unitRef="usd">250500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzMtMS0xLTEtOTc0Nzc_b9841bfc-d703-4be9-aee1-2f456548cb83"
      unitRef="usd">2339500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzMtMy0xLTEtOTc0Nzc_7bb9602d-a703-43f9-a6ae-b63cba6c20d2"
      unitRef="usd">1170300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzQtMS0xLTEtOTc0Nzc_2f0fa7c6-97d9-4332-8e73-0382ae3f4b97"
      unitRef="usd">2441300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8yOC9mcmFnOmYxMzgyZjZhOTllNTQ0ODQ5MjYzZjhlYTJjYTY3YTk0L3RhYmxlOmQ3Yjc0OWE2YjYxNDQzNTA4ODkxYTc4OWY1YzM3YTNmL3RhYmxlcmFuZ2U6ZDdiNzQ5YTZiNjE0NDM1MDg4OTFhNzg5ZjVjMzdhM2ZfNzQtMy0xLTEtOTc0Nzc_5c06eefd-d945-462d-be7d-d10a06f10046"
      unitRef="usd">1420800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNC9mcmFnOmVmMDk1MTExZmNmOTQ3NDJhOWQ1MDUyZTViYTFlNDVjL3RleHRyZWdpb246ZWYwOTUxMTFmY2Y5NDc0MmE5ZDUwNTJlNWJhMWU0NWNfMjM3Mg_7cd90694-a581-4ea8-8f77-00ba881f5dd9">Basis of Presentation&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited consolidated financial statements of Hologic, Inc. (&#x201c;Hologic&#x201d; or the &#x201c;Company&#x201d;) presented herein have been prepared pursuant to the rules of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) for quarterly reports on Form 10-Q and do not include all of the information and disclosures required by U.S. generally accepted accounting principles (&#x201c;GAAP&#x201d;) for annual financial statements. These unaudited financial statements should be read in conjunction with the consolidated financial statements and related notes for the fiscal year ended September&#160;24, 2022 included in the Company&#x2019;s Form&#160;10-K filed with the SEC on November&#160;15, 2022. In the opinion of management, the unaudited financial statements and notes contain all adjustments (consisting of normal recurring accruals and all other necessary adjustments) considered necessary for a fair presentation of the Company&#x2019;s financial position, results of operations and cash flows for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The unaudited consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with GAAP requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from management&#x2019;s estimates if past experience or other assumptions do not turn out to be substantially accurate. Operating results for the three months ended December&#160;31, 2022 are not necessarily indicative of the results to be expected for any other interim period or the entire fiscal year ending September&#160;30, 2023. Fiscal 2023 is a 53-week fiscal year, and the additional week is included in the first quarter of fiscal 2023 consistent with the Company's historical fiscal calendar.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Subsequent Events Consideration&lt;/span&gt;&lt;/div&gt;The Company considers events or transactions that occur after the balance sheet date but prior to the issuance of the financial statements to provide additional evidence for certain estimates or to identify matters that may require additional disclosure. Subsequent events have been evaluated as required. There were no material recognized or unrecognized subsequent events affecting the unaudited consolidated financial statements as of and for the three months ended December&#160;31, 2022.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfODI4NA_5b4eab0a-2da0-4f5f-bff0-2c344b704550">Revenue&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company accounts for revenue pursuant to ASC 606, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Revenue from Contracts with Customer&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 606) and generates revenue from the sale of its products, primarily medical imaging systems and related components and software, diagnostic tests and assays and surgical disposable products, and related services, which are primarily support and maintenance services on its medical imaging systems, and to a lesser extent installation, training and repairs. In addition, the Company generates service revenue from performing laboratory testing services through its Biotheranostics CLIA laboratory, which is included in its Molecular Diagnostics business. The Company's products are sold primarily through a direct sales force, and within international markets, there is more reliance on distributors and resellers. Revenue is recorded net of sales tax. The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company considers revenue to be earned when all of the following criteria are met: the Company has a contract with a customer that creates enforceable rights and obligations; promised products or services are identified; the transaction price, or the amount the Company expects to receive, including an estimate of uncertain amounts subject to a constraint to ensure revenue is not recognized in an amount that would result in a significant reversal upon resolution of the uncertainty, is determinable; and the Company has transferred control of the promised items to the customer. A performance obligation is a promise in a contract to transfer a distinct good or service to the customer and is the unit of account in the contract. The transaction price for the contract is measured as the amount of consideration the Company expects to receive in exchange for the goods and services expected to be transferred. A contract's transaction price is allocated to each distinct performance obligation and recognized as revenue when, or as, control of the distinct good or service is transferred. Transfer of control for the Company's products is generally at shipment or delivery, depending on contractual terms, but occurs when title and risk of loss transfers to the customer which represents the point in time when the customer obtains the use of and substantially all of the remaining benefits of the product. As such, the Company's performance obligation related to product sales is satisfied at a point in time. Revenue from support and maintenance contracts, extended warranty, and professional services for installation, training and repairs is recognized over time based on the period contracted or as the services are performed as these methods represent a faithful depiction of the transfer of goods and services.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a receivable when it has an unconditional right to payment, which represents the amount the Company expects to collect in a transaction and is most often equal to the transaction price in the contract. Payment terms are typically 30 days in the U.S. but may be longer in international markets. The Company treats shipping and handling costs performed after a customer obtains control of the good as a fulfillment cost and records these costs within costs of product revenue when the corresponding revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also places instruments (or equipment) at customer sites but retains title to the instrument. The customer has the right to use the instrument for a period of time, and the Company recovers the cost of providing the instrument through the sales of disposables, namely tests and assays in Diagnostics and handpieces in GYN Surgical. These types of agreements include an embedded lease, which is generally an operating lease, for the right to use an instrument and no instrument revenue is recognized at the time of instrument delivery. The Company recognizes a portion of the revenue allocated to the embedded lease concurrent with the sale of disposables over the term of the agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Revenue from laboratory testing services, which is generated by the Company's Biotheranostics business, is recognized based upon contracted amounts with payors and historical cash collection experience for the same test or same payor group. Revenue is recognized once the laboratory services have been performed, the results have been delivered to the ordering physician, the payor has been identified, and insurance has been verified. The estimated timeframes for cash collection are three months for Medicare payors, six months for Medicare Advantage payors, and nine months for commercial payors.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Some of the Company's contracts have multiple performance obligations. For contracts with multiple performance obligations, the Company allocates the transaction price to each performance obligation using its best estimate of the standalone &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;selling price of each distinct good or service in the contract. The Company determines its best estimate of standalone selling price using average selling prices over 3- to 12-month periods of data depending on the products or nature of the services coupled with current market considerations. If the product or service does not have a history of sales or if sales volume is not sufficient, the Company relies on prices set by its pricing committees or applicable marketing department adjusted for expected discounts. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company exercises judgment in estimating variable consideration, which includes volume discounts, sales rebates, product returns and other adjustments. These amounts are recorded as a reduction to revenue and classified as a current liability. The Company bases its estimates for volume discounts and sales rebates on historical information to the extent it is reasonable to be used as a predictive tool of expected future rebates. To the extent the transaction price includes variable consideration, the Company applies judgment in constraining the estimated variable consideration due to factors that may cause reversal of revenue recognized. The Company evaluates constraints based on its historical and projected experience with similar customer contracts. The Company's contracts for the sale of capital equipment and related components, and assays and tests typically do not provide the right to return product, however, its contracts for the sale of its GYN Surgical and Interventional Breast Solutions surgical handpieces provide for a right of return for a limited period of time. In general, estimates of variable consideration and constraints are not material to the Company's financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied was approximately $875.7 million. These remaining performance obligations primarily relate to support and maintenance obligations and extended warranty in the Company's Breast Health and Skeletal Health reportable segments. The Company expects to recognize approximately 35% of this amount as revenue in fiscal 2023, 32% in fiscal 2024, 20% in fiscal 2025, 9% in fiscal 2026, and 4% thereafter. As permitted, the Company does not include remaining performance obligations related to contracts with original expected durations of one year or less in the amounts above.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contract Assets and Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company discloses accounts receivable separately in the Consolidated Balance Sheets at their net realizable value. Contract assets primarily relate to the Company's conditional right to consideration for work completed but not billed at the reporting date. Contract assets at the beginning and end of the period, as well as the changes in the balance, were immaterial. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities primarily relate to payments received from customers in advance of performance under the contract. The Company records a contract liability, or deferred revenue, when it has an obligation to provide service, and to a much lesser extent product, to the customer and payment is received or due in advance of performance. Deferred revenue primarily relates to support and maintenance contracts and extended warranty obligations within the Company's Breast Health and Skeletal Health reportable segments. Contract liabilities are classified as other current liabilities and other long-term liabilities in the Consolidated Balance Sheets. The Company recognized revenue of $66.8&#160;million and $56.4&#160;million in the three months ended December 31, 2022 and December 25, 2021, respectively, that was included in the contract liability balance at September 24, 2022 and September 25, 2021, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Practical Expedients&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies a practical expedient to expense costs to obtain a contract with a customer as incurred when the amortization period would have been one year or less. These costs solely comprise sales commissions and typically the commissions are incurred at the time of shipment of product and upon billings for support and maintenance contracts.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfODI4Mg_4f4e1ec8-17f3-4352-868d-3180ef976525">The following tables provide revenue from contracts with customers by business and geographic region on a disaggregated basis:&#160;&#160;&#160;&#160;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;78.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;328.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;97.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;413.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;145.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;212.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;52.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;264.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;57.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;270.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;64.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;250.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:3.196%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.677%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.680%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Business &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cytology &amp;amp; Perinatal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;130.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Molecular Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;528.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;285.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;813.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Blood Screening&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;615.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;335.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Imaging&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;208.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;282.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interventional Breast Solutions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;271.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;88.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;458.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Geographic Regions (&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;in millions&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;823.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,012.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;63.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides revenue recognized by source:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:60.790%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.954%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.956%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Revenue by type &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-style:italic;font-weight:700;line-height:100%"&gt;(in millions)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Disposables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;727.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,106.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital equipment, components and software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;158.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;197.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Service&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;183.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;162.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:Revenues
      contextRef="i3714d8a36f9a4f34b0cbd75cd016e460_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMy0yLTEtMS05NzQ3Nw_595e9f14-8992-4d66-a151-82140bdfd0d3"
      unitRef="usd">78200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0064a9d141464479bd6959095d0a5614_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMy0zLTEtMS05NzQ3Nw_afcd1905-83e0-4a7a-aed4-8f468fb2d1bf"
      unitRef="usd">48600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if05c15bd87b943b8a89e3a90c5706964_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMy00LTEtMS05NzQ3Nw_6f24be7a-f303-45a4-9325-f26ca34fa822"
      unitRef="usd">126800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i67c7d17962b5422eb16f38be2f358d0b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNC0yLTEtMS05NzQ3Nw_6698914e-bf0b-4e42-b302-f4d668bcb15f"
      unitRef="usd">328200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7494f976d4084d799b3eb03ac448aba0_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNC0zLTEtMS05NzQ3Nw_5fd90908-c8cd-4afd-b7fa-26317bd895f4"
      unitRef="usd">97000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i03bc4a9519ab4934844ac430543e9341_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNC00LTEtMS05NzQ3Nw_b1f5c6ea-fed0-4639-93ef-f8ca55cc9bc6"
      unitRef="usd">425200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icba05cf621b045f1b0ded77db74e0969_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNS0yLTEtMS05NzQ3Nw_f98f9a28-8ffe-44a2-93fc-3d0cd55f1c1e"
      unitRef="usd">7300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iabf98c37c1ac4489bfce80d1f1a39c3c_D20220925-20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNS0zLTEtMS05NzQ3Nw_56552a13-9e8e-47bb-9deb-cee3b7e8b66b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="idee014b8532443d785b4a01fa597c5c7_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNS00LTEtMS05NzQ3Nw_9133f51f-d9f2-4f66-84f1-571479206efc"
      unitRef="usd">7300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib42c16151a9a4724a372b6e2e07aec81_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNi0yLTEtMS05NzQ3Nw_f2c173e4-6cf9-49b0-91a4-889e12f0c925"
      unitRef="usd">413700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i22f2dbcd7d0a4089b97103d3d3afe54f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNi0zLTEtMS05NzQ3Nw_2bbcc649-5113-44fd-9b84-e15531fcd7dc"
      unitRef="usd">145600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfNi00LTEtMS05NzQ3Nw_c1cd07b1-0e5d-4f90-98a1-7a4aaf796fb4"
      unitRef="usd">559300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7f36606e666b4146adad29c31c074863_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfOS0yLTEtMS05NzQ3Nw_8eda560d-1034-46da-acd9-714d0dcd2964"
      unitRef="usd">212200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7a65e517835843be8d27d7cb21ff1b36_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfOS0zLTEtMS05NzQ3Nw_89c3001c-fc58-42f5-a985-da70aa1f2f37"
      unitRef="usd">52200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51a2e59e54574cd080bad373ef124b26_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfOS00LTEtMS05NzQ3Nw_2915273b-8694-4ae9-8abe-c8539164ab11"
      unitRef="usd">264400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7388165a9fbe4c68874d5c98159e6efd_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTAtMi0xLTEtOTc0Nzc_ade7c6b2-36b9-4856-809f-bec16242b2bd"
      unitRef="usd">57800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i08c907a0b9364379897608caed02a091_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTAtMy0xLTEtOTc0Nzc_37afbecd-5645-4638-be0f-1cdc181c886c"
      unitRef="usd">12000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id1416b6917304ee989571d01c9094fd5_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTAtNC0xLTEtOTc0Nzc_72bea9c6-0005-45cd-af50-aea0294f21bd"
      unitRef="usd">69800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ibe4ef9ffa5b8469f929dfa4f3760db7d_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTItMi0xLTEtOTc0Nzc_cb4f47b7-e414-4d41-a179-05d1227ec1d8"
      unitRef="usd">270000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie73d75b7f9d449cd9fbf4cc4956c951a_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTItMy0xLTEtOTc0Nzc_ca261fbf-7f0c-474d-9d81-e719c380c08b"
      unitRef="usd">64200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTItNC0xLTEtOTc0Nzc_6524cccf-3e36-4a48-8e71-b8544f511858"
      unitRef="usd">334200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i51bc8c3e08e64a4d966f2689b7b9fca3_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTQtMi0xLTEtOTc0Nzc_f29f949c-e9a6-49f3-8af8-dc55a41a2bce"
      unitRef="usd">123100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4e1959574bed4110a1c49d33f2343bce_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTQtMy0xLTEtOTc0Nzc_b8bf0e3e-9509-432a-b362-bbc1b4788bd4"
      unitRef="usd">31000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTQtNC0xLTEtOTc0Nzc_88fb53ae-b628-4b2c-9fa0-2c52229de32d"
      unitRef="usd">154100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if28f4b47974c4a738dd6e022d463262a_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTgtMi0xLTEtOTc0Nzc_0f88bd66-acc0-4367-981d-0fbbf6b15ed6"
      unitRef="usd">16800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i04bff6a5d47648fea88ce5c7a9bd0e30_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTgtMy0xLTEtOTc0Nzc_b9647f5e-36c4-4ba9-a6f4-34f0f748ad49"
      unitRef="usd">9800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTgtNC0xLTEtOTc0Nzc_78cdff7a-a690-48ef-a177-eb877492b552"
      unitRef="usd">26600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTktMi0xLTEtOTc0Nzc_e1af5a64-4e25-4771-95aa-5bab9d2d2e7b"
      unitRef="usd">823600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i17810aabf3f24d38be45e8306c3d0ebd_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTktMy0xLTEtOTc0Nzc_93064085-f2ea-4a3c-a8d1-52b95769541b"
      unitRef="usd">250600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmY0ZDY1ZTI2NThmNjQxYzRiZjY4MDYzNzg2ZGRmNThmL3RhYmxlcmFuZ2U6ZjRkNjVlMjY1OGY2NDFjNGJmNjgwNjM3ODZkZGY1OGZfMTktNC0xLTEtOTc0Nzc_40a84919-ac30-470f-96e6-6bc82afbc1bf"
      unitRef="usd">1074200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie4035e7e2acf45e69da33b7c6c319979_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMy0yLTEtMS05NzQ3Nw_018428a3-e7fe-4afe-bf47-19c813f8c942"
      unitRef="usd">80900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4254426126b9489587816dbe55a313ef_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMy0zLTEtMS05NzQ3Nw_740bb86a-623f-457d-b5c9-da58b3277db2"
      unitRef="usd">49800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia7b6e942d3ce4287ae8dd825a5bbc626_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMy00LTEtMS05NzQ3Nw_ff137045-7352-4d18-bd07-412857252152"
      unitRef="usd">130700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8db75acc45cb41b3936f464bdb0755de_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNC0yLTEtMS05NzQ3Nw_914faf2f-daa8-472b-9bbc-fca53f077853"
      unitRef="usd">528000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="id80a68949b1d49319e7efed985768c09_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNC0zLTEtMS05NzQ3Nw_756ae398-1eb6-40b7-a1e0-4cb6b900e351"
      unitRef="usd">285300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i52bce32474874a61a1c93ed216e5bf26_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNC00LTEtMS05NzQ3Nw_56921375-8744-4d56-9ea3-b5c773749cb7"
      unitRef="usd">813300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae21e80b749742799ade28f359a906e9_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNS0yLTEtMS05NzQ3Nw_ed7801a0-88a9-48ec-9339-6ef247aa653f"
      unitRef="usd">6400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1eee1f1f7fda47a79e60a0733d804ab4_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNS0zLTEtMS05NzQ3Nw_22a9fac9-7e00-46e2-a149-c2b4f0081502"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ife508b03a0c24293b8380f77af515a15_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNS00LTEtMS05NzQ3Nw_b5b17e0c-ad19-4a4f-80a7-96d1b738b286"
      unitRef="usd">6400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieb2242435a5340c69a48e6d30b767133_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNi0yLTEtMS05NzQ3Nw_f6d88acd-3752-4348-8655-39ca46518307"
      unitRef="usd">615300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if2f090269cb448819fb3699673bc74d2_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNi0zLTEtMS05NzQ3Nw_ed3af565-b6b2-4065-a120-a187c448bc4f"
      unitRef="usd">335100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfNi00LTEtMS05NzQ3Nw_3f1cc308-e2d8-469d-b867-447bc1e50400"
      unitRef="usd">950400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if0eed27597194772ac078e57b5d5f7a4_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfOS0yLTEtMS05NzQ3Nw_56d92f7b-40bc-4df8-b3ad-6cbf4d8ba28c"
      unitRef="usd">208900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="icf8975b9a0604bacb2f2ab4ca1780919_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfOS0zLTEtMS05NzQ3Nw_862e998e-f3c8-40c0-8bbc-5b97088050d8"
      unitRef="usd">73400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib09726cd3d914adbaa7747d82b3d9f72_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfOS00LTEtMS05NzQ3Nw_a1395871-a274-4a58-938f-87d73b1bc752"
      unitRef="usd">282300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ice7600161d394a1f844a8709af83b0be_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTAtMi0xLTEtOTc0Nzc_250c1423-7ad1-4bcb-af9b-3703eeb05036"
      unitRef="usd">62100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84a573e910f34c268f9a51a69f8fa78b_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTAtMy0xLTEtOTc0Nzc_3916a180-a136-432c-8992-4313aa2fad4b"
      unitRef="usd">14900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie1f3865bf0674bd6b94548118ff2d889_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTAtNC0xLTEtOTc0Nzc_00371c72-a36a-4500-8ca0-8a978595bd9f"
      unitRef="usd">77000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i76b0a758c01b41e190b861904f705b3e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTItMi0xLTEtOTc0Nzc_f9d94dbb-7986-4ab5-ae05-589f3be6cc47"
      unitRef="usd">271000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i972d2eac12d5498a8229fc8889a43517_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTItMy0xLTEtOTc0Nzc_df40cc0d-cdaa-4b37-bbf8-3818c081dbf5"
      unitRef="usd">88300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTItNC0xLTEtOTc0Nzc_a0444688-4fbc-48f4-afe6-2b51722bcba2"
      unitRef="usd">359300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ie8a130a7154a42b4a3e2498da03f0bd9_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTQtMi0xLTEtOTc0Nzc_76b2a5a7-c041-4f0a-9bd5-a03fefc258f7"
      unitRef="usd">109300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8a538d4146054e4d87047cc9f7975933_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTQtMy0xLTEtOTc0Nzc_4131925a-1f6e-452e-ae3c-3a4c38fd0c7f"
      unitRef="usd">25000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTQtNC0xLTEtOTc0Nzc_e24eddf1-fd1e-4ff2-98df-f162a0de0fef"
      unitRef="usd">134300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic3fd7aa5f38f43d0a2cb58912a4606e3_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTgtMi0xLTEtOTc0Nzc_8e77ff0a-82ce-499b-a9b5-9f79b111ea1f"
      unitRef="usd">16800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib1a36d0d1182460d99b0fa319a28cb37_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTgtMy0xLTEtOTc0Nzc_6ccc5b94-cdab-4e12-b724-d102ff5f9221"
      unitRef="usd">10300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTgtNC0xLTEtOTc0Nzc_a84bb4b7-1aa9-435d-9551-fc497f955412"
      unitRef="usd">27100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTktMi0xLTEtOTc0Nzc_52797bf5-8b74-4bb9-b22d-0e942726b846"
      unitRef="usd">1012400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i121cb63f710c4e60938523f4c50dfe98_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTktMy0xLTEtOTc0Nzc_82123636-0279-41fd-8169-070203f0a510"
      unitRef="usd">458700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOjM2YTk2NzA4MjViZjRlYWU4ZmVkMWE4MTI4MjcyMmY2L3RhYmxlcmFuZ2U6MzZhOTY3MDgyNWJmNGVhZThmZWQxYTgxMjgyNzIyZjZfMTktNC0xLTEtOTc0Nzc_3b9075d7-69f3-4a2b-85fd-70b448e3e7b2"
      unitRef="usd">1471100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMi0yLTEtMS05NzQ3Nw_ad7a5b26-2e74-4d5d-b15d-8f40109d6c7c"
      unitRef="usd">823600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMi0zLTEtMS05NzQ3Nw_a1b3101b-3ab6-4df9-844e-f0abb73f2b41"
      unitRef="usd">1012400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i023b583e3a5743b689087ebe2014e742_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMy0yLTEtMS05NzQ3Nw_595f2f83-f1ef-4c1d-a52c-5310e122bbc9"
      unitRef="usd">147400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7927fb2683384ee6ba18bcb24820aa75_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfMy0zLTEtMS05NzQ3Nw_df34ab5a-bad0-4e5a-8a82-94eb1f5c1145"
      unitRef="usd">295100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i9158b0a900c0492c87e53bb0bfe60c76_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNC0yLTEtMS05NzQ3Nw_5d247bc1-b8d8-4649-85a2-e8d37a61159b"
      unitRef="usd">63800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i7e03307d675a4c4794cdacb42a15022b_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNC0zLTEtMS05NzQ3Nw_5bb67453-d272-4df1-b3eb-bf95e5f94464"
      unitRef="usd">119700000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia2dd7194daee4e2687e5b9ae50540cdf_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNS0yLTEtMS05NzQ3Nw_9a3fd4ac-33fe-4061-97b1-01ffde16dbd2"
      unitRef="usd">39400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i84475ed4b97b45d2a58bd44b2464b6fd_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNS0zLTEtMS05NzQ3Nw_d285cab8-d0c2-411d-9ec6-a8c1eb2715eb"
      unitRef="usd">43900000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNi0yLTEtMS05NzQ3Nw_4d5d45e7-4d4e-4249-bc59-147f5f58a7f9"
      unitRef="usd">1074200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmRlMmI2MjFkOTQ0OTRlY2ViZTI0ZjQ3OWZhNjc4NWM4L3RhYmxlcmFuZ2U6ZGUyYjYyMWQ5NDQ5NGVjZWJlMjRmNDc5ZmE2Nzg1YzhfNi0zLTEtMS05NzQ3Nw_a2168899-9131-4859-aad3-c591cdfeb270"
      unitRef="usd">1471100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i5288beb020944838ab3e1ad08f68dad4_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMi0yLTEtMS05NzQ3Nw_4a2fe078-ca06-43d6-a642-aa3d4ab4f56d"
      unitRef="usd">727800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3dbe4b4d36594aadabeeb6b5788626b0_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMi0zLTEtMS05NzQ3Nw_3f22f32a-92e2-436d-accb-89a7fbd2f707"
      unitRef="usd">1106300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i1d55ea19e5c248d3aefe288d6d5f6d43_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMy0yLTEtMS05NzQ3Nw_7c15e32e-65eb-448d-9b45-ba2d36ea56c3"
      unitRef="usd">158500000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3b62910ac86e4f18a8f2319faba92b2a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfMy0zLTEtMS05NzQ3Nw_e357983e-77e2-4e75-8842-dde83ab5c9ae"
      unitRef="usd">197000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iae7f2df5e66048c5a4d97e51f384eea7_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNC0yLTEtMS05NzQ3Nw_d0b5d169-3554-49dc-bd33-863ab5db0210"
      unitRef="usd">183300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i461d5f7bb915496b935d3720acf6161c_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNC0zLTEtMS05NzQ3Nw_e4719a62-a239-4ee1-bdf9-5c537cabd1d9"
      unitRef="usd">162800000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i01d38c9b3ccb4db89e86e540ca7bfbba_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNS0yLTEtMS05NzQ3Nw_6aeb2a3d-a066-4008-846b-c781d12eca41"
      unitRef="usd">4600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3a3686a6966f49ad893900200aa534f4_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNS0zLTEtMS05NzQ3Nw_31c0d6f1-9a59-45f8-85b5-2d62655e49fb"
      unitRef="usd">5000000.0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNi0yLTEtMS05NzQ3Nw_346e6861-f89a-4324-a2fb-645229fb6c6f"
      unitRef="usd">1074200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RhYmxlOmMzZTI0MDFjNzNlYzQ1M2I5YzgwOWNlMmExYWQ3ZTY3L3RhYmxlcmFuZ2U6YzNlMjQwMWM3M2VjNDUzYjljODA5Y2UyYTFhZDdlNjdfNi0zLTEtMS05NzQ3Nw_9360b994-90e1-4917-8b45-d69f913f88fe"
      unitRef="usd">1471100000</us-gaap:Revenues>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjMwNQ_6756c54d-1516-44a2-a781-ab559ff34d95"
      unitRef="usd">875700000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="iab3be1fea9b347e08c0fbc486d6eba52_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjU0Ng_907c926f-563c-4caf-a45a-d14784eb8775"
      unitRef="number">0.35</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i0170159e5fc647ee9b73c9274f3ad654_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjU5MQ_6a728109-dab7-4df6-9958-d832b570980d"
      unitRef="number">0.32</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="ib03f3840b4e04200a761acaf93092033_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjYxMA_7d83b456-b737-4c21-8758-d6dc53a6a912"
      unitRef="number">0.20</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="i343ac5e6f3c84d52b2f78181c3170b97_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjYyOQ_71b411ea-9ba3-4346-9a0e-5d18be5df233"
      unitRef="number">0.09</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:RevenueRemainingPerformanceObligationPercentage
      contextRef="if2ae0d1ec03043af95521f9690cafd90_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNjY1Mg_843b17eb-0292-4abe-ade0-b8030df92117"
      unitRef="number">0.04</us-gaap:RevenueRemainingPerformanceObligationPercentage>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNzk1OA_58d67c11-5a7c-462f-a7d5-b0b9ae591a25"
      unitRef="usd">66800000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl8zNy9mcmFnOjcyNTUyYmVkNTE1ZTQ1OWE5YTQzMTEwMmJjMmUzZWU0L3RleHRyZWdpb246NzI1NTJiZWQ1MTVlNDU5YTlhNDMxMTAyYmMyZTNlZTRfNzk2NQ_2a038356-1585-4150-89db-48d452bb7762"
      unitRef="usd">56400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80My9mcmFnOjI3OWNkNGRiYzMyMzQ3MTFhMTJhY2M3NDk0Y2NiNzcwL3RleHRyZWdpb246Mjc5Y2Q0ZGJjMzIzNDcxMWExMmFjYzc0OTRjY2I3NzBfMTAxMQ_041709af-c3ab-4895-914c-bd47e71ae408">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company's consolidated revenue for all periods presented.</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80My9mcmFnOjI3OWNkNGRiYzMyMzQ3MTFhMTJhY2M3NDk0Y2NiNzcwL3RleHRyZWdpb246Mjc5Y2Q0ZGJjMzIzNDcxMWExMmFjYzc0OTRjY2I3NzBfMTAxMQ_060fbf70-38ca-4f23-a69d-03b14eb30da4">LeasesLessor Activity - Leases where Hologic is the LessorCertain assets, primarily diagnostics instruments, are leased to customers under contractual arrangements that typically include an operating lease and performance obligations for disposables, reagents and other consumables. These contractual arrangements are subject to termination provisions which are evaluated in determining the lease term for lease accounting purposes. Contract terms vary by customer and may include options to terminate the contract or options to extend the contract. Where instruments are provided under operating lease arrangements, some portion or the entire lease revenue may be variable and subject to subsequent non-lease component (e.g., reagent) sales. Sales-type leases are immaterial. The allocation of revenue between the lease and non-lease components is based on stand-alone selling prices. Lease revenue represented less than 3% of the Company's consolidated revenue for all periods presented.</us-gaap:LesseeFinanceLeasesTextBlock>
    <holx:LeaseRevenuePercentageOfTotalRevenue
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80My9mcmFnOjI3OWNkNGRiYzMyMzQ3MTFhMTJhY2M3NDk0Y2NiNzcwL3RleHRyZWdpb246Mjc5Y2Q0ZGJjMzIzNDcxMWExMmFjYzc0OTRjY2I3NzBfOTQw_1c9fc5b0-72d8-4d0f-ae71-7cdc0fdfcaff"
      unitRef="number">0.03</holx:LeaseRevenuePercentageOfTotalRevenue>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzIzMQ_0a8f22db-b307-4290-8e87-06a58dd0ffd3">Fair Value Measurements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets/Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has investments in derivative instruments comprised of an interest rate swap, forward foreign currency contracts and foreign currency option contracts, which are valued using analyses obtained from independent third-party valuation specialists based on market observable inputs, representing Level 2 assets. The fair values of these derivative contracts represent the estimated amounts the Company would receive or pay to terminate the contracts. Refer to Note 9 for further discussion and information on derivative contracts. In addition, the Company has a contingent consideration liability that is recorded at fair value and based on Level 3 inputs. The contingent consideration liability as of December 31, 2022 and December 25, 2021 was related to the Acessa acquisition. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;31, 2022:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 31, 2022 and December 25, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Assets Measured and Recorded at Fair Value on a Nonrecurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company remeasures the fair value of certain assets and liabilities upon the occurrence of certain events. Such assets are comprised of equity investments and long-lived assets, including property, plant and equipment, intangible assets, and goodwill. During the first quarter of fiscal 2022, the Company recorded a $4.3&#160;million charge to write-off an equity method investment acquired in the Mobidiag acquisition. There were no other remeasurements in the three months ended December&#160;31, 2022 and December&#160;25, 2021. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disclosure of Fair Value of Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s financial instruments mainly consist of cash and cash equivalents, accounts receivable, equity investments, an interest rate swap, forward foreign currency contracts, foreign currency option contracts, insurance contracts, accounts payable and debt obligations. The carrying amounts of the Company&#x2019;s cash and cash equivalents, accounts receivable and accounts payable approximate their fair value due to the short-term nature of these instruments. The Company&#x2019;s interest rate swap, forward foreign currency contracts and foreign currency option contracts are recorded at fair value. The carrying amount of the insurance contracts are recorded at the cash surrender value, as required by U.S. GAAP, which approximates fair value. The Company believes the carrying amounts of its equity investments approximate fair value.&lt;/span&gt;&lt;/div&gt;Amounts outstanding under the Company&#x2019;s 2021 Credit Agreement of $1.5 billion aggregate principal as of December&#160;31, 2022 are subject to variable rates of interest based on current market rates, and as such, the Company believes the carrying amount of these obligations approximates fair value. The Company&#x2019;s 4.625% Senior Notes due 2028 (the &#x201c;2028 Senior Notes&#x201d;) and 3.250% Senior Notes due 2029 (the &#x201c;2029 Senior Notes&#x201d;) had fair values of $373.9 million and $819.2 million, respectively, as of December&#160;31, 2022 based on their trading prices, representing a Level 1 measurement. Refer to Note 7 for the carrying amounts of the various components of the Company&#x2019;s debt.</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzIzMg_45b9e6fb-ad6f-4689-b5ad-36d7fce320d9">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Assets and liabilities measured and recorded at fair value on a recurring basis consisted of the following at December&#160;31, 2022:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:40.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.765%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.373%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.525%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value at Reporting Date Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Quoted&#160;Prices&#160;in&lt;br/&gt;Active&#160;Market&#160;for&lt;br/&gt;Identical&#160;Assets&lt;br/&gt;(Level&#160;1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Other&lt;br/&gt;Observable&lt;br/&gt;Inputs&#160;(Level&#160;2)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Significant&lt;br/&gt;Unobservable&lt;br/&gt;Inputs&#160;(Level&#160;3)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Liabilities Measured and Recorded at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Changes in the fair value of recurring fair value measurements using significant unobservable inputs (Level 3), which solely consisted of contingent consideration liabilities, during the three month periods ended December 31, 2022 and December 25, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.976%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.583%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.828%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.698%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.701%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Month Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at beginning of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Contingent consideration recorded at acquisition&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at end of period&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;71.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ie91293e66d194ed7b35c5cfe9f42b0a4_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC0xLTEtMS05NzQ3Nw_44c90b20-6723-4c5f-b40b-03d7d9f49afb"
      unitRef="usd">35100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i1d3fb98231024d8aaeb5bb8323a77efe_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC0zLTEtMS05NzQ3Nw_c07f2cbe-cdc1-45d1-ba3c-bc7c75097642"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9b9400e507d84e678a5c359b9f85f0a5_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC01LTEtMS05NzQ3Nw_a2c41ad6-4f30-4575-b36c-7cf4203e23cd"
      unitRef="usd">35100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6f9f58b445784504a1bf2cb52ed1b1dd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNC03LTEtMS05NzQ3Nw_e82863b1-217e-4f23-a8da-fb91b9914324"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ifcc81839fd2d4dabbd199e560f9aff75_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi0xLTEtMS0xMDY2OTg_18de4f8d-fadc-4297-bcc2-b126741c3520"
      unitRef="usd">3000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i11cfef20f9384ec3a5c511ca3d5c9667_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi01LTEtMS0xMDY3MDA_69e25a10-a869-4c8f-8060-c575958f744f"
      unitRef="usd">3000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="id87e29cdda514b4fba2087505293883f_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi0xLTEtMS05NzQ3Nw_19ea0c4e-5bf4-4731-beb1-307530ba042b"
      unitRef="usd">1000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i8b7d6e54b06f4b8ca98b5e0a69ed1552_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi0zLTEtMS05NzQ3Nw_08c21c87-210a-42be-bd46-ad7ef30013dc"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i6da937d0b81c484fafd31d8ccb9153a3_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi01LTEtMS05NzQ3Nw_4369d2cc-ef0a-449b-b255-bcf12209f5b4"
      unitRef="usd">1000000.0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i4cc1dbc4bf77455684932730e1b2c790_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNi03LTEtMS05NzQ3Nw_cf3b5cc2-6e43-47bf-b07a-5568db8bcb14"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy0xLTEtMS05NzQ3Nw_afbd5e03-61d3-43c9-9cf5-337bf97dad9e"
      unitRef="usd">39100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="idddbd7f5e3d144eb82b55c015f5f4a19_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy0zLTEtMS05NzQ3Nw_28802a0a-1f15-4b37-8abc-ab9e1807ec26"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ibc27b2eb58e94a3ea4a4352a38a0b0d6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy01LTEtMS05NzQ3Nw_df408ffd-4f49-40d8-96cf-fcf39b6b0428"
      unitRef="usd">39100000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i35ebbdfc813948f5b2ac23261acc5170_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfNy03LTEtMS05NzQ3Nw_925d1cda-1fd1-4eb4-b5d7-d6c9e57e4b24"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i9338d4109670455dbe967e46d7506077_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS0xLTEtMS05NzQ3Nw_2056295f-8f83-40a2-98d7-4c7f37145f08"
      unitRef="usd">23400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="i2050fb386a4c429cbc768ceb88089203_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS0zLTEtMS05NzQ3Nw_60d956e5-688d-4870-86e8-74ecfb0230b2"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="ief97bdd54b7c44619fbcf4a88df99626_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS01LTEtMS05NzQ3Nw_97ccf89d-f0b5-4270-a3bb-aed7cd7afc8e"
      unitRef="usd">0</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure
      contextRef="idab2972813444a1590e68c0af622c531_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfOS03LTEtMS05NzQ3Nw_9c78f0a6-762e-4a39-bc29-2cf62a4678f8"
      unitRef="usd">23400000</us-gaap:ContingentConsiderationClassifiedAsEquityFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i89cf56ee2c6d48f79ce43d6e357253e1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtMS0xLTEtOTc0Nzc_db805ca1-7be1-438b-9a59-a958ce38f027"
      unitRef="usd">900000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i9895e82979cd46e5b9e29032558cf8f0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtMy0xLTEtOTc0Nzc_b07baf98-8ebe-4537-a815-d5ce5c101170"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="i7fa3655b5c4b41899337fbf34ce3a418_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtNS0xLTEtOTc0Nzc_fed6cf6f-fb81-4363-bcfa-260505a636bc"
      unitRef="usd">900000</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:InvestmentsFairValueDisclosure
      contextRef="ib24e943c04e946d3b20fd2005eebdcf2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTEtNy0xLTEtOTc0Nzc_be877132-2092-4ece-a451-0e49cd78b869"
      unitRef="usd">0</us-gaap:InvestmentsFairValueDisclosure>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItMS0xLTEtOTc0Nzc_03c2fce5-20ea-44f4-a5d0-f415d45d598f"
      unitRef="usd">24300000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="idddbd7f5e3d144eb82b55c015f5f4a19_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItMy0xLTEtOTc0Nzc_432b24d2-13dd-4034-ad6f-4247d6879150"
      unitRef="usd">0</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="ibc27b2eb58e94a3ea4a4352a38a0b0d6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItNS0xLTEtOTc0Nzc_309ae921-2f7d-4b94-9f2d-cae936f511c4"
      unitRef="usd">900000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations
      contextRef="i35ebbdfc813948f5b2ac23261acc5170_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOjYyYWEyYzY3NzQ2ZTQzZDFiY2Q4NWVmN2VmMmQ0OTUyL3RhYmxlcmFuZ2U6NjJhYTJjNjc3NDZlNDNkMWJjZDg1ZWY3ZWYyZDQ5NTJfMTItNy0xLTEtOTc0Nzc_a746a339-2749-4f7e-9221-0447dc9ede39"
      unitRef="usd">23400000</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisObligations>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMi0yLTEtMS05NzQ3Nw_ad0610d8-99c1-4901-9b5a-d2ff1faacf78"
      unitRef="usd">23400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMi00LTEtMS05NzQ3Nw_2584fe26-6752-432a-877c-8a76230eb3b8"
      unitRef="usd">75100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMy0yLTEtMS05NzQ3Nw_6700ad90-928f-489b-9633-c9e877396437"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfMy00LTEtMS05NzQ3Nw_d6e3adb8-bc97-4d27-ab6a-fd570f8e93fd"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNC0yLTEtMS05NzQ3Nw_86e69df9-efff-4a06-a4f2-2362c2a3d3e1"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNC00LTEtMS05NzQ3Nw_b31330b9-3d4e-4459-97f7-7ee3a0a09de3"
      unitRef="usd">-4100000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNS0yLTEtMS05NzQ3Nw_f69b8ca1-919a-483f-bb57-81efa82280fb"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNS00LTEtMS05NzQ3Nw_b0b5da9c-954b-494e-9d35-43141b1546fa"
      unitRef="usd">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNi0yLTEtMS05NzQ3Nw_bbef819e-5628-461f-8686-46b9bac2cc4b"
      unitRef="usd">23400000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RhYmxlOmY1OGJiZjE5ZjJhODRmYzVhOWI4ZWQ0MTA3MjU2MzExL3RhYmxlcmFuZ2U6ZjU4YmJmMTlmMmE4NGZjNWE5YjhlZDQxMDcyNTYzMTFfNi00LTEtMS05NzQ3Nw_3994bf0b-c7e8-4cc3-8e3b-a879a59f1322"
      unitRef="usd">71000000.0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:LossOnSaleOfInvestments
      contextRef="iefd5e2be463d4709a964b3675267c84b_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMTY2Ng_c45f3cc9-25e8-4ed1-a73f-d95ccca3cc89"
      unitRef="usd">4300000</us-gaap:LossOnSaleOfInvestments>
    <holx:PrincipalAmountOfBorrowings
      contextRef="ie8285876f9504f55b719cb94a43fd897_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMjY2Ng_0be8e1ee-05b3-4675-b1ce-143d92885aa3"
      unitRef="usd">1500000000</holx:PrincipalAmountOfBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMjkxNw_a170d7a7-706b-4ec4-801b-47157937809c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMjk3Mg_30b630f3-1000-4278-b36b-11ee949a8b62"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFairValue
      contextRef="ib8c253e80fb5495fa148fef676c31327_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzA0Mg_45e49d86-fb92-4de9-b9c1-6e86b2ab660b"
      unitRef="usd">373900000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:DebtInstrumentFairValue
      contextRef="i1c866db25ccd49bf9837ddb6f3695f2e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80Ni9mcmFnOjg2NWMyODBmZTAwMjQ5MmE4ZDIwNjkxODhiZmE0ZjdiL3RleHRyZWdpb246ODY1YzI4MGZlMDAyNDkyYThkMjA2OTE4OGJmYTRmN2JfMzA0OQ_a7c58b62-ce67-41c1-98a8-4fc6b1984aa7"
      unitRef="usd">819200000</us-gaap:DebtInstrumentFairValue>
    <us-gaap:BusinessCombinationDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ4MDM_7f73a07e-500a-4441-af33-c806b784ec8e">Business Combinations&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fiscal 2022 Acquisition&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Bolder Surgical&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 29, 2021, the Company completed the acquisition of Bolder Surgical Holdings, Inc. ("Bolder"), for a purchase price of $160.1&#160;million. Bolder, located in Louisville, Colorado, is a developer and manufacturer of energy vessel sealing surgical devices used in both laparoscopic and open procedures. Bolder's results of operations are reported in the Company's GYN Surgical reportable segment from the date of acquisition.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Bolder's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationship&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In performing the purchase price allocation, the Company considered, among other factors, the intended future use of acquired assets, analysis of historical financial performance and estimates of future performance of Bolder's business. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the purchase price allocation, the Company determined the identifiable intangible assets are developed technology, customer relationships and trade names. The fair value of the intangible assets was estimated using the income approach, and the cash flow projections were discounted using a 16.0% rate. The cash flows were based on estimates used to price the transaction, and the discount rate applied was benchmarked with reference to the implied rate of return from the transaction model and the weighted average cost of capital. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The developed technology assets are comprised of know-how, patents and technologies embedded in Bolder's products and relate to currently marketed products. The developed technology assets comprise the primary product families under the JustRight and CoolSeal technology platforms.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimate of the weighted average life for the developed technology, customer relationship, and trade name assets is 10 years. The calculation of the excess of the purchase price over the estimated fair value of the tangible net assets and intangible assets acquired was recorded to goodwill. Factors contributing to the recognition of the amount of goodwill were primarily based on anticipated strategic and synergistic benefits that are expected to be realized from the Bolder acquisition. These benefits include expanding the Company's surgical portfolio and utilizing GYN Surgical's sales and regulatory expertise to drive adoption and revenue growth. None of the goodwill is expected to be deductible for income tax purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingent Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a contingent consideration liability related to its acquisition of Acessa Health, Inc. ("Acessa"), which occurred in August 2020. Acessa developed the ProVu laparoscopic radiofrequency ablation system. The Company estimated the fair value of this liability to be $81.8&#160;million as of the acquisition date. The contingent payments are based on a multiple of annual incremental revenue growth over a three-year period ending annually in December of each of 2021, 2022, and 2023. There is no maximum earnout. Pursuant to ASC 805, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Business Combinations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 805), the Company recorded its estimate of the fair value of the contingent consideration liability utilizing the Monte Carlo simulation based on future revenue projections of Acessa, revenue growth rates of comparable companies, implied volatility and applying a risk adjusted discount rate. Each quarter the Company is required to remeasure the fair value of the liability as assumptions change and such adjustments are recorded in operating expenses. This fair value measurement was based on significant inputs not observable in the market and thus represented a Level 3 measurement as defined in ASC 820, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This fair value measurement is directly impacted by the Company's estimate of future incremental revenue growth of the business. Accordingly, if actual revenue growth is higher or lower than the estimates within the fair value measurement, the Company would record additional charges or gains. During the year ended September 24, 2022, the Company remeasured the contingent consideration and recorded a gain of $39.5&#160;million to record the liability at fair value. The reduction in fair value was primarily due to a decrease in forecasted revenues over the measurement period and to a much lesser extent an increase in the discount rate driven by market rates. During the three months ended December 25, 2021, the first measurement period was completed, and the Company recorded a gain of $4.1&#160;million to decrease the contingent consideration liability to fair value based on actual revenue results in the first earn-out period. During the second quarter of fiscal 2022, the Company made a payment of $12.2&#160;million for the first earn-out period. During the three months ended December 31, 2022, the second measurement period was completed, resulting in an estimated amount of $7.2&#160;million. No additional adjustment was recorded based on actual and forecasted results. As of December 31, 2022, the contingent consideration liability was $23.4&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:BusinessCombinationDisclosureTextBlock>
    <us-gaap:BusinessCombinationConsiderationTransferred1
      contextRef="iea43d0cf9441456ca855066f24c915b7_D20211129-20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjA2_177a918b-811a-4501-9eb9-e6991c5bfce7"
      unitRef="usd">160100000</us-gaap:BusinessCombinationConsiderationTransferred1>
    <us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ4MDQ_4d45a8f1-2168-430b-b97f-3f6fb7026ac3">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total purchase price was allocated to Bolder's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:62.865%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:62.853%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:25.878%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accounts payable and accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable intangible assets: &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;73.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationship&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred income taxes, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(11.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Purchase Price&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMC0yLTEtMS05NzQ3Nw_4ecd7d87-fa73-46e2-b1c6-e64659457705"
      unitRef="usd">1900000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMS0yLTEtMS05NzQ3Nw_80430051-e027-474f-b648-b68c5740a200"
      unitRef="usd">1300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMi0yLTEtMS05NzQ3Nw_cbae4e68-3eae-47d3-a86a-cf9b47b237ff"
      unitRef="usd">3300000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfNC0yLTEtMS05NzQ3Nw_e33ce48c-03f6-4df7-9b7b-fb8ef5ed4635"
      unitRef="usd">3000000.0</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfNS0yLTEtMS05NzQ3Nw_0792a70e-69ed-4bc4-8052-1194db01c2ae"
      unitRef="usd">3200000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfOC0yLTEtMS05NzQ3Nw_afa10c9b-1bca-4b0a-87fb-ec4fa2c67c70"
      unitRef="usd">73600000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfOS0yLTEtMS05NzQ3Nw_86eae5ce-5870-43b5-ac8c-d5d370375bbb"
      unitRef="usd">21700000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTAtMi0xLTEtOTc0Nzc_35dcccb0-83b3-4649-87d9-c5260b66574b"
      unitRef="usd">1400000</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTMtMi0xLTEtOTc0Nzc_89da620c-c4fb-46af-a930-80f7558ac806"
      unitRef="usd">11700000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities>
    <us-gaap:Goodwill
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTQtMi0xLTEtOTc0Nzc_9786a75b-e7f3-48bd-8ea6-b6c583b4bcc8"
      unitRef="usd">68800000</us-gaap:Goodwill>
    <us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
      contextRef="i07a25a5a908f4f19b6e6162e1d775e3d_I20211129"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RhYmxlOjM3OTlmMDJhYWFhZTRhNDNhMmI3ZTJjYWNhOTE2YTUzL3RhYmxlcmFuZ2U6Mzc5OWYwMmFhYWFlNGE0M2EyYjdlMmNhY2E5MTZhNTNfMTUtMi0xLTEtOTc0Nzc_61017e3a-722f-47e1-bfeb-8f4fa734ef3b"
      unitRef="usd">160100000</us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet>
    <holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue
      contextRef="iea43d0cf9441456ca855066f24c915b7_D20211129-20211129"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTU0NQ_c3b8f993-abb3-40cd-bef2-4edc78b64884"
      unitRef="number">0.160</holx:BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="i1481f69a4d9244499f5a549cc0eebe59_D20211129-20211129"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjIwMQ_48af52b9-57ab-4f48-b9fe-163887f4912a">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iba6cbbe07ee948f583f8d1f77e05e475_D20211129-20211129"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjIwMQ_a5579a2e-de85-4f6a-90a9-108357ed8da5">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
      contextRef="iab72fa2f468444a685a69c28852ec73b_D20211129-20211129"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMjIwMQ_a6ca8004-d527-4a35-97da-76f944bc0346">P10Y</us-gaap:AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="i4698c57aad0746b78ce06e44b93c84fc_I20200823"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTIzNjA_1a08f645-964f-4b23-b14d-56d331044f70"
      unitRef="usd">81800000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <holx:AnnualIncrementalRevenueGrowthPeriod
      contextRef="iae84daa015564a61a94ab772911423dd_D20200823-20200823"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ4MDg_1a7d2de8-8227-4c3b-957d-ba131d807196">P3Y</holx:AnnualIncrementalRevenueGrowthPeriod>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i343e49832f164c1a89e8c46e7295b5be_D20210926-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTA5OTUxMTY2ODMzNQ_f6e0b41a-d1a7-4787-a7cf-a26ed52dd92b"
      unitRef="usd">39500000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="iaea12adf8afb44a3a25469e63012eb04_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ0ODc_dd3cd79e-ee95-460b-9f07-3d5d5f8abfb2"
      unitRef="usd">4100000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <holx:BusinessCombinationContingentConsiderationPayments
      contextRef="ia8ff31aae0694a0aa8817256292f1722_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ2ODk_b57bbcea-3098-46b8-9474-e74dda024abc"
      unitRef="usd">12200000</holx:BusinessCombinationContingentConsiderationPayments>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="ia8ff31aae0694a0aa8817256292f1722_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTA5OTUxMTY2ODY1OA_45d8bab9-9197-4344-b235-ea0caef9f0e6"
      unitRef="usd">7200000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationLiability
      contextRef="iacaca98377e84dea8c3dcc6d430e498c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl80OS9mcmFnOjA4NDk4OTZmM2EwYTRkOTlhMTk2NThhM2Y3OGRkYTA1L3RleHRyZWdpb246MDg0OTg5NmYzYTBhNGQ5OWExOTY1OGEzZjc4ZGRhMDVfMTQ3ODc_86f7aa05-b328-4034-b840-4447a7f191ca"
      unitRef="usd">23400000</us-gaap:BusinessCombinationContingentConsiderationLiability>
    <us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfMTQ2Mw_d90897cf-0d57-43d5-815a-5c65cf738f09">&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;(6) Restructuring&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the first quarter of fiscal 2022, the Company finalized its decision to close its Danbury, Connecticut facility where it manufactures its Breast Health capital equipment products. The manufacturing of the Breast Health capital equipment products and all other support services will be moved to the Company's Newark, Delaware facility. In addition, research and development, sales and services support and administrative functions will be moved to the Newark, Delaware and Marlborough, Massachusetts facilities. The transition is expected to be completed by the third quarter of fiscal 2025. The majority of employees located in Danbury were given the option to relocate to the new locations. As a result of this plan, the Company expects a number of employees to not relocate resulting in their termination. The employees were notified of the closure during the first quarter of fiscal 2022, but were not communicated about their termination and related severance benefits until the third quarter of fiscal 2022. The Company is recording severance benefits pursuant to pursuant to ASC 420, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Exit or Disposal Cost Obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 420), and the severance benefits are being expensed ratably over the required service period. As a result, the Company recorded severance charges of $0.7&#160;million in the first quarter of fiscal 2023 and $1.6&#160;million in fiscal 2022, respectively. The Company estimates that total severance charges, including retention, will be approximately $7.0&#160;million.&lt;/span&gt;&lt;/div&gt;</us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock>
    <us-gaap:RestructuringCharges
      contextRef="i3506cb7a03e440d886dbc72ce84c14b7_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfNTQ5NzU1ODE5ODYz_33ea71c2-59fc-40b7-bbaa-95b1096a8f1e"
      unitRef="usd">700000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringCharges
      contextRef="i30bcf60271074f93a183af070bda3ce1_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfNTQ5NzU1ODE5ODkw_47e8b682-8486-4838-9925-ae5ff08dd4d1"
      unitRef="usd">1600000</us-gaap:RestructuringCharges>
    <us-gaap:RestructuringAndRelatedCostExpectedCost1
      contextRef="ideae2329e17d435e83ee4db40e5b76df_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81Mi9mcmFnOmUxMzdiM2M4ODgwNDQ0ZWE5YWI4ZjJlMjk1MGZhOGRhL3RleHRyZWdpb246ZTEzN2IzYzg4ODA0NDRlYTlhYjhmMmUyOTUwZmE4ZGFfMTQ2MA_9493d04a-aa5c-476f-93ef-065d405bfcb6"
      unitRef="usd">7000000</us-gaap:RestructuringAndRelatedCostExpectedCost1>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0NjU_b6a50394-269b-4dab-b93a-6772b4249aff">Borrowings and Credit Arrangements&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,475.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,808.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:4pt;text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2021 Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;On September 27, 2021, the Company refinanced its then existing term loan and revolving credit facility with Bank of America, N.A. in its capacity as Administrative Agent, Swing Line Lender and L/C Issuer, and certain other lenders (the "2018 Credit Agreement") by entering into a Refinancing Amendment (the "2021 Credit Agreement"). On August 22, 2022, the Company further amended the 2021 Credit Agreement by entering into an amendment to address the planned phase out of LIBOR by the UK Financial Conduct Authority. Under this amendment, the interest rates applicable to the loans under the 2021 Credit Agreement denominated in U.S. Dollars were converted to a variant of the secured overnight financing rate (&#x201c;SOFR&#x201d;), as established from time to time by the Federal Reserve Bank of New York, plus a corresponding spread.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:36pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement provides for a $1.5&#160;billion secured term loan facility (the "2021 Term Loan") and a $2.0&#160;billion revolving credit facility (the "2021 Revolver"). As of December 31, 2022, the principal amount outstanding under the 2021 Term Loan was $1.5&#160;billion, and the interest rate was 5.43% per annum. No amounts were outstanding under the 2021 Revolver and the full amount was available to be borrowed by the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to ASC 470, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (ASC 470), the accounting for the refinancing was evaluated on a creditor-by-creditor basis to determine whether each transaction should be accounted for as a modification or extinguishment. Certain creditors under the 2018 Credit Agreement did not participate in this refinancing transaction and ceased being creditors of the Company. As a result, the Company recorded a debt extinguishment loss of $0.7&#160;million in the first quarter of fiscal 2022 to write-off the pro-rata amount of unamortized debt discount and deferred issuance costs related to these creditors. For the remainder of the creditors, this transaction was accounted for as a modification. Pursuant to ASC 470, third-party costs of $7.0&#160;million were recorded as a reduction to debt representing deferred issuance costs and fees paid directly to the lenders.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's interest rate swap, which fixes the rate on $1&#160;billion of aggregate principal under the 2021 Term Loan at 1.23%, resulted in the Company receiving $6.6&#160;million in the first quarter of fiscal 2023, which was recorded as a reduction to interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2021 Credit Agreement contains two financial covenants; a total leverage ratio and an interest coverage ratio, both of which are measured as of the last day of each fiscal quarter. These terms, and calculations thereof, are defined in further detail in the 2021 Credit Agreement. As of December 31, 2022, the Company was in compliance with these covenants.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the Company had 4.625% Senior Notes due 2028 (the "2028 Senior Notes") outstanding in the aggregate principal balance of $400 million. The 2028 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries and mature on February&#160;1, 2028. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December 31, 2022, the Company had 3.250% Senior Notes due 2029 (the "2029 Senior Notes") outstanding in the aggregate principal balance of $950&#160;million. The 2029 Senior Notes are general senior unsecured obligations of the Company and are guaranteed on a senior unsecured basis by certain of the Company's domestic subsidiaries and mature on February 15, 2029.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounts Receivable Securitization Program&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During April 2022, the Company repaid the outstanding balance of $248.5&#160;million under its accounts receivable securitization program (the "Securitization Program"). On June 10, 2022, the Company amended the Credit and Security agreement with lenders, temporarily suspending the ability to borrow and the need to comply with covenants for up to a year. As of December 31, 2022, the Company did not have any borrowings under this program.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0ODM_dda80a07-e79f-4d5c-9f60-c6cf63c3df95">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s borrowings consisted of the following:&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.461%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.180%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.329%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current debt obligations, net of debt discount and deferred issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term debt obligations, net of debt discount and issuance costs:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term Loan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,472.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,475.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;937.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;936.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total long-term debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,806.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,808.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total debt obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,826.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,823.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:LongTermDebtCurrent
      contextRef="i333952b4e5b04176801bb8b51ea10d2b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMi0xLTEtMS05NzQ3Nw_d1f5efc7-2b64-4ddd-b4ec-67c69931dfc5"
      unitRef="usd">20600000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="iab94eadaf80646c99688a0bc7890d803_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMi0zLTEtMS05NzQ3Nw_0d00930a-a070-43b0-90cd-52ba1615d237"
      unitRef="usd">15000000.0</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfNi0xLTEtMS05NzQ3Nw_e9743203-b173-4c55-b0a0-fdad180d99c6"
      unitRef="usd">20600000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfNi0zLTEtMS05NzQ3Nw_1f5ab705-d5a7-42df-b2dc-c745876b0cf5"
      unitRef="usd">15000000.0</us-gaap:LongTermDebtCurrent>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i333952b4e5b04176801bb8b51ea10d2b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfOC0xLTEtMS05NzQ3Nw_4b611c00-a8be-48c1-863c-6f201edca1e1"
      unitRef="usd">1472700000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="iab94eadaf80646c99688a0bc7890d803_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfOC0zLTEtMS05NzQ3Nw_be340dab-09e2-49ad-98ff-a08fe2b1144b"
      unitRef="usd">1475700000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="ia2d07a69cb1c487c91cc762762bc1d0e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTAtMS0xLTEtOTc0Nzc_c7f82ed0-2aa0-409a-b4de-49c2f7e28b41"
      unitRef="usd">396300000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="iadc35cfa947f44998ff3996d2aa84afd_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTAtMy0xLTEtOTc0Nzc_ee78a108-b07b-44c3-8d6e-403fe03fe91d"
      unitRef="usd">396100000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i34650814b5cc4021acd04ac86d799f20_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTEtMS0xLTEtOTc0Nzc_a57791fc-213f-48e1-bb9f-1196c7454be4"
      unitRef="usd">937200000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <holx:LongTermDebtObligationsWithoutConvertibleNotes
      contextRef="i79d0d70331034758a653310fab36e412_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTEtMy0xLTEtOTc0Nzc_e24cb36f-849a-4dca-8c77-89182695838d"
      unitRef="usd">936600000</holx:LongTermDebtObligationsWithoutConvertibleNotes>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTMtMS0xLTEtOTc0Nzc_befff357-3af3-49cf-9314-375e86b00427"
      unitRef="usd">2806200000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTMtMy0xLTEtOTc0Nzc_65d9438a-da07-4fab-90ed-aa87ce64884e"
      unitRef="usd">2808400000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebt
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTQtMS0xLTEtOTc0Nzc_9113939d-bf7b-4197-9199-ce58c733cba0"
      unitRef="usd">2826800000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjAzMTU3MjY2NWU2MDQ3Y2VhODBkMTMyZjQ3YThkN2UxL3RhYmxlcmFuZ2U6MDMxNTcyNjY1ZTYwNDdjZWE4MGQxMzJmNDdhOGQ3ZTFfMTQtMy0xLTEtOTc0Nzc_ad079fc7-018d-4a8c-9cd7-cf17a6893aa0"
      unitRef="usd">2823400000</us-gaap:LongTermDebt>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i345a638c3ba941e1855a959c897f7176_I20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3MjkzNw_46f64623-e009-4c59-9f90-efdb09931a4e"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i16715a72d92e441993d6789cac1dbd2f_I20210927"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTQ1NQ_e38bcc57-0ad6-4a8f-b7e2-34954843a9f6"
      unitRef="usd">2000000000</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i10401dc3383842b09980d3a937fb7508_I20221231"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfNDUxNDU_f9f366f3-4555-4428-904a-26d0a0e850cb"
      unitRef="usd">1500000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i10401dc3383842b09980d3a937fb7508_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3MjkwOQ_8632dcd8-f21f-4b86-b820-3d86fd53b08a"
      unitRef="number">0.0543</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:GainsLossesOnExtinguishmentOfDebt
      contextRef="i6f5ef2ef76fd4192b1f4f10266a76b4e_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfNjU2MQ_4de1b635-860f-440a-8e5d-aa7c3e972bbb"
      unitRef="usd">-700000</us-gaap:GainsLossesOnExtinguishmentOfDebt>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="idfaac04d4a484d258c3db28ddc02ff2e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfNjg1MA_02882f86-8a25-4a3d-be97-4dd8bc95b4b4"
      unitRef="usd">7000000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0NjA_5f277121-b412-4f87-ada2-3fbae6c5f977">&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense, weighted average interest rates, and the interest rate at the end of period under the 2021 Credit Agreement were as follows:&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.274%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.128%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.129%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.63&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate at end of period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMi0xLTEtMS05NzQ3Nw_38e70d84-c2f9-4b2b-b831-72b014ae93fa"
      unitRef="usd">20400000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="ica33b08d41d34461b027e01d397de44f_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMi0zLTEtMS05NzQ3Nw_73bb2d00-f49d-4c32-8311-0c036770212d"
      unitRef="usd">5300000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMy0xLTEtMS05NzQ3Nw_2a7ddc6a-6b2e-48ec-bb5c-699b7780469d"
      unitRef="number">0.0463</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateDuringPeriod
      contextRef="ica33b08d41d34461b027e01d397de44f_D20210926-20211225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfMy0zLTEtMS05NzQ3Nw_d8f0987b-c2d3-45cf-83bb-346210431bd4"
      unitRef="number">0.0109</us-gaap:LineOfCreditFacilityInterestRateDuringPeriod>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="ie8285876f9504f55b719cb94a43fd897_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfNC0xLTEtMS05NzQ3Nw_c7c2c984-95f5-49bf-90bc-ed73d01388bc"
      unitRef="number">0.0543</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd
      contextRef="i0e9943e6f8ff4c8aaec563317ae88d47_I20211225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOjIwMTVjYjUwMmQ0ZjQ0NDdiMzc3Njk5MTBiZjViNjIwL3RhYmxlcmFuZ2U6MjAxNWNiNTAyZDRmNDQ0N2IzNzc2OTkxMGJmNWI2MjBfNC0zLTEtMS05NzQ3Nw_5ca90e2b-ee10-4c7a-9ed1-814f4dbad994"
      unitRef="number">0.0110</us-gaap:LineOfCreditFacilityInterestRateAtPeriodEnd>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk1MQ_bc1884d1-e4a0-4844-b0fa-e2e708f3bd53"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk2Mw_2e0a4d9d-954a-495c-bb89-756cd7c80777"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities
      contextRef="i0ca833a47aa541e992640c358c110349_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk3MA_35ce33b0-c5a4-4224-80a5-02a3ef19aa32"
      unitRef="usd">6600000</us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk4NA_9cf80363-2030-4f83-9935-2ed31c56d29c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfOTQ3MA_e03a6dc0-1464-431a-abbb-2c6d841ae139"
      unitRef="usd">400000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTA5OTUxMTY3Mjk5Mg_549010d1-9c08-4124-9be9-891d2cf7b679"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:SeniorNotes
      contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfOTgxNg_01e2ced5-052d-4432-a8c1-fc6e5002a157"
      unitRef="usd">950000000</us-gaap:SeniorNotes>
    <holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTE0NzQ_7457e9f7-00dc-4fe5-b939-80ce952371df">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense for the 2029 Senior Notes and 2028 Senior Notes was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:58.549%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.788%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.792%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2029 Senior Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.250&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i8106951e543c45718bc14b8faa6ff745_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfMy0xLTEtMS05NzQ3Nw_a170d7a7-706b-4ec4-801b-47157937809c"
      unitRef="number">0.04625</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="id225da1e135b44f7a25d7b8427d9693e_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfMy0zLTEtMS05NzQ3Nw_fe4ba797-1251-4d55-811f-c8292680e398"
      unitRef="usd">5200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="id9b7e75f146848e4bc229589975b5948_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfMy01LTEtMS05NzQ3Nw_aba58075-2856-4939-bcc2-cbe6dc6172db"
      unitRef="usd">4800000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i73a6b6dfd2a144cdb914d656abdc6688_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNC0xLTEtMS05NzQ3Nw_30b630f3-1000-4278-b36b-11ee949a8b62"
      unitRef="number">0.03250</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i34f00671c17749c98d26591f7dc95d11_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNC0zLTEtMS05NzQ3Nw_77980c3c-5048-4cc4-9fd4-4a6420be49d6"
      unitRef="usd">8900000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i3c0114bb00874bbcae4df17922168466_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNC01LTEtMS05NzQ3Nw_6433a86b-43df-4971-9148-621552346255"
      unitRef="usd">8200000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i60ac9cd428ef42a7a8b91fa784f5f45e_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNS0zLTEtMS05NzQ3Nw_fed6ecd2-8d75-4cb5-a3c4-9a68b965951e"
      unitRef="usd">14100000</us-gaap:InterestExpenseBorrowings>
    <us-gaap:InterestExpenseBorrowings
      contextRef="i6764b5e8e67e48f791728d79a2e34122_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RhYmxlOmQ2Njc3NmQ5YWM1MDQ1OGNiYTk2MGY5M2IyMjhmMmIxL3RhYmxlcmFuZ2U6ZDY2Nzc2ZDlhYzUwNDU4Y2JhOTYwZjkzYjIyOGYyYjFfNS01LTEtMS05NzQ3Nw_c60c6a84-5d8d-4506-a42d-2cfd9d22e40b"
      unitRef="usd">13000000.0</us-gaap:InterestExpenseBorrowings>
    <us-gaap:RepaymentsOfOtherDebt
      contextRef="i167654f352a04de29b14663bc8cdcfc0_D20220401-20220430"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81NS9mcmFnOjE1NzUyNzhlNGQwYzQwNzRiNTlkNzM0NGIxODFmYzdjL3RleHRyZWdpb246MTU3NTI3OGU0ZDBjNDA3NGI1OWQ3MzQ0YjE4MWZjN2NfMTAyNDI_851bd551-cf66-4eb3-b145-3f1e729d6eba"
      unitRef="usd">248500000</us-gaap:RepaymentsOfOtherDebt>
    <us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RleHRyZWdpb246YmQzNTRkYzIwMDNmNGFkZWJkMmUyMzQzMDYzYWUxYzZfMTkwMg_00dbfbd7-83a8-4422-b3a7-8e6da13fe15f">Trade Receivables and Allowance for Credit Losses&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies ASU No. 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to its trade receivables and allowances for credit losses, which requires that financial assets measured at amortized cost be presented at the net amount expected to be collected. The expected credit losses are developed using an estimated loss rate method that considers historical collection experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount. The estimated loss rates are applied to trade receivables with similar risk characteristics such as the length of time the balance has been outstanding and the location of the customer. In certain instances, the Company may identify individual trade receivable assets that do not share risk characteristics with other trade receivables, in which case the Company records its expected credit losses on an individual asset basis. For example, potential adverse changes to customer liquidity from new macroeconomic events, such as the COVID-19 pandemic, must be taken into consideration. To date, the Company has not experienced significant customer payment defaults, or identified other significant collectability concerns. In connection with assessing credit losses for individual trade receivable assets, the Company considers significant factors relevant to collectability including those specific to the customer such as bankruptcy, length of time an account is outstanding, and the liquidity and financial position of the customer. If a trade receivable asset is evaluated on an individual basis, the Company excludes those assets from the portfolios of trade receivables evaluated on a collective basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is a rollforward of the allowance for credit losses as of December 31, 2022 compared to December 25, 2021:&lt;/span&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.455%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.540%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&lt;br/&gt;of Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Credit Loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Write-offs,&lt;br/&gt;Payments and Foreign Exchange&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;39.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RleHRyZWdpb246YmQzNTRkYzIwMDNmNGFkZWJkMmUyMzQzMDYzYWUxYzZfMTkwMw_0012a15f-30b9-46e1-856f-38b44895056d">The following is a rollforward of the allowance for credit losses as of December 31, 2022 compared to December 25, 2021:</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi0yLTEtMS05NzQ3Nw_b3062c16-1905-4c46-92ee-23b1619732f6"
      unitRef="usd">37700000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi00LTEtMS05NzQ3Nw_f368c13c-8045-4f4a-bef9-bbc2d402e5f3"
      unitRef="usd">1200000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi04LTEtMS05NzQ3Nw_76fd22be-16f2-446f-945e-114c1ca93d95"
      unitRef="usd">-200000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMi0xMC0xLTEtOTc0Nzc_4a42dc93-34cc-434a-9cd2-3a67cdeaf5a7"
      unitRef="usd">39100000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy0yLTEtMS05NzQ3Nw_9031c6b7-3873-403e-b323-06d89a4b9494"
      unitRef="usd">40500000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy00LTEtMS05NzQ3Nw_48c5796b-89a2-4a5d-8b0c-cc11bb16ec80"
      unitRef="usd">3100000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy04LTEtMS05NzQ3Nw_15b93fdf-1b4b-41e3-9a08-c13819d5e4ce"
      unitRef="usd">1600000</us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl81OC9mcmFnOmJkMzU0ZGMyMDAzZjRhZGViZDJlMjM0MzA2M2FlMWM2L3RhYmxlOjkzMTdjYWQ1NjA1MDQyMjU5MTQ4MWJjMTBhYmU1N2NmL3RhYmxlcmFuZ2U6OTMxN2NhZDU2MDUwNDIyNTkxNDgxYmMxMGFiZTU3Y2ZfMy0xMC0xLTEtOTc0Nzc_39793575-6bcd-4e4f-8b5b-d63e8d3166dc"
      unitRef="usd">42000000.0</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:DerivativesAndFairValueTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg2OQ_788828fa-d6c1-4550-b580-411d0f61ddca">Derivatives&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Interest Rate Swap - Cash Flow Hedge&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company manages its exposure to some of its interest rate risk through the use of interest rate swaps, which are derivative financial instruments. The Company does not use derivatives for speculative purposes. For a derivative that is designated as a cash flow hedge, changes in the fair value of the derivative are recognized in accumulated other comprehensive income ("AOCI") to the extent the derivative is effective at offsetting the changes in the cash flows being hedged until the hedged item affects earnings.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In fiscal 2019, in order to hedge a portion of its variable rate debt, the Company entered into an interest rate swap contract with an effective date of December 23, 2020 and a termination date of December 17, 2023.  On August 25, 2022, the interest rate swap agreement was restructured (consistent with the 2021 Credit Agreement)  to convert the benchmark interest rate from LIBOR to the SOFR rate effective September 23, 2022 with a termination date of December 17, 2023. The Company applied the practical and optional expedients in ASC 848, Reference Rate Reform, in evaluating the impact of modifying the contract, which resulted in no change to the accounting for this derivative contract. The notional amount of this swap is $1.0 billion. The restructured interest rate swap effectively fixes the SOFR component of the variable interest rate on $1.0 billion of the notional amount under the 2021 Credit Agreement at 1.23%. The critical terms of the restructured interest rate swap are designed to mirror the terms of the Company&#x2019;s SOFR-based borrowings under the 2021 Credit Agreement and therefore are highly effective at offsetting the cash flows being hedged. The Company designated this derivative as a cash flow hedge of the variability of the SOFR-based interest payments on $1.0 billion of principal. Therefore, changes in the fair value of the swap are recorded in AOCI. The fair value of this derivative was in an asset position of $35.1 million as of December&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Forward Foreign Currency Exchange Contracts and Foreign Currency Option Contracts&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into forward foreign currency exchange contracts and foreign currency option contracts to mitigate certain operational exposures from the impact of changes in foreign currency exchange rates. Such exposures result from the portion of the Company's cash and operations that are denominated in currencies other than the U.S. dollar, primarily the Euro, the UK Pound, the Australian dollar, the Canadian dollar, the Chinese Yuan and the Japanese Yen. These foreign currency contracts are entered into to support transactions made in the ordinary course of business and are not speculative in nature. The contracts are generally for periods of one year or less. The Company did not elect hedge accounting for these contracts and as of December 31, 2022 the notional amount was $369.2&#160;million. The change in the fair value of these contracts is recognized directly in earnings as a component of other income (expense) income, net.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Realized and unrealized gains and losses from these contracts, which were the only derivative contracts not designated for hedge accounting, for the three months ended December 31, 2022 and December 25, 2021, respectively, were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Financial Instrument Presentation&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of (loss) gain recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DerivativesAndFairValueTextBlock>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTE2MQ_87813d74-76e3-4ea3-a5c9-6690c0841689"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTI1OQ_6bfde1a5-4e6a-44c5-b31c-8a2f49bf7b4d"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeVariableInterestRate
      contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTMyMA_e3953590-7ef8-45d3-b595-c730a0957146"
      unitRef="number">0.0123</us-gaap:DerivativeVariableInterestRate>
    <us-gaap:DerivativeNotionalAmount
      contextRef="i112cd2ca5f0743c3aadcca41b3836c5b_I20220924"
      decimals="-8"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTY2Ng_e4ffad0d-1183-46a8-b15e-58f7c08bad47"
      unitRef="usd">1000000000</us-gaap:DerivativeNotionalAmount>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMTgxNg_21b1c7ee-3a99-45ed-a627-7a498b1842e1"
      unitRef="usd">35100000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <holx:NotationalAmount
      contextRef="ie72a76382d1b4c529a23dfa89ceadc2c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfNTQ5NzU1ODIxNTY2_2a495cc9-77a6-4e20-b272-a28a55111a2c"
      unitRef="usd">369200000</holx:NotationalAmount>
    <us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg3Mg_378e806b-d8dd-4827-9f89-06642402f140">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.341%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.535%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.813%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of realized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(12.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of unrealized gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount of gain (loss) recognized in income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(24.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(19.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ib8c4e34d9d094f1fbf48292741f16b5d_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMy0xLTEtMS05NzQ3Nw_4107415d-55de-4d49-9ba4-45cf88090161"
      unitRef="usd">-2400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ied698bc89eaf4b6f80e13382683a1a03_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMy0zLTEtMS05NzQ3Nw_51be3c6a-0896-4bda-af4b-7608de83d573"
      unitRef="usd">-12400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iec75d669bbf346d6903c94657e8133f1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNC0xLTEtMS05NzQ3Nw_e29010df-194a-475c-b0f3-29a358c9fce5"
      unitRef="usd">-200000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="iadefe818aff343f093532897c969439a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNC0zLTEtMS05NzQ3Nw_972742dd-eb3b-4737-b022-c3405a98e883"
      unitRef="usd">0</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="i55939d7a42bd4556a498a480de79cd50_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNS0xLTEtMS05NzQ3Nw_b7a5ab38-a47c-4451-a76d-1447a88d33a7"
      unitRef="usd">-2600000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:DerivativeGainLossOnDerivativeNet
      contextRef="ifee71b2ee2b34924938fe48b466219ce_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNS0zLTEtMS05NzQ3Nw_a4616a89-de68-4823-be9e-bb68d336c471"
      unitRef="usd">-12400000</us-gaap:DerivativeGainLossOnDerivativeNet>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ib8c4e34d9d094f1fbf48292741f16b5d_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNy0xLTEtMS05NzQ3Nw_65ab0370-d53f-4fda-b2ad-b5e12b29452d"
      unitRef="usd">-13800000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ied698bc89eaf4b6f80e13382683a1a03_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfNy0zLTEtMS05NzQ3Nw_7e521f17-caa7-4c54-af55-529412460fb4"
      unitRef="usd">-6800000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="iec75d669bbf346d6903c94657e8133f1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOC0xLTEtMS05NzQ3Nw_79c8ec60-10a8-49e1-ac39-eeecab83a4cb"
      unitRef="usd">-8300000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="iadefe818aff343f093532897c969439a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOC0zLTEtMS05NzQ3Nw_3cfe22e7-98a6-40bb-b5f5-f9bb01012333"
      unitRef="usd">0</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i55939d7a42bd4556a498a480de79cd50_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOS0xLTEtMS05NzQ3Nw_00d5b2a2-db0b-4443-9411-a800dd22e570"
      unitRef="usd">-22100000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="ifee71b2ee2b34924938fe48b466219ce_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfOS0zLTEtMS05NzQ3Nw_b8df3b0e-12fd-483e-a52f-981c7c52e6ab"
      unitRef="usd">-6800000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMTEtMS0xLTEtOTc0Nzc_159d4fba-67d5-40cb-90cc-c3de421ae99a"
      unitRef="usd">-24700000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOjJiNWYxYmM4ZmUxODRmYjVhZDVkMjYxMmE5OGQ3NTBkL3RhYmxlcmFuZ2U6MmI1ZjFiYzhmZTE4NGZiNWFkNWQyNjEyYTk4ZDc1MGRfMTEtMy0xLTEtOTc0Nzc_50d1fc01-8429-486d-9f02-e60b247cea02"
      unitRef="usd">-19200000</us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet>
    <us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg2NQ_0eb9052d-6d7b-42d6-8a3e-95658db8e0af">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table below presents the fair value of the Company's derivative financial instruments as well as their classification on the balance sheet as of December&#160;31, 2022: &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.215%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.882%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.524%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance Sheet Location&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivative instruments designated as a cash flow hedge:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 32.5pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap contract&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Foreign currency option contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Prepaid expenses and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Derivatives not designated as hedging instruments:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forward foreign currency contracts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i44fe85004cc04b32b3a10a1559c2e2ef_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNS0zLTEtMS05NzQ3Nw_4fbae32a-1537-4531-ae36-488f8c4fcfcf"
      unitRef="usd">35100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ibac4befa17b047999f00b91ca7b94ef7_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNS01LTEtMS05NzQ3Nw_becf4555-4b15-4f69-b1bf-d5904f4a8a1b"
      unitRef="usd">31900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="if13d8d495368452eb77bee9ff19dc345_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNi01LTEtMS05NzQ3Nw_cf8709ce-4756-4964-9ca4-a4e86a055b33"
      unitRef="usd">7000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9926b76c62324c0b958fed2b0e24ea5a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNy0zLTEtMS05NzQ3Nw_547c484f-d6f1-4aef-ae3b-0b466bc49d77"
      unitRef="usd">35100000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib2198af10da940cf86ae64d703bc53c5_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfNy01LTEtMS05NzQ3Nw_e2dccc5d-196b-404b-9078-3136aa888760"
      unitRef="usd">38900000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i56899b92d8d848078cfec5556948bfc9_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTAtMy0xLTEtOTc0Nzc_424f31a2-e40a-4515-b60b-531cffb45062"
      unitRef="usd">3000000.0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="id4c139a224444cffae631f02c7acba9f_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTAtNS0xLTEtOTc0Nzc_f0f00ddd-4993-4979-8a7b-c6c83626a5c6"
      unitRef="usd">15800000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="ib71a2388896942158d0fc786a95eba81_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTEtMy0xLTEtOTc0Nzc_217e98b7-1a93-4f71-b88e-172ba3a81a21"
      unitRef="usd">1000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i5fe6a4b393534f29abeeb1a68c843b13_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTEtNS0xLTEtOTc0Nzc_7e4c1e08-c035-4f36-968f-4534da880b56"
      unitRef="usd">10600000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i9e837bb262414d9dbc7e423824de0ec6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTItMy0xLTEtOTc0Nzc_b12e996d-7c30-4621-a73b-10391b2f540c"
      unitRef="usd">4000000.0</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:DerivativeFairValueOfDerivativeAsset
      contextRef="i270cd6664faf43379c84adce180639da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMTItNS0xLTEtOTc0Nzc_d873d9b8-657b-4373-9392-757a40daa76d"
      unitRef="usd">26400000</us-gaap:DerivativeFairValueOfDerivativeAsset>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i6d535ec00f0f411dafec44429b007238_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMjAtMy0xLTEtOTc0Nzc_379965fd-4a9a-4b67-b2ad-152102308278"
      unitRef="usd">900000</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue
      contextRef="i3ff63602d630435f9e63019c5e7f9b83_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmJhMWU5NDQyMzM2ZjQ4NTFhYjdhMGFjN2YyM2UyZjBjL3RhYmxlcmFuZ2U6YmExZTk0NDIzMzZmNDg1MWFiN2EwYWM3ZjIzZTJmMGNfMjAtNS0xLTEtOTc0Nzc_0cf5f290-9c6d-4072-a75c-48e090e7d650"
      unitRef="usd">0</us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue>
    <us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RleHRyZWdpb246N2UzNDlmMjRjNjQyNDUwM2JiZTVhNzc0MDA5ZThjNGJfMzg1NQ_d6813788-8c41-4bb7-8af1-2897be66fe23">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the unrealized gain (loss) recognized in AOCI related to the interest rate swap for the following reporting periods:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.636%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.666%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.668%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amount of (loss) gain recognized in other comprehensive income, net of taxes:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate swap&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0ca833a47aa541e992640c358c110349_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfMy0xLTEtMS05NzQ3Nw_070c808e-1b88-4f1a-94e3-cdc86c76d618"
      unitRef="usd">-2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="i0e402eb79be640de87443d033aa21455_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfMy0zLTEtMS05NzQ3Nw_bc009732-ab0f-42c4-9908-42fadcabe41e"
      unitRef="usd">7900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfNS0xLTEtMS05NzQ3Nw_2b7eee11-cc1b-45f8-9943-438665fa2b6f"
      unitRef="usd">-2900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82MS9mcmFnOjdlMzQ5ZjI0YzY0MjQ1MDNiYmU1YTc3NDAwOWU4YzRiL3RhYmxlOmExMmU4MGI5YzZkYzQwMjk4OWJjNDk2OWI2MzgyYThmL3RhYmxlcmFuZ2U6YTEyZTgwYjljNmRjNDAyOTg5YmM0OTY5YjYzODJhOGZfNS0zLTEtMS05NzQ3Nw_5e8d2db1-f6bc-4042-9716-14bf3cbe4dae"
      unitRef="usd">7900000</us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfNzkxMQ_d999ca3d-1e86-4eec-9ca7-6bd0e5f8a68c">Commitments and Contingencies&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Litigation and Related Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On November 6, 2015, the Company filed a suit against Minerva Surgical, Inc. (&#x201c;Minerva&#x201d;) in the United States District Court for the District of Delaware, alleging that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 6,872,183 (the '183 patent), U.S. Patent 8,998,898 and U.S. Patent 9,095,348 (the '348 patent). On January 25, 2016, the Company amended the complaint to include claims against Minerva for unfair competition, deceptive trade practices and tortious interference with business relationships. On February 5, 2016, the Company filed a second amended complaint to additionally allege that Minerva&#x2019;s endometrial ablation device infringes U.S. Patent 9,247,989 (the '989 patent). On March 4, 2016, Minerva filed an answer and counterclaims against the Company, seeking declaratory judgment on the Company&#x2019;s claims and asserting claims against the Company for unfair competition, deceptive trade practices, interference with contractual relationships, breach of contract and trade libel. On June 2, 2016, the Court denied the Company&#x2019;s motion for a preliminary injunction on its patent claims and denied Minerva&#x2019;s request for preliminary injunction related to the Company&#x2019;s alleged false and deceptive statements regarding the Minerva product. On June 28, 2018, the Court granted the Company's summary judgment motions on infringement and no invalidity with respect to the &#x2018;183 and &#x2018;348 patents. The Court also granted the Company&#x2019;s motion for summary judgment on assignor estoppel, which bars Minerva&#x2019;s invalidity defenses. The Court also denied all of Minerva&#x2019;s defenses, including its motions for summary judgment on invalidity, non-infringement, no willfulness, and no unfair competition.&lt;/span&gt;&lt;span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;On July 27, 2018, after a two-week trial, a jury returned a verdict that: (1) awarded the Company $4.8 million in damages for Minerva&#x2019;s infringement; (2) found that Minerva&#x2019;s infringement was not willful; and (3) found for the Company regarding Minerva&#x2019;s counterclaims. Damages continued to accrue as Minerva continues its infringing conduct. On May 2, 2019, the Court issued rulings that denied the parties' post-trial motions, including the Company's motion for a permanent injunction seeking to prohibit Minerva from selling infringing devices. Both parties appealed the Court's rulings regarding the post-trial motions. On March 4, 2016, Minerva filed two petitions at the United States Patent and Trademark Office ("USPTO") for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '348 patent. On September 12, 2016, the Patent Trial and Appeal Board of the USPTO (&#x201c;PTAB") declined both petitions to review patentability of the '348 patent. On April 11, 2016, Minerva filed a petition for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;inter partes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the '183 patent. On October 6, 2016, the PTAB granted the petition and instituted a review of the '183 patent. On December 15, 2017, the PTAB issued a final written decision invalidating all claims of the &#x2018;183 patent. On February 9, 2018, the Company appealed this decision to the United States Court of Appeals for the Federal Circuit ("Court of Appeals"). On April 19, 2019, the Court of Appeals affirmed the PTAB's final written decision regarding the '183 patent. On July 16, 2019, the Court of Appeals denied the Company&#x2019;s petition for rehearing in the appeal regarding the '183 patent. On April 22, 2020, the Court of Appeals affirmed the district court&#x2019;s summary judgment ruling in favor of the Company of no invalidity and infringement, and summary judgment that assignor estoppel bars Minerva from challenging the validity of the &#x2018;348 patent. The Court of Appeals also denied the Company&#x2019;s motion for a permanent injunction and ongoing royalties for infringement of the &#x2018;183 patent. The Court of Appeals denied Minerva&#x2019;s arguments for no damages or, alternatively, a new trial. On May 22, 2020 both parties petitioned for en banc review of the Court of Appeals decision. On July 22, 2020, the Court of Appeals denied both parties' petitions for en banc review. On August 28, 2020, the district court entered final judgment against Minerva but stayed execution pending resolution of Minerva&#x2019;s petition for Supreme Court review. On September 30, 2020, Minerva filed a petition requesting Supreme Court review on the issue of assignor estoppel. On November 5, 2020, the Company filed a cross-petition requesting Supreme Court review on the issue of assignor estoppel. On January 8, 2021, the Supreme Court granted Minerva&#x2019;s petition to address the issue of assignor estoppel and denied the Company's petition. Oral argument before the Supreme Court was held on April 21, 2021. On June 29, 2021, the Supreme Court ruled 5-4 to uphold the assignor estoppel but limited its application to situations in which an assignor&#x2019;s claim of invalidity contradicts a prior representation the assignor made in assigning the patent. The Court also vacated the ruling of the Court of Appeals and remanded the case for further proceedings consistent with its opinion. On August 11, 2022, the Court of Appeals affirmed the district court ruling on the issue of assignor estoppel, which barred Minerva from challenging the validity of the patent rights it assigned to the Company and reinstated its earlier judgment against Minerva on infringement. On September 11, 2022, Minerva petitioned for &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;en banc&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt; review of the Court of Appeals decision. The Company filed its response on October 25, 2022, and on November 10, 2022, the Court of Appeals denied Minerva's petition ending the appeals process. During the first quarter of 2023, the Company received a payment for infringement damages in the amount of $7.4&#160;million, which included the original award of  $4.8&#160;million plus post-trial damages and interest. This amount was recorded as a credit to general and administrative expenses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 11, 2017, Minerva filed suit against the Company and Cytyc Surgical Products, LLC (&#x201c;Cytyc&#x201d;) in the United States District Court for the Northern District of California alleging that the Company&#x2019;s and Cytyc&#x2019;s NovaSure ADVANCED endometrial ablation device infringes Minerva&#x2019;s U.S. patent 9,186,208 (the '208 patent). Minerva is seeking a preliminary and permanent injunction against the Company and Cytyc from selling this NovaSure device as well as enhanced damages and interest, including lost profits, price erosion and/or royalty. On January 5, 2018, the Court denied Minerva's motion for a preliminary injunction. On February 2, 2018, at the parties&#x2019; joint request, this action was transferred to the District of Delaware. On March 26, 2019, the Magistrate Judge issued a claims construction ruling regarding the disputed terms in the patent, which the District Court Judge adopted in all respects on October 21, 2019. On July 27, 2021, the Delaware district court granted the Company&#x2019;s motion for summary judgment on invalidity of the '208 patent and entered judgment in favor of the Company. On &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;August 24, 2021, Minerva appealed this and the other rulings to the Court of Appeals. At this time, based on available information regarding this litigation, the Company is unable to reasonably assess the ultimate outcome of this case or determine an estimate, or a range of estimates, of potential losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&#160;&#160;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is a party to various other legal proceedings and claims arising out of the ordinary course of its business. The Company believes that except for those matters described above there are no other proceedings or claims pending against it, the ultimate resolution of which could have a material adverse effect on its financial condition or results of operations. In all cases, at each reporting period, the Company evaluates whether or not a potential loss amount or a potential range of loss is probable and reasonably estimable under ASC 450,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Contingencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(ASC 450). Legal costs are expensed as incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <holx:AmountAssessedInDamages
      contextRef="i0dcc9f20204945ec878054956bb77035_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfMTg4Ng_652180f5-8d84-4dad-a534-b42156c2d533"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:LossContingencyNewClaimsFiledNumber
      contextRef="idaaa4b233a9344908933211ba063dc5f_D20160304-20160304"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfMjQzNA_fa8c4086-f4a7-482b-b94f-32d37d4e71b0"
      unitRef="petition">2</us-gaap:LossContingencyNewClaimsFiledNumber>
    <us-gaap:ProceedsFromLegalSettlements
      contextRef="i667766d52416443f8777bd5eeca5cef5_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfNTQ5NzU1ODI1MDI5_0286e2d5-7054-4baf-8be1-7f096026b79b"
      unitRef="usd">7400000</us-gaap:ProceedsFromLegalSettlements>
    <holx:AmountAssessedInDamages
      contextRef="i0dcc9f20204945ec878054956bb77035_I20180727"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82NC9mcmFnOjljNTY4ZDk1ZTM3NDRkY2VhYTU4NTQ3OWFjNjk5ODU5L3RleHRyZWdpb246OWM1NjhkOTVlMzc0NGRjZWFhNTg1NDc5YWM2OTk4NTlfNTQ5NzU1ODI1MDU2_c473f646-689e-4eae-9247-04b8ab578b0c"
      unitRef="usd">4800000</holx:AmountAssessedInDamages>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RleHRyZWdpb246YzdmZmFmYmZlMDNjNDI3YmI2YjI1NWNjOTJmZTdiMDdfMTEy_ac92a23b-2ffb-4f08-9df6-0fb87115343b">Net Income Per Share&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RleHRyZWdpb246YzdmZmFmYmZlMDNjNDI3YmI2YjI1NWNjOTJmZTdiMDdfMTE0_72aa47bf-892c-4ab0-9b30-364673068323">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of basic and diluted share amounts is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.797%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.584%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.534%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.585%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;247,319&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;253,499&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,962&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,571&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diluted weighted average common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;249,281&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;256,070&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average anti-dilutive shares related to:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding stock options and restricted stock units&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,631&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMi0xLTEtMS05NzQ3Nw_01869c1b-1838-40a1-93a9-973c952da1cf"
      unitRef="shares">247319000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMi0zLTEtMS05NzQ3Nw_2ec5ba01-e3ee-41a2-92f6-cdf4ca45e4cf"
      unitRef="shares">253499000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMy0xLTEtMS05NzQ3Nw_68600656-f112-46ea-a7a4-297a07655683"
      unitRef="shares">1962000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfMy0zLTEtMS05NzQ3Nw_e31223d8-804f-4086-81a8-82729c679b00"
      unitRef="shares">2571000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNS0xLTEtMS05NzQ3Nw_dc3e3392-748e-411e-b507-1339e15118e2"
      unitRef="shares">249281000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNS0zLTEtMS05NzQ3Nw_a9d382bb-4b4d-4f73-8ee3-09728d4f1135"
      unitRef="shares">256070000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i435ccc0a3ea14ff99da3eb507f45b519_D20220925-20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNy0xLTEtMS05NzQ3Nw_30a470fa-8d13-4d4f-9b96-341bfb372da9"
      unitRef="shares">1631000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i8933fd8cce38473bb6574d4ef3ed3dda_D20210926-20211225"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl82Ny9mcmFnOmM3ZmZhZmJmZTAzYzQyN2JiNmIyNTVjYzkyZmU3YjA3L3RhYmxlOmMzMGEwOGQyZTEzNjQ2NGQ4ZGYxYWZkZmFiYjg2OTVkL3RhYmxlcmFuZ2U6YzMwYTA4ZDJlMTM2NDY0ZDhkZjFhZmRmYWJiODY5NWRfNy0zLTEtMS05NzQ3Nw_0a4d10b1-946d-4e0b-9357-643b9c235494"
      unitRef="shares">868000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE5OQ_530e854b-9d90-4b29-8005-0496cf5f0571">Stock-Based Compensation&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted options to purchase 0.5 million and 0.6 million shares of the Company's common stock during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, with weighted-average exercise prices of $74.26 and $71.15, respectively. There were 4.5 million options outstanding at December&#160;31, 2022 with a weighted-average exercise price of $51.67.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company granted 0.6 million and 0.6 million restricted stock units ("RSUs") during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, with weighted-average grant date fair values of $74.30 and $71.15 per unit, respectively. In addition, the Company granted 0.1 million and 0.1 million performance stock units ("PSUs") during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively, to members of its senior management team, which have a weighted-average grant date fair value of $74.35 and $71.16 per unit, respectively. Each recipient of PSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of a three-year performance period, provided that the Company&#x2019;s defined Return on Invested Capital metrics are achieved. The Company also granted 0.1 million and 0.1&#160;million of FCF PSUs based on a three-year cumulative free cash flow measure ("FCF PSUs") to its senior management team, which had a grant date fair value of $74.35 and $71.16 per unit during the three months ended December 31, 2022 and December 25, 2021, respectively. Each recipient of FCF PSUs is eligible to receive between zero and 200% of the target number of shares of the Company's common stock at the end of the three-year measurement period. The PSUs and FCF PSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense ratably over the required service period based on its estimate of the number of shares that will vest upon achieving the measurement criteria. If there is a change in the estimate of the number of shares that are probable of vesting, the Company will cumulatively adjust compensation expense in the period that the change in estimate is made. The Company also granted 0.1 million and 0.1 million market-based awards ("MSUs") to its senior management team during the three months ended December&#160;31, 2022 and December&#160;25, 2021, respectively. Each recipient of MSUs is eligible to receive between zero and 200% of the target number of shares of the Company&#x2019;s common stock at the end of a three-year performance period based upon achieving a certain total shareholder return relative to a defined peer group. The MSUs were valued at $97.91 and $75.43 per share using the Monte Carlo simulation model in fiscal 2023 and 2022, respectively. The MSUs cliff-vest three years from the date of grant, and the Company recognizes compensation expense for the MSUs ratably over the service period. At December&#160;31, 2022, there was 1.7 million in aggregate unvested RSUs, PSUs, FCF PSUs and MSUs outstanding. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At December&#160;31, 2022, there was $23.1 million and $95.3 million of unrecognized compensation expense related to stock options and stock units (comprised of RSUs, PSUs, FCF PSUs and MSUs), respectively, to be recognized over a weighted-average period of 2.4 and 2.2 years, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE4NQ_17cf6fb0-fe15-44bf-9d15-21b7ce99e127">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following presents stock-based compensation expense in the Company&#x2019;s Consolidated Statements of Income:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenues&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling and marketing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;General and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock>
    <us-gaap:ShareBasedCompensation
      contextRef="i046a8b5e3d6b499bacae51fc5c4a8ab5_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMi0xLTEtMS05NzQ3Nw_77a9041d-f3d4-4dab-969a-2da4e4d20c81"
      unitRef="usd">2900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i10182a4e9dbd401592fba602d8fc0dfc_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMi0zLTEtMS05NzQ3Nw_0b33eb57-6272-4bd7-aa36-a67effe45ca5"
      unitRef="usd">2300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ia43275c19d1d4deb9bd1023171cfc883_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMy0xLTEtMS05NzQ3Nw_9ae27b61-717b-4424-8327-17e9dd84b694"
      unitRef="usd">3400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i47792d9e50e24ce180eb23c262315201_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfMy0zLTEtMS05NzQ3Nw_b015be61-1b7b-482c-b897-e2849edf2b23"
      unitRef="usd">2700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ibfd8fe55e66344279f13b5494e40abef_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNC0xLTEtMS05NzQ3Nw_cad31447-b4ac-4ee7-8933-6d42a24b747d"
      unitRef="usd">3300000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i26800c2f43ab47478ff80253b55d85cc_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNC0zLTEtMS05NzQ3Nw_7be74396-3317-4310-a427-e68a35484aae"
      unitRef="usd">2600000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="if448d6a552274a47bac66865fb2016c6_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNS0xLTEtMS05NzQ3Nw_2fcf8544-6643-4036-937a-16d72eea0524"
      unitRef="usd">10900000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i5214cfde47fd4e71851f007985469117_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNS0zLTEtMS05NzQ3Nw_9fe159a7-9606-49c4-ab7f-9274ddf38f6a"
      unitRef="usd">11100000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNy0xLTEtMS05NzQ3Nw_ae694529-9198-4eb5-8745-4f69e95d7349"
      unitRef="usd">20500000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOmUzZTFkOTVhOWQ4MzQ0MGY5NjZiZjc3NWE5ZDk2ZTQ0L3RhYmxlcmFuZ2U6ZTNlMWQ5NWE5ZDgzNDQwZjk2NmJmNzc1YTlkOTZlNDRfNy0zLTEtMS05NzQ3Nw_ca8815ab-f15e-4849-943a-d3013df3ad07"
      unitRef="usd">18700000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTg4_deaa6563-9e25-4cd2-84b4-5a9a4faa1244"
      unitRef="shares">500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i04a4cd810a09430fa9d6e1eb34765cf6_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTk1_bcf4245b-4f14-4a60-8ef4-e3b680dbc9b5"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE1_a6ad263b-b0cc-4ff6-a3e8-1d3489b21189"
      unitRef="usdPerShare">74.26</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i04a4cd810a09430fa9d6e1eb34765cf6_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzIy_b81c8fa2-417e-4c7f-aac5-40fbe559b482"
      unitRef="usdPerShare">71.15</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzUx_5386d14e-0fe8-4d7c-b73d-faab0bc0c017"
      unitRef="shares">4500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNDIy_d80b2214-659e-4a86-8369-db98a7f1a341"
      unitRef="usdPerShare">51.67</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE5Nw_036dd188-f9ee-4a55-b0d6-665336d6043c">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses a binomial model to determine the fair value of its stock options. The weighted-average assumptions utilized to value these stock options are indicated in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.099%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:63.100%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.800%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.300%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;34.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average fair value of options granted&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.81&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.03&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMi0xLTEtMS05NzQ3Nw_e48d50a0-7f2b-4ae7-8389-e9a6baef278a"
      unitRef="number">0.043</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMi0zLTEtMS05NzQ3Nw_46d023e9-aa99-4199-8a6a-25b8c663318d"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMy0xLTEtMS05NzQ3Nw_7149cd2f-bf0c-4bd4-9c93-d593769349c7"
      unitRef="number">0.339</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfMy0zLTEtMS05NzQ3Nw_bbdfcb8d-9157-487d-be31-18566d2e3efa"
      unitRef="number">0.342</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNC0xLTEtMS05NzQ3Nw_9db3b5af-12a7-4ec9-bc8b-022f6f61b711">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNC0zLTEtMS05NzQ3Nw_67ef15fb-1c3e-4d79-b1dd-a6867fd51d97">P4Y9M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNS0xLTEtMS05NzQ3Nw_e50afd70-8839-43ef-8980-dd98da7543f2"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNS0zLTEtMS05NzQ3Nw_8864dc82-ee14-4472-8357-6b548dd2f991"
      unitRef="usd">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNi0xLTEtMS05NzQ3Nw_f6d36ae4-834a-4608-90fc-db82a4f76fe3"
      unitRef="usdPerShare">25.81</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RhYmxlOjg0YWEzNGIyYTViNDQyOGY4ZDMwNDNiM2VmZGFjZGQyL3RhYmxlcmFuZ2U6ODRhYTM0YjJhNWI0NDI4ZjhkMzA0M2IzZWZkYWNkZDJfNi0zLTEtMS05NzQ3Nw_1dcdc1b6-a2d1-4d24-a8e7-77b246512cee"
      unitRef="usdPerShare">21.03</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="idb6f997f16b34e71947022ff6714b032_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNjQ0_e8c1ee37-c598-4e9d-aabf-4200c8ef6bcf"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i85e3227c7fe14f10bc6686036ba0ac71_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNjUx_4f3147c0-1437-45b6-82c8-8bbae277f3c0"
      unitRef="shares">600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idb6f997f16b34e71947022ff6714b032_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNzg2_99301e57-f47c-44da-aa03-98c565b17f72"
      unitRef="usdPerShare">74.30</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i85e3227c7fe14f10bc6686036ba0ac71_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfNzkz_bb62995e-8193-4ebd-aa49-6c79ccc73896"
      unitRef="usdPerShare">71.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i503690e214944a309e402e9960e2e6e6_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfODUz_142f714b-3284-4bd4-9e3c-e2bb511291a0"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="idab51929268f46bc932b7830d8baf571_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfODYw_1e13b1d1-7271-4c08-b750-196d78527c8e"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i503690e214944a309e402e9960e2e6e6_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTA0NQ_2422dde1-40dd-460f-80b1-6eae4445922e"
      unitRef="usdPerShare">74.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="idab51929268f46bc932b7830d8baf571_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTA1Mg_bb8c6690-4af9-404e-86c2-e2913e5dff16"
      unitRef="usdPerShare">71.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTEzMw_2aa91e3a-9945-4604-b745-c4f139464659"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTE0MA_7459e811-bdeb-4487-92f0-4c9cb668152b"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTMyNg_c211e2bf-a723-4a64-ad4c-edf2a039c262"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="iddf3093b029a43d79dbb42728abb753e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTMzMw_bf2f7b67-69b1-4a0d-87f5-7379e142276c"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTQ4MQ_3401a8ab-306a-40d5-be0d-855771dfe716"
      unitRef="usdPerShare">74.35</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="iddf3093b029a43d79dbb42728abb753e_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTQ4OA_5d7f6e73-9d0e-43fa-a131-a2b5acc740f8"
      unitRef="usdPerShare">71.16</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTYzNA_9f333566-dc45-442d-a987-39b621a45fc9"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTY0MQ_eec84346-a20a-49ca-9673-f2d1c6bd024c"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i0363b05c2e9a4008adb75f8e16cb825d_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMTc4Nw_d7a01cfe-66a8-4d40-9784-52e6d2942de3">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjIzMA_19d5a48f-59da-480f-bd21-321ed01114b1"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i9771af51c0794b19a9578e0b8ec0d00a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjIzNw_97ba693d-fede-4e45-b47d-d28e7e6a0236"
      unitRef="shares">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjQwNw_2aa91e3a-9945-4604-b745-c4f139464659"
      unitRef="number">0</holx:MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent>
    <holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjQxNA_7459e811-bdeb-4487-92f0-4c9cb668152b"
      unitRef="number">2</holx:MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjYwOQ_76f778c6-70b2-414c-afc0-8b7d781fc589"
      unitRef="usdPerShare">97.91</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9771af51c0794b19a9578e0b8ec0d00a_D20210926-20211225"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjYxNg_f397a42e-71b0-4a09-9f97-d82ccb459d2f"
      unitRef="usdPerShare">75.43</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod
      contextRef="i2a106e0ede8c4698b23312c503e453da_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjcyNw_6beac003-4721-4e48-aee6-1e03fa46f267">P3Y</holx:SharedBasedCompensationArrangementRestrictedStockVestingPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="ib205930814294a04ac8c44fa4d6e33e2_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjg2NQ_de3de514-a843-4771-b5d9-0724bb8c3399"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i43f6168bd52d48f3ac7b8903f2798ac8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjk1Mg_9d332ddb-ebc0-4668-a1ca-c4dde35ad4fe"
      unitRef="usd">23100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i8512fea0d6de4301aa283764d9659897_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMjk1OQ_5481d419-829a-4982-9c82-bac1e3f06244"
      unitRef="usd">95300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE1MQ_4edbe580-61de-4ec3-a364-60e1586552e6">P2Y4M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="idb6f997f16b34e71947022ff6714b032_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83MC9mcmFnOmMwNTI3NWZhNjcxNTQ3N2E5ZjQyMGFmZjY2NTIxYjg4L3RleHRyZWdpb246YzA1Mjc1ZmE2NzE1NDc3YTlmNDIwYWZmNjY1MjFiODhfMzE1OA_5f0d008c-0774-46cc-a689-88cfdf693499">P2Y2M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <holx:DetailsOfCertainBalanceSheetAccountsTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTc5NQ_a681bf25-911c-4cb3-b24e-3ae57c2cf245">Other Balance Sheet Information&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(705.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In September 2020 and October 2020, the Company was awarded grants of $7.6&#160;million and $119.3&#160;million, respectively, from the Department of Defense Joint Acquisition Task Force ("DOD") to expand production capacity for the Company's two SARS-CoV-2 assays. These grants were specifically to fund capital equipment and labor investments to increase manufacturing capacity to enable the Company to provide a certain amount of COVID-19 tests per month for the U.S. market. The Company is accounting for the funds received under these grants as a reimbursement of the purchased capital equipment. The Company procures and pays for the capital equipment and necessary resources to build out its facility and construct the manufacturing lines to meet the requirements specified in the grant agreement. Subsequent to the Company paying for the capital equipment, the DOD will reimburse the Company upon it meeting certain requirements. However, the DOD retains title to assets purchased under the agreement, and title is transferred to the Company upon meeting certain milestones of the manufacturing efforts and obtaining approval from the DOD that the respective milestone has been met. As of December 31, 2022, the Company had $20.5&#160;million of capital equipment that was awaiting approval from the DOD pending approval of completion of the defined milestones. In fiscal 2022, the Company received $75.0&#160;million from the DOD for reimbursement of capital equipment, which was recorded as a reduction of the cost basis of the purchased equipment. In addition, a portion of the DOD grant funds expenditures in connection with the project that do not qualify for capitalization and are recorded as a reduction to expenses, which was $7.6&#160;million in fiscal 2022. During the three months ended December 31, 2022 and December 25, 2021, the Company received $0.0&#160;million and $21.3&#160;million, respectively, from the DOD, which was recorded as a reduction of the cost basis of the purchased equipment. Payments under these grants are subject to satisfaction of the conditions of the grants, including applicable governmental appropriations.&lt;/span&gt;&lt;/div&gt;</holx:DetailsOfCertainBalanceSheetAccountsTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTc5Nw_453c7e87-eaff-44c4-88ca-6f254f52b045">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.318%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.321%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.324%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Inventories&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;308.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;252.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;298.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;310.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;677.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;623.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMi0xLTEtMS05NzQ3Nw_7dca046a-ff2f-4e58-9687-8ea267d157e5"
      unitRef="usd">308400000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMi0zLTEtMS05NzQ3Nw_e8716034-5ab3-4eee-8b25-e781e52e67a8"
      unitRef="usd">252900000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMy0xLTEtMS05NzQ3Nw_e2a1d6b2-5044-4ad4-a193-41c5f3ace7de"
      unitRef="usd">70700000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfMy0zLTEtMS05NzQ3Nw_131092bc-d357-4204-9ba6-21da338441a2"
      unitRef="usd">60100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNC0xLTEtMS05NzQ3Nw_52d149aa-e4c9-4db3-b570-a6b4922869fd"
      unitRef="usd">298600000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNC0zLTEtMS05NzQ3Nw_4759cfee-8122-4889-b8a5-2eeae60fbd17"
      unitRef="usd">310700000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNS0xLTEtMS05NzQ3Nw_0f590a7c-1f36-44ad-a49b-5c4ab2d8fa5e"
      unitRef="usd">677700000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjNiNGQ4YTA3NzhkNzQ4MGI5NzNmZjgwYjY0NzFjNjUyL3RhYmxlcmFuZ2U6M2I0ZDhhMDc3OGQ3NDgwYjk3M2ZmODBiNjQ3MWM2NTJfNS0zLTEtMS05NzQ3Nw_c17de386-069f-4af6-8ee0-a59ad610440d"
      unitRef="usd">623700000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTgwNA_6d836b0c-9656-4ea9-80d6-d5899ecee7b7">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.480%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.243%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.244%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Property, plant and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;396.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;394.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Equipment under customer usage agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;506.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;486.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building and improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;196.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;40.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right of use asset&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,222.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,187.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less &#x2013; accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(728.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(705.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMS0xLTEtMS05NzQ3Nw_b75a26df-3fa0-4278-af7f-8f7765097da2"
      unitRef="usd">396300000</holx:ManufacturingEquipmentAndSoftware>
    <holx:ManufacturingEquipmentAndSoftware
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMS0zLTEtMS05NzQ3Nw_2d167c5d-546c-4255-bd47-61fe5a12580d"
      unitRef="usd">394800000</holx:ManufacturingEquipmentAndSoftware>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMi0xLTEtMS05NzQ3Nw_301d099a-5bee-4f76-9089-ea32e15fcc25"
      unitRef="usd">506000000.0</holx:EquipmentUnderCustomerUsageAgreements>
    <holx:EquipmentUnderCustomerUsageAgreements
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMi0zLTEtMS05NzQ3Nw_907871fd-8270-47ae-ab87-ec2d61c74001"
      unitRef="usd">486500000</holx:EquipmentUnderCustomerUsageAgreements>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMy0xLTEtMS05NzQ3Nw_ab34ce87-f318-45c7-abd6-594791fe1191"
      unitRef="usd">206100000</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:BuildingsAndImprovementsGross
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMy0zLTEtMS05NzQ3Nw_9f95f438-53f4-4115-9746-fc1bb75e613f"
      unitRef="usd">196000000.0</us-gaap:BuildingsAndImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNC0xLTEtMS05NzQ3Nw_a7e7b580-5822-4932-bbf4-30f38acc1e2e"
      unitRef="usd">46700000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:LeaseholdImprovementsGross
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNC0zLTEtMS05NzQ3Nw_41bc2b9c-5af3-4f26-9d88-c6008ee203da"
      unitRef="usd">44800000</us-gaap:LeaseholdImprovementsGross>
    <us-gaap:Land
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNS0xLTEtMS05NzQ3Nw_d960ae81-a068-4c0f-baeb-6367ee665f93"
      unitRef="usd">41100000</us-gaap:Land>
    <us-gaap:Land
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNS0zLTEtMS05NzQ3Nw_085e47a8-02a0-4d5e-8a36-5fc2f380e020"
      unitRef="usd">40900000</us-gaap:Land>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNi0xLTEtMS05NzQ3Nw_c14f68f2-6995-46d8-8daa-8992c180de87"
      unitRef="usd">18000000.0</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FurnitureAndFixturesGross
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNi0zLTEtMS05NzQ3Nw_3ceb59fb-a73d-4132-93ce-85b5ef658c99"
      unitRef="usd">16700000</us-gaap:FurnitureAndFixturesGross>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNy0xLTEtMS05NzQ3Nw_cdf3cba8-b6b0-4fcb-b60c-3fc4b76794cc"
      unitRef="usd">8300000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfNy0zLTEtMS05NzQ3Nw_36302914-ca03-4746-bf79-0f6160806eec"
      unitRef="usd">7500000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOC0xLTEtMS05NzQ3Nw_8fa376d3-fcfe-4550-a471-cd385e4b079b"
      unitRef="usd">1222500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOC0zLTEtMS05NzQ3Nw_85262fdf-4f1f-42a6-ad94-1e66f39905d8"
      unitRef="usd">1187200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOS0xLTEtMS05NzQ3Nw_7b7d3278-e64d-49c7-a2a5-af43d543d7b2"
      unitRef="usd">728200000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfOS0zLTEtMS05NzQ3Nw_a025afea-800f-424a-ae61-40ffa7f9e2d3"
      unitRef="usd">705600000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMTAtMS0xLTEtOTc0Nzc_25a2b47a-f0a8-42df-965a-96204a7268c8"
      unitRef="usd">494300000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RhYmxlOjg0NTY4MGVlODRlMzQ4MjhhMmNlZGQyM2I2NzhhMDhjL3RhYmxlcmFuZ2U6ODQ1NjgwZWU4NGUzNDgyOGEyY2VkZDIzYjY3OGEwOGNfMTAtMy0xLTEtOTc0Nzc_ee5458af-7d1f-4fe3-95d7-ea8560e854dd"
      unitRef="usd">481600000</us-gaap:PropertyPlantAndEquipmentNet>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="ib922bf6da6cc4631a901c3990795d953_D20210627-20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTE1_baddbc1d-e15b-40f6-9f00-b15ee7245a19"
      unitRef="usd">7600000</holx:GrantsReceivedFromDepartmentOfDefense>
    <holx:GrantsReceivedFromDepartmentOfDefense
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTIy_ad0e0a4d-5838-4501-b4b1-c3d5cb2ee782"
      unitRef="usd">119300000</holx:GrantsReceivedFromDepartmentOfDefense>
    <us-gaap:GrantsReceivableCurrent
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTI0MA_1020ada9-cc53-4b2d-b86e-935609854c32"
      unitRef="usd">20500000</us-gaap:GrantsReceivableCurrent>
    <holx:DepartmentOfDefenseFundsReceived
      contextRef="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfNTQ5NzU1ODE3MzM5_27adbd6a-abc0-4cc1-a2df-d98e046e09c5"
      unitRef="usd">75000000</holx:DepartmentOfDefenseFundsReceived>
    <holx:DepartmentOfDefenseFundsReceivedNotCapitalized
      contextRef="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfNTQ5NzU1ODE3Mzk3_f6dc219f-fe94-4bb3-8b43-4a4f43353d1f"
      unitRef="usd">7600000</holx:DepartmentOfDefenseFundsReceivedNotCapitalized>
    <holx:DepartmentOfDefenseFundsReceived
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTQyMA_9aaf003d-54de-4698-bcd1-c0d7fb0626da"
      unitRef="usd">0</holx:DepartmentOfDefenseFundsReceived>
    <holx:DepartmentOfDefenseFundsReceived
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83My9mcmFnOjA4Y2UwZWI5YTVkZDQyODFiNGI0MzViNTJlYTZhYjc3L3RleHRyZWdpb246MDhjZTBlYjlhNWRkNDI4MWI0YjQzNWI1MmVhNmFiNzdfMTQyNw_77921e6d-7768-4928-a69e-00150daa49c4"
      unitRef="usd">21300000</holx:DepartmentOfDefenseFundsReceived>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfMTgxMw_863988b3-6181-487a-bfd6-843cf52bb41c">Business Segments and Geographic InformationThe Company has four reportable segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The Company measures and evaluates its reportable segments based on segment revenues and operating income adjusted to exclude the effect of non-cash charges, such as intangible asset amortization expense, goodwill and intangible asset impairment charges, transaction and integration expenses for acquisitions, restructuring, consolidation and divestiture charges, litigation charges, and other one-time or unusual items. &lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Identifiable assets for the reportable segments consist of inventories, intangible assets, goodwill, and property, plant and equipment. The Company fully allocates depreciation expense to its reportable segments. The Company has presented all other identifiable assets as corporate assets. There were no inter-segment revenues during the three months ended December&#160;31, 2022 and December&#160;25, 2021. Segment information is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,881.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,579.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,290.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:5pt;text-align:center;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had no customers that represented greater than 10% of consolidated revenues during the three months ended December&#160;31, 2022 and December&#160;25, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in the following major geographic areas noted in the below chart. Revenue data is based upon customer location. Other than the United States, no single country accounted for more than 10% of consolidated revenues. The Company&#x2019;s sales in Europe are predominantly derived from the United Kingdom, Germany, France, Spain, Italy and the Netherlands . The Company&#x2019;s sales in Asia-Pacific are predominantly derived from China, Australia and Japan. The &#x201c;Rest of World&#x201d; designation includes Canada, Latin America and the Middle East.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfNzI_d8bedf2d-ad52-480a-8613-247d6f11a32e"
      unitRef="segment">4</us-gaap:NumberOfReportableSegments>
    <us-gaap:Revenues
      contextRef="if1c4506326454758a9ff17a52cc3174d_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_23075d20-e6e9-44b5-a812-b1a7c7ea40fb"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if1c4506326454758a9ff17a52cc3174d_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_a51de1d4-6eda-4c46-8cd6-dc2d85c46858"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d7693a500ed4ec4af97863e7ccb013a_D20210926-20211225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_ac75e167-0d23-4404-aa30-7fabafc4695d"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i4d7693a500ed4ec4af97863e7ccb013a_D20210926-20211225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfOTgw_edd44283-8347-48a7-9cb1-0528562e1c85"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfMTgwNw_cb928c4e-b196-448b-adfb-f297312240fc">egment information is as follows:&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.134%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.416%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.533%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.417%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenues:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;559.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;950.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;334.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;359.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;154.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;134.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,074.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,471.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income from operations:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;151.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;531.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;81.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;262.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;641.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Depreciation and amortization:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;59.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;69.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capital expenditures:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.929%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.522%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;September 24,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Identifiable assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Diagnostics&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,950.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,881.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Breast Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,262.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,245.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;GYN Surgical&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,466.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,461.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Skeletal Health&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Corporate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,579.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,454.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,290.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,071.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMy0xLTEtMS05NzQ3Nw_66c08712-5154-403a-b0f0-83005734de5a"
      unitRef="usd">559300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMy0zLTEtMS05NzQ3Nw_a73e3d25-19a2-4b42-87aa-82a7920e74de"
      unitRef="usd">950400000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNC0xLTEtMS05NzQ3Nw_1d3f6048-fe29-456e-a887-ba5c14790d5a"
      unitRef="usd">334200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNC0zLTEtMS05NzQ3Nw_660d32ad-6528-4b3a-b7ed-e2888a994c0d"
      unitRef="usd">359300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNS0xLTEtMS05NzQ3Nw_4473a990-69a0-4c35-a0fa-b1f939cc23b0"
      unitRef="usd">154100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNS0zLTEtMS05NzQ3Nw_f8227678-792c-4e0e-b719-6daee4f2400b"
      unitRef="usd">134300000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNi0xLTEtMS05NzQ3Nw_3305c7ce-6842-404e-9d25-16f6a0c5a837"
      unitRef="usd">26600000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfNi0zLTEtMS05NzQ3Nw_a8a29310-65e5-4df2-a682-db2f09c3cec9"
      unitRef="usd">27100000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfOC0xLTEtMS05NzQ3Nw_bb84b9e4-9d98-4961-94e8-284cd42ae2db"
      unitRef="usd">1074200000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfOC0zLTEtMS05NzQ3Nw_6cb3e026-3050-43e9-9836-202d9998c2f7"
      unitRef="usd">1471100000</us-gaap:Revenues>
    <us-gaap:OperatingIncomeLoss
      contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTAtMS0xLTEtOTc0Nzc_3b3ca1ff-c6b9-498c-a85e-14ea7ac4edf9"
      unitRef="usd">151100000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTAtMy0xLTEtOTc0Nzc_8fafac86-9bee-4ecd-9b3c-2ac5de92fef7"
      unitRef="usd">531800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTEtMS0xLTEtOTc0Nzc_97a99f81-7bb0-428d-a346-07cf2948077e"
      unitRef="usd">60500000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTEtMy0xLTEtOTc0Nzc_50ee6b13-3eab-4234-8fee-7a663d8855f2"
      unitRef="usd">81700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTItMS0xLTEtOTc0Nzc_3cdd67c8-d9b5-4ee0-bdad-a9a9b1a62f1a"
      unitRef="usd">48800000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTItMy0xLTEtOTc0Nzc_598c285c-fe64-4a78-b9c0-c1c265ffb49f"
      unitRef="usd">26600000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTMtMS0xLTEtOTc0Nzc_562fad43-0289-4048-a56f-79b24b70c787"
      unitRef="usd">2000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTMtMy0xLTEtOTc0Nzc_a2ae872d-de66-4ead-b41a-c64dfbbce544"
      unitRef="usd">1200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTUtMS0xLTEtOTc0Nzc_0a467110-fbd2-4ec0-ab9e-2b51bc7685c2"
      unitRef="usd">262400000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTUtMy0xLTEtOTc0Nzc_23e54e5e-aeee-4817-950b-5b7f9d268083"
      unitRef="usd">641300000</us-gaap:OperatingIncomeLoss>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTctMS0xLTEtOTc0Nzc_cb138800-2345-43ff-b025-2ddbd044a79f"
      unitRef="usd">59900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTctMy0xLTEtOTc0Nzc_32c17cbb-8fbd-4247-95f6-9dd738d561f1"
      unitRef="usd">69400000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTgtMS0xLTEtOTc0Nzc_c6979f10-95a8-4095-9450-4e29da70a0b0"
      unitRef="usd">13600000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTgtMy0xLTEtOTc0Nzc_1102afc6-c520-4056-b045-3727e3130f24"
      unitRef="usd">15500000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTktMS0xLTEtOTc0Nzc_310f3bf8-a35f-46e0-b4b5-8437112b78c4"
      unitRef="usd">12300000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMTktMy0xLTEtOTc0Nzc_e8992984-88a7-4bd4-a521-ceae6eb7e27f"
      unitRef="usd">22900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjAtMS0xLTEtOTc0Nzc_840cd126-76f6-4e00-8338-9528e37e827b"
      unitRef="usd">100000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjAtMy0xLTEtOTc0Nzc_7ec0c305-3c9b-48bc-b614-43014b86f37a"
      unitRef="usd">200000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjItMS0xLTEtOTc0Nzc_d4a9aac1-ff13-4f62-ac6f-c70c56361f07"
      unitRef="usd">85900000</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:DepreciationAmortizationAndAccretionNet
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjItMy0xLTEtOTc0Nzc_fe26ec07-8bf9-4c43-b313-54636c488917"
      unitRef="usd">108000000.0</us-gaap:DepreciationAmortizationAndAccretionNet>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i804cd53aba7f4d47957d68d769115cd1_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjQtMS0xLTEtOTc0Nzc_5443c99f-546f-40d9-ab58-8ba3e0df2dbf"
      unitRef="usd">15900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ia05653e355504b53be8959ec4476671a_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjQtMy0xLTEtOTc0Nzc_b5ad67b5-5697-4dfa-bf21-7725c4837c81"
      unitRef="usd">31000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i472f6e99c870413c85fd442d0b43925f_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjUtMS0xLTEtOTc0Nzc_77b9aef1-b8b1-403f-94ce-1cc7cf4954ad"
      unitRef="usd">7200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="if226a104cd72445a97cbeb0ce9d422c8_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjUtMy0xLTEtOTc0Nzc_6018db35-18ef-42bd-aa1b-af6eba4d47ab"
      unitRef="usd">4200000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ied652bf38a0f4ee7aaa24253d28f582b_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjYtMS0xLTEtOTc0Nzc_07d0026e-41e7-40fe-9c43-b74d8b349e99"
      unitRef="usd">3900000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ieccc5106509a4574969c55e07bb0b6be_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjYtMy0xLTEtOTc0Nzc_eddb94ad-6b2a-4d21-b278-29ac9b8d4f96"
      unitRef="usd">2100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ib015bd8926a441f69d50128b8d601218_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjctMS0xLTEtOTc0Nzc_e856a896-8507-41d7-82c5-111453dde87a"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i75bb887740f84a759adc8c5a80d8642e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjctMy0xLTEtOTc0Nzc_8c570446-e0cc-4a13-9d3f-599153764e17"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i5e16a16ccca84227b6bdd8b921503333_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjktMS0xLTEtOTc0Nzc_915df54d-682c-439b-a266-5bf112fa8a81"
      unitRef="usd">2000000.0</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="i2d14d558aa9940c5b745ed86dca4facb_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMjktMy0xLTEtOTc0Nzc_e02b2653-db99-4086-a103-d3ce4f20f882"
      unitRef="usd">100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMzAtMS0xLTEtOTc0Nzc_560f34ab-ef99-4394-920b-81804c2b1b53"
      unitRef="usd">29100000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:PaymentsToAcquireProductiveAssets
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjA0MWY2ZWNhZDI2YjQxMzFhODc5MDNlODQ0ZDk2MWY1L3RhYmxlcmFuZ2U6MDQxZjZlY2FkMjZiNDEzMWE4NzkwM2U4NDRkOTYxZjVfMzAtMy0xLTEtOTc0Nzc_bfae66ae-bf6d-42cb-bdd2-4819e4a8fe65"
      unitRef="usd">37500000</us-gaap:PaymentsToAcquireProductiveAssets>
    <us-gaap:Assets
      contextRef="i8044d1c646c14ad7a8ca13af6376e2c0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMi0xLTEtMS05NzQ3Nw_96abef08-9fcc-4de6-9528-8f8a7cabbbec"
      unitRef="usd">2950700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="iab62225f35a54fdf891fb942549d470a_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMi0zLTEtMS05NzQ3Nw_a7d7a735-c0a2-4c03-acc2-8debe781ad69"
      unitRef="usd">2881700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i47bb3619ac514e9396f3997cc99a8206_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMy0xLTEtMS05NzQ3Nw_b037f7bf-df99-4a54-b717-7bf188f228ac"
      unitRef="usd">1262000000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i88ad24968acd4cb992c6185f64aafc61_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfMy0zLTEtMS05NzQ3Nw_1a7dc551-7ac1-4916-803e-ff7384f020ef"
      unitRef="usd">1245800000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="id048a530970b4115ad934dd57bfb2bd1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNC0xLTEtMS05NzQ3Nw_b300fe7d-3375-44d8-80ba-e6ffbadaf88f"
      unitRef="usd">1466100000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i922f9de14bf045b4aaeafaf2502b6528_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNC0zLTEtMS05NzQ3Nw_d7ee9711-b72d-438b-93ea-2dc7d29f9361"
      unitRef="usd">1461500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i9d3b3986fbd9494f904cb1a010337a73_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNi0xLTEtMS05NzQ3Nw_66875151-d3f1-46a7-be2d-84f704292869"
      unitRef="usd">31600000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7e1bd6b8680642e296a44c25673ce7a7_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNi0zLTEtMS05NzQ3Nw_10b726b6-9fae-4a42-9424-8323df4d9745"
      unitRef="usd">27500000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i1ab2eb9bf2244498bacafb726d13a41a_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNy0xLTEtMS05NzQ3Nw_363446da-68cb-4b82-b395-e4c238df043a"
      unitRef="usd">3579900000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i7d747f63ad01496a9ffd93aa08a24d54_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfNy0zLTEtMS05NzQ3Nw_e2db7b03-29db-465e-8964-f5e4447a95a4"
      unitRef="usd">3454700000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfOC0xLTEtMS05NzQ3Nw_57fda0bd-82c8-4d0c-99e5-b89843c890ac"
      unitRef="usd">9290300000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjU0NmRlZWQ1YzM5NzRhYjM5Njk0OWE0MjUyZGUwMmEyL3RhYmxlcmFuZ2U6NTQ2ZGVlZDVjMzk3NGFiMzk2OTQ5YTQyNTJkZTAyYTJfOC0zLTEtMS05NzQ3Nw_fac04f3d-b1c0-4b00-81eb-785fdc21a309"
      unitRef="usd">9071200000</us-gaap:Assets>
    <us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RleHRyZWdpb246ZWU2MjAzMmJhMTQ5NDdmOGFiNGY1NWFiNmQyMDQ2NDZfMTgyMA_b3a18df1-6a2d-4aac-9569-7b1729e5d02c">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenues by geography as a percentage of total revenues were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.206%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.537%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 25,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rest of World&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock>
    <holx:PercentageOfRevenues
      contextRef="i5d8ec3721f1b4363b09265be2667928c_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMi0xLTEtMS05NzQ3Nw_dff2dcb1-df23-4686-b936-196c4481da29"
      unitRef="number">0.767</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i24f42b3f15a14c8cb0935b1c1e4c9b76_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMi0zLTEtMS05NzQ3Nw_3042d91b-4eb3-4d99-bb3f-d7dd1a73ae20"
      unitRef="number">0.688</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i023b583e3a5743b689087ebe2014e742_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMy0xLTEtMS05NzQ3Nw_a3aad290-67cb-4bb4-85ac-bed31e3adf1d"
      unitRef="number">0.137</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i7927fb2683384ee6ba18bcb24820aa75_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfMy0zLTEtMS05NzQ3Nw_ab828c66-2ac0-4fdc-bd9f-724db47cdb34"
      unitRef="number">0.201</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9158b0a900c0492c87e53bb0bfe60c76_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNC0xLTEtMS05NzQ3Nw_4cf76b9a-a00c-4be7-b957-fed28e67860d"
      unitRef="number">0.059</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i7e03307d675a4c4794cdacb42a15022b_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNC0zLTEtMS05NzQ3Nw_a5b84a65-41f3-41ed-a840-44f97f02606a"
      unitRef="number">0.081</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i9a1210ecf0f441c481be084c5fc7365e_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNS0xLTEtMS05NzQ3Nw_6955b3a5-94c3-427b-a81e-daa1f4181cc4"
      unitRef="number">0.037</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="i56bcae300f9d40398f2e76fd994f2a30_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNS0zLTEtMS05NzQ3Nw_0a406a5e-fa69-4baa-9729-9f5800f21da4"
      unitRef="number">0.030</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNi0xLTEtMS05NzQ3Nw_97f9c489-fd31-486b-82ec-abdf0785c2e4"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <holx:PercentageOfRevenues
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83Ni9mcmFnOmVlNjIwMzJiYTE0OTQ3ZjhhYjRmNTVhYjZkMjA0NjQ2L3RhYmxlOjJjZGQ4OWIwZDVmYjRhNjFiMmY5MzEyZTUzYzdlYTYwL3RhYmxlcmFuZ2U6MmNkZDg5YjBkNWZiNGE2MWIyZjkzMTJlNTNjN2VhNjBfNi0zLTEtMS05NzQ3Nw_9adb140e-3498-45ab-9438-e34c7feb34cc"
      unitRef="number">1.000</holx:PercentageOfRevenues>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83OS9mcmFnOmQzZmUxNjIzNDc1NjRlYmE5ZDRhNjIxMzA2ZmZjMmZmL3RleHRyZWdpb246ZDNmZTE2MjM0NzU2NGViYTlkNGE2MjEzMDZmZmMyZmZfMzIyNQ_6aca18ca-5086-4b37-b272-7faaf4bf35ab">Income Taxes&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with ASC 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, each interim period is considered integral to the annual period, and tax expense is measured using an estimated annual effective tax rate. An entity is required to record income tax expense each quarter based on its annual effective tax rate estimated for the full fiscal year and use that rate to provide for income taxes on a current year-to-date basis, adjusted for discrete taxable events that occur during the interim period.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s effective tax rate for the three months ended December 31, 2022 and December 25, 2021 was 21.6% and 19.7%, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The effective tax rate for the three months ended December 31, 2022 was higher than the U.S. statutory tax rate primarily due to income tax reserves, the global intangible low-taxed income inclusion, and state income taxes, partially offset by the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by our international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:24.75pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The effective tax rate for the three months ended December 25, 2021 was lower than the U.S. statutory tax rate primarily due to the impact of the U.S. deduction for foreign derived intangible income, the geographic mix of income earned by the Company's international subsidiaries, which are taxed at rates lower than the U.S. statutory tax rate, and federal and state tax credits, partially offset by state income taxes, and unbenefited foreign losses.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Non-Income Tax Matters&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;The Company is subject to tax examinations for value-added, sales-based, payroll, and other non-income tax items. A number of these examinations are ongoing in various jurisdictions. The Company takes certain non-income tax positions in the jurisdictions in which it operates. In the normal course of business, the Company's positions and conclusions related to its non-income tax positions could be challenged, resulting in assessments by governmental authorities. Pursuant to ASC 450, the Company has recorded loss contingencies with respect to some of these positions. Such amounts were not material for the three months ended December 31, 2022 and December 25, 2021. While the Company believes its estimated losses recorded are reasonable, certain audits are still ongoing and additional charges could be recorded in the future.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83OS9mcmFnOmQzZmUxNjIzNDc1NjRlYmE5ZDRhNjIxMzA2ZmZjMmZmL3RleHRyZWdpb246ZDNmZTE2MjM0NzU2NGViYTlkNGE2MjEzMDZmZmMyZmZfNTg3_57f69fb8-7747-4276-b0c4-94b90cd5d9a5"
      unitRef="number">0.216</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl83OS9mcmFnOmQzZmUxNjIzNDc1NjRlYmE5ZDRhNjIxMzA2ZmZjMmZmL3RleHRyZWdpb246ZDNmZTE2MjM0NzU2NGViYTlkNGE2MjEzMDZmZmMyZmZfNjI0_ced0d3cc-3677-4269-96ee-ec9a85bcbef1"
      unitRef="number">0.197</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RleHRyZWdpb246ZjFjNzk3YzNkM2QzNDYxNzlmN2MxYWMyMDRmM2IwOWJfMjQ0_eb6bafe8-58d4-4b0d-b41d-1f665183f7aa">Intangible Assets&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,602.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,520.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,565.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,458.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,513.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,269.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,465.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,237.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;31, 2022 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RleHRyZWdpb246ZjFjNzk3YzNkM2QzNDYxNzlmN2MxYWMyMDRmM2IwOWJfMjQ2_81181745-86ab-43c6-b804-0f1f7cf77403">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Description&lt;/span&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;As of September 24, 2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:29pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross&lt;br/&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated&lt;br/&gt;Amortization&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Acquired intangible assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed&#160;technology&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,602.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,520.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,565.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,458.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;36.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;33.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;607.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;601.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;535.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;267.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;265.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;203.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total acquired intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,513.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,269.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,465.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,197.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Internal-use software&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software embedded in products&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,567.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,311.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,518.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,237.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia9bb3f8b8a35456aa7b21ae62f2ed3ca_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy0xLTEtMS05NzQ3Nw_e1a675e1-5d08-4362-b2a8-3605f5413da3"
      unitRef="usd">4602500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia9bb3f8b8a35456aa7b21ae62f2ed3ca_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy0zLTEtMS05NzQ3Nw_ad28c0e9-045d-4d71-9b8e-1d41c2ebb4b6"
      unitRef="usd">3520600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie794110f347e4793b515e8bde9c5a5e6_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy01LTEtMS05NzQ3Nw_9accd188-19f1-410e-b65f-7a2783964719"
      unitRef="usd">4565600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie794110f347e4793b515e8bde9c5a5e6_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMy03LTEtMS05NzQ3Nw_d928b1ee-6ca8-4cb3-8577-eb19e3c989f2"
      unitRef="usd">3458200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3aa2073a325f423cbcb061411d2f553b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC0xLTEtMS05NzQ3Nw_3806da71-cdeb-40f8-9c70-7d6b4785ef8d"
      unitRef="usd">36200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3aa2073a325f423cbcb061411d2f553b_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC0zLTEtMS05NzQ3Nw_dac59110-0b29-4997-babf-1e80ca811314"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="icbe0934c8334473cad9c3b424110753c_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC01LTEtMS05NzQ3Nw_6f9dcd53-9f61-4cb1-8254-767243e6101c"
      unitRef="usd">33000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="icbe0934c8334473cad9c3b424110753c_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNC03LTEtMS05NzQ3Nw_01f43e35-e7af-4b95-978b-8b776d301d1e"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ie1169e0270b74fe6be508c370950a863_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS0xLTEtMS05NzQ3Nw_1e6fb5ec-a6e1-4a9c-89a9-d96cb3e17497"
      unitRef="usd">607200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ie1169e0270b74fe6be508c370950a863_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS0zLTEtMS05NzQ3Nw_fa613c72-3df6-4a22-b481-9b40f863e560"
      unitRef="usd">542600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i18960c3349fe4eb0a59368d1094a8ddd_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS01LTEtMS05NzQ3Nw_bd96e95b-3615-4cea-bd0f-5b3b128184f7"
      unitRef="usd">601900000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i18960c3349fe4eb0a59368d1094a8ddd_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNS03LTEtMS05NzQ3Nw_9b53d753-212a-448c-9ed9-6799eb5a642d"
      unitRef="usd">535600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i67fea90f60574367b621cebdab180dd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi0xLTEtMS05NzQ3Nw_2ee3cae0-beab-4299-a194-8c0a201c996c"
      unitRef="usd">267400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i67fea90f60574367b621cebdab180dd0_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi0zLTEtMS05NzQ3Nw_92213234-ab05-47dc-be03-78bfe476f3ac"
      unitRef="usd">206600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i7207b97bd8c2409ea04c174faf5b7855_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi01LTEtMS05NzQ3Nw_46e4f63d-1b51-4760-b687-7e81d9784615"
      unitRef="usd">265200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i7207b97bd8c2409ea04c174faf5b7855_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfNi03LTEtMS05NzQ3Nw_b14a9003-97a5-4a87-910c-50779a5a4b85"
      unitRef="usd">203300000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i365291db08214202af3bee07bb3e066c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtMS0xLTEtOTc0Nzc_e75ff995-0e8e-46d0-a854-51a715eb502f"
      unitRef="usd">5513300000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i365291db08214202af3bee07bb3e066c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtMy0xLTEtOTc0Nzc_93567ee3-6a39-45ff-9f7c-a2ec87518d8a"
      unitRef="usd">4269800000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i57e724ba87534f28bfba9adaf851c705_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtNS0xLTEtOTc0Nzc_f05c69d0-3fc1-4ab9-8d71-918be1ab3936"
      unitRef="usd">5465700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i57e724ba87534f28bfba9adaf851c705_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTAtNy0xLTEtOTc0Nzc_744dc4d9-2548-40f4-b0af-b37de0eb2b36"
      unitRef="usd">4197100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i36ab5815693d4b4c96b98c8708a6fcb8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItMS0xLTEtOTc0Nzc_d4068141-ac7b-4846-a0b7-c4f68279d9ab"
      unitRef="usd">26700000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i36ab5815693d4b4c96b98c8708a6fcb8_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItMy0xLTEtOTc0Nzc_3aab5284-c597-4063-90d8-20718d30aa8f"
      unitRef="usd">20700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2251dfc34b1f4dee9b06523ab53696b9_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItNS0xLTEtOTc0Nzc_98717d7a-ec40-45c0-89ba-22191002344c"
      unitRef="usd">26000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2251dfc34b1f4dee9b06523ab53696b9_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTItNy0xLTEtOTc0Nzc_1639fc67-fc84-4e89-90be-f2fffb07615d"
      unitRef="usd">19900000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i25c1b55962c14bd28656aef42077ee23_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtMS0xLTEtOTc0Nzc_304b09c3-5e8d-4dae-98cf-a3d713f989be"
      unitRef="usd">27000000.0</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i25c1b55962c14bd28656aef42077ee23_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtMy0xLTEtOTc0Nzc_6681ff67-abd8-4bdb-92d5-7e2556157a93"
      unitRef="usd">21100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i3dd84f06f8354c2c99790984e0e949ec_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtNS0xLTEtOTc0Nzc_cb37fe11-7c5e-4f0f-a77b-571ca975af51"
      unitRef="usd">26500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i3dd84f06f8354c2c99790984e0e949ec_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTMtNy0xLTEtOTc0Nzc_1b87849b-e0dc-4b39-b9af-b2f3ed606806"
      unitRef="usd">20600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtMS0xLTEtOTc0Nzc_ccc52e83-4591-4bbd-b139-a4264dcbe77e"
      unitRef="usd">5567000000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtMy0xLTEtOTc0Nzc_4a090919-f3b4-4821-a1b4-f2dc467b508f"
      unitRef="usd">4311600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtNS0xLTEtOTc0Nzc_3a2f27bb-d68e-420c-aea6-29bab4c3faac"
      unitRef="usd">5518200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOmUyZDdkZTdmMzUzNzQ2ZjE5YWM1ZGMwNDkxNDIwMjgxL3RhYmxlcmFuZ2U6ZTJkN2RlN2YzNTM3NDZmMTlhYzVkYzA0OTE0MjAyODFfMTQtNy0xLTEtOTc0Nzc_74b4d3ad-7868-4bb9-964f-9a10d91ed4ea"
      unitRef="usd">4237600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RleHRyZWdpb246ZjFjNzk3YzNkM2QzNDYxNzlmN2MxYWMyMDRmM2IwOWJfMjYw_4dbce382-d856-41dc-b624-bea174d1ea3d">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimated remaining amortization expense of the Company's acquired intangible assets as of December&#160;31, 2022 for each of the five succeeding fiscal years was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:82.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of Fiscal 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;175.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;224.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2026&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fiscal 2027&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;89.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMC0xLTEtMS05NzQ3Nw_3402a77f-2e31-48ef-bbbb-d50ebb4fec69"
      unitRef="usd">175800000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMS0xLTEtMS05NzQ3Nw_74e1094c-5fd7-4ec0-9bdf-223d863f9ae1"
      unitRef="usd">224200000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMi0xLTEtMS05NzQ3Nw_ee18d2d0-997a-4122-b78c-002f53b096e8"
      unitRef="usd">209300000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfMy0xLTEtMS05NzQ3Nw_8d735142-a52e-4138-8231-afe5eb05e80b"
      unitRef="usd">177100000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84Mi9mcmFnOmYxYzc5N2MzZDNkMzQ2MTc5ZjdjMWFjMjA0ZjNiMDliL3RhYmxlOjQyYzliMTZiMjM4MTRkZWE4ZGY5YTEyOGJmMWY4ZGRmL3RhYmxlcmFuZ2U6NDJjOWIxNmIyMzgxNGRlYThkZjlhMTI4YmYxZjhkZGZfNC0xLTEtMS05NzQ3Nw_41b2b964-2792-4b17-bc0d-e44bbb944b2a"
      unitRef="usd">89900000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:ProductWarrantyDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RleHRyZWdpb246NjQ1MGM4YmY2MjhjNDY4NGIyNzdkYjJhM2ZlY2UwNTJfODk_05e0bc95-9c81-40d5-b4bf-6fc844ddf2db">Product Warranties&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ProductWarrantyDisclosureTextBlock>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RleHRyZWdpb246NjQ1MGM4YmY2MjhjNDY4NGIyNzdkYjJhM2ZlY2UwNTJfODE_0fa20056-6c17-4048-8754-114e3ef5d2cc">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Product warranty activity was as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.829%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.619%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.530%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.624%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;Beginning&#160;of&lt;br/&gt;Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Provisions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Settlements/&lt;br/&gt;Adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance&#160;at&lt;br/&gt;End&#160;of&#160;Period&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Three Months Ended:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i748118924a534325be3931e7f281d5da_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi0xLTEtMS05NzQ3Nw_cc1e4e21-e046-4fbf-a69b-8f9aa2b30f88"
      unitRef="usd">8000000.0</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi0zLTEtMS05NzQ3Nw_80ef45b7-6959-4aac-8c7a-79d11ebef5a6"
      unitRef="usd">2600000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi05LTEtMS05NzQ3Nw_6dcdc3a8-4371-4b4e-9088-819aeb3083d3"
      unitRef="usd">2200000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i381b04db1e184cdfbcb810bfeedfddfd_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMi0xMS0xLTEtOTc0Nzc_d87d8399-45bd-4705-8d7e-618d625991a2"
      unitRef="usd">8400000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i2e2412dad56648b0aa359a7eafc2c6f8_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy0xLTEtMS05NzQ3Nw_41809795-b9ed-45d3-ac49-2b5666af7a09"
      unitRef="usd">8800000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ProductWarrantyAccrualWarrantiesIssued
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy0zLTEtMS05NzQ3Nw_6d475058-a0b2-473b-b84f-2e05098139d0"
      unitRef="usd">2100000</us-gaap:ProductWarrantyAccrualWarrantiesIssued>
    <us-gaap:ProductWarrantyAccrualPayments
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy05LTEtMS05NzQ3Nw_00ea6c0e-33c5-46dc-bebb-4f8dd8232034"
      unitRef="usd">2300000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrual
      contextRef="i89925438e2f24d4eb20e04c9c4ec5ef8_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84NS9mcmFnOjY0NTBjOGJmNjI4YzQ2ODRiMjc3ZGIyYTNmZWNlMDUyL3RhYmxlOjNmNDMxNDkwMjU3MjRkY2JiNzAzZjE2MDY0NTJlZjZmL3RhYmxlcmFuZ2U6M2Y0MzE0OTAyNTcyNGRjYmI3MDNmMTYwNjQ1MmVmNmZfMy0xMS0xLTEtOTc0Nzc_cf5ea3b4-b7c3-452f-bbe3-2a97e0199d25"
      unitRef="usd">8600000</us-gaap:ProductWarrantyAccrual>
    <us-gaap:ComprehensiveIncomeNoteTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RleHRyZWdpb246OGRhM2ZhN2U2NTU5NDU3YThmZmY4MTg5NzZiOTk4NzZfMTc0_f0cd1226-2132-4aa6-8873-e3fdabd8fe66">Accumulated Other Comprehensive Loss&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ComprehensiveIncomeNoteTextBlock>
    <us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RleHRyZWdpb246OGRhM2ZhN2U2NTU5NDU3YThmZmY4MTg5NzZiOTk4NzZfMTc4_c692af2b-95da-40d2-9675-a23a8c9c2ada">&lt;div style="text-align:justify;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following tables summarize the changes in accumulated balances of other comprehensive loss for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.239%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.507%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.508%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(267.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(238.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;110.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(153.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(127.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:49.935%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.586%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.539%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.590%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended December 25, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Foreign Currency Translation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Pension Plans&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Hedged Interest Rate Swaps&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(59.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other comprehensive income (loss) before reclassifications&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(37.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(80.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(89.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock>
    <us-gaap:StockholdersEquity
      contextRef="iba33d49d790247138728e16304550207_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi0xLTEtMS05NzQ3Nw_88f8ac23-9203-488c-96f8-7e12da079760"
      unitRef="usd">-267200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7714e4ad6e2f403ca6e488d1c5b4956c_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi0zLTEtMS05NzQ3Nw_74641618-2263-4976-9cf8-87b91eb874b6"
      unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6bedb97f35ab4eadbc7dfdf485949c64_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi03LTEtMS05NzQ3Nw_9de35f26-adac-4ee4-ad31-e898870e7654"
      unitRef="usd">29300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie45f7058af534e8dba563c02009f5cac_I20220924"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMi05LTEtMS05NzQ3Nw_56e28d8e-e6e9-4147-bc6e-1da4698ce9a5"
      unitRef="usd">-238200000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i6fd0ad2aef5b404eab15f293436efcc7_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy0xLTEtMS05NzQ3Nw_7002edb4-50fb-4d41-9bea-5e6a74904ac6"
      unitRef="usd">113800000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i2ffc46097a444b81abc0a82e463c5c4e_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy0zLTEtMS05NzQ3Nw_6037986b-78f0-47de-8d3c-02bf8b1dabd7"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i3fa140a2e91a4da0849a54c6a2cf483d_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy03LTEtMS05NzQ3Nw_e257c79c-0b65-40ce-9676-1d65d09be37b"
      unitRef="usd">-2900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfMy05LTEtMS05NzQ3Nw_d9ee4628-1cbc-48d9-a424-af7a41f82f60"
      unitRef="usd">110900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="ida477b36723f466a839eca19b439840e_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi0xLTEtMS05NzQ3Nw_5e94057e-1ba0-4d85-9fa1-1460fc8281c3"
      unitRef="usd">-153400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i053a359de4994764bcc53d5d8bd87247_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi0zLTEtMS05NzQ3Nw_3a7eb600-2f98-4eb0-b1d3-39c408aa38cd"
      unitRef="usd">-300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if56004b6ce284c0a88a74e229ff23a11_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi03LTEtMS05NzQ3Nw_70655b51-9e84-48d5-a7fd-78f3f4bd1304"
      unitRef="usd">26400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i14951cf020f246d1996832691a0edc4c_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOmE4OTYyYzU2NjdhYzRkNjlhMzkwZjgxYjRhMjJmZTY2L3RhYmxlcmFuZ2U6YTg5NjJjNTY2N2FjNGQ2OWEzOTBmODFiNGEyMmZlNjZfNi05LTEtMS05NzQ3Nw_7488b929-bb7a-4aa7-b1b9-91b80d55e57c"
      unitRef="usd">-127300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i05e36b9f6d534537b938515e96a9b738_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi0xLTEtMS05NzQ3Nw_ad00b81e-a1ec-4395-9608-0fcc5eb8e6a3"
      unitRef="usd">-43100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i420e29ca33f74637b19b79f051f15a88_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi01LTEtMS05NzQ3Nw_a5a7fbbe-a027-4a25-86fc-502c9b5beb4e"
      unitRef="usd">-1300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5e589736d905406c8090a6aa9422698b_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi05LTEtMS05NzQ3Nw_19cb9c9e-07da-48a8-b9ab-1a2b3802e097"
      unitRef="usd">-14700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie4a69d1c0d994885bd6c5a0c8cc6aeb7_I20210925"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMi0xMS0xLTEtOTc0Nzc_a37bec89-2cec-4cfc-9d9e-1bf03224853c"
      unitRef="usd">-59100000</us-gaap:StockholdersEquity>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="ifa137501c2f640d8a89b78da55d9a00e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy0xLTEtMS05NzQ3Nw_7c26361f-c9e5-41b1-b9e9-3c50aad640ba"
      unitRef="usd">-37800000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i79417d9e4a134491875ae60fa840bf0d_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy01LTEtMS05NzQ3Nw_a24eefd9-67d9-4eca-922c-5c5bc29a12a0"
      unitRef="usd">0</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="i38bcb736614e47149fc6af7f459d9a0e_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy05LTEtMS05NzQ3Nw_3cf94793-77a2-4cfd-a133-f35faebc5615"
      unitRef="usd">7900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent
      contextRef="iecb61044316048ea975ec1ffddfd5492_D20210926-20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfMy0xMS0xLTEtOTc0Nzc_361bec1f-c40e-4bce-afa6-2d962e17bd30"
      unitRef="usd">-29900000</us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent>
    <us-gaap:StockholdersEquity
      contextRef="i10878f2ace9949af8c060f1bca337922_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS0xLTEtMS05NzQ3Nw_4f30d422-ec30-4d09-94d3-bc801462a8ed"
      unitRef="usd">-80900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i407e328e7a8e4cb7bd6a3598b8ad7ca3_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS01LTEtMS05NzQ3Nw_a1412a23-df12-413a-8dcd-ab509612eab6"
      unitRef="usd">-1300000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6db04a89d01143309b15081f34133a3a_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS05LTEtMS05NzQ3Nw_22f4e4fb-cf9d-4217-896c-f521f6c8e9ea"
      unitRef="usd">-6800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5d4f66d97be24ea29c9e72a2c1b943b1_I20211225"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl84OC9mcmFnOjhkYTNmYTdlNjU1OTQ1N2E4ZmZmODE4OTc2Yjk5ODc2L3RhYmxlOjlhM2Y2NDhkNjA1MzQxOWQ4N2EwMzljZWVjNzMxZTZiL3RhYmxlcmFuZ2U6OWEzZjY0OGQ2MDUzNDE5ZDg3YTAzOWNlZWM3MzFlNmJfNS0xMS0xLTEtOTc0Nzc_0b14d019-4626-46c6-8232-efe2a8d5b5e1"
      unitRef="usd">-89000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTM0_24628e8f-34cb-41b0-a8d0-91f7e9a2d66a">Share RepurchaseOn September 22, 2022, the Board of Directors authorized a new stock repurchase program, with a five-year term, to repurchase up to $1.0&#160;billion of the Company's outstanding common stock, effective as of the close of trading September 23, 2022. This new repurchase program replaced the previous $1.0&#160;billion authorization. During the three months ended December 31, 2022, the Company repurchased 1.5&#160;million shares of its common stock for total consideration of $100.0&#160;million. As of December 31, 2022, $900.0&#160;million remained available under this authorization.</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="i92f1d854058b4a7badb00114d82a50c1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTQ5NzU1ODE3MzI0_bdd28ea9-8972-46ad-8364-c10471acd525"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchaseProgramAuthorizedAmount1
      contextRef="ib36279872040402a85b53f40877fc6bc_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTQ5NzU1ODE3NTU5_53d1f8e7-4781-4172-bb9a-2d76cdb05d01"
      unitRef="usd">1000000000</us-gaap:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:StockRepurchasedDuringPeriodShares
      contextRef="iec5a478ebcd24022ac3b46935f9c1298_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfMzM1_d2fce962-f830-49dd-9b35-8cefbfa0adc9"
      unitRef="shares">1500000</us-gaap:StockRepurchasedDuringPeriodShares>
    <us-gaap:StockRepurchasedDuringPeriodValue
      contextRef="ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfMzky_4a8a4522-410b-423e-ae2c-c111c9f5651d"
      unitRef="usd">100000000</us-gaap:StockRepurchasedDuringPeriodValue>
    <us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
      contextRef="i92f1d854058b4a7badb00114d82a50c1_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjE4YjlmYTdlYTY3ZDQ0ODliMDkyZjdhNThhZDI5MmZmL3NlYzoxOGI5ZmE3ZWE2N2Q0NDg5YjA5MmY3YTU4YWQyOTJmZl85MS9mcmFnOmVjZjA3MTFkZTQxYTQxYzdhZDdjYWQ0ZjZhNDkwODI4L3RleHRyZWdpb246ZWNmMDcxMWRlNDFhNDFjN2FkN2NhZDRmNmE0OTA4MjhfNTQ5NzU1ODE2MDAx_7284c6f0-f8db-4f58-b3f3-12aa674b8894"
      unitRef="usd">900000000</us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>89
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[>/!%44?+ :*+TTKF7&%C<F\)OC7 80.P.]SSM5VH!>H_HR$OP%02P,$%
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M$,>_"N$5Q08XMDA*LI0' VVR;@7:+6C:[34C,;90251%VD[VZ7=ZB!Y,BDZ
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M^*$$T@3@\X40^KECSN+VTRO^"U!+ P04    " ";@$%6!P%P\UD.  !YIP
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M6>^*IOWXMZ>2Y=5ZL7XTG0-^V3D09YJUB:C>5E],9^&F%<5!&=Y!&=X.Z)\
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ME"\]49_V1.GKA*^7&YJN$W0,ZS&%6I]0&H?2!(JFCKVT/GW:^K2K<Z!AUFD
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M!-"K'S!V@[\<X7/,KE3G3L6DQDQZ*^7Z (G$M27V1N'+<RI''PNV%7%>!#]
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M0_7OI>>?KO[OI*U]/%C3->VGZW9=BF6Z'QJN$A3!=%L1@- Z*_>;]N\U>GG
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M C@O+?B_6_ %PW]!BW\ 4$L#!!0    ( )N 05;XJV\1$1   +HM   9
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M&DL:*31;"@:"#]16KQJ($MT+E:%0I.3H\YH\.#.61*M0#N&X_OQ:/GDIUJ9
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M()H=-Z NY)1HH9:[&N@(Q^4*9@+F(O6^\JCOP$ZLJ;6REG$M+&9:<[=JUXR
M(0_=C68<BIN(Z3RB:2U&!\NXV\O0^@(1"2=Z6 'TA]L;RM&=40_/8LZU"R)J
M3@.A@2#ZO#2<X%'1D?VYS4C7,21#7FY(<.E2WP#Q&!A>GN>=A3A03]E65ION
M&!(HA&[T4[]3Y2'&$L63*B-?_W(GF">%(O0R&;8K"=C;*N^,%3RD;%U-=D%.
M<<T!(=W@T.AG3:)=G^5?HAF]NIA&E/X$M,9VWR 4 -7P<[?UJ8Z.R(&*X==P
MV5SM5,5A!P&B2AKX.[DQF 5:%B;+T";ZY%3K&GF#)=7N([%2&-<Q>N2TH6-
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M <ZA%[ROT".\<\:5.@<=(%8(G?4&?:1C"BH$C.$,&J_I(&IS@$*KTKH0=1Y
M6TI82^>.311A&08N(+J^']$':*GJ'G)J <YMJPQ9>F5+%#^*J2+$0Z-S90A>
MV]RT!8*R0-/$JZAMV<'24@&T)-/%Y@@N,[I4?& #T"(Q"XT+*C-(;&CJE(+/
M7HZ$"06:)[(_@=\JJM+3K%A,:+._:2"PFHB>#I3$HE2XG0X2=5_IO!);W"G3
MJDC:*6D%=O9,G5/:T><UX=FKR7/76I'7M)Z(,ZM-ST>, ^QH]D%V&)(I8FKU
M)4NNZ>2/***$/ H#BC<RPH>(!#&VF,!':8-1+461R*3SVM?O7\489>L, K&#
MQGE)$(7D +2CCRU!Y=BA;5'(9\C"-!="!(WR3(\!/[?D"M;9\\XW=W7C+*_]
MB)-R,M3V)00EM;SGKW/JH3Y:)T#33P<E12LCU09J+Y=W)73;@5"&<8]H1W5B
M2H\$#WQ ,FEO0@B1S,Z5H2V@WPTC9?0Z9SJW7RGV* /!<F\036EX"XL73(*#
M;BB LH<?@O2G,[J0-CJZ<\,0<VY\[8H  ]CDQ%RY'.;*Y7^<*]_B]SQ7GN?*
M\USY7\R5='1KI'XIY6[,R-1IW05R6!VNW]?=K?.+>7=W?Z]\23U!G+?D.IW\
M1*/&=_?A[B6Z1NZ@F8O4G/)8T5\(]&Q ^UOGXO&% PQ_2M;_ %!+ P04
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M[-8"=9()7$RHLU1R%BABV=TP:Q>A!VBZOZ8YN.^QG_-$D-Q$46$9W(5ND\[
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MM@#[=EJW/$41Z&Y F1LX9#U#(9>-!K-%+X^E;IQ:ZDI.L^=K\<78[=/2;J>
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MI4!4<QHQD#S)/+G:'=#Y&)T)-@]58TS":,C.*:J(9(6&KVG8#^W=;3"EQ/Q
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M[:<6\A0])!F_%PL/2V%\1X%4;L/MV3[R:AJ.9== X_75(EOT3G5C][>5/I2
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MLI(Z"RC&5FA5,!J-/![4ZO*/K^_?',Q>$V!G#*DQ54W;5D%=LP 4'QVS8WE
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MFW7C?"/1/,C8_GI^>R7&PT%7?'I$-UO'XZFV('8<MN*W3*M5*IAXU\J^[\8
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M@$6(!1#+RS)#Z*:9("5H @7?L"H(.&1/*@J%F'*B$ 3G>_04L1MP"$=LEMB
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MI@D8GRD@-3S0!LU_(2[_!5!+ P04    " ";@$%6Z3#FZ+\(  "0&   &0
M 'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6RU66UOX[@1_BN$+[TF@$^VY;QO
M$L#);G!I]Y @V6U1%/U 2[1%K$2J)!4G]^OO&5*2)<=Y*7 %%BN+FAG.ZS-#
MYFRES0^;">'84Y$K>S[(G"M/1R.;9*+@-M*E4/BRT*;@#J]F.;*E$3SU3$4^
MBL?CPU'!I1I<G/FU.W-QIBN72R7N#+-547#S?"ERO3H?3 ;-PKU<9HX61A=G
M)5^*!^&^EW<&;Z-62BH+H:S4BAFQ.!_,)J>7^T3O"?XAQ<IV?C.R9*[U#WJY
M2<\'8U)(Y")Q)('C\2BN1)Z3(*CQWUKFH-V2&+N_&^G7WG;8,N=67.G\GS)U
MV?G@>,!2L>!5[N[UZE=1VW- \A*=6_\_6P7:0Q GE76ZJ)FA02%5>/*GV@\=
MAN/Q*PQQS1![O<-&7LO/W/&+,Z-7S! UI-$/;ZKGAG)245 >G,%7"3YW\5D8
M^<C),_9LY""0ED=)S7P9F.-7F*?L-ZU<9MD7E8JTSS^"(JTV<:/-9?RFP,\B
MB=AT,F3Q.([?D#=MK9MZ>=-WK6,WRCI3(9V<95RE[%>1+J5:LAFEA7126/99
MVB37MC*"_7LV!SE2YC_;O!(VW=^^*971J2UY(LX'J!,KS*,87/S\T^1P_.D-
MD_9;D_;?DOY>P-YDWJY:1R*\Y 0^.';/G6 /*UZR7]@5MQF[1OEZIPGV+1/L
M2A<E5\],6B:>2FU%RIQFB3 .0,",M#_@9CS(Q0NC"S;7+F,2SI]76!36,@"+
MX52:(2 BT4H7,F%XIM*O1[VM"JX $]8+\7M2H+"IU85@>N'79:._(?U)#>8R
MHZMEAJ=@E0V4/2H+*^V0K3*99-!9H*C;K%E(Q54B>0Z>-G_Z:J4:.BGMO/"T
MXTL@)K.E2*H\R"HK0XX"._"$\>XV+N..7)D**Y<*2J6,PRLL(<\OR/,9>7[(
MDHPK[P/E[5EP:=@CSRMO%JUTA)(I!EY=*OD[!$J"P*0J2!V\(AS"P-<%$B$C
MD 6'5 GY<G<PN[VZ&>R1<TFF>'(P>U,\17ZQ$$G8RT&!A17.4<")<D/3UA(D
M@" :;U#**N5D[BGJ!>E$P;@7C VX42"&RVX48F$3!"(>3TZ&)%8;:$,Z>DYX
MJ]3&(WV="X_(/S[/18AR*N9NZ#=J B=\%I!C((.K+5E!J>A1 *",[ 7-VN*4
MB+ 3($L4<R@23SULC7TR<P99@&N?WR]I)T>>=AJQ6\5FU1(XS^*# 'M!R2W*
M\*41@A*0K9 <]-%4B:O(A%TH:J7U8?*JD@@(F[ K?):.S1I>'U10/Z)2/=5<
MJ"1#/_ZQL:4OVJ\WE[?W31H\W%[?AV]K+SR(TO7,CVM7?=3^;B7QLLPE 0G6
M2G*[I'B3.W5)<O""NH<]'L21 ;.'*W:\?SQD]V(!U54B F[A%1W;)XF@ZN!M
M5DKLE%"NLD*G<O'<9FL=Z 8&X >T]5 U2M?)W#@"9:0I;PG:4,DN\Y7;%D8C
M*Q@'9 BJ\X*80IV"P8<4SYU)-&9SF>>@"AR]R&[)@];[^3-JX@DUUD:'REDK
MT6PCUC70EX.8=/=MJ#=UK92OL-=RB:I^$L73OP2]$R-#Q"CTMI'YGC4!< GV
M0@LII#$Z;-J34R?)SS\=QY.C3];;^PO-8RE:"UA6A!/O:ZQ\>AE*D("0&<8V
M./)-*-N.71MM8 W=FPFQ#<K[ 9*Y=,_-4L>RUE\E?PZCRY;(E0:X+4N>>X6"
M:1_H%*WWJ4< 2GVN$_ 'NS89^B81 E%#P3\+5P%ZK6RP=V=Z$$T0QZ @M[W*
M;X8[WP17W*3TQ.BLV%5EJ(2?V9>GNMRNZD(*\\$+NEL/"AVJ;YO@;@.V+^J=
M%K6$I)$@FIV2WDXOZ +\=*A\GCJYI"QN9IYVG DPY<<3&V"TCSR=R+RN$14(
MVMY#!3!:2PNPM!;:Z7B=&OFK#=D6D+,=LOR0$<J-!JV0J[+=G";@,!2 ,"3-
M]^@APGR3Y]P,*<W0)B1JA3Y]J8P.G>K[W]D=T"(-;[.*YN9<0D+#Z#7#[):^
M6,QH$!3L7Q7E4:A,]C<.$_RJ"'B(GR_<U(D7[.DU<AH(JY(<PT"B+$^"]05/
M15,,2'>8;TA.9<)(V$ZEOGL;CX6]Z8T: 2<4J\&NI\%2*+@Y)T &=L'E4J<^
M[P'&[!E3#+9D.<1O8(9,_3[^C-J,,9O-A1S0S\]72FHKA%.A[DP/3Z*XJ<A:
M_Y!FKZ%#;T]INW-D*O'B8"IUUWH^JR&NVWU"*C43)?5M9<5>O3!D2J _W@MD
M"LDDJRIEFM<EZBF8BN.8[5115ZVF5:\$'0,HJBI_WM:'PW3>P6?RZZ:SAXVW
MZ;P@!,8#?[ 5=+#=XFK2;3WYA<D-WU"?9=.;AT$S3@>!G)K'*1Q/HKMGYBVB
M7XAELW9RZ'F([9)W]C9F_-KCUZ]AWMHK.VPWCO;WZ#GQ/Z[?Q;W=<13O,=^#
MXT]!P&%'P%K1C6#^":I.IM&QW^J0GA]0]3B:]E6-H\E:P%K5=_7[IAWJB23L
M1T?!VA-RPW5[-ES?+; [.E8K%^9>*C3GQZ\YW7ZQ,GRTKW3D-7R_=P*EK%J)
M/*<G."$HR=&(Y0+S5V@(H:[G/.<T%8?[O5=PXY1=UF0/GNRKKH6\S,W.N+]?
M+\VH_R.W.U<M747?.=&>KF\<MIRZX,R2 R-K] B04!]<?>!=&#\H0?S0@<<D
M.GE3YJUGK]F:]#C"1+46<0P1W4N1#?B '5E]>=2Q]/0C>?P_&>1UFAQ$QQ_(
M]H\+IN%Q,HX.(7O?[Q ?1OOL:SV$8@@X_3_9/DL24XF.BCML#$?OM$'P4Z>'
M2C]X^[KI5<R'0(4F6"R%2X[ZP+;EV-&@_7I#>)"F*?RJ^_>?@->UAE[;OIJO
M7[_XWN@A@3]1-+8DLP?>$X*B(WAPC4_KM6T7C:/.+7$AS-+?A5OF.V"X,&Y7
MV^OV6;AE7I.'N_K?N%E2B\[% JSCZ.A@P$RX_PXO3I?^SGFNG=.%_YD)3&"&
M"/!]H;5K7FB#]H\0%W\ 4$L#!!0    ( )N 05:@MP9O7@P  $,D   9
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M9!_W"M^I#;Y>4NX#<)+#5'-#G%BSE@6#<8CY3F(\'"-[^3I0C4H[;T*Y2 =
MQ2F+&TO-*3"FDE18%FLJ%"K  */\)NU%5XC0%S-'\C05$C0\?"JK; M(]K 8
MHJ!3O#SM:%&F[M'/.O"[>W3PX6;>H/X.=6^BW7=3;(/DQ#V':>M-VTWKM/%4
M<:^Q4GU16</VJ]'SL>V4,T6XM:= [ 7C0X-.H$P2=GC=Y*JST\3NP;00.PLZ
M>Q_!U,XQ*!-+.V%QW)N:7/1UWV^.,VN<>_$/'YTF"\$RHW!RGU[*6 ?5&9IS
M2XW_TR=V>[1^C=4IHBD)I! 14P5;J3U,48VZ4 6%;4+(,!<<==JLJ\-" ?O
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MO7<:_ATEIC2\*VPY<&408686!BW%:+& 6*]G%-9$A?J3G!7OF$V?;20V:+?
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M@>:OP>\GQDCHOETZ2# Z:!DF"[X,@_G,F]@RJ%.,>ZV?HKBGI&U0L,H'>*%
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M";>B;"5L(6&.J[,5P7JEO="%8O7".?1147$N_1U<!33T3R>'5!B3;U39F/I
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MZ/1D(%R^;.278-MTP%_:@.M">JQQ/R/'&_"]LC9L7]A ?^-;_ 502P,$%
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M$ZD0)_A&?9.CP#=Z@>]+*WUS ([].E\[M/0O_#[69Z09'Z?Q_IBY1N:PX&0
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MRI7=@/6UE&88V -V;]S9/U!+ P04    " ";@$%6NO(B8MX#  "K"0  &0
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M)C2A'TF:AO&P6?E6Q6 T($^,WE2B-:2(QVB19Q1=%7$23DF>.K>/FI5 )&O
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M"]3]&.XW5K5^]*V5Q>[TRPJ_7$ [!3S?*&4/&^=@^!9:_ -02P,$%     @
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M:_=497G>/N8#R>:F WMB4O5SYG*F6F[@.D#=GS(FUP/]@+*)'_\%4$L#!!0
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M/0%^'N ;[LU AO*.2#+H<;9"7/=6V?2%*=5$*SB:ZE492ZZ>4A4G!R-80KH
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M])XZVL8AB0::+C3FVB"U>5@V]*Z ]0&TOS$&CX9/,+Q4Y5]02P,$%     @
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M 422/L0;V1=O;14%="1F.O[/%=4X3!=RD #"B;4<)"Z82H"II \Y6!KI4D6
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MXTDRUO# 8'L)U)X8[*[*NI= -T5F-FT;70 0LU9DS(4B8P @UH<B8YUOPS&
M"NLNQ[J7P\$;;;-7MD^C K ":UD6N)!E 0 KZ$.6!9WOO 7 JJ"[+#MBI32Z
M[T*&!4#)P%J&!2[P%@#>@CYD6&GDW% =H]I;'-D;,7<\>9)1BD*QU&W&PT"7
M5E*\9%*<J'B3O]@QBY6*U_GA2G#-M^P+^O-E'*O7D^Q=D>I5G^E_4$L#!!0
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MR@MT0V7,N*FZ6HW]]5F#H5L%J?R[2:2N2Y$<@=5$ZI4B]5I+XS.7$FG"<\(
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MS[@L#C#?SX49G.N-(L%V">?X?U!+ P04    " ";@$%6HA-*$\4"  !*!P
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M7'_'UL_(\F6RU.X)ZS8W\"!;:B.K%DP**BZ:-WMJZ[ %()Y^0-0"HEW \ U
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M;MP\+M2%";@V4.LSIKXMZ4!OD%W!AO\ 4$L#!!0    ( )N 05;G<QUNSP(
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MA(!"K P"UK\#S(%2 Z1I_*HPK3JD<6RVG]$_%]JUEC66,.?T.TG4;F9-+)3
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M)&5'\:RXUM=<Z4="T=SI9QP(8Z#G-YRKYXYY*=0/P^@/4$L#!!0    ( )N
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MVU"2GGQ;Y'ZCIZRPEE:3AI5_0@>'3BOH[5T&E'/T;5\\<T=^\^]XJZY\SGL
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M:;#%N>$2;RV@K &^GTMIMA/KH+D')7\ 4$L#!!0    ( )N 058C$;5N:@,
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M;W)K<VAE971S+W-H965T-C<N>&ULK55=3]LP%/TK5H8FD$8^VQ18&@E:H?&
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M1#=Q>C1Q%H#$)'TYM:7:DR;;8;7^O%S?/;%^'UTS*A.!WM((H@;_H-W?<5L
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M!VU]PO-]M:?T/N<\3ZO#'24;6I0&XOY#GO/GD[*!XS[FQ7]02P,$%     @
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M;"]W;W)K<VAE971S+W-H965T-S(N>&ULK93);MLP$(9?A5"!+D!A;8[3NI(
M+RV:0P CZ7(H>J"ED46$BTK2EO/VY2*K3J"D/?1B<9G_T_QCS62=D'>J =#H
MR"A7>=!HW<[#4)4-,*PFH@5N;FHA&=9F*W>A:B7@RHD8#9,HFH4,$QX4F3O;
MR"(3>TT)AXU$:L\8EO=+H*++@S@X'=R07:/M05AD+=[!+>BO[4::73A0*L*
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MH4U'NF5C9B9(&V#N:R'T:6-?,$SAXC=02P,$%     @ FX!!5J?1;7,2!0
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M."%'A%?D%O-Q5J>!09V6+<@[31>M)OJ"ICGD/AE%'P@-*24/BSDY/CKY%R9
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MP) HJMZ#.^^C</6>"M?_GQS^!E!+ P04    " ";@$%6EXJ[',     3 @
M"P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%
MBD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L
M'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<UYVE/=LO3T%O@*\Z3'%":4A+
M,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A(E@6FD7)TZ(=I7\=Q_:0T^FO
M8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0    ( )N 05:.4-TI
MP@4  ,4R   /    >&PO=V]R:V)O;VLN>&ULQ9M;3^,Z$(#_BM4G]H'3-M==
M!$A<! >) Q5%[./*3=S6(HDK.Z&[^^MWDE Z9LOHO Q]HG5"\F5B^QM?>KPV
M]GEFS+/X61:5.QDLZWIU-!RZ;*E*Z?XQ*U7!D;FQI:SAJUT,W<HJF;NE4G59
M#(/1*!F64E>#T^/-M29VB+^86F6U-A44M@5/6JW=]GC[5;QHIV>ZT/6ODT'W
MN5 #4>I*E_JWRD\&HX%P2[/^UUC]VU2U+*:9-45Q,ACW!YZ4K77V5_&TA7R4
M,]>5U'+V( 'D9)",X()S;5W=G=%=7P+CBX*3^V]-;:YT42M[*6MU;4VSTM6B
MO0P\Q1 ]1A>'S=\^B$?V_X31S.<Z4Y<F:TI5U7T<K2I:P,HM]<H-1"5+=3*X
M,"_*BHE<J/:AX"XW>?^ -9"A<-DC#0?L3=XQ<O)4SA0ZA[OG8MI"M/_@A)F+
MFRHS"#(@((.]05Z8<H4@0P(RW"/DCP!!1@1D](F0Y[*05:9$UVP< HP)P'AO
M@.)@(A%D0D F>WO5T]ID"#(E(-/]U4?IE@CR*P'YE1?R7#K=(4VL<G!J=P9"
M^T:@?>-%>U OJFJ\;GI$]=,C7IQ;)9W"C71,6H-9&U=26_$DBT:)_P"LL7WE
MPGB4+\;,PCAOG*Z4<ZT>9KKJ3\!PE"?&S*)XM#)7XD%E2K](N+43LLK%65&8
M==O;84S*%&-F53PH5]LFJQL+N1*&HNPP9M;#N;'6K &H#]J%5;FNQ9FULEI
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M LKNJULC\\VO,#:_(#G] U!+ P04    " ";@$%6>NU.;58"  ".+0  &@
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M.X'>@7H'@=Z!>@>!WH%Z!X'>@7H'@=Z!>@>!WH%Z!X'>,?G9A$#O0+V#0.]
MO8- [T"]@T#OC'IG KTSZIT)],ZH=R;0.Z/>F4#OC'IG KTSZIT)],ZH=R;0
M.T]^%OQ)O8?QZU"&:\_W&I__DU2/YWO+]?&7Y??)"3L7G.O;BN'I+U!+ P04
M    " ";@$%65:BY9Q("  !S+   $P   %M#;VYT96YT7U1Y<&5S72YX;6S-
MVM].VS 4!O!7J7*+&M?_-T2Y 6XW+O8"7G+:1DUBRS:LO/V<%) VL0I4I'TW
MC5K;YSOQD7Y7O?KQ%"@M#D,_IG6URSE<,I::'0TNU3[06%8V/@XNEZ]QRX)K
M]FY+3*Q6AC5^S#3F99YJ5-=7M[1Q#WU>W!W*SZGSX[J*U*=J<7/<.&6M*Q="
MWS4NEW7V.+9_I2R?$^IR<MZ3=EU(%V5#Q=Y,F%;^'?!\[OLCQ=BUM+AW,7]S
M0]G%#CU+^:FG5)\N\4:/?K/I&FI]\S"4(W4*D5R;=D1YZ.MCT8O3R;G<,!T_
M^=GY<YE3@67G??0AE8E%^GC<RTBFT\M0"E',W>E7?$TLI<]^/YJFW5+[SNQR
MO;]\W,_S2&Q^G'_'?\[XM?X'^Q @?4B0/A1('QJD#P/2AP7IXPM('U]!^N K
ME$901.4HI'(44SD*JAQ%58["*D=QE:/ RE%D%2BR"A19!8JL D56@2*K0)%5
MH,@J4&05*+(*%%DEBJP215:)(JM$D56BR"I19)4HLDH4626*K!)%5H4BJT*1
M5:'(JE!D52BR*A19%8JL"D56A2*K0I%5H\BJ4635*+)J%%DUBJP:15:-(JM&
MD56CR*I19#4HLAH460V*K 9%5H,BJT&1U:#(:E!D-2BR&A19+8JL%D56BR*K
M19'5HLAJ462U*++:_RGK3^_WGQP_/^O!=>-+/IO_:WS]&U!+ 0(4 Q0    (
M )N 058'04UB@0   +$    0              "  0    !D;V-0<F]P<R]A
M<' N>&UL4$L! A0#%     @ FX!!5DXRB/KN    *P(  !$
M ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ FX!!5IE<G",0
M!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q0
M2P$"% ,4    " ";@$%63DD0OLT%  "]'@  &               @($-"
M>&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ FX!!5F).7*$G
M!@  Z1D  !@              ("!$ X  'AL+W=O<FMS:&5E=',O<VAE970R
M+GAM;%!+ 0(4 Q0    ( )N 05;#*>;=$0,  )@(   8              "
M@6T4  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " ";@$%6
MH/FPN64"  "]!0  &               @(&T%P  >&PO=V]R:W-H965T<R]S
M:&5E=#0N>&UL4$L! A0#%     @ FX!!5GMTAFMZ!@  1AL  !@
M     ("!3QH  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    (
M )N 05;40V_ YP(  (8)   8              " @?\@  !X;"]W;W)K<VAE
M971S+W-H965T-BYX;6Q02P$"% ,4    " ";@$%6!P%P\UD.  !YIP  &
M            @($<)   >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#
M%     @ FX!!5N%V<M0 "   YR$  !@              ("!JS(  'AL+W=O
M<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( )N 058'8QB#>P4  !$-
M   8              " @>$Z  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q0
M2P$"% ,4    " ";@$%6^*MO$1$0  "Z+0  &0              @(&20
M>&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( )N 05;Z((UB
MS@,  * ,   9              " @=I0  !X;"]W;W)K<VAE971S+W-H965T
M,3$N>&UL4$L! A0#%     @ FX!!5CR(K0FP!@  \1(  !D
M ("!WU0  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4    " ";
M@$%6%#A8D] )  !T&0  &0              @('&6P  >&PO=V]R:W-H965T
M<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( )N 059AC+?V4@4  -8,   9
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M970Q."YX;6Q02P$"% ,4    " ";@$%6$^K/ >0"  "T!@  &0
M    @('EC@  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    (
M )N 05;A >7!]@8  )P4   9              " @0"2  !X;"]W;W)K<VAE
M971S+W-H965T,C N>&UL4$L! A0#%     @ FX!!5H9@8"EQ!@  )0\  !D
M             ("!+9D  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"
M% ,4    " ";@$%6S\V.85T&  "I#P  &0              @('5GP  >&PO
M=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( )N 05;*OY:8< 4
M /T-   9              " @6FF  !X;"]W;W)K<VAE971S+W-H965T,C,N
M>&UL4$L! A0#%     @ FX!!5AUL%%#* P  ;0@  !D              ("!
M$*P  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4    " ";@$%6
MZ,EU6%P"  !S!0  &0              @($1L   >&PO=V]R:W-H965T<R]S
M:&5E=#(U+GAM;%!+ 0(4 Q0    ( )N 05:+YIPZ( ,  +X'   9
M      " @:2R  !X;"]W;W)K<VAE971S+W-H965T,C8N>&UL4$L! A0#%
M  @ FX!!5NH=W2D" P  V@8  !D              ("!^[4  'AL+W=O<FMS
M:&5E=',O<VAE970R-RYX;6Q02P$"% ,4    " ";@$%6S?L6JJH$  #O"@
M&0              @($TN0  >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+
M 0(4 Q0    ( )N 05:Z\B)BW@,  *L)   9              " @16^  !X
M;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ FX!!5M;^8R0Y
M P  PP8  !D              ("!*L(  'AL+W=O<FMS:&5E=',O<VAE970S
M,"YX;6Q02P$"% ,4    " ";@$%6V?S'<V@"  !1!0  &0
M@(&:Q0  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( )N
M058W,@")\0,  "$*   9              " @3G(  !X;"]W;W)K<VAE971S
M+W-H965T,S(N>&UL4$L! A0#%     @ FX!!5KD"'8]F!   ? P  !D
M         ("!8<P  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4
M    " ";@$%6B5:1;_,"  "^!@  &0              @('^T   >&PO=V]R
M:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( )N 05;YW0JJM ,  )X(
M   9              " @2C4  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL
M4$L! A0#%     @ FX!!5ICDYC-E P  L@<  !D              ("!$]@
M 'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " ";@$%6+K*+
M? \$  "6"0  &0              @(&OVP  >&PO=V]R:W-H965T<R]S:&5E
M=#,W+GAM;%!+ 0(4 Q0    ( )N 05:ACC*-] ,  !<)   9
M  " @?7?  !X;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @
MFX!!5@'WI?5E @  < 4  !D              ("!(.0  'AL+W=O<FMS:&5E
M=',O<VAE970S.2YX;6Q02P$"% ,4    " ";@$%6>#]21C #  "O!P  &0
M            @(&\Y@  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4
M Q0    ( )N 05;R W?$4 D  !!3   9              " @2/J  !X;"]W
M;W)K<VAE971S+W-H965T-#$N>&UL4$L! A0#%     @ FX!!5C:GE?1L P
MT \  !D              ("!JO,  'AL+W=O<FMS:&5E=',O<VAE970T,BYX
M;6Q02P$"% ,4    " ";@$%6[\@/>;@#  "A$   &0              @(%-
M]P  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    ( )N 059I
M5"=EHP(  +H&   9              " @3S[  !X;"]W;W)K<VAE971S+W-H
M965T-#0N>&UL4$L! A0#%     @ FX!!5A-4">A# P  F1(  !D
M     ("!%OX  'AL+W=O<FMS:&5E=',O<VAE970T-2YX;6Q02P$"% ,4
M" ";@$%6,#(MD2H"  "U!   &0              @(&0 0$ >&PO=V]R:W-H
M965T<R]S:&5E=#0V+GAM;%!+ 0(4 Q0    ( )N 05;8_X:63@8  /8S   9
M              " @?$# 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L!
M A0#%     @ FX!!5BL:W^,&!   HQ4  !D              ("!=@H! 'AL
M+W=O<FMS:&5E=',O<VAE970T."YX;6Q02P$"% ,4    " ";@$%6@Q4O=.L"
M  !!"   &0              @(&S#@$ >&PO=V]R:W-H965T<R]S:&5E=#0Y
M+GAM;%!+ 0(4 Q0    ( )N 05;7!@<01@4  $ H   9              "
M@=41 0!X;"]W;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ FX!!
M5C2=]M$!!   LA0  !D              ("!4A<! 'AL+W=O<FMS:&5E=',O
M<VAE970U,2YX;6Q02P$"% ,4    " ";@$%6YU#MT.D"  #A!P  &0
M        @(&*&P$ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0
M   ( )N 059O27OY+@,  )X+   9              " @:H> 0!X;"]W;W)K
M<VAE971S+W-H965T-3,N>&UL4$L! A0#%     @ FX!!5L&VHGAY P  2@\
M !D              ("!#R(! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q0
M2P$"% ,4    " ";@$%6MP/,X88&  #..0  &0              @(&_)0$
M>&PO=V]R:W-H965T<R]S:&5E=#4U+GAM;%!+ 0(4 Q0    ( )N 05:B$TH3
MQ0(  $H'   9              " @7PL 0!X;"]W;W)K<VAE971S+W-H965T
M-38N>&UL4$L! A0#%     @ FX!!5@3\UM!3 P  C@T  !D
M ("!>"\! 'AL+W=O<FMS:&5E=',O<VAE970U-RYX;6Q02P$"% ,4    " ";
M@$%6YW,=;L\"   D"@  &0              @($",P$ >&PO=V]R:W-H965T
M<R]S:&5E=#4X+GAM;%!+ 0(4 Q0    ( )N 05:]57>"VP,  ",1   9
M          " @0@V 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#
M%     @ FX!!5N#W+I=]!   VAL  !D              ("!&CH! 'AL+W=O
M<FMS:&5E=',O<VAE970V,"YX;6Q02P$"% ,4    " ";@$%6[&$L<MX"  #O
M"   &0              @('./@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM
M;%!+ 0(4 Q0    ( )N 059)XI[MU@(  !,)   9              " @>-!
M 0!X;"]W;W)K<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ FX!!5B,1
MM6YJ P  FPH  !D              ("!\$0! 'AL+W=O<FMS:&5E=',O<VAE
M970V,RYX;6Q02P$"% ,4    " ";@$%6D=-<=+$#  !P$0  &0
M    @(&12 $ >&PO=V]R:W-H965T<R]S:&5E=#8T+GAM;%!+ 0(4 Q0    (
M )N 05;1_OUJ< 8  *(F   9              " @7E, 0!X;"]W;W)K<VAE
M971S+W-H965T-C4N>&UL4$L! A0#%     @ FX!!5CA)'AT@ P  SP@  !D
M             ("!(%,! 'AL+W=O<FMS:&5E=',O<VAE970V-BYX;6Q02P$"
M% ,4    " ";@$%6W0X]%IP"  #S!@  &0              @(%W5@$ >&PO
M=V]R:W-H965T<R]S:&5E=#8W+GAM;%!+ 0(4 Q0    ( )N 05:PZD'"'P4
M %49   9              " @4I9 0!X;"]W;W)K<VAE971S+W-H965T-C@N
M>&UL4$L! A0#%     @ FX!!5H9S@"8% P  M L  !D              ("!
MH%X! 'AL+W=O<FMS:&5E=',O<VAE970V.2YX;6Q02P$"% ,4    " ";@$%6
MZY:$%)<&  #3+   &0              @('<80$ >&PO=V]R:W-H965T<R]S
M:&5E=#<P+GAM;%!+ 0(4 Q0    ( )N 05:_=3C090,  !,0   9
M      " @:IH 0!X;"]W;W)K<VAE971S+W-H965T-S$N>&UL4$L! A0#%
M  @ FX!!5I!9E35( @  D04  !D              ("!1FP! 'AL+W=O<FMS
M:&5E=',O<VAE970W,BYX;6Q02P$"% ,4    " ";@$%6I]%M<Q(%   Q'0
M&0              @('%;@$ >&PO=V]R:W-H965T<R]S:&5E=#<S+GAM;%!+
M 0(4 Q0    ( )N 059"_968@P(  $@&   9              " @0YT 0!X
M;"]W;W)K<VAE971S+W-H965T-S0N>&UL4$L! A0#%     @ FX!!5O3C\]/J
M @  _@<  !D              ("!R'8! 'AL+W=O<FMS:&5E=',O<VAE970W
M-2YX;6Q02P$"% ,4    " ";@$%6>9P<2XX$  !:%P  &0
M@('I>0$ >&PO=V]R:W-H965T<R]S:&5E=#<V+GAM;%!+ 0(4 Q0    ( )N
M05;#" .T[0(  /D)   9              " @:Y^ 0!X;"]W;W)K<VAE971S
M+W-H965T-S<N>&UL4$L! A0#%     @ FX!!5KWC%"9$ P  K!0   T
M         ( !TH$! 'AL+W-T>6QE<RYX;6Q02P$"% ,4    " ";@$%6EXJ[
M',     3 @  "P              @ %!A0$ 7W)E;',O+G)E;'-02P$"% ,4
M    " ";@$%6CE#=*<(%  #%,@  #P              @ $JA@$ >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ FX!!5GKM3FU6 @  CBT  !H
M     ( !&8P! 'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ FX!!5E6HN6<2 @  <RP  !,              ( !IXX! %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&     %4 50!*%P  ZI !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>303</ContextCount>
  <ElementCount>297</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>88</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>6</UnitCount>
  <MyReports>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - Consolidated Statements of Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofIncome</Role>
      <ShortName>Consolidated Statements of Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - Consolidated Statements of Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical</Role>
      <ShortName>Consolidated Statements of Comprehensive Loss (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Basis of Presentation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BasisofPresentation</Role>
      <ShortName>Basis of Presentation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Business Combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinations</Role>
      <ShortName>Business Combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Trade Receivables and Allowance for Credit Losses</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Restructuring</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Restructuring</Role>
      <ShortName>Restructuring</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Borrowings and Credit Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangements</Role>
      <ShortName>Borrowings and Credit Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Derivatives</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/Derivatives</Role>
      <ShortName>Derivatives</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Net Income (Loss) Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShare</Role>
      <ShortName>Net Income (Loss) Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Other Balance Sheet Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformation</Role>
      <ShortName>Other Balance Sheet Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Business Segments and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</Role>
      <ShortName>Business Segments and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwill</Role>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Product Warranties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarranties</Role>
      <ShortName>Product Warranties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Accumulated Other Comprehensive Loss</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</Role>
      <ShortName>Accumulated Other Comprehensive Loss</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Share Repurchase</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchase</Role>
      <ShortName>Share Repurchase</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Revenue</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/FairValueMeasurements</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Business Combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsTables</Role>
      <ShortName>Business Combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessCombinations</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Borrowings and Credit Arrangements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsTables</Role>
      <ShortName>Borrowings and Credit Arrangements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BorrowingsandCreditArrangements</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Derivatives (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesTables</Role>
      <ShortName>Derivatives (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Derivatives</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Net Income (Loss) Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareTables</Role>
      <ShortName>Net Income (Loss) Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/StockBasedCompensation</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Other Balance Sheet Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationTables</Role>
      <ShortName>Other Balance Sheet Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/OtherBalanceSheetInformation</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Business Segments and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables</Role>
      <ShortName>Business Segments and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/BusinessSegmentsandGeographicInformation</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Intangible Assets and Goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillTables</Role>
      <ShortName>Intangible Assets and Goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IntangibleAssetsandGoodwill</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Product Warranties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesTables</Role>
      <ShortName>Product Warranties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/ProductWarranties</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Accumulated Other Comprehensive Loss (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</Role>
      <ShortName>Accumulated Other Comprehensive Loss (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Revenue - Business Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueBusinessRevenueDetails</Role>
      <ShortName>Revenue - Business Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Revenue - Geographical Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueGeographicalRevenueDetails</Role>
      <ShortName>Revenue - Geographical Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Revenue - Revenue by Type (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRevenuebyTypeDetails</Role>
      <ShortName>Revenue - Revenue by Type (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>0000045 - Disclosure - Revenue - Remaining Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails</Role>
      <ShortName>Revenue - Remaining Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>0000046 - Disclosure - Leases - Additional Lease Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails</Role>
      <ShortName>Leases - Additional Lease Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>0000047 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail</Role>
      <ShortName>Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>0000048 - Disclosure - Fair Value Measurements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail</Role>
      <ShortName>Fair Value Measurements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>0000049 - Disclosure - Fair Value Measurements - Roll Forward (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails</Role>
      <ShortName>Fair Value Measurements - Roll Forward (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>0000050 - Disclosure - Business Combination - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationNarrativeDetails</Role>
      <ShortName>Business Combination - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>0000051 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails</Role>
      <ShortName>Business Combinations Business Combinations - Purchase Price Allocation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>0000052 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails</Role>
      <ShortName>Trade Receivables and Allowance for Credit Losses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>0000053 - Disclosure - Restructuring (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/RestructuringDetails</Role>
      <ShortName>Restructuring (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/Restructuring</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>0000054 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Company's Borrowings (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>0000055 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail</Role>
      <ShortName>Borrowings and Credit Arrangements - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>0000056 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>0000057 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails</Role>
      <ShortName>Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>0000058 - Disclosure - Derivatives - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesAdditionalInformationDetails</Role>
      <ShortName>Derivatives - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>0000059 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails</Role>
      <ShortName>Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>0000060 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails</Role>
      <ShortName>Derivatives - Fair Value of Derivative Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>0000061 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails</Role>
      <ShortName>Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>0000062 - Disclosure - Commitments and Contingencies (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/CommitmentsandContingenciesDetail</Role>
      <ShortName>Commitments and Contingencies (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/CommitmentsandContingencies</ParentRole>
      <Position>62</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>0000063 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail</Role>
      <ShortName>Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/NetIncomeLossPerShareTables</ParentRole>
      <Position>63</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>0000064 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail</Role>
      <ShortName>Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>0000065 - Disclosure - Stock-Based Compensation - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>0000066 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail</Role>
      <ShortName>Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>0000067 - Disclosure - Other Balance Sheet Information - Inventories (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail</Role>
      <ShortName>Other Balance Sheet Information - Inventories (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>0000068 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail</Role>
      <ShortName>Other Balance Sheet Information - Property, Plant and Equipment (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>0000069 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Additional Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>0000070 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail</Role>
      <ShortName>Business Segments and Geographic Information - Segment Information (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>0000071 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail</Role>
      <ShortName>Business Segments and Geographic Information - Revenues by Geography (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>0000072 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/IncomeTaxes</ParentRole>
      <Position>72</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>0000073 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>0000074 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail</Role>
      <ShortName>Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>0000075 - Disclosure - Product Warranties - Product Warranty Activity (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail</Role>
      <ShortName>Product Warranties - Product Warranty Activity (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>0000076 - Disclosure - Accumulated Other Comprehensive Income (Detail)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail</Role>
      <ShortName>Accumulated Other Comprehensive Income (Detail)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="holx-20221231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>0000077 - Disclosure - Share Repurchase Share repurchase (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails</Role>
      <ShortName>Share Repurchase Share repurchase (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 5 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  holx-20221231.htm 4</Log>
    <Log type="Warning">[dqc-0015-Negative-Values] Fact us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs has a value of -200000 which is less than zero. This element should not have a negative value. The preparer should consider if the value is input correctly for this assertion and, after considering the appropriateness of the input, if incorrect, input the amount as a positive (i.e., absolute) value and provide a negated label. The properties of this us-gaap:AllowanceForDoubtfulAccountsReceivableWriteOffs fact are: Context: ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231, Unit: usd, Rule Element Id: 252. holx-20221231.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="holx-20221231.htm">holx-20221231.htm</File>
    <File>holx-20221231.xsd</File>
    <File>holx-20221231_cal.xml</File>
    <File>holx-20221231_def.xml</File>
    <File>holx-20221231_lab.xml</File>
    <File>holx-20221231_pre.xml</File>
    <File>holx_q1-2023ex311.htm</File>
    <File>holx_q1-2023ex312.htm</File>
    <File>holx_q1-2023ex321.htm</File>
    <File>holx_q1-2023ex322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="797">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="29">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>95
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "holx-20221231.htm": {
   "axisCustom": 0,
   "axisStandard": 22,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 797,
    "http://xbrl.sec.gov/dei/2022": 29
   },
   "contextCount": 303,
   "dts": {
    "calculationLink": {
     "local": [
      "holx-20221231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "holx-20221231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "holx-20221231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "holx-20221231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "holx-20221231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "holx-20221231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 509,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 5,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 10
   },
   "keyCustom": 36,
   "keyStandard": 261,
   "memberCustom": 41,
   "memberStandard": 43,
   "nsprefix": "holx",
   "nsuri": "http://www.hologic.com/20221231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover Page",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.hologic.com/role/CoverPage",
     "shortName": "Cover Page",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:Security12bTitle",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Revenue",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.hologic.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.hologic.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Fair Value Measurements",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.hologic.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Business Combinations",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.hologic.com/role/BusinessCombinations",
     "shortName": "Business Combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Trade Receivables and Allowance for Credit Losses",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses",
     "shortName": "Trade Receivables and Allowance for Credit Losses",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Restructuring",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.hologic.com/role/Restructuring",
     "shortName": "Restructuring",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Borrowings and Credit Arrangements",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangements",
     "shortName": "Borrowings and Credit Arrangements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Derivatives",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.hologic.com/role/Derivatives",
     "shortName": "Derivatives",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativesAndFairValueTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Commitments and Contingencies",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.hologic.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Net Income (Loss) Per Share",
     "menuCat": "Notes",
     "order": "19",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShare",
     "shortName": "Net Income (Loss) Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - Consolidated Statements of Income",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
     "shortName": "Consolidated Statements of Income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ProductRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Stock-Based Compensation",
     "menuCat": "Notes",
     "order": "20",
     "role": "http://www.hologic.com/role/StockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Other Balance Sheet Information",
     "menuCat": "Notes",
     "order": "21",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformation",
     "shortName": "Other Balance Sheet Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:DetailsOfCertainBalanceSheetAccountsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Business Segments and Geographic Information",
     "menuCat": "Notes",
     "order": "22",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation",
     "shortName": "Business Segments and Geographic Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "23",
     "role": "http://www.hologic.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Intangible Assets and Goodwill",
     "menuCat": "Notes",
     "order": "24",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwill",
     "shortName": "Intangible Assets and Goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Product Warranties",
     "menuCat": "Notes",
     "order": "25",
     "role": "http://www.hologic.com/role/ProductWarranties",
     "shortName": "Product Warranties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Accumulated Other Comprehensive Loss",
     "menuCat": "Notes",
     "order": "26",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss",
     "shortName": "Accumulated Other Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ComprehensiveIncomeNoteTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Share Repurchase",
     "menuCat": "Notes",
     "order": "27",
     "role": "http://www.hologic.com/role/ShareRepurchase",
     "shortName": "Share Repurchase",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Revenue (Tables)",
     "menuCat": "Tables",
     "order": "28",
     "role": "http://www.hologic.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisaggregationOfRevenueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Fair Value Measurements (Tables)",
     "menuCat": "Tables",
     "order": "29",
     "role": "http://www.hologic.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - Consolidated Statements of Comprehensive Loss",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
     "shortName": "Consolidated Statements of Comprehensive Loss",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Business Combinations (Tables)",
     "menuCat": "Tables",
     "order": "30",
     "role": "http://www.hologic.com/role/BusinessCombinationsTables",
     "shortName": "Business Combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Trade Receivables and Allowance for Credit Losses (Tables)",
     "menuCat": "Tables",
     "order": "31",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Borrowings and Credit Arrangements (Tables)",
     "menuCat": "Tables",
     "order": "32",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables",
     "shortName": "Borrowings and Credit Arrangements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Derivatives (Tables)",
     "menuCat": "Tables",
     "order": "33",
     "role": "http://www.hologic.com/role/DerivativesTables",
     "shortName": "Derivatives (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Net Income (Loss) Per Share (Tables)",
     "menuCat": "Tables",
     "order": "34",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareTables",
     "shortName": "Net Income (Loss) Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Stock-Based Compensation (Tables)",
     "menuCat": "Tables",
     "order": "35",
     "role": "http://www.hologic.com/role/StockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Other Balance Sheet Information (Tables)",
     "menuCat": "Tables",
     "order": "36",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationTables",
     "shortName": "Other Balance Sheet Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Business Segments and Geographic Information (Tables)",
     "menuCat": "Tables",
     "order": "37",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables",
     "shortName": "Business Segments and Geographic Information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Intangible Assets and Goodwill (Tables)",
     "menuCat": "Tables",
     "order": "38",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables",
     "shortName": "Intangible Assets and Goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Product Warranties (Tables)",
     "menuCat": "Tables",
     "order": "39",
     "role": "http://www.hologic.com/role/ProductWarrantiesTables",
     "shortName": "Product Warranties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical",
     "shortName": "Consolidated Statements of Comprehensive Loss (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Accumulated Other Comprehensive Loss (Tables)",
     "menuCat": "Tables",
     "order": "40",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables",
     "shortName": "Accumulated Other Comprehensive Loss (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Revenue - Business Revenue (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
     "shortName": "Revenue - Business Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i17810aabf3f24d38be45e8306c3d0ebd_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Revenue - Geographical Revenue (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
     "shortName": "Revenue - Geographical Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i023b583e3a5743b689087ebe2014e742_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Revenue - Revenue by Type (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.hologic.com/role/RevenueRevenuebyTypeDetails",
     "shortName": "Revenue - Revenue by Type (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i5288beb020944838ab3e1ad08f68dad4_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Revenue - Narrative (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.hologic.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "iab3be1fea9b347e08c0fbc486d6eba52_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000045 - Disclosure - Revenue - Remaining Performance Obligation (Details)",
     "menuCat": "Details",
     "order": "45",
     "role": "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
     "shortName": "Revenue - Remaining Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "iab3be1fea9b347e08c0fbc486d6eba52_I20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligationPercentage",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000046 - Disclosure - Leases - Additional Lease Information (Details)",
     "menuCat": "Details",
     "order": "46",
     "role": "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails",
     "shortName": "Leases - Additional Lease Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "holx:LeaseRevenuePercentageOfTotalRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000047 - Disclosure - Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "menuCat": "Details",
     "order": "47",
     "role": "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail",
     "shortName": "Fair Value Measurements - Fair Value Assets and Liabilities Measured on Recurring Basis (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "iefd5e2be463d4709a964b3675267c84b_D20210926-20211225",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000048 - Disclosure - Fair Value Measurements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "48",
     "role": "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail",
     "shortName": "Fair Value Measurements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "iefd5e2be463d4709a964b3675267c84b_D20210926-20211225",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LossOnSaleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000049 - Disclosure - Fair Value Measurements - Roll Forward (Details)",
     "menuCat": "Details",
     "order": "49",
     "role": "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails",
     "shortName": "Fair Value Measurements - Roll Forward (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - Consolidated Balance Sheets",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheets",
     "shortName": "Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "iea43d0cf9441456ca855066f24c915b7_D20211129-20211129",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000050 - Disclosure - Business Combination - Narrative (Details)",
     "menuCat": "Details",
     "order": "50",
     "role": "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
     "shortName": "Business Combination - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "iea43d0cf9441456ca855066f24c915b7_D20211129-20211129",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationConsiderationTransferred1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000051 - Disclosure - Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "menuCat": "Details",
     "order": "51",
     "role": "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
     "shortName": "Business Combinations Business Combinations - Purchase Price Allocation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i07a25a5a908f4f19b6e6162e1d775e3d_I20211129",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000052 - Disclosure - Trade Receivables and Allowance for Credit Losses (Details)",
     "menuCat": "Details",
     "order": "52",
     "role": "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails",
     "shortName": "Trade Receivables and Allowance for Credit Losses (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000053 - Disclosure - Restructuring (Details)",
     "menuCat": "Details",
     "order": "53",
     "role": "http://www.hologic.com/role/RestructuringDetails",
     "shortName": "Restructuring (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:RestructuringAndRelatedActivitiesDisclosureTextBlock",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i3506cb7a03e440d886dbc72ce84c14b7_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RestructuringCharges",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000054 - Disclosure - Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "menuCat": "Details",
     "order": "54",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
     "shortName": "Borrowings and Credit Arrangements - Company's Borrowings (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000055 - Disclosure - Borrowings and Credit Arrangements - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "55",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
     "shortName": "Borrowings and Credit Arrangements - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i0ca833a47aa541e992640c358c110349_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromDerivativeInstrumentFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000056 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "menuCat": "Details",
     "order": "56",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Credit Agreement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i497eb3d7de9e444aad1e5e87636da8d4_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i8106951e543c45718bc14b8faa6ff745_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "reportCount": 1,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000057 - Disclosure - Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "menuCat": "Details",
     "order": "57",
     "role": "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
     "shortName": "Borrowings and Credit Arrangements - Interest Expense Senior Notes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "id225da1e135b44f7a25d7b8427d9693e_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:InterestExpenseBorrowings",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeNotionalAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000058 - Disclosure - Derivatives - Additional Information (Details)",
     "menuCat": "Details",
     "order": "58",
     "role": "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
     "shortName": "Derivatives - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ie72a76382d1b4c529a23dfa89ceadc2c_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "holx:NotationalAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000059 - Disclosure - Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "menuCat": "Details",
     "order": "59",
     "role": "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
     "shortName": "Derivatives - Schedule Of Change in Fair Value Of Derivative Contracts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i96ba3fb9d79b41ad81b3e13be53cf91a_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000060 - Disclosure - Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "menuCat": "Details",
     "order": "60",
     "role": "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
     "shortName": "Derivatives - Fair Value of Derivative Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i9e837bb262414d9dbc7e423824de0ec6_I20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DerivativeFairValueOfDerivativeAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000061 - Disclosure - Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "menuCat": "Details",
     "order": "61",
     "role": "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
     "shortName": "Derivatives - Gain (Loss) on Fair Value Hedges Recognized in AOCI (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i0dcc9f20204945ec878054956bb77035_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000062 - Disclosure - Commitments and Contingencies (Detail)",
     "menuCat": "Details",
     "order": "62",
     "role": "http://www.hologic.com/role/CommitmentsandContingenciesDetail",
     "shortName": "Commitments and Contingencies (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i0dcc9f20204945ec878054956bb77035_I20180727",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:AmountAssessedInDamages",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000063 - Disclosure - Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "menuCat": "Details",
     "order": "63",
     "role": "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail",
     "shortName": "Net Income (Loss) Per Share - Reconciliation of Basic and Diluted Share Amounts (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000064 - Disclosure - Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "menuCat": "Details",
     "order": "64",
     "role": "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail",
     "shortName": "Stock-Based Compensation - Stock-Based Compensation Expense in Consolidated Statements of Operations (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "holx:ScheduleOfShareBasedCompensationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i046a8b5e3d6b499bacae51fc5c4a8ab5_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000065 - Disclosure - Stock-Based Compensation - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "65",
     "role": "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
     "shortName": "Stock-Based Compensation - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i46d591fe60574510bc40cbab471b0b5f_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000066 - Disclosure - Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "menuCat": "Details",
     "order": "66",
     "role": "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail",
     "shortName": "Stock-Based Compensation - Weighted-Average Assumptions Utilized to Value Stock Options (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000067 - Disclosure - Other Balance Sheet Information - Inventories (Detail)",
     "menuCat": "Details",
     "order": "67",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail",
     "shortName": "Other Balance Sheet Information - Inventories (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000068 - Disclosure - Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "menuCat": "Details",
     "order": "68",
     "role": "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail",
     "shortName": "Other Balance Sheet Information - Property, Plant and Equipment (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "holx:ManufacturingEquipmentAndSoftware",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000069 - Disclosure - Business Segments and Geographic Information - Additional Information (Detail)",
     "menuCat": "Details",
     "order": "69",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
     "shortName": "Business Segments and Geographic Information - Additional Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i915f4bf376ce4531ab8345e5adf8a97a_D20210926-20220924",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i2e2412dad56648b0aa359a7eafc2c6f8_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000007 - Statement - Consolidated Statements of Stockholders' Equity",
     "menuCat": "Statements",
     "order": "7",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i2e2412dad56648b0aa359a7eafc2c6f8_I20210925",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000070 - Disclosure - Business Segments and Geographic Information - Segment Information (Detail)",
     "menuCat": "Details",
     "order": "70",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
     "shortName": "Business Segments and Geographic Information - Segment Information (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:DepreciationAmortizationAndAccretionNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000071 - Disclosure - Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "menuCat": "Details",
     "order": "71",
     "role": "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
     "shortName": "Business Segments and Geographic Information - Revenues by Geography (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "holx:PercentageOfRevenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000072 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "72",
     "role": "http://www.hologic.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000073 - Disclosure - Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "menuCat": "Details",
     "order": "73",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Intangible Assets (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000074 - Disclosure - Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "menuCat": "Details",
     "order": "74",
     "role": "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail",
     "shortName": "Intangible Assets and Goodwill - Schedule of Estimated Amortization Expense (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i381b04db1e184cdfbcb810bfeedfddfd_I20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000075 - Disclosure - Product Warranties - Product Warranty Activity (Detail)",
     "menuCat": "Details",
     "order": "75",
     "role": "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail",
     "shortName": "Product Warranties - Product Warranty Activity (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProductWarrantyAccrual",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "i748118924a534325be3931e7f281d5da_I20220924",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000076 - Disclosure - Accumulated Other Comprehensive Income (Detail)",
     "menuCat": "Details",
     "order": "76",
     "role": "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
     "shortName": "Accumulated Other Comprehensive Income (Detail)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:OciBeforeReclassificationsBeforeTaxAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000077 - Disclosure - Share Repurchase Share repurchase (Details)",
     "menuCat": "Details",
     "order": "77",
     "role": "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails",
     "shortName": "Share Repurchase Share repurchase (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockRepurchasedDuringPeriodValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000008 - Statement - Consolidated Statements of Cash Flows",
     "menuCat": "Statements",
     "order": "8",
     "role": "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
     "shortName": "Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Basis of Presentation",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.hologic.com/role/BasisofPresentation",
     "shortName": "Basis of Presentation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "holx-20221231.htm",
      "contextRef": "ideac705093d6445f9b22f9d354f5c00c_D20220925-20221231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 88,
   "tag": {
    "country_US": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "UNITED STATES",
        "terseLabel": "United States"
       }
      }
     },
     "localname": "US",
     "nsuri": "http://xbrl.sec.gov/country/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r689"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r690"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r691"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r687"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r686"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r688"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.hologic.com/role/CoverPage"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "holx_A2021CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Credit Agreement",
        "label": "2021 Credit Agreement [Member]",
        "terseLabel": "2021 Credit Agreement"
       }
      }
     },
     "localname": "A2021CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2021RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Revolver",
        "label": "2021 Revolver [Member]",
        "terseLabel": "2021 Revolver"
       }
      }
     },
     "localname": "A2021RevolverMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2021TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2021 Term Loan",
        "label": "2021 Term Loan [Member]",
        "terseLabel": "2021 Term Loan"
       }
      }
     },
     "localname": "A2021TermLoanMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028And2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 and 2029 Senior Notes",
        "label": "2028 and 2029 Senior Notes [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "A2028And2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2028SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2028 Senior Notes [Member]",
        "label": "2028 Senior Notes [Member]",
        "terseLabel": "2028 Senior Notes"
       }
      }
     },
     "localname": "A2028SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_A2029SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "2029 Senior Notes",
        "label": "2029 Senior Notes [Member]",
        "terseLabel": "2029 Senior Notes"
       }
      }
     },
     "localname": "A2029SeniorNotesMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AccumulatedOtherComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated Other Comprehensive Income [Abstract]",
        "label": "Accumulated Other Comprehensive Income [Abstract]",
        "terseLabel": "Accumulated Other Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeAbstract",
     "nsuri": "http://www.hologic.com/20221231",
     "xbrltype": "stringItemType"
    },
    "holx_AcessaHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acessa Health",
        "label": "Acessa Health [Member]",
        "terseLabel": "Acessa Health"
       }
      }
     },
     "localname": "AcessaHealthMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AcquiredintangibleassetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Acquired intangible assets [Member]",
        "label": "Acquired intangible assets [Member]",
        "terseLabel": "Total acquired intangible assets"
       }
      }
     },
     "localname": "AcquiredintangibleassetsMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AllOtherCountriesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All other countries.",
        "label": "All Other Countries [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "AllOtherCountriesMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_AmortizationCostofGoodsSold": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortization, Cost of Goods Sold",
        "label": "Amortization, Cost of Goods Sold",
        "terseLabel": "Amortization, Cost of Goods Sold"
       }
      }
     },
     "localname": "AmortizationCostofGoodsSold",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AmountAssessedInDamages": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount assessed in damages.",
        "label": "Amount Assessed In Damages",
        "terseLabel": "Assessed damages"
       }
      }
     },
     "localname": "AmountAssessedInDamages",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_AnnualIncrementalRevenueGrowthPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Annual Incremental Revenue Growth Period",
        "label": "Annual Incremental Revenue Growth Period",
        "terseLabel": "Annual incremental revenue growth period"
       }
      }
     },
     "localname": "AnnualIncrementalRevenueGrowthPeriod",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_AssetSecuritizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset Securitization",
        "label": "Asset Securitization [Member]",
        "terseLabel": "Asset Securitization"
       }
      }
     },
     "localname": "AssetSecuritizationMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BasisofPresentationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Basis of Presentation [Abstract]",
        "label": "Basis of Presentation [Abstract]",
        "terseLabel": "Basis of Presentation [Abstract]"
       }
      }
     },
     "localname": "BasisofPresentationAbstract",
     "nsuri": "http://www.hologic.com/20221231",
     "xbrltype": "stringItemType"
    },
    "holx_BloodScreeningMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Blood Screening [Member]",
        "label": "Blood Screening [Member]",
        "terseLabel": "Blood Screening"
       }
      }
     },
     "localname": "BloodScreeningMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BolderSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bolder Surgical",
        "label": "Bolder Surgical [Member]",
        "terseLabel": "Bolder Surgical"
       }
      }
     },
     "localname": "BolderSurgicalMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast health.",
        "label": "Breast Health [Member]",
        "terseLabel": "Breast Health"
       }
      }
     },
     "localname": "BreastHealthMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BreastImagingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Breast Imaging [Member]",
        "label": "Breast Imaging [Member]",
        "terseLabel": "Breast Imaging"
       }
      }
     },
     "localname": "BreastImagingMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_BusinessCombinationContingentConsiderationPayments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Contingent Consideration, Payments",
        "label": "Business Combination, Contingent Consideration, Payments",
        "terseLabel": "Contingent consideration payment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationPayments",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Customer Relationships",
        "terseLabel": "Customer relationship"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedCustomerRelationships",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Developed Technology",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedDevelopedTechnology",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Fair Value",
        "terseLabel": "Intangible assets, fair value (percentage)"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedIntangibleAssetsFairValue",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Trade Names",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedTradeNames",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CapitalEquipmentComponentsandSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capital Equipment, Components and Software [Member]",
        "label": "Capital Equipment, Components and Software [Member]",
        "terseLabel": "Capital equipment, components and software"
       }
      }
     },
     "localname": "CapitalEquipmentComponentsandSoftwareMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CapitalizedsoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Capitalized software [Member]",
        "label": "Capitalized software [Member]",
        "terseLabel": "Capitalized software embedded in products"
       }
      }
     },
     "localname": "CapitalizedsoftwareMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ConsumablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consumables [Member]",
        "label": "Consumables [Member]",
        "terseLabel": "Disposables"
       }
      }
     },
     "localname": "ConsumablesMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ContingentConsiderationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contingent Consideration",
        "label": "Contingent Consideration [Member]",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Costofservice": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cost of service",
        "label": "Cost of service",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "Costofservice",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_CreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Credit agreement.",
        "label": "Credit Agreement [Member]",
        "terseLabel": "Credit Agreement"
       }
      }
     },
     "localname": "CreditAgreementMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CustomerRelationshipsContractsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationships contracts.",
        "label": "Customer Relationships Contracts [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsContractsMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_CytologyPerinatalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cytology &amp; Perinatal [Member]",
        "label": "Cytology &amp; Perinatal [Member]",
        "terseLabel": "Cytology &amp; Perinatal"
       }
      }
     },
     "localname": "CytologyPerinatalMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DanburyClosureMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Danbury closure",
        "label": "Danbury closure [Member]",
        "terseLabel": "Danbury closure"
       }
      }
     },
     "localname": "DanburyClosureMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_December112020Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "December 11, 2020",
        "label": "December 11, 2020 [Member]",
        "terseLabel": "December 11, 2020"
       }
      }
     },
     "localname": "December112020Member",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DepartmentOfDefenseFundsReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Department of defense funds received",
        "label": "Department of defense funds received",
        "terseLabel": "Department of defense funds received"
       }
      }
     },
     "localname": "DepartmentOfDefenseFundsReceived",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DepartmentOfDefenseFundsReceivedNotCapitalized": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Department of Defense funds received, not capitalized",
        "label": "Department of Defense funds received, not capitalized",
        "terseLabel": "Department of Defense funds received, not capitalized"
       }
      }
     },
     "localname": "DepartmentOfDefenseFundsReceivedNotCapitalized",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_DetailsOfCertainBalanceSheetAccountsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Details of certain balance sheet accounts.",
        "label": "Details Of Certain Balance Sheet Accounts [Text Block]",
        "terseLabel": "Other Balance Sheet Information"
       }
      }
     },
     "localname": "DetailsOfCertainBalanceSheetAccountsTextBlock",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_DevelopedTechnologyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Developed technology.",
        "label": "Developed Technology [Member]",
        "terseLabel": "Developed Technology",
        "verboseLabel": "Developed\u00a0technology"
       }
      }
     },
     "localname": "DevelopedTechnologyMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_DiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Diagnostics.",
        "label": "Diagnostics [Member]",
        "terseLabel": "Diagnostics"
       }
      }
     },
     "localname": "DiagnosticsMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_EarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Line Items]",
        "label": "Earnings Per Share [Line Items]",
        "terseLabel": "Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "EarningsPerShareLineItems",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EarningsPerShareTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Earnings Per Share [Table]",
        "label": "Earnings Per Share [Table]",
        "terseLabel": "Earnings Per Share [Table]"
       }
      }
     },
     "localname": "EarningsPerShareTable",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_EquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount at the balance sheet date of long-lived, depreciable asset that are equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Equipment Under Customer Usage Agreements",
        "terseLabel": "Equipment under customer usage agreements"
       }
      }
     },
     "localname": "EquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GrantsReceivedFromDepartmentOfDefense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Grants received from Department of defense",
        "label": "Grants received from Department of defense",
        "terseLabel": "Grants received from Department of defense"
       }
      }
     },
     "localname": "GrantsReceivedFromDepartmentOfDefense",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_GynSurgicalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "GYN surgical.",
        "label": "Gyn Surgical [Member]",
        "terseLabel": "GYN Surgical"
       }
      }
     },
     "localname": "GynSurgicalMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternalusesoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internal-use software [Member]",
        "label": "Internal-use software [Member]",
        "terseLabel": "Internal-use software"
       }
      }
     },
     "localname": "InternalusesoftwareMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InternationalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "International [Member]",
        "label": "International [Member]",
        "terseLabel": "International"
       }
      }
     },
     "localname": "InternationalMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_InterventionalBreastSolutionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interventional Breast Solutions [Member]",
        "label": "Interventional Breast Solutions [Member]",
        "terseLabel": "Interventional Breast Solutions"
       }
      }
     },
     "localname": "InterventionalBreastSolutionsMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_LeaseRevenuePercentageOfTotalRevenue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lease Revenue, Percentage Of Total Revenue",
        "label": "Lease Revenue, Percentage Of Total Revenue",
        "terseLabel": "Lease revenue as a percentage of total (percentage)"
       }
      }
     },
     "localname": "LeaseRevenuePercentageOfTotalRevenue",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/LeasesAdditionalLeaseInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "holx_LongTermDebtObligationsWithoutConvertibleNotes": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long term debt obligations without convertible notes.",
        "label": "Long Term Debt Obligations Without Convertible Notes",
        "terseLabel": "Long term debt obligations. excluding convertible notes"
       }
      }
     },
     "localname": "LongTermDebtObligationsWithoutConvertibleNotes",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ManufacturingEquipmentAndSoftware": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount as of the balance sheet date of long-lived, depreciable assets that include manufacturing and other equipment with finite lives used to produce goods and services, and computer equipment and software.",
        "label": "Manufacturing Equipment And Software",
        "terseLabel": "Equipment"
       }
      }
     },
     "localname": "ManufacturingEquipmentAndSoftware",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_MarketBasedAwardsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Market Based Awards [Member]",
        "label": "Market Based Awards [Member]",
        "terseLabel": "Market Based Awards"
       }
      }
     },
     "localname": "MarketBasedAwardsMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum target number percentage of shares issued based on stock performance.",
        "label": "Maximum Target Number Of Shares Issued Based On Stock Performance In Percent",
        "terseLabel": "Maximum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MaximumTargetNumberOfSharesIssuedBasedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MinervaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minerva [Member]",
        "label": "Minerva [Member]",
        "terseLabel": "Minerva"
       }
      }
     },
     "localname": "MinervaMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Minimum target number percentage of shares that would be issued based on stock price performance.",
        "label": "Minimum Target Number Of Shares Issued On Stock Performance In Percent",
        "terseLabel": "Minimum eligible percentage to receive target number of shares of company's common stock"
       }
      }
     },
     "localname": "MinimumTargetNumberOfSharesIssuedOnStockPerformanceInPercent",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_MolecularDiagnosticsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Molecular Diagnostics [Member]",
        "label": "Molecular Diagnostics [Member]",
        "terseLabel": "Molecular Diagnostics"
       }
      }
     },
     "localname": "MolecularDiagnosticsMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Netincome": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net income attributable to Hologic",
        "label": "Net income",
        "terseLabel": "Net income"
       }
      }
     },
     "localname": "Netincome",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_NotationalAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Notational Amount",
        "label": "Notational Amount",
        "terseLabel": "Notational Amount"
       }
      }
     },
     "localname": "NotationalAmount",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Translation adjustment, net tax, excluding amounts reclassified from AOCI",
        "terseLabel": "Changes in foreign currency translation adjustment"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetTaxExcludingAmountsReclassifiedFromAOCI",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_OtherTypeofRevenueMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Type of Revenue [Member]",
        "label": "Other Type of Revenue [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherTypeofRevenueMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PSUFreeCashFlowMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PSU Free Cash Flow [Member]",
        "label": "PSU Free Cash Flow [Member]",
        "terseLabel": "PSU Free Cash Flow [Member]"
       }
      }
     },
     "localname": "PSUFreeCashFlowMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The payment of minimum statutory tax withholdings to taxing authorities on the behalf of employees from the net share settlement upon vesting of restricted stock units. This payment is not an expense of the Company nor an operating activity.",
        "label": "Payment For Tax Withholding Related To Vested And Released Restricted Stock Units",
        "negatedTerseLabel": "Payment of minimum tax withholdings on net share settlements of equity awards"
       }
      }
     },
     "localname": "PaymentForTaxWithholdingRelatedToVestedAndReleasedRestrictedStockUnits",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsToManufactureEquipmentUnderCustomerUsageAgreements": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow related to equipment placed at customer locations for which title is not transferred to the Company's customers.",
        "label": "Payments To Manufacture Equipment Under Customer Usage Agreements",
        "negatedLabel": "Increase in equipment under customer usage agreements"
       }
      }
     },
     "localname": "PaymentsToManufactureEquipmentUnderCustomerUsageAgreements",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PaymentsUnderFinanceLeaseObligations": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments under finance lease obligations",
        "label": "Payments under finance lease obligations",
        "negatedTerseLabel": "Payments under finance lease obligations"
       }
      }
     },
     "localname": "PaymentsUnderFinanceLeaseObligations",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PercentageOfRevenues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of revenues.",
        "label": "Percentage Of Revenues",
        "terseLabel": "Revenues"
       }
      }
     },
     "localname": "PercentageOfRevenues",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "holx_PrepaidIncomeTaxesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Prepaid Income Taxes-Current",
        "label": "Prepaid Income Taxes-Current",
        "terseLabel": "Prepaid Income Taxes-Current"
       }
      }
     },
     "localname": "PrepaidIncomeTaxesCurrent",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_PrincipalAmountOfBorrowings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the aggregate outstanding principal of amounts borrowed under the Credit Agreement.",
        "label": "Principal Amount Of Borrowings",
        "verboseLabel": "Borrowed principal"
       }
      }
     },
     "localname": "PrincipalAmountOfBorrowings",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProceedsReceivedFromGovernmentGrantsForCapacityExpansion": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Proceeds received from government grants for capacity expansion",
        "label": "Proceeds received from government grants for capacity expansion",
        "terseLabel": "Proceeds from the Department of Defense"
       }
      }
     },
     "localname": "ProceedsReceivedFromGovernmentGrantsForCapacityExpansion",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_ProductRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Product Revenue",
        "label": "Product Revenue",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "ProductRevenue",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_Purchaseofinsurancecontracts": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of insurance contracts",
        "label": "Purchase of insurance contracts",
        "negatedTerseLabel": "Purchase of insurance contracts"
       }
      }
     },
     "localname": "Purchaseofinsurancecontracts",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RSUPSUMSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "RSU, PSU, MSU [Member]",
        "label": "RSU, PSU, MSU [Member]",
        "terseLabel": "RSU, PSU, MSU"
       }
      }
     },
     "localname": "RSUPSUMSUMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_Repaymentsofacquiredlongtermdebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Repayments of acquired long term debt",
        "label": "Repayments of acquired long term debt",
        "negatedTerseLabel": "Repayments of acquired long term debt"
       }
      }
     },
     "localname": "Repaymentsofacquiredlongtermdebt",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_RestofWorldMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rest of World [Member]",
        "label": "Rest of World [Member]",
        "terseLabel": "Rest of World"
       }
      }
     },
     "localname": "RestofWorldMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_RevolverMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revolver [Member]",
        "label": "Revolver [Member]",
        "terseLabel": "Revolver"
       }
      }
     },
     "localname": "RevolverMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Line Items]",
        "label": "Schedule Of Geographical Segments [Line Items]",
        "terseLabel": "Schedule Of Geographical Segments [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsLineItems",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfGeographicalSegmentsTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Geographical Segments [Table]",
        "label": "Schedule Of Geographical Segments [Table]",
        "terseLabel": "Schedule Of Geographical Segments [Table]"
       }
      }
     },
     "localname": "ScheduleOfGeographicalSegmentsTable",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of interest expense under convertible notes.",
        "label": "Schedule Of Interest Expense Under Convertible Notes [Table Text Block]",
        "terseLabel": "Schedule Of Interest Expense Under Convertible Notes"
       }
      }
     },
     "localname": "ScheduleOfInterestExpenseUnderConvertibleNotesTableTextBlock",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_ScheduleOfShareBasedCompensationExpenseTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of share-based compensation expense.",
        "label": "Schedule Of Share Based Compensation Expense [Table Text Block]",
        "terseLabel": "Stock-Based Compensation Expense in Consolidated Statements of Operations"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationExpenseTableTextBlock",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "holx_SecuredTermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Secured Term Loan",
        "label": "Secured Term Loan [Member]",
        "terseLabel": "Secured Term Loan"
       }
      }
     },
     "localname": "SecuredTermLoanMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_SegmentReportingDisclosureLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Segment Reporting Disclosure [Line Items]",
        "label": "Segment Reporting Disclosure [Line Items]",
        "terseLabel": "Segment Reporting Disclosure [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingDisclosureLineItems",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_September222022Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "September 22, 2022",
        "label": "September 22, 2022 [Member]",
        "terseLabel": "September 22, 2022"
       }
      }
     },
     "localname": "September222022Member",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_ServiceRevenue": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_Revenues",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Service Revenue",
        "label": "Service Revenue",
        "terseLabel": "Service and other"
       }
      }
     },
     "localname": "ServiceRevenue",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "holx_SharedBasedCompensationArrangementRestrictedStockVestingPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period of time that must lapse in order for the restricted stock units to vest.",
        "label": "Shared Based Compensation Arrangement Restricted Stock Vesting Period",
        "verboseLabel": "Performance stock units vesting period"
       }
      }
     },
     "localname": "SharedBasedCompensationArrangementRestrictedStockVestingPeriod",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "holx_SharerepurchaseplanLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for share repurchase plan [Table]",
        "label": "share repurchase plan [Line Items]",
        "terseLabel": "share repurchase plan [Line Items]"
       }
      }
     },
     "localname": "SharerepurchaseplanLineItems",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SharerepurchaseplanTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "share repurchase plan [Table]",
        "label": "share repurchase plan [Table]",
        "terseLabel": "share repurchase plan [Table]"
       }
      }
     },
     "localname": "SharerepurchaseplanTable",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "holx_SkeletalHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Skeletal health.",
        "label": "Skeletal Health [Member]",
        "terseLabel": "Skeletal Health"
       }
      }
     },
     "localname": "SkeletalHealthMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "holx_TermLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term Loan [Member]",
        "label": "Term Loan [Member]",
        "terseLabel": "Term Loan"
       }
      }
     },
     "localname": "TermLoanMember",
     "nsuri": "http://www.hologic.com/20221231",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_AsiaPacificMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Asia Pacific [Member]",
        "terseLabel": "Asia-Pacific"
       }
      }
     },
     "localname": "AsiaPacificMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ConsolidationItemsAxis": {
     "auth_ref": [
      "r233",
      "r270",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r292",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r369",
      "r371",
      "r372",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Axis]",
        "terseLabel": "Consolidation Items [Axis]"
       }
      }
     },
     "localname": "ConsolidationItemsAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ConsolidationItemsDomain": {
     "auth_ref": [
      "r233",
      "r270",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r292",
      "r361",
      "r362",
      "r363",
      "r364",
      "r366",
      "r367",
      "r369",
      "r371",
      "r372",
      "r728",
      "r729"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Consolidation Items [Domain]",
        "terseLabel": "Consolidation Items [Domain]"
       }
      }
     },
     "localname": "ConsolidationItemsDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r294",
      "r595",
      "r668",
      "r684",
      "r725",
      "r726",
      "r732",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r294",
      "r595",
      "r668",
      "r684",
      "r725",
      "r726",
      "r732",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r295",
      "r296",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r669",
      "r685",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r295",
      "r296",
      "r639",
      "r641",
      "r642",
      "r643",
      "r644",
      "r645",
      "r646",
      "r647",
      "r648",
      "r649",
      "r669",
      "r685",
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationRevenuesbyGeographyDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r15",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r300",
      "r301"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, less reserves"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r18"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": {
     "auth_ref": [
      "r28",
      "r32",
      "r126",
      "r696",
      "r697",
      "r698"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.",
        "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]",
        "terseLabel": "Pension Plans"
       }
      }
     },
     "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r78",
      "r195"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less \u2013 accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": {
     "auth_ref": [
      "r210",
      "r217",
      "r218",
      "r506",
      "r656",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent.",
        "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]",
        "terseLabel": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent"
       }
      }
     },
     "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r30",
      "r31",
      "r32",
      "r201",
      "r607",
      "r619",
      "r623"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive loss"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": {
     "auth_ref": [
      "r216",
      "r217",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).",
        "label": "Accumulated Other Comprehensive Income (Loss) [Table]",
        "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r29",
      "r32",
      "r126",
      "r564",
      "r614",
      "r615",
      "r696",
      "r697",
      "r698",
      "r708",
      "r709",
      "r710"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccumulatedTranslationAdjustmentMember": {
     "auth_ref": [
      "r27",
      "r32",
      "r126",
      "r217",
      "r218",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r696"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.",
        "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]",
        "terseLabel": "Foreign Currency Translation"
       }
      }
     },
     "localname": "AccumulatedTranslationAdjustmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": {
     "auth_ref": [
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Acquired Finite-Lived Intangible Assets, Weighted Average Useful Life",
        "terseLabel": "Intangible assets useful life"
       }
      }
     },
     "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r7",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r472",
      "r473",
      "r474",
      "r708",
      "r709",
      "r710",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r54",
      "r74"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsForNewAccountingPronouncementsAxis": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r237",
      "r238",
      "r239",
      "r240",
      "r249",
      "r303",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r472",
      "r473",
      "r474",
      "r484",
      "r485",
      "r486",
      "r487",
      "r499",
      "r500",
      "r501",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r548",
      "r549",
      "r552",
      "r553",
      "r554",
      "r555",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r597",
      "r598",
      "r599",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by amendment to accounting standards.",
        "label": "Accounting Standards Update [Axis]",
        "terseLabel": "Adjustments for New Accounting Pronouncements [Axis]"
       }
      }
     },
     "localname": "AdjustmentsForNewAccountingPronouncementsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r104",
      "r105",
      "r438"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net income to net cash provided by operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r202",
      "r302",
      "r314"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "periodEndLabel": "Balance\u00a0at End of Period",
        "periodStartLabel": "Balance\u00a0at Beginning of Period"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs": {
     "auth_ref": [
      "r317"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of direct write-downs of accounts receivable charged against the allowance.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Writeoff",
        "negatedTerseLabel": "Write-offs, Payments and Foreign Exchange"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableWriteOffs",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r54",
      "r68",
      "r74"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of acquired intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Weighted-average anti-dilutive shares (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r164",
      "r176",
      "r199",
      "r230",
      "r278",
      "r284",
      "r290",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r504",
      "r507",
      "r531",
      "r683",
      "r728",
      "r729",
      "r746"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "terseLabel": "Identifiable assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "ASSETS"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r192",
      "r205",
      "r230",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r504",
      "r507",
      "r531",
      "r683",
      "r728",
      "r729",
      "r746"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Fair Value Disclosure [Abstract]",
        "terseLabel": "Assets:"
       }
      }
     },
     "localname": "AssetsFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r134",
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BalanceSheetRelatedDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Balance Sheet Related Disclosures [Abstract]",
        "terseLabel": "Balance Sheet Related Disclosures [Abstract]"
       }
      }
     },
     "localname": "BalanceSheetRelatedDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_BuildingsAndImprovementsGross": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of building structures held for productive use including addition, improvement, or renovation to the structure, including, but not limited to, interior masonry, interior flooring, electrical, and plumbing.",
        "label": "Buildings and Improvements, Gross",
        "terseLabel": "Building and improvements"
       }
      }
     },
     "localname": "BuildingsAndImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessAcquisitionAcquireeDomain": {
     "auth_ref": [
      "r497",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.",
        "label": "Business Acquisition, Acquiree [Domain]",
        "terseLabel": "Business Acquisition, Acquiree [Domain]"
       }
      }
     },
     "localname": "BusinessAcquisitionAcquireeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessAcquisitionAxis": {
     "auth_ref": [
      "r108",
      "r109",
      "r497",
      "r678",
      "r679"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business combination or series of individually immaterial business combinations.",
        "label": "Business Acquisition [Axis]",
        "terseLabel": "Business Acquisition [Axis]"
       }
      }
     },
     "localname": "BusinessAcquisitionAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessAcquisitionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition [Line Items]",
        "terseLabel": "Business Acquisition [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BusinessCombinationConsiderationTransferred1": {
     "auth_ref": [
      "r116",
      "r117",
      "r119"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.",
        "label": "Business Combination, Consideration Transferred",
        "terseLabel": "Consideration transferred"
       }
      }
     },
     "localname": "BusinessCombinationConsiderationTransferred1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1": {
     "auth_ref": [
      "r503",
      "r703"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of right to a contingent consideration asset.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset",
        "negatedTerseLabel": "Contingent consideration - fair value adjustment"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r503",
      "r703"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "terseLabel": "Change in contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationLiability": {
     "auth_ref": [
      "r115",
      "r118",
      "r502"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.",
        "label": "Business Combination, Contingent Consideration, Liability",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationDisclosureTextBlock": {
     "auth_ref": [
      "r120",
      "r498"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).",
        "label": "Business Combination Disclosure [Text Block]",
        "terseLabel": "Business Combinations"
       }
      }
     },
     "localname": "BusinessCombinationDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents",
        "verboseLabel": "Cash"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables",
        "verboseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable",
        "negatedLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities",
        "negatedTerseLabel": "Deferred income taxes, net"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": {
     "auth_ref": [
      "r110",
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of inventory recognized as of the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": {
     "auth_ref": [
      "r111"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.",
        "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net",
        "totalLabel": "Purchase Price"
       }
      }
     },
     "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_BusinessCombinationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Combinations [Abstract]",
        "terseLabel": "Business Combinations [Abstract]"
       }
      }
     },
     "localname": "BusinessCombinationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r50",
      "r56",
      "r57"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash and cash equivalents, end of period",
        "periodStartLabel": "Cash and cash equivalents, beginning of period",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r50",
      "r157"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash and cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowHedgeDerivativeInstrumentAssetsAtFairValue": {
     "auth_ref": [
      "r137"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of all asset derivatives designated as cash flow hedging instruments.",
        "label": "Cash Flow Hedge Derivative Instrument Assets at Fair Value",
        "terseLabel": "Interest rate swap at fair value"
       }
      }
     },
     "localname": "CashFlowHedgeDerivativeInstrumentAssetsAtFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r80",
      "r356",
      "r357",
      "r640",
      "r727"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r708",
      "r709",
      "r742"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r6",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, $0.01 par value \u2013 750,000 shares authorized; 299,485 and 298,533 shares issued, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r33",
      "r213",
      "r215",
      "r222",
      "r603",
      "r609"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNoteTextBlock": {
     "auth_ref": [
      "r44",
      "r221",
      "r602",
      "r608"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.",
        "label": "Comprehensive Income (Loss) Note [Text Block]",
        "terseLabel": "Accumulated Other Comprehensive Loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNoteTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLoss"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ContingentConsiderationClassifiedAsEquityFairValueDisclosure": {
     "auth_ref": [
      "r149"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of contingent consideration in a business combination that is classified in shareholders' equity.",
        "label": "Contingent Consideration Classified as Equity, Fair Value Disclosure",
        "terseLabel": "Contingent consideration"
       }
      }
     },
     "localname": "ContingentConsiderationClassifiedAsEquityFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r428"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Contract with Customer, Liability, Revenue Recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueNarrativeDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CorporateMember": {
     "auth_ref": [
      "r713"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Component of an entity that usually provides financial, operational and administrative support and is considered an operating segment. Excludes intersegment elimination and reconciling items.",
        "label": "Corporate Segment [Member]",
        "terseLabel": "Corporate"
       }
      }
     },
     "localname": "CorporateMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r40",
      "r595"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Product"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cost of Revenue [Abstract]",
        "terseLabel": "Costs of revenues:"
       }
      }
     },
     "localname": "CostOfRevenueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenues"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r114"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer Relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r92",
      "r228",
      "r379",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r390",
      "r397",
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Borrowings and Credit Arrangements"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r2",
      "r3",
      "r4",
      "r165",
      "r166",
      "r175",
      "r233",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r551",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r159",
      "r161",
      "r374",
      "r551",
      "r664",
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "terseLabel": "Senior notes, face amount"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFairValue": {
     "auth_ref": [
      "r388",
      "r530",
      "r664",
      "r665"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.",
        "label": "Debt Instrument, Fair Value Disclosure",
        "terseLabel": "Fair value of debt instrument"
       }
      }
     },
     "localname": "DebtInstrumentFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r20",
      "r375"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Stated interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r21",
      "r233",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r551",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r21",
      "r94",
      "r95",
      "r96",
      "r97",
      "r158",
      "r159",
      "r161",
      "r174",
      "r233",
      "r374",
      "r375",
      "r376",
      "r377",
      "r378",
      "r380",
      "r386",
      "r387",
      "r388",
      "r389",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r399",
      "r551",
      "r663",
      "r664",
      "r665",
      "r666",
      "r667",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r160",
      "r730"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Debt Issuance Costs, Net"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r54",
      "r107",
      "r483",
      "r490",
      "r491",
      "r707"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "terseLabel": "Deferred income taxes"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r476",
      "r477"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "terseLabel": "Deferred Income Tax Liabilities, Net"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueCurrent": {
     "auth_ref": [
      "r693"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Deferred Revenue, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "DeferredRevenueCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredRevenueNoncurrent": {
     "auth_ref": [
      "r694"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Deferred Revenue, Noncurrent",
        "terseLabel": "Deferred revenue, net of current portion"
       }
      }
     },
     "localname": "DeferredRevenueNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r54",
      "r76"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationAmortizationAndAccretionNet": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Depreciation, Amortization and Accretion, Net",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationAmortizationAndAccretionNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.",
        "label": "Derivative Contract [Domain]",
        "terseLabel": "Derivative Contract [Domain]"
       }
      }
     },
     "localname": "DerivativeContractTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DerivativeFairValueOfDerivativeAsset": {
     "auth_ref": [
      "r26",
      "r136",
      "r162",
      "r206",
      "r655"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.",
        "label": "Derivative Asset, Subject to Master Netting Arrangement, before Offset",
        "terseLabel": "Derivative asset"
       }
      }
     },
     "localname": "DerivativeFairValueOfDerivativeAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeGainLossOnDerivativeNet": {
     "auth_ref": [
      "r739"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.",
        "label": "Derivative, Gain (Loss) on Derivative, Net",
        "terseLabel": "Amount of realized gain (loss) recognized in income"
       }
      }
     },
     "localname": "DerivativeGainLossOnDerivativeNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "auth_ref": [
      "r135",
      "r137",
      "r142",
      "r143",
      "r655"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of derivative contract.",
        "label": "Derivative Instrument [Axis]",
        "terseLabel": "Derivative Instrument [Axis]"
       }
      }
     },
     "localname": "DerivativeInstrumentRiskAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosure [Abstract]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments and Hedging Activities Disclosures [Line Items]",
        "terseLabel": "Derivative Instruments and Hedging Activities Disclosures [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosuresLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": {
     "auth_ref": [
      "r132",
      "r135",
      "r142",
      "r143",
      "r146",
      "r147",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Table]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsGainLossLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative Instruments, Gain (Loss) [Line Items]",
        "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]"
       }
      }
     },
     "localname": "DerivativeInstrumentsGainLossLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet": {
     "auth_ref": [
      "r141",
      "r740"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of realized and unrealized gain (loss) of derivative instruments not designated or qualifying as hedging instruments.",
        "label": "Derivative Instruments Not Designated as Hedging Instruments, Gain (Loss), Net",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsGainLossNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Derivative [Line Items]",
        "terseLabel": "Derivative [Line Items]"
       }
      }
     },
     "localname": "DerivativeLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeNotionalAmount": {
     "auth_ref": [
      "r737",
      "r738"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nominal or face amount used to calculate payment on derivative.",
        "label": "Derivative, Notional Amount",
        "terseLabel": "Derivative notional amount"
       }
      }
     },
     "localname": "DerivativeNotionalAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeTable": {
     "auth_ref": [
      "r129",
      "r130",
      "r131",
      "r132",
      "r133",
      "r139",
      "r142",
      "r144",
      "r145",
      "r147",
      "r513"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.",
        "label": "Derivative [Table]",
        "terseLabel": "Derivative [Table]"
       }
      }
     },
     "localname": "DerivativeTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DerivativeVariableInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Variable interest rate in effect as of the balance sheet date related to the interest rate derivative.",
        "label": "Derivative, Variable Interest Rate",
        "terseLabel": "Variable interest rate"
       }
      }
     },
     "localname": "DerivativeVariableInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DerivativesAndFairValueTextBlock": {
     "auth_ref": [
      "r148",
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for derivatives and fair value of assets and liabilities.",
        "label": "Derivatives and Fair Value [Text Block]",
        "terseLabel": "Derivatives"
       }
      }
     },
     "localname": "DerivativesAndFairValueTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Derivatives"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivative instruments designated as a cash flow hedge"
       }
      }
     },
     "localname": "DesignatedAsHedgingInstrumentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r427",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r732"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r441",
      "r468",
      "r469",
      "r471",
      "r475",
      "r680"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-Based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net income per common share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r223",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r250",
      "r252",
      "r257",
      "r258",
      "r259",
      "r263",
      "r524",
      "r525",
      "r604",
      "r610",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Basic (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r223",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r252",
      "r257",
      "r258",
      "r259",
      "r263",
      "r524",
      "r525",
      "r604",
      "r610",
      "r659"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Diluted (in usd per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r260",
      "r261",
      "r262",
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r540"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "terseLabel": "Effect of exchange rate changes on cash and cash equivalents"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "terseLabel": "Company's effective tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r470"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted-average period for recognition of unrecognized stock-based compensation, years"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock option plans"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r93",
      "r187",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r265",
      "r311",
      "r416",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r523",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r564",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityMethodInvestmentsMember": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Investment in the stock of an investee which is adjusted for the investor's share of the earnings or losses of the investee after the date of acquisition.",
        "label": "Equity Method Investments [Member]",
        "terseLabel": "Equity Method Investments"
       }
      }
     },
     "localname": "EquityMethodInvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]",
        "terseLabel": "Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]"
       }
      }
     },
     "localname": "FairValueBalanceSheetGroupingFinancialStatementCaptionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByBalanceSheetGroupingTable": {
     "auth_ref": [
      "r149",
      "r155",
      "r156"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities.",
        "label": "Fair Value, by Balance Sheet Grouping [Table]",
        "terseLabel": "Fair Value, by Balance Sheet Grouping [Table]"
       }
      }
     },
     "localname": "FairValueByBalanceSheetGroupingTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r388",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r528",
      "r568",
      "r569",
      "r570",
      "r664",
      "r665",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r388",
      "r431",
      "r436",
      "r528",
      "r568",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Quoted\u00a0Prices\u00a0in Active\u00a0Market\u00a0for Identical\u00a0Assets (Level\u00a01)"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r388",
      "r431",
      "r436",
      "r528",
      "r569",
      "r664",
      "r665",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Significant Other Observable Inputs\u00a0(Level\u00a02)"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r388",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r528",
      "r570",
      "r664",
      "r665",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Significant Unobservable Inputs\u00a0(Level\u00a03)"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisObligations": {
     "auth_ref": [
      "r149",
      "r150"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of obligations measured on a recurring basis.",
        "label": "Obligations, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisObligations",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "terseLabel": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]"
       }
      }
     },
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r529"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Fair value adjustments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of purchases of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases",
        "terseLabel": "Contingent consideration recorded at acquisition"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements",
        "terseLabel": "Payments"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r151"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsRollForwardDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r388",
      "r431",
      "r432",
      "r433",
      "r434",
      "r435",
      "r436",
      "r568",
      "r569",
      "r570",
      "r664",
      "r665",
      "r675",
      "r676",
      "r677"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, off-Balance-Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable": {
     "auth_ref": [
      "r134",
      "r139",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule that discloses the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.",
        "label": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]",
        "terseLabel": "Fair Values Derivatives, Balance Sheet Location, by Derivative Contract Type [Table]"
       }
      }
     },
     "localname": "FairValuesDerivativesBalanceSheetLocationByDerivativeContractTypeByHedgingDesignationTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease obligations"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r557"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease obligations, net of current portion"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r556"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 7.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r305",
      "r306",
      "r315",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r399",
      "r414",
      "r513",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r661",
      "r716",
      "r717",
      "r718",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r197",
      "r339"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "Fiscal 2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "Remainder of Fiscal 2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "Fiscal 2027"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "Fiscal 2026"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r75"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Fiscal 2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofEstimatedAmortizationExpenseDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r337",
      "r338",
      "r339",
      "r340",
      "r596",
      "r600"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r73",
      "r600"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Value"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r69",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeContractMember": {
     "auth_ref": [
      "r655",
      "r675",
      "r682"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.",
        "label": "Foreign Exchange Contract [Member]",
        "terseLabel": "Foreign currency option contracts"
       }
      }
     },
     "localname": "ForeignExchangeContractMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate.",
        "label": "Foreign Exchange Forward [Member]",
        "terseLabel": "Forward foreign currency contracts"
       }
      }
     },
     "localname": "ForeignExchangeForwardMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignExchangeOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An option that allows the holder to buy (if call) or sell (if put) an underlying currency at a fixed exercise rate, expressed as an exchange, during a specified period (an American option) or at a specified date (a European option).",
        "label": "Foreign Exchange Option [Member]",
        "terseLabel": "Foreign currency option contracts",
        "verboseLabel": "Foreign Exchange Option"
       }
      }
     },
     "localname": "ForeignExchangeOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForwardContractsMember": {
     "auth_ref": [
      "r741"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts negotiated between two parties to purchase and sell a specific quantity of a financial instrument, foreign currency, or commodity at a price specified at origination of the contract, with delivery and settlement at a specified future date.",
        "label": "Forward Contracts [Member]",
        "terseLabel": "Forward Contracts"
       }
      }
     },
     "localname": "ForwardContractsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesGross": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 6.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures, Gross",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainsLossesOnExtinguishmentOfDebt": {
     "auth_ref": [
      "r54",
      "r90",
      "r91"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.",
        "label": "Gain (Loss) on Extinguishment of Debt",
        "negatedLabel": "Debt extinguishment losses",
        "negatedTerseLabel": "Debt extinguishment loss",
        "terseLabel": "Debt extinguishment loss"
       }
      }
     },
     "localname": "GainsLossesOnExtinguishmentOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r196",
      "r327",
      "r601",
      "r662",
      "r683",
      "r720",
      "r721"
     ],
     "calculation": {
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GrantsReceivableCurrent": {
     "auth_ref": [
      "r695"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer.",
        "label": "Grants Receivable, Current",
        "terseLabel": "Grants Receivable, Current"
       }
      }
     },
     "localname": "GrantsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r39",
      "r230",
      "r278",
      "r283",
      "r289",
      "r292",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r531",
      "r660",
      "r728"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GuaranteesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guarantees [Abstract]",
        "terseLabel": "Guarantees [Abstract]"
       }
      }
     },
     "localname": "GuaranteesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationAxis": {
     "auth_ref": [
      "r132",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Axis]",
        "terseLabel": "Hedging Designation [Axis]"
       }
      }
     },
     "localname": "HedgingDesignationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_HedgingDesignationDomain": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designation of purpose of derivative instrument.",
        "label": "Hedging Designation [Domain]",
        "terseLabel": "Hedging Designation [Domain]"
       }
      }
     },
     "localname": "HedgingDesignationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r35",
      "r163",
      "r170",
      "r183",
      "r278",
      "r283",
      "r289",
      "r292",
      "r605",
      "r660"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r342",
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r231",
      "r480",
      "r481",
      "r482",
      "r488",
      "r492",
      "r494",
      "r495",
      "r496"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r232",
      "r247",
      "r248",
      "r276",
      "r478",
      "r489",
      "r493",
      "r611"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued expenses and other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r658"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities, excluding the effect of acquisitions:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidTaxes": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of consideration paid in advance for income and other taxes that provide economic benefits in future periods.",
        "label": "Increase (Decrease) in Prepaid Taxes",
        "negatedTerseLabel": "Prepaid income taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidTaxes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "auth_ref": [
      "r253",
      "r254",
      "r255",
      "r259",
      "r440"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "terseLabel": "Weighted average common stock equivalents from assumed exercise of stock options and issuance of restricted stock units"
       }
      }
     },
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Intangible Assets and Goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r67",
      "r71"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r160",
      "r173",
      "r219",
      "r272",
      "r550"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseBorrowings": {
     "auth_ref": [
      "r172"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate amount of interest expense on all borrowings.",
        "label": "Interest Expense, Borrowings",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseBorrowings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestRateSwapMember": {
     "auth_ref": [
      "r681"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.",
        "label": "Interest Rate Swap [Member]",
        "terseLabel": "Interest Rate Swap",
        "verboseLabel": "Interest rate swap"
       }
      }
     },
     "localname": "InterestRateSwapMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/DerivativesAdditionalInformationDetails",
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IntersegmentEliminationMember": {
     "auth_ref": [
      "r270",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r288",
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Eliminating entries used in operating segment consolidation.",
        "label": "Intersegment Eliminations [Member]",
        "terseLabel": "Intersegment"
       }
      }
     },
     "localname": "IntersegmentEliminationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r65",
      "r652"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r203",
      "r650",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r65",
      "r654"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r65",
      "r653"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work-in-process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationInventoriesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r42",
      "r271"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type [Axis]"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r624",
      "r625",
      "r626",
      "r627",
      "r628",
      "r629",
      "r630",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r637",
      "r638"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments [Domain]"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_InvestmentsFairValueDisclosure": {
     "auth_ref": [
      "r527"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of investment securities, including, but not limited to, marketable securities, derivative financial instruments, and investments accounted for under the equity method.",
        "label": "Investments, Fair Value Disclosure",
        "terseLabel": "Assets measured at fair value on a recurring basis"
       }
      }
     },
     "localname": "InvestmentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Land": {
     "auth_ref": [
      "r692"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 5.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depletion of real estate held for productive use, excluding land held for sale.",
        "label": "Land",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "Land",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsGross": {
     "auth_ref": [
      "r77"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 4.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation of additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements, Gross",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r11",
      "r167",
      "r179",
      "r683",
      "r706",
      "r719",
      "r743"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r19",
      "r193",
      "r230",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r505",
      "r507",
      "r508",
      "r531",
      "r683",
      "r728",
      "r746",
      "r747"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesFairValueDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Fair Value Disclosure [Abstract]",
        "terseLabel": "Liabilities:"
       }
      }
     },
     "localname": "LiabilitiesFairValueDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liability [Member]",
        "terseLabel": "Liability"
       }
      }
     },
     "localname": "LiabilityMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateAtPeriodEnd": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate at the end of the reporting period.",
        "label": "Line of Credit Facility, Interest Rate at Period End",
        "terseLabel": "Interest rate at end of period"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateAtPeriodEnd",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityInterestRateDuringPeriod": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The effective interest rate during the reporting period.",
        "label": "Line of Credit Facility, Interest Rate During Period",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "LineOfCreditFacilityInterestRateDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r16"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Revolving credit facility borrowings"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r16",
      "r705"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseCreditAgreementDetails",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LoansNotesTradeAndOtherReceivablesDisclosureTextBlock": {
     "auth_ref": [
      "r715"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for claims held for amounts due a entity, excluding financing receivables. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Includes disclosure for allowance for credit losses.",
        "label": "Loans, Notes, Trade and Other Receivables Disclosure [Text Block]",
        "terseLabel": "Trade Receivables and Allowance for Credit Losses"
       }
      }
     },
     "localname": "LoansNotesTradeAndOtherReceivablesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLosses"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r4",
      "r166",
      "r177",
      "r387",
      "r401",
      "r664",
      "r665"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.",
        "label": "Long-Term Debt",
        "totalLabel": "Total debt obligations"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r17"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-Term Debt, Current Maturities",
        "verboseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r200"
     ],
     "calculation": {
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.",
        "label": "Long-Term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term debt, net of current portion",
        "verboseLabel": "Total long-term debt obligations"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r21"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-Term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r21",
      "r89"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-Term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsCompanysBorrowingsDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r81",
      "r82",
      "r358",
      "r359",
      "r360",
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingencyNewClaimsFiledNumber": {
     "auth_ref": [
      "r723",
      "r724"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The total number of new claims filed pertaining to a loss contingency during the period.",
        "label": "Loss Contingency, New Claims Filed, Number",
        "terseLabel": "Petitions filed"
       }
      }
     },
     "localname": "LossContingencyNewClaimsFiledNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_LossOnSaleOfInvestments": {
     "auth_ref": [
      "r699",
      "r700",
      "r704",
      "r749",
      "r750"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the carrying value and the sale price of an investment. A loss would be recognized when the sale price of the investment is less than the carrying value of the investment. This element refers to the Loss included in earnings and not to the cash proceeds of the sale.",
        "label": "Loss on Sale of Investments",
        "terseLabel": "Loss on Sale of Investments"
       }
      }
     },
     "localname": "LossOnSaleOfInvestments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Movement in Standard and Extended Product Warranty Accrual, Increase (Decrease) [Roll Forward]",
        "terseLabel": "Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]"
       }
      }
     },
     "localname": "MovementInStandardAndExtendedProductWarrantyIncreaseDecreaseRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash used in financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r50",
      "r52",
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash provided by operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r36",
      "r55",
      "r171",
      "r182",
      "r191",
      "r211",
      "r214",
      "r218",
      "r230",
      "r237",
      "r241",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r256",
      "r278",
      "r283",
      "r289",
      "r292",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r525",
      "r531",
      "r660",
      "r728"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "totalLabel": "Net income",
        "verboseLabel": "Net income"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NondesignatedMember": {
     "auth_ref": [
      "r132"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).",
        "label": "Not Designated as Hedging Instrument [Member]",
        "terseLabel": "Derivatives not designated as hedging instruments"
       }
      }
     },
     "localname": "NondesignatedMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails",
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r714"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OciBeforeReclassificationsBeforeTaxAttributableToParent": {
     "auth_ref": [
      "r32"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax and reclassification adjustments of other comprehensive income (loss) attributable to parent.",
        "label": "OCI, before Reclassifications, before Tax, Attributable to Parent",
        "terseLabel": "Other comprehensive income (loss) before reclassifications"
       }
      }
     },
     "localname": "OciBeforeReclassificationsBeforeTaxAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r278",
      "r283",
      "r289",
      "r292",
      "r660"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Income from operations",
        "verboseLabel": "Income (loss) from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r128"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BasisofPresentation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r134",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r198"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax": {
     "auth_ref": [
      "r209"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax",
        "terseLabel": "Tax"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLossParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax": {
     "auth_ref": [
      "r207",
      "r208"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after tax and before reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification, after Tax",
        "terseLabel": "Gain (loss) recognized in other comprehensive income (loss), net"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax": {
     "auth_ref": [
      "r207",
      "r208",
      "r509",
      "r510",
      "r512"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax and reclassification, of gain (loss) from derivative instrument designated and qualifying cash flow hedge included in assessment of hedge effectiveness.",
        "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax",
        "terseLabel": "Amount of (loss) gain recognized in other comprehensive income, net of taxes:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesGainLossonFairValueHedgesRecognizedinAOCIDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r34",
      "r93",
      "r212",
      "r215",
      "r221",
      "r541",
      "r546",
      "r547",
      "r602",
      "r608",
      "r696",
      "r697"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).",
        "label": "Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Other comprehensive income activity"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r212",
      "r215"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive income (loss)"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentAssetsMember": {
     "auth_ref": [
      "r134",
      "r146"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other current assets.",
        "label": "Other Current Assets [Member]",
        "terseLabel": "Other Current Assets"
       }
      }
     },
     "localname": "OtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r22"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other long-term liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "auth_ref": [
      "r55"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.",
        "label": "Other Noncash Income (Expense)",
        "negatedTerseLabel": "Other adjustments and non-cash items"
       }
      }
     },
     "localname": "OtherNoncashIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other income (expense), net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities": {
     "auth_ref": [
      "r49"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.",
        "label": "Payment for Contingent Consideration Liability, Financing Activities",
        "negatedTerseLabel": "Payment of deferred acquisition consideration"
       }
      }
     },
     "localname": "PaymentForContingentConsiderationLiabilityFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "auth_ref": [
      "r701",
      "r702"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other.",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "negatedTerseLabel": "Payments for (Proceeds from) Other Investing Activities"
       }
      }
     },
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForProceedsFromProductiveAssets": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net cash outflow or inflow from purchases, sales and disposals of property, plant and equipment and other productive assets, including intangibles.",
        "label": "Payments for (Proceeds from) Productive Assets",
        "negatedLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsForProceedsFromProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to reacquire common stock during the period.",
        "label": "Payments for Repurchase of Common Stock",
        "negatedLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "auth_ref": [
      "r45"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "negatedTerseLabel": "Acquisition of businesses, net of cash acquired"
       }
      }
     },
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireProductiveAssets": {
     "auth_ref": [
      "r225",
      "r734",
      "r735",
      "r736"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets.",
        "label": "Payments to Acquire Productive Assets",
        "terseLabel": "Capital expenditures"
       }
      }
     },
     "localname": "PaymentsToAcquireProductiveAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance Shares"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r5",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r5",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r5",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, $0.01 par value \u2013 1,623 shares authorized; 0 shares issued"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r204",
      "r325",
      "r326",
      "r651"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid Expense, Current"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesFairValueofDerivativeFinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromDerivativeInstrumentFinancingActivities": {
     "auth_ref": [
      "r226",
      "r657"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow provided by derivative instruments during the period, which are classified as financing activities, excluding those designated as hedging instruments.",
        "label": "Proceeds from Derivative Instrument, Financing Activities",
        "terseLabel": "Proceeds from Derivative Instrument, Financing Activities"
       }
      }
     },
     "localname": "ProceedsFromDerivativeInstrumentFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions": {
     "auth_ref": [
      "r46",
      "r103"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from issuance of shares under share-based payment arrangement. Includes, but is not limited to, option exercised.",
        "label": "Proceeds, Issuance of Shares, Share-Based Payment Arrangement, Including Option Exercised",
        "terseLabel": "Proceeds from issuance of common stock pursuant to employee stock plans"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLegalSettlements": {
     "auth_ref": [
      "r51"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received for the settlement of litigation during the current period.",
        "label": "Proceeds from Legal Settlements",
        "terseLabel": "Proceeds from Legal Settlements"
       }
      }
     },
     "localname": "ProceedsFromLegalSettlements",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/CommitmentsandContingenciesDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromRepaymentsOfOtherLongTermDebt": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from other long-term debt.",
        "label": "Proceeds from (Repayments of) Other Long-Term Debt",
        "terseLabel": "Proceeds from long-term debt, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromRepaymentsOfOtherLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrual": {
     "auth_ref": [
      "r85",
      "r86",
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers.",
        "label": "Standard and Extended Product Warranty Accrual",
        "periodEndLabel": "Balance\u00a0at End\u00a0of\u00a0Period",
        "periodStartLabel": "Balance\u00a0at Beginning\u00a0of Period"
       }
      }
     },
     "localname": "ProductWarrantyAccrual",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "auth_ref": [
      "r83"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "negatedLabel": "Settlements/ Adjustments"
       }
      }
     },
     "localname": "ProductWarrantyAccrualPayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualWarrantiesIssued": {
     "auth_ref": [
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in the standard and extended product warranty accrual from warranties issued.",
        "label": "Standard and Extended Product Warranty Accrual, Increase for Warranties Issued",
        "terseLabel": "Provisions"
       }
      }
     },
     "localname": "ProductWarrantyAccrualWarrantiesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesProductWarrantyActivityDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyDisclosureTextBlock": {
     "auth_ref": [
      "r88"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for standard and extended product warranties and other product guarantee contracts, including a tabular reconciliation of the changes in the guarantor's aggregate product warranty liability for the reporting period.",
        "label": "Product Warranty Disclosure [Text Block]",
        "terseLabel": "Product Warranties"
       }
      }
     },
     "localname": "ProductWarrantyDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarranties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r77",
      "r194"
     ],
     "calculation": {
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "totalLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r79",
      "r180",
      "r606",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/OtherBalanceSheetInformationPropertyPlantandEquipmentDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r79"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r224",
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Credit Loss"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Receivables [Abstract]"
       }
      }
     },
     "localname": "ReceivablesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RepaymentsOfLongTermDebt": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.",
        "label": "Repayments of Long-Term Debt",
        "negatedLabel": "Repayment of long-term debt"
       }
      }
     },
     "localname": "RepaymentsOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RepaymentsOfOtherDebt": {
     "auth_ref": [
      "r48"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for the payment of debt classified as other.",
        "label": "Repayments of Other Debt",
        "terseLabel": "Repayments of Other Debt"
       }
      }
     },
     "localname": "RepaymentsOfOtherDebt",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r106",
      "r184",
      "r748"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 6.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings",
        "terseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes ( in shares)"
       }
      }
     },
     "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted stock units"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.",
        "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings",
        "negatedTerseLabel": "Vesting of restricted stock units, net of shares withheld for employee taxes"
       }
      }
     },
     "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock": {
     "auth_ref": [
      "r344",
      "r346",
      "r349",
      "r354",
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled.",
        "label": "Restructuring and Related Activities Disclosure [Text Block]",
        "terseLabel": "Restructuring and Related Activities Disclosure"
       }
      }
     },
     "localname": "RestructuringAndRelatedActivitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Restructuring"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestructuringAndRelatedCostExpectedCost1": {
     "auth_ref": [
      "r345",
      "r348",
      "r351",
      "r353"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount expected to be recognized in earnings for the specified restructuring cost.",
        "label": "Restructuring and Related Cost, Expected Cost",
        "terseLabel": "Restructuring and Related Cost, Expected Cost"
       }
      }
     },
     "localname": "RestructuringAndRelatedCostExpectedCost1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCharges": {
     "auth_ref": [
      "r54",
      "r350",
      "r351",
      "r722"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 4.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.",
        "label": "Restructuring Charges",
        "terseLabel": "Restructuring charges"
       }
      }
     },
     "localname": "RestructuringCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestructuringCostAndReserveLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Restructuring Cost and Reserve [Line Items]",
        "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]"
       }
      }
     },
     "localname": "RestructuringCostAndReserveLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringCostsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restructuring Costs [Abstract]"
       }
      }
     },
     "localname": "RestructuringCostsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by individual restructuring plan.",
        "label": "Restructuring Plan [Axis]",
        "terseLabel": "Restructuring Plan [Axis]"
       }
      }
     },
     "localname": "RestructuringPlanAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RestructuringPlanDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identification of the individual restructuring plans.",
        "label": "Restructuring Plan [Domain]",
        "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]"
       }
      }
     },
     "localname": "RestructuringPlanDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r8",
      "r98",
      "r178",
      "r618",
      "r623",
      "r683"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r187",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r311",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r523",
      "r614",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Retained Earnings"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]",
        "terseLabel": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r422",
      "r425",
      "r426",
      "r429",
      "r430"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r423"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, Remaining Performance Obligation, Amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationPercentage": {
     "auth_ref": [
      "r731"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Percentage",
        "terseLabel": "Revenue, Remaining Performance Obligation, Percentage"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationPercentage",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRemainingPerformanceObligationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r220",
      "r230",
      "r269",
      "r270",
      "r282",
      "r287",
      "r288",
      "r294",
      "r295",
      "r298",
      "r307",
      "r361",
      "r362",
      "r364",
      "r365",
      "r366",
      "r368",
      "r370",
      "r372",
      "r373",
      "r531",
      "r605",
      "r728"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenues",
        "totalLabel": "Revenues",
        "verboseLabel": "Total revenues"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails",
      "http://www.hologic.com/role/RevenueGeographicalRevenueDetails",
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenuesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenues [Abstract]",
        "terseLabel": "Revenues:"
       }
      }
     },
     "localname": "RevenuesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable"
       }
      }
     },
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/TradeReceivablesandAllowanceforCreditLossesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r32",
      "r744",
      "r745"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).",
        "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "verboseLabel": "Changes in Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveLossTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": {
     "auth_ref": [
      "r108",
      "r109",
      "r497"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.",
        "label": "Schedule of Business Acquisitions, by Acquisition [Table]",
        "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/BusinessCombinationsBusinessCombinationsPurchasePriceAllocationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of gain (loss) on derivative and nonderivative instruments designated and qualifying as cash flow hedge recorded in accumulated other comprehensive income (AOCI) and reclassified into earnings.",
        "label": "Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block]",
        "terseLabel": "Schedule of Unrealized Loss Recognized in AOCI"
       }
      }
     },
     "localname": "ScheduleOfCashFlowHedgesIncludedInAccumulatedOtherComprehensiveIncomeLossTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Company's Borrowings"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeAssetsAtFairValueTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of derivative assets at fair value.",
        "label": "Schedule of Derivative Assets at Fair Value [Table Text Block]",
        "terseLabel": "Schedule of Derivative Assets at Fair Value"
       }
      }
     },
     "localname": "ScheduleOfDerivativeAssetsAtFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock": {
     "auth_ref": [
      "r135",
      "r142",
      "r511"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.",
        "label": "Derivative Instruments, Gain (Loss) [Table Text Block]",
        "terseLabel": "Derivative Instruments, Gain (Loss)"
       }
      }
     },
     "localname": "ScheduleOfDerivativeInstrumentsGainLossInStatementOfFinancialPerformanceTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r711"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Reconciliation of Basic and Diluted Share Amounts"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r527",
      "r528"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value Assets and Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r154",
      "r155"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, off-Balance-Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r69",
      "r72",
      "r596"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r69",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r12",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Other Balance Sheet Information of Inventories"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/OtherBalanceSheetInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "terseLabel": "Schedule of Line of Credit Facilities"
       }
      }
     },
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "auth_ref": [
      "r87"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "terseLabel": "Product Warranty Activity"
       }
      }
     },
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ProductWarrantiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.",
        "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]",
        "terseLabel": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed"
       }
      }
     },
     "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfRestructuringAndRelatedCostsTable": {
     "auth_ref": [
      "r345",
      "r346",
      "r347",
      "r348",
      "r351",
      "r352",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Table presenting the description of the restructuring costs, such as the expected cost; the costs incurred during the period; the cumulative costs incurred as of the balance sheet date; the income statement caption within which the restructuring charges recognized for the period are included; and the amount of and periodic changes to an entity's restructuring reserve that occurred during the period associated with the exit from or disposal of business activities or restructurings for each major type of cost by type of restructuring.",
        "label": "Schedule of Restructuring and Related Costs [Table]",
        "terseLabel": "Schedule of Restructuring and Related Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfRestructuringAndRelatedCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RestructuringDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock": {
     "auth_ref": [
      "r38",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the names of foreign countries from which revenue is material and the amount of revenue from external customers attributed to those countries. An entity may also provide subtotals of geographic information about groups of countries.",
        "label": "Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]",
        "terseLabel": "Revenues by Geography"
       }
      }
     },
     "localname": "ScheduleOfRevenueFromExternalCustomersAttributedToForeignCountriesByGeographicAreaTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationAdditionalInformationDetail",
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r59",
      "r60",
      "r61",
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Segment Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r437",
      "r439",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Weighted-Average Assumptions Utilized to Value Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Estimated Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r348",
      "r353",
      "r662",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r266",
      "r267",
      "r268",
      "r278",
      "r281",
      "r286",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r297",
      "r298",
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "Business Segments and Geographic Information"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingAndMarketingExpense": {
     "auth_ref": [],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.",
        "label": "Selling and Marketing Expense",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingAndMarketingExpenseMember": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling and marketing expense.",
        "label": "Selling and Marketing Expense [Member]",
        "terseLabel": "Selling and marketing"
       }
      }
     },
     "localname": "SellingAndMarketingExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SeniorNotes": {
     "auth_ref": [
      "r169",
      "r181"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer). Senior note holders are paid off in full before any payments are made to junior note holders.",
        "label": "Senior Notes",
        "terseLabel": "Senior notes"
       }
      }
     },
     "localname": "SeniorNotes",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SeniorNotesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors.",
        "label": "Senior Notes [Member]",
        "terseLabel": "Senior Notes"
       }
      }
     },
     "localname": "SeniorNotesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsAdditionalInformationDetail",
      "http://www.hologic.com/role/BorrowingsandCreditArrangementsInterestExpenseSeniorNotesDetails",
      "http://www.hologic.com/role/FairValueMeasurementsAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ServiceMember": {
     "auth_ref": [
      "r668"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.",
        "label": "Service [Member]",
        "terseLabel": "Service"
       }
      }
     },
     "localname": "ServiceMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/RevenueRevenuebyTypeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation expense"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Shares granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Restricted stock units (RSUs), weighted average grant date fair values (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r453",
      "r454"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r466"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend": {
     "auth_ref": [
      "r465"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of the weighted average expected dividend for an entity using a valuation technique with different dividend rates during the contractual term.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Expected Dividend",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageExpectedDividend",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate": {
     "auth_ref": [
      "r464"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rate of weighted-average expected volatility for award under share-based payment arrangement.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail",
      "http://www.hologic.com/role/StockBasedCompensationStockBasedCompensationExpenseinConsolidatedStatementsofOperationsDetail"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r733"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Options granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r459"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value of options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number",
        "terseLabel": "Share-based compensation, stock options outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise price of options outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-average exercise prices (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationAdditionalInformationDetail"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareRepurchaseProgramAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by share repurchase program.",
        "label": "Share Repurchase Program [Axis]",
        "terseLabel": "Share Repurchase Program [Axis]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareRepurchaseProgramDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the share repurchase program.",
        "label": "Share Repurchase Program [Domain]",
        "terseLabel": "Share Repurchase Program [Domain]"
       }
      }
     },
     "localname": "ShareRepurchaseProgramDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r463"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected life (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/StockBasedCompensationWeightedAverageAssumptionsUtilizedtoValueStockOptionsDetail"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Balance (in shares)",
        "periodStartLabel": "Balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r190",
      "r266",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r292",
      "r298",
      "r328",
      "r329",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r343",
      "r348",
      "r353",
      "r662",
      "r751"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessSegmentsandGeographicInformationSegmentInformationDetail",
      "http://www.hologic.com/role/RevenueBusinessRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r24",
      "r93",
      "r187",
      "r216",
      "r217",
      "r218",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r248",
      "r265",
      "r311",
      "r416",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r523",
      "r541",
      "r542",
      "r543",
      "r544",
      "r545",
      "r547",
      "r564",
      "r614",
      "r615",
      "r616"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r234",
      "r235",
      "r236",
      "r265",
      "r595"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockCompensationPlanMember": {
     "auth_ref": [
      "r712"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement in which award of equity shares are granted. Arrangement includes, but is not limited to, grantor incurring liability for product and service based on price of its shares.",
        "label": "Share-Based Payment Arrangement [Member]",
        "terseLabel": "Outstanding Stock Options and stock units"
       }
      }
     },
     "localname": "StockCompensationPlanMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan.",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "terseLabel": "Common stock issued under the employee stock purchase plan (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "terseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "terseLabel": "Common stock issued under the employee stock purchase plan"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r24",
      "r93",
      "r98"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramAuthorizedAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Authorized Amount",
        "terseLabel": "Stock Repurchase Program, Authorized Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount remaining of a stock repurchase plan authorized.",
        "label": "Stock Repurchase Program, Remaining Authorized Repurchase Amount",
        "terseLabel": "Stock Repurchase Program, Remaining Authorized Repurchase Amount"
       }
      }
     },
     "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodShares": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Shares",
        "terseLabel": "Stock Repurchased During Period, Shares"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockRepurchasedDuringPeriodValue": {
     "auth_ref": [
      "r5",
      "r6",
      "r93",
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.",
        "label": "Stock Repurchased During Period, Value",
        "terseLabel": "Stock Repurchased During Period, Value"
       }
      }
     },
     "localname": "StockRepurchasedDuringPeriodValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchaseSharerepurchaseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r6",
      "r9",
      "r10",
      "r63",
      "r683",
      "r706",
      "r719",
      "r743"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 7.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/ConsolidatedBalanceSheets",
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "auth_ref": [
      "r121",
      "r122",
      "r127",
      "r187",
      "r188",
      "r217",
      "r234",
      "r235",
      "r236",
      "r238",
      "r246",
      "r311",
      "r416",
      "r472",
      "r473",
      "r474",
      "r486",
      "r487",
      "r523",
      "r541",
      "r542",
      "r547",
      "r564",
      "r615",
      "r616",
      "r706",
      "r719",
      "r743"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.",
        "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest"
       }
      }
     },
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r101",
      "r229",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r413",
      "r415",
      "r416",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Share Repurchase"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ShareRepurchase"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade Names",
        "verboseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/BusinessCombinationNarrativeDetails",
      "http://www.hologic.com/role/IntangibleAssetsandGoodwillScheduleofIntangibleAssetsDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r305",
      "r306",
      "r399",
      "r414",
      "r513",
      "r565",
      "r566",
      "r567",
      "r568",
      "r569",
      "r570",
      "r571",
      "r572",
      "r573",
      "r574",
      "r575",
      "r576",
      "r577",
      "r578",
      "r579",
      "r580",
      "r581",
      "r582",
      "r583",
      "r584",
      "r585",
      "r586",
      "r587",
      "r588",
      "r589",
      "r590",
      "r591",
      "r592",
      "r593",
      "r594",
      "r716",
      "r717",
      "r718",
      "r752",
      "r753",
      "r754",
      "r755",
      "r756",
      "r757",
      "r758"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/AccumulatedOtherComprehensiveIncomeDetail",
      "http://www.hologic.com/role/FairValueMeasurementsFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetail"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r23",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Stock"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r23",
      "r99"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "terseLabel": "Treasury stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "auth_ref": [
      "r6",
      "r93",
      "r98"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury.",
        "label": "Treasury Stock, Shares, Acquired",
        "terseLabel": "Repurchase of common stock (in shares)"
       }
      }
     },
     "localname": "TreasuryStockSharesAcquired",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r23",
      "r99",
      "r100"
     ],
     "calculation": {
      "http://www.hologic.com/role/ConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury stock, at cost \u2013 52,940 and 51,401 shares, respectively"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TreasuryStockValueAcquiredParValueMethod": {
     "auth_ref": [
      "r93",
      "r98",
      "r99"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the par value method.",
        "label": "Treasury Stock, Value, Acquired, Par Value Method",
        "negatedTerseLabel": "Repurchase of common stock"
       }
      }
     },
     "localname": "TreasuryStockValueAcquiredParValueMethod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TypeOfAdoptionMember": {
     "auth_ref": [
      "r185",
      "r186",
      "r187",
      "r188",
      "r189",
      "r237",
      "r238",
      "r239",
      "r240",
      "r249",
      "r303",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r313",
      "r472",
      "r473",
      "r474",
      "r484",
      "r485",
      "r486",
      "r487",
      "r499",
      "r500",
      "r501",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r532",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537",
      "r538",
      "r539",
      "r548",
      "r549",
      "r552",
      "r553",
      "r554",
      "r555",
      "r559",
      "r560",
      "r561",
      "r562",
      "r563",
      "r564",
      "r597",
      "r598",
      "r599",
      "r612",
      "r613",
      "r614",
      "r615",
      "r616",
      "r617",
      "r618",
      "r619",
      "r620",
      "r621",
      "r622",
      "r623"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amendment to accounting standards.",
        "label": "Accounting Standards Update [Domain]",
        "terseLabel": "Type of Adoption [Domain]"
       }
      }
     },
     "localname": "TypeOfAdoptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r54"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "terseLabel": "Amount of unrealized gain (loss) recognized in income"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/DerivativesScheduleOfChangeinFairValueOfDerivativeContractsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r251",
      "r259"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Diluted (in shares)",
        "totalLabel": "Diluted weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Weighted average number of shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r250",
      "r259"
     ],
     "calculation": {
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail": {
       "order": 1.0,
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Basic (in shares)",
        "verboseLabel": "Basic weighted average common shares outstanding"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/ConsolidatedStatementsofIncome",
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Basic [Abstract]",
        "terseLabel": "Weighted-average anti-dilutive shares related to:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.hologic.com/role/NetIncomeLossPerShareReconciliationofBasicandDilutedShareAmountsDetail"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 6
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "37",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123455525&loc=d3e2207-128464",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "30",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "805",
   "URI": "https://asc.fasb.org/topic&trid=2303972",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41641-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41678-113959",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=127000641&loc=SL5629052-113961",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "25",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577467&loc=d3e76258-113986",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "815",
   "URI": "https://asc.fasb.org/topic&trid=2229140",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "820",
   "URI": "https://asc.fasb.org/topic&trid=2155941",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13467-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13476-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=SL51823488-111719",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.16)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.7,8)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.16(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(15))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(16))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e640-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(21))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(c))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04(a))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.3,4)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1707-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1757-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1500-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a),(b),(c)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(i),(j),(k)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669646-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "https://asc.fasb.org/topic&trid=2134510",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/subtopic&trid=2144471",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.3)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(1))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(b)(2))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(e))",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "420",
   "URI": "https://asc.fasb.org/topic&trid=2175745",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(i)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1F",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031897-161870",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "220",
   "URI": "https://asc.fasb.org/topic&trid=2134417",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126962052&loc=d3e4991-113900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(l)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "https://asc.fasb.org/topic&trid=2228938",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e7008-128479",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624171-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624181-113959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=121577181&loc=SL110061190-113977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r558": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r559": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r560": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r561": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r562": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r568": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r569": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r570": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r571": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r572": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r573": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r574": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r575": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r576": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r577": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r578": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r579": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r580": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r581": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r582": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r583": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r584": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r585": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r586": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r587": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r588": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r589": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r590": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r591": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r592": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r593": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r594": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r595": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r596": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r597": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r598": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r599": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r600": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r601": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r602": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r603": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r604": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r605": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r606": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r607": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r608": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(19))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r609": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r610": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r611": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r612": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r613": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r614": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r615": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r616": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r617": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r618": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r619": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r620": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r621": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r622": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r623": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r624": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r625": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r626": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r627": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r628": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r629": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r630": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r631": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r632": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r633": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r634": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r635": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r636": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r637": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r638": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r639": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=123583895&loc=d3e30768-111565",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r640": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r641": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r642": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r643": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r644": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r645": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r646": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r647": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r648": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r649": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r650": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r651": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r652": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r653": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r654": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r655": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r656": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124507222&loc=d3e1436-108581",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r657": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3505-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r658": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r659": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r660": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r661": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r662": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r663": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r664": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r665": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r666": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r667": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r668": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r669": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r670": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r671": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r672": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r673": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r674": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r675": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r676": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r677": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r678": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r679": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(a)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r680": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r681": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r682": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r683": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r684": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r685": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r686": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r687": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r688": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r689": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r690": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r691": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r692": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r693": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r694": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r695": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r696": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r697": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r698": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r699": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(7)(c))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r700": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(b)(9)(a))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r701": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r702": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r703": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r704": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r705": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r706": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r707": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r708": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r709": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r710": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r711": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r712": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r713": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r714": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r715": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/subtopic&trid=2196772",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r716": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r717": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r718": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r719": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r720": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r721": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(h)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r722": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=109237686&loc=d3e17752-110868",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r723": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r724": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r725": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r726": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r727": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r728": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r729": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r730": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r731": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r732": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r733": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r734": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=127000608&loc=d3e9135-128495",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r735": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9212-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r736": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "30",
   "SubTopic": "50",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126928898&loc=d3e9215-128498",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r737": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r738": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5580258-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r739": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r740": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4CC",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL109998890-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r741": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5624177-113959",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r742": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r743": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r744": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r745": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r746": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r747": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r748": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r749": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(13))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r750": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(a))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r751": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r752": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r753": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r754": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r755": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r756": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r757": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r758": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=124440162&loc=d3e12053-110248",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(2))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "((c)(3))",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(5)",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "460",
   "URI": "https://asc.fasb.org/topic&trid=2155896",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "50",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "https://asc.fasb.org/topic&trid=2208564",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>96
<FILENAME>0000859737-23-000004-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000859737-23-000004-xbrl.zip
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M7AB*0A)94A):L%R48 R;G&"#8/.0@U@*PSP(P\>< =@$!!E=VS%R["9<:,=
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M'P4&(9* H!(KG]$U)"YL5)-KR@HQ7\!O==C!/S#Q!=)"*B$)K87+UAF$!"Y
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M=F(ER8K#)L"2&ZT?=XS)M/1$@S7",YTV*0%S!4Q90%U8*[L0BFK +)0O8-+
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M#?D:U_1'W>KW\L4V^M)%&TG-*-O@V9$&P@+1%B](:M9^ZS5*%+I!U&PI3W-
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M@%0*6S(MBU#)88H8RJ+8LJ6<SD9.IV5/HY.HM/>^YM&5-#Z+DAQ[WF HHF_
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ML(#O<0S2%(B%)3A51BTQ>@V&#.;B,;@/',.=3#VZ16/\P9R8;RP"OQ#VZVO
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M9G?M&X# [GNP>\+^"(&#D2FBX(U#/(:(K&01.168#(Q$1W&V/W6<JGY:=B^
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M(E.V=FL#E*V/LI/KD,HPX:1"UC"/N,%Y,J)+<1*;F DX.$Y"IBQ7:[SQE%T
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M&C1)@26%AEL%X.F]>3II$IR*5)"$,DU+IKL-R/J$4;G(*^H4N8DXFX3[;U'
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M)- $D( $F@ 2D$ 30 *R"4B@"2 !"30!)""!)H $)- $D(!L A)H DA  DT
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M"30!)""!)H $)- $D(!L A)H DA  DT "4B@"2 !"30!)"";@ 2: !*00!-
M A)H DA  DT "<@F(($F@ 0DT 20@ 2: !*00!-  K()2* )( $)- $D(($F
M@ 0DT 20@&P"$F@"2$ "30 )2* )( $)- $D()N !)H $I! $T "$F@"2$ "
M30 )R"8@@2: !"30!)" !)H $I! $T "L@E(H D@ 0DT 20@@2: !"30!)"
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MTMT7S;9[OGM2&NQU?U">8F,T&G3<R<BZ;MSKM_N]\AR#?C<__J?M_$39@HY
M>VO6WLET.$XQSVX3(UHV%[BB#FG, V*6".JUY(*4<KZKRM#[E[A[% %>FE/"
M6Z=QX#OC,\+5X>!6_[A$9?C4AX2OQ)?EA@S]D\SPUF5[+/HDW <OC!(I8N>X
M-<F0*(VV1D;K@@N^R@XN JK&V<&2BE_,QJ^_L7D\2:]^N#N.^V6'"# MGTT8
MQ506'38N*)9UT/G 2]W/+(LF3\J=U#9ZBB,U96V.WOO2F9DI\T@G"V[W0* 2
M-1WHA/C/??QGV:")3'I/35)4<(6=$22P%%,,/&%MTZ^&B.O-]O0041T=^?D(
M =;YMB/$1&J.=21P)@WB7 7$,=5(,QF1DIBH,MH;[5?6Q?WWIT$A%D4A8(2
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M?*P1:UV;".:=SOEYISWT@38K'0"%#+';Z)_%1CR_:'6N8AR^?W'9]6>V%QN
M6NWG#G%>/N2K<Q#SWE#2U8=>#>7\"L1<O*0SPI^8])(>OC[A'D1)>4+"*PGH
M)Q)RP20$6YDP-%J2#-[8(O+1E51JW#%@)55ZY?HZK*24ZGI"?R?H%LHY,^;>
M\)/B@]<G6M,0<!"()(ESCR.-G X!,#>)Q#"U@JF-+7-+99>BS;76YH*Y14I%
M2D5*14I+*Z72/:PPU\)<A\QUTEEZ>J(5-98FBJ@A(5-7@IQ/#*@KUI+Z''!:
M.^JZ-D&DU9)'#M9[?M#SB]CNV3SW)6QT[<\ BY2*E-:0*&R'3Y>]_GEL]WO'
MG6V8N3P"VWIEFV&_O6,OFGW;JDX9*M#<&</,-_&_E\U>LQ_?QNZ7IH\#AO$F
M^LYIN[I*138*IYB)4^Q_G?*&?3WQ40IJC4?<"PL_E$!:8H*$4D19;+"T)E<Z
MGEN%J:+Y!9^+E(J4BI2*E(J4ZN4.6UK)%Y9;6.X8RYWPG'W:/E$Z8>(P1H2G
MB+@F&#G*/<(L1<JQ35;1VM'<M0DV/(S]1K/M.^>Q! ^N_1E0D5*14I%2D=)<
M>H;/*T_DK-/Z]A*VJ<$N52C9;)3LVX\VD@/'X^'K$Y\4DXQ')'VBB%//@)%)
MA;"@AC/&.,F=10C1M3K-+ I:8+1(J4BI2*F$>*T@S1GYM(#I[%=,YZ].K^2Y
MSLYV)AU0!R>*&2^)C(@*SA#'+B*KM$!24A8\%B8F7#^ZLS;!6T?]L]BMPK:Z
M\2RV>\TO<>B1:F0A?&GVKTH<U]J?QQ0I%2D5*14I%2DMM91F*H_(, G&,B\]
MY]19I['$WBI!HA*2N7M0ZSNZ&5>48V><<?R@W*-R,X5ZST:]<P/WKS>H]ZX_
M(<R;()5'C :"N+8<:4D"DLI196-27(%5:?"FJ$>-F:+#!6F+E.HII1*15?;8
MLL=.NK?>G= HK(R,(L>I1=SEEJS..(0UT\8E8Z0@==ICUR:TZDV\+L[62=G!
M=5W5K81:K?U93)%2D5*14I%2D5*14I'2<YWGWU[EU5M!B!..:,6E(4[G=!5%
M.;%1.(5GKO)ZW(VV=]F]&FN%M>W_>]GLYMY_J=,]MWVX[;?^R_;E.0J=/AI>
MK)1YG<T\^@ZFT=5-%^3G$RX9%98)A$W$B$O!D(U5' !A46NK/4AAB[X0 M?H
M]'].:OUH5;[-H'I.3?Z?QPAC!B'4W&WS6(B:BCJZ 5%5[ML(H5[9;O7W0>R?
M=4JOT@= $KY92VH?("D2ESOR:>(3XMXZI TG2$9/I1,^"W=CBRBQ21[ALJD?
M&I5 Q(()!1,J3)CPXOH3D6)4!D?$%&8Y2]8@K9E$G'-%5&36Y/IR-<*$M8E/
M_-VV;-O'ANTWWL:+?CQWL=N@_$4C:]%S1R:.M:'.D]GKM)IAY9JVWVJE)<&M
MXAC8/<"=C\1XQZGD-#D:*27V9/^>+3C&6@T5:VR.,(=O-MWPY.#U"<8\5W_0
M*&JN$ _ ?*PP!"G"F8W:$::!^5"C7P@VW7;H86?9]U.1!9UR_WPP]S;A'H\
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M(G*1%!;:)L%XU,%9(9G'%&.3A+?^;N2[(]R\V+1S0+D;"5P,[G%"G!,L2(R
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MR]7E\A9.><0"R _3**BB&>CK$MI9#D*7A:<5S9VSYDY0-)J$D<E0Y%7.*6=
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MDW6[:?9S4^MX;*L=,2I0\,%\9X4;WTHK9.YDM&A4GNEJ90_W5J#*,?8',.H
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MO6WR@1@LD&81(VZ5138&T/;$I4Z.!N+2QA;7MW3H6Z!Z/[RS]M+H_?T><64
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M#W>F+#1#>+*))B!:5B.NJ$,&-CB4O!4L8:6T8+FYI2[M7^JJ6T%C*[7AQI'
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M0"NV>TV+7EG?3$W_Q.1B+7K+&"*TP]9@[#$WU .S$"R73$E18C^TR0JY>&(
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MC#36X/MX_KB1MX"*.VZZIVJ:F_I%;IPU]M"B/3:>_X.!8BJQR9@SV&/)K O
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M3H([X*J8A5?(7_ULU4[>"P'Z/POL7:CCG.56*$6D9)()HI4P7G#A?:Z=M3Z
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M K6$<Q^<(3Q((:T+7DI] Z?82J$^7:&*ZM&AX 83' @R'FO$">7(N&A2:\I
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M-:&7>Z._ 3=M"5DC;LYW655[SRMS9>6,O1A\SN")8-A)A@N&8,$Q D-6(\?
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M>>#141PQ]\;SZ$4<N'OS0J&5N_<H#)J*KS&C#!-*(.E\0#SR JPMX5"0+.H
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M2BR8U:-FYEJK9Q:BWED:SI"C*=&/M.-Q;';2-^I-G^;RM[7-G8_;:[\/N(Y
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M[E]6Z7<8YY\GD\<U^V>??AWLG<+8MJ^J5P=G,$92_?&Y7J.?+O9_5!F,X^H
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M'?8?->( C3QP&)PPXWY9/[QRK<#JG>LG]5VJ<<@I538\K)3YSM"R^!Q#;,.
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M<DK5C$%=9(+81MJV X0LZ_O)2!31W/Q2@'TP"(%X&GWO_+C5*(<T [= X%)
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M3"..+4&&68.,8MX(&L";3W2P7*TS,F?2PGLIC-=D?ET!Q'T!XJFDIBN 6!B
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M<"XB=L@PH9#DS!E/&7B/?.V#EC<Q("W.[EXZ8VOQ!KPL5SZU4VZ_0"D9^'P
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M]B^TL3IQL/S/<$E72N#!2F"ZWD@1;GR@!7(%]HG7E2/C#4-!&*:D8?"I6OO
MV"L7QB\\T"]@5?X2 =!"&Y\K )HG $W1+KI0>*<#,D0HQ+4*R$5&$-%"RD C
MBP6XS8QOT!4 +8+]N(J;SK0T&_4B5GZK-RN7T;8[O\\CEK%,./]L"3()I=W=
M0.[N ^2#Q=J+[3,REBL+;^__"+UV6KP5C-\)XS-X(DUPS E;($(MP'CT!CFO
M'8)U+60AB5.$I.BGOK%?['-$_=[3;GN4#;7:;4NQVR:-IM1T@XC"(>)93-GL
ML-M(",A*+14L-PE&/7:WO0%#8@E#5EOUGZ OFZ%R68^-FY-4WIFS.'<:F^W:
MYY?T%0<8.%C=\0*=HOXK!G05VZUEK\UY63R<IG>, MLB*(RT9@9Q\!F1-AJC
M$(P.5@G."IKRF30(Q+\7PX]<Q9*6F+AEA0Z+C Z3UI+6D@>O*8HQU<]S19%F
MJ969$UR' /K#D.5!AS=@GRUAH&>P=2N#FHGQ2HM!742?W>4I3.KWYAA[U?EX
M,,?8PXC"%E;?W%"/^T2S=.Z%N;?R">0/MVPW#G74LA?HOJR&F<[]*V1@TL;4
MW8U;Q"76R.#"H^!2;]-"R2*FWE%B0\\KF>8EK<\G<B^NP&V1WNT1X/9$HWH%
M;LL%;I/F,PD^>.(DLC00Q /ER.JHD%*I8E<0"GL@%=!OX-=M K7$QO.**_%6
MKL2'T?,$)\&C4P61CJ4N#X:K= I52$6XPXR^'"_BI__MU;N7V\U.M]W++% [
MW>/8WCNVS14%WOTY5$YV\6'4GL3(%/(BTV*;@*QU!>(4C&L="^E\<0<%WL,9
M$[6(C%+E51$)+Q*G7&KM@YET%H.Y/Z_&K2M!>BE!^O[KD!>,<.4Q(ARDB0M0
M:YIZC;1SJ5>S*IC'=PA2*D  7$[ 5)(B)"GJ5'Y;^_KM>V?M]]>A4<Q060E@
M]XQ$)A[-IOA$")V?Q?= P7_SMN#CA?_JB!X:PS")0J$"M@#B/%A 4<R0T5Y(
MX8@J%,U<BPS/CVOQB2BZDJ4%E*73JT/G)#5&1*2)8:E11=+(W"#IE?'>*Z:-
MO(F)L7(>VUET)BD9MT%-@^F?+EH?9:I]I"4H0,H,CI1PP[EEV$2.:31&PM^B
MC/-JSK=2X"\C=SM;WZ\.":=%TD*(4<W[!0N1>12I<P+0PQ";%?ATH.T)EF"P
M<&]# :-TP<'6-(PZI1D.VME"K"S!I1.D_8M#$@ES)!"DJ"*(>ZR14P(,0R.#
MT@(TEHYW"!+ 6)[>IH\3IN#?+V(*=EN5LWQ99\CV%9OU5KL"0[*E'%6ZT9Z!
MT7A<]\>58[ 69W&2SC0>'VL[/A%T5_I^X;9+=6\3UW8/*:<TA A[!8>0#CD*
MI+$C2$8;.>?"4!I+ZW&&QG^L]?A$Y%U)TR)*$ZD>@?V8BLP-1MP6!D2*@R4I
M/04];@B+(A3@?);VXPQ7_";[\9,%E&O#ZI_7$_8!@B4@KM0!<1OUHWJB"@3,
MA LB?*'B8O<BQN;-ML#,6C5J"981QQ"UY])H1QDCU /L12Y8L/?/0#QN-7[]
M4:TWZV>]LSW;/HK=DL:[SP;:V>YT>C'L-#,+Z-_7NB;+6 K_3F=5PX@O6NT
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M7$G3(DK3K]K18<&,LIQ&I(A+66W8(%,8A8*FWCN Y4"+M0]*;/#I,ND<Q\]
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M '7^4-MZ$1SWAW8@[I^J],^Z&8PZM'KIY'RPN^YU[++\T<27F* W W9SMRD
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M8PD9[B,BWBN?N!'<AK4-M0)+P&4#Q_(DX!2]7;C>3E$:B8D.C@E$= 37BKJ
MK"4.60!@9[-_;-W:!E\!O7T"C&8%(V@E\^91,F\*,"X6&'=G2W*J@#&5$7$2
MP=?#*2)3KY@I'K1CW  _!5_O*8:<BM[>6\I-T=N%Z^UTLDT(SH"S@:2C%O%
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MGS7HU3Y\_*+:A#'M@WS9^GU_6GCP^"7YZ13__B$.AGED/O?Z[5!_1GZ'!PU
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M:F?/YJ*(-0VJM>F;;8\BL@%T[,6XG"*J?;\LCR?]7KL]%KA>76T2J "Z8'1
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M96OL;&:Z5L<YMW<\;I[Z+U&)E(P1"$<=$9<!(ZL%1X)8141T M.TMB%>"+(
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M/3S>._CZ???@PW[C -ZSLTNGUWUV<TSNX,^#)GS7I&\.FF_?T^W/KT^W=_Z
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MRN]P5@5\%8%IS=?'^K@J9P%3'%AB:LQ>=YG(OF+3#@\SIF.=F:'VA;;SS?!
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M& 09>GA*C,,W1? N?KD\/T %0?71[P?@3#4;(>Z*KC3*3K2ITUU6[?6NR*X
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MI.;&X[>$6N]=%3:^FWT:MEW4W2W[N"4@")8;[-57][K7'=X-[8!HU!P1#<V
MX5^,ED?71D-?5<*_7]Y=-((WBE8EW( XK"_9L$Z"!D5228RY: 3OKM4U_/9>
M?%>H0#2LI[8RY>!S2B7PK6>^,=])W["&9\.8?XW*9] (/J1=O63K/OXUO4[Y
MJ\H?O2#LJJ$O+?OO?[77&//N,^"[%%GT=_A0@G5Y16K1)5V%P.SF@K6A0[BL
M\&.D^5(B(NWW3<,Y1DT3Y+L9P@0[PI.64Q$:WCQ+00JIR0&X-6C<7MW;XEY6
MY<.(#;K\ N%]D^#UK:'-/^>!CM$'I7D<"P[ZUW[$#*7#GVNTS\WAN%E*.EV1
M:-X*K5Z'X4^ZT)7A"R3=="T0P"K00,AE29<0(-U24Z(5_J2($_@"QZ3]AO;
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MNX9%U?<M>I6(\W2.C+2O!JX$*$UMZDV7=V3ANE$ZCM!;K624"P%SD H%2XE
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M,^BI ;82 6$\&J6#3(R'(-,FP"Y&-3)KOP4&#6(*J2DW XC"#);?I-FW/HA
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M!+PVF+0+E)H UPO0#BH+ADB:))+5H1M5# -8*1RD,&IC\"'MJA[H(L%_2/=
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MA5CDX']^%G^==Y+[RK%M"0#@","X@8 ?OPK(\Q.GU@SW;J_R_3_ 8K-K$<3
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M9C)B:RINU#WO<Y,M<NGH>2[C$N-QEG[G3 U.>(S V)]4E0MU D-M0GT5X/"
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M:K= E_!HF[L4@B?\Z)=80I?V?E0N#EDU?I,$+12E"+QFD:F+T%0M&5DATR!
M!\Q!*1RO7'GJ(BP6"T96:-G+U8)8"M^MEZ.Z"+!FE<.N"QK)T@)9CNFUZR9=
M1*ZPH&&%4IE/BT@IO"_(Z&+35V;@K4!HDJ"%HQ3F-V3RNPA/=5;>"I]&$5J
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M95KH2TF]ZGUDU4_[*%6/E'Z4%Z"3%F*Q1<S.&C80K$6^E"/<8/-9!S%>N:'
M-N%1P:K%J2)16!#320PTN_;DBA$.EF%.9N7F;BI=BV0IN6BP2U"=/Y?Z?@Z+
MY!UT>S6P;!_>;*% "WTID64$_6O,8PC^12 (U$]\7LA]:B0AF'"B7EMZ7KM0
MI36(#6Y:B7>9*.4HT9Z1I?I?IP,M8O<DH(Q?,V'KA&VM1FL4Y1UA&QE%K!HI
MW9TTB,)>[X91>X/=YXW2M/"6LEW%/>FZT;ZK ,IOG[F13VZ\TZFT>AID&:L;
M+Z>3M_)P[ C+/KT#15K82XFQ5=A3O>C&0[%F1(-B\@R>YQPHT]]UP\C0805T
MSFD L2J5_5,&26J(W-@BK#7H3.%]*=&V:@H%T-D*Z)E25-#:=0/X@FD@$Q$L
M[ZA_$'="PCOBL$E _PN393"Z.;W8V "L-6@-H)1N6S4 J3 ]#\-6!H%8+\H5
MRT%"JNZD%33<\&85\NGE:!$MI=$:[XOK8NQ6>7!,&C*TB$]5X9@GUVH=:*XS
MZD?R7GM),YK)S_79(;HC95K82UFYI@-M?;1: CFZJS(H TE*D= FY>BBH52?
M8*M^FL0Z-*C[&L+-G/!XF<+*?EZV#%JS*J4(:X_A-;Q*XT"8(1H^[) 7[M76
MTJ;;/HEH+U=K$^9',U\SACJ OQ+YD6_BCI[ ^"=R8U,TFZM.\"A@= :_2C#E
M<"GVF_FN!I!M]&H-I)1+;#"0M"#]I"2H4!24E@4)EKB=2A)*RM-%,VHZL7L1
M/$'%&+?U.NUD:N$O90UU!X)ERC#3\@KJ*@"W\0=AE[?P5H![)C]3-<]3^SN
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MK,.@A0P&SE'2 G7H6XG8>:7C)R">!A.#^M[BI7QPSCA$7U^IF,)3%UCOB*K
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MZJX5LWU E:2MJ8/5PD\31QMJ9+P<]Z-7X=3M:R&,5S/\Z:?_ 5!+ P04
M" ";@$%6<-C)*'T>  !8(P$ %0   &AO;'@M,C R,C$R,S%?8V%L+GAM;.U]
M6W,;1[+F^_P*K?=UTZK[Q3$S)R39\E&$QU)(\O%Y0]0EB\0:!+C=@"[SZS<+
M "5>0)$$JLFF=AUAB@):W5]6?EV96965^??_^'0R>_(!NWZZF/_C!_XC^^$)
MSM,B3^='__CAC_<OP?WP'__\V]_^_C\ _OOYV]^>_+Q(JQ.<+Y^\Z# L,3_Y
M.%T>/_DS8__7D](M3I[\N>C^FGX( /]<_Z,7B]//W?3H>/E$,"$O?]O])*44
MP2D+3F@!*F""($R 4!(OG NNL_M?1S]E'[SCHD RA8'*)4.T)8+#%!03(H3"
MUS>=3>=__51_Q-#C$Q)NWJ__^H\?CI?+TY^>/OWX\>./GV(W^W'1'3T5C,FG
M9U?_L+W\TY7K/\KUU=Q[_W3][9=+^^FN"^FV_.E__^NW=^D83P),Y_TRS%-]
M0#_]J5]_^-LBA>5ZS&_$]>3:*^K?X.PRJ!\!%R#YCY_Z_,,___;DR68XNL4,
MWV)Y4O_\X^VK"X\\7LP61]/T8UJ</*W?/WVQF/>+V317Y;Y;TL^J[7Y17A$K
M3JH(ZULN/Y_B/W[HIR>GLR^?'7=8Z-Z+V2>"(@07&R#_\X8[/OT*-(596LW6
MX_(;_7U[WPJK'6;\M,1YQLWXG#UXMD@7+II5[2RZLW\Y"Q%GZT\GJQZ.0CB=
M_-HM^OY-MRC3Y21[="%DTD!T&A3)#9YI!8B)9Y&3],E=&B02IB=IUNHLH8]K
MG6[O_;2.WE.<+?NS3];CN1[+'8_?#.#^DKS%#SA?83\QGL>2C8-<7 *5#$)P
M@=XV'C./T>H4<F,QSIY]489S-'C6I2>++F-'<],/3SYBG4FVT]0&2.C2%7Y<
M?$FV5SSM5R<GZWO"E AR]N_KG-5&L\M%@W'=*(T@'ZK5%XM^^;K\NECD_MD\
MO\/NPS1A_VXQRQ/AO>962&"B*%"^&'")9F#/@F11>AF8;*SGZ]'<1O/BJ^;A
M4:B^T> ?3(8Z%T^>G2RZY?3?:_DKL,4&V!J-%<F+C!*29Q846@M1>0M2,Y]4
M\3)K?=/T?M-#;J-A^5@TW'1$V^AW@Z#?D&SBL_:97"<P+!CBER.A3$Z 2B O
M/J/ ="N-7KCM;72H'I4.]Q^U9E/TZU/L2-[YT2^?3G'>DZ5(TDF9F ;O)9$G
M<0\QI @8LI#>95-,:#PS7P%QJ%3G7X[7Y(&1YWLTC3-\UO>X["=22X]12<#Z
MDBAE%3GRB&!+4H'^L]:IQB)^&]&87(_#&''9"C741#/.O\,9?75$5O%?H?L+
MS\DZR4E+E9P!2Z\<*&,U6<:004?K#,VJAIG6;LGU:.[HECPB5C320#-&_(IS
M$F]&>)[ED^E\VB^KL!_P#)3)AEEDA&(]-:./$'P08(SB)AFNG&6-:7$#I#LZ
M-(^(&RUUT8P@;Y%@K-)RU9&8+XY#=T12UKB)1Q9 (B<W6B<.02A-7G46R6)R
MG%U>ES@\5KV*XXY^T2.BPL&CWDS_SU?]=(Y]_V)Q$J?SK=,]KX+B?%E7?J9Y
M+7@=](Y,W&;QAR#3KZ_F9 17<PK&KOLGU1;R270E).,%)"<H1/>F0 B)IK\L
MC0W1,E9:VYY[$.LV[-3WY;6WI>?82-%RMD.ZS3'-P3_C!YPM3BORLPG8*8-"
MUVE7" 2:;A%"E(J"31=$Y!6P;S_M70_H-@PSCW7^:Z2'AM38+B@RQT74R4+D
M$:OG[L%G+T';B#:&(ET4][)0>\>5"HK9,YF4[;TFY$-0V!TBF0]-ZF$H('#&
MP#@FBA;%:\YOM51Q\;YC"NCV4MF%=8H#QJS-\M)V]?(,@"QUV5HFT*;NU\6L
MP'D*(JW,O!A)?D"^W?K2Q?N.*=XZ7&D'C%FSV6*S]_7;HN]?DH0;2[>BV7$[
M39*]>XYET>'FNO?A$_:_?")_GP:;#&KW^16-4?_[@KZ=+VGX:LSX:K[$COS"
M"4<I.!$. JN+V (EA%2E2HI)2W.@TZUCL@'%.3B"#=-Y7Y%A_WI.#Z5;KZ;]
M<;47K\O/&)<3$Y,(@0O0PG#RFYV#Z%D"R3$ZG8H1MK2.86\"-:9I<BQ<O1(/
M-]5L^X7CK^,VX399:VP"XS,9AH(6G,[DK'HC3* HW14[U-+Q5QACFL;'2JI#
MM=?00FRD.7-JO0_"IRA <*/K)DBDYX<,H:C"R&I%*UN[E9<@C&JK<*S\.41M
M#;GS@2#4B7 C_A?)C%_'1ARDL*%*QB%B-!"5#:C)W2$1FY-H-Y8Q+<Z-ETP-
M]-C.L"V/L2,I%Q>GR#.F:XD40M@(MFY6*309',V:P+DTR6L=K6V=H/1M1'=<
M8/M_DF$-==J,9[_C\ISQM<9+[IR&8*PD'RY&^DTIX,(YX;5@TK>V>Q< M(GT
M2*/;,7V.<ZRY$2$&0Y; 0G:<PE<:4 @<'4B5BPM&8LJM%[6O@7+'6&-8N[Z_
M\J].GH</_*.(]X6S6ND<('(D8\ $@D],@@S64]QC*=9IG>!Z;_'^PP8IK<GX
M\/H?-,H5(HEL'*\I"9&LA6#@'$7?3BECH^%9B,$2I-I-V.<3V )G)CM2=,0L
M0$E-5E65*J!0FGE,C%U>!!\L=WPDR4][ZOO*XLV>HSQ@?A^B=T5R#D:E HH<
M:@B:%7"!Q<PTB]:U7@>\(;_O@1.N6^O\L"&_I/F_/[T\1+_1WQL?JWFQ.#GM
M\)C 3C]L)I<+8 X[87/UY@,>MKE!DD;G;BX\9<,:LJ&O"QFTB> V:9\E(!-U
M,99IB$Y:,+D$M"%):UOOCG\#3I-@>,?]Z]">/>--S?"D5W>Y[*9QM0QQAN\7
M;T)'&IDDP4LJ+M:!H,C*1:3W2"6PL@@?B@J,M=ZD.1#RF*Q1*Y[M#(?O2:L#
MQ<LQ!L:9Y6"9I?#&($+,!0'1:!=*X3&UCBN_$2\_K/\^%$WV'_&VBW$',-5K
M7J)5$22J#"IX"[Y80U&PY3HY%X-LG:+9=/YI.V(O0G_\<K;X^)^8C[#N*]8/
M-Q'96TRST/?3,MT<"7Y6*.RJ! I:!9/)"<HARGIPD$.PD@$OC/O@"XWB?<[@
M>X@PIAG]/OE\EUE_:&:T20/ZE@0O">KT:/YBU=% I<_ONS#OMVK._WNUV5Z@
M$5XOE*79JM86V&1@]E\%Q%R7+9Z]?O%J@DE&:;D!#(KFS1PX1$&R>DL:""DE
M4RX'^;M3C.X/\YA,TD/P?,P4N:^H[GF8U2(/[XZQGBH[,(J[>+/&4=LWD#:*
MTMXM%^DOPD#$[W_Y/ZOI\G.EE8O&>9!<.:)5\1!\CH#&Y>@40R)68V-V%<6A
M%OX- 4.B<%[?^K_";(43Y;T-3'FPQGI0UA4(+A$A@W-$16Y1F<:"[8 Q)DM[
MH/8O&\]#![UA3863D\7\' H,WB>;!'C)::KD7H/3VD"RCKSUDCQ/EX_/-UAP
MN(!A3):GL=X/&NYF2G^6\[3*'F9OPC2_FK\(I]-EF$T81XN> CNGD8&JUL<)
MJX&5B!B"]<$V/\B\&\J8SB,VID"+P6]X_F))WCGF7T(W)_^D?Y;2ZJ0.->:?
MD5STZ7+"R>\.,FN*]B7],(D!350)$C))F'5!TSIBNQG5F/*@&O.CL4J:4>5]
MAZ%?=9_/6ZPD' 5G2!QE 11&!L&8#"QX5Y0KEJG6>^A748SJ1&!C+APXYNT,
MQE<.WB84J_M=LJ12P$F;ZS*A@!"00Q$%=9":R=PZJ^V.$,=TRJ^U@1E06<T8
M]=LTQ.F,#"'VFP!Z.2&WU_" !K33-5.$PO6HO /B=! FYAQDZYWDJR@.EFLQ
M/WJ/W4D]27$F&+>,Q>02%"X3*)4=^'K$7%F;F;4V:-%Z#V\'C#%%4P=J_S+C
M#QWTEO/D>H'G3?A<UY_.L'AIL&Z/0"ZZU$J?'((T K(WUNJLC=2Q_72X \F8
M(JO&'&@P]"UIT*TP[Y(P&YYRMH"N+O(%;L%CJIG"1HE"7CY%^NV9L!O,F&*L
M]F1HH(!F?/AYN]BS/3Q[AH6)'(I*Q,TU%DX.??22@>$"?6!&L^9%*W<C&5,T
MU9@)#8:^&0U>3N=UC?HW\NGQ3,S/9XA$D ZU1<C*"D+$/3BK+$26DS799=>\
M3MZW\(SI&$AC2C13PQ#.<*VM>C4<<,F%8H6!X.K^%3/K;2$'Q<D<$J>HO[3.
M.[@)TP ! $?+HE(28M+KM5"$&&CL#;?%%)-%:)Y*NI]5?  W^7!>7'&:#U-
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ME\R!"Q3G.^U\844K4UI+?1V6L94I'H(X5T]0-M!+RR7XA)C7)6S/(]OL:5Z
M5WCR*16PMNY@629(7*> 6Q8<)RN<L#5M;@UN3/'-/=%H&,6UB8R^XEF4D,BF
M=IAG!&E)D'*%5-N:)AL-9,7K4J.T$ J%YN32Z>!0*S27UWMV!T@W/6E4_4T&
M9D;[H6\WRVPQO5QT!'#5I>/08^T&^J7>Q 1ES,A9S9V1"E2* 0):!L(ACYR
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M6U'\!\1:6TV/"<E$A;)UG=@[0CS4NEWSN"O/6>MK(M!DKDT&RXP$)8V#F,@
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M53&NO>8VV68[-=I^OO@TFGS!Y0[]_G*:SDF"[T<PGM'V'+1 <FAM+@2[9,M
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M*[[F+#KA&(A:S^N"XTIZF6/K3)%]L?6_[31GS/K)THE:.D@EO2N(<YB>X6S
MM5?6&$=K+J5Z@9[Y&"2SSLE<=-8>6D?\MN%XZ;1XC+B[&)MP[;C=0]JKV3'*
M1ZM%=JR4+&L]I6$A&V )#)?$6\-MZTWD 'A]A5 ZITE7*CF5*,J=5;T?P=*2
M][D8GS-9\J8V1].H&#C.6;2I)&EL)B%VN>VL@#Q]!*6QUN_;A!XE_0YVH0U0
M5^;_/K Z"ICL@/0T89(&2GN(!D=(O$="U.DUD U92)JL)AV"8,!%8$B\ST$E
MD*IU,]U>B?! &*0_'APBZ.:=#6 <+Z=?7M.9=#G%56%M0 71199E3>;GJK!
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M.[@/N.]MG5\)[+W4M5L!.DZ]<$%J&9,.149O:C=;YWR07'O^T*W ?>_MYF+
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MY1 I=^+^WSL?Q G"@84\9UO-F&*1>9$<<]E8+JSBQG97&GDJ4UFZ8L+1$N_
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M?/CIQR]OQF0=+6ML%T.OZTOHAS]^V14_649?8P:#T7E&6[0FMX9LY*A<8ME
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M'.,41H3O5;X@.=<,DAJ'O@M2.E'[A@>F=2821Y-9*-HP3$%X2]ZCX*VWDKV
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MB9WNT4V-= 8L2I'=Y:^_L7OUY(F71=ZL([OOLD>YD'[DP1BG2*W[?+4"#)B
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MZ)1WG\6W^H7BX/<53I,XC#"':JV6Z+-:!&G" JCFAB2-8A[YJ5%TTV0(EZ:
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M=6,45]9R<8D(1T)QMIM9)>*2L<_%X>+U(]:[+THE,?7;!Z);[C,3^5$D/!K
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M;8BP*A-RQN11E4&>MS5;,9 S1NS7_SAWR<BB[&H:]UZ^5'.SK'Y#6!.CTXB
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M>)(P</M\!PB7;3@X-S"X?$SX:%'5A=19AC(F5GY*./(1@FE"U,PP\#V8QD+
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M'/A;&-TP1E.WX0@_B>*N)(_W&2/K3^*N<1_=/<<^E3S!E.D<+AY$(2$PC9&
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MWN>@L0;LF0/>YJ S:*YQL?@>S#4^,WTW^G$Z?&7V7JO=VU/?DQI\+39K#J@
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M<=;_,<\$$:ZG^7%IRJ3>2%6NI'@E5_J'W6<]3=O;?;U2^_4KBIP4(@&%)"E
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M';%@S=VM!YZXQ[LK(*>MWIWO$/Z0MW.6T@2M_R7IYIN>/+G ."D8*R3@<4H
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M.71Z7Z.G\$W^W+W2#OU[@9)4<9DIH*C1Z84( RS2 N1Y1A/)BD1*Z%0G=&'
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M^LC>O5%:R <!/'R'^>O,>JD&]$' '.A/'^;^UQ;LM,U4GEX_;C:FY>1Q@8B
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M\5 =K7W=T<UN9O/TW+(7F*V;B,F[<K5JDA1KBZ:<PHRD^C6N*$B9I/K=KG+
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MM[K#/-B]X\=!=^S=$0ULM<7;FFUDN7_YO4;YUVAO?'1[&6;G&, =L4 1@</
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MQ9PQ@&,N$)<PY\J)9QW'GQNK[LTWI_MG&UW\JS7=<<_,=6)L3_M'@WOTL_X
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M'<(KY)QS.-0NW]&]I]W#.^?6R0[=V0_Y'@,/),HU[Z*"Q@+3O  RDRE 6:P
MSDW#O50(*5',4JC<#GLOCCFW"*!S9%AVC@S%44XJK7MDJ^7ZCTB';7>.-5@V
M4V%[4!L4X-&/8X<3>T>(#QP "G:N>GG$B4]/K2$X/2.UO]2W%&I5I:L9I?MV
MAVBO8=_L(AF]^[M55;23ZILD,8< )4H'&-!H [(X 2KG)(&(,"R=1+/<AI\;
M5[76UZTO6ON/^EFT^\0')UPKJ)SFQXZUQD-]9 (+"[A']94/;L$*LIP&G[A&
MRP>8T[(MK[MXRFB<[O)\V&=IY5E.<M-<5.1% 5!J.FDD"0()PRK&<8QDBIVD
M- 8&FQNIG=ODO")=;A!G.[H*A=[(Y.0/G+N\A@4BH20VAH::5F;#PND3J0V;
M:]P(1,AR\7:UTY3T]9XNE^T(BT+BM$A3S10,:LXH9 X8R3( L6*(2RFS/+/A
MC)[[SXTF:A.CRL;]P8@=-?0A.,P& 7 9F0#<(+%^Z"\X?N8YWTK^E[OUC__0
M5]:/N/[A\&3WW6^2A_F",^WS>^EC5QRZ?%\O]17;MYH0=D\?USMY3G!%9:2
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M,<,B7^2S?C&>]$[G\WKUN*;?OTCC&36G<;NN>/MKZB:S\2PON,29U(20:WY
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MOM#6F!M0F7,#*H.J[/N=26!ODV.5E"O&SXYX1AJ5@1GJB@$!WQZJ_PS2$2\
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M%5T^KU?BA6\^K9N2,578=$XQ(TBO/ 27"42$I)#QA$!<8+WN2#,IF-7*HTO
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M($*J@(4BF5XD*J72E%&&8Z_(^#/"IK9P; 7 M2LF?-OJZQNH?@YG.YH/A=[
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M)C]Y_KB]P[O,.VGOW7EAUV1NCX$FB7_^^[]L_T7_8>)2__U?_C]02P,$%
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MU8@Y;PJY8%"X(1:QQ"$JD\C;,XQ;CE;P75>BQSFZ.PCJUSIM)/1';G K"0P
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M9N']KGXXQ\'F'@D]]6;M&B['L_E4X[=-&"N,IXNJ(''Q=OKZ:V70U7CQJ6Z
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MDT-3I$\[G]@\KO?3D^3T&Q4])P1;R:09O'IR\]<[ZA,NZ;B8=.KSWY_IK &
M'8OL*1I@,0LNG0'ND@052X+@A "/$:UTS#'\SJ,!!YLO*T/EH?52MR,F;V/Q
M$40(I.T],2Q(SR#SE,EL0<-L\U*>5L1_7U&(0U!YLKG:1-[?093U99B$:<(/
MG[#6])^H8>\/UEJ)[B"UO9[\>3RER<9A\FZV&*]VQ$U/V2+1&%; E!1 21$)
M #Q#MBID0D<M>^Y..3Y)U\G])U8]#FY6R8-0M9D89.<M*$VFAJM]600!OJ@8
MC-:M??'[% Q&-[5!PJ-6$\>S>P#N[YKZS3N=MT]RF&24*,2/*!$4#Q&B)?VH
M,83,,CIA6WL+6PGI%SJG2'8K2$YA\P"P4H_7^M_K_[H:?PD37 4_:2GC1#J]
M_H*._?L_N//)44C>AU1WED7RHF1-PQ6& 6,\V)BM2#L?Y#[* SV%X"%@[R3
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MF@MA ,"ZH=L;AQ8-A\QEH0V!HIKK"7S4&(U@5KO6Y7P' :1CX[8)0(YBY@!
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M PVX8=2WZ[4P@24R4U^_C0Q4DA*"9Q*\$,2VXK7"UHW@=M'3;]BG(Q@U$\
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M@S7\-+L,X^E(",-BC@C!$_TJ\ "!F 1.,QY(["6DUMC92LA ,'.ZH&>MN3X
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M-7UJONRJA)L%)4IP$DS*H3Z@01J<!P4LZ*!<%#S8]ND=1]7==A;P.2N&3I/
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M5JY%'N/=.8<8_SM&^B?QLF<,O%B,P[N0QF6<-L0GI:10O':9(38HK(G85GI
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MD&6K$25HIPLHAPC1J0(U$)!TE.CC7NV]_GN$=4\!8E-1# !:>VTL^F&JTKO
MD:;S1B3N 94@AROX ,%Q"UX3\QB&Q)J_A70@B8/4@$?BXQ@M>*2POA<L[E+R
MM>WS+/,11FE<2 7<*LG>"0%1>56O<9GBJ?BL>P'I'K0/4FV>$;VMQ?L'<+)'
M#R(&[=WL$3^[H_UP43>N]H]'<O17# M<O,AYO.ZWMOK^S71%P(D1BWV';L'#
MHY;1*$ZQF?O:Q33<.:R%:D55,XDL9G"6MKY+VK,DI!7[E?\>H$7O4W!29LQJ
MJ TB;X_$M^7C;'G3\F8497!2! 6U33 MT6>(QG'P/ B&T>;RR-W;GB6SSVS]
M&B8G"/=>JDQSO@Y40_\<QO/_#).:"1065_-5?XC%S0]?+!:X2BN\C@6/:WKJ
MZH-Y-GV/Z6H^)PWX,BS&B_66/4;Q-*>AA8;JEC&-5-D-/631I,FL3G^+?1W(
MX1>2 7.IFL5"@P\E@]0FU%YY4J;625"[Z#G5;+X9^^6WEV%23]L/GQ"7O\QG
M5Y^)U6N?5S/IN,X6#'F^M&8MP DD?R"$4N@W=>%=K7D'7?WJQ&8H>6CJ-A?)
M +RS.VNZ^?(_QC@GHCY]^Y44_Z9E3J&#)2H'.B&MRD@-P416N]S&X# I65K[
M7OM1-A"H-4/$TY!K)9XA@6[K87.SONO\7QTQFB) QI79H6I@+T:0UI440_"J
M>1^]@P@<# 2;(>0I$#87UY"P^&;Z^6JY6'&,;_+$L\RVH.* R?KZP!@9O%FP
MVBA<>L:*T*XSY#TF9R X:P^"I^!VHD0&"BYQ7:O$BI;*:$#/."A+?(IH QC&
MN'<N^<#%&< EAO"X=+_@.D8B P67O&Y,AH(E91G07JGMF)6 $#F#1*H^9BUJ
M+L$9P"6'\))UO^ Z1B)# -=X2N;L.$S>3,ESNJH\6]D1.3)'^Z2 L#R $KF6
MZ9)9:Z-F#AFW/K2^DWZ"E(%HK,XL_P8"& "./L[#=$$SW];UK2Z MJQN42OU
M%MM_M=F;I(-S\<1/OKJG"C*"M\&2)<MH=X;$6&X=NVY)?\\&7 M S08BW;XK
M=&L6'RUU58X^78Q)<BLYWKQ$*9E)DDA7GEBJZ2#QW O0.A@AB,4J/HR6/-D$
MXNEI^H53?Z*?=2*' >C*U<M2N%B^#TO\\'OXO%D%^F M:@N6DS&J(O'%RX2T
M'N\,YU$4UMI1V$Y)OR=N[X!K**:CP?8%YW'6RL2;S7%\,7W]-7T*M(6N$Y.O
M^R5$%7RL;R>'6G5O:QUB]AYH%<SK$!49Q:T-O5T$]>M## 9\[80V (7W8#%O
M/]_1W<X:Z:W@D&*RH+@LX!1Q2B4>G+&.ME/SJZVGR>GW];FAHN]H@0T >W>]
MME_KIZLL5Y%RSYD,BDR%X!0H0YP*005@(:E0T$:F]WHB]P#@/47+0.(F7;FX
M340P4"AM-EL1W!EF)+C"R13@7H*/0D)D,0=:5^'L'& :@O_91MI[0.@(U@\
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M^]6U9X#K.43X/969W99_/JK\O+^<$\K(=LW169G8W@L[1QF8#ZXD5?N_!!E
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M93:B)&L?9I)LCR[MF&0@-Z)=2WG6 <L'44)]/TAWKS"\9BGF.Z\V&*=CBEE
M" ;K#7.$@)P#5X5E)DO4IMO[KEW4#23O\TPX[%AZ SB0[Z_LAK\CY%9$)PVX
MDHE;%C.="3G1Z>"4CBH$<JP[!>$-*0,I;>T5<<?)90#P^G6V6+R=?@C5$KD3
M8!D%%&@X$\ Y)^(YK< +6@L6AD(X973)C>'U!"D#J1D[,[Q:R.5[RJA\/YM,
M?I[-?P_S?,)#(/L.W5G^Y'/+.$?:I,J^T%DF0#A&!YRH39-RH&^#TR9QG=L_
MUWF6[OEW^%Q?W/S;=!87./]2/:1UD\;ZS"\9I)/Q.OOX?EKR3;7P6DT[EUS2
MM!E35(+LTRAI'SD-M+UT2"E[C\U[XG2QD(&X':?B<)\^U><5^M'*\_/J$:S5
M<Y:==5C?AQ5/<.+=U3Q]JB_-C-"R(HIS$'TVH'PQX&-F(#'G:B#S@JV/^*[6
M,A"G9RB[H*GH!V"D-N;#+V$\K?;5FVF:7-%A_&;Z.LRGJ[!%L2$9U :8M62R
MZ=I;G]>'1:).,<2@4_.@^-D6-Q _;>";I!$X_GB[Y@,NEY.UE3OBIC!=O(:L
M26B*V0C!^02)Y%<S$67*G?4D;[Z:@3B8 ]\7QXK_.]X(NXU)'8+F"FNZ5+V4
M2:QZXCI!(8M2)J&82)W==IW=@]#_;>#?3N@G>A"OI[FS$,S+J\5XBHO%J]EE
M'$]7H_T6YK4&_0N>$'[99]@6H9>#R6\4=MDR[RU8HU.),XG@LB:EZ)FLI=6D
M%(-01GA5G&^=?[.+GG;5JM>SO$C_=35>K,J#%R^_W?EN?4GM&?=2.@$1Z2A0
M->^\MIT'\JR+R\8'65J'G?Z_]KZLR:T<5_-]_@MFN"\O$^&RRW4KHKKLL%W=
M,4\*+J"MVVG)5U*ZROWK!Y1R<Z:4J85'A^GNF(GJM-/W$ 0^@@"(Y5 :1VZ#
MUPH]NZM6!Q!5!_?WEEVML[IX\%FXX,"GVCPPVE+[3DJ05I3 /#/9M7;6=I#2
M2PWK$/*_WZ:S@3 ZQ53]<8'7:6 Z!Y/(^@ N8QVFX>ELDN$+)K/,E;+>-)]5
M^"11?2BPDT2_!YR.E\/824@_S2](!.\O%V2NA(OK#$"O=*JU73GXVI<T>G &
M,S!ID/%"9DFX7V6_/?MHV]?[0\0)TINW9.786'B1B#'AOS!<K#[=5D)83,H
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ML @9*UNNZ;?6"1G(W-1IW55.5=-5"/!">*.2B9FU#FS>IV'DI_LS NDD[G>
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M9O[Q=>-[CS)$&\DEJ04I3!;P12 X;X.*9,:J>#\LNV/PR9:O=X:"8V0V;\G
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MQ7I RLNU5IOB=9I6Q(@V2 $I, \J9;*E,&O(Y&[H$DUA:;\DB!T+C!->:X^
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ME\3P/<FN?E'_$XG>__N__C]02P,$%     @ FX!!5JA;(P4+"   )"8  !4
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M &/AG^_RW$<WSWYL5%[CIT_A(ZRS_P%02P,$%     @ FX!!5KH=]]QB!0
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M>"TR,#(R,3(S,2YX<V102P$"% ,4    " ";@$%6<-C)*'T>  !8(P$ %0
M            @ $07@( :&]L>"TR,#(R,3(S,5]C86PN>&UL4$L! A0#%
M  @ FX!!5JV>5/Y25@  C*8# !4              ( !P'P" &AO;'@M,C R
M,C$R,S%?9&5F+GAM;%!+ 0(4 Q0    ( )N 05;(D^ \<NP  .:M"0 5
M          "  473 @!H;VQX+3(P,C(Q,C,Q7VQA8BYX;6Q02P$"% ,4
M" ";@$%6"I[-X124  !3>08 %0              @ 'JOP, :&]L>"TR,#(R
M,3(S,5]P<F4N>&UL4$L! A0#%     @ FX!!5JA;(P4+"   )"8  !4
M         ( !,50$ &AO;'A?<3$M,C R,V5X,S$Q+FAT;5!+ 0(4 Q0    (
M )N 05;Z5/JI[@<  -\E   5              "  6]<! !H;VQX7W$Q+3(P
M,C-E>#,Q,BYH=&U02P$"% ,4    " ";@$%6NAWWW&(%  "G$P  %0
M        @ &09 0 :&]L>%]Q,2TR,#(S97@S,C$N:'1M4$L! A0#%     @
MFX!!5G8P4QU+!0  91,  !4              ( !)6H$ &AO;'A?<3$M,C R
@,V5X,S(R+FAT;5!+!08     "@ * )8"  "C;P0    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
